date,datetime,title,summary,url,source,search_query,query_type,date_range,fda_milestone_type,market_impact_type,company_news_category,priority_score,drug_specific,company_mentioned,sentiment_score,weighted_sentiment,sentiment_label,sentiment_weight
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-11,2020-06-11 07:00:00,Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection) - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5"" target=""_blank"">Mylan and Biocon Announce U.S. FDA Approval of Semglee™ (insulin glargine injection)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPZWtPRnhZNm1pemVzTi1Kd1pDV2ZqRkdCcTFtaTBGWkhHcWtsVk4wdUZ3RUEwNDJjNFFCWnhZSzdMOUl2NjJPZE12eEZjNzd6eVQxZDk1UHVkZkpTLXRLX0RJeFF0VDJvZFB5WFVjNFRheE1ncjhJb1pWYXhUXzFzaTFaZ3B0eldwajhVUk5abVdJaklYMGRHTUItUU5HcHJYdE9HV3Z6b1J0UkJRMzdHd2t2U1lHMXpzWkhkdVpzM0FTQkF0UVJfaGEzOEppUERi?oc=5,Google News - FDA Journey + Company News,Biocon FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOTk1oVUE4dUU3MWZESDFmbmg0d0I3bG5nc1BkenBxVDRYSWgwbGZEb1NyZDdxNUotUUNieEZ4MTJGSlNfbGpJV2VsT0k5QUh3V3VWNHpWZzZyUE9aRXRoRmRySGxMcVc4TmZoY1dYdUpuQ3B4SS1LODVnRTB1R0phUUZMQ19XSGdOQjVtbGhFUnM5VGtPMTlfZXplX255YWRwZUJxWF83TG1YdE9SWEszTXdB0gG3AUFVX3lxTE1ZOElQQ1pUOVZ6OHdObXk4T0dzRmhWaDlrUmxaSVpsWExQbm95dXQzdmwzQTRhNXp0MzNnRzFhWG5zaDFMcFJQVFh4MlA0bEFCeDVaSlljUkdGemRJcEZRQU5YbTRHOUhnTko4bWJuTV9UNHgzRVRIMzNRSk52MWJQaXpFUmVtcVA0aV92Ulp1amhnb3IyOTFfVWtzOFpHaW1LSTQ1NEh0V0VDME85eTcyelI5S0VwOA?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOTk1oVUE4dUU3MWZESDFmbmg0d0I3bG5nc1BkenBxVDRYSWgwbGZEb1NyZDdxNUotUUNieEZ4MTJGSlNfbGpJV2VsT0k5QUh3V3VWNHpWZzZyUE9aRXRoRmRySGxMcVc4TmZoY1dYdUpuQ3B4SS1LODVnRTB1R0phUUZMQ19XSGdOQjVtbGhFUnM5VGtPMTlfZXplX255YWRwZUJxWF83TG1YdE9SWEszTXdB0gG3AUFVX3lxTE1ZOElQQ1pUOVZ6OHdObXk4T0dzRmhWaDlrUmxaSVpsWExQbm95dXQzdmwzQTRhNXp0MzNnRzFhWG5zaDFMcFJQVFh4MlA0bEFCeDVaSlljUkdGemRJcEZRQU5YbTRHOUhnTko4bWJuTV9UNHgzRVRIMzNRSk52MWJQaXpFUmVtcVA0aV92Ulp1amhnb3IyOTFfVWtzOFpHaW1LSTQ1NEh0V0VDME85eTcyelI5S0VwOA?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2020-06-12,2020-06-12 07:00:00,"Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Mylan receive US FDA approval for Semglee, an insulin glargine injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.36755,1.10265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxNcEFTdFZtZlNDd2ZYdFlzQ2lXcXd4ZlBjcGVYdUE4Rm9Sa0UweXRXakIwcTJsbll0UWVpNDdxbzhBVU11TE9JdzBnd1g4ZkRScVdqSHNXQ0ZkSWFpYWFjdUpMenRhNXBleThCejd6ZnlLbFFQRHBLeGcxTnhQV3EwUnM4cG9vTk5ERWRFb3J2bkU4MGptVEpLREROeWQ0NXJHdG9QdFdLaGxmYXpvLTdDbGtWS1BJdUhGOFhOV0tWMTY2YzQ1RGxRRndRYTRhQ1k4S09hWFc4M1hvUFNtVm1JT0dCc0d4NFk4dm55TVRPMF9BVDVGQnfSAfsBQVVfeXFMTWx6NnAtal9OcTBCS2Z4QVBXNTNVMkFxdGxJOGhTX29Cejg0cDR2dk5UamZYN3JCWlh1WG9KOWZSaXN6enppRU91eEp1dlluNzhHSmJKY01qa1VQcEhvYnp2VzVseTh3QTNKTVRWU1Z1UlNlNk94UWdkRnlaam5CbDJSb19wSXhwMEF4Sm9VQTJ0TnViZGlzMXVNMGFpdFdITUhSRjVtVnFrZmV3WlhPRHc3c3hXMmI0VEhMckdoZjlIcnhfVVNHMDh6TWZCd0hOdEY2eHVWOXhmbDdXYzVnV3dxdlg1VjZMTlRCNU5YV3pxaGsyOEJJZGhuVkE?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxNcEFTdFZtZlNDd2ZYdFlzQ2lXcXd4ZlBjcGVYdUE4Rm9Sa0UweXRXakIwcTJsbll0UWVpNDdxbzhBVU11TE9JdzBnd1g4ZkRScVdqSHNXQ0ZkSWFpYWFjdUpMenRhNXBleThCejd6ZnlLbFFQRHBLeGcxTnhQV3EwUnM4cG9vTk5ERWRFb3J2bkU4MGptVEpLREROeWQ0NXJHdG9QdFdLaGxmYXpvLTdDbGtWS1BJdUhGOFhOV0tWMTY2YzQ1RGxRRndRYTRhQ1k4S09hWFc4M1hvUFNtVm1JT0dCc0d4NFk4dm55TVRPMF9BVDVGQnfSAfsBQVVfeXFMTWx6NnAtal9OcTBCS2Z4QVBXNTNVMkFxdGxJOGhTX29Cejg0cDR2dk5UamZYN3JCWlh1WG9KOWZSaXN6enppRU91eEp1dlluNzhHSmJKY01qa1VQcEhvYnp2VzVseTh3QTNKTVRWU1Z1UlNlNk94UWdkRnlaam5CbDJSb19wSXhwMEF4Sm9VQTJ0TnViZGlzMXVNMGFpdFdITUhSRjVtVnFrZmV3WlhPRHc3c3hXMmI0VEhMckdoZjlIcnhfVVNHMDh6TWZCd0hOdEY2eHVWOXhmbDdXYzVnV3dxdlg1VjZMTlRCNU5YV3pxaGsyOEJJZGhuVkE?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-07-29,2021-07-29 07:00:00,Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5"" target=""_blank"">Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMibkFVX3lxTE9lUDVIWEFPd0ZxQ214RDM4VU8wY3U5NmFrU0QzWXI3X3NIdllFZEtVRVd5N214ZmI3bnRkeHM5QS0taU85M21YSENrQnFRR1NCMDhKWmUxdXBJTTRfZ3l5Slh1VUFJNUlNUjY0aTRR?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.4508833333333333,1.35265,positive,3.0
2021-07-29,2021-07-29 07:00:00,Biocon Biologics interchangeable insulin Semglee gets US FDA approval - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics interchangeable insulin Semglee gets US FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,True,0.30501666666666666,0.9150499999999999,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2021-08-03,2021-08-03 07:00:00,"Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval - Diabetes In Control","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5"" target=""_blank"">Semglee, a Biosimilar Insulin to Glargine, Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQTmlfcWFyQTh5WEJpWEJueHFGeEdNN1YtV0hTTldVN3VRcGZvY24tems3TjRvNHFBakZTNFduWWtGUTc3eER6SklScFV0dmpoZTB5U0JXZlR6aEFBN0Zmbi04dkYzSlZkcEpoWE90WkNtNzNNVXNTTFdsM3ZXU0JVMmtxSFNXYmc3VnIwbVV5Z1lyVFVrX3pnRnEwbEdHdw?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,21,True,False,0.23835,0.71505,positive,3.0
2023-10-18,2023-10-18 07:00:00,Syngene shares plunge after contract research firm trims revenue guidance - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene shares plunge after contract research firm trims revenue guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,financial_impact,financial_results,15,False,False,0.19668333333333332,0.19668333333333332,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,market_rumors,15,False,True,0.36755,0.7351,positive,2.0
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,market_rumors,15,False,True,0.36755,0.7351,positive,2.0
2025-01-07,2025-01-07 08:00:00,"Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock zooms over 8% on Psoriasis drug approval from Japan, Jefferies rating upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,market_rumors,15,False,True,0.36755,0.7351,positive,2.0
2025-02-11,2025-02-11 08:00:00,Biocon betting big on new product launches for growth - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon betting big on new product launches for growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,post_approval,Other,research_development,13,False,True,0.23895194805194803,0.31063753246753245,positive,1.3
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News - FDA Journey + Company News,Biocon FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,True,0.36755,0.7351,positive,2.0
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,True,0.36755,0.7351,positive,2.0
2019-12-03,2019-12-03 08:00:00,Biocon gets FDA approval to produce pegfilgrastim in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5"" target=""_blank"">Biocon gets FDA approval to produce pegfilgrastim in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxPVlFlbHpoSGZRU2RObzdFU1NSTnRYdzNIUkQwbU9sX09HSUZ6VVNzbkh0LVRCOFBXMGFvaFV2YVFKS091V3padVZOb0FiVDF5RGtqR1ZRUTJwdndqazFTQ1JqZC1jRHFUd2dZa21jbzE5UFFLRlBWNUx6UkxSN3dhUEdNdDBGWVNpbTV4WVhRajFTNUhvR1FjMV9qMk5JbEpidkZYRnI2Z1pWVjZOS2U4QW9JXzg?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,True,0.36755,0.7351,positive,2.0
2020-08-31,2020-08-31 07:00:00,Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMiYkFVX3lxTE9KRlkzTW82Rk1ZZi16NVJraG11Nnl1U3Y0cWhhRlMwR2hJYWFHRjBHV2N6eVFiT0xQc3hLel9IOWxvTEJVbmVLcTlCV2U0UGJqVDRUeDJRdWYzXzhWNXkyXzBB?oc=5"" target=""_blank"">Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMiYkFVX3lxTE9KRlkzTW82Rk1ZZi16NVJraG11Nnl1U3Y0cWhhRlMwR2hJYWFHRjBHV2N6eVFiT0xQc3hLel9IOWxvTEJVbmVLcTlCV2U0UGJqVDRUeDJRdWYzXzhWNXkyXzBB?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.015625,0.0234375,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5"" target=""_blank"">Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5"" target=""_blank"">Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.2787,0.41805000000000003,positive,1.5
2020-08-31,2020-08-31 07:00:00,Semglee Now Available for Patients With Diabetes - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxOSFdxWFR6R1NwdTNVdnZnWlVmaHd1eWxoamNJQ1p6V2NmRzljU1NNM0xwZ3V4RFlZcjlfVm1ET0hJT29EVDBEZFNodGVQT0FFTFNQTDlwby03dk1xM0JlTC1jSmNvU3JZZlVnMXVhdmhsbVFubTJSLWp6eU1MYm03N0gxRVZlajY5XzdxNA?oc=5"" target=""_blank"">Semglee Now Available for Patients With Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxOSFdxWFR6R1NwdTNVdnZnWlVmaHd1eWxoamNJQ1p6V2NmRzljU1NNM0xwZ3V4RFlZcjlfVm1ET0hJT29EVDBEZFNodGVQT0FFTFNQTDlwby03dk1xM0JlTC1jSmNvU3JZZlVnMXVhdmhsbVFubTJSLWp6eU1MYm03N0gxRVZlajY5XzdxNA?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.1,0.15000000000000002,positive,1.5
2020-08-31,2020-08-31 07:00:00,Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5"" target=""_blank"">Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch - Beyond Type 1,"<a href=""https://news.google.com/rss/articles/CBMiYkFVX3lxTE9KRlkzTW82Rk1ZZi16NVJraG11Nnl1U3Y0cWhhRlMwR2hJYWFHRjBHV2N6eVFiT0xQc3hLel9IOWxvTEJVbmVLcTlCV2U0UGJqVDRUeDJRdWYzXzhWNXkyXzBB?oc=5"" target=""_blank"">Fourth Major Insulin Manufacturer Enters US Market with Semglee Launch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Beyond Type 1</font>",https://news.google.com/rss/articles/CBMiYkFVX3lxTE9KRlkzTW82Rk1ZZi16NVJraG11Nnl1U3Y0cWhhRlMwR2hJYWFHRjBHV2N6eVFiT0xQc3hLel9IOWxvTEJVbmVLcTlCV2U0UGJqVDRUeDJRdWYzXzhWNXkyXzBB?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.015625,0.0234375,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5"" target=""_blank"">Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5"" target=""_blank"">Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.2787,0.41805000000000003,positive,1.5
2020-08-31,2020-08-31 07:00:00,Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5"" target=""_blank"">Biocon Biologics and Mylan launch Semglee (insulin glargine injection) in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPNmpWd2kyc2UwUUloYjZuUEtFWDdVQkNCMFdSQVhjN1I2Q3JVaE14UEY2aERSRUF5d0xEV2Q1YnVWLUdBeG52eHlsOENCdmVPbnZxRU1xc2NVSDlWbFdhclY1Nk1majJ4b3hBVnlIZEc4TkxUQWVQQ2UtNUVpUHNXZGtLQnNpVGdkVnQ4eVlRNTdMVDRaZjJ1YkdwTGpqNU1CRlZJeGlyUdIBrAFBVV95cUxPdXN3TkgwZFoyRlhOZ1VUVElYc3plOWVLdFprUnh3ZTMyVUdMZ2VLRTE1SVR2UnlXenNlWkp2ZzlVZEVtdEsxaGFIdEVzZmZITTZvRFFTczBSSnpwakxZRHdFUWlReDhFZ1F6d2pISEhQekNZZG9VbXB1RWlBbXA1RTdlcDFSR2dCLUZtSVI2cTl6eWNzaU9SY180UUFNUFhueHRpY2pKU29EMnUw?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2020-08-31,2020-08-31 07:00:00,Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5"" target=""_blank"">Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMiowJBVV95cUxOWmhETXVZRS1NUWFGS25nY1BpbmNDeUJFcXNjWXUzcUhxRFMtZTB1OU9oQ1JtUXRDVW16MmVUR2hVVjVHYU4wRmtOa0NyNkNGS1pGRE1Xa1NuMjE5NTdHbXVZbmFTWlV6Y0dtOHUtVjhvUF9FSWJuTG4waEVVd1dWMUk1QTUydW9DQ09zWWh3NHlxQzVRZWl1WEgwNm8zYkdLQWJnTjMtZkpPeVhhSFRrNE1VNDc0bDZ0Vk5rOGNNQkE4MWx0aE0zQkZPZWpMZDFUMHlJTHh3RXFFa1AyVFJsRXpmaTNCbXZzODV1YWYtUnd4S3VzcDRaRjdjUEt2U1pKeGsxZWIyVmZkTVEtbVVQXzdiY1o1Q2R2SGZWeEFDcUk5azQ?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.2787,0.41805000000000003,positive,1.5
2020-09-01,2020-09-01 07:00:00,Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.3404,0.5105999999999999,positive,1.5
2020-09-01,2020-09-01 07:00:00,Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.3404,0.5105999999999999,positive,1.5
2020-09-01,2020-09-01 07:00:00,Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US - Diabetes In Control,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5"" target=""_blank"">Semglee: Insulin Glargine “Biosimilar” Approved for Diabetes in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Diabetes In Control</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOSml6X0d0cjlzclN4UWFKRU9kZlc3c3lSMXBUNG9SR19BVDNmdW41TWxpcHk5RjJad3VpVGlFSnU1YXpXd2Z3VlUtVzZNNGtGbGVLeXE2a09WZjVlZEgyMC1JalJxcFVJQURjQlZxVnh6SEpyWko3aXVlOWtNN2xOeG1TUnlqSjJGTG5OV3dYcnlGUDZwWnlZaURTdUhwdWhXRUlGbA?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.3404,0.5105999999999999,positive,1.5
2020-09-03,2020-09-03 07:00:00,Semglee now available for better blood sugar control in diabetes - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee now available for better blood sugar control in diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.50015,0.7502249999999999,positive,1.5
2020-09-03,2020-09-03 07:00:00,Semglee now available for better blood sugar control in diabetes - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee now available for better blood sugar control in diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.50015,0.7502249999999999,positive,1.5
2020-09-05,2020-09-05 07:00:00,Biocon rating: Buy — Semglee launch in the US boosts prospects - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSGd6OVZxcDA1dUZxd1pDZWxtU01yT2NWdmNQU2tma3V5V1BKaGJhYklqcXU0Z01CdUNaNXlQMll3SE9zNk5JT0VCWWhscDREQ3lwNEZBUTVkM2M4RWR4R0trcm1tTzJkVmQyZDMzak11SWdQZzh1TGFqZ0tWSHBTaWc5YlZ1RkZaNUdjWGlsb2ZFMjdsTHg0WnB2d2tCZEFtR2JRYm9EdFBScmpxQ1NzZkNBc0VCWnRpSUNV?oc=5"" target=""_blank"">Biocon rating: Buy — Semglee launch in the US boosts prospects</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxQSGd6OVZxcDA1dUZxd1pDZWxtU01yT2NWdmNQU2tma3V5V1BKaGJhYklqcXU0Z01CdUNaNXlQMll3SE9zNk5JT0VCWWhscDREQ3lwNEZBUTVkM2M4RWR4R0trcm1tTzJkVmQyZDMzak11SWdQZzh1TGFqZ0tWSHBTaWc5YlZ1RkZaNUdjWGlsb2ZFMjdsTHg0WnB2d2tCZEFtR2JRYm9EdFBScmpxQ1NzZkNBc0VCWnRpSUNV?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.35015,0.525225,positive,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Biocon Biologics FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Biocon revenue,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-23,2021-07-23 07:00:00,Biocon Updates on Semglee Interchangeable Status - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5"" target=""_blank"">Biocon Updates on Semglee Interchangeable Status</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHU1b0ZXWl8xcFJyRHlqYXFncGE5RlJEcE9mOTd2NEJXZEItREJrblFhaWZuZl84eU5QUGlIYmYyM3FKenpMZ3B1enlLRWVsbWdIOEQ4NVZYWVFhSXhxNGdEa1RSSWtjQ1BCV1VkUlprLTd1UEgzWi1Va1dwZHcwWk41cjE2amlHSjc4UmEwWktLU2E5?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,-0.025,-0.037500000000000006,neutral,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - FDA Journey + Company News,Biocon FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA approves Semglee as first biosimilar interchangeable insulin - Regulatory Affairs Professionals Society | RAPS,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5"" target=""_blank"">FDA approves Semglee as first biosimilar interchangeable insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Regulatory Affairs Professionals Society | RAPS</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNVHNqNlBHdFJ3d1NvQzhkZ2l1N0VlN2FWZm8xTDNPYzFLMWNUNC1JdWtZZ1FuZWdUdEYyNkd5WDg3MHJCSFVWeVdIVFZHXy1tQ25jWExZN2kxQ1VXbGdqNmVDN3Fzc256STZ4bktRZi1pWnhtcHY5NkFXbzgtRENkc2RyWHNrbC14WF8zbFNrLTUzSTlrc0FpY0xQTUpyai1GSU95NW5hNlZnOURfMnVN?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-28,2021-07-28 07:00:00,FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5"" target=""_blank"">FDA Approves Semglee Insulin Glargine as First Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxNY1NaRzFiMjg5akRNbXB5eUhGSGRIdVhCT2g1eThvRUYxeDFnQUxleTIzMVV0TFFqVENXLXZueEVFeUI3YUE2bk1kNEpZY2hYcTg5THBjUFlUbzRsSzFVN1R2TFVxODF0elVFaE5GUTBLLTNKRHJPVTl6Z2FBT1NzT2dlMTZjVk9feUhvbDJXaDRKSC1SWkJPOVY0b3hiVGV1blRIRlMyaXBzUVRpS2dVeTR5TjktZw?oc=5,Google News - Market + Complete Company News,Semglee real world evidence,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.37984999999999997,0.5697749999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes - Pharmacy Times,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5"" target=""_blank"">FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes - Pharmacy Times,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5"" target=""_blank"">FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes - Pharmacy Times,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5"" target=""_blank"">FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,"FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product - HCPLive","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5"" target=""_blank"">FDA Approves Semglee, Its First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">HCPLive</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxQWXl3bFgzTDRpczZtTUxhMEhaOTVmTUgxU2pVOUtUVEpiUVB1US1nLWpvYzBVX0ptSmxkeXlISnQxdTR6RXQ5anFRZGtuMFQ3bk8xeFFaaUFHYzFaY0dNei1tX2lpYUNacFZMZ0xYbi1ZZGtDT2xZN3FnaDVSSkxvSGpQQm8xeXUwNjgxMUNFRjk4eGNlZ2IxeUJNQktVTmc?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,An FDA First: Semglee Is Approved As An Interchangeable Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5"" target=""_blank"">An FDA First: Semglee Is Approved As An Interchangeable Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPeHJNYWVrWmkwZ1NQaHJ6RXdMcEt5NldsTDlyWVY2S293cmdwNXR2S2MybEtHM0pXQ2xQYzNocjFLcjJna2U5eXVaandtVXJ4Mnh3UmtlUjRSOGpzdUpYeV9fR0c0Q1RONG5CQ0U4NzhhdjRVcXZNd3U4WTZwanhtWWo1MWJCNV9kNUFFYmJtQ1BHRks5azRyR1VVV3V5V2tZZTZYNl9fZ0d2Zldpbm5ySGV0UQ?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4237333333333333,0.6355999999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-29,2021-07-29 07:00:00,Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar... - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Diabetes cure: USFDA approves Biocon's long-acting insulin Semglee as first interchangeable biosimilar...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes - Pharmacy Times,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5"" target=""_blank"">FDA Approves Insulin Glargine-yfgn as First Interchangeable Biosimilar Insulin Product for Diabetes</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmacy Times</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxPTUFDRGVGUW01NW1SOVU2Y2kwSHg3OFpzME0xYVl3a1AyNjNTNHNsYkhmREIzbW1uc0I4cTAyRVVzTWRVcVJfRW9HaTR4SDhxZGlLNVZIQ0lsX3JGd290cFkzTjgwTDVQNzJZV2FiYmV3WmhiY3QzemhOYklaeUJlY2xWRUZ5XzBNWURuOUFlTV9EZE9OTFg5c3ZaLURVeEcxUnBKV0RsNGJEQ3Y5TFdrWURObkdaMFQ1QU12a1Vtb2JVQ0IyZ1pZdlJSQUtHeE0?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4131833333333333,0.619775,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,Semglee Approved as First Interchangeable Biosimilar Insulin Product - Medical Professionals Reference,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5"" target=""_blank"">Semglee Approved as First Interchangeable Biosimilar Insulin Product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Professionals Reference</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQWGpTY29Mam1qV1dSWFZPQUlpQ3NQM24tRTZuYjAzQVRWZFNFMnRvNjRxSDlfdmNIVjRtMm85VWpBLXppRkVFT1ZNN0YxMm1UUFZ5UlVHV2NuYmdlcnkyRlJQeDAwSnVkSVlEODJjelFqZXRoZFpvR25jeHA3bV9GNVdwemRaUWpnNXJxd1p3OW9wLTdwclJFdU1XVWpEZC1oUGRDRFNZd2pOV1hhNUF1T3lqTkw?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.4029,0.6043499999999999,positive,1.5
2021-07-29,2021-07-29 07:00:00,FDA clears interchangeable insulin biosimilar Semglee - Drug Store News,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5"" target=""_blank"">FDA clears interchangeable insulin biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Store News</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxOYWJBQlBmalc2M3FaNVEyRU1tSmNHLVFIaUJxREdLaWRPcmd5S2JmV21feDB3YkhIU2Vxc1p3V1RIWWh3ajNUN29ydk1CNDRvMG42OWhyQXFxLTh3WXU5TjdGWVlUX0hQV0FLdjM4U0ZhRk1zdWpidUEyT3JiZzZWVWRmNlNxUQ?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.07655,0.11482500000000001,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.43005,0.645075,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxOVFdMekpzb0hxU21fYnJNc3ViZ0xsSVEtNm5DeE5MdDdPUE92dlVXVU1FSGJkdHhQX2NJdFVsMVA0TkNBQkE5UUwxM19kSTNLQk9KbEJoOF9MZTZGV2daT2x1NUdXamtWWERnc2VQS3ctMVp4UDhDLUFUQ09vTWFELWg1THg1UDhRWGhxY184d1ZqQVpyZUd2dG4zZnRDTUZOcHAwWnNQc1g1aUJQV0t0SUV6YlFaUdIBuwFBVV95cUxNbmZoYWdwZGNiODdSNDJuVTB5a0ZVLVc1c0RtUEJiclNBQUdCMVNBRjFJV0FnT0l4elZ1UHlkWHhDeE1YVWJmWWNib1RwTndQZEc2bjBBWVoxOTYtMG1iVWw3WUVoSm9td1ROdVVKalV3YXM5clBvYWx1N2o2SDlzZVp0RzdaUEVOY0E3U0phdThQd0ktei03QlREbFVBTUtVNDZtTFVuYnFXWXlVZHZWUjhlS0kzb192QWtZ?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.43005,0.645075,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxOVFdMekpzb0hxU21fYnJNc3ViZ0xsSVEtNm5DeE5MdDdPUE92dlVXVU1FSGJkdHhQX2NJdFVsMVA0TkNBQkE5UUwxM19kSTNLQk9KbEJoOF9MZTZGV2daT2x1NUdXamtWWERnc2VQS3ctMVp4UDhDLUFUQ09vTWFELWg1THg1UDhRWGhxY184d1ZqQVpyZUd2dG4zZnRDTUZOcHAwWnNQc1g1aUJQV0t0SUV6YlFaUdIBuwFBVV95cUxNbmZoYWdwZGNiODdSNDJuVTB5a0ZVLVc1c0RtUEJiclNBQUdCMVNBRjFJV0FnT0l4elZ1UHlkWHhDeE1YVWJmWWNib1RwTndQZEc2bjBBWVoxOTYtMG1iVWw3WUVoSm9td1ROdVVKalV3YXM5clBvYWx1N2o2SDlzZVp0RzdaUEVOY0E3U0phdThQd0ktei03QlREbFVBTUtVNDZtTFVuYnFXWXlVZHZWUjhlS0kzb192QWtZ?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.43005,0.645075,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-07-30,2021-07-30 07:00:00,USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA okays Biocon insulin Semglee as first interchangeable biosimilar drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.43005,0.645075,positive,1.5
2021-07-30,2021-07-30 07:00:00,"Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee, first-of-its-kind insulin product made by India’s Biocon, gets US approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.23835,0.357525,positive,1.5
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5"" target=""_blank"">Average Net Price for Insulin Glargine Declined After Basaglar Won FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNM2JWNFdSUFp3SlpDclRKNF9sejJqRlFTaW11eGpZSy1oYlRqMWphSjJyQnJ4dFlfRko0RFZMWFVKTjJja2pBaDl4emVPazczQmRSTDBuUms3X2w4emdXMXdUM2p1SlVpVHFCSmM0VGFkYmtsNnhFWHlCSDlObG5ZcUNha1lYX2ZXc0Q2SHlsN0JfNVBHd3BKZlpsT192X0JaT01Xa3ZjYS1aWWNBOXFTOV9iNVRDemgzQ1QwcHRB?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.41924999999999996,0.8384999999999999,positive,2.0
2021-08-02,2021-08-02 07:00:00,FDA Propels Insulin Affordability with Semglee - diaTribe,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5"" target=""_blank"">FDA Propels Insulin Affordability with Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">diaTribe</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxOdFhfaXdVUmFGT3g2dWd0M1hOUDkxUXZKcEhpbGpaaVZISUUyQUNfeFFjRnk4bkl2dTZ4Sk9UZFBZbk55eVhTMlBPWUF2MExyZGlpbllVa0x0d1prMTBzdzQxUG9pM3lpLTZuUFlmdVVUR3FYVzJjcXloVWlfZVZSUTRoa0tJQTNBWVEw?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-08-06,2021-08-06 07:00:00,Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5"" target=""_blank"">Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.3753,0.5629500000000001,positive,1.5
2021-08-06,2021-08-06 07:00:00,Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5"" target=""_blank"">Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.3753,0.5629500000000001,positive,1.5
2021-08-06,2021-08-06 07:00:00,Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5"" target=""_blank"">Biosimilar and Interchangeable Semglee Insulin Could Save U.S. Healthcare Hundreds of Millions</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNd2xqMW5ndHp6VVV2cDdFaTV2QzFWbk9TTU9oSmwzU3puc3k0Vm5sLVhfQUVSSzdTLUxobmtmbS1CN0drTGhISGF1cFhYZGJ2N0t6ZjVsOU00M05MQk1aWFVjOXNsWXo1NWpmM0VoYlJyS19rVDd2eHhHSU9seGNERFhrS3ZMWm5JRXdQb1NXcWIzTlBydEJGNF9mSGpyaDVNcnlTU1EwcmNHVG5JcDJBamlIQVY1Z0tKMzBGZEpWUFd6enZ2VUR1ZTVsaGZQZ2IyR0hwdWlYWEk?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.3753,0.5629500000000001,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMHYxbU1zZElISUlTdHZyRHdOWXR1S1RNTk1ETllEY2Q2RWRpSkdlWjlNdUh0amJsYnZKRDB0bWYyM0xDbDBHLTJSVUpnanlwWUYxY0xIYjdSMllieWZ6N2FuYWRhZVFEWUNrNS1mM0h6aFJjZk8za0R6bi0zeE4wc0E3WGI4VkpKWkVpWFFJT2NpcEFhRGQ0LVI2NmRrY3doaXN1Y0dfUk1VNS1Mck9iTnAyOFlQMXUzWTY2ZC1aYTNZUEpsNVJuWNIBzwFBVV95cUxQOGdOb2hjTWNMT1VDdUZTUzVTbEJMd3oyVmZEQy1xUTlPX0pWaGNMWTlQTFdiSlJKQkFTd3hpeXgxRVFPbC0tMU1SYW92UXdHekhrTXhnOHdJNDV1MWlqdEhXSm83b3BZVzJCMjJGTWhDS0NtVGVfd1RzWTA4TDVTeXNhR0c3ZkZQRkdYRTRsZVMzOFMzVFJ0UExmWERDQ050MVJMMlFrN0FudVltUG9CaXgtZVh6c05DUnc5eVhXd3ZBOUJSdm02bm0zQ18wQ0U?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMHYxbU1zZElISUlTdHZyRHdOWXR1S1RNTk1ETllEY2Q2RWRpSkdlWjlNdUh0amJsYnZKRDB0bWYyM0xDbDBHLTJSVUpnanlwWUYxY0xIYjdSMllieWZ6N2FuYWRhZVFEWUNrNS1mM0h6aFJjZk8za0R6bi0zeE4wc0E3WGI4VkpKWkVpWFFJT2NpcEFhRGQ0LVI2NmRrY3doaXN1Y0dfUk1VNS1Mck9iTnAyOFlQMXUzWTY2ZC1aYTNZUEpsNVJuWNIBzwFBVV95cUxQOGdOb2hjTWNMT1VDdUZTUzVTbEJMd3oyVmZEQy1xUTlPX0pWaGNMWTlQTFdiSlJKQkFTd3hpeXgxRVFPbC0tMU1SYW92UXdHekhrTXhnOHdJNDV1MWlqdEhXSm83b3BZVzJCMjJGTWhDS0NtVGVfd1RzWTA4TDVTeXNhR0c3ZkZQRkdYRTRsZVMzOFMzVFJ0UExmWERDQ050MVJMMlFrN0FudVltUG9CaXgtZVh6c05DUnc5eVhXd3ZBOUJSdm02bm0zQ18wQ0U?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-08-19,2021-08-19 07:00:00,Semglee approval to provide huge opportunities in the US insulin biosimilar market - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxOMHYxbU1zZElISUlTdHZyRHdOWXR1S1RNTk1ETllEY2Q2RWRpSkdlWjlNdUh0amJsYnZKRDB0bWYyM0xDbDBHLTJSVUpnanlwWUYxY0xIYjdSMllieWZ6N2FuYWRhZVFEWUNrNS1mM0h6aFJjZk8za0R6bi0zeE4wc0E3WGI4VkpKWkVpWFFJT2NpcEFhRGQ0LVI2NmRrY3doaXN1Y0dfUk1VNS1Mck9iTnAyOFlQMXUzWTY2ZC1aYTNZUEpsNVJuWNIBzwFBVV95cUxQOGdOb2hjTWNMT1VDdUZTUzVTbEJMd3oyVmZEQy1xUTlPX0pWaGNMWTlQTFdiSlJKQkFTd3hpeXgxRVFPbC0tMU1SYW92UXdHekhrTXhnOHdJNDV1MWlqdEhXSm83b3BZVzJCMjJGTWhDS0NtVGVfd1RzWTA4TDVTeXNhR0c3ZkZQRkdYRTRsZVMzOFMzVFJ0UExmWERDQ050MVJMMlFrN0FudVltUG9CaXgtZVh6c05DUnc5eVhXd3ZBOUJSdm02bm0zQ18wQ0U?oc=5"" target=""_blank"">Semglee approval to provide huge opportunities in the US insulin biosimilar market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.5995833333333334,0.899375,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Express Scripts puts insulin biosimilar Semglee on preferred formulary - Fierce Healthcare,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5"" target=""_blank"">Express Scripts puts insulin biosimilar Semglee on preferred formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Healthcare</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Express Scripts puts insulin biosimilar Semglee on preferred formulary - Fierce Healthcare,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5"" target=""_blank"">Express Scripts puts insulin biosimilar Semglee on preferred formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Healthcare</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee hospital formulary,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-10-20,2021-10-20 07:00:00,Express Scripts puts insulin biosimilar Semglee on preferred formulary - Fierce Healthcare,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5"" target=""_blank"">Express Scripts puts insulin biosimilar Semglee on preferred formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Healthcare</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5,Google News - Market + Complete Company News,Semglee hospital formulary,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-10-20,2021-10-20 07:00:00,Express Scripts puts insulin biosimilar Semglee on preferred formulary - Fierce Healthcare,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5"" target=""_blank"">Express Scripts puts insulin biosimilar Semglee on preferred formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Healthcare</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUl9Zbi1KVEZWQlp6X3ZIOU91akpxQktNZ253TUFXaTNCOGgzNWhOb3Q1SmxfV2RranZXbnFZQnlKdVBhTTJMdElZZ1o0VGRjLTRBa2t5VGdUWkFfOGRleXdOMElkMnR4dHJ5Ylk2R0NkbTFsLXdRdjV5QkEzUG5Vd0dpS04tWk91eHpUejI3eFVoTGplSW5CbkIzbXNadlp6SEx4SHBuVXRUUQ?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-10-20,2021-10-20 07:00:00,Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5"" target=""_blank"">Preferred Status for Semglee Will Test Value Proposition of Insulin Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNYVRQMG5keFN2UkF2LXU4Ui1GZjVpUUpYNlZycGJYeU1yZmNCaUl6SnRzQ0toclZtSDlQakFJNG9YeENDLWZnZzNxY21YdHRlTGhsZDJzSW5zUm1RTXROU2JsTkRnOUhNNkZSNzJGZ19tR0s0Y2w0Rldvem13bjRueUtqLVpqck5PS1hBM0JHcFIxRlAwcm1DX2pXRVNvYjNOeEpPcHZBUm1meUU1dlU4dXhvZ2w3a1BudFY4NnRn?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.26794999999999997,0.401925,positive,1.5
2021-11-05,2021-11-05 07:00:00,Prime Therapeutics to list Semglee and Insulin Glargine - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxPbm5mbmJrNVhOQk1LMjA0WDRYSm9YRUppc3cxOGpRVnJydTRWSTJvb0UtS3YwNmRvX0dIU2pQM1JoMm1CMGRvTk16SzNlUkhoUWFDX2IyN3VaajdYc2QxYjQzMWtYM01Tdl9VSTlqY2k1d1dHd3ZaLVk1TUxPZ2lhUlhCTXhuNFA1MVgxYjFMSVpCQkxEcDY1b3ZZTVQ3M3Jw0gGnAUFVX3lxTE9PNlROYnpHRnltX1Zad3Q1X0lZS2J0RUpxSFJpemhVWmphcnpnSjFLMTB0MmZMR0ZmU2NwTGZjalBtZG00WC02a0lnSldhcHpUTkJLbXk4TGtVQ1JCdFhLdzAxanZsMURWT0prNkJPQ2ZWR0dwUXRpdmw3YlEzZ0VYUVZUdXZjRTVsM25NaUlWT0MwaHNtcGxBNXhveXQ2T1RaZlZQbGY0?oc=5"" target=""_blank"">Prime Therapeutics to list Semglee and Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxPbm5mbmJrNVhOQk1LMjA0WDRYSm9YRUppc3cxOGpRVnJydTRWSTJvb0UtS3YwNmRvX0dIU2pQM1JoMm1CMGRvTk16SzNlUkhoUWFDX2IyN3VaajdYc2QxYjQzMWtYM01Tdl9VSTlqY2k1d1dHd3ZaLVk1TUxPZ2lhUlhCTXhuNFA1MVgxYjFMSVpCQkxEcDY1b3ZZTVQ3M3Jw0gGnAUFVX3lxTE9PNlROYnpHRnltX1Zad3Q1X0lZS2J0RUpxSFJpemhVWmphcnpnSjFLMTB0MmZMR0ZmU2NwTGZjalBtZG00WC02a0lnSldhcHpUTkJLbXk4TGtVQ1JCdFhLdzAxanZsMURWT0prNkJPQ2ZWR0dwUXRpdmw3YlEzZ0VYUVZUdXZjRTVsM25NaUlWT0MwaHNtcGxBNXhveXQ2T1RaZlZQbGY0?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Launches Biosimilar Semglee - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Launches Biosimilar Semglee - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5"" target=""_blank"">Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5"" target=""_blank"">Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Launches Biosimilar Semglee - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Launches Biosimilar Semglee - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5"" target=""_blank"">Biocon Launches Biosimilar Semglee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxQbFpVT2xaTlU3bGFlR0hBQTFueTlTSmpmLUpINnlYVkVxdVppTGFOZWlhaVRTZlM0RHhIc2VWU2ZVVXF1VDRCT0JSV2xTdXF6dVZBUjN1YmhnSUlwRzdMXy1yMlo2TjE2SXV2bG5mRVJZYjdmdE55YWh0MzJlY0pNYW9HRVg0NUJQMlE?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5"" target=""_blank"">Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5"" target=""_blank"">Biocon Biologics launches interchangeable biosimilars SEMGLEE and Insulin Glargine injection in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxOaVBUS1VZaXVJc1BJb21DTWstRS1WT0V6UWszcnN2OXFZeEpjdnBZbjNQY1VyTGxYSC1YSkFlQlptTFIyYldOQlZYYzhtT0VtYzc0WW5jS3VTcGVXUGx0YVRSYnFkZ2lDck03SFNCVFJJZ3puZkJlQUQ2QXF4RWE1UlhZYkg3Z1B0YjZpem5LMmVDNTV5VWNlUHVUZGlrNEx6cXRYNjBGdFZhYTNjcTUtYkVlRlA4bURodXFOdURqVHZ3Zm1jRFFaaDlNUjhDeG41M1Q1UmRDV3JhNmxCWXhFVWNsSDQ?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-16,2021-11-16 08:00:00,Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5"" target=""_blank"">Viatris and Biocon Biologics Announce Launch of Interchangeable SEMGLEE® (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMitwJBVV95cUxPeFdZZElGeWNuVDhIc19nNG1ld1FRei1mSm5wYVozSmJhNE5CbWNBcE56czVrMk5oTEdmV205TDBMS3ZLbFQxaWVXcVlYd0VZWkZaeUtsSktQcjF0UkRXVFdsb3RKUlZ5ZzFPNG9aaTJrRkd3LWctbmx2Sld0VlpWQjlLQk02NU5IV1JLZUEyODFTbkQ3ZHY5cGVQLTI1WFplaUlISjk2Y182NUtUSVY5SGo3YWpiTmhrVkUyZTN3d3BRa2pfUENIcWVGTVBEYzVjOXctbTdQMHFmaGlYRnlxYWNXV2szY29BUFF5NjZjYjc2V2JmVl9mWWxkR28zd0o1amJBUVA4MDRYLVFKNk9qQjZaZTNCNTM3TXdGZERZbDBBNFVPNHlaMUQtbFFubWhORTZ1UVVhQQ?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-17,2021-11-17 08:00:00,Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5"" target=""_blank"">Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healthcare Radius</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-17,2021-11-17 08:00:00,Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5"" target=""_blank"">Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healthcare Radius</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-17,2021-11-17 08:00:00,Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection - Healthcare Radius,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5"" target=""_blank"">Biocon Biologics and Viatris announce launch of interchangeable SEMGLEE (insulin glargine-yfgn) Injection and Insulin Glargine (insulin glargine-yfgn) Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healthcare Radius</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxNcVo4UXpmWDVBNkZ3Rk9zQkhMNG9IN1MwaG5TQm9RTjVKLWJkcU9Gd0p1STRNNkozYlBDb09UZWFXYkZjUWdVVkpOaWdiaFM3akJTOWM1UktZMEM4bkw2YURvY0dhSjhrV3NUeGc2TXZRbEFRbDJ2QU91dDFqSU9BcEcyVjlhQWxHdnhMb2Jxb2NERW9GOEZzNkZKWVBrRTFhSjJEWUdCNk5zWlVtY3Zza0xURzlWWEZJMlQ5WVBZek5QdHRPQVNQVVgzNzdKTnhTOFEyMzVzSEx6OTViSEJXbUVfTnI?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,True,0.0,0.0,neutral,1.5
2021-11-23,2021-11-23 08:00:00,OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5,Google News - FDA Journey + Company News,Semglee clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-11-23,2021-11-23 08:00:00,OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5,Google News - Market + Complete Company News,Semglee clinical trial,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-11-23,2021-11-23 08:00:00,OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5,Google News - Market + Complete Company News,Semglee hospital formulary,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2021-11-23,2021-11-23 08:00:00,OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5"" target=""_blank"">OptumRx Excludes the Diabetes Biosimilar Semglee from Formulary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPdktpX0xDWUJQTU9HWHZXa2hXbmp1Q3ZDVDZzdnZPM1owTUh4MGRqSWFMS3A2TjRxb2VkZUF4UmRMbExxNXUtd3J3RTVCUDhDQmEtejFlX3NaRlJWR1d0NU1LS1d0WGJaTHF2c0ZDZVZjc25Fc1p0NEF3c1Y0X3l1Zmw3Y3puU3ZTREhtb0ZVWFgzcDZUNzdURExOb3c0X1JiSVNnTzREdmIya1hCTkdnaQ?oc=5,Google News - Market + Complete Company News,Semglee real world evidence,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.0,0.0,neutral,1.5
2022-01-20,2022-01-20 08:00:00,Viatris yanks one batch of diabetes med Semglee because of missing label risks - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGZZYWc3cXRDUE1faWZjendDTXJFTjlwSThVNlFveHh2bmdCc0xOdHdnQWtGUmNMSGhfMy1MRVByNVpNaG05VzdzS0JHUFJnMjRTZzFJNVlqc0wwV0NNN0x4U0JmeWFzQlk4SXZaNDViOEgtQmQ0aTdJdk0yeW9JaC05WjRYazQyeDl3ODl0dFRXYXo3U3h3Y0pYTEZZcXREdVpRdTFBU01Sb1BzMS1F?oc=5"" target=""_blank"">Viatris yanks one batch of diabetes med Semglee because of missing label risks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGZZYWc3cXRDUE1faWZjendDTXJFTjlwSThVNlFveHh2bmdCc0xOdHdnQWtGUmNMSGhfMy1MRVByNVpNaG05VzdzS0JHUFJnMjRTZzFJNVlqc0wwV0NNN0x4U0JmeWFzQlk4SXZaNDViOEgtQmQ0aTdJdk0yeW9JaC05WjRYazQyeDl3ODl0dFRXYXo3U3h3Y0pYTEZZcXREdVpRdTFBU01Sb1BzMS1F?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,-0.40191666666666664,-0.6028749999999999,negative,1.5
2022-01-20,2022-01-20 08:00:00,Viatris yanks one batch of diabetes med Semglee because of missing label risks - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGZZYWc3cXRDUE1faWZjendDTXJFTjlwSThVNlFveHh2bmdCc0xOdHdnQWtGUmNMSGhfMy1MRVByNVpNaG05VzdzS0JHUFJnMjRTZzFJNVlqc0wwV0NNN0x4U0JmeWFzQlk4SXZaNDViOEgtQmQ0aTdJdk0yeW9JaC05WjRYazQyeDl3ODl0dFRXYXo3U3h3Y0pYTEZZcXREdVpRdTFBU01Sb1BzMS1F?oc=5"" target=""_blank"">Viatris yanks one batch of diabetes med Semglee because of missing label risks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxPWGZZYWc3cXRDUE1faWZjendDTXJFTjlwSThVNlFveHh2bmdCc0xOdHdnQWtGUmNMSGhfMy1MRVByNVpNaG05VzdzS0JHUFJnMjRTZzFJNVlqc0wwV0NNN0x4U0JmeWFzQlk4SXZaNDViOEgtQmQ0aTdJdk0yeW9JaC05WjRYazQyeDl3ODl0dFRXYXo3U3h3Y0pYTEZZcXREdVpRdTFBU01Sb1BzMS1F?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,-0.40191666666666664,-0.6028749999999999,negative,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee hospital adoption,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2022-11-03,2022-11-03 07:00:00,IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5"" target=""_blank"">IQVIA: Semglee Experience Can Help Predict Adalimumab Biosimilar Adoption</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQZm13V2syMnFBcGlVNFZVY3BVNm5WdUt6UFNyUk83UFF2VHMtMndkZUVURno2dHJia0tVNEhlMVVXV2NpQThMbG9UdTd3aWt4YjYxdUVqRlFIU0JkekQ0LWZwejVEeGRwWDdEY0NBaUM5NU1SaldvS1FEc2ZTLXU5U0FOUzdZNEVkanhwaXctVXh3dUs5OERMWkJZYXhOT3F3NXlDa1JRYm9TUUM5WFhFal81dzg?oc=5,Google News - Market + Complete Company News,Semglee commercial success,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.30484999999999995,0.45727499999999993,positive,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee prescription volume,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee hospital formulary,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee pharmacy,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-18,2023-07-18 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - AJMC,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQSXYybkpjanZ0ckhORHI2SFFJYjZ6Y0ZqNU1aN0l5SG1iSnBNcHhlazhBNXp2cnM5UlJLTlVCS00xb0RxR3hmMk9QVVhlV0RVRnctX21SOTNDSjItQTN2N1h3eWdNOU9sRWlKTnk5cnBGYy1VMzhTNE5wQTcwbHhjVVZpRDg0NnY5RFdteEJKbUU?oc=5,Google News - Market + Complete Company News,Semglee commercial success,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.04755,0.071325,neutral,1.5
2023-07-20,2023-07-20 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.02255,0.033825,neutral,1.5
2023-07-20,2023-07-20 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.02255,0.033825,neutral,1.5
2023-07-20,2023-07-20 07:00:00,Payer Controls Limiting Semglee Uptake Despite Patient Demand - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5"" target=""_blank"">Payer Controls Limiting Semglee Uptake Despite Patient Demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQR3E3OG9USk1vYUpjdGxlaWtNc243WHJ6UmMzSkxDSHNXSHhLSVJKaWotX19TRzJlb3czRFg2cy1Tck1KS3I1N0EweHBydV84VFdsRzF6MGNBNXpIMmY5eUxQQUhINlFEMGlPbjNjXzQyWEdlcFhveHZhX0lsQkxvRjlpYWFQTklETWM2UnM2V1N6MEY2b0tvbUtFTjVMOGw5RllqYUxB?oc=5,Google News - Market + Complete Company News,Semglee real world evidence,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,11,True,False,0.02255,0.033825,neutral,1.5
2024-02-29,2024-02-29 08:00:00,"Biocon Biologics to launch Stelara biosimilar in US in Feb 2025, post FDA approval - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQYWdZZC01VmJhSVBzeVRDTVpScEkxNFNhbExnTVN3bXRLMzVkRmJLc010S05uTGpJUUpGWkM1WHpIbDcyNmp4QUNmaXkxQ3JRODI4NzZkendVLVBMOXlkckFMOW12Q0szczlleGViZlk4SDk0LUpZQ2xHUnRXVkNVbWJ4b0FIdlpuSlpLSEdpc1ZNeWFDZ2pzYS0wNFRad25PRzliYVZpX0tmWHJwY0xCT3VBcDRacnVfaGRoZkIwYVl3NWxIZlZtQUhhMmdwQQ?oc=5"" target=""_blank"">Biocon Biologics to launch Stelara biosimilar in US in Feb 2025, post FDA approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQYWdZZC01VmJhSVBzeVRDTVpScEkxNFNhbExnTVN3bXRLMzVkRmJLc010S05uTGpJUUpGWkM1WHpIbDcyNmp4QUNmaXkxQ3JRODI4NzZkendVLVBMOXlkckFMOW12Q0szczlleGViZlk4SDk0LUpZQ2xHUnRXVkNVbWJ4b0FIdlpuSlpLSEdpc1ZNeWFDZ2pzYS0wNFRad25PRzliYVZpX0tmWHJwY0xCT3VBcDRacnVfaGRoZkIwYVl3NWxIZlZtQUhhMmdwQQ?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.23835,0.4767,positive,2.0
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.43125,0.8625,positive,2.0
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.43125,0.8625,positive,2.0
2024-12-02,2024-12-02 08:00:00,Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5"" target=""_blank"">Biocon's Shares Price Jumps 4% after FDA Approval of Yesintek; Technical Charts & Resistance Levels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1p0dkQwbWFUZzN3YkVzclVDOUFRQ3hCM0NYUEU2S3QzZl9PVHk3RFR6WUlfWkY4dHZrTjhDRWh0WEZTS25Cck16aHVCSWRNZVRIcEV1SmdnR3NZQ1FRa3I5REhhc05WOVVyTTNlV05JaWdobUQ3M0Y4bTk2RjN3YjgwcnpDY0l2MTNiZlFzTjVpOTBRaGtuRnVmZU56Y1dDbE1za0owVmJlay0zRTFhdzIxWlpJR1NvRUE?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.43125,0.8625,positive,2.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.4734,0.9468,positive,2.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.4734,0.9468,positive,2.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 8% after Psoriasis drug approval from Japan, Jefferies upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.4734,0.9468,positive,2.0
2025-02-20,2025-02-20 08:00:00,First Insulin Aspart Biosimilar Receives FDA Approval - AJMC,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5"" target=""_blank"">First Insulin Aspart Biosimilar Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.30085,0.6017,positive,2.0
2025-02-20,2025-02-20 08:00:00,First Insulin Aspart Biosimilar Receives FDA Approval - AJMC,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5"" target=""_blank"">First Insulin Aspart Biosimilar Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.30085,0.6017,positive,2.0
2025-02-20,2025-02-20 08:00:00,First Insulin Aspart Biosimilar Receives FDA Approval - AJMC,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5"" target=""_blank"">First Insulin Aspart Biosimilar Receives FDA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxPd3FKdEVHejF0VUJlUzM3d3pHZ3lxSzRneDNmSHJXNWl6a1h5Z0E5RjFINzJ4bHlFREtuYlRHclNsNkZnN2dXVFdzdkI2ZkcyUXZuUHZxazBJSXNBQ2FiRmRESC1mZUlmNnpYcEhzQi13Z3A4OC1ZTmoxSE9pdmtpT2wwelNLUQ?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,False,0.30085,0.6017,positive,2.0
2025-04-10,2025-04-10 07:00:00,"Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5"" target=""_blank"">Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQcG5TMThQVFo3VWx4b2R4aWtKYVFYLWV4REk5SFc1M01TdTJ1SzZiU1AyUlEzNVBNNzUxYVduVUFoeDFUMm5TRUoxWU1LXzl3bm90UkZuLUtuTm5IRXpranhkc0RDckRBbkIxREVRNmNlejRpdlVuaXFGeTAweTRzQktueE5SS3RVc3ItTG52UHhnVkZ3V1lpV2xIQ0otVEU5Vko4T1FSVlhTdElPRFdTdUttSGhxOXpIYUo4MEoxWWtaWXpvNDJ0clNhQnV6VC1sWjJPMHlIZVBrd1JjVGhOWDl0ZXBXYzNmSFJjdTdleWxHdVExUXVtX3Nn?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.36755,0.7351,positive,2.0
2025-04-11,2025-04-11 07:00:00,Biocon share price rises 4% on US FDA approval for cancer drug - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price rises 4% on US FDA approval for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,-0.0258,-0.0516,neutral,2.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar - Samco,"<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5"" target=""_blank"">Biocon Share Price Rises 5.5% After USFDA Approval For JOBEVNE Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxOT2tPSFdjb2k4bFdmQ1ozeG95NkpOcG5DcGFxZDRUazJEVExuaUluYTkwc1NyLUlySHVIR2tWWUJEaUZfZV9jbS05Vk9HTUhJM1BQVUpkTVF4b253SlY1NWwyYU5XSHhSSDloZTZUNGJLSEhrbXMtOEduX25kTUV6ZE9QdFNSM3J5YjdRWjJuSEhqWDdDZDZWUGd4WWIxU0pTVU5jMXJQMTRfNDVGd2xIamRLdVdIT3FOT2VYMVNheERwdw?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,approval_process,Other,Other,11,False,True,0.43125,0.8625,positive,2.0
2017-08-08,2017-08-08 07:00:00,FDA Inspection Notes 10 Problems With Biocon's Manufacturing Facility - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQSGRCeU15d05zaXJLSlNFTU9UcDktVjhWZ3R4N2dtS2pZZ0c0bkNTZlU4TTl2NGd4YmVTM3NBRk1HZXQ0R1lvRlNCU1dWWDdqVGFxQ0ZJcG5kTDZJQ19ReW00REI0QnpKMVc2dGVYMVJVMHpwdDhVNlZlY3M2OENEeEdpOVhIUzRielMtS3p5ZmpYZWtxeWVfS3pSOWxac0xGcVhYbGdmYm9qdWdtek1Z?oc=5"" target=""_blank"">FDA Inspection Notes 10 Problems With Biocon's Manufacturing Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQSGRCeU15d05zaXJLSlNFTU9UcDktVjhWZ3R4N2dtS2pZZ0c0bkNTZlU4TTl2NGd4YmVTM3NBRk1HZXQ0R1lvRlNCU1dWWDdqVGFxQ0ZJcG5kTDZJQ19ReW00REI0QnpKMVc2dGVYMVJVMHpwdDhVNlZlY3M2OENEeEdpOVhIUzRielMtS3p5ZmpYZWtxeWVfS3pSOWxac0xGcVhYbGdmYm9qdWdtek1Z?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,regulatory_review,Other,Other,10,False,True,-0.35485,-0.63873,negative,1.8
2017-09-18,2017-09-18 07:00:00,"Biocon's Vizag API plant clears US FDA inspection, shares up - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Vizag API plant clears US FDA inspection, shares up</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,regulatory_review,Other,Other,10,False,True,0.3062,0.5511600000000001,positive,1.8
2018-10-25,2018-10-25 07:00:00,"Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2018-10-25,2018-10-25 07:00:00,"Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit jumps 167% to Rs 184 crore, beats analyst estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2018-10-26,2018-10-26 07:00:00,Biocon Sep-quarter net profit sees five-fold surge on exceptional income - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Sep-quarter net profit sees five-fold surge on exceptional income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon quarterly results,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.4612611111111111,0.4612611111111111,positive,1.0
2018-10-26,2018-10-26 07:00:00,Biocon Sep-quarter net profit sees five-fold surge on exceptional income - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Sep-quarter net profit sees five-fold surge on exceptional income</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.4612611111111111,0.4612611111111111,positive,1.0
2019-05-08,2019-05-08 07:00:00,"Biocon, partnering with Mylan, to share profits in global commercialisation of Hulio - Express Pharma","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, partnering with Mylan, to share profits in global commercialisation of Hulio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.42405,0.42405,positive,1.0
2019-10-23,2019-10-23 07:00:00,Biocon Q2 net profit at Rs 216 crore - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5"" target=""_blank"">Biocon Q2 net profit at Rs 216 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2019-10-23,2019-10-23 07:00:00,Biocon posts 39% fall in net profit Q2 even as biologics business booms - Mint,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSGZUVW5wODdIM3lReXNCbnN2R2VHM1NEcHo2RDdKR3hvVW1xa1k4UllDR3pnMWdFRUYtWUZ5Qi1uU2ZLUk1TRDdYa0l4OWZCU2JOS01uTDZBcFJvallZYjdZM3BFY3I3Y2UtWTRNV0R5UTRzWW9HUDM2VWdNeDF4UjlHMDBHZENTb0RJQ1ZqYk1UNXpYNVd0N2VKSUU0blk0YTZYaEwxV1ppeFdGY082N3JKVUNoel9odklKcktsc1FNaU91WHhSRjVjN0hwc2pObDlrcW1LTV_SAd4BQVVfeXFMTUFwQ2dtdlotdkhxNVRuc0gwSnI4a19KQlE5bHRTLUdSMGIwNTRCV2RFY1ljNEx0OUx0R3dzR3AwUFBQR0hyRGtRTGpMUWprOS1KZWh2RllMU21acUlSTG82d2stU2dYLW1Bc3RTbV93WEk3UFo4YnBuSVBYbWt2MmM3M1pHblJHaElyODZSdG5kazZMajN0bGFVSTR2WmZZdi1venNnaUZ6akxuQ29NOGZiRXRkM3VoREVvSnhiU1ZLQnhVUGVwREdJVGVtYTRlSEd4MlBhVVFCMFlqZkJn?oc=5"" target=""_blank"">Biocon posts 39% fall in net profit Q2 even as biologics business booms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxQSGZUVW5wODdIM3lReXNCbnN2R2VHM1NEcHo2RDdKR3hvVW1xa1k4UllDR3pnMWdFRUYtWUZ5Qi1uU2ZLUk1TRDdYa0l4OWZCU2JOS01uTDZBcFJvallZYjdZM3BFY3I3Y2UtWTRNV0R5UTRzWW9HUDM2VWdNeDF4UjlHMDBHZENTb0RJQ1ZqYk1UNXpYNVd0N2VKSUU0blk0YTZYaEwxV1ppeFdGY082N3JKVUNoel9odklKcktsc1FNaU91WHhSRjVjN0hwc2pObDlrcW1LTV_SAd4BQVVfeXFMTUFwQ2dtdlotdkhxNVRuc0gwSnI4a19KQlE5bHRTLUdSMGIwNTRCV2RFY1ljNEx0OUx0R3dzR3AwUFBQR0hyRGtRTGpMUWprOS1KZWh2RllMU21acUlSTG82d2stU2dYLW1Bc3RTbV93WEk3UFo4YnBuSVBYbWt2MmM3M1pHblJHaElyODZSdG5kazZMajN0bGFVSTR2WmZZdi1venNnaUZ6akxuQ29NOGZiRXRkM3VoREVvSnhiU1ZLQnhVUGVwREdJVGVtYTRlSEd4MlBhVVFCMFlqZkJn?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2019-10-23,2019-10-23 07:00:00,Biocon Q2 net profit at Rs 216 crore - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5"" target=""_blank"">Biocon Q2 net profit at Rs 216 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxNa2gxZEh0QmI4cnlmNjR0UEp4WEVHWjVnakY5NktwV1JUSUxMaXVienYwUTZ6WUtvR09oYXowMFBwYXZnN3VCWGRpcGdkZFZhcjVQNjRHU0NGNmNCYTZvVV9Nck1BQU44TmhFSXk5M3FhWDNnQ21GX3NpaXBDT2VIcG1oMDRVNHJ5alHSAY8BQVVfeXFMTk9qM1JOWXc0d3o2alpKT1JjaWxCNTFKV1o2T1JyVkMzdkJtUWRsYkdFRXFDQlFCTXpvbjBMcFRacWJQT1VNQnRlRE5QOTd6MUlNODV2bzFpczF4cEF3ZGZESTNKek1qaHhpTGdWTzlUdFNrbFJFbUpzendQdU9zSDVqdEFSUXN1N0xRbkF5cUk?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-05-15,2020-05-15 07:00:00,Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-05-15,2020-05-15 07:00:00,Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon profit slumps 42% in Q4 as covid-19 disrupts biologics business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-05-15,2020-05-15 07:00:00,Biocon shares slump over 4% as profit declines 42% in March quarter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares slump over 4% as profit declines 42% in March quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxOaHV1Vktpd2daV3k0Wnp4VTlzemlXYzZldUsyQXlza3JVT2toSWFKV0hPbjBEZ2drS3pPNURTTFdldjlCVXRaYzVtQlJiMTRnWGVTSWNFUjhZWVJfU3A3R1VlMGFQdng0Zy1McGtvTC00RmJEQjVjWFlTZWhfQjV3aFR1bHNNUmtDMzdoZm16VkFicDl4dkliUERFR0hPWGtoaGxwRWVTNXpYamxldjl4VmFxdm9ETXVpUjZUVzJQWnl6eVprRC1MRDc3YS1IVmhi0gHWAUFVX3lxTFBZZUN2LVF0U3NuUEpIQ1Zhb1FaS1VTVk85a2RpRzdVNUdSX3A3Sk1qMVg2SVZxTS1Ybi1MZVB0b3c5SXBXNzRPWEJPZmM2bV92ZUh6dXVDdkg1SXNQSzhPbG9pSFlua2Q1eHE5UHZQQndLVi1qNFZrZWhhaVAwRE9ybzNSYXk0YlBpTkFlT2ZjdmY5WUxoRWxKdzBxSGFTMDNnQlJvTnc5TVloUzNNMGdxYkwwcWxhTEFDWHRXSlh2SmYzQVI4RFpjSms2cEstQm1yYWlIb1E?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.42405,0.42405,positive,1.0
2020-05-16,2020-05-16 07:00:00,Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr - The Indian Wire,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNY1FVbGJRX0pGemdxLVc2SHF6dGdfcnFPc3JvRVNCRVFPYldudnludHU0cXRqWnNLU19Wd1VEeW5jbTJYM28yRUZWUHMzR19oa2tvUV9va0FwOTR5SGxoMmdhWEZ4UVp3R1BHcWhzaGFMNEZDMDIyaGxTVnd1RTZMZlRZX0ZxY3pGWWVmUmpRQTFaQkpkQzdRTGxKTDhNUnZMYzlXM2xVN3FPMXA1RWJha0dvLUVpMGw5X0HSAboBQVVfeXFMTWNRVWxiUV9KRnpncS1XNkhxenRnX3JxT3Nyb0VTQkVRT2JXbnZ5bnR1NHF0alpzS1NfVndVRHluY20yWDNvMkVGVlBzM0dfaGtrb1Ffb2tBcDk0eUhsaDJnYVhGeFFad0dQR3Foc2hhTDRGQzAyMmhsU1Z3dUU2TGZUWV9GcWN6RlllZlJqUUExWkJKZEM3UUxsSkw4TVJ2TGM5VzNsVTdxTzFwNUViYWtHby1FaTBsOV9B?oc=5"" target=""_blank"">Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Wire</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-05-16,2020-05-16 07:00:00,Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr - The Indian Wire,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biopharma Co. Biocon Posts a Q4FY20 Profit fall of 42% at ₹123 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Wire</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-07-24,2020-07-24 07:00:00,"Biocon Q1 net profit declines 26 pc, revenue up 14 pc - The Statesman","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQME9KSGNveUcwYzFDVTdtTUpJaFRiTE1sVUdFOGtoejNxNGFqX2dSUnFBZkhLb3hkNUVDS2swR21ESmZmUHQ3N09ta0hDb2JDdzZfYmhJcGdOclo4VndxNW9EUHBjVXNrUGZuR0tVeF94V3BrRkxPNEVyVkwxMnh2M1F6SW1zSVpXLXVWandfMjNWQ0ZOTmlDZUxTWEZDNDFRTjFKLXFn0gGrAUFVX3lxTE1RY21jbzkxcGt6Tm9uWTZ4TE0tVFVIS0t2NWV6QlphY0JiRElsd3dDakdtTUJCcnV4a0wzOUZDcHlNblpuRXpiVUxGQkQ3ZUltOFBzQ0otbXZUYXZVX21jWlpnc0hZN2I4SVRWc1BONU9kRXdzdm9jWWlOenIzeG83UFppbjk2LURMWHVWbVVhTjMxQ1V3UUJZMEpYQUJVQ0JZLVZLbFdHQ3RjVQ?oc=5"" target=""_blank"">Biocon Q1 net profit declines 26 pc, revenue up 14 pc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQME9KSGNveUcwYzFDVTdtTUpJaFRiTE1sVUdFOGtoejNxNGFqX2dSUnFBZkhLb3hkNUVDS2swR21ESmZmUHQ3N09ta0hDb2JDdzZfYmhJcGdOclo4VndxNW9EUHBjVXNrUGZuR0tVeF94V3BrRkxPNEVyVkwxMnh2M1F6SW1zSVpXLXVWandfMjNWQ0ZOTmlDZUxTWEZDNDFRTjFKLXFn0gGrAUFVX3lxTE1RY21jbzkxcGt6Tm9uWTZ4TE0tVFVIS0t2NWV6QlphY0JiRElsd3dDakdtTUJCcnV4a0wzOUZDcHlNblpuRXpiVUxGQkQ3ZUltOFBzQ0otbXZUYXZVX21jWlpnc0hZN2I4SVRWc1BONU9kRXdzdm9jWWlOenIzeG83UFppbjk2LURMWHVWbVVhTjMxQ1V3UUJZMEpYQUJVQ0JZLVZLbFdHQ3RjVQ?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2020-12-25,2020-12-25 08:00:00,IKEA India FY20 loss widens to Rs 720 cr; net sales up 64.7% at Rs 566 cr - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">IKEA India FY20 loss widens to Rs 720 cr; net sales up 64.7% at Rs 566 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,False,-0.2787,-0.2787,negative,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon revenue,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.19724920634920634,0.19724920634920634,positive,1.0
2021-01-22,2021-01-22 08:00:00,Biocon’s net profit falls 19% in December quarter - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5"" target=""_blank"">Biocon’s net profit falls 19% in December quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon financial results,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon investor call,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon reports 17% drop in net profit, Christiane Hamacher steps down as MD of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.19724920634920634,0.19724920634920634,positive,1.0
2021-01-22,2021-01-22 08:00:00,Biocon’s net profit falls 19% in December quarter - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5"" target=""_blank"">Biocon’s net profit falls 19% in December quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxON2dYbnhoTDhDX1kwSXJjMFBQLV9IRm5WSXhKMU5RZGpWNVFDdVVrT2xNdlNQX0x6dlBUemdhLXdKYjF3M2UyeEp2UzcxQ3BzQnh6bXBDZFFKUGliaU5ONDdhU0M3NmdNYVVCcWFlQ3JzdjFpMmh1aWZhbzhqb1NoTlBlZURqOHRicGVZQ0dPNl81dFdzRFJXcG81ajJTazjSAaQBQVVfeXFMTUpEVHFWU20zTXpXVEk3UG5JY0NtYnotbm1IaVg5RW80MnctYmw5UVk1YUh4WkhNMjVqeTUzWTVPZkVHZWFUU2xFQmoyMndzdmdVOTFlcmJBeDVlbFlnVHdkUzltRXNXLTdKTldJejBXa1RjSFI5MnFuOFpHTjJyN0tZS1BWUlBrdmlFZ1VCdm1kNkxmNEV0X25KMFVIYll3Ti1MM00?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-01-22,2021-01-22 08:00:00,"Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5"" target=""_blank"">Biocon Q3FY21 Revenue at ₹ 1,879 Crore, Up 7%; EBITDA at ₹427 Crore; Net Profit at ₹169 Crore; Biosimilars up 11% at ₹769 Crore; Research Services up 13% at ₹585 Crore; Generics down 3% at ₹561 Crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBaemtkU0FXUHBxWUlrU3IxMXhodU1xNUg5eHFoajVaZXdaYkR1VnhvM2wxcVFVSmprTjFIVmtoR0xKV1FzaFUxdEM1d19JQ2puNXkyVXplMFE?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3190388888888889,0.3190388888888889,positive,1.0
2021-04-29,2021-04-29 07:00:00,Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.07655,0.07655,neutral,1.0
2021-04-29,2021-04-29 07:00:00,Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 86 pc to Rs 296.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxPelB6bmVJUmdReTEzcTh0X19UQUUzX0ctZVBHYUlGQ2dBYXdrRm1HNDlsUVFsTWV0VE9Tbk82R0VEUzlfZmpkcXA0cTlRdGt0aWx2VU5od1JYRE5TWGRCSUJPLVZDaHRWN1NhX01DcnZaOVAzazhSN2U0WThTWVRUd3paRjFvSjlEeXMzd1EtUFVuTGhMUm1TTU1IZnZ6cW41RzIyVVY4WVg0eDjSAbABQVVfeXFMTTN3Zmh5WlVZWE5WUEFhRDVPa013WWlOZ2pVb3VIandHamxVUnlhakxHcGFGMlMtZE9IMjR4UFNhYlR3Wl9iZVFlV0gzVEZIV2xaRHA0em5DZ3EzZXc3SjJVUjd4OExyUHR6WkxXT3YwblR3OUNQNTk5SGRYNjJpODBad2xVLTJOUVg3V29PXzE3VXNETE5RLXhKNkxyMzBFQWdaNnBaSUlSeFY4d1RDeFI?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.07655,0.07655,neutral,1.0
2021-04-30,2021-04-30 07:00:00,Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxNMUtBV3pzOXJ4WEhhZHVIYlc5ckpReHBodkVPTEl5Zm9uR2stTDBJQVlaS3l2X2N5SGZMcFFJTHhoTXpESF9pTmdLSEtQSGhKVlJjY1hPLUhSSVVyLUhPazJBdndfdEVnV1QwZHNMUjd3T3VWTjMta3JBTnYyU2cxMkRhalE0SVBLcWY0OXN2dHJQS0VxUkdCbUZZV1EtdkRIVFNhalFwSHhfR1dmZV9RQkZ6UDk0a1dQcDBzdklnczEwX0pnazZGa2pNRHRBSHU5Wk9zOUlSWdIB3AFBVV95cUxOaTVOaWJjbXZnT0JGZ1lPQ0NKQW44ay04SExKZVhDQlV6bFRQUHdqTFdvQVpRVUdQcXU3cW9DYmpYSGptYjJSeU5qaGlLcVpWX2k3eWozSVA5SE9TTmNod1FOcWJQbndCNzhYaHYzdkdxYnA1ZUxkeGxWQ3k1VDQ5LW1YaGI4MVh4VXpCNUpidUh4R2JHbUdvbmJVcm1sdUZ0OE0xdDdIWWJTOUtDRXk4VmotWkdNbnRkVm1MSy1BLXMtbnd2U3BTOHVuVFJTQUZaeUtHb2JqMk5qbHRO?oc=5"" target=""_blank"">Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.3605666666666667,0.3605666666666667,positive,1.0
2021-04-30,2021-04-30 07:00:00,Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biotechnology major Biocon Q4 net profit surges 86% to Rs 296.4 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3605666666666667,0.3605666666666667,positive,1.0
2021-06-10,2021-06-10 23:01:52,Biocon Q2 net profit increases to Rs 306 crore - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5"" target=""_blank"">Biocon Q2 net profit increases to Rs 306 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-06-10,2021-06-10 23:01:52,Biocon Q2 net profit increases to Rs 306 crore - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5"" target=""_blank"">Biocon Q2 net profit increases to Rs 306 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxPUW96UkJxQktNeUNJS0NpZGY4OUhHd0FKUGhNQkE4WklzV0tHeFJoNElEeDhpMmtwM2F3U3VnSkd1RGRsNlNGM0VkOWlPS1pfeGJpckp5VFhNRUJzdDFDcWtBaVdpa1dxQ1BwWWRkbmI4M1Y3cmx3MENCRXlzajB2SU5R?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - FDA Journey + Company News,Biocon revenue,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,Biocon Q1 net profit declines 35 pc to Rs 108.4 cr - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5"" target=""_blank"">Biocon Q1 net profit declines 35 pc to Rs 108.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - FDA Journey + Company News,Biocon financial results,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMlZqaGFOeVJTd3BjSXVicUh4bGxmMTM3WG16SkpVNmE0dFlJc1B5eGdaYVJwckdPT3F4VE9sMFZmRm52NFVkSWUxTjA4VGlKN29jWnpmbFVrYjZZMGlJdVNNVnV6cURyQ0ZEa243QUlqUW9Zd1RfM21BRE96bkFuTnFadVJfWHpwQ19XTEhzaUUxQUVFTjF4VlJMVkFnMmNEZ2tKcUIwaTJWWTFhZkdWTE9HUmV6ZEhvcm1XRDdkRTjSAcYBQVVfeXFMUF83QnBlazNKR29sMGZSaU82RU10RlJaNV9wbzEwcGhjVkxQeE91X1NHYjhXQ2VqdEhzcjhjTVdYQ1pCS2tOMEZxMmdYM3VJeFBFMExLeEhrUUljcnl1N2lkQkpnbThVSUwxOGoyZmN2WEtzMjVBZ01HT1M1MzlaY1c0TzJ4Q0dWWG55eHRGbjhqakNkelVjbnRLUmxXWENsVUJRR1pLZGRGWTBLNmtFOXp2RE5TdW5Ia014dkkyXzducTRibDVR?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,Biocon Q1 net profit declines 35 pc to Rs 108.4 cr - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5"" target=""_blank"">Biocon Q1 net profit declines 35 pc to Rs 108.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxPc3hTd0pmVWVxQjFacWp6bUlUaHJkR2EzX1FyN1R2aEpqbEtrRHR1cnRwcTU0QlZfU2VUeE56eTBDV2c5TUNSUmxXa1o1YlYzUE5vc2xhWmxnc0xXZ1ExdTZkVlRVT2pDUEFXZjE5MUtaNFp1SGFMM2w5YTU2WVVuOFY0aHJZcGhJNUJCOHN4LV9hcWhOSEdqc2lFME0wcVd3V1ItdDRPZVJSQzJGTkZ3?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-07-23,2021-07-23 07:00:00,Biocon net profit falls 35% to Rs 108 crore in Apr-Jun - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon net profit falls 35% to Rs 108 crore in Apr-Jun</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2021-07-23,2021-07-23 07:00:00,"Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5"" target=""_blank"">Biocon Q1FY22 Revenue at Rs 1,808 Cr, Up 6%; EBITDA at Rs 437 Cr; Biosimilars Up 10 % at Rs 758 Cr; Research Services Up 41 % at Rs 595 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5kbmhFVFFBZEtlYmk4T2RRVlBTVTNEcW5hVVV3Zkk2YWhlbHJhT2lJOUhWeXRvWTdXQzBIZ1NJWnZyMGtOc3ZOU0RGcUdfcFpiall0SUc3cUQ?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2021-08-10,2021-08-10 07:00:00,Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,False,-0.2787,-0.2787,negative,1.0
2021-08-10,2021-08-10 07:00:00,Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kalyan Jewellers Q1 consolidated loss narrows to Rs 51 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,-0.2787,-0.2787,negative,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Biocon revenue,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Semglee real world evidence,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2021-10-25,2021-10-25 07:00:00,"Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5"" target=""_blank"">Biocon Biologics Reports Biosimilar Revenues, Manufacturing Site Corrective Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOdV81c0RjU1I1LWF1TlBFdjdTRUx2MGR5ZnJtZmhNNl9pcVdxcEVZd3ZkS21WU2dpOU1DWDU3c1J5eHA4cDUyaU1DelBFbUdIdDlVZGlMNW1ocGxoNDZBT0pBQjNZZHdBMHFtZVRsdnE2TkNEYjMyS0xHejdCcmRiWVJUZGFGSTJWMGc5T2dsNDZaN2pQdDZpRlpqN05Ib29lckJVQXNMbENlb1ZMZ3NYRGdodHh3SDBXem5sNExR?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.025,-0.025,neutral,1.0
2022-01-21,2022-01-21 08:00:00,Biocon Q3: Net profit jumps 18% to Rs 220 cr - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3: Net profit jumps 18% to Rs 220 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2022-04-14,2022-04-14 07:00:00,FDA announces new insulin recall due to potential labeling issue - Cardiovascular Business,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNcTZxNzVmd1ZhMmp1REVuQnY3YllEYXJJNkpjZUhhZWVMMnpDQm9FbnZqZXV6NzItaVREaWRHYXl0SFZFQm9kZmJuOTVUZW5hLXQzVENacEJhTkJvT0RrMVBRaHJPQXR6eVlzaDNrODI5QkZIdTJwVXpyR3VlbVo0RS1uVjJTLVM5YzMzaENaNERIZWFrYm1uZjFFTUF0VWE0cGpqcWJxNDdxc3p1MjdwM3dvQjFDQ19iekhqT3dZSF9qX1k?oc=5"" target=""_blank"">FDA announces new insulin recall due to potential labeling issue</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Cardiovascular Business</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNcTZxNzVmd1ZhMmp1REVuQnY3YllEYXJJNkpjZUhhZWVMMnpDQm9FbnZqZXV6NzItaVREaWRHYXl0SFZFQm9kZmJuOTVUZW5hLXQzVENacEJhTkJvT0RrMVBRaHJPQXR6eVlzaDNrODI5QkZIdTJwVXpyR3VlbVo0RS1uVjJTLVM5YzMzaENaNERIZWFrYm1uZjFFTUF0VWE0cGpqcWJxNDdxc3p1MjdwM3dvQjFDQ19iekhqT3dZSF9qX1k?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,regulatory_issues,Other,Other,9,False,False,0.001623376623376622,0.002759740259740257,neutral,1.7
2022-04-29,2022-04-29 07:00:00,Biocon Q4 results show Consolidated revenue up by 21% - The Statesman,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPYzV0OXJ4ZU1xLUJVRXFSVWdPYlloUG0wb25jcHZTam5RV2prX2NPWVAtNm1paHRvWGtDd2hmcUxhZ0NkMjJmVFUtc2NxZk85NklGa3dVMUE4T2EtalNqblotVldYVUF3U0M4aXNfMlA1OVk3U3M0Y2JJNXlFMXQwSE9TQTB2aGFFOGhFc3pCbkJHN1I2N0VCZUFWLUgwRjdiU3fSAacBQVVfeXFMTUR6ak1pd2hLUVB5WFkwbnB0eXU1OGU1UnpCelUwRlJLSmdHQ2trTzh0bUpmNDBGOW9rWjZtV2RpVlVOSF82Y2lzbnlUNHdFLTdZRk9NYUxubWxyUnF1Sm5tQWdqMjJnYkQ0N191cG9oU0c1YVlnUDlHTjdKN1F3MGl4dUdWWkktU29nLVFwcDhNQ2VnR0k5LXV4QWZSMWVDbUZmMi04bmM?oc=5"" target=""_blank"">Biocon Q4 results show Consolidated revenue up by 21%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Statesman</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPYzV0OXJ4ZU1xLUJVRXFSVWdPYlloUG0wb25jcHZTam5RV2prX2NPWVAtNm1paHRvWGtDd2hmcUxhZ0NkMjJmVFUtc2NxZk85NklGa3dVMUE4T2EtalNqblotVldYVUF3U0M4aXNfMlA1OVk3U3M0Y2JJNXlFMXQwSE9TQTB2aGFFOGhFc3pCbkJHN1I2N0VCZUFWLUgwRjdiU3fSAacBQVVfeXFMTUR6ak1pd2hLUVB5WFkwbnB0eXU1OGU1UnpCelUwRlJLSmdHQ2trTzh0bUpmNDBGOW9rWjZtV2RpVlVOSF82Y2lzbnlUNHdFLTdZRk9NYUxubWxyUnF1Sm5tQWdqMjJnYkQ0N191cG9oU0c1YVlnUDlHTjdKN1F3MGl4dUdWWkktU29nLVFwcDhNQ2VnR0k5LXV4QWZSMWVDbUZmMi04bmM?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2022-07-07,2022-07-07 07:00:00,Mylan Pharmaceuticals recalls insulin glargine injection pens for potential missing labels - Healio,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOeTJOWEw3eGRwYnpiYVpjNWFUaWhtb2VoZy1YcUFaOWJnSGx1RDNGNTdYc0dWZHBwV3BaaGcxdzRZUEFySmszR3JJU3dBSVZTT19BcjNqUWl2YnBrNFZ2djQxZEEtWE1PVFFubUhzZG91NnJxM2RFbGlGNjFoblJORXhsYzZWa19GcXQyVTAtYXd2cXRJMnVlOWxaR2hLRElVajk5emZnSTRtWWdhTF9nVkFwNWt0eGl0aF9HZE9LMTRHWk1CRW5TcmRFVjhMcUF2cEhSMkZtS1E?oc=5"" target=""_blank"">Mylan Pharmaceuticals recalls insulin glargine injection pens for potential missing labels</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Healio</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOeTJOWEw3eGRwYnpiYVpjNWFUaWhtb2VoZy1YcUFaOWJnSGx1RDNGNTdYc0dWZHBwV3BaaGcxdzRZUEFySmszR3JJU3dBSVZTT19BcjNqUWl2YnBrNFZ2djQxZEEtWE1PVFFubUhzZG91NnJxM2RFbGlGNjFoblJORXhsYzZWa19GcXQyVTAtYXd2cXRJMnVlOWxaR2hLRElVajk5emZnSTRtWWdhTF9nVkFwNWt0eGl0aF9HZE9LMTRHWk1CRW5TcmRFVjhMcUF2cEhSMkZtS1E?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,regulatory_issues,Other,Other,9,False,False,-0.30334999999999995,-0.5156949999999999,negative,1.7
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2022-11-14,2022-11-14 08:00:00,"Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&D Spend at Rs 252 Crore, Up 52% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5"" target=""_blank"">Biocon Q2FY23 Revenue at Rs 2,384 Cr, Up 23%; Core EBITDA at Rs 816 Cr, Up 34% Gross R&amp;D Spend at Rs 252 Crore, Up 52%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5FbUd0SHUzc3M5dUo2RTA0ai1ScGRUaHZRSWNIWWM4NURrUVFZQzkxUXVtR2toX09TbDRqNG5JLUVmUnJWMC1Oa0ZZaUVRbC11aG9yc3pxZUE?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.36755,-0.36755,negative,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5"" target=""_blank"">Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE9hMEZZcmFuWjJzNnFJRDdGNVdKLWk2c2JpVnoyY01MS1RRNlVOcHR2X0sxVWdpcDlMZHN4SVpGWThVbHU5clB4WVRjYjVaU0tQV3paYmQ5X1g?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-02-28,2023-02-28 08:00:00,Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5"" target=""_blank"">Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.5146333333333333,0.5146333333333333,positive,1.0
2023-02-28,2023-02-28 08:00:00,Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5"" target=""_blank"">Viatris Earnings Top $1 Billion Thanks to Sale of Its Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxORGtFOTNKMWRVVUxPTVBXZUpjZGhtd25GSjdUaW1lRERHNl85SjFxaVVyb1hmRGpVaHpCVDE3VFNRdmJhNm9xaDBvNHdoS3B2OXZYVlJySDNFM3VBTzI1QThEQjlYS2tDLW5rU3UwYXRjMm81RmRJOFlGak53NnhabkhHQlJLWnJrVFNfRzZXdlpEYTZ0VzJZZ2NxbDMzMWd5VWUyR2I3QnRBcDZwLTJRN245ODU4UQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.5146333333333333,0.5146333333333333,positive,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5922944444444445,0.5922944444444445,positive,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi9gFBVV95cUxPNW03TGtEV19ZNEw0MXdTWHdpdEZFc3NYWFFZVVBzeFJGLUN0c1dhTUV1UU5Pc2g1S01sazlIMmZtSGVGNlZLdldkVGhneEhwQ3dXTm1lMHF3TEJ2WVZIMmFJYUVMYm5pUXY5UmowVFNjaHBKdGlyQ0pIOEl3SWJfRk9sNlcweWZFYVhXTWFrSGhNbkw3aGlBaTY1TjZlbGxjcnVpZnhkTThiVm8zSXpNT0YzQXRId0d6MjdpZGZWZmMySGJGU09xN3l1ZVlocWhXTHZFX29rUDJGeExnSHRmVXVlanVFdDlGd05MY09CR2lSdE43bGfSAfsBQVVfeXFMT1ZqNDg4Qkt3aEhiTlVjX2lZOFpuUjZiME9odGpMRGFJWGN3aVdfZHlHT3VPNTJFZldTWGpLR05YbFY2c05lRUpGVjVZYkVXWnlGcmJKOFFpM3BrV3JMb2ZwNG03LUJkLXlIZjE4aHdvdmtlRGNBY0FPc0lzUGF0T1J1NzI2NnViRTBFa0NmYU9fWTlDNDNWc0Z2M2IxR04yWFVrcVotdzRDRGd5STExRmZoWmlzWW1CQzZFUGk0dFBhdU45Z0xSUXBkN3NIQmx3VEZDVUhPVzMxTHlJLVY3VWN0c0U5TVREUW85cGJMR1BxTFBCYnN1N1V1N0k?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5922944444444445,0.5922944444444445,positive,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5"" target=""_blank"">Biocon Q4FY23 Revenue at Rs 3,929 Cr, Up 59%; Biosimilars Up 114%; Research Services Up 31%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE0xaWhvUHVSMW1qMG85cGtrWURJamlKRlFuLTFjY0NhbmdmNHpwcFBNY09EcDVPcl9JbGVjenFQOVRiU0FoVU01X3RYdTVfYW94TTBSZ202eWM?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-05-23,2023-05-23 07:00:00,"Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Consolidated PAT jumps 31% YoY, EBITDA records strong growth; declares 30% dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5922944444444445,0.5922944444444445,positive,1.0
2023-05-24,2023-05-24 07:00:00,Biocon net profit up 31 percent in Q4 - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5"" target=""_blank"">Biocon net profit up 31 percent in Q4</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-05-24,2023-05-24 07:00:00,Biocon net profit up 31 percent in Q4 - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5"" target=""_blank"">Biocon net profit up 31 percent in Q4</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxNSnpnaEM0b0hkaGEtOGdMR1RiWVAwUjljckJONjBXOFh1MUtzZVdOdVFxclRFNzNkX2E2eklxZ2R1OGUzQWpTd2IwSElodTF0WjhTaGJtZkNzSG9GQ2x2YjloSWQ4Y1BlVFVBVVRPOVY0NGFfLUJuUlFPbTlEOUN6bmFNa3RtQ2k4Y21YVndfVHZ2eGU0djNZT9IBngFBVV95cUxPR09Tc0ZDdWxiT0FHNmNPMXMzWDRUWW5OdFZ0YWZMLVM5WXA5UWUwNmN4MnMwQmtqN3pIc1RRc05RQnFORFRBdG13bV9tRndVYTBmajNnNkFCY0l4R3BoTlpqbDBiaWgzRmhWQU5wNV92SC10SU96MkZFRnJXME5RVzFxTldTYkFUMUk1Mzd3VTdzNjhOM2R3ZHFYUFY4QQ?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-05-24,2023-05-24 07:00:00,"Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2023-05-24,2023-05-24 07:00:00,"Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics crosses $1 billion revenue, Kiran Mazumdar-Shaw says biosimilars a key growth driver</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2023-05-25,2023-05-25 07:00:00,India's Biocon Biologics says biosimilars put revenue on $1 billion trajectory - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">India's Biocon Biologics says biosimilars put revenue on $1 billion trajectory</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-07-04,2023-07-04 07:00:00,Biosimilar Humira likely to boost US revenues for Biocon Biologics - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biosimilar Humira likely to boost US revenues for Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.32985,0.32985,positive,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-08-10,2023-08-10 07:00:00,"Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5"" target=""_blank"">Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE1FZGNCM3N4NHhNa01VTkZDaGRLVTZqelBVSDNHeDBhMzdYZ3lDQ3hPUDZRVVhEYUlBMlFjNlJJdEwzazNSMnZtckdEdHhnQ3lPdXZSZ1hwVkg?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5"" target=""_blank"">Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,Biocon Q2 results: Net profit rises multifolds to ₹172.7 crore - Mint,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQS2dqbENOekxvU3YyVXNqbFg1U2pSam5uTjQ1a21tR2FxNUF5YmVGQXpWUDJPNlBFSUtVMEduYUZiRlVlaGllNklYTnU3RC1mZEhwbmZKa21PcWZiV2R4X0VINmgtemNGVl9Vb25xVVhKdm9ZRmlPajJhdVh5czVpazV0cDd0enBwUmtmOVR0VEFvaF9KckhTOUFhRUtUcGRJU2ZRaFJYZ1MtNWw0U2lBcUxBVXJpaDBzaFQzdUg2VGhCQ2w1dDlZN1p6eGpqd9IB0wFBVV95cUxOaUU4akNVd1locnRaWURmelB0TjQ5SGJib01yVlhRR0I4MVpUU0ZGZXFiSjl5OWNvODFhZ0xldWhhcWU4SjZGZ0JJV3BxRXB6M0JOTW9kc21oOS1FYUF2OVVIZEdpSHNDN3BWa0s5SDJ1N0xhR0s4MktaZ011WGl0U3Mtb1BGaV9Eb0hPSjRZXzNFV05QaHpqN3pxV0h0Y2hKQmw5WEd4RWlWbjBFcmgySnZ6UUlMNUtrbGJrc2h1NG01NHlrZXpUTGVURkhfZkdkTHdN?oc=5"" target=""_blank"">Biocon Q2 results: Net profit rises multifolds to ₹172.7 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5"" target=""_blank"">Biocon Q2 Results 2023: Profit jumps 111% to ₹173 crore, beats estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxNWHpQRml1VVo2RU83TWJiSnh1RWJFSmlManFiY01Nd0ZFWDVmUTdMZDIteFRZRG95NWJsLU54aXRzWEozSnRvZzBDQmhSdV9FQWlJZ3RTSnlRS0xqWUUzUDFUb2dJbUZYUTgwR3NoRUFwblFhSmpYWWY0Nm5fY3FqX2ZrN1M5YmpKeVgxY29FVmRmQdIBlwFBVV95cUxQSzl3Zlh0UXczNlpHM0RHeGkyakcyV09BbF9mWlRYaktXaTlSSTZVM0VqOFNvMGhiVC1QUHBxSldBOFRySElXdlJyYTRmbXY3VGM2THFMMzNRODlRNlN0SE1LQjQ5OVJLamUwS09JMGZTQUoza1V6Qnl0VS1lTkl1dHZLZTQ4QU0wM2dzaFFqQUJSc2d1amMw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net profit zooms over two-fold to Rs 173 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-10,2023-11-10 08:00:00,"Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5"" target=""_blank"">Biocon Q2FY24 Revenue at Rs 3,620 Cr, Up 52%; Biosimilars Up 97%; Research Services Up 18% EBITDA at Rs 900 Cr, Up 68%; Core EBITDA at Rs 1,100 Cr, Up 35% Net Profit at Rs 126 Cr, Up 168%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE5hSUUxcjJfNHNDT3puS3dzSGJ0R1NSa0tIODdHZkZ6WkxxaHJKNmZnRDNrLU5tWFlFN3RHMFoyNkl3WVdsM2tKeTRiTHFnTHZORXQtOXNLc20?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2023-11-13,2023-11-13 08:00:00,Biocon: Should you buy the stock after Q2 results? Here's what brokerages say - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon: Should you buy the stock after Q2 results? Here's what brokerages say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOcGRaTC0wUlEwb3FHZUJsTzhreVExNVpYb1FacHhCbnRLQVlQRmYxV2NPS2hLdUVRV0tqeUxYcHZOeVE3ZDYwV2V2RmdMTVo3MUdxckx2YkU4NXR6U0JzdG9saERmY1B1TFZhaGZaZ0luaDJnSHBSU19HazduM1RfeEdoNW9ON3Rva3loTW9OLTNmSEJUdXZhbGNRNTdaQngyQTlPbFRRel9QODAydHZGYkJxNUs0QlZSRlkxNkk3V2dpR0pPUVlDTUgxVGU1VkFhc3ZhWGJEc05oZW94UTFLR1ZCaVN5SnNObDNILXVLbkE0U3pENEZKcDZfM3lwMENOa2VWQg?oc=5"" target=""_blank"">Q3 Results 2024: LIC, Grasim Industries, Patanjali Foods, Biocon, Schneider Electric Infrastructure and more to post earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxOcGRaTC0wUlEwb3FHZUJsTzhreVExNVpYb1FacHhCbnRLQVlQRmYxV2NPS2hLdUVRV0tqeUxYcHZOeVE3ZDYwV2V2RmdMTVo3MUdxckx2YkU4NXR6U0JzdG9saERmY1B1TFZhaGZaZ0luaDJnSHBSU19HazduM1RfeEdoNW9ON3Rva3loTW9OLTNmSEJUdXZhbGNRNTdaQngyQTlPbFRRel9QODAydHZGYkJxNUs0QlZSRlkxNkk3V2dpR0pPUVlDTUgxVGU1VkFhc3ZhWGJEc05oZW94UTFLR1ZCaVN5SnNObDNILXVLbkE0U3pENEZKcDZfM3lwMENOa2VWQg?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.16666666666666666,0.16666666666666666,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-02-08,2024-02-08 08:00:00,"Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5"" target=""_blank"">Biocon Q3FY24 Revenue at Rs 4,519 Cr, Up 50%; Biosimilars Up 65%; Research Services Up 9%; EBITDA at Rs 1,492 Cr, Up 106%; Net Profit at Rs 660 Cr Pre-Paid USD 200 Mn towards Debt Reduction</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBnRGxwWVZQblc5MkRZNGZnS1RteHBKa25vSWFQZ0VPLS1lWXlzb0hrSTlxNFNCQmRBbjViTktCblBpM0xlT0FieUxweXgzRm1qZ1drSUdyc3M?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.10115,0.10115,positive,1.0
2024-05-03,2024-05-03 07:00:00,"NSE Q4 results: Net profit rises 20% to Rs 2,478 crore, revenue up 34% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">NSE Q4 results: Net profit rises 20% to Rs 2,478 crore, revenue up 34%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint","<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNSlVScmlTSWxQVmQ1bV9oaC1LNy1DX1JWWHNzMXc5ZFp4SnF1ODJiWXNOTURRNW9QVHNNeFZqNnQ2blNqeFh4TTkyeVZUcExVcXUtbjl5YS15TkRKTW11UXhOYTc1TU9WYWVHYV9jRF9NOW0zSGZtVWNxVlROTUlIdzF2VU5uM0o4eDdvUV95Y1VxbXRrclg4bVBKMUlzN0hmSldvbExoQ1o2ZWhPUG9GVFV1ejdIR3o4c0NzQmRXZWt3My1kZzE4ZmtqbmZfbWxNd2h0Z2JKbW9xRzVGbXVCZmZKU1EzR3ZHN2dZczNnRk1GdDV2bTc4MVdBUGNoVGk4M0JndHRIUdIBjAJBVV95cUxQaDM5Z2dXMkx3NkN1Tlk0Q3hxLW5hdU9nd01SMHRSREZiM085M2w0YzVTVVVGMXVhRUJWYmRpbm1nY3ZzVTktWUQxZndvaU5ZWHhITUNSXzN5b3R2VDdCQnBVZkw4LUlHd0p0VEtGc2E5OVA4dTdpY1FBRzNhV1EzU0lwbmNmUk02UlBTck9RbmZNWkpmM0VuREFOakJ6YUlHeTZWU1pzZGRxRUZZb3pBSFp6bTJ1dlM2UlduSjhCSlBINjkxc1VRSzhWVHhFbDNrQndlbExoaERhNEJqT05UT3NiTnVDTVhkVGtnY290clMwajRPZ1dKYW81RUNQWmowVC1IZzlYY29lLVRz?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.32235,0.32235,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.32235,0.32235,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.32235,0.32235,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&M among 94 companies to post earnings on May 16 - Mint","<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNSlVScmlTSWxQVmQ1bV9oaC1LNy1DX1JWWHNzMXc5ZFp4SnF1ODJiWXNOTURRNW9QVHNNeFZqNnQ2blNqeFh4TTkyeVZUcExVcXUtbjl5YS15TkRKTW11UXhOYTc1TU9WYWVHYV9jRF9NOW0zSGZtVWNxVlROTUlIdzF2VU5uM0o4eDdvUV95Y1VxbXRrclg4bVBKMUlzN0hmSldvbExoQ1o2ZWhPUG9GVFV1ejdIR3o4c0NzQmRXZWt3My1kZzE4ZmtqbmZfbWxNd2h0Z2JKbW9xRzVGbXVCZmZKU1EzR3ZHN2dZczNnRk1GdDV2bTc4MVdBUGNoVGk4M0JndHRIUdIBjAJBVV95cUxQaDM5Z2dXMkx3NkN1Tlk0Q3hxLW5hdU9nd01SMHRSREZiM085M2w0YzVTVVVGMXVhRUJWYmRpbm1nY3ZzVTktWUQxZndvaU5ZWHhITUNSXzN5b3R2VDdCQnBVZkw4LUlHd0p0VEtGc2E5OVA4dTdpY1FBRzNhV1EzU0lwbmNmUk02UlBTck9RbmZNWkpmM0VuREFOakJ6YUlHeTZWU1pzZGRxRUZZb3pBSFp6bTJ1dlM2UlduSjhCSlBINjkxc1VRSzhWVHhFbDNrQndlbExoaERhNEJqT05UT3NiTnVDTVhkVGtnY290clMwajRPZ1dKYW81RUNQWmowVC1IZzlYY29lLVRz?oc=5"" target=""_blank"">Q4 results today: GAIL, HAL, Biocon, JK Paper, Vodafone Idea, M&amp;M among 94 companies to post earnings on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.32235,0.32235,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 Results 2024 Updates: M&M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5"" target=""_blank"">Q4 Results 2024 Updates: M&amp;M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 Results 2024 Updates: M&M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5"" target=""_blank"">Q4 Results 2024 Updates: M&amp;M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5"" target=""_blank"">Biocon Q4FY24 Revenue at Rs 3,966 Cr, EBITDA at Rs 964 Cr; Net Profit (before exceptional items) at Rs 144 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFBJRWVIOGdUTENSWnhRUEtrbjJ3MDNLM0RnNzVBLWRuX0lCcHNPS2xsMFpqMWlxLXcyY0JpUVJWOWtFa2lQeGwyRWFsVkZFRThMWHhtbXdLRWQ?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4834833333333334,0.4834833333333334,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit drops 57% to ₹135 crore, revenue up 4%; dividend declared</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Q4 Results 2024 Updates: M&M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5"" target=""_blank"">Q4 Results 2024 Updates: M&amp;M, Hindustan Aeronautics, Container Corporations of India, Vodafone Idea, GAIL India, more announced earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMirgJBVV95cUxNLWpRV3F0SUdpaVR5ekxKMjM2bmNtZW4wMjlNWEtEOWdNWTBEZklkQlFhdkxkYjd4eTJjc2ZLRWZZZ1BMd0NRRGVuemJHVFZla3hUeHJRZUFDUF9WMFRoc2tUWmoyVTZFa0lzbjA3bVVIaVNpd2tHZERFUS1sN0lVbFdQTUVPakFaYUVIRU04ZlFGZXVjc3hoU053b0d0SmVaSUtWWlBycjZDRXMwMlladXBsYVV2OEgxQjJMOFBXOXRpbFdvNVlkRGwxS1hGcDNkOHUySUpvQUpsVnhVZzBsZ2hpTWZSbFRiSDR6ZGF5VGxQRXM5OE1rTnBxNjlGbkdfeXpTbjdIeWxRWlVsNmdJN3B3OHplTjBJcUtsYngxRUVRQ25peWlmQUwyaU9fZw?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Biocon Q4 Results | Revenue, margins beat estimates, net profit declines - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results | Revenue, margins beat estimates, net profit declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon bets on weight-loss drugs as major growth engine for the business - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bets on weight-loss drugs as major growth engine for the business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3392833333333333,0.3392833333333333,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon rises nearly 2% even as Q4 net profit drops 57% - Upstox,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5"" target=""_blank"">Biocon rises nearly 2% even as Q4 net profit drops 57%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Biocon Q4 Results | Revenue, margins beat estimates, net profit declines - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxOOVhrOXVlRzNFb1VnaTc4NWFWejZmZXJaVzVNOWltZlhSaGNKcUd3UkN2TTBwY3NqTkxwem5IZWpOdXZaNks1eC1PN0s3Yi1vZkViZXpuUTdXU2JmQ3AyVlVRdlZNMXM0YWlPaktmRkFVU0xkdzZzOC1QSVVvNnQ3b0MxTEhvTFY3TGRCMmFvekZfOVhwOUhvSmE5eXhteWhySnlfRlh3WHNGRV9mMzNzTTdXbmU1UWc5bV9WRExJZklIUWZKb3hZR2JUd1FmeF9jWkZkd2NQZzBLQdIB3wFBVV95cUxOb09jVXhJNTlGUnk4WUdXVG1hVmNjS1F2OVo0MThHVlVrMVRJUnF4Z3R6RktPQi12S0NOZjRBeHJQWVh0ZFVoRHVubkJNNDA4WlJCVEFwS0g4MkxQTlFUV3RNUFpTR0Z4SWFGT2VDMTRpSkJNVmoxU3hiY0JaTElOc3JGWUJmZ1FKeUdtLTJhSkZ6eUs4QnFaNjVrTGhTdlktZ01SNy01eFVGY3UyNXQtNFNCSXhzcUg2Y1EwVmhQOTRROUd0OGtNSnI2X19yVU9zNTl1NWlmNmMtal9QTGM0?oc=5"" target=""_blank"">Biocon Q4 Results | Revenue, margins beat estimates, net profit declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxOOVhrOXVlRzNFb1VnaTc4NWFWejZmZXJaVzVNOWltZlhSaGNKcUd3UkN2TTBwY3NqTkxwem5IZWpOdXZaNks1eC1PN0s3Yi1vZkViZXpuUTdXU2JmQ3AyVlVRdlZNMXM0YWlPaktmRkFVU0xkdzZzOC1QSVVvNnQ3b0MxTEhvTFY3TGRCMmFvekZfOVhwOUhvSmE5eXhteWhySnlfRlh3WHNGRV9mMzNzTTdXbmU1UWc5bV9WRExJZklIUWZKb3hZR2JUd1FmeF9jWkZkd2NQZzBLQdIB3wFBVV95cUxOb09jVXhJNTlGUnk4WUdXVG1hVmNjS1F2OVo0MThHVlVrMVRJUnF4Z3R6RktPQi12S0NOZjRBeHJQWVh0ZFVoRHVubkJNNDA4WlJCVEFwS0g4MkxQTlFUV3RNUFpTR0Z4SWFGT2VDMTRpSkJNVmoxU3hiY0JaTElOc3JGWUJmZ1FKeUdtLTJhSkZ6eUs4QnFaNjVrTGhTdlktZ01SNy01eFVGY3UyNXQtNFNCSXhzcUg2Y1EwVmhQOTRROUd0OGtNSnI2X19yVU9zNTl1NWlmNmMtal9QTGM0?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon rises nearly 2% even as Q4 net profit drops 57% - Upstox,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5"" target=""_blank"">Biocon rises nearly 2% even as Q4 net profit drops 57%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon shares: Why brokerages divided on this pharma counter after Q4 results - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: Why brokerages divided on this pharma counter after Q4 results</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Biocon Q4 Results | Revenue, margins beat estimates, net profit declines - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results | Revenue, margins beat estimates, net profit declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-05-17,2024-05-17 07:00:00,Biocon rises nearly 2% even as Q4 net profit drops 57% - Upstox,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5"" target=""_blank"">Biocon rises nearly 2% even as Q4 net profit drops 57%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOOHA5VTk0alhXblRnbXdFTFVtZFQzX3FyRDF3MUpkM0MwQnFGbC1uMlh2MG5OazZGdGpkR0xCemFNdjB2V2gxeDVnckhGY3FMejBSVkRTSU5xV1ljUFpxOHRfdHpzNkRsdnRQX2VILVFvOEhKeGNXazQ3SGwtQVpXeDZIT3NEMmpsZ0NWOHp2bFlQa0h5LUpQcV9xQ1EwT3k4WDE4ZW03LWFfZjQ2LUYwdjhNVGZZdms?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-05-31,2024-05-31 07:00:00,"Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGtfRXBaUWE1MlJ0MXNLNmNuRG1SMWZSVEFYSmQ4ZTEybkdXM2pBUDE2RUMtWEw1dFBDS25YTmtOQkc0ZHNPZkNFTFNlbnR3TWxyNGRVTE80UWNqcHNRWDVIZFQyQU12ei1GVmFDM0l3c3h1b05TcnpkNHFaRk1xSlNiTEIyUWZjeGV4QmxUbm9QWHp6UGNMYlo1bmpJVldTUkM4bEYxWnNoVW1BMlRTQ3dSZmVzTGU5WVg5TGxBbUpHemNTSE0tSUF6YURWNFFBOHVGajY5dWMyb3JRdDRacVdrWnpPVWxCUDBYZjlCV1IyWUQ0UERSd1RPSDQwdEl0T1pXUUxPeVBCWHotbmIzS2Jmd1NxZ1I2MW0tcmZMX0dGWHRZeDFXcnZURUxycjZTZjZIT0dCQUlWeWdzc0Zta3ZfbGs?oc=5"" target=""_blank"">Q4 Results 2024 Updates: Apollo Hospitals, Godfrey Phillips, Reliance Infra, Yatra, V2 Retail, more to announce earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMixAJBVV95cUxQZGtfRXBaUWE1MlJ0MXNLNmNuRG1SMWZSVEFYSmQ4ZTEybkdXM2pBUDE2RUMtWEw1dFBDS25YTmtOQkc0ZHNPZkNFTFNlbnR3TWxyNGRVTE80UWNqcHNRWDVIZFQyQU12ei1GVmFDM0l3c3h1b05TcnpkNHFaRk1xSlNiTEIyUWZjeGV4QmxUbm9QWHp6UGNMYlo1bmpJVldTUkM4bEYxWnNoVW1BMlRTQ3dSZmVzTGU5WVg5TGxBbUpHemNTSE0tSUF6YURWNFFBOHVGajY5dWMyb3JRdDRacVdrWnpPVWxCUDBYZjlCV1IyWUQ0UERSd1RPSDQwdEl0T1pXUUxPeVBCWHotbmIzS2Jmd1NxZ1I2MW0tcmZMX0dGWHRZeDFXcnZURUxycjZTZjZIT0dCQUlWeWdzc0Zta3ZfbGs?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-08-06,2024-08-06 07:00:00,"Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxQVFVJbkFXY3puaEhBV1VnZHVWT1BINVBRMkFwNGVPeGY0S09oR0doc1MtOXBTaWdGU0hBU3gtRzJVdnJqNkp3bUIxZ05GV0ZrdGRRZFFLOVNuRWxIeHhKQ29PckpGVkRTVl96bXYtSl9JT1FacTIxalA5NXFzSi1uRERwbEtFU2NYUDNDRTZXb0VxRGVkREttcTRGWWZKRmFFMDE3dkpLYXA5SmJOekFmNEI4UVZFekstM3lSVmQ3S1RrZGQzdkFWZFUxWmp2Mzh5YzdhU3hXS1Z6MG9sbFdnQy1iQzlvTnd2NFNSeS05TmZiNUJtdkEwUzZvQk5Fc191RjBvVTdfUkpJWmZfMENVdmYxdm90bk0?oc=5"" target=""_blank"">Q1 Results 2024: Vedanta, TVS Motor, Lupin, Fortis Healthcare, Raymond, and around 100 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxQVFVJbkFXY3puaEhBV1VnZHVWT1BINVBRMkFwNGVPeGY0S09oR0doc1MtOXBTaWdGU0hBU3gtRzJVdnJqNkp3bUIxZ05GV0ZrdGRRZFFLOVNuRWxIeHhKQ29PckpGVkRTVl96bXYtSl9JT1FacTIxalA5NXFzSi1uRERwbEtFU2NYUDNDRTZXb0VxRGVkREttcTRGWWZKRmFFMDE3dkpLYXA5SmJOekFmNEI4UVZFekstM3lSVmQ3S1RrZGQzdkFWZFUxWmp2Mzh5YzdhU3hXS1Z6MG9sbFdnQy1iQzlvTnd2NFNSeS05TmZiNUJtdkEwUzZvQk5Fc191RjBvVTdfUkpJWmZfMENVdmYxdm90bk0?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-07,2024-08-07 07:00:00,"Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch? - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5"" target=""_blank"">Biocon Q1 Results 2024: Date, Earnings Call Time, and Where to Watch?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxORHlONXphZnM4UFBJdHJnS2FVUWVWRUxCWXpSVTd5LTRFbEdNM0lCVEI2THhRX3RqMUVLS2tuQWR1ZzEtWllOVTViS2VDUHpiLTA2dkp0SFlpeXVPNU04RlUzQVg3OC1YTDFqNTNjWWJYSXUzS05xSTJ0QktBaERxSHhPS0VJSEx1VEZYRHE2M3AzVzRZYnM0bnM2U1A2ZVYyOFpQZ3dPR3RLNVd2Zmk3cmY0OXlyS3Y4a20tNWlWQ2lkaTFNTm1DVw?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxQY3d5NDlNaTB3VEljQ0NGSkVxbGtWWmh2b3Q0T3dvTXJKMzlKYXZnWW4yWHJtbVFDTFZCRWlPQTRQM1p2YXFIMEVnVUZHWmlVdTIyZDZLcjVHZ3ludkM3a3pTbVktb3B6WC1SVllJVVZTcmhIdE1MUlQtdFEyaTl1Y3Z1NllOOFhYMGJHSTM4dUt6RVVHbklTY3d2U3lGcXg2ZEhzRzV1blZCdWUtMUozSEI0UEJVVUttSE5ReDFoQWljRFQ1Snk2QlE5YVBoenh5SHBKWk9MRUg2aEo5NExBU3diY9IB6AFBVV95cUxOaUhNT3IwRFVERzJUQlhhcWdUOUhiOW5jaHN0dUZGeW4xNWhCcTdHc3RDSWUzd2ctVTRZZDN2TkJCRE00bzZacVVWMWF5dk9jM2piOTlMdHg4eUdpNGNpMkt2R0JqQjhfTUxLTG1MejJKcWlWU240aTBUY0lMVzVjZnoyaExWejBrNWhPOGRXeERNdmFKbHpTcDBsN2xKc251Tm04SndfeUE1U0pSTlJzY01VbE9OeHZFQVl6ZWo2cWNOd01wZjM2MFV2Vldtal9MQlZWZHJyUEM0b1Y1YVlsTDRtajRVMEVq?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxQUWxKQjZRbjBoMGdkRXRGeUwtY2V5dEpIYjVnaDFmQUdqeFVPaTE2RnNCQmpaN2FWWEVKUXpVaW1wWU9mdWw0S3ZDcG90dU1DQmMyLTg4Nzh6dzV5S1haUXdfdkZKelNLRkItUlVlQ3RPQnBNeUdsUDJscUhfZzg5ZTNjMm1FWW5LcngweDJoTF9oY1FKU0l2S2s1ODZNUFBpTVZ6dVpVYkpSejVwOEw2NHZlVWloVmN0bHcydHJONThPNS1EcmIzbmtXVVUxMzFxOUZ0aGlzN0bSAd4BQVVfeXFMTmZXNDVORnZUYVNHUXFleU82YnFFaDN2NUNwQmZkMHlNcDFqZ05GX3J1YjlSbnVyeGxXcU1uLUthaGpkSG45UXJINVFEVk83QXF5SWYwV2p3blhMMThNakEwVUh3dEZjMl9seGRFODFqRnBHa3ZXY3AtVUh0YXJoZXZ2d3UtRnI3R2dvMzg2SlpPamxqVUlCc0ZtN3FKQlBNRGRPTHlkU2RWMnVmU2lmQzVyM2dna3hudEE5VFphcnA4UFFaUnFkMWZab3FDQkROLUczcFNHVDFpUHB2Mjdn?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.34515,0.34515,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4559,0.4559,positive,1.0
2024-08-08,2024-08-08 07:00:00,"LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY - Upstox","<a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUzM5Rmdmek1BV3BocFpRZkJLYzBDME55Vm03cHY3bnJpY212MDA0WTd0R2dsTkRURmdra0Fmd3J0VWR4bl9GN3BYRmJucFBUeDJEYVAxZVRjdk43RWpZZ21LWXJwWHRXa2E2N3hYNUU5MFIteWxtbFI3eUZBMVU3dG4zNGFTTHNMV195Tm0tNUhVVjZpY25lSFNXaVphZVo0bkwzRFltNmlFanBzOGh5Y3g5QjAydWFnNUphdUpaQ1F6T1RzbkdZbWxYanF5OFpfdE1EVTB2dzRNY3hFbDdxQ2FpTQ?oc=5"" target=""_blank"">LIC Q1 Results Highlights: Net profit rises 9.6% YoY to ₹10,461 crore, total premium income surges 15.6% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxQUzM5Rmdmek1BV3BocFpRZkJLYzBDME55Vm03cHY3bnJpY212MDA0WTd0R2dsTkRURmdra0Fmd3J0VWR4bl9GN3BYRmJucFBUeDJEYVAxZVRjdk43RWpZZ21LWXJwWHRXa2E2N3hYNUU5MFIteWxtbFI3eUZBMVU3dG4zNGFTTHNMV195Tm0tNUhVVjZpY25lSFNXaVphZVo0bkwzRFltNmlFanBzOGh5Y3g5QjAydWFnNUphdUpaQ1F6T1RzbkdZbWxYanF5OFpfdE1EVTB2dzRNY3hFbDdxQ2FpTQ?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.34515,0.34515,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxQY3d5NDlNaTB3VEljQ0NGSkVxbGtWWmh2b3Q0T3dvTXJKMzlKYXZnWW4yWHJtbVFDTFZCRWlPQTRQM1p2YXFIMEVnVUZHWmlVdTIyZDZLcjVHZ3ludkM3a3pTbVktb3B6WC1SVllJVVZTcmhIdE1MUlQtdFEyaTl1Y3Z1NllOOFhYMGJHSTM4dUt6RVVHbklTY3d2U3lGcXg2ZEhzRzV1blZCdWUtMUozSEI0UEJVVUttSE5ReDFoQWljRFQ1Snk2QlE5YVBoenh5SHBKWk9MRUg2aEo5NExBU3diY9IB6AFBVV95cUxOaUhNT3IwRFVERzJUQlhhcWdUOUhiOW5jaHN0dUZGeW4xNWhCcTdHc3RDSWUzd2ctVTRZZDN2TkJCRE00bzZacVVWMWF5dk9jM2piOTlMdHg4eUdpNGNpMkt2R0JqQjhfTUxLTG1MejJKcWlWU240aTBUY0lMVzVjZnoyaExWejBrNWhPOGRXeERNdmFKbHpTcDBsN2xKc251Tm04SndfeUE1U0pSTlJzY01VbE9OeHZFQVl6ZWo2cWNOd01wZjM2MFV2Vldtal9MQlZWZHJyUEM0b1Y1YVlsTDRtajRVMEVq?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMimwJBVV95cUxNUVcxUmJHUV9pWjAtbnBKckRHSEF3Sk1mR1o3Rkt6QnQ4Nkh5T0VDVUtzWnk1SUFqdFdOcUVfWnRKZmUwZnNNODRYNVlEQzlYSUVQNDctNVU4TFlLYlRoSDF2VHZEZjUwMDQ3aGFOejFmOHkwbGdkTWxzbmx2bXhJd25NcXpxQS0xb1kxNGtzZEw1UjdCbmVhVWlvTkd5YmdTM2ZZcFRqOHdkdi10SS1xamtZYk9kTHVjYnJSN3VZck4zall0eDFNekJib3hRTFlYX1J2MDdWcUdMOHh0YzRqbkM1aXpRNF9mVDNRYklvRXg4OERqbTJsTjhxRE1ZbjZ2SHF0RGdLX3hEWWNUbFdxeHFCWnZzeWhFOFpR0gGgAkFVX3lxTE1HNmNvM2FMak45dVdkVkRqQmROZjdWS2JaQVhxR3R3VnBFdVBZa2VHbE82ZXVBSHNldUFhVElELXcxb1l1TUs4X1pBWkFmcWdrSWhhYTlQN2tPOEdlaXpUakxSN3Q0TzlHMFRsczhEOERCZmVxbjhORTkwU1MzN0dUZnFzUEFJYXBzdDNnSEltY2ZvejhuYlh6dFNwTV93Q016UnpGc1BNc3NxWUUweTZWXzRCbUFNc00yS0ZMYXkyOFFISjdmM2o2UHRpUGxCWVFHTmctLXlTMC01UWRuMVgwcmZuNENGSEx4OHgxeHl4RlVPdklqQkw5VVNXNGNlVzNVUDF4aW80bDBHTjR5VE1lcnZpWjg2ZHYyZVpRQnYxaA?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxQUWxKQjZRbjBoMGdkRXRGeUwtY2V5dEpIYjVnaDFmQUdqeFVPaTE2RnNCQmpaN2FWWEVKUXpVaW1wWU9mdWw0S3ZDcG90dU1DQmMyLTg4Nzh6dzV5S1haUXdfdkZKelNLRkItUlVlQ3RPQnBNeUdsUDJscUhfZzg5ZTNjMm1FWW5LcngweDJoTF9oY1FKU0l2S2s1ODZNUFBpTVZ6dVpVYkpSejVwOEw2NHZlVWloVmN0bHcydHJONThPNS1EcmIzbmtXVVUxMzFxOUZ0aGlzN0bSAd4BQVVfeXFMTmZXNDVORnZUYVNHUXFleU82YnFFaDN2NUNwQmZkMHlNcDFqZ05GX3J1YjlSbnVyeGxXcU1uLUthaGpkSG45UXJINVFEVk83QXF5SWYwV2p3blhMMThNakEwVUh3dEZjMl9seGRFODFqRnBHa3ZXY3AtVUh0YXJoZXZ2d3UtRnI3R2dvMzg2SlpPamxqVUlCc0ZtN3FKQlBNRGRPTHlkU2RWMnVmU2lmQzVyM2dna3hudEE5VFphcnA4UFFaUnFkMWZab3FDQkROLUczcFNHVDFpUHB2Mjdn?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.34515,0.34515,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4559,0.4559,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxQUWxKQjZRbjBoMGdkRXRGeUwtY2V5dEpIYjVnaDFmQUdqeFVPaTE2RnNCQmpaN2FWWEVKUXpVaW1wWU9mdWw0S3ZDcG90dU1DQmMyLTg4Nzh6dzV5S1haUXdfdkZKelNLRkItUlVlQ3RPQnBNeUdsUDJscUhfZzg5ZTNjMm1FWW5LcngweDJoTF9oY1FKU0l2S2s1ODZNUFBpTVZ6dVpVYkpSejVwOEw2NHZlVWloVmN0bHcydHJONThPNS1EcmIzbmtXVVUxMzFxOUZ0aGlzN0bSAd4BQVVfeXFMTmZXNDVORnZUYVNHUXFleU82YnFFaDN2NUNwQmZkMHlNcDFqZ05GX3J1YjlSbnVyeGxXcU1uLUthaGpkSG45UXJINVFEVk83QXF5SWYwV2p3blhMMThNakEwVUh3dEZjMl9seGRFODFqRnBHa3ZXY3AtVUh0YXJoZXZ2d3UtRnI3R2dvMzg2SlpPamxqVUlCc0ZtN3FKQlBNRGRPTHlkU2RWMnVmU2lmQzVyM2dna3hudEE5VFphcnA4UFFaUnFkMWZab3FDQkROLUczcFNHVDFpUHB2Mjdn?oc=5"" target=""_blank"">Biocon Q1 Results | Net profit zooms 6-fold to ₹660 crore, revenue flat and below estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.34515,0.34515,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4559,0.4559,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q1 results today: LIC, Oil India, Bharat Forge, SAIL, Cochin Shipyard, Bayer Cropscience, ABB & more to report earnings</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.16666666666666666,0.16666666666666666,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4559,0.4559,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 net profit up 551%, driven by gain from Eris Life partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4559,0.4559,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5"" target=""_blank"">Biocon Q1FY25 Revenue up 30% at Rs 4,567 Cr EBITDA up 117% at Rs 1,755 Cr Net Profit at Rs 660 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE51S2lXS3k2cjl0c080ZXdWcmdDUVo2YmNzd2JESi02cElxMEJQS2NUczI4S2dhc05jN3FfMEpuWVBOU2Jkc3lTcDNRbmJObzBaNDZwRDRFdDI?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-08-08,2024-08-08 07:00:00,"Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3% - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 results: Net profit zooms nearly 550% to ₹659.7 crore, revenues up 8.3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.37015000000000003,0.37015000000000003,positive,1.0
2024-08-09,2024-08-09 05:58:34,Biocon Share Price Falls As Q1 Revenue Misses Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5"" target=""_blank"">Biocon Share Price Falls As Q1 Revenue Misses Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.27115,0.27115,positive,1.0
2024-08-09,2024-08-09 05:58:34,Biocon Share Price Falls As Q1 Revenue Misses Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5"" target=""_blank"">Biocon Share Price Falls As Q1 Revenue Misses Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNRThTUmV5ZWtNaHp5NnFEYnNSSjVfSmZDMEZGU05QSi13UDNubFlrT1ZqQkh5ZmRKOUp1UmltWGxBLWZIdTJRUkJLQklTckVhZWR5eWtybXpMQkNsWXBMNDJxQnhJSDRJOG44NjYydW16el82cXJrMXBwTXRZekwyMTZ3Z0FrWHJVbHZYV25BcXRoOC1q?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.27115,0.27115,positive,1.0
2024-08-09,2024-08-09 07:00:00,Biocon Q1 Results Live : profit rise by 550.59% YOY - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results Live : profit rise by 550.59% YOY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3956045454545455,0.3956045454545455,positive,1.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,Biocon Q1 Results Live : profit rise by 550.59% YOY - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results Live : profit rise by 550.59% YOY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxOM2N1U0g1RTVLbkFXSDNxWUpINVNyeUhXUnFzMGlMeF9SWlh4N3pWR0hUTHdZT0UzUGhRcDNRLTVFSDBvODdTbDVJS21VNTRnOVpBSkt4OFB0VjZUcFVFNjhNamhsdUEtdzBub0dLYkVQQ3RZRVU1R290cW5YZks0WXhPeDVCY1VnUXVpTzZ5aVAyMDE5a3VZWjdnWUg2V0dOcDZYc1pBd3BlRk5hd1lTaTMxbHBHQzE1NnEw0gHAAUFVX3lxTE5KQVhVbGhGR3luSzlOMThtNGJUWUVEQjlRZk5hOWk0RnVXVTU5RlZvQXBpS09vbE5QXzBYSk5tZ3RfdmZyTTk5S00wNEQwLVlrenV4clVGRW5xUFN4bEcteFhmS3FMNml6Mi1UTjM4TG90cEsxem9TUzJUQ003RzlFMnR4ZENBZEo5dnNlOTRDem9YQlpiWFR0bzA5d2h6eWN5YVNUeXJYYzJkV1N5MjJMQzRpbFFHUndqcTJsbVQyWg?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3956045454545455,0.3956045454545455,positive,1.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,Biocon Q1 Results Live : profit rise by 550.59% YOY - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results Live : profit rise by 550.59% YOY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3956045454545455,0.3956045454545455,positive,1.0
2024-08-09,2024-08-09 07:00:00,Biocon Q1 Results Live : profit rise by 550.59% YOY - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results Live : profit rise by 550.59% YOY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3956045454545455,0.3956045454545455,positive,1.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,Biocon Q1 Results Live : profit rise by 550.59% YOY - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q1 Results Live : profit rise by 550.59% YOY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3956045454545455,0.3956045454545455,positive,1.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,"Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5"" target=""_blank"">Q1 Results 2024: LIC, Biocon, Eicher Motors, Oil India, Cochin Shipyard and over 150 others reporting Q1 earnings today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxQUVZZOW5KMWw0RE5ucndibjJCaEZWTkFFT0ZITW5nY1g5RzhHS3ZwT05XUFRRZENZYnk3THNpNVVTZFljQ2g4SEpsZ29xTjdpa3hoR1plLUxURi13LU9RNjBNOFpMSURlSEdTV0JKLWxXOFJHM0tRNVpPX1ZGYkZxVHdYdTJBQzVFRVFqdDkzLTBtck5YaExRdkpnWmRtN1VHZE03SzI4M085a09GN0VEYXIzQmtxazVsTzlxRVZfc0djTFBvenQxeGFsYWNnYTA3X1JfeEhUR1RFM3I0YUVlajl1ZUs3R0s1WjdEUE55aDlXdTM4M1hHZ3RXTGRiMC10LUg5X1hjNHVhVlRMRHNRX1VlVkNtUQ?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-08-22,2024-08-22 07:00:00,Generic Weight-Loss Drugs Won’t Come for Years - Barron's,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE1SYTktTkJPTE5kZ2xvRUxDWnBhSGoyMmpNZGc1aGVBaVlCMTRkZHBienRWSEdOcGFOOHljUzhOVUR1VUFzRjZ0WmFPS09sM2Jsa3pMUDhIaXpCaHo5V1lab2l5aVBKRGc0QVBHTXlOY2NRVDEtN1E?oc=5"" target=""_blank"">Generic Weight-Loss Drugs Won’t Come for Years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Barron's</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE1SYTktTkJPTE5kZ2xvRUxDWnBhSGoyMmpNZGc1aGVBaVlCMTRkZHBienRWSEdOcGFOOHljUzhOVUR1VUFzRjZ0WmFPS09sM2Jsa3pMUDhIaXpCaHo5V1lab2l5aVBKRGc0QVBHTXlOY2NRVDEtN1E?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2024-09-19,2024-09-19 07:00:00,"Stock Market Highlights September 19, 2024: Sensex, Nifty close higher after Fed rate cut; profit-booking caps gains - BusinessLine","<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxPWUZJRnRQTXNrQkx5SGdGMVZZODlVVVpROGZBQTFsWklJblJTTHVycUxOOGhnbEw4cTgtRlNITVNYMVdzVkpqYlppQ0xsdDJaY0F6QUpzQjlmd2s2ZlEwRDN3ZENwcWtmeHIxbnI2djZwTHM1Rl9qa05Iazh1ZFhwR2p6d3NkRXVtLXdGbE0ydUVwTzdLTmlQNm9wR3NaUEc5NDJSb0tYdUR6REU1TGdqUDNySkhYclhUV2NB?oc=5"" target=""_blank"">Stock Market Highlights September 19, 2024: Sensex, Nifty close higher after Fed rate cut; profit-booking caps gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxPWUZJRnRQTXNrQkx5SGdGMVZZODlVVVpROGZBQTFsWklJblJTTHVycUxOOGhnbEw4cTgtRlNITVNYMVdzVkpqYlppQ0xsdDJaY0F6QUpzQjlmd2s2ZlEwRDN3ZENwcWtmeHIxbnI2djZwTHM1Rl9qa05Iazh1ZFhwR2p6d3NkRXVtLXdGbE0ydUVwTzdLTmlQNm9wR3NaUEc5NDJSb0tYdUR6REU1TGdqUDNySkhYclhUV2NB?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.3620333333333333,0.3620333333333333,positive,1.0
2024-09-24,2024-09-24 07:00:00,"Federal Bank, TCS and 3 more: Axis Direct recommends buying 5 stocks for 5-15 days | Check targets, stop losses - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">Federal Bank, TCS and 3 more: Axis Direct recommends buying 5 stocks for 5-15 days | Check targets, stop losses</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,-0.08809999999999998,-0.08809999999999998,neutral,1.0
2024-09-26,2024-09-26 07:00:00,Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Accenture raises FY25 revenue growth guidance to 3-6% despite FY24 miss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.3426,0.3426,positive,1.0
2024-09-30,2024-09-30 07:00:00,Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-09-30,2024-09-30 07:00:00,Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-09-30,2024-09-30 07:00:00,Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-09-30,2024-09-30 07:00:00,Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Share Price: Pharma stock drops ahead of Q2 results; Macquarie has a say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26335,0.26335,positive,1.0
2024-09-30,2024-09-30 07:00:00,"Stock Market Highlights: Nifty, Sensex record biggest losses in two months amid broad-based selling - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Market Highlights: Nifty, Sensex record biggest losses in two months amid broad-based selling</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2024-10-23,2024-10-23 07:00:00,"Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q2 results: PAT down by 8.93%, revenue drops by 2%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,-0.025925925925925925,-0.025925925925925925,neutral,1.0
2024-10-30,2024-10-30 02:53:53,"Tata Power, L&T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5"" target=""_blank"">Tata Power, L&amp;T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2202,0.2202,positive,1.0
2024-10-30,2024-10-30 02:53:53,"Tata Power, L&T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5"" target=""_blank"">Tata Power, L&amp;T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2202,0.2202,positive,1.0
2024-10-30,2024-10-30 02:53:53,"Tata Power, L&T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5"" target=""_blank"">Tata Power, L&amp;T, Biocon, Dabur India Among 77 Companies To Declare Q2 Results Today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQ295cDZSLU42WGxfd0JEa2s3YXBWcWJVbUZteDVNWXZuaVhqc1gyeFZtdjZaWUg1bkRabjJkT0puVjVIMTYzMXhhdnBEcGhiSTQ2c0xZRl9mWkN5S0IxRERIY3NDZWZEd1FjbHRpU25GUmEyR0hTbmJWNjBIY3FNOW9PRzNmT1lLWl9SZEgwd3YtTlpSNXdBaHdIM256ckVtS0dDdEwwdmhxcW9iNm1vU1J2eXllTlpHU3NKSHFqdVRuems?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2202,0.2202,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.25203333333333333,-0.25203333333333333,negative,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxOUHJRdzdPdWFCVnNCX0hBcy1QMVRtQ01PUjhOZ1ZIcUFaWk1iaHBTcHd2eGNEaHhXVzh0bTA2d3NOSW5vdXJZLWk0MXNLNUwzc0dDN0VJbDF3bks1cWRSMm4tN21OZ1Jmd0EwX3ZaTW5ZNV9zUkoyUlZTajlEWll2cDR3XzRKV3dmdUdzQzFhMkhBdEtlR2RVZDBMdGRJXzNscURQSDU0ekx1ZE9PQk9HX01kSEphZDJRTFdSUkFvQ1Z6WnJMU1pJektpbXdhREXSAdQBQVVfeXFMTlZYeUNfdllYbFZpaVh2ZEdCSkFreS12VXFoLTNCVzBZUFBfall1dUQ4NERhenEzVHBTREFzdHV3eFlJYUFXVnNReUhOeXJ4enRQdHMtZktKNF95d1lMS3ZqNFdFMTFNdjVGUm10aHlzdG1xRGNIRnJGbjRFbmRQREV2ZlNGa0k1dTJZa3pjSzhKbEdPcmpmd3RGNXpockVqVW1GQ2xEVURiWlY1VW9ib1VveDFnNWZhRmVRQWltdFRON1RNQXJlemhVazNyMWdVQUJRVkw?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26781666666666665,0.26781666666666665,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dabur Q2 results: Net profit falls 17% to Rs 425 crore on low urban demand</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.1366,0.1366,positive,1.0
2024-10-30,2024-10-30 07:00:00,Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Unity Small Finance Bank Q2: Net profit rises 36% to Rs 187 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,-0.30501666666666666,-0.30501666666666666,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNREI0SFBuWExKSUc0X2k1ZnItS1VsT0UxNkZ1ZTY2X0Zoamhtb1NHbzE3YUp6enc0ZUZoSW9XLW9DS255MGFXQlJHSlRlUEpkczRncGtDbHBjb1pSQkhmeElQMl85TXFrVGY2SjV6TWJiSWhNbXNFQnp3NzJsOEpmYVJCR21QdXIycHVKbmNjdUNlRm5jZklvQlhCVi1mOGpOUjRmNGx0R2kyRzFiS01nLUx5SDVOeWZmQ1EyZmYxYVVCVjRZYWxQN3lsZnRpNjFmOFhV0gHYAUFVX3lxTFBqbkRyc25nQjl2dl9LNGJ4SmxSWThPZXBCSG1SZV8tUkQ1eWw5LUF4QUczdDAyLXBjMDNycGJ4NnJkWVFCQ2I3Snk5dVFoYkI5czQwWkszZkh5cm9DMmNhZ0pWRGxCX2NzX1drNmpwR0gwRUh3QlJQZUFiY1p5NHVFbmo2Z1VEUk56M05xWmwzb2U5ekpxVUtiX21aS2RKSm5COU9fNXhrX09BVDBTOFlTdXkzaEJJRW5wOWlMUG9nZ3lhQkp0Z0MzbnlNd1dibHk2Z2IzNmFmVg?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Events on Oct 30: Tata Power, Biocon Q2 results, Choti Diwali, India-China resume patrolling at LAC, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.26781666666666665,0.26781666666666665,positive,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 net profit declines 84 per cent to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3774227272727273,0.3774227272727273,positive,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4% - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNREI0SFBuWExKSUc0X2k1ZnItS1VsT0UxNkZ1ZTY2X0Zoamhtb1NHbzE3YUp6enc0ZUZoSW9XLW9DS255MGFXQlJHSlRlUEpkczRncGtDbHBjb1pSQkhmeElQMl85TXFrVGY2SjV6TWJiSWhNbXNFQnp3NzJsOEpmYVJCR21QdXIycHVKbmNjdUNlRm5jZklvQlhCVi1mOGpOUjRmNGx0R2kyRzFiS01nLUx5SDVOeWZmQ1EyZmYxYVVCVjRZYWxQN3lsZnRpNjFmOFhV0gHYAUFVX3lxTFBqbkRyc25nQjl2dl9LNGJ4SmxSWThPZXBCSG1SZV8tUkQ1eWw5LUF4QUczdDAyLXBjMDNycGJ4NnJkWVFCQ2I3Snk5dVFoYkI5czQwWkszZkh5cm9DMmNhZ0pWRGxCX2NzX1drNmpwR0gwRUh3QlJQZUFiY1p5NHVFbmo2Z1VEUk56M05xWmwzb2U5ekpxVUtiX21aS2RKSm5COU9fNXhrX09BVDBTOFlTdXkzaEJJRW5wOWlMUG9nZ3lhQkp0Z0MzbnlNd1dibHk2Z2IzNmFmVg?oc=5"" target=""_blank"">Biocon Q2 falls short of estimates; net profit dives 84% but revenue up 4%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.25203333333333333,-0.25203333333333333,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 results: Net loss of Rs 16 cr on high tax, revenue at Rs 3,590 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.25203333333333333,-0.25203333333333333,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 FY25 results: Net profit declines 84% to Rs 27.1 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5"" target=""_blank"">Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA2dEprTHlEWHQ0Ty1nM1dqczRKcDJUbFd0TVBGeElMRDUtcFZjZmtIUmZhYV9QSXU1eGJ5UkF2eWkwY1pmbFdORGxteE0tbHdhTEJDS2xtb3Q?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q2 Results 2024 Updates: Biocon reports loss of Rs 16 cr; revenue at Rs 3,590.4 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2787,-0.2787,negative,1.0
2024-10-30,2024-10-30 07:00:00,"Q2 Result 2024: L&T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5"" target=""_blank"">Q2 Result 2024: L&amp;T, Dabur India, Biocon, TTK Prestige, TCI Express, others releasing Q2 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxORWhaZ0l5RU1KdEhnM01LSXZiVmpreEVmdk9JcHVjM3BuUVZka1BRa3FwQUFPQXVsRkJHMkdFT3FSZEVFaDZ0R2VmQmxWNVQtS0pJNm1oNndjWkhMZ0FvcHN2dFFjMUhPaGYzZmlLdnNmLVhlanhNYVgxaVRSU0VtYTVqemxjdWVlSy1ROTZZOHpMMXUzVmVTRVZkaEFIQ3pMRnJyRUVBdzlISkUzWFhETTZTb1NLTnNPaFJjS2R0eUdwSXFCSW5zNllHVkpvNzdCTkpvdnZ2NzFYTEpDcmljeDhUZFdyUHdsMjhEY1FaT2ZNTFdLSkl5WmhjdUE?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2024-10-30,2024-10-30 12:14:28,Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.43205,0.43205,positive,1.0
2024-10-30,2024-10-30 12:14:28,Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.43205,0.43205,positive,1.0
2024-10-30,2024-10-30 12:14:28,Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.43205,0.43205,positive,1.0
2024-10-30,2024-10-30 12:14:28,Biocon Q2 Results: Profit Falls 84% But Beats Estimates - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5"" target=""_blank"">Biocon Q2 Results: Profit Falls 84% But Beats Estimates</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQS3MzZ1Y2NVlPNTVmZ3ZDbE13RHl1b0wwaDlZX3NuUV9HWWx5S0NQSXJmcVphX2pPMHA1Ty1lUklHdXRrNGQwWm1xNE1oTkdRcm8ycURNQlp4NUgyelFkdzE4SThIMHB6VmQ1QXRESHM4TWY1aFNfc29kaXhEYkVKakE4RkZPTnpoZHZKQTJmcGo2SXk4bG1ZMjFBZ00?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.43205,0.43205,positive,1.0
2024-10-30,2024-10-30 15:10:57,Biocon Biologics' Bengaluru Facility Receives Voluntary Action Classification From FDA - NDTV Profit,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOOEo0Rm01VWZTd1FIcDQxSmxEN2p4UEUxaXp0T3lXS2t6R3p5eDlMLVNZSTMtMUgxemtrQ2R2LXBpOTdNeUw2bTJ2SnRrSjdwOGxveGx1OGpoWGxVQTMyWEFaeUM1RWw0S0RRUEo2SHFrNnd3bkdLTmlTNzRlNXdONl9GZVY3V29KejJyNGpCS2hORWhQUnE3cklfb1FsMElHTlB3M0RxbWRyQlpEQjk0NXVYMmU2T3A5UTg1ZWNn?oc=5"" target=""_blank"">Biocon Biologics' Bengaluru Facility Receives Voluntary Action Classification From FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOOEo0Rm01VWZTd1FIcDQxSmxEN2p4UEUxaXp0T3lXS2t6R3p5eDlMLVNZSTMtMUgxemtrQ2R2LXBpOTdNeUw2bTJ2SnRrSjdwOGxveGx1OGpoWGxVQTMyWEFaeUM1RWw0S0RRUEo2SHFrNnd3bkdLTmlTNzRlNXdONl9GZVY3V29KejJyNGpCS2hORWhQUnE3cklfb1FsMElHTlB3M0RxbWRyQlpEQjk0NXVYMmU2T3A5UTg1ZWNn?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.25353333333333333,0.25353333333333333,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.05135,-0.05135,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.05135,-0.05135,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.05135,-0.05135,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxNUHRjMWxPeGVTYnNxbDltanJrZzVZTUtBUm5MUFBxbF9HR09LNzlQcWR0bC01WENacWF4amJZQ29xZEJxOWo2eDZiU3RiTzNVUDlmZ2lGVjV3SUdBejM1d1Fkd0FYY1dZdE9hNmlrZkRmbU5tT1JWS1VJTkNsVkpYalFibVNWU25BSW5VcDRBa0pHQWtUMTIzOTVrT01BN3VLaXV2MkdIZl9FMjRpSTdzWVFTSEhBeVRlU0RwQnhVZFVuSTFERnNpWmVHYXM5Z9IB0wFBVV95cUxNRVJHbXRrRUFHN1JuSHFqV0FhNkliVWdfdzJtQnF5Qi1HUlRBT3Iza2dYZ09OSktjSWRxN2R5MVdyY2w1c3BoVGp0VThQaHVXbENvS2QxWXltOVdlT1phR29wMmhPMEdHTFJtRkJjMkZGQkNOQ2p0NVhhUWc4Z085TlRIMGhxU1R6cEZyU19FM1pvY0lSTjJWemV6ZjRucHF0eFFabkNpajhGNWR3LUV6ZkVnZk1CZGdQZVJFZmNxWExEc3VLdE5fLTY4aUJMYnJCTUVn?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.05135,-0.05135,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q2 Results: Loss at ₹16Cr, Revenue Increased by 3.7% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.05135,-0.05135,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-10-31,2024-10-31 07:00:00,Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 6% after Q2 net profit dives 84%. What should investors do?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4735,0.4735,positive,1.0
2024-11-01,2024-11-01 07:00:00,"Biocon reports loss of Rs 16 crore
on account of higher tax - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon reports loss of Rs 16 crore
on account of higher tax</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.20142727272727273,-0.20142727272727273,negative,1.0
2024-11-04,2024-11-04 08:00:00,Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5"" target=""_blank"">Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.125,0.125,positive,1.0
2024-11-04,2024-11-04 08:00:00,Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5"" target=""_blank"">Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.125,0.125,positive,1.0
2024-11-04,2024-11-04 08:00:00,Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5"" target=""_blank"">Biocon's Q2 Results Decoded. Exclusive Interview With Biocon's Management On Earnings & Plans Ahead</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNOFRSeV9RYjNvX2d3aVBjTDdyY3Z4N1FPVUxqZzROVnAyZ1VmUldDLUdsSUNpeUdncG9MT2tuOF8wdUtwQXRyNjNDWXlPOXdvVnJ1U2hqRnYyVUQ0Z1ZaRkEwNDBUZ3FSNWxPT1lPZzBvN05iVjUwRnpBQjNyR0lYdTdYLUJ4THFSajIyS0NkYVZpaTQxN2h3b3JBN0k2TVlqNUl3WG9GSl9XSzk0QVM2cXJBSUFFWm5CTy03cUwzVTR6S2VSQldwUnBxZUE0MVJ3dnlwYzJFM2sxV1RMZk9mTjlKbTBLaHFRSXdYcEJORXl5d3ZXcHoydWl30gH_AUFVX3lxTE9ael95d0tPbmxvZHNhZndFM1lMREt2aGVXN2pFT2lYWEpzb3pTUVF1N05KZE1mcHNpdEJYX0dvNDFSVVUwV0Q4NWtNblQ4TUVFcFVFNzJOb3VZSkRBaGFmd3dqMkxnYzBsRWpWZ212N2FNR1p2MGl4NnJ1MHdkUHNfQ3kyazNHSEptUmtoQWx5aDBhR3J0SVVVeVpTZnBsUkxhSG5WZERtM0RpT2poUTBSMnlGbDJBSlVpNDZ5cV85U2dpWDdJTWxCZ1lTM2x3NS1WdGhKNVdpWXl5b0l6Sm1GeUl4N1VneXZxaUpDN2ZUUjhXUjZOV2s1TlZIYW1XTQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.125,0.125,positive,1.0
2025-01-23,2025-01-23 08:00:00,"Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-01-23,2025-01-23 08:00:00,"Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6% - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene International Q3 results: PAT rises 17.6%, revenue up 10.6%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-01-23,2025-01-23 08:00:00,"After Axis, HDFC Bank, investors eye ICICI Bank Q3 results; what to expect? - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">After Axis, HDFC Bank, investors eye ICICI Bank Q3 results; what to expect?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-01-29,2025-01-29 08:00:00,Waaree Energies share price rises ahead of Q3 results announcement - Upstox,"<a href=""https://news.google.com/rss/articles/CBMi7gFBVV95cUxNU3p4ZXpVajdrWjF3S1ZMb0RORXZ4c0p3WkQ0TkpSQ3diMHNBM0pBMXZwVmJzZTBmNldpdHdfbXR1MzdJME5UbnprOXFFZnN2QXJmdzRsQU56ajFXVERTLVNNRlpxX18xUWVMMjdtRnhXemNfbENxT2NfY1c1bmVOWlZHUnRDdXJDS0V0Q1pxU3l6NjVTUXBOdnRmRTJDWXpPQUk4MTZFS3MxcFhiejhhLTAzTUs0c1p1clBYb1NRUzJxNFhhNkFudzJheW8xSG1XSVpuMk91dUpSUG5uYlo5dUVFUVB3RGx1bnFkWjV3?oc=5"" target=""_blank"">Waaree Energies share price rises ahead of Q3 results announcement</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7gFBVV95cUxNU3p4ZXpVajdrWjF3S1ZMb0RORXZ4c0p3WkQ0TkpSQ3diMHNBM0pBMXZwVmJzZTBmNldpdHdfbXR1MzdJME5UbnprOXFFZnN2QXJmdzRsQU56ajFXVERTLVNNRlpxX18xUWVMMjdtRnhXemNfbENxT2NfY1c1bmVOWlZHUnRDdXJDS0V0Q1pxU3l6NjVTUXBOdnRmRTJDWXpPQUk4MTZFS3MxcFhiejhhLTAzTUs0c1p1clBYb1NRUzJxNFhhNkFudzJheW8xSG1XSVpuMk91dUpSUG5uYlo5dUVFUVB3RGx1bnFkWjV3?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.36755,0.36755,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,Biocon's Q3 revenue up 10%; banks on obesity drugs for future growth - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Q3 revenue up 10%; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.1909,0.1909,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxQcGZfVHI4U0hJLVp2cFhlYVNlSm1jaUFaN0lZQk5mOE1uejJwVm9MLUdUblcwUjhoOEhJT3Q1ZW5VN1ZicGJTMHBPcy1tTUdrdGtaZFRfbXBQcHplMzVIQUVPRTVWVldMTnNNOGhpUUJkSThjZ2VEU0FzTWxwWGRDRDdTeUNqek9FQXFSdHRmM3N2TDRrSHZwTldhUmpNZWdScjhRSjUzX0JuTVRraUxRNjR4MzZyVXJBZDFqaHBaUE5OdnAzSlNRbDB5NTczNFFq0gHWAUFVX3lxTE42Vm9yYkVvS3N3VkY1QlZXTEphNU1fY1Z6WXFvaldOYWFxUUxybGdoYnJ6bU5LdW01eHFuUlFoRUlWNy11LWxwaktYdjNvRFB1bnBCek9Kb0k5YnBzWnRGOTVSbGZlZEpwdExlX21QOVp0a2dVdWZjLUdLMFhIaDJ2ZDROTFNCaWdPd2xrc2lzc0lLaEp1WnhMMUZpOWVXT3ZnbDlXcFlqY0dGNWM2NUIzYjQ4VkhMLUFOMUZmS0xFaENYRWRodEZpYzFnNlQwc0V3UGVidEE?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxQcGZfVHI4U0hJLVp2cFhlYVNlSm1jaUFaN0lZQk5mOE1uejJwVm9MLUdUblcwUjhoOEhJT3Q1ZW5VN1ZicGJTMHBPcy1tTUdrdGtaZFRfbXBQcHplMzVIQUVPRTVWVldMTnNNOGhpUUJkSThjZ2VEU0FzTWxwWGRDRDdTeUNqek9FQXFSdHRmM3N2TDRrSHZwTldhUmpNZWdScjhRSjUzX0JuTVRraUxRNjR4MzZyVXJBZDFqaHBaUE5OdnAzSlNRbDB5NTczNFFq0gHWAUFVX3lxTE42Vm9yYkVvS3N3VkY1QlZXTEphNU1fY1Z6WXFvaldOYWFxUUxybGdoYnJ6bU5LdW01eHFuUlFoRUlWNy11LWxwaktYdjNvRFB1bnBCek9Kb0k5YnBzWnRGOTVSbGZlZEpwdExlX21QOVp0a2dVdWZjLUdLMFhIaDJ2ZDROTFNCaWdPd2xrc2lzc0lLaEp1WnhMMUZpOWVXT3ZnbDlXcFlqY0dGNWM2NUIzYjQ4VkhMLUFOMUZmS0xFaENYRWRodEZpYzFnNlQwc0V3UGVidEE?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.31845,0.31845,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,Biocon's Q3 revenue up 10%; banks on obesity drugs for future growth - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Q3 revenue up 10%; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.1909,0.1909,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.31845,0.31845,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.31845,0.31845,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q3 results: All business segments grow; EBITDA up 16%, revenue rises 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOZkZjYWR0WF9qd0tUSDhNUk1sOWNiaGVLYTZkS2w5MS10ejVzSmdYTkNJNGczVlJiR2lDb29WR1M4Q2c4Qkd0N0JmQ0gtbEc5aV95eV9aYjFmWGk5cFFZTVhrR1ZYaVl1M3RhWFB2Q19oRW1HSFJzUlE2Z0oySnhVMjdON1BYZUZ3QXUtM3lOTFF1ZEJjYlJFR1NZS0dUMHlpREk2bU9TR2d6VlB2bU5QdHZiNkh5c3kxYTRZMlI3NUtPRGt3Skp5MGhtWDRuWUVBanhXV1dRYk0wd1Z3Vmx5aklB0gHnAUFVX3lxTE54b0FhZnFxdXc2dzVwbkRCTGxjNlFfOGRqcTJvaWt3VEVaOXVFR3N0MWRCSTBZQkMzZGJCV3MzaXFpaF9wd0xxSmhhTEt6ZU5zUDRuSHY4TkVmTGJzNUZhUDJ2djVJUDg4Sk9WOUNpRU5iXzNZSnFZbGVkR0ZkeGNxa1hmRkk4UVc4aFppeUVpSW9PUEZocFZmak9wQzZjS3NWbGlyT0M5aERUdU9Bd19OYjZuLTZVY2g4QnFHcjhCX1kxV3RSaGRicnd1T3RRU08yTm1qUkNQM2M3ZExWODRlTU8ycWlKNA?oc=5"" target=""_blank"">Q3 results Highlights: Bajaj Holdings' revenue up 17%, CONCOR's growth offset by margin slips</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.31845,0.31845,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxQcGZfVHI4U0hJLVp2cFhlYVNlSm1jaUFaN0lZQk5mOE1uejJwVm9MLUdUblcwUjhoOEhJT3Q1ZW5VN1ZicGJTMHBPcy1tTUdrdGtaZFRfbXBQcHplMzVIQUVPRTVWVldMTnNNOGhpUUJkSThjZ2VEU0FzTWxwWGRDRDdTeUNqek9FQXFSdHRmM3N2TDRrSHZwTldhUmpNZWdScjhRSjUzX0JuTVRraUxRNjR4MzZyVXJBZDFqaHBaUE5OdnAzSlNRbDB5NTczNFFq0gHWAUFVX3lxTE42Vm9yYkVvS3N3VkY1QlZXTEphNU1fY1Z6WXFvaldOYWFxUUxybGdoYnJ6bU5LdW01eHFuUlFoRUlWNy11LWxwaktYdjNvRFB1bnBCek9Kb0k5YnBzWnRGOTVSbGZlZEpwdExlX21QOVp0a2dVdWZjLUdLMFhIaDJ2ZDROTFNCaWdPd2xrc2lzc0lLaEp1WnhMMUZpOWVXT3ZnbDlXcFlqY0dGNWM2NUIzYjQ4VkhMLUFOMUZmS0xFaENYRWRodEZpYzFnNlQwc0V3UGVidEE?oc=5"" target=""_blank"">Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxPR3FxQ0s3b1FNLWg1VW1rVE5EMHRsdXUzVjZKR0tQZU1GbU83M2JZTzlSRkFoUkpXaWc0aUlfeHVzVTdJZ0s1czMzX1RZVk1TdVUyQWVxaEFOUjhCanQ0X0VFSy05Tm1lNDF4dk52ZWJpbkxVNWpNRHlMdWdQVm1aYnI0M2l3andmOE1RQ2dqYmozZE8wRWJWTEEybU9LcHdFWTFwVjR0SnhLb2VTZnNuWVZHdlRMZWp6SUtxbTVrSXJVNXBSR2s3alYyb2dpWlNCNW9lTzA4bGkyQjAwanRxNDRuTTJWVzgxTjZrVWRHLXlNNHhudUl0dER0dmIwQdIBgwJBVV95cUxPNVJYWV9OdWo1WnBCdmlzaFRxVXQtUURDUVlNSUg0ZWRsMDJ2RFB0dmtNM3NZTGxuRFBpbGFTelF6TlVDZll3VUhoMm1mRVJHQkhpRGoyRHJlZlVwdzZoVktaWHljWk9FX1RvZlplaTM5VmQxRHhZYTJJamhFc0lyOFlJeEoyX0tQOHotc3otRF9VLXlqUkFYc1VlQVZRRTZtSG0wSHVzSVZ1c0FyaEthQW9HcWJCTlZzQm1pYmdVUTNYUmV2eG1tQi02RXljNHlzWDE5VkZVREZhUE5XRm5CVlVscG15OHR0djctVUtmb1BQbmpuWGtIVVhIakJzSHdvejR3?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxPR3FxQ0s3b1FNLWg1VW1rVE5EMHRsdXUzVjZKR0tQZU1GbU83M2JZTzlSRkFoUkpXaWc0aUlfeHVzVTdJZ0s1czMzX1RZVk1TdVUyQWVxaEFOUjhCanQ0X0VFSy05Tm1lNDF4dk52ZWJpbkxVNWpNRHlMdWdQVm1aYnI0M2l3andmOE1RQ2dqYmozZE8wRWJWTEEybU9LcHdFWTFwVjR0SnhLb2VTZnNuWVZHdlRMZWp6SUtxbTVrSXJVNXBSR2s3alYyb2dpWlNCNW9lTzA4bGkyQjAwanRxNDRuTTJWVzgxTjZrVWRHLXlNNHhudUl0dER0dmIwQdIBgwJBVV95cUxPNVJYWV9OdWo1WnBCdmlzaFRxVXQtUURDUVlNSUg0ZWRsMDJ2RFB0dmtNM3NZTGxuRFBpbGFTelF6TlVDZll3VUhoMm1mRVJHQkhpRGoyRHJlZlVwdzZoVktaWHljWk9FX1RvZlplaTM5VmQxRHhZYTJJamhFc0lyOFlJeEoyX0tQOHotc3otRF9VLXlqUkFYc1VlQVZRRTZtSG0wSHVzSVZ1c0FyaEthQW9HcWJCTlZzQm1pYmdVUTNYUmV2eG1tQi02RXljNHlzWDE5VkZVREZhUE5XRm5CVlVscG15OHR0djctVUtmb1BQbmpuWGtIVVhIakJzSHdvejR3?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3787214285714286,0.3787214285714286,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5"" target=""_blank"">Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTFA1YlREZW90TW8yN3NfMzlNRkthazI1QVpTOTlOanhyd2twdWJIZWJNMWJWUC02Z1B2NmhMTi00eTlVZ1lZcUJOU0xHYzhfT2dEeGJoZWdwOWs?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Q3 Results 2025: Tata Consumer, Adani Enterprises, L&T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5"" target=""_blank"">Q3 Results 2025: Tata Consumer, Adani Enterprises, L&amp;T, Max Healthcare, Dabur, Biocon, others releasing Q3 results today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMilwJBVV95cUxOekJDRVpPdWdGMFlTSU44REJwZi1hWlpuT2IxZ3poVC0tUVNGd3RmUk9maEpoQUVQMlo1aWlicE9LazE3bDllVFVqeWk1Z3FVWVZlZzhCSGNKTnRJcHdlZW1UYkF0bDZRNUlQTkJoS2J6UmotbV9sMl9UTkFSLVNBWmQtaU01cUVLelFmSlliaWpvOHVoRzdWWktFN1pWSE5lNXJYOXZvSVlDYkIwRjJnQ09MMDZEVXJCLTFEV0RGM3lLcVI0RHREMzUyNFlGaG81U1RPUEc5bmxHR1l1Wi1RbXo4RXJDQ3hmYmh4anREMTdwSlZBSG5KX0dXdzE0QUtqbFQtblpENlFIYzUwcTFreFlxYl9EbG8?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5"" target=""_blank"">Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.39364814814814814,0.39364814814814814,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Biocon's Q3 revenue dips; banks on obesity drugs for future growth - Reuters,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5"" target=""_blank"">Biocon's Q3 revenue dips; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.1909,0.1909,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7% - BusinessLine,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYXBMLUU1OTNhUjJ6MVp3TDJHSDEtLXlHQjJzUm9DeG9XZy1LNFlieGl1YWV4aGNWQlVwSHNpQmdfRUx3blZqc1E5RnNBMGJ3NnFNQjRZN216RGJVbGJjek5qaVlGMC1IMHdscGppTm15cUNIZzRqTVBRZ2o4Mk5yWDFlZWZpdFNQVlFOdkgySUp0SWtmOVdlblpYWGhsa2R5MHJOdHFEWXlDT0l4c3RFVUt0bUhLUWxw0gG_AUFVX3lxTE5oa2VVMUVPX2RhQWVsdFYwQml4eUM0R0V1TmkwSW0zLUFSb1BCZHpJNTBkeFNkVGNjSEtyLTVLMzhwejU5N2VKQ09TQ0ttdlNGdFlTZHZwdThpSVI2VDVSVk1Va1V6T0o4cHFGbHA4QjR3b0VDdndLTGVKUWtQLTFHaU1QSFhYS0phOUV2NFAxajluOVNLeTBwMk1RNk9ORGZkOGxLVzE0eWVWODJuWVlNc0dtUW53N0dnNmQ3b3dv?oc=5"" target=""_blank"">Biocon Q3 Results: PAT plunges 96% to ₹25 cr; revenue up 7%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYXBMLUU1OTNhUjJ6MVp3TDJHSDEtLXlHQjJzUm9DeG9XZy1LNFlieGl1YWV4aGNWQlVwSHNpQmdfRUx3blZqc1E5RnNBMGJ3NnFNQjRZN216RGJVbGJjek5qaVlGMC1IMHdscGppTm15cUNIZzRqTVBRZ2o4Mk5yWDFlZWZpdFNQVlFOdkgySUp0SWtmOVdlblpYWGhsa2R5MHJOdHFEWXlDT0l4c3RFVUt0bUhLUWxw0gG_AUFVX3lxTE5oa2VVMUVPX2RhQWVsdFYwQml4eUM0R0V1TmkwSW0zLUFSb1BCZHpJNTBkeFNkVGNjSEtyLTVLMzhwejU5N2VKQ09TQ0ttdlNGdFlTZHZwdThpSVI2VDVSVk1Va1V6T0o4cHFGbHA4QjR3b0VDdndLTGVKUWtQLTFHaU1QSFhYS0phOUV2NFAxajluOVNLeTBwMk1RNk9ORGZkOGxLVzE0eWVWODJuWVlNc0dtUW53N0dnNmQ3b3dv?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,Biocon's Q3 revenue dips; banks on obesity drugs for future growth - Reuters,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5"" target=""_blank"">Biocon's Q3 revenue dips; banks on obesity drugs for future growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxONGRVNGRtX0pPNGtSTmJyQ1ZEemIwZWR3TnBwY2xLTWtMZEdpUDZJQWJoaTlKZ3BuQ3lHandTV2RUQnZsLWFGMjlKNEhOS0FidVRLOURoZHNvRERtV2N5SS14d01DNlBUTmI1TWdyUDhmcmtmVHN1UXNDdktxSFJEODJEalVXbjZ0UkFsU3V0ZzJKVWE3UldYUTVYZzZfR2d6dFF0RGR6dzNadVk5b0Q2cWRwUGdtNHNXb29CMWtlTHFxam1jV3BlTQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.1909,0.1909,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQk1MTVBQdzB4bGxhdlQwbFczS0lNUkk0SGFRMC1scUtramE4cGNkakNGazhIMnlLZ0cyYkdNZ2tKR1BXc1l4SFlnQldzSUJrcktoX3FwV2UyT3RHbW45NUNZTkFOVHRRNTNmb1kwRWZOVjJvLWZEZ3hkTUdSWlNsY1ZRTHYyTmFycHNIT2ZrMWlLR05DYTFEUmlvaGlzaTZEQ0xjdThWbjJtd2hiR25BbWVITC1vQ1JaRkxZbV9jVU91Z0cwNWgyMVEybmFyMlFz0gHWAUFVX3lxTE4tZFhjVF9GRVFKRVhqZV9EcDR2TzFOQ2x2UU1LNnRmajZpbTBvbnNkNHdWYlRndmpSTFBzQ3VJQXhLT2pLOXRPT3lsMFBWU0ktRU9uNXpUUUJESGRndHNUZ054NkE0Tm9McjNEY01tYUd1ZURXblBQSUhpelExWG1BRm1IcHpTeVo2V2I1b1J6NWd1RWo4U3hhQmxiY1BYSGppdHR1eFpacnVQWmhXN3luU0pCQlEtSGxNWnpQc19VSW1PNFhHS21PcV9zYWY0NEgzV1FRVWc?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5"" target=""_blank"">Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.39364814814814814,0.39364814814814814,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Here's why Biocon share price gained 4% despite fall in profits in Q3 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price gained 4% despite fall in profits in Q3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2921,0.2921,positive,1.0
2025-01-31,2025-01-31 08:00:00,Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5"" target=""_blank"">Q3 Results 2025: Vedanta profit surges 70.01%; Pfizer profit down 1.83%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQam5XbmE5SF83MzE2UTRLMW5mVDRKLVdtbnN2VlFGbGxwbVZRYjVqdnpNdHJQNDdHc2pzb2t4XzNxVnlfZlRUWHZUWURjbnRHVFJHNWgtU0tBN0J4QXZERXVvd1VhVTN2QWV0OVE5RERJZVNQZVNZQ2ZXSTIxak44QUhkR0ZJaWluVW1ILV9MWFRqSm4xcnpsNGpaakxuZDRFWXd2Rk9DaUEzR2Y3eDdrLVJsQ2N5Q2FUWWZBX3ZpVms1N2U0T2VlT1FheXVrX1hqU0FEX1Z6Tmtmak52ekFNWkF1LVJQSWpvSVdSb2ttT1hLOGhhWmcxUUxn?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.39364814814814814,0.39364814814814814,positive,1.0
2025-02-01,2025-02-01 08:00:00,Biocon Biologics investors are more confident after revenue growth: Mittal - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQVnhiSEVxdF8zUjNXbWFBRF9ud0tFckRhY0NFX01NcFN2d3hnbUFuUlVvQ0UtWXpnSDJOMXVRU214U08zV0hUMk5zc19LNDFueFQ1TDQ1U0Q3RHpZazFXNnpJWHlWcXQtWUhpNEhzSlEzZFhFLUN0aG5mUGZFR1BoNlVFY0FjSGs1MUxWbm1OaGtvZmFaZERKQ210WVdoWk5vQlhYZHdoa05ISWp4cW5DSmFZQmNra0FGYWFqUW0xdWQwR25vVTc1U3VKTEZOVEdyZExjejFiSzVoWkdS0gHiAUFVX3lxTE5VbTRBX25wMVNzUGxMVTR2TFZuV0l6NGt6RjhMeC0yeE1WUXBDTEVMcDBvLW1tQkNrQVF6MUV4WnloLVZLbUlMNnNxOXN3eDZ2RXN6MzhJbnpQRlFGSUN1STVtS3IzcEZTcndqSGZEOW5ZNF83SGRnanlBV1M2MmViNC1xTG5iU21zR3VJdXZfQ01SX1hUcTExNVU5NW5yOU84b1l1LTlacmxUaWl1RnFZOWxwcnV4SlVrUFpnM3dwc1VmQTBReVZ4ellLaUJsVWhFaVdPenZkQ1hOR2t1Z01xZmc?oc=5"" target=""_blank"">Biocon Biologics investors are more confident after revenue growth: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.6186166666666667,0.6186166666666667,positive,1.0
2025-02-01,2025-02-01 08:00:00,Biocon Biologics investors are more confident after revenue growth: Mittal - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxQVnhiSEVxdF8zUjNXbWFBRF9ud0tFckRhY0NFX01NcFN2d3hnbUFuUlVvQ0UtWXpnSDJOMXVRU214U08zV0hUMk5zc19LNDFueFQ1TDQ1U0Q3RHpZazFXNnpJWHlWcXQtWUhpNEhzSlEzZFhFLUN0aG5mUGZFR1BoNlVFY0FjSGs1MUxWbm1OaGtvZmFaZERKQ210WVdoWk5vQlhYZHdoa05ISWp4cW5DSmFZQmNra0FGYWFqUW0xdWQwR25vVTc1U3VKTEZOVEdyZExjejFiSzVoWkdS0gHiAUFVX3lxTE5VbTRBX25wMVNzUGxMVTR2TFZuV0l6NGt6RjhMeC0yeE1WUXBDTEVMcDBvLW1tQkNrQVF6MUV4WnloLVZLbUlMNnNxOXN3eDZ2RXN6MzhJbnpQRlFGSUN1STVtS3IzcEZTcndqSGZEOW5ZNF83SGRnanlBV1M2MmViNC1xTG5iU21zR3VJdXZfQ01SX1hUcTExNVU5NW5yOU84b1l1LTlacmxUaWl1RnFZOWxwcnV4SlVrUFpnM3dwc1VmQTBReVZ4ellLaUJsVWhFaVdPenZkQ1hOR2t1Z01xZmc?oc=5"" target=""_blank"">Biocon Biologics investors are more confident after revenue growth: Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.6186166666666667,0.6186166666666667,positive,1.0
2025-02-05,2025-02-05 08:00:00,"Q3 results highlights: Waaree Energies net profit rises 295% to ₹492.6 crore, Adani Enterprises net profit down 88% - Upstox","<a href=""https://news.google.com/rss/articles/CBMikwJBVV95cUxPVFJRV3pVZVNpT2dFUTZNX2k0YWkzejQ0d2VBdXdvcl9wSjgwdUFpRnhGZzR4ckc2dlZNQWJ0MkJtZHRVc3ZtVEFZajRRbkhieUtpeDRMaDMwSHg1VG5DR2JRcWdIRnp4T0c5NGh3cUNaSmxIWUo2SzFOanpwWEItRGJ5TVFlWWJCdHRPWHNERDJWVmJzTEVQdXQ3alJuT09kREktS080WTA4Q3FXbms1TE1DOXBEQlREdlFoT29uLTlJVXNOVnBsSjdYMEtUTDIxODBuZUVjeXRLY3FRSW91VEgwUXE4ejI3ak9XaWJldXd5Z2QxdlNZbW15aVhTZTZRLTRpaVZOU2VhSHJZd01iWVJoaw?oc=5"" target=""_blank"">Q3 results highlights: Waaree Energies net profit rises 295% to ₹492.6 crore, Adani Enterprises net profit down 88%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMikwJBVV95cUxPVFJRV3pVZVNpT2dFUTZNX2k0YWkzejQ0d2VBdXdvcl9wSjgwdUFpRnhGZzR4ckc2dlZNQWJ0MkJtZHRVc3ZtVEFZajRRbkhieUtpeDRMaDMwSHg1VG5DR2JRcWdIRnp4T0c5NGh3cUNaSmxIWUo2SzFOanpwWEItRGJ5TVFlWWJCdHRPWHNERDJWVmJzTEVQdXQ3alJuT09kREktS080WTA4Q3FXbms1TE1DOXBEQlREdlFoT29uLTlJVXNOVnBsSjdYMEtUTDIxODBuZUVjeXRLY3FRSW91VEgwUXE4ejI3ak9XaWJldXd5Z2QxdlNZbW15aVhTZTZRLTRpaVZOU2VhSHJZd01iWVJoaw?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4400777777777778,0.4400777777777778,positive,1.0
2025-02-05,2025-02-05 08:00:00,Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxNWVZyY0VlZEJrR25OX0phVVlxZ3ZkY1hVbXoyTmtCd3BWNjFCVWdDZUpfaVNRNGpjeENpV2pleGpiRGd2N2ViVC04YWY0Ql9ZMUp2TW1wV0dmbGZLQTQ4RGpIdHI1blFQaHBFbi1hQXdWZ1RBVlZmYksxMVZkNEpkd3BlY0hSR2xRZXI3Y1VTUHNITEd5UWxnUG53WEI1alpIb2pRUnZ5bmNtVHd4M0VmWkFmaHRzV1hKQWdZZ1lzTVNpR0EtZ2ViZnFnSHVaWTTSAdQBQVVfeXFMT0c5Xzc2NTVBenUwMnlNYndmNEZXNmFkdzB4RkNMdjRFbW9SVkY5UWszX2VPcnZIWHVQdFBfVGk3UThBLWVGTm9CMnd1YzBWSHZyd1NTYkxJNUZRRWJ4Y0JqY2c3cjBsU19NUHl5VV9PMkhOaFVidFhqQ2d3T0t5SUp4N3F3dkNzMDBRTlZhRzNVZGpxallWWklyNS1fOGhaWjJJdE9jaHdyRjJHZUVoZ0laS3puMjhXdzhVUHgxdUc0SjlqQnVkN2U1QVg2Q1hIcmdfeEs?oc=5"" target=""_blank"">Eris Life soars 13% on strong Q3 revenue; Co reduces debt ahead of guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.29923333333333335,0.29923333333333335,positive,1.0
2025-02-07,2025-02-07 08:00:00,NHPC dividend 2025 announced in Q3 results; record date on Feb... - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">NHPC dividend 2025 announced in Q3 results; record date on Feb...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-02-10,2025-02-10 08:00:00,Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon - Investing.com India,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxPM2ZXdlQ1LUtQRm0weWt3UTJkTTZpOWtUblVvN1dqZVdMWHN2ajRyNVdfVXZrbUpUdDRKQjQtbGZPRUcwSTk3LUxNYXZERi16MWdPTE1JclVnV190dXdVbFRMVmFJazBsX2N5anFLRDF0R090QTZ4cXdaRzE2SlNYR2MwVFRLZkJPaUF4cFNvUDJsM2ZFaGZUR0wwZUlRTV9GTUM4Vg?oc=5"" target=""_blank"">Profit Booked: How Fair Value Unlocked a 50.4% Gain in Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxPM2ZXdlQ1LUtQRm0weWt3UTJkTTZpOWtUblVvN1dqZVdMWHN2ajRyNVdfVXZrbUpUdDRKQjQtbGZPRUcwSTk3LUxNYXZERi16MWdPTE1JclVnV190dXdVbFRMVmFJazBsX2N5anFLRDF0R090QTZ4cXdaRzE2SlNYR2MwVFRLZkJPaUF4cFNvUDJsM2ZFaGZUR0wwZUlRTV9GTUM4Vg?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.7095333333333333,0.7095333333333333,positive,1.0
2025-02-26,2025-02-26 08:00:00,Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQekxTMVk2bTB3dkJNdTBPdUtQeFZrZFJpNnc5UFdrTU5aUFYwbzNPTE9mQ2pva3JmMXliRVB0OTBHWEcwQ1JEY2prWEN1UTFSTlg4TFR6NVNvVzJGMm5tREZIcnh3Sm9LZzc3Q3k4ZFNQM0o4dWtMdndpaE9QNnpNcG1QQ0xPY2RtQnVrM3JMSXFRcFhha1dYeW81VnlFaXR2MzNzOGJtMnlIWDZ3VjFHZFh5a00wdW1HWU9yTlhYbjVPU3NFZzNvMnFrM01kMU5mdWJGRjhWWXZwOWpLWFBvZG1YaWZVckNzU29nUmV6U3Nud0tXOVlNeGJn0gH_AUFVX3lxTE1LOGJ3dzVNbzIyemlZWnduZkpnc2NwSVpXZmV1cGZaN2JQZE9OWDJxejZ4dUdoeXo0WUE0MmpubHVUSXQ1ZVBYdW13dHJkNHUtM0lfb3BDcGN6Z1ZNSFpRb0JxM0Rkd2UxeHRUQmxtTGxxQ2lmMExjT3p6QXpQdXdvMzB2dE1mNUR3NVZIX1pWVDRCVEZ3a2x6ZHZZNHFsblRTd2w3cHZLbElxd1c2dFRKSFR6ZUhtWjVaU0hER2M4Yi0tYVhSZUp1eUJ5eDFSVWpvUzluRS1FeFFTcTc5T2twWktDbGt3RFItQkgxa3lpQkxOeWdHelFEYzBudjloUQ?oc=5"" target=""_blank"">Natural Biocon (India) standalone net profit rises 212.50% in the December 2024 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQekxTMVk2bTB3dkJNdTBPdUtQeFZrZFJpNnc5UFdrTU5aUFYwbzNPTE9mQ2pva3JmMXliRVB0OTBHWEcwQ1JEY2prWEN1UTFSTlg4TFR6NVNvVzJGMm5tREZIcnh3Sm9LZzc3Q3k4ZFNQM0o4dWtMdndpaE9QNnpNcG1QQ0xPY2RtQnVrM3JMSXFRcFhha1dYeW81VnlFaXR2MzNzOGJtMnlIWDZ3VjFHZFh5a00wdW1HWU9yTlhYbjVPU3NFZzNvMnFrM01kMU5mdWJGRjhWWXZwOWpLWFBvZG1YaWZVckNzU29nUmV6U3Nud0tXOVlNeGJn0gH_AUFVX3lxTE1LOGJ3dzVNbzIyemlZWnduZkpnc2NwSVpXZmV1cGZaN2JQZE9OWDJxejZ4dUdoeXo0WUE0MmpubHVUSXQ1ZVBYdW13dHJkNHUtM0lfb3BDcGN6Z1ZNSFpRb0JxM0Rkd2UxeHRUQmxtTGxxQ2lmMExjT3p6QXpQdXdvMzB2dE1mNUR3NVZIX1pWVDRCVEZ3a2x6ZHZZNHFsblRTd2w3cHZLbElxd1c2dFRKSFR6ZUhtWjVaU0hER2M4Yi0tYVhSZUp1eUJ5eDFSVWpvUzluRS1FeFFTcTc5T2twWktDbGt3RFItQkgxa3lpQkxOeWdHelFEYzBudjloUQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4137,0.4137,positive,1.0
2025-03-04,2025-03-04 08:00:00,Biocon targets mid-teen revenue growth with new product pipeline - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon targets mid-teen revenue growth with new product pipeline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3639045454545455,0.3639045454545455,positive,1.0
2025-03-04,2025-03-04 08:00:00,Biocon targets mid-teen revenue growth with new product pipeline - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon targets mid-teen revenue growth with new product pipeline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.3639045454545455,0.3639045454545455,positive,1.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics partners with US non-profit co to make diabetes treatment cheaper for Americans</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.0,0.0,neutral,1.0
2025-03-28,2025-03-28 07:00:00,Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUkdkcng4X3VKTVNpbHhVa0wtcExXSEtPb04taDJTYS1NTjZDamNzdE9VdEVPdzJwUFpiX2tKYU9wYllpRjFjM0J2VUI3VThxbjB2MEpmRDJZQ01mSHdjYTB1eWtpbzN5eV9PekJhTlZ2bTZENWZ5M1FRa21WQmR5Tm0xeWF2ZTlZTU5VdVBLbmRSOFE1T00xbzkzTzc1WWE5ME1RdXI5a2FIeFdTSTFUZTVvTUptX0t4ZENoWXF0bnBqNWpoZlljc0JOVGJUeTJTR2JaZw?oc=5"" target=""_blank"">Biocon Faces Technical Adjustments Amidst Strong Institutional Confidence and Profit Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUkdkcng4X3VKTVNpbHhVa0wtcExXSEtPb04taDJTYS1NTjZDamNzdE9VdEVPdzJwUFpiX2tKYU9wYllpRjFjM0J2VUI3VThxbjB2MEpmRDJZQ01mSHdjYTB1eWtpbzN5eV9PekJhTlZ2bTZENWZ5M1FRa21WQmR5Tm0xeWF2ZTlZTU5VdVBLbmRSOFE1T00xbzkzTzc1WWE5ME1RdXI5a2FIeFdTSTFUZTVvTUptX0t4ZENoWXF0bnBqNWpoZlljc0JOVGJUeTJTR2JaZw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5658666666666667,0.5658666666666667,positive,1.0
2025-04-08,2025-04-08 07:00:00,Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxONjNLNnVYNllDM2FlaHBuU1BHeGktY1Zqcl9LYVhacmkzdVoxUTBMNHZJdGozMWwzczdhZTF3b2FYMkhrOWtGMTFieERza05jeVBGQXE4RUt1dU1KUzIyX3JOQTg3WHd3Sk5ZYzI4a1Q0bnBDUTFHUk1vOWFMRWltZnJHdGFJaUcwT3dCTzc5WWYybTk0ZjdweVpPR3ZWZXJOdDU1SDVwd1JibmtENllvQ0lNRVd4OHloUDZqYjJVZlB1VW5zRXpzUERNUlhSRUE?oc=5"" target=""_blank"">Biocon Faces Technical Shift Amid Declining Profits and Mixed Market Signals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxONjNLNnVYNllDM2FlaHBuU1BHeGktY1Zqcl9LYVhacmkzdVoxUTBMNHZJdGozMWwzczdhZTF3b2FYMkhrOWtGMTFieERza05jeVBGQXE4RUt1dU1KUzIyX3JOQTg3WHd3Sk5ZYzI4a1Q0bnBDUTFHUk1vOWFMRWltZnJHdGFJaUcwT3dCTzc5WWYybTk0ZjdweVpPR3ZWZXJOdDU1SDVwd1JibmtENllvQ0lNRVd4OHloUDZqYjJVZlB1VW5zRXpzUERNUlhSRUE?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-04-11,2025-04-11 07:00:00,"Anil Singhvi Recommends Buying Sun Pharma, Biocon, Cipla Targets Stoploss Explained - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">Anil Singhvi Recommends Buying Sun Pharma, Biocon, Cipla Targets Stoploss Explained</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.21075,0.21075,positive,1.0
2025-04-16,2025-04-16 03:39:18,Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSFBLYVV0ay03bWp0NGZuMzhGckgtVXEzaXZkMC01YTdTbzMtWW9iM0pwcFhiM2gweGtDQ3lGY05CdzdGX1NkWmVlSjJkYjMzOTJDTG5tUHM0ZnR0ZFhOc1dOcG1ac2tyOF9nckpnQWgyWTh4cXZmSWlQRldiQU81aUpWWkw0ZlhPRlpyWW45dGJ6NnZGbGdveUVNb0QwdDNrU3Rfcm5LdzI0TFZfeVNmaUhYTVdnV29oeDRyVllNYmxlb3FOeTJ3Tm1CdE9SZ09OaGZndXY5OA?oc=5"" target=""_blank"">Biocon Faces Profitability Challenges Amidst Strong Stock Performance and Investor Interest</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxPSFBLYVV0ay03bWp0NGZuMzhGckgtVXEzaXZkMC01YTdTbzMtWW9iM0pwcFhiM2gweGtDQ3lGY05CdzdGX1NkWmVlSjJkYjMzOTJDTG5tUHM0ZnR0ZFhOc1dOcG1ac2tyOF9nckpnQWgyWTh4cXZmSWlQRldiQU81aUpWWkw0ZlhPRlpyWW45dGJ6NnZGbGdveUVNb0QwdDNrU3Rfcm5LdzI0TFZfeVNmaUhYTVdnV29oeDRyVllNYmxlb3FOeTJ3Tm1CdE9SZ09OaGZndXY5OA?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.6067444444444444,0.6067444444444444,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook - outlookbusiness.com","<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Shares Nosedive 10% On Q4 Profit Drop, Subdued FY26 Outlook</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.3592,0.3592,positive,1.0
2025-04-24,2025-04-24 07:00:00,Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Crash: Syngene shares fall 10% after revenue miss; disappointing FY26 guidance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,-0.63125,-0.63125,negative,1.0
2025-04-30,2025-04-30 07:00:00,Global Industrial Co (GIC) Q1 2025 Earnings Call Highlights: Resilience Amidst Challenges - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxQdmJUVC1adDlKd1AtS2dMd01iRFRmUXNLZW1UZ1JWVWlCUUxNUWFiS0dXbFZfX3U1ZmJBZUNGQ2V6RjBEbEZhV2NHOUw3VDJldWtCWUM2NWJfbDc2clNCSFpZNDZOZ1pEOUQwOUZGMEMxbHdKUkFiYTJXUVpjUEtTbGVR?oc=5"" target=""_blank"">Global Industrial Co (GIC) Q1 2025 Earnings Call Highlights: Resilience Amidst Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxQdmJUVC1adDlKd1AtS2dMd01iRFRmUXNLZW1UZ1JWVWlCUUxNUWFiS0dXbFZfX3U1ZmJBZUNGQ2V6RjBEbEZhV2NHOUw3VDJldWtCWUM2NWJfbDc2clNCSFpZNDZOZ1pEOUQwOUZGMEMxbHdKUkFiYTJXUVpjUEtTbGVR?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0386,0.0386,neutral,1.0
2025-05-03,2025-05-03 07:00:00,"Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11 - Goodreturns","<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQd2gzWXREMWY1OWpfT01maWpUek1vWTBzYXdPdmdId3NYYml3SEw0MDdTdHp3Q19CQlpZLTdyRWE2b1Jqdk5uS3lweU1LZEdJNGY4eXc5d2xjM3lMNExLWUJ2QXRPR2czaGRBZXQ1aVBmU1Y0VEJDY04xOHhiMTJnekcya1FKZnlmTUI5VzJvbDVrSV9tdlU3VWNmb0xhYjVIaktQLXNqLXhRZjVQMDd6LVdkei1SWkdKQU1RY0p1a3RKcWNDbHlYeWEtd3FOQQ?oc=5"" target=""_blank"">Q4 Results Next Week: Dabur, Britannia, Biocon, Paytm, Swiggy Others to Steal Spotlight From May 5 to 11</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQd2gzWXREMWY1OWpfT01maWpUek1vWTBzYXdPdmdId3NYYml3SEw0MDdTdHp3Q19CQlpZLTdyRWE2b1Jqdk5uS3lweU1LZEdJNGY4eXc5d2xjM3lMNExLWUJ2QXRPR2czaGRBZXQ1aVBmU1Y0VEJDY04xOHhiMTJnekcya1FKZnlmTUI5VzJvbDVrSV9tdlU3VWNmb0xhYjVIaktQLXNqLXhRZjVQMDd6LVdkei1SWkdKQU1RY0p1a3RKcWNDbHlYeWEtd3FOQQ?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.3753,-0.3753,negative,1.0
2025-05-05,2025-05-05 07:00:00,"Q4 Results 2025 Today: M&M, Indian Hotels, Coforge, Bombay Dyeing, JK Bank To Call Earnings, Dividend on May5 - Goodreturns","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxPM2pmMWstQVFHX01UNTc1dTZwWGpnQk9rQWtycnZsbF9NREtTdjc5TlRfc1Q5NE9XSHhNbUh3YWtjNFVDWTlWNW9tZjlUR2YwSHdXV2kyTWUxU2h6LXRLd3puY2hic0hCeDU5ZHlYWjQzS1RxRXgzTVZsQkF3MWhjZWowNmR4d3VwOS1QMkVwcHNHeDRKNGFLRXBPUWNjSnlTUDY4Qk9aajdBeEVOWUhaN2xpNXhqbmxFMUEyd1BaNURMZDFRM3ZMT0R1eGZSdE1QTVhBRi1wb0MzZGp5?oc=5"" target=""_blank"">Q4 Results 2025 Today: M&amp;M, Indian Hotels, Coforge, Bombay Dyeing, JK Bank To Call Earnings, Dividend on May5</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxPM2pmMWstQVFHX01UNTc1dTZwWGpnQk9rQWtycnZsbF9NREtTdjc5TlRfc1Q5NE9XSHhNbUh3YWtjNFVDWTlWNW9tZjlUR2YwSHdXV2kyTWUxU2h6LXRLd3puY2hic0hCeDU5ZHlYWjQzS1RxRXgzTVZsQkF3MWhjZWowNmR4d3VwOS1QMkVwcHNHeDRKNGFLRXBPUWNjSnlTUDY4Qk9aajdBeEVOWUhaN2xpNXhqbmxFMUEyd1BaNURMZDFRM3ZMT0R1eGZSdE1QTVhBRi1wb0MzZGp5?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.32235,0.32235,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.32157857142857144,0.32157857142857144,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Pidilite Q4 results: PAT rises 41% to ₹428 cr; total income at ₹3,222 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.42157857142857147,0.42157857142857147,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4063,0.4063,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.42157857142857147,0.42157857142857147,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4063,0.4063,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.42157857142857147,0.42157857142857147,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4 profit rises two-fold to Rs 344 cr - theweek.in,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5"" target=""_blank"">Biocon Q4 profit rises two-fold to Rs 344 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theweek.in</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4063,0.4063,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxOMmZFTGhCc2REWUZWXzB2OTBzVmRlQUV5VTloRFVrQmtTdUFlWDdZOFdUVFQtNVQ4MXczUXlvRDFVU09tc09ublpxZWN4ellZdFVpcXhCUWVROVNWbW9NYVR3ZnBlTEhYUm90R1pTdk4tLVpxYlFSczBkNUt2djdQeTBoYVcyLWwzRTlJTW1CcUY4WkNobjR2bVpnQ0V6bFRWQlBOVjRnbW9SY002U3B2REdrMkFjMGJVVTRkZ3JycEFlUWRvMVHSAcsBQVVfeXFMTUNRTmd5UXdhT0NnenFpdkxmUVZNcFk2djB6MGhvWUlXdDdJYkRlQnBfT3M2U0Y0b21taXY3Q19May1RZUdNemtRc185SXJRR1VmVnRLOVhzT1FULXdyNG45VmJ2VVpXX0FYRF9oQUxTdU1BcjNBS0dJMm02TXUtVlM5V1Z5MHl6dEFBMnhGRWt0RzhaQVFLUkZuZnQ4RXBQeWdHbldaRU9mQ2xBOXYxZEFEUnlSTVVfTGdDQnhreVhzZU9qd1lWMk5GOVk?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.42157857142857147,0.42157857142857147,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4FY25 results: Consolidated net profit rises 153% to ₹344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4 profit rises two-fold to Rs 344 cr - theweek.in,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5"" target=""_blank"">Biocon Q4 profit rises two-fold to Rs 344 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theweek.in</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Sula Vineyards net profit falls 4% to Rs 13 crore, firm announces final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.32157857142857144,0.32157857142857144,positive,1.0
2025-05-08,2025-05-08 07:00:00,Boardwalk Real Estate Investment Trust (BOWFF) Q1 2025 Earnings Call Highlights: Strong Revenue ... - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxPV1liM3BocEFKTlgzT2FqU2Jrak9lUGFTVUdkRDBIWldoaDFqUElsZ2ZPWk5QcVg4SWhTejJwT2lWLXB6a0lUWVFXLXluWkdqOVQ4MjV5S0FDYklpU3RMOHQtNzBjeGRWQ0ZINVprRVFyX3BjWTB6bEZEZ3FrbkVTLWVadXROWENFajhqdUFhZmY?oc=5"" target=""_blank"">Boardwalk Real Estate Investment Trust (BOWFF) Q1 2025 Earnings Call Highlights: Strong Revenue ...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxPV1liM3BocEFKTlgzT2FqU2Jrak9lUGFTVUdkRDBIWldoaDFqUElsZ2ZPWk5QcVg4SWhTejJwT2lWLXB6a0lUWVFXLXluWkdqOVQ4MjV5S0FDYklpU3RMOHQtNzBjeGRWQ0ZINVprRVFyX3BjWTB6bEZEZ3FrbkVTLWVadXROWENFajhqdUFhZmY?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.5875166666666667,0.5875166666666667,positive,1.0
2025-05-08,2025-05-08 07:00:00,Kimball Electronics Inc (KE) Q3 2025 Earnings Call Highlights: Strategic Growth Amidst Sector ... - Yahoo,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxOVU5BeTZYMkJWRzNTN3FicVVSWU1sd3EyVVhjeTZOUk02YzVXY1RkN3NmYVh0TUZFZnZ1S3VFdGFobnVOVGlvS3NVMnBlUG5KbFRfTEQzWGpBVTR1TzJGdlhoTWhtTXBjcG5WZnNwMWdDRW1ObF9GRDlxYWNTTzZuZG1QNTI?oc=5"" target=""_blank"">Kimball Electronics Inc (KE) Q3 2025 Earnings Call Highlights: Strategic Growth Amidst Sector ...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Yahoo</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxOVU5BeTZYMkJWRzNTN3FicVVSWU1sd3EyVVhjeTZOUk02YzVXY1RkN3NmYVh0TUZFZnZ1S3VFdGFobnVOVGlvS3NVMnBlUG5KbFRfTEQzWGpBVTR1TzJGdlhoTWhtTXBjcG5WZnNwMWdDRW1ObF9GRDlxYWNTTzZuZG1QNTI?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.31845,0.31845,positive,1.0
2025-05-08,2025-05-08 07:00:00,Biocon Q4 profit rises two-fold to Rs 344 cr - theweek.in,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5"" target=""_blank"">Biocon Q4 profit rises two-fold to Rs 344 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theweek.in</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPWGZEdWYyTUNRb0lZRm5EbGw1VDhLNU9aTmJYWXNNRE9kWjNmLU1MYVNzd2NFSERqazJDMkZZMjhpVWdpeGhGei1meWhNS1dBQ3A0OHNnUlB6bEVCdTV4VmFwYVhzaWZrSmpIdzI0M0lUSkotOVlUMC11NzNsZUR1Qm5uVmsxQUZtUGcyZEdn0gGTAUFVX3lxTE1Eam1uU3ZKNnBkcHJoTS1GQU9QOGdJdGJ3UDFWWW8xTEhBc0FRdWF6Tm4wZmxfUVE4Nkk1SFlwVmNNb3NrWnNqMGpxRGxUQllxeFhYazFmdDlRWEt6aWN2aEtRdEl1QmFBLWtmWHRXSTB3dEdfeXBEb3ItLThZSmlvV08tRk9hRC1CS1NRSmtfNXV6RQ?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4063,0.4063,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore - Upstox,"<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5"" target=""_blank"">Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Q4 results today: L&T, Union Bank, Britannia, Zeel, Asian Paints on May 8 - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 results today: L&amp;T, Union Bank, Britannia, Zeel, Asian Paints on May 8</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.0,0.0,neutral,1.0
2025-05-08,2025-05-08 07:00:00,Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiiAJBVV95cUxPWUJmRmtIMkw1eFc1bWQxY0hUU2FkSG5wQ2lPYkFLenVOa3h0Z3gySHFhVG9tS2lPMWJNODBPem5nRTd2c3VnTVEwZXFoWURQNDZMRnBIcUU1VFBnNzZGMHdJU2RNZjctX2pZODFfTFpRblJGbkxwMXc5NmdwQ0hFRm10NUY0OEtKS21DaE45T3MxbElyQ25JT3NFN3BXMXVSSklzdVdBUV9OXzJOTDRuLURRTVMzNVNTajdReC1UZURWZHo4UEM4MWVUWGJTRTlTWUdHQ1RqVzZ6cWxfQjRmejlkTEZMakI4WkZ4TWJlNXpKR0xZc3Y3SWF4UGs2ZXY5czN6c0dQUWvSAY4CQVVfeXFMTTZkZkl5TTctZnpmcWJ0OTFCd0l3T3ZDZmh2RXROd2d5c3dieWpmSENwbEhYc2Q1Wmkwd2cwYlBHa1diWk9Nc3hPNTRhLVpCa05Za1JkbXpqcjRzd2t0emlucHdUODVYcnEyS05HU3lXRnBkOVVVeUFjUWFQSnNUT0ZDSThWWFo0LTJTZ1pYbndXNm5PZG5XbE9TbjNFYU9VOUJxMzRRU2gzbFVlS3hGVGt2WkxlbVJfZzhfbWYzdGpZeU5uWmlUOFpha2JfU3I5WkhBRjdpQUNHbmpZYUZLVVRxdG1La0dnTmxXOVdNb0lhMEc2SXUtY1MyR0FDX0hQbTc3NTI1SEVndHJmUWJn?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4521,0.4521,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153% - Biocon","<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5"" target=""_blank"">Biocon Q4FY25 Revenue at Rs 4,454 Cr, Up 15%** EBITDA at Rs 1,115 Cr; Up 16%; Net Profit at Rs 344 Cr, Up 153%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE95dUpkc1RUazlvODhfc2oxMklWMkYyX2VlS0JTLUtMZmVReHMwVWxkdzJ4cTZudEJUU0c1bnBwbEJfcnF6SXA4TEF3NC14UjQ4N1VRRXNIMlo?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 Results: Net profit more than doubles YoY, beats estimates; declares final dividend</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxOMmZFTGhCc2REWUZWXzB2OTBzVmRlQUV5VTloRFVrQmtTdUFlWDdZOFdUVFQtNVQ4MXczUXlvRDFVU09tc09ublpxZWN4ellZdFVpcXhCUWVROVNWbW9NYVR3ZnBlTEhYUm90R1pTdk4tLVpxYlFSczBkNUt2djdQeTBoYVcyLWwzRTlJTW1CcUY4WkNobjR2bVpnQ0V6bFRWQlBOVjRnbW9SY002U3B2REdrMkFjMGJVVTRkZ3JycEFlUWRvMVHSAcsBQVVfeXFMTUNRTmd5UXdhT0NnenFpdkxmUVZNcFk2djB6MGhvWUlXdDdJYkRlQnBfT3M2U0Y0b21taXY3Q19May1RZUdNemtRc185SXJRR1VmVnRLOVhzT1FULXdyNG45VmJ2VVpXX0FYRF9oQUxTdU1BcjNBS0dJMm02TXUtVlM5V1Z5MHl6dEFBMnhGRWt0RzhaQVFLUkZuZnQ4RXBQeWdHbldaRU9mQ2xBOXYxZEFEUnlSTVVfTGdDQnhreVhzZU9qd1lWMk5GOVk?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.42157857142857147,0.42157857142857147,positive,1.0
2025-05-08,2025-05-08 07:00:00,Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore - Upstox,"<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5"" target=""_blank"">Q4 Results Highlights: Titan profit rises 11% YoY to ₹870 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMihwJBVV95cUxNM3pEWVdGcEpiYm85OHloM3hpNnktMjdKT1BJYnFWbjJKc29fR3BDNVlwTzhDT1N4T0I0Y2t0WDVidW04OUotREUzQXVmS3UwMlhTU2szeVJpOEE3ZkVxdUlLSE1XSzFkelRUZjhzX2hlN092V0htZTNOZTRmNG5KOTJaT2dNNFpsSU1fY1pmdE5TUXlTSGJWQldybllsRWNaRXVRYlVIRE9RaVVYUURKdUFxOWZaNXZpNzN5bEtUWnphRFBVRzRkWEh6QTJueldfRGluU1k2b1FrLVh5M2hVNl9ORkd2ZEFRMVk4bXhRUDdTV1BDUW9CNVR1X0YtZTkxbF9BZ04zbw?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-08,2025-05-08 07:00:00,"Biocon Q4 net profit surges 153%, biosimilars, generics drive growth - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 net profit surges 153%, biosimilars, generics drive growth</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiywFBVV95cUxOOVBBZG14bTV2bVBiQkstZFpwYUVrWkhseXctN2d1SXBYd0cwS05TcS1Qb21DSjRkclBBeEU3aE1MRXlKMWJDSUQ1dXBMeld6aEtiUE5hR0dTY3hxUnJuTUdIcDBOMHB3Uk1tY0pMUEdtY2NpMkpiNi11WlY5MER5WkE3dnhzVEJTa1lxZVRucFRqaEZfUHdtV3ZxVENsYkUzaEJieWR5eEtvVmpxN2l6TDc4YzZsOWl5R2xxaEp1RG9fUTR0aUZlNHpnUdIB0AFBVV95cUxOVm9MOG52RWl0akctRUZPQ3pmMW1ac0tHLWlXZ0xNNTgyUEF6UnlZTlpJTE84MVZhTFBqSXQyUmJobnk2bEJnOUtiU2hIaW9LdG9UZ1huLW5LNHBhV0dGMlVzaGQyeWFORFBadEItVDNZNTRBQ013SFd2NGdJZTR6TmpTclVrZTlFbXRocUtKa1BPcmJiSzNidkZkcERKODlRUXlKYWp5QjBJeTRJZlEzWEpJd3M1OHlKRVdDRUVhQTcwLVo2VnRaLW5SVmNCdzVN?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4063,0.4063,positive,1.0
2025-05-08,2025-05-08 07:00:00,Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results: Britannia Industries Profit Beats Estimates; Union Bank Profit Up; Rain Industries Remains In Loss</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4521,0.4521,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 results: Net profit surges 153% at Rs 344 crore - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 153% at Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxPZ2M3VFhBdzJLNnJRdmNtMmZfOFBhdzBFQ0pXckxkclBWN2RCLXRidUpla1dQcGtfQkJtVXduZ0REa0M3MU5lMnh4a3NYakpsNE84TVU4azdENzZuQnBUREN6Sl9VV3lLdjctOFluYlN0cEExVHd3bDFOb2hBcXV1N2Mxb1NZYzlWWVdFREM5ZVlaU2QwMlNwY1A4WkRWc3RfOF81enVlLVRyWU00R21BLTczNlJxQ0tDMlFpQnNPSFVHem1QZTIxcU1vSVFpd9IB0wFBVV95cUxOaHkzVkRKTjRXRXZjeUJ2eWpYNkpWOTFWVVBhdTJxQVVUdHFBSkJtVUNEeHJqcGZSZk9YVi1OUF92RGxYaWppenhYUHVQMHh4V1VDRFdxMXVJUXhVZU5DM0NIa2hhMHlxVFhVSzNQc2Jib3FQTjVPbTFrNFNDcllsQ25QV19MRnk4dm85d0lCU0NORlY3aGJsRmRrZXBZM09pamg2WWVWTW0wY0FIbHkyOXI2R0dxaXZRMklzRU5mczZJS3RIY1ZtTXdLM3ZLSDB0X0JV?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.39015,0.39015,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 results: Net profit surges 153% at Rs 344 crore - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 153% at Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.39015,0.39015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon posts more than twofold increase in Q4 profit - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5"" target=""_blank"">Biocon posts more than twofold increase in Q4 profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5211,0.5211,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 results: Net profit surges 153% at Rs 344 crore - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 results: Net profit surges 153% at Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.39015,0.39015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon posts more than twofold increase in Q4 profit - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5"" target=""_blank"">Biocon posts more than twofold increase in Q4 profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxOTFg5SG9TTmhUR2l1TGM2OWh2NXFyeGEyV2hHMUxoZHZDbzZaNjB2eFNyVk1tZnNqcWNtNVMyeUZoYjJFeVFmdll5Y2Q2QV9ra1AxWDJGMGJOYllDcGN2X19lU2FfYkRhTnZhZkhNZFdyelkyeGxrbGFxVG42b05zdWtRcDE2WG1PcHc0d196ejZGN240bm5HaUlnMTlVXzJXN0ZXUU5LeHE4TTI30gGyAUFVX3lxTFBEM1BBanFzTUFKODNKQzFuUFpkNXIxaVVGT2Y1T0tkaXZpVHVSYmdUd3FjVEMySi1Mam52cy10Z1F6c0xRZF9QMlZvYlMtX0QwZ1VkOHcyck5JZkRVcXN4QURnZjI3Nk04clZ4OWRLODRKTTVHVm1GTThwc00yMVgwU0szLWtvN0kwWjB1MDgzMERyVkhEaERfX1JhVG0wWnFKWG1FMmNMTU1FSmJWTE9jQ1E?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5211,0.5211,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon consolidated net profit rises 154.24% in the March 2025 quarter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon consolidated net profit rises 154.24% in the March 2025 quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51% - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Q4 Results Highlights: Britannia beats Street, declares ₹75 Dividend; Union Bank of India profit up 51%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.35015,0.35015,positive,1.0
2025-05-09,2025-05-09 07:00:00,Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15% - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Asian Paints profit dips by 44.93%; Canara Bank profit rises by 33.15%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNVy04T3lYVnFobnBHMFktaHZNd1g5a1V0Z2xZM0luMnZ0cFVXMTlGU0F6RkpiYkpQekIydENtYVdYc3lkM3FBUjdGbU5SdDVPVFlsNnk4amoxMWNlZjcyR2ZZTEtqM1Bjb2ZPZk43QVIyVU9pcjlBeHhCcnpadjFaQnhhWXJVRnoxT2JPZkZaLVFRNnc2NDBDWWNoZUtRR2V2TTE5dGdGTVRJV0NvMEFsUUZlYUFILUJCLTg2MzZ4Q0FwdVo1cHgyRVhhZHVFMlRSbk1xQURjc0VHdw?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.4455,0.4455,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Biocon sees mid-teens revenue growth on biosimilars, generics push - Mint","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5"" target=""_blank"">Biocon sees mid-teens revenue growth on biosimilars, generics push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxPZUgzNl80Mm1nM0xFb3hZVXJtTkNfUUNBV0YwMGdfZDB4N2tNYWo4V0RYeDhtMjJLaEc1QVRSUHRXLTBMaHdsMU50bTFwcFlQeWRwMG1pR1Y0Z2hyQ1djdDJMbW1KcGwtQ1NYVEdUdmJmVWNPeUpBRkNydm9wdHl3aEpnTFpIM2x2QVF4OG5hdGNpeXNtbUlDU3B3bGpEZzM2LU5sTmpaWVVDc1AxTmxkdS1B?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.31845,0.31845,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Biocon geared up to be major supplier of insulins, GLP-1 weight loss drugs: Kiran Mazumdar-Shaw - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon geared up to be major supplier of insulins, GLP-1 weight loss drugs: Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,-0.2578666666666667,-0.2578666666666667,negative,1.0
2025-05-13,2025-05-13 07:00:00,"Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi9AFBVV95cUxObmdvWTFDeXdVQm5lcERoQ0hYYVMwc0kyM3dlM1lqM3VsQXY4ZGhyakFRU3B3TjROX2EtYl9BVUE3RXdWVnRTRTdEUHRhUU9CV3E0ZU9OYTVKZDRtU3hmS2lmaE0yYjdvYlhRMXczRlZ0WldCM1dNUzh3UHk5aG01VGFsU1hjNkN6TjluS3doSDgwejh4SzJpTmR2SjNEZ2NrWVh3YWpCUGNfVUdoTnJrVEJRMkxPclVXb1lJZ0JnNkRGRkd5T3MtdDFjZlNpel9oSVB3VGtYWW9BSXhydmxJX2RJbERKTlUyQUpJVTNnNkdUWDhR?oc=5"" target=""_blank"">Q4 Results 2025 Highlights: Tata Steel Q4 Profit jumps 117% to Rs 1,201 crore, announces dividend of Rs 3.60 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9AFBVV95cUxObmdvWTFDeXdVQm5lcERoQ0hYYVMwc0kyM3dlM1lqM3VsQXY4ZGhyakFRU3B3TjROX2EtYl9BVUE3RXdWVnRTRTdEUHRhUU9CV3E0ZU9OYTVKZDRtU3hmS2lmaE0yYjdvYlhRMXczRlZ0WldCM1dNUzh3UHk5aG01VGFsU1hjNkN6TjluS3doSDgwejh4SzJpTmR2SjNEZ2NrWVh3YWpCUGNfVUdoTnJrVEJRMkxPclVXb1lJZ0JnNkRGRkd5T3MtdDFjZlNpel9oSVB3VGtYWW9BSXhydmxJX2RJbERKTlUyQUpJVTNnNkdUWDhR?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,False,0.3953,0.3953,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon Sets Floor Price At Rs 340.20 For Rs 4,500-Crore QIP - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQbFg1MjQ4TVhPWjc0ejhjN3IzeTJTb3ZoLXRrdGNzMldLS2pGbjV4dnJxcFZOYmdYTHNNNXdwc0F5MjNRcTZlbmNyMGdDR1dVNTFfWlEtOGJoblQ0Tlc2cEpLSlhlR1BoSmVob2xMOVJ6MmNYbDUzT0k1YXhnSG9vSXFreW9Pc2FtNnQyRWx1anpiTUVMcmFWStIBngFBVV95cUxQMUdRWW5YZWlpeUYwZWl4c2dRb2tBeXB3QTRoOWlkd1VRdngyNTZvNXFCXzY0bDJEdTE5bWhGNTRheDJNTENmbWhJWEp5aWhFbDZPRl9rNnRqcUxlaTk4X01VX2FFS0J6UjM1aWpMQ1dFNDMxSUxidjlvY3l5bGkzS21QMkRXSVZXWlFYS1NGTEc3ZmJac2ROYUM5dzl1QQ?oc=5"" target=""_blank"">Biocon Sets Floor Price At Rs 340.20 For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxQbFg1MjQ4TVhPWjc0ejhjN3IzeTJTb3ZoLXRrdGNzMldLS2pGbjV4dnJxcFZOYmdYTHNNNXdwc0F5MjNRcTZlbmNyMGdDR1dVNTFfWlEtOGJoblQ0Tlc2cEpLSlhlR1BoSmVob2xMOVJ6MmNYbDUzT0k1YXhnSG9vSXFreW9Pc2FtNnQyRWx1anpiTUVMcmFWStIBngFBVV95cUxQMUdRWW5YZWlpeUYwZWl4c2dRb2tBeXB3QTRoOWlkd1VRdngyNTZvNXFCXzY0bDJEdTE5bWhGNTRheDJNTENmbWhJWEp5aWhFbDZPRl9rNnRqcUxlaTk4X01VX2FFS0J6UjM1aWpMQ1dFNDMxSUxidjlvY3l5bGkzS21QMkRXSVZXWlFYS1NGTEc3ZmJac2ROYUM5dzl1QQ?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.2202,0.2202,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4548333333333333,0.4548333333333333,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxPWWp6Y2YyUk1veTVrdjZlN291T193LXBPNlBfNnRORGllZEZoNDdrY2xhUmpmTi1Bc1lvVWRtT1BpR1U2Z01kOVJadFhTaVpONUk1WFRkNWZFbnhpNGRzbHY4UUNqMnFHeFJvR0YwVFJQUEwxMk84RDRYSkdWSWZ5LUoxZUxIc3dJeF9DdUE4VVIzdzh0V3lsMlhkcTV5ajlBRzdHYVJ4UUlNdXBQQWlRUlZ30gG3AUFVX3lxTE5NdS1VQTRfOS1xQ0Y4QnprTVM3ODZnaVpzWFEydkRzMXRkeHhVRXJlUDZOMVNSWnVocUt5Q1dRUWhKN2x0ajVmWW5aR0ZQTGlyRG5WdUJOR0dCSGFqQ2hBZ2gzcXY5dlZjLUVlNV9jRXpsc3piM0k4cC1FUlRXd245UFRlcHhRdFByd2dQRVJQS1p6d3kzUmFBcG1LaDhXWllLNklrYlBadERSc1YtX1pyQlg1TENfUQ?oc=5"" target=""_blank"">Biocon Shares Trade Higher After Board Sets Floor Price For Rs 4,500-Crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.4548333333333333,0.4548333333333333,positive,1.0
2025-06-18,2025-06-18 07:00:00,"Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5"" target=""_blank"">Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-06-18,2025-06-18 07:00:00,"Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5"" target=""_blank"">Buy, Sell Or Hold: BSE, Bajaj Finance, Biocon, UCO Bank — Ask Profit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxON2x6TXR4ck82TndHS3ExX0hjTWM2Szk0bjQwRFdqLV9fQ1VVekFpS2dCM2RnUzJjcTRyMmYyODdlMlN6NFkzaFFwY0NUaC1TQVdib0tnMU1GMTc2dUxJMy1JU25QRVJoZ2tIM2txQUZmczFDN1hjeEk0RGNEeERBV0VVZk5WY2JlZ2Z4d240Smk5OWtkLXNFcU1zY1rSAaIBQVVfeXFMT3J0RGQ4cGtJYUtvV0lJc0I4MXpYZFoxakg3NVV1TzB5Q0tKbFFrZThhMlVDUm5ydHBrR1FrMHJWOXVIRFY5azZOb05ZYjdNMEg1ODlCUGxhTjZRbElsWEUta2psREdoQXoyTG8yOUtYSGZXOWRMLVJseUJaR2ZMVWtjSWVIX3g5cHhQa2hOQ045VXVJTi1FZVRxR0MzUF93bm1B?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.35015,0.35015,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.23835,0.23835,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.23835,0.23835,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.23835,0.23835,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP - NDTV Profit,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Gets Target Price Cut From HSBC Over Likely Impact On Earnings Per Share Post QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxONm0zcVhReEtNcnpRQjFpenY4SVY4SHM4Q2d0dXp6MW9TMlVqVDZ1blNMMGpqNVJtOUQ3MzR3TC1MMktxeHBiaDZXby1GREt3b1hoSHdKN1ZPX1h2Y1dqdkFSa2gyOGgyYzJWampEMjAxdG9wSUpGZFBPRXZIXzUyQ2daQmVoYTNIcTBHWmxhTlVEblJIR3FvT21yMTBQcmhLcGlKOGRQdkpSY2JRU2RZczlibkNZbjBXaE55alBvTGTSAcYBQVVfeXFMUHZyWi1YdTVfeTQtek9OZ3RLVkFXeVNMX2p0SlZQYWxPVHlYSWVjaWpGQWNsTVhCMENVdi1MYzZqV2lJa2dQbzBDV1U2VGxoWkl6N1hUbnZ5bVVjUDRDVDVTSlJ2QnZqbUVpZUU3YkduQnMzVWFELVhCb3ZPN0hsZGduZ1hNUDZDVER6ekt2eVlQZ3pia2tuVVktNUZQUTExUkRSTlpYcEdQZzViZjVfdjk4UDhad3NtSTlZWGozVmJTM1FsdWlR?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.23835,0.23835,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar - NDTV Profit","<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQVnVwaVhDaVZvUDJJUEpVX004MUJpTUhyYUhmSGltdExKR2pjVVFQZUNLUVo5ZU1RV004UEp2SDNvMmV6eEdFeWpDeENXN2JtamZKby14QUVXNFZFN2dBRVRhb2hvb0FRZ3p3LWk2NmJ3OG8xY1JoM1F0X3RoaVZRWmhDT3JOOXhhNnRhSjJKNmNXTUxGVU1Hc3QtRUhjQnc1ZWQ2RXh2S2tKT2paNlJV0gG0AUFVX3lxTE9BempiTzdnakcyR3dkd3RWNFpBcFI3bmE0WTB1SkRTYTczZVRNUUd5U0lsRlVfOGo0R3FySDlqUGhOZFBFTTZ0MWJlSWRkS0htOVRtNHdtVmdWR0pIZnBCT1o1a2Z1WGlJU1Z2S1B4RUpxWUlCeDl1Ukxwb0Vma2NKSG52bjNnMHNMaDBTckVjZ2E5eUM3WmhhbnltSy1zQ09VTllKdmRfV25VdmtUNHU1cy1GTA?oc=5"" target=""_blank"">Stock Recommendations Today: Siemens Energy, Trent, Biocon On Brokerages Radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.36345,0.36345,positive,1.0
2025-06-22,2025-06-22 04:15:35,Biocon Full Year 2025 Earnings: Beats Expectations - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Full Year 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.11666666666666665,0.11666666666666665,positive,1.0
2025-06-22,2025-06-22 04:15:35,Biocon Full Year 2025 Earnings: Beats Expectations - simplywall.st,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxOSDBNZHZWY0hxeF9GbjdseU1oZDFvUUJaUzBWNGdRRUdCdHpSV2lsWnBaUnVYRFQzM2NpeHlkYVRRUG1WV2pFWXhuVDI5eFQwY2NOT0hZcUh6am1fSl9vWkFEX1ZDSTNjTGtsRUdYbnNINW9VeXFkbk0zdVNfVDd3TThoV0NZdnJGMFRlOGd4YjhkWHBXTlN5WHFEWlBhYnI4OGxjOWxXUnotT2ptRGJJZ2U0QlBfa1pEUHpJMWhKbWlpVGhQTnpvSzN3RGtSRmxj0gHWAUFVX3lxTE84Qy1oQWpOMFJ3UGJUdWs5ZGs5NGxual85NnN4MGxGTDA2OGN4Vm9HRzV1WHpUT3BkX0dRNHM2MVU4ODZ0N1otV202bkhpckhNWUdYdFZ2dktWODl1dTdPWGh6MWs0XzV3VWpZd3g5WE94d0FXTUxvVnU0OUNKUGRyR0NibUFHOHBhN25uTUJBYmpaSXFURHdNbkhlRVIwQk9adzBRZWJFN2d3WWpCeDd1cWFueG14SGJ3My1BSlFJb2gxWng5aGg4bG90UDJGQkZLVGlvbUE?oc=5"" target=""_blank"">Biocon Full Year 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.11666666666666665,0.11666666666666665,positive,1.0
2025-06-22,2025-06-22 07:00:00,Biocon Full Year 2025 Earnings: Beats Expectations - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Full Year 2025 Earnings: Beats Expectations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.11666666666666665,0.11666666666666665,positive,1.0
2025-06-24,2025-06-24 00:56:18,"Biocon To Use Rs 4,500-Crore QIP To Free Up Equity, Hike Stake In Subsidiary: CEO Mittal - NDTV Profit","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon To Use Rs 4,500-Crore QIP To Free Up Equity, Hike Stake In Subsidiary: CEO Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV Profit</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,financial_results,9,False,True,0.5628833333333333,0.5628833333333333,positive,1.0
2016-11-17,2016-11-17 08:00:00,City of Juneau awards Veolia business contract for thermal sludge dryer installation - waterworld.com,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOeF9BQzBZenZhVzMyaHVKOGl2SmRqWHNZQ2N1bWRib0hVZlM1UllsRFZQaS1jS1A3MUFFT0N2M0VSU0RQdDY2dFFVaDhTUmYxSElBWC0wT3NpaTVaUHpWU2xwQ2F0WUwwSEYteHJDdl9zTnpPdUtoRG42REFObEdOWDlWdUNCbmdTbDhWRXN4SWYyOWt0YjRVNGdjQW5OdzZCUFVxWFVpWG1kT1VsQkd4TjR3V0MtRGJlQUhfUUI5N1Bwdkctem1CQ1lRSWY0Zw?oc=5"" target=""_blank"">City of Juneau awards Veolia business contract for thermal sludge dryer installation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">waterworld.com</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOeF9BQzBZenZhVzMyaHVKOGl2SmRqWHNZQ2N1bWRib0hVZlM1UllsRFZQaS1jS1A3MUFFT0N2M0VSU0RQdDY2dFFVaDhTUmYxSElBWC0wT3NpaTVaUHpWU2xwQ2F0WUwwSEYteHJDdl9zTnpPdUtoRG42REFObEdOWDlWdUNCbmdTbDhWRXN4SWYyOWt0YjRVNGdjQW5OdzZCUFVxWFVpWG1kT1VsQkd4TjR3V0MtRGJlQUhfUUI5N1Bwdkctem1CQ1lRSWY0Zw?oc=5,Google News - Comprehensive Company News,Biocon new facility,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,partnerships_deals,8,False,False,0.3592,0.3592,positive,1.0
2017-01-25,2017-01-25 08:00:00,"Biocon wins MYR 300 Million contract for Insulin from MoH, Malaysia - ET HealthWorld","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon wins MYR 300 Million contract for Insulin from MoH, Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.5063,0.5063,positive,1.0
2017-03-02,2017-03-02 08:00:00,Herbalife opens R&D centre in partnership with Syngene | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Herbalife opens R&amp;D centre in partnership with Syngene | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.0,0.0,neutral,1.0
2017-03-13,2017-03-13 07:00:00,Roche's Herceptin one step closer to biosim battle with Mylan licensing deal - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOWUVfb29BZTlkTV95Z2JTVmpoMlY2ZGxuMVBucnJ5N0dBWmd5U0dDVWdlcl9rc2YzQm5xWDJGTzF4dF94Y2hlZExhTXFkWklWSE9JdXhyZ0QyUVg4M2lVc2VaQzBoalY2blhhbTJXamF4X1Q1TjlrbEpvMmdKalFWWHlvM2lKRnhXaGJ2WHFB?oc=5"" target=""_blank"">Roche's Herceptin one step closer to biosim battle with Mylan licensing deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxOWUVfb29BZTlkTV95Z2JTVmpoMlY2ZGxuMVBucnJ5N0dBWmd5U0dDVWdlcl9rc2YzQm5xWDJGTzF4dF94Y2hlZExhTXFkWklWSE9JdXhyZ0QyUVg4M2lVc2VaQzBoalY2blhhbTJXamF4X1Q1TjlrbEpvMmdKalFWWHlvM2lKRnhXaGJ2WHFB?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,-0.31845,-0.31845,negative,1.0
2017-11-14,2017-11-14 08:00:00,Biocon arm widens partnership terms with Bristol-Myers Squibb - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm widens partnership terms with Bristol-Myers Squibb</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2018-01-19,2018-01-19 08:00:00,Biocon and Sandoz strike biosimilars partnership - pharmaphorum,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTFA4aFA1aDgwX3Rkd0pkMmxsa1JqclVZV3BzaUtXRGU4S09hS3ZPODBaVkYzck0waTJISlFxaWxHd2x6dVM1eW0tUVBaMFo5UEtUVmd3b1JndGMxcjFWSUt5QkljajBfLXROQjRJamtOeHlLTFZERzI2OURjSEFCcnc?oc=5"" target=""_blank"">Biocon and Sandoz strike biosimilars partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">pharmaphorum</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTFA4aFA1aDgwX3Rkd0pkMmxsa1JqclVZV3BzaUtXRGU4S09hS3ZPODBaVkYzck0waTJISlFxaWxHd2x6dVM1eW0tUVBaMFo5UEtUVmd3b1JndGMxcjFWSUt5QkljajBfLXROQjRJamtOeHlLTFZERzI2OURjSEFCcnc?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,-0.125,-0.125,negative,1.0
2018-01-19,2018-01-19 08:00:00,Biocon and Sandoz strike biosimilars partnership - pharmaphorum,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTFA4aFA1aDgwX3Rkd0pkMmxsa1JqclVZV3BzaUtXRGU4S09hS3ZPODBaVkYzck0waTJISlFxaWxHd2x6dVM1eW0tUVBaMFo5UEtUVmd3b1JndGMxcjFWSUt5QkljajBfLXROQjRJamtOeHlLTFZERzI2OURjSEFCcnc?oc=5"" target=""_blank"">Biocon and Sandoz strike biosimilars partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">pharmaphorum</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTFA4aFA1aDgwX3Rkd0pkMmxsa1JqclVZV3BzaUtXRGU4S09hS3ZPODBaVkYzck0waTJISlFxaWxHd2x6dVM1eW0tUVBaMFo5UEtUVmd3b1JndGMxcjFWSUt5QkljajBfLXROQjRJamtOeHlLTFZERzI2OURjSEFCcnc?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,-0.125,-0.125,negative,1.0
2019-03-01,2019-03-01 08:00:00,Infosys Fines Biocon CEO Kiran Mazumdar Shaw For Violating Insider Trading Norms - Swarajyamag,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQM2lmSjB2NkFvRi1WRUNrVWcybWd6T1ZFSlp4cE9BLWM0b2xKc0kzclR4M2IwVXh3VVA3eWJhaDZFcFVQMmJYY0prNzJ1R1g1VC1ZVEFkMXRoanlIeGRxSWZrNDdiTUMxVDB5ZjZ3alBHa2tZaXJCWmJNY3BaMktXOUxobkpkZkF2aFVxM1FiUHZFaHM1bGhGa21Ob1hRM3NfOE5XZlAwUzRkNUJRMWI40gG_AUFVX3lxTE5YcHZ5bnNfNGtOZFFOclkxNGFlajIwUWc1Qjd4eGNOVS1zS1lBZnQxNXRxWFlXZlo2c3Jvd2wwZzRvOG9FWjhZZGYzNTJTYVc2VmdVXzZxUzZ5Vk80NTJSM1JzUjhjMlctMjVJQ293bml5c3Y5c3dVYzFGOXlhRzdpNjUtTU05ZWdFb0RYRVZ6X0Y2NFMwZ21PeE9kSjFhRHdCc3V3Uy1Ca05fR1ZQQk1ULTRYam5WaTBOa0p2U3FR?oc=5"" target=""_blank"">Infosys Fines Biocon CEO Kiran Mazumdar Shaw For Violating Insider Trading Norms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQM2lmSjB2NkFvRi1WRUNrVWcybWd6T1ZFSlp4cE9BLWM0b2xKc0kzclR4M2IwVXh3VVA3eWJhaDZFcFVQMmJYY0prNzJ1R1g1VC1ZVEFkMXRoanlIeGRxSWZrNDdiTUMxVDB5ZjZ3alBHa2tZaXJCWmJNY3BaMktXOUxobkpkZkF2aFVxM1FiUHZFaHM1bGhGa21Ob1hRM3NfOE5XZlAwUzRkNUJRMWI40gG_AUFVX3lxTE5YcHZ5bnNfNGtOZFFOclkxNGFlajIwUWc1Qjd4eGNOVS1zS1lBZnQxNXRxWFlXZlo2c3Jvd2wwZzRvOG9FWjhZZGYzNTJTYVc2VmdVXzZxUzZ5Vk80NTJSM1JzUjhjMlctMjVJQ293bml5c3Y5c3dVYzFGOXlhRzdpNjUtTU05ZWdFb0RYRVZ6X0Y2NFMwZ21PeE9kSjFhRHdCc3V3Uy1Ca05fR1ZQQk1ULTRYam5WaTBOa0p2U3FR?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,-0.3953,-0.3953,negative,1.0
2019-03-01,2019-03-01 08:00:00,Infosys Fines Biocon CEO Kiran Mazumdar Shaw For Violating Insider Trading Norms - Swarajyamag,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQM2lmSjB2NkFvRi1WRUNrVWcybWd6T1ZFSlp4cE9BLWM0b2xKc0kzclR4M2IwVXh3VVA3eWJhaDZFcFVQMmJYY0prNzJ1R1g1VC1ZVEFkMXRoanlIeGRxSWZrNDdiTUMxVDB5ZjZ3alBHa2tZaXJCWmJNY3BaMktXOUxobkpkZkF2aFVxM1FiUHZFaHM1bGhGa21Ob1hRM3NfOE5XZlAwUzRkNUJRMWI40gG_AUFVX3lxTE5YcHZ5bnNfNGtOZFFOclkxNGFlajIwUWc1Qjd4eGNOVS1zS1lBZnQxNXRxWFlXZlo2c3Jvd2wwZzRvOG9FWjhZZGYzNTJTYVc2VmdVXzZxUzZ5Vk80NTJSM1JzUjhjMlctMjVJQ293bml5c3Y5c3dVYzFGOXlhRzdpNjUtTU05ZWdFb0RYRVZ6X0Y2NFMwZ21PeE9kSjFhRHdCc3V3Uy1Ca05fR1ZQQk1ULTRYam5WaTBOa0p2U3FR?oc=5"" target=""_blank"">Infosys Fines Biocon CEO Kiran Mazumdar Shaw For Violating Insider Trading Norms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQM2lmSjB2NkFvRi1WRUNrVWcybWd6T1ZFSlp4cE9BLWM0b2xKc0kzclR4M2IwVXh3VVA3eWJhaDZFcFVQMmJYY0prNzJ1R1g1VC1ZVEFkMXRoanlIeGRxSWZrNDdiTUMxVDB5ZjZ3alBHa2tZaXJCWmJNY3BaMktXOUxobkpkZkF2aFVxM1FiUHZFaHM1bGhGa21Ob1hRM3NfOE5XZlAwUzRkNUJRMWI40gG_AUFVX3lxTE5YcHZ5bnNfNGtOZFFOclkxNGFlajIwUWc1Qjd4eGNOVS1zS1lBZnQxNXRxWFlXZlo2c3Jvd2wwZzRvOG9FWjhZZGYzNTJTYVc2VmdVXzZxUzZ5Vk80NTJSM1JzUjhjMlctMjVJQ293bml5c3Y5c3dVYzFGOXlhRzdpNjUtTU05ZWdFb0RYRVZ6X0Y2NFMwZ21PeE9kSjFhRHdCc3V3Uy1Ca05fR1ZQQk1ULTRYam5WaTBOa0p2U3FR?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,-0.3953,-0.3953,negative,1.0
2019-11-21,2019-11-21 08:00:00,Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.0129,0.0129,neutral,1.0
2019-11-21,2019-11-21 08:00:00,"Kiran Mazumdar Shaw settles alleged insider trading case with SEBI in Infosys matter, pays Rs 3 lakh charges - Firstpost","<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw settles alleged insider trading case with SEBI in Infosys matter, pays Rs 3 lakh charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Firstpost</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,-0.14648333333333333,-0.14648333333333333,negative,1.0
2019-11-21,2019-11-21 08:00:00,Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxPM05NN3dXN2QzR3A2MjllbkZnOVhpMmZWLXBQTzk4UFJGekZiV3RMaGNSYWV0YW9VcDNjNEY1YktwZjRqbk5UWnN0QU9NSkcxeEdudmhtWVhpa3ZRUklHRkltWC04RnRzTGRydllPLXBGbDBJMXY1QVd6VUpqNFgxakFLaFdEamphQUNxZ2lFZlktbngyajRjaEw3c3dzbGFVRnpvTndPTDR5emRLaGNpelp4Y1ZiUWh6eWkyMDNreXRyaE92eDlEQ3Z5YVd5bV8yc21TZzhMTk5ZVm5nRVJqTXVvNGVrdE95Tzg1c2p2c9IB9AFBVV95cUxNVUt4dlpZOVRtSWJSWm5DWXZmME1UM25DRkZSYUNpYVBKWW9lckhUcksyVG01LUNjcGJzQVFwdFdhZ195d0ZFWUdKX29KWXBBY1c0WGFVVlluU3N5bVJMYXZXMGtOVU1wUzU3YWZPbFFsdkQ3VHh0YWZjOWF1V2wxLWNjTm5yWHN5bDJ0Um9mRmV0R1JTaWp1Y1R6ZFlSVnBla3BILTJrbHNOcllqbFFweTNoVGdtczdVZ3JoOGhOc284TnJXREJzNDcwM3ZDQUxYMm9GeWdBY3lEREFnRzI1YlVjSy1fSWlNSEJ6bzdLRkJHcTAz?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.0129,0.0129,neutral,1.0
2019-11-22,2019-11-22 08:00:00,Kiran Mazumdar Shaw Reaches A Rs 3.01 Lakh Settlement With Market Regulator SEBI On Infosys Insider Trading Case - Swarajyamag,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw Reaches A Rs 3.01 Lakh Settlement With Market Regulator SEBI On Infosys Insider Trading Case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.05135,0.05135,neutral,1.0
2019-11-22,2019-11-22 08:00:00,Kiran Mazumdar Shaw Reaches A Rs 3.01 Lakh Settlement With Market Regulator SEBI On Infosys Insider Trading Case - Swarajyamag,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWUhTbGxycXdrOHBTaEh1VTJBTmJKOWRzQzg0djVYcS1PU1RLWUFzaHlaaTFBNzI4WXR5YTZncHhsaTFSTktwZmRBVkNzaUlBMlB2a2RzZ3V3R0pad3Y1QTJfNVRPU1RON0JzRnljU0hUNlVTNTZCb2ZBY1VFNEYtVm9uUDdyRS1qMGdRelkwLXM2NU5Gbkozc3N6eHRYXzc2T1JZM1B0ODQzZks1NC1FcS1sb2hyMVY0dlJrcXhJMV85QjBVeGFNN0tqQldFbHFmRTZvMTRrNlPSAegBQVVfeXFMTlAxeGpEa1ZpSExLeVB0Qi1iZUR6b0FoUVdVa3ZURVNQVXVZUUNqdUVLbVppV0xKWlJSZVNrZnBrVVd1QkN0YTZpdG1BcVUwVXB5eWF1Z1czM0xkYkw3OUZGbmQyVkFFamVwNXJIS3hTNUtLS19SRHl6WWJMcHI3RlM3T09JVHFibFh4TEVhY1Y5VjJPcWlmNk9RNlNDRk1vbTZrUTNhcE52bzZ5a0FzYjV2TXEzTXRYQjV0eGFXYzhtTVFRYnZRbXYzVGcwTnVZaHFmZC1SZjJOQm04TTNYQzVSN3BvT3VWYQ?oc=5"" target=""_blank"">Kiran Mazumdar Shaw Reaches A Rs 3.01 Lakh Settlement With Market Regulator SEBI On Infosys Insider Trading Case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.05135,0.05135,neutral,1.0
2019-11-23,2019-11-23 08:00:00,Kiran Mazumdar Shaw reaches settlement with SEBI in Infosys insider trading case - The News Minute,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw reaches settlement with SEBI in Infosys insider trading case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.05135,0.05135,neutral,1.0
2019-11-23,2019-11-23 08:00:00,Kiran Mazumdar Shaw reaches settlement with SEBI in Infosys insider trading case - The News Minute,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Kiran Mazumdar Shaw reaches settlement with SEBI in Infosys insider trading case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,False,0.05135,0.05135,neutral,1.0
2020-06-22,2020-06-22 07:00:00,Biocon enters into licensing agreement with DKSH - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQXzZ0ZUJpaFR1bmEzT3ZKTjNSZWlST2ZzS18tb05fTDZ2T2g0VTh4U1hHRXdkSzZjV0lUeTVxUGNhZVhBZzNUQkI3Tm5TR0lCV1RsMnljM29tVTVxTEh5NFdHazB2aThiT0VjbXh5MGpZVkZfNk1FSDF5SFQ4WG53VWpVTU5SbWNVeERGcnFpdVlqdXlaM0x0MUxzU1o3RjBiUWNoYnlRcGdUQzZGdjlDMHdobVZQZ1VtSWfSAb8BQVVfeXFMUGZlYW1aTzRxZUJ1SmQxaGgwQTFXZm91QXVQS1lnX18ya1I2NDZHX1p6SHpEc3h0SWthZVhLR1RoVlZkUVVtV0x6ZTl3cXRHREFEWVBpNFNhYXhhd3FfQnJraVVRcXNjYlZLODhVd2hRVlBjRm5WXy1NYlRmbmtNXzJoeG5mWVdEclFfNXJ6WkkyVzFtdEJOU2QwS2sxUy05bWtYWmNVeExlc3lrYUZpb2JzSHRqZ1dlR0ZEYmp3d3M?oc=5"" target=""_blank"">Biocon enters into licensing agreement with DKSH</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2020-07-14,2020-07-14 07:00:00,Key phase 3 clinical trial waived for Biocon drug - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Key phase 3 clinical trial waived for Biocon drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,clinical_trials,Other,Other,8,False,True,0.0,0.0,neutral,1.5
2020-07-21,2020-07-21 07:00:00,Biocon Biologics and Voluntis join hands for global collaboration on digital therapeutics for insulins - BW Businessworld,"<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPeXc3SmtIUmpObzI0dERaTWg3ZDd3YURLR1BUVGJqR0JEQnVZd1k1SWtMWkpqd0xwVlBEMzVDRWllTXBBRC1VSVpkeXFabkJ1ZFhoclBidFBCY2V6RGJFQk1Zdm9LckJQT2pwZjdJeHR4MDR5MVpIdERyaGM2cHEtSGVqMC1USjMweEF2QktlR2FYOUVrWnhod3NoenI4bWZRYVB4THRqa1RzTXh5cklFdUgwbGhrNFczY3c3QnFzMDl0SUJTYngxQXN4SmNveTA3bEc2SUM0YTlwN0xpekhQQw?oc=5"" target=""_blank"">Biocon Biologics and Voluntis join hands for global collaboration on digital therapeutics for insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPeXc3SmtIUmpObzI0dERaTWg3ZDd3YURLR1BUVGJqR0JEQnVZd1k1SWtMWkpqd0xwVlBEMzVDRWllTXBBRC1VSVpkeXFabkJ1ZFhoclBidFBCY2V6RGJFQk1Zdm9LckJQT2pwZjdJeHR4MDR5MVpIdERyaGM2cHEtSGVqMC1USjMweEF2QktlR2FYOUVrWnhod3NoenI4bWZRYVB4THRqa1RzTXh5cklFdUgwbGhrNFczY3c3QnFzMDl0SUJTYngxQXN4SmNveTA3bEc2SUM0YTlwN0xpekhQQw?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.26335,0.26335,positive,1.0
2020-09-07,2020-09-07 07:00:00,A Good Registry Means Accountable Clinical Trials. But Does India Have One? - The Wire Science,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxQdkZWeExqNGZKMDFMdXZFbHNmVHo0LWMwY2lEOWVHS1hBZk9RS3ZtbVI2WEd3cXBRSEtxVVZGUExKbE0xaV9mRDE3UFJIek1oNjlxOTBXUl8wMEVKeGp1aWZkZ2VnVGs0UDZnc0gyUm9lUG5UaVVwaFN3ZERwMlN6WlN2UEJNaWdZVlZQVkJ3cEJSRHlKUUZYdDIxekEwREladk50WXNqc08?oc=5"" target=""_blank"">A Good Registry Means Accountable Clinical Trials. But Does India Have One?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Wire Science</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxQdkZWeExqNGZKMDFMdXZFbHNmVHo0LWMwY2lEOWVHS1hBZk9RS3ZtbVI2WEd3cXBRSEtxVVZGUExKbE0xaV9mRDE3UFJIek1oNjlxOTBXUl8wMEVKeGp1aWZkZ2VnVGs0UDZnc0gyUm9lUG5UaVVwaFN3ZERwMlN6WlN2UEJNaWdZVlZQVkJ3cEJSRHlKUUZYdDIxekEwREladk50WXNqc08?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,clinical_trials,Other,Other,8,False,False,0.6063833333333333,0.9095749999999999,positive,1.5
2021-02-04,2021-02-04 08:00:00,Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5"" target=""_blank"">Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,-0.43445,-0.43445,negative,1.0
2021-02-04,2021-02-04 08:00:00,Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5"" target=""_blank"">Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,-0.43445,-0.43445,negative,1.0
2021-02-04,2021-02-04 08:00:00,Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5"" target=""_blank"">Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.43445,-0.43445,negative,1.0
2021-02-04,2021-02-04 08:00:00,Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5"" target=""_blank"">Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.43445,-0.43445,negative,1.0
2021-02-04,2021-02-04 08:00:00,Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5"" target=""_blank"">Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxPLTRGUGdEcmZ0akRsLXE0a0ZSSmd5S19oQW9pUS1zUy1rNWFzdFRMTE9JNjZiT0l2TUdHb0F4WFBPS1dTdnY1ZjhyWUFJN29TQ1MzSnlwVndpTGlhdC12UDk5RmQxRE8tZ0VOWjhiazgxRE5JclJPbVhMVzdEcW1GRnRJcHBlQVpVZU9jdExpc0VhNjdVejd1VEhtNUs3dzNSRHpBT1hFUEtEaWVVOW05emFjMlFNcTVDT1NZZ09kQjFOM3JCVmhzVw?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.43445,-0.43445,negative,1.0
2021-03-08,2021-03-08 08:00:00,CHAI and ACS announce agreement to expand Cancer Access Partnership - Clinton Health Access Initiative,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5"" target=""_blank"">CHAI and ACS announce agreement to expand Cancer Access Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Clinton Health Access Initiative</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.0258,0.0258,neutral,1.0
2021-03-08,2021-03-08 08:00:00,CHAI and ACS announce agreement to expand Cancer Access Partnership - Clinton Health Access Initiative,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5"" target=""_blank"">CHAI and ACS announce agreement to expand Cancer Access Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Clinton Health Access Initiative</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.0258,0.0258,neutral,1.0
2021-03-08,2021-03-08 08:00:00,CHAI and ACS announce agreement to expand Cancer Access Partnership - Clinton Health Access Initiative,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5"" target=""_blank"">CHAI and ACS announce agreement to expand Cancer Access Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Clinton Health Access Initiative</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.0258,0.0258,neutral,1.0
2021-03-08,2021-03-08 08:00:00,CHAI and ACS announce agreement to expand Cancer Access Partnership - Clinton Health Access Initiative,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5"" target=""_blank"">CHAI and ACS announce agreement to expand Cancer Access Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Clinton Health Access Initiative</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPQndIY2hRYzdJdVQ4WUtYSmRENXVuMk53WUM4dzFlVFhzSnRxdXZzQm1jcmRZVzNJV1kzRld4aHFmQ3ktUW9xbi1odG5yOFp3RnlhMlRPQU5EYmVCT2ZTSVV6Um1TV2toUU5fVUE0bllrRFMtR2NDbmxRQTVQWWUxMEtuMmwtYkhna3EzLVVvWU1Zb2VVbkRtbEN5eHltRU1BRHVhenR5dFI0Y2RRYXc?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.0258,0.0258,neutral,1.0
2021-07-09,2021-07-09 07:00:00,"SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares - Moneylife","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5"" target=""_blank"">SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneylife</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,Sebi bars Allegro Capital for insider trading activities in Biocon shares - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Sebi bars Allegro Capital for insider trading activities in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,Sebi bars Allegro Capital for insider trading activities in Biocon shares - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Sebi bars Allegro Capital for insider trading activities in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,"SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares - Moneylife","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5"" target=""_blank"">SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneylife</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,"SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares - Moneylife","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5"" target=""_blank"">SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneylife</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,Sebi bars Allegro Capital for insider trading activities in Biocon shares - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxORHdUTVlXNzJYdVo0S2RRNmJZOWpUeHBOYkFQYjhHSDRqSXRwLW0tdW9FcGZpSEFMeFgtdEhSVnZUUnNUZGhZS0R2dVVHekx2UExfcmN6c3I5YWxTaVhUUWFTQmpZaV9nUjBuV0dLbDBDRWhURk9HUmtncGV6cHZJdUhwLS01c1dacUtUY3BtRkM5aG16TEV4QVFiczBWc0lEckg1Q0o3WjNfS0htUEp3NWpxaTFWaVBmVXpONk0zSDVKSFRFT3FmaXJfTENtRHRRZnBYRlJJeW9aWEXSAeABQVVfeXFMT3ZuOU9EQ3lRYTR6RUx4Y3N4VXFJc3FldmNjWWVnRVJSTW9jSkJMcUxKVUl1ZjJkZnJudE9CbE1tTGFSSEhrekdER3hlcThSS3dSTjJPRlRVRzJKbmN1eFBwU3hQTW9FU0o4M2tKMFgtRWVRLWRjRnczTnFKQ3ZScllDU3hYR21Fbk9HVjQ5X1pDREdNUHp2NVNCdTRyRGhpSnVGQl9UTjFBeHdmMlVtNm1WM2ZXakE0UjVmbVVkRmxTell3MnpRVzRKaFlfOF8zdnRvTW9MSmlYb1FoN1VtVG8?oc=5"" target=""_blank"">Sebi bars Allegro Capital for insider trading activities in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,Sebi bars Allegro Capital for insider trading activities in Biocon shares - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Sebi bars Allegro Capital for insider trading activities in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxORHdUTVlXNzJYdVo0S2RRNmJZOWpUeHBOYkFQYjhHSDRqSXRwLW0tdW9FcGZpSEFMeFgtdEhSVnZUUnNUZGhZS0R2dVVHekx2UExfcmN6c3I5YWxTaVhUUWFTQmpZaV9nUjBuV0dLbDBDRWhURk9HUmtncGV6cHZJdUhwLS01c1dacUtUY3BtRkM5aG16TEV4QVFiczBWc0lEckg1Q0o3WjNfS0htUEp3NWpxaTFWaVBmVXpONk0zSDVKSFRFT3FmaXJfTENtRHRRZnBYRlJJeW9aWEXSAeABQVVfeXFMT3ZuOU9EQ3lRYTR6RUx4Y3N4VXFJc3FldmNjWWVnRVJSTW9jSkJMcUxKVUl1ZjJkZnJudE9CbE1tTGFSSEhrekdER3hlcThSS3dSTjJPRlRVRzJKbmN1eFBwU3hQTW9FU0o4M2tKMFgtRWVRLWRjRnczTnFKQ3ZScllDU3hYR21Fbk9HVjQ5X1pDREdNUHp2NVNCdTRyRGhpSnVGQl9UTjFBeHdmMlVtNm1WM2ZXakE0UjVmbVVkRmxTell3MnpRVzRKaFlfOF8zdnRvTW9MSmlYb1FoN1VtVG8?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-07-09,2021-07-09 07:00:00,"SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares - Moneylife","<a href=""https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5"" target=""_blank"">SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneylife</font>",https://news.google.com/rss/articles/CBMitgFBVV95cUxObW5YME5GRDMyNnVqNl9keFNQck0xUkhOcnlkZ3FmeVd1aDZHdzI0TkVMb0pyTTdMeE1XVnliMk9SWHJ0WndWaGNpdm1XemJ0QVowdEV1LTlIU3BMQU1XOU43MkJYUnlpYUN1Z3Bxc0xnLVN3aVBQZnprSWUweldJcGVFTUI2ZEVxd3ZnekZ4VTdmT0tBdl9PTjdkTEc3NUUwV2R3MS1mc0E4OGUwdVphTGQ2a1dDQQ?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,0.148,0.148,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.com/rss/articles/CBMihwJBVV95cUxOeC1qbkFSLURXZVlJV2JzSHRLbDNJLXVxVmMtVWQtZ3VoSEJPZkxKQk5uZ3B5cjNCaUlSb0N4TXQ1U3paaGVqc1RNekt4VndTNzkzS1REN254a3pWbVBKdWJPTW5IZjZibHBPVHIxZHJlV2RWeHhQaXdEdHBlNE1vOHZpcmNLZnZGcWxrdWNLQm1IZktnb1hhdER6aVZlejcxZndkMFlFa0xHb1BDdFpwRzZ0d0dpUC10dl9yT0c4Z2NQYzRTNFFxOTZGVUtTek9xNjRkaXRqYksyZ3J5U1RSNjR6RDNocG9rczZiTE0xS3FWaHpTR0lOc1N4UU1fcEpxbGdFVUlDd9IBjAJBVV95cUxOVTZqU1M4Qlg0MjNFRXVNTzk2RExPM2xDWmFFbzdPZTJrN0pkSTBNdm8xUzhDWU1RVXNvV0t4Y1JCUzNac215WVJfZERBU3NEX0Flalc1OG81SlN0LWc2SWxkOXJMeEo5eDJGQWdJVkxGX2duWGttWFdZNlk1QldvOFJZZUtoWlVLQm50Y09GckhzSDVXcGZqODdkM3ZXZFo2RmNMWHF6azJ2UllyRHlFejYza2ZNMFBPd1MwZXdhN1dlRlhjcC02cS1kOEdzRXVqNS1iQXJWLV9kdzNiZGVCVmhxbmpZYlFjRFQ5U080eTg5eHk0UlV5V0NpWTU4aEF5VVJ5R0VqU0xhNnBI?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxOeC1qbkFSLURXZVlJV2JzSHRLbDNJLXVxVmMtVWQtZ3VoSEJPZkxKQk5uZ3B5cjNCaUlSb0N4TXQ1U3paaGVqc1RNekt4VndTNzkzS1REN254a3pWbVBKdWJPTW5IZjZibHBPVHIxZHJlV2RWeHhQaXdEdHBlNE1vOHZpcmNLZnZGcWxrdWNLQm1IZktnb1hhdER6aVZlejcxZndkMFlFa0xHb1BDdFpwRzZ0d0dpUC10dl9yT0c4Z2NQYzRTNFFxOTZGVUtTek9xNjRkaXRqYksyZ3J5U1RSNjR6RDNocG9rczZiTE0xS3FWaHpTR0lOc1N4UU1fcEpxbGdFVUlDd9IBjAJBVV95cUxOVTZqU1M4Qlg0MjNFRXVNTzk2RExPM2xDWmFFbzdPZTJrN0pkSTBNdm8xUzhDWU1RVXNvV0t4Y1JCUzNac215WVJfZERBU3NEX0Flalc1OG81SlN0LWc2SWxkOXJMeEo5eDJGQWdJVkxGX2duWGttWFdZNlk1QldvOFJZZUtoWlVLQm50Y09GckhzSDVXcGZqODdkM3ZXZFo2RmNMWHF6azJ2UllyRHlFejYza2ZNMFBPd1MwZXdhN1dlRlhjcC02cS1kOEdzRXVqNS1iQXJWLV9kdzNiZGVCVmhxbmpZYlFjRFQ5U080eTg5eHk0UlV5V0NpWTU4aEF5VVJ5R0VqU0xhNnBI?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-08-26,2021-08-26 07:00:00,First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">First interchangeable biosimilar insulin's approval to increase competition with payer contracts: GlobalData</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Semglee commercial success,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.49695,0.49695,positive,1.0
2021-09-16,2021-09-16 07:00:00,"Biocon Biologics, Serum Institute Life Sciences announce strategic alliance - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Serum Institute Life Sciences announce strategic alliance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2021-09-16,2021-09-16 07:00:00,"Biocon Biologics, Serum Institute Life Sciences announce strategic alliance - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Serum Institute Life Sciences announce strategic alliance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2021-09-17,2021-09-17 07:00:00,SII announces strategic partnership with Biocon Biologics - ANI News,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxPZUZiUFdXaDV1RVlwTF9HeWttUUItdGRESTlJcEpsaE5WekExZnZvZmEwZDNOUkFFdllOajFxT3RuZ0xiUkpGLWRPLVhaSV9veW1fdFFSNHcxOGhsMkV0c2xmdUVXRVBPX3FjWWZkRFNuV2NaN2xGTGEyNmx5Z3pmS2FyWXhSNjh5bFRwZ1dtNU5ic1RmWE41MFpuTHJIeFYwOUhETUhmTDN0TUlkQnpBVWY1cEZLWnBQZWFSZnNn?oc=5"" target=""_blank"">SII announces strategic partnership with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxPZUZiUFdXaDV1RVlwTF9HeWttUUItdGRESTlJcEpsaE5WekExZnZvZmEwZDNOUkFFdllOajFxT3RuZ0xiUkpGLWRPLVhaSV9veW1fdFFSNHcxOGhsMkV0c2xmdUVXRVBPX3FjWWZkRFNuV2NaN2xGTGEyNmx5Z3pmS2FyWXhSNjh5bFRwZ1dtNU5ic1RmWE41MFpuTHJIeFYwOUhETUhmTDN0TUlkQnpBVWY1cEZLWnBQZWFSZnNn?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2021-09-17,2021-09-17 07:00:00,SII announces strategic partnership with Biocon Biologics - ANI News,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxPZUZiUFdXaDV1RVlwTF9HeWttUUItdGRESTlJcEpsaE5WekExZnZvZmEwZDNOUkFFdllOajFxT3RuZ0xiUkpGLWRPLVhaSV9veW1fdFFSNHcxOGhsMkV0c2xmdUVXRVBPX3FjWWZkRFNuV2NaN2xGTGEyNmx5Z3pmS2FyWXhSNjh5bFRwZ1dtNU5ic1RmWE41MFpuTHJIeFYwOUhETUhmTDN0TUlkQnpBVWY1cEZLWnBQZWFSZnNn?oc=5"" target=""_blank"">SII announces strategic partnership with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxPZUZiUFdXaDV1RVlwTF9HeWttUUItdGRESTlJcEpsaE5WekExZnZvZmEwZDNOUkFFdllOajFxT3RuZ0xiUkpGLWRPLVhaSV9veW1fdFFSNHcxOGhsMkV0c2xmdUVXRVBPX3FjWWZkRFNuV2NaN2xGTGEyNmx5Z3pmS2FyWXhSNjh5bFRwZ1dtNU5ic1RmWE41MFpuTHJIeFYwOUhETUhmTDN0TUlkQnpBVWY1cEZLWnBQZWFSZnNn?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2022-02-06,2022-02-06 14:59:51,Strategic Alliance with Serum Institute to Impact Global Health - Biocon,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxQY1Z3aXdaWnJ3VFd6cU1UQWFQU1NQa1hIWEtkM0w2UWh4c2V1U1JNVUt2cmVrWU1sWlZuZExzRU1KU01ONWFnYVRIMkc1anZSZGE2WEVDSUc3TG95enYwN1hhektiSDlsS2puc2kwWHRpOERTdjY5OTlZYTVscklUY3NUOFA3OGh6d01FRng2eUI?oc=5"" target=""_blank"">Strategic Alliance with Serum Institute to Impact Global Health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxQY1Z3aXdaWnJ3VFd6cU1UQWFQU1NQa1hIWEtkM0w2UWh4c2V1U1JNVUt2cmVrWU1sWlZuZExzRU1KU01ONWFnYVRIMkc1anZSZGE2WEVDSUc3TG95enYwN1hhektiSDlsS2puc2kwWHRpOERTdjY5OTlZYTVscklUY3NUOFA3OGh6d01FRng2eUI?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Biocon Biologics to Acquire Viatris’ Biosimilars Assets in $3.3B Deal - Contract Pharma,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNSmN6WjRabkZmNFpKOU8xUHFvRlVIcjNQRnhiOVlLcTRoanVwN3VvY3NRTmdqY0p6MGRxU3VCOGlhTEl3aks5ZDU3MF84ZENuQ05NZ3Jaa21uanNvX2pGT3pqeDdtWWVXcF9PbmNNUnU4eWxKUkFNbjdROW1zTC1SQXBJQnpIZXYwOGEtSmhLNU5XWGtBcmJIWXBqRXRtalZ5by1rYUJac3VJdloxTXRlcmRR?oc=5"" target=""_blank"">Biocon Biologics to Acquire Viatris’ Biosimilars Assets in $3.3B Deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Contract Pharma</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNSmN6WjRabkZmNFpKOU8xUHFvRlVIcjNQRnhiOVlLcTRoanVwN3VvY3NRTmdqY0p6MGRxU3VCOGlhTEl3aks5ZDU3MF84ZENuQ05NZ3Jaa21uanNvX2pGT3pqeDdtWWVXcF9PbmNNUnU4eWxKUkFNbjdROW1zTC1SQXBJQnpIZXYwOGEtSmhLNU5XWGtBcmJIWXBqRXRtalZ5by1rYUJac3VJdloxTXRlcmRR?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.17,0.17,positive,1.0
2022-07-06,2022-07-06 07:00:00,Biocon arm Syngene ends contract with Bioinnovat Research over graft case - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm Syngene ends contract with Bioinnovat Research over graft case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2022-08-04,2022-08-04 07:00:00,SAT quashes insider trading charges against Biocon official Shreehas Tambe - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">SAT quashes insider trading charges against Biocon official Shreehas Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,-0.24695,-0.24695,negative,1.0
2022-08-04,2022-08-04 07:00:00,SAT quashes insider trading charges against Biocon official Shreehas Tambe - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">SAT quashes insider trading charges against Biocon official Shreehas Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,True,-0.24695,-0.24695,negative,1.0
2022-08-05,2022-08-05 07:00:00,Eris Lifesciences enters licensing deal with Biocon for insulin glargine - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Eris Lifesciences enters licensing deal with Biocon for insulin glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2022-09-26,2022-09-26 07:00:00,SC stops Sebi's regulatory overreach in Abhijit Rajan insider trading case - BizzBuzz,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOZnpFZ2dtNmVncC1WazA2cExKQ1pJUHAzNzM1d3VjbGx2V29ralYxVko2N3FEWmltTWN0cjNNb3pQNE55dmNSNTJYZ3Bjcno2Q25tMVhzMUVGS05lMHBCc1ppaWxjamgyUlVWUUNDVExBR3dicTd5cElKdnJ4Qnp1QkxBa2QyemlIZDI2cGFWV3ZfYzR2bnJaN0JMbVpzZDFLX2VzR201QlJHM0Q1dVRLR0swc0EzY1E?oc=5"" target=""_blank"">SC stops Sebi's regulatory overreach in Abhijit Rajan insider trading case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOZnpFZ2dtNmVncC1WazA2cExKQ1pJUHAzNzM1d3VjbGx2V29ralYxVko2N3FEWmltTWN0cjNNb3pQNE55dmNSNTJYZ3Bjcno2Q25tMVhzMUVGS05lMHBCc1ppaWxjamgyUlVWUUNDVExBR3dicTd5cElKdnJ4Qnp1QkxBa2QyemlIZDI2cGFWV3ZfYzR2bnJaN0JMbVpzZDFLX2VzR201QlJHM0Q1dVRLR0swc0EzY1E?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,False,-0.148,-0.148,negative,1.0
2022-09-26,2022-09-26 07:00:00,SC stops Sebi's regulatory overreach in Abhijit Rajan insider trading case - BizzBuzz,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxOZnpFZ2dtNmVncC1WazA2cExKQ1pJUHAzNzM1d3VjbGx2V29ralYxVko2N3FEWmltTWN0cjNNb3pQNE55dmNSNTJYZ3Bjcno2Q25tMVhzMUVGS05lMHBCc1ppaWxjamgyUlVWUUNDVExBR3dicTd5cElKdnJ4Qnp1QkxBa2QyemlIZDI2cGFWV3ZfYzR2bnJaN0JMbVpzZDFLX2VzR201QlJHM0Q1dVRLR0swc0EzY1E?oc=5"" target=""_blank"">SC stops Sebi's regulatory overreach in Abhijit Rajan insider trading case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOZnpFZ2dtNmVncC1WazA2cExKQ1pJUHAzNzM1d3VjbGx2V29ralYxVko2N3FEWmltTWN0cjNNb3pQNE55dmNSNTJYZ3Bjcno2Q25tMVhzMUVGS05lMHBCc1ppaWxjamgyUlVWUUNDVExBR3dicTd5cElKdnJ4Qnp1QkxBa2QyemlIZDI2cGFWV3ZfYzR2bnJaN0JMbVpzZDFLX2VzR201QlJHM0Q1dVRLR0swc0EzY1E?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,False,-0.148,-0.148,negative,1.0
2022-10-17,2022-10-17 07:00:00,Biocon Biologics inks out-licensing agreement with Yoshindo Inc - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics inks out-licensing agreement with Yoshindo Inc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.4419666666666667,0.4419666666666667,positive,1.0
2022-10-18,2022-10-18 07:00:00,Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZHZ0bFlhSDNVSHMxN3RVRzlITk9QM3cyY0xOcDZqS3pYekxwZEt2M0JuUUthU1VEZUszOEM0b0RydFZPc3VmbDdJTThhX1dPOW1zU2pUbkZ6LUlyZmtENFVpVTNNcGxhT2FfYTlHaDd1SVdkY3FMQm1kNENPcGF3NXJVbFdqNFVVQUVSOVotOEdJemlJRmROd2cyOXpIV05pSjNndlZzQVVCbzUweGFCalJ1alJldnNnZUpzZ0NULUVyS1NHSmZlNXdPQWZyQmZ2dWtCM0pIUUhIZw?oc=5"" target=""_blank"">Biosimilar Business News Recap: Mepolizumab Study; New Licensing Deal; Hukyndra Launches in Switzerland</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxNZHZ0bFlhSDNVSHMxN3RVRzlITk9QM3cyY0xOcDZqS3pYekxwZEt2M0JuUUthU1VEZUszOEM0b0RydFZPc3VmbDdJTThhX1dPOW1zU2pUbkZ6LUlyZmtENFVpVTNNcGxhT2FfYTlHaDd1SVdkY3FMQm1kNENPcGF3NXJVbFdqNFVVQUVSOVotOEdJemlJRmROd2cyOXpIV05pSjNndlZzQVVCbzUweGFCalJ1alJldnNnZUpzZ0NULUVyS1NHSmZlNXdPQWZyQmZ2dWtCM0pIUUhIZw?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.021590909090909088,0.021590909090909088,neutral,1.0
2023-09-20,2023-09-20 07:00:00,"For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxNLV9vb1c1Qlp6YTZ6NjhrZVlyeW5lNWV6LV9DczRPYU9CSml0V2RNNWFLTzlGUVpiLVotRktvUnV4Z1dPZ0c2ZnRjU1JteHRoUkZpNUNwOTI0RWFyWVIwaC1QNVlnWkxKNVRGb3QxUDJLUlhrZTdDWE1tY1NFY2NEMXFvbmZma3I3YWxLY3Z1RzU5bzBScVV1M0pZbjVaSk5NdGdHWkV0Qlk?oc=5"" target=""_blank"">For Biocon Biologics' CEO, the Humira biosimilar clash isn't only about market share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxNLV9vb1c1Qlp6YTZ6NjhrZVlyeW5lNWV6LV9DczRPYU9CSml0V2RNNWFLTzlGUVpiLVotRktvUnV4Z1dPZ0c2ZnRjU1JteHRoUkZpNUNwOTI0RWFyWVIwaC1QNVlnWkxKNVRGb3QxUDJLUlhrZTdDWE1tY1NFY2NEMXFvbmZma3I3YWxLY3Z1RzU5bzBScVV1M0pZbjVaSk5NdGdHWkV0Qlk?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,hospital_adoption,Other,8,False,True,0.148,0.148,positive,1.0
2024-02-09,2024-02-09 08:00:00,Biocon expands Sandoz partnership to sell biosimilars in Australia - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon expands Sandoz partnership to sell biosimilars in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.14660454545454546,0.14660454545454546,positive,1.0
2024-02-13,2024-02-13 08:00:00,Biocon Biologics focusing on market share gains of biosimilars in key markets - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics focusing on market share gains of biosimilars in key markets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMihgJBVV95cUxNYnExOWE1bF9rM0VGdlowcEFFbTlqQVhkUnlDeXFGZW9XZzFRazh5elYwazcwUkVLUkJMU2lXRDl0VVRyTVpPdDA4U0ltbG5MN3oyRXNkN1RwQjVOYkRGTjJaZVFDeXpxakFZYmVmczNocWpiX1E2WXpDWnBWbmhqcU5pQjBVUS1KWkE4dVFCRGVPOUpFOERyV2pRN01PRjdFbklya2ljMHM2aWw5TWNHdEhqNy1FdXhjMi1XeUVHZ2VrZWY2ZkdqZC16UjdKWUhjT0J3b3Z4d3RPaW1zR19NMFVzQjktcjA5MUR1X1BZNjQ3RU1wNVRQczBvbU1mZFhWRGpJd0VB0gGLAkFVX3lxTE0zUTVTbkJoRWRZVmVyMTZubHJHQlpyMnZoaGVWbzBlRmo4c0JGZWc0RFRtZjZBX0ViYmw4dmtmeU55cW1hVF9Nd1BPeloySlNlNzZMVWR6ZC1SUU9SR19oZ2xXYlJ3aWx3eUhrSDRWV0ptU20zcVVCMWtkNGRQTUVBUm04VUNBT0FFaEVOeFdzN0R0d19HczJDSmZSM051cXpZVkJ3azcxMVhuTEFPcF9VeDRtZzAtanFSRUdyWlZrQmRFNnZuenk2akRucE52bFZDeGtNY2JhWHAwT3ZPQWJqd1N4NW9iOUV2WUNrelpZQVB0emZjMS1NcmRqTmxSbHVmM2ZOb2s5clI3UQ?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,hospital_adoption,Other,8,False,True,0.441,0.441,positive,1.0
2024-02-21,2024-02-21 08:00:00,"Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5"" target=""_blank"">Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.025,-0.025,neutral,1.0
2024-02-21,2024-02-21 08:00:00,"Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5"" target=""_blank"">Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.025,-0.025,neutral,1.0
2024-02-21,2024-02-21 08:00:00,"Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5"" target=""_blank"">Eye on Pharma: VA Picks Hadlima; Biocon, Sandoz Partnership; A Stelara Settlement Abroad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOZFFHbUlST2g3U0dXS1RxU1hBQ3NUV2hmbFNBNnpGa0ItLWc2Y1o3TjhYMHdxeWhibzBuYVhVRXdBYlYwUFV4WnctaXRMSktfZEdkN050QW9HVFFPRjVXcHRfWFh6UWtFOVZFaWN4RXZkWllMeWVtR3l5VkZ6STFobUxaWldzSWNwVW9PSWw2aHlnc0NUb3FWMUJHYnNaR0MwaVlOV2xKVnFqRjZMT3FFRmp5TlFDNDRhRU5KMFp3UzVnREl1?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.025,-0.025,neutral,1.0
2024-02-29,2024-02-29 08:00:00,Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen Biotech for psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2024-03-14,2024-03-14 07:00:00,"Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,.. - ET HealthWorld","<a href=""https://news.google.com/rss/articles/CBMiwgJBVV95cUxPTE9MRFFaNWlERFM1QmFYUjVPOWVpUkJHVjg3a1RvUHBXLTM3ZzBQem42MFUxQzZFSmdfekFiMjQ5VXk2bklvdGtVZVNDZWlxdFJFbWxnS1M2aGg1Y3pMNVROeTk0MVdvV1MxclRZcnQyVkpNZGdYWXNEZDRpVGREaHBGOHAybU96Zmc4clBpVlI0VnMtSS1rZWUtY1hGRWxyNUFyYVEyTUN0SHM0akNSdm5SREYzTlVZTFE1SEN5T2M5SHFTeHVRZmdIM1VZbnBpdFhJWVFXdnhiY3RRN0ZjLVhWcE9RclFRT283Mnk4TTBWVUR0N2cwUmVOTHVlUlJLUERNQkdqaVJhLU1fempjeGFuZ21iUTM1NmxCdUJQLWxZanRCbHZMcVlETnpIQ0ZKNlZpaXZWN2d1LVNLblVhc2Rn0gHHAkFVX3lxTE5tN3ZUWFFOeFdWSXNhdUN2ckJnZ2dRY3BPYVU0VGN1VjBva3VFRW91QmZRSmpXQ0NZSFNKOFBEYjFIVDI2d0ZkRjdQY0xmWC1lc1hHUUxETDh4bDROREZlbTlGQkFwSzZhTnM3UGVYelNFQXNhb0gwaW5wT21nWnBRal9ZTDA4UUh3NUZ4eF8xWDBZOGd6cExNUmgzWDBRcUtNWmY3RV96Qm9kdkdhUEVReE9jaVFLZTFGRGVVaFRPcjFqSFItX1lob3VuTlkycEpZQlR6TDZmLVRsWkdOVzJKSlhzLVdJNUl6WGcwV0tHWl9xbHFkQkZyRnhvcFlmUUc0cnV3LUptMy1YbjZZY19lbWk0Q2NjLTJWc2paMDNnWjFOMXVONmd4eEFvQm9Jam5GdHZvZXJwY3RNd1VKR3NpLW5GSXI1WQ?oc=5"" target=""_blank"">Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,..</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.2787,0.2787,positive,1.0
2024-03-14,2024-03-14 07:00:00,"Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,.. - ET HealthWorld","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Eris Lifesciences announce long-term collaboration to expand patient access to metabolics,..</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.2787,0.2787,positive,1.0
2024-03-15,2024-03-15 07:00:00,Biocon Biologics enters a commercial collaboration with Eris Lifesciences - European Pharmaceutical Manufacturer,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics enters a commercial collaboration with Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2024-03-15,2024-03-15 07:00:00,Biocon Biologics enters a commercial collaboration with Eris Lifesciences - European Pharmaceutical Manufacturer,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics enters a commercial collaboration with Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">European Pharmaceutical Manufacturer</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2024-05-24,2024-05-24 07:00:00,Biocon signs licensing deal with Handok in South Korea - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon signs licensing deal with Handok in South Korea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2024-05-24,2024-05-24 07:00:00,Biocon signs licensing deal with Handok in South Korea - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon signs licensing deal with Handok in South Korea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxQLUxDUTlhalF4NENOb3lJaHpOZGR0X0lhOEhZMngwY2VWTjU4TkN2WGVNcDlLY01yb0N4QUE5Vmszc3dINEpIellMT19zcEprYm0wTEl4dzEzNGtmYnJCZ3VsRVhGc1JfVzdES3Bhc0Z6X0ZCdVdjb0pBUWpvYmUtdTFFTGpWVWxOYlNYdjlSMnBMWTBvT1FfVmNyTlA4a3NjZE5MU3NYZVBOYzExejNuZnB6UUJvNnVuTDhpSkRHelpDZUM5b2FPVHVn0gHQAUFVX3lxTFBvdmQwSUNfYzN1Sk91amQzd1pHTmlUS3dVSTZSVGZZZVhVX3F4emlsTDYzYUtvbzZYY1J1Z3YtRTd1MkUwb0xJZHgxUHRLZlNWanlvQlZoWWdYMzZFa3NVSnlSZ2xQQ3ZQV0kydTBVUVctY0FEdzc2WkJhckwwcmU0LTBKSUxNb0RIbXRVeEs0aGw4YXlyRVEwLTBYRkFIckF1S280ZHBaYW1BdjdKWWk3azFHbXB0dHp6NTBrb3lnQ0ppTDFtdlBPWG1sZWV3VDU?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.0,0.0,neutral,1.0
2024-08-26,2024-08-26 07:00:00,Minister: Biocon Failed Human Insulin Supply Contractual Obligations - Galen Centre,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUFpUWpvaW1mX3d2TVlfbzRNclRHdk5IaDlqSzF0VzUtaV9EU2FWWVk5VXAxRHlMNkptNnZkTHBaM1JtdUdDNVJCMnMtYmI1ck5Rc18xV2YwX01BdlR5M1otelMxWjVPcDJmWDhMT3d3NW11RGl3VE9UUVZ4V1M0WXpUR3B2bW9CanFramF2djM1amFTTTNpZnpqa05tMF9xdjljWThIMWR1eXluY2c?oc=5"" target=""_blank"">Minister: Biocon Failed Human Insulin Supply Contractual Obligations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUFpUWpvaW1mX3d2TVlfbzRNclRHdk5IaDlqSzF0VzUtaV9EU2FWWVk5VXAxRHlMNkptNnZkTHBaM1JtdUdDNVJCMnMtYmI1ck5Rc18xV2YwX01BdlR5M1otelMxWjVPcDJmWDhMT3d3NW11RGl3VE9UUVZ4V1M0WXpUR3B2bW9CanFramF2djM1amFTTTNpZnpqa05tMF9xdjljWThIMWR1eXluY2c?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,-0.48250000000000004,-0.48250000000000004,negative,1.0
2024-08-29,2024-08-29 07:00:00,Biocon Biologics signs agreement with Janssen to market Bmab 1200 - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPNVVhWVVuNXpsTXhXWTlORV9mZmFiT0tQd2N5amJjQ3JreG1DVHcyelpLbVJFVEstaVR5UTF1eWxxemFJRDUwWW4yYV9BaXpDYjVkSkN0QkM1OUM0cFRQSVA5X2NFTVNlMzJxX3lhWmN6R1d0S1kxZnY3SXJIWTd6UnU5dHdSOGxHMVE?oc=5"" target=""_blank"">Biocon Biologics signs agreement with Janssen to market Bmab 1200</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPNVVhWVVuNXpsTXhXWTlORV9mZmFiT0tQd2N5amJjQ3JreG1DVHcyelpLbVJFVEstaVR5UTF1eWxxemFJRDUwWW4yYV9BaXpDYjVkSkN0QkM1OUM0cFRQSVA5X2NFTVNlMzJxX3lhWmN6R1d0S1kxZnY3SXJIWTd6UnU5dHdSOGxHMVE?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2024-10-03,2024-10-03 07:00:00,"Bharat Electronics, Israel Aerospace Industries form joint venture firm - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxQaVRPTUxTZENmUTExR0tnOEFoLTFOczlsa2RMNWxReWxieFBEV3pqZEVkamZjRlJuR3Q4YVVzV0dJQV8xV203VFM2RG9mdm0xTnoyQjh3cDdub3pLWTdNLVdUeDF0eTFYY1NZSnJSb245Y3l2dkJVd0gweGRLMGt4RzV2T3p6SWFHOEtKekdLb1l6LTMxc3VDOXVCdzlIbFZiQVhiSnk5ZF9VaW1jTFpWbzJ4ZnVxM2hKTnNMblJxLUJVUkxXUUpTdnhJNVFlWWU5MTg3eEVn0gHbAUFVX3lxTE9nTVJxbkpXNER0V2xHd3JwSktrb0xkbFVtZWd3VW1WbUJrcE13N0FBazd6STVFd0MwXzBBb0xYcWg1TGVaSk9RMGQxc2JmanFLT09zLXBSTTV4SDBwUHdnZTI2YmNuVlhvMVFsNFdFTG9ndTBId2RpdzhCYVQwWjYyODdCRDIzdndvV3N4aHZaOXFhRGxBWHlxWDlKdTBzMy1JeU9wMmVfNDZISTQ0aXRxajhaMkVjam5MMU5WUkJGU1JGYWRmSTFrZ0c3dGpfazBRaG9YQmFfR1AxTQ?oc=5"" target=""_blank"">Bharat Electronics, Israel Aerospace Industries form joint venture firm</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,-0.03333333333333333,-0.03333333333333333,neutral,1.0
2024-10-25,2024-10-25 07:00:00,"Give contract to fix Bengaluru roads to Elcita, not BBMP contractors, Kiran Mazumdar-Shaw tells Karnataka - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Give contract to fix Bengaluru roads to Elcita, not BBMP contractors, Kiran Mazumdar-Shaw tells Karnataka</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5"" target=""_blank"">Equillium Maintains Rights to Itolizumab Following Ono Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Wire</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5"" target=""_blank"">Equillium Maintains Rights to Itolizumab Following Ono Partnership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Wire</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxPOUVGQzZCYVAxQU1qZktUdjdqSG9yTjFRNjRJcEJ1alM5SzdzcFFOek5PdFdBa21RVVZxZUx1SEoxTUI2U2dvSDRBcW5XUEZxaGhMUXJCM3BfR2ExUDZaY3pKanZwMjJIWWI3ZlVsck5YLWtCdzJEVGxLajY2Nks5MGI3ZlBabVpremh6U1phX0xvNTdTRk5LMmhZemRTb0p6dnZGeXhtMXVZbVlfU2tpX3FtUTc2MHJJWUROVGFzNXU?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.0,0.0,neutral,1.0
2024-11-19,2024-11-19 08:00:00,"Industry, govt, academia collaboration in focus at Bengaluru Tech Summit - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi1gFBVV95cUxNWnFXdDVzMzRXS0Vrdm1zUy1SUXBsVlgzdVVCckV1VXhOTDRIM0ZmSnBhaTBxcHpNN3p4YkthRUdUX2VvcjdUcklqRGhwVWQ4UDItUFhISFpkSUh3aWZha0F3d0FIdFdldGtYVWh3WGVvRWVNREVxNnhpbzNUN0JCOE9hTFpqWGNvN2hyQkdOMDdOOUhscXdfQllrelRId3duQkwwNDdDMjFoUDRlQlRHNGJJeUhGMmlrcEhlUVlkRTd1dDNIZG93QTJtVllRbFBnQjlWSDhR0gHbAUFVX3lxTE9meGhNZ18xRUhzbFYyZ0Y2Z0FZN1dwS1VBU3E5OXRmNXB0VHhPNHpGUGdWTGdreHR1dk1CSWh5bVh6cUpxTmlVYmZJaTdFYmI4R3Ywa2JlRFZsQ2gzWXJiRy1iNFFwZVZvcmUwTDJCWjJVTjY1cFEzRFRZSkdtUm5EU0wxX3lLNUZDYzlPd2tHUGhZUWZoSDZDUTV6cHhzWnFwVW5qSmNyYVdURi02Z0tfSjZ6YUxPTVM1QnBaSkRVekFVall3WEtDd09MQ05RTmRfbDZvbXVHTlVPbw?oc=5"" target=""_blank"">Industry, govt, academia collaboration in focus at Bengaluru Tech Summit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.0,0.0,neutral,1.0
2024-12-31,2024-12-31 08:00:00,"Contract research firm Anthem Biosciences files for Rs 3,395 crore IPO - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Contract research firm Anthem Biosciences files for Rs 3,395 crore IPO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxOY182M1NFMFJMaF9sUEREa3ZSa3lTdVkyaGxPRHhYWHJ4azRUZ0ZpTWs4akEySWVISEh0YkRpMVBWOGR3X3lwQmJWcXRuRjZtVEdwREhnVEo4RzNQM2hfNU5nS3ZiTk05TldCaVFFbnpjRlZrS3ZSMktkbWNmSVhjRXhkQ3hPRVFreWV6VW84bjZzbE9CakNJTEItdElpV2tUNVB3WnZLQTM5QnU2Slg2bmlrMHFNUWPSAbwBQVVfeXFMT0NucDRvUFVsbkgzS0tGODItU3lpZzl3RE81MzVmX3I4eG9pRF9FRGVZOWtpUC0wUWN0TEx6dmJDWUk1X005T3BnV1lEQThyNjZQWXM3bUIxa3dZZnFiVVJDSTB6Wnc3SDItOGY4UEZZTlFXVGxqam1XSEVpa2k2Y21NdXJEam1tN25OX2RBc1pSR3cxUWFCa3RlQm14RGcyVWlRN3lSNS1qd1REdXNrSUNCNTlKZFRtaHJkcWI?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,-0.06666666666666667,-0.06666666666666667,neutral,1.0
2025-03-03,2025-03-03 08:00:00,Beneath Tip Of The Iceberg: Defenses For Insider Trading - Live Law,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Beneath Tip Of The Iceberg: Defenses For Insider Trading</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live Law</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,False,0.2040909090909091,0.2040909090909091,positive,1.0
2025-03-03,2025-03-03 08:00:00,Beneath Tip Of The Iceberg: Defenses For Insider Trading - Live Law,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Beneath Tip Of The Iceberg: Defenses For Insider Trading</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live Law</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,insider_trading,8,False,False,0.2040909090909091,0.2040909090909091,positive,1.0
2025-03-07,2025-03-07 08:00:00,Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.48246666666666665,0.48246666666666665,positive,1.0
2025-03-07,2025-03-07 08:00:00,Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.48246666666666665,0.48246666666666665,positive,1.0
2025-03-07,2025-03-07 08:00:00,Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.48246666666666665,0.48246666666666665,positive,1.0
2025-04-15,2025-04-15 07:00:00,"Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron - Times of India","<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5"" target=""_blank"">Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2025-04-15,2025-04-15 07:00:00,Biocon Biologics inks a settlement and license agreement with Regeneron - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics inks a settlement and license agreement with Regeneron</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxNbWpzT3NPclFleDZwaDdkQjNKaXJnc3ZHX3VZTmc3cVZUemFSNURUeTNRY3lmWjh6MXE0Z1JmY2pMLVJYZFotcEtqWHZnbkYtclU2UzBZVmdyY1FjTk14X2RUUU1KS3oxejBzajVaekkwX2R5UzR0YnV4bzlDMUtrdm5zYkwyTVVONWJHLWwyTUtxWXYwaVFMSkR4bFpVNldncWdMWlo2OUs2djhIanhISG5GZkpPZ3d6R3RWZVh3cFp2cDFqSEpramM4UThnVVN0QzMtWmpEXzlrOGRFendGa1RORXBlMkst0gHuAUFVX3lxTFAtX01qakoyUmRFLU5OTVpwNzd3Y21mM2U1V2JhQjdvZHBDMzBCS051Rmk1SXNqTXVBVnU0NlZhVTRuNTFUOEt0TjVIRzNPTzU2OGh0XzVFenV5WEU0bzF1MjhHV3dNbG5jR1g5LUFra25UNjloX0syd1Z2Uk81NTJmWnhBeE1GeFhsNy1kdXcyMTZJSlFPck8tTHlvbVV0SkU0SEtOaGZjQUVWZDB3TUFwSm82bXpLOEF2VEZ1X0NUSTJVM3lHVV9ic213UzBPZUJrY1l6aVhPQXBKQTdLa3ZFS2JzeklDcjJRVnJMSUE?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2025-04-15,2025-04-15 07:00:00,"Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US - Ophthalmology Times","<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVm9YZXd4M1BUVW1HdmhyNEN2QlZQQnBLMDJ4cXVPclJJbWRQN01FZEc3UnM5b2tVWmxSUWJ1aVItSU8zNm5UdmxFZmYwbk4xMXU2ekhCdUtLVjB5WnVmRXBTRF9zdG1veDd5X1djeHB0em55M1J4YWU4S2NZdDNGNzRUR0FXLXN5d3dfb1Y1V01LLUNFWGRmTkl2UERlbnNMNUNET1dJcDJ3T1QtUk9CMF9nbVRndFBZa3c1SUppc3ZDWmR4V2Z1S2JiNXJ5Mi14MExyVkk2WVlUbTg?oc=5"" target=""_blank"">Biocon reaches settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili, in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Ophthalmology Times</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNVm9YZXd4M1BUVW1HdmhyNEN2QlZQQnBLMDJ4cXVPclJJbWRQN01FZEc3UnM5b2tVWmxSUWJ1aVItSU8zNm5UdmxFZmYwbk4xMXU2ekhCdUtLVjB5WnVmRXBTRF9zdG1veDd5X1djeHB0em55M1J4YWU4S2NZdDNGNzRUR0FXLXN5d3dfb1Y1V01LLUNFWGRmTkl2UERlbnNMNUNET1dJcDJ3T1QtUk9CMF9nbVRndFBZa3c1SUppc3ZDWmR4V2Z1S2JiNXJ5Mi14MExyVkk2WVlUbTg?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.38915,0.38915,positive,1.0
2025-04-15,2025-04-15 07:00:00,"Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron - Times of India","<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5"" target=""_blank"">Biocon Biologics' Yesafili to enter US market, following agreement with Regeneron</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYndZUktwNWthcG5nNGZjOXR2cTkxdEZKUmJqVnlkc0JKQVlLX0F1TVU5S1hXdHNVN1Z1OGZvZl9wUWlNWjM0b2hlR1BoZ2F6Z0U5ZWNTeElEXzhJUXpfUEJZbEg3SFRxLW1sTU9Od3l6UlM5LXhGZUltUGZQM3BaZDdQcFUyRHlEMGVjTDNjbllPei13OUphVW1SZUdTRHcyRDdlaGtZZU94dWQtcmJaa2JYaF9aVlAtQXhpaU5LNkRyXy1JMmlLWWZqd0ZvNzNxdjBOUFF1V2dtNXJxVEpVZU9DMVdTbFpqRFJkMl9ZY0pTcC1kU081T9IB_gFBVV95cUxPemJCOHlCZ3hrdldGUU9ncFA3SFJDd1NRbEl3OXI3SFlKdFhQZk15T0E0RHZBUFNEeEluLUlMdEhneVNFeUFTY2tnckJ1V2luMzVONk8ySnR4Sk1QaS16QTFwdkNYZ0xxZExLY3R1WWhGNUNER2RrMzFCWmlhNFVHTFJCd19VbktURDVENEdJb2ktQWZvSlljWFpFcDZnYWw2MjBlZ2Q0Yk9nZThUckg3X3Q2NjFId05oMDNxOHQ5TWNiVGVjc2ZJQzd6clp5d2RyeTRfNTFLcGlZcWZNdkJING4xaWNvNkdMcVNYS3BCU1BhNHYwUmtKa0ZQTTByQQ?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2025-05-11,2025-05-11 07:00:00,Biocon bullish on US market share with over 70% payer access - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bullish on US market share with over 70% payer access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,hospital_adoption,Other,8,False,True,0.26335,0.26335,positive,1.0
2025-05-11,2025-05-11 07:00:00,Biocon bullish on US market share with over 70% payer access - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bullish on US market share with over 70% payer access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,hospital_adoption,Other,8,False,True,0.26335,0.26335,positive,1.0
2025-05-12,2025-05-12 10:58:04,"India Biosimilar Contract Manufacturing Market Size, Growth Report 2035 - Market Research Future","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQMGUwbTc2NjdZLXZyai1qajVpMzFTZDlMdEJlcnpOcjR3X2NJbWg1VG1XRTdQY210aURHWXptNWZldTRQZ3hJWFptTG9SMU9JNnBsbjBkRlk0NXBDYjVKalFzTGgzV1padFBfZV94WWJHS2g3ZW9jTk1IU0xqaURIaTgyMUNLbXh0VFkwRjlCQmN3QndoakFpZ0E1TkFNUQ?oc=5"" target=""_blank"">India Biosimilar Contract Manufacturing Market Size, Growth Report 2035</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Market Research Future</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQMGUwbTc2NjdZLXZyai1qajVpMzFTZDlMdEJlcnpOcjR3X2NJbWg1VG1XRTdQY210aURHWXptNWZldTRQZ3hJWFptTG9SMU9JNnBsbjBkRlk0NXBDYjVKalFzTGgzV1padFBfZV94WWJHS2g3ZW9jTk1IU0xqaURIaTgyMUNLbXh0VFkwRjlCQmN3QndoakFpZ0E1TkFNUQ?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,False,0.31845,0.31845,positive,1.0
2025-05-22,2025-05-22 07:00:00,Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon Biologics announces extension of insulin supply agreement with Govt. of Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.3753,0.3753,positive,1.0
2025-06-10,2025-06-10 07:00:00,"Biocon Foundation in collaboration with BeST Cluster, NCBS introduces BioWISE Program - to Empower Women... - Medical Dialogues","<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxQMW1kQ2RNdVhnbkI5eHpsZkRoMlluaFV6aEJaUGZBTEhETm8xc2lrN3ozNWJ2NkZudmpzSTJJNEpXVTdsbmtWN0Q5MU1pRC05bnZRQ0s2N0E3UmMwRjR2ZWVSMzcxYlU4M0k4TDBBd25oYUE3aFFQSWZuM1lpZkxvaTlCUlFLc1FqdXJuNmpiMGRaZlBKN29KdUhfVUp3bFg2dW5QejRueUtySkZCWUtYa1FmNnlUc2VtRC0tNmIzQktpYUFGOENCM0NGbG5ESDRDRl9GaExQTTh1aXNlQncyQVFfWWc4Q2dsTmhkZG9UTzVGLUhsSEZ3UNIB_gFBVV95cUxORGVLWDVzaWs4dXlMZ3hKb1VzQnc4MFdGeklhVEpmdmdGdmcyUmx5Snd0QUx5RnpFV2JuUWNEbGRvWVUxdkR3T1F5eTZZS2lrUGY3ckR0QUlVS2xBdk1la2poUjBGeXY1Q2k3a19wNmczbHZJZmZrUW5ZSzBja0tFMXZxUFRIRXBJcWozR2Q1M2thTUoybWRPV3lJRFpJOU9PeWRoZzVFRUZ2M3NyTWpzUGJqUDZldDVsZlFtMy1jdWFHeWxJNldBcUpTdDgzbTJFRjdsVFE3ZDk3Tm00N3V3cjFfU3hSTFRkclVpa1dGaWlOY2RmZE0wcUdQLVRXZw?oc=5"" target=""_blank"">Biocon Foundation in collaboration with BeST Cluster, NCBS introduces BioWISE Program - to Empower Women...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxQMW1kQ2RNdVhnbkI5eHpsZkRoMlluaFV6aEJaUGZBTEhETm8xc2lrN3ozNWJ2NkZudmpzSTJJNEpXVTdsbmtWN0Q5MU1pRC05bnZRQ0s2N0E3UmMwRjR2ZWVSMzcxYlU4M0k4TDBBd25oYUE3aFFQSWZuM1lpZkxvaTlCUlFLc1FqdXJuNmpiMGRaZlBKN29KdUhfVUp3bFg2dW5QejRueUtySkZCWUtYa1FmNnlUc2VtRC0tNmIzQktpYUFGOENCM0NGbG5ESDRDRl9GaExQTTh1aXNlQncyQVFfWWc4Q2dsTmhkZG9UTzVGLUhsSEZ3UNIB_gFBVV95cUxORGVLWDVzaWs4dXlMZ3hKb1VzQnc4MFdGeklhVEpmdmdGdmcyUmx5Snd0QUx5RnpFV2JuUWNEbGRvWVUxdkR3T1F5eTZZS2lrUGY3ckR0QUlVS2xBdk1la2poUjBGeXY1Q2k3a19wNmczbHZJZmZrUW5ZSzBja0tFMXZxUFRIRXBJcWozR2Q1M2thTUoybWRPV3lJRFpJOU9PeWRoZzVFRUZ2M3NyTWpzUGJqUDZldDVsZlFtMy1jdWFHeWxJNldBcUpTdDgzbTJFRjdsVFE3ZDk3Tm00N3V3cjFfU3hSTFRkclVpa1dGaWlOY2RmZE0wcUdQLVRXZw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.6777500000000001,0.6777500000000001,positive,1.0
2025-06-10,2025-06-10 07:00:00,Biocon Foundation in Partnership with NCBS and BeST Cluster Launches BioWISE Program – to Empower Women in STEM - indiaeducationdiary.in,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSzRWS09lNU1tR3lFX1kyUU9pMXAxalVVbWJZbnNGTnNOQTc3UkxlRGtXTHZ0MzBKeWNLTHFPdlRGdlpuVG1aaWpOZ2tkZTk5eVdVM0cyajNXa3NkZjlpRk1YU0JudFJ6NE9JYmdrTVFwVDlfR1labXlCcWxEMWhIVEVXVVhYVlVYMTFpX285NERoY1pueEhJNHZjdEloQlNMdjc3NGRveFYxbVUyX3JMOER0NW9qSUp3ZWoyYlRIcTR5ZXJ3am1XblJpc014ZkNJUm5ldG1qdGU?oc=5"" target=""_blank"">Biocon Foundation in Partnership with NCBS and BeST Cluster Launches BioWISE Program – to Empower Women in STEM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">indiaeducationdiary.in</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSzRWS09lNU1tR3lFX1kyUU9pMXAxalVVbWJZbnNGTnNOQTc3UkxlRGtXTHZ0MzBKeWNLTHFPdlRGdlpuVG1aaWpOZ2tkZTk5eVdVM0cyajNXa3NkZjlpRk1YU0JudFJ6NE9JYmdrTVFwVDlfR1labXlCcWxEMWhIVEVXVVhYVlVYMTFpX285NERoY1pueEhJNHZjdEloQlNMdjc3NGRveFYxbVUyX3JMOER0NW9qSUp3ZWoyYlRIcTR5ZXJ3am1XblJpc014ZkNJUm5ldG1qdGU?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.7610833333333333,0.7610833333333333,positive,1.0
2025-06-13,2025-06-13 07:00:00,Biocon Foundation in partnership with NCBS and BeST Cluster launches BioWISE programme to empower women in STEM - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNRTlWaWdLNWxxWDZXZE1YcEdmUlZhcmpYWWtlMVpaX2dfbXBYb3dULXl4OElrNmxlRkxqNkYxR29pNkxNWFFOY0FtQVBEdEx2bFZDeWl5bkhyOXRuZEg3VDNXXzZ6Vnd4V1hDb0U3Q2ttTEtWa1IwVVhZY2xkbkJCak9wbnZoS0hLYUNpanhWYzd6eVJmTEtqUlNjZHIwUW1BV2RQTksxWU11QUNpYzFkTHZaUGtHSEJ6TExVTVpSNTgtSlV0LWV5LUFoeGltZ0t6U1pSUWQyNEFzLTZXb213VTROYkhnRzRjSXhMWl9ENWg1S2pVMjJZbw?oc=5"" target=""_blank"">Biocon Foundation in partnership with NCBS and BeST Cluster launches BioWISE programme to empower women in STEM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxNRTlWaWdLNWxxWDZXZE1YcEdmUlZhcmpYWWtlMVpaX2dfbXBYb3dULXl4OElrNmxlRkxqNkYxR29pNkxNWFFOY0FtQVBEdEx2bFZDeWl5bkhyOXRuZEg3VDNXXzZ6Vnd4V1hDb0U3Q2ttTEtWa1IwVVhZY2xkbkJCak9wbnZoS0hLYUNpanhWYzd6eVJmTEtqUlNjZHIwUW1BV2RQTksxWU11QUNpYzFkTHZaUGtHSEJ6TExVTVpSNTgtSlV0LWV5LUFoeGltZ0t6U1pSUWQyNEFzLTZXb213VTROYkhnRzRjSXhMWl9ENWg1S2pVMjJZbw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.7610833333333333,0.7610833333333333,positive,1.0
2025-06-13,2025-06-13 07:00:00,Biocon Foundation in partnership with NCBS and BeST Cluster launches BioWISE programme to empower women in STEM - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi-AFBVV95cUxNRTlWaWdLNWxxWDZXZE1YcEdmUlZhcmpYWWtlMVpaX2dfbXBYb3dULXl4OElrNmxlRkxqNkYxR29pNkxNWFFOY0FtQVBEdEx2bFZDeWl5bkhyOXRuZEg3VDNXXzZ6Vnd4V1hDb0U3Q2ttTEtWa1IwVVhZY2xkbkJCak9wbnZoS0hLYUNpanhWYzd6eVJmTEtqUlNjZHIwUW1BV2RQTksxWU11QUNpYzFkTHZaUGtHSEJ6TExVTVpSNTgtSlV0LWV5LUFoeGltZ0t6U1pSUWQyNEFzLTZXb213VTROYkhnRzRjSXhMWl9ENWg1S2pVMjJZbw?oc=5"" target=""_blank"">Biocon Foundation in partnership with NCBS and BeST Cluster launches BioWISE programme to empower women in STEM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi-AFBVV95cUxNRTlWaWdLNWxxWDZXZE1YcEdmUlZhcmpYWWtlMVpaX2dfbXBYb3dULXl4OElrNmxlRkxqNkYxR29pNkxNWFFOY0FtQVBEdEx2bFZDeWl5bkhyOXRuZEg3VDNXXzZ6Vnd4V1hDb0U3Q2ttTEtWa1IwVVhZY2xkbkJCak9wbnZoS0hLYUNpanhWYzd6eVJmTEtqUlNjZHIwUW1BV2RQTksxWU11QUNpYzFkTHZaUGtHSEJ6TExVTVpSNTgtSlV0LWV5LUFoeGltZ0t6U1pSUWQyNEFzLTZXb213VTROYkhnRzRjSXhMWl9ENWg1S2pVMjJZbw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.7610833333333333,0.7610833333333333,positive,1.0
2025-06-21,2025-06-21 14:02:00,Biocon India and Morocco: A Pharmaceutical Partnership to Strengthen Health Security in Africa - الصحيفة,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxNS3lGTGpGSWJPdmpKNmtaZ0lVWi1pMUJpQUU4Nk5oMUVmdDdrWTdRMlZJWExwcms1OHhBcUlUN0VnVllRcFA3bjR0cnRpTEVXak02WjlIRWJscjdBV21CbkNuakxHcGNGNDMzZm9UdWRtbHpUZTY4YXZuNHhuNk42RnNQTG9DQ0hxRWdkdTJyeVUyTE41UmlhNzl1UDZ2WFRxaDdZWmVnQmJlX3h2YVA2YjRJN1Q1dl9QQ3FfakFfbm9tZ3dHVFFkeTFNQnVYMm92?oc=5"" target=""_blank"">Biocon India and Morocco: A Pharmaceutical Partnership to Strengthen Health Security in Africa</a>&nbsp;&nbsp;<font color=""#6f6f6f"">الصحيفة</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxNS3lGTGpGSWJPdmpKNmtaZ0lVWi1pMUJpQUU4Nk5oMUVmdDdrWTdRMlZJWExwcms1OHhBcUlUN0VnVllRcFA3bjR0cnRpTEVXak02WjlIRWJscjdBV21CbkNuakxHcGNGNDMzZm9UdWRtbHpUZTY4YXZuNHhuNk42RnNQTG9DQ0hxRWdkdTJyeVUyTE41UmlhNzl1UDZ2WFRxaDdZWmVnQmJlX3h2YVA2YjRJN1Q1dl9QQ3FfakFfbm9tZ3dHVFFkeTFNQnVYMm92?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,partnerships_deals,8,False,True,0.4063,0.4063,positive,1.0
2016-04-27,2016-04-27 07:00:00,Biocon appoints former Sebi chief M. Damodaran as independent director | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon appoints former Sebi chief M. Damodaran as independent director | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon sebi,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2016-07-23,2016-07-23 07:00:00,Supreme Court rules against Sebi in CIS cases - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Supreme Court rules against Sebi in CIS cases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon sebi,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,regulatory_compliance,7,False,False,0.2787,0.2787,positive,1.0
2017-08-03,2017-08-03 07:00:00,No investigation against Roche for anti-competitive practices against Biocon and Mylan until next hearing - Mint,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPUmFTMkxuZ2ZNU010Y1hpMXJoMVhhLTZkRWJSRUNRYjNNcWtTZ2lwS1JOamVNbjZHcmQ3TUt3dnRmc3BFaTBma1FJVXY3eFpTWFEtbEJva2RCeTdaMnBLQjZKcnR6QlBkaFBsSnBRTGkwb0U1bUsxYkpFb2dzMTB6aFQ5MUhjUVhyWG0zU0FOYXJidV8wVzI0TnFhcmc4Q0xzWE9rT1ZwYmxHNlFwLU9fU3VZdzhydVNtWFUyZThfdw?oc=5"" target=""_blank"">No investigation against Roche for anti-competitive practices against Biocon and Mylan until next hearing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxPUmFTMkxuZ2ZNU010Y1hpMXJoMVhhLTZkRWJSRUNRYjNNcWtTZ2lwS1JOamVNbjZHcmQ3TUt3dnRmc3BFaTBma1FJVXY3eFpTWFEtbEJva2RCeTdaMnBLQjZKcnR6QlBkaFBsSnBRTGkwb0U1bUsxYkpFb2dzMTB6aFQ5MUhjUVhyWG0zU0FOYXJidV8wVzI0TnFhcmc4Q0xzWE9rT1ZwYmxHNlFwLU9fU3VZdzhydVNtWFUyZThfdw?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,-0.148,-0.148,negative,1.0
2017-09-07,2017-09-07 07:00:00,Biocon’s Malaysia facility receives EU GMP Compliance certificate - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxNZmNBQjZ4aWlPZV92eUtxLTN6bDRRMjZOay1ZYzM0U2RHSEVaempFb19pQXc2bjEtMndRYTRXQTAyQnROazFqeHhNQnpsX21Oc2dQV2JERnpUTmU1cEZJUkloMTFSdWhCZjNXM1pZZ09Pc3NESVpCd2pYbEFBOWh0NEJ5QUtQa3lJb0l6Qll4OFY2dlFMamhFUFJR0gGfAUFVX3lxTE5RNC1oWk9mbmxUWmlUQjJ5S1NobllCTThidzBXRXVSUTcxbFlmU1hfVFFuTUpQUVZVNzFIRVRsdUFiTTZyZHp6eS1MNEkyemdHTldmQmJGd19pbHlCdTlOMTh5RnJTd2RMWVFYWHI1RmszZ0xMRWtsekpKRWRXYXlvNFhyNUFwV0VjZDNkN1dVbFc1RWpiQ3VSdHQ5Mlh2RQ?oc=5"" target=""_blank"">Biocon’s Malaysia facility receives EU GMP Compliance certificate</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxNZmNBQjZ4aWlPZV92eUtxLTN6bDRRMjZOay1ZYzM0U2RHSEVaempFb19pQXc2bjEtMndRYTRXQTAyQnROazFqeHhNQnpsX21Oc2dQV2JERnpUTmU1cEZJUkloMTFSdWhCZjNXM1pZZ09Pc3NESVpCd2pYbEFBOWh0NEJ5QUtQa3lJb0l6Qll4OFY2dlFMamhFUFJR0gGfAUFVX3lxTE5RNC1oWk9mbmxUWmlUQjJ5S1NobllCTThidzBXRXVSUTcxbFlmU1hfVFFuTUpQUVZVNzFIRVRsdUFiTTZyZHp6eS1MNEkyemdHTldmQmJGd19pbHlCdTlOMTh5RnJTd2RMWVFYWHI1RmszZ0xMRWtsekpKRWRXYXlvNFhyNUFwV0VjZDNkN1dVbFc1RWpiQ3VSdHQ5Mlh2RQ?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2017-09-07,2017-09-07 07:00:00,Biocon’s Malaysia facility receives EU GMP Compliance certificate - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxNZmNBQjZ4aWlPZV92eUtxLTN6bDRRMjZOay1ZYzM0U2RHSEVaempFb19pQXc2bjEtMndRYTRXQTAyQnROazFqeHhNQnpsX21Oc2dQV2JERnpUTmU1cEZJUkloMTFSdWhCZjNXM1pZZ09Pc3NESVpCd2pYbEFBOWh0NEJ5QUtQa3lJb0l6Qll4OFY2dlFMamhFUFJR0gGfAUFVX3lxTE5RNC1oWk9mbmxUWmlUQjJ5S1NobllCTThidzBXRXVSUTcxbFlmU1hfVFFuTUpQUVZVNzFIRVRsdUFiTTZyZHp6eS1MNEkyemdHTldmQmJGd19pbHlCdTlOMTh5RnJTd2RMWVFYWHI1RmszZ0xMRWtsekpKRWRXYXlvNFhyNUFwV0VjZDNkN1dVbFc1RWpiQ3VSdHQ5Mlh2RQ?oc=5"" target=""_blank"">Biocon’s Malaysia facility receives EU GMP Compliance certificate</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxNZmNBQjZ4aWlPZV92eUtxLTN6bDRRMjZOay1ZYzM0U2RHSEVaempFb19pQXc2bjEtMndRYTRXQTAyQnROazFqeHhNQnpsX21Oc2dQV2JERnpUTmU1cEZJUkloMTFSdWhCZjNXM1pZZ09Pc3NESVpCd2pYbEFBOWh0NEJ5QUtQa3lJb0l6Qll4OFY2dlFMamhFUFJR0gGfAUFVX3lxTE5RNC1oWk9mbmxUWmlUQjJ5S1NobllCTThidzBXRXVSUTcxbFlmU1hfVFFuTUpQUVZVNzFIRVRsdUFiTTZyZHp6eS1MNEkyemdHTldmQmJGd19pbHlCdTlOMTh5RnJTd2RMWVFYWHI1RmszZ0xMRWtsekpKRWRXYXlvNFhyNUFwV0VjZDNkN1dVbFc1RWpiQ3VSdHQ5Mlh2RQ?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2017-09-18,2017-09-18 07:00:00,Biocon’s First Overseas Insulin Unit in Malaysia receives EU GMP Compliance - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWnotV2hUUkt3T0FXNHhuZkFhOTR2NDBYa3dnRXZDeVdmUWxqOEFIRHhSLTlJZTh2MTI3V1J6eFB1YnA5c2x1SHpJenNyblMyOTFVcnVaUmR5R0JqWFRiRTRCWXR1S1Jkc3hvaURzTm1JeXBfbzJaaVE1UXgxa1c2M3ZvM3lrWU81NERfU3pfTGxoaVRYMVh1TkFWU2duc1Y2ZWZheWNVZ0NMdExoWWZhUEJUd0c1ZFlSRW9qTXdmYXBYQjg?oc=5"" target=""_blank"">Biocon’s First Overseas Insulin Unit in Malaysia receives EU GMP Compliance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWnotV2hUUkt3T0FXNHhuZkFhOTR2NDBYa3dnRXZDeVdmUWxqOEFIRHhSLTlJZTh2MTI3V1J6eFB1YnA5c2x1SHpJenNyblMyOTFVcnVaUmR5R0JqWFRiRTRCWXR1S1Jkc3hvaURzTm1JeXBfbzJaaVE1UXgxa1c2M3ZvM3lrWU81NERfU3pfTGxoaVRYMVh1TkFWU2duc1Y2ZWZheWNVZ0NMdExoWWZhUEJUd0c1ZFlSRW9qTXdmYXBYQjg?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.08333333333333333,0.08333333333333333,neutral,1.0
2019-01-02,2019-01-02 08:00:00,Nephros Announces Acquisition of Biocon - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd3QwZXdtRUFNalJPNTlnNG5OTTFaN2pnUHZLTmRNa2c4SWRGMUw5MkhoZlY2bmNOZU85NkJaVm4zY3dmNnJKS3R6M0Vya1pwXzJYYldILUNZME1oOExfeFk1MWo1S3N5dzRaQVhsVXlORy0yc3o2VV8zX3g2Q1pwSnhjODdFZnY4WHRxeUJPNWNGUFJhWlo0a09mSTJmUVVJS051dU80dEc0eVA3WlY3aA?oc=5"" target=""_blank"">Nephros Announces Acquisition of Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd3QwZXdtRUFNalJPNTlnNG5OTTFaN2pnUHZLTmRNa2c4SWRGMUw5MkhoZlY2bmNOZU85NkJaVm4zY3dmNnJKS3R6M0Vya1pwXzJYYldILUNZME1oOExfeFk1MWo1S3N5dzRaQVhsVXlORy0yc3o2VV8zX3g2Q1pwSnhjODdFZnY4WHRxeUJPNWNGUFJhWlo0a09mSTJmUVVJS051dU80dEc0eVA3WlY3aA?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2019-06-14,2019-06-14 07:00:00,Biocon's biologics facilities in Bengaluru receive GMP compliance certificate from EMA - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's biologics facilities in Bengaluru receive GMP compliance certificate from EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2019-11-21,2019-11-21 08:00:00,Kiran Mazumdar Shaw settles case with Sebi - The Hans India,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxNT3MtU2FaLU9PTm9pa290eGNZMElNZ0Q3ZEVDMjdDRERSREp4eUYzTm5pdnJZeDJDNFBlNU5Ddmd6NTVRamhuMTNTTmxUODBybkFVSzNpQ25jOXJXb2ZmVUxIREYxeFh1dW01TTRlNXp3enNNQ21hRlJreEhlMWtYaUN2aW83V1ZXVUNuZUc0a210Zw?oc=5"" target=""_blank"">Kiran Mazumdar Shaw settles case with Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxNT3MtU2FaLU9PTm9pa290eGNZMElNZ0Q3ZEVDMjdDRERSREp4eUYzTm5pdnJZeDJDNFBlNU5Ddmd6NTVRamhuMTNTTmxUODBybkFVSzNpQ25jOXJXb2ZmVUxIREYxeFh1dW01TTRlNXp3enNNQ21hRlJreEhlMWtYaUN2aW83V1ZXVUNuZUc0a210Zw?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-04-12,2021-04-12 07:00:00,"Biocon arm gets GMP compliance certificate from MHRA, UK - Medical Dialogues","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm gets GMP compliance certificate from MHRA, UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-04-12,2021-04-12 07:00:00,"Biocon Pharma gets GMP compliance certificate from MHRA, UK - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxQX2dMT1dfTzlqQnZNbV9sa1ltS3dLWVRJOTlwY0ZiNjM2bjNNUVBDajYtR2VzczRJSlNYcFRqT0JjWUI3ZTc3OVo4SEFRX1ZXMkkwNEJ0YWFPb2t2dGpGbEZLa0NaNEtpMzdNZTZRLXY5TWVSNEZBVXVOZXRvQW50c3R5ajFlYUh3blFIbHdISGh2UdIBlwFBVV95cUxQMU85Ry1nSkh5S0VUTXg5UEY4Z3c0Z2ZYOVRZbUVkMmg0QXBHRUJFYjlna0hqSUw1YkJ5elpVMXpnUkhEbExfXzI5cER5VVpEdFVpZ2l1djZ5U0szWmRNdW41Q0xvZWFjZmZhbnBIaXFkeWJsUU1jMTNETU5uUHdvS21yMmFSNDNnVjdIWHNGZ01hUjkxNFJV?oc=5"" target=""_blank"">Biocon Pharma gets GMP compliance certificate from MHRA, UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxQX2dMT1dfTzlqQnZNbV9sa1ltS3dLWVRJOTlwY0ZiNjM2bjNNUVBDajYtR2VzczRJSlNYcFRqT0JjWUI3ZTc3OVo4SEFRX1ZXMkkwNEJ0YWFPb2t2dGpGbEZLa0NaNEtpMzdNZTZRLXY5TWVSNEZBVXVOZXRvQW50c3R5ajFlYUh3blFIbHdISGh2UdIBlwFBVV95cUxQMU85Ry1nSkh5S0VUTXg5UEY4Z3c0Z2ZYOVRZbUVkMmg0QXBHRUJFYjlna0hqSUw1YkJ5elpVMXpnUkhEbExfXzI5cER5VVpEdFVpZ2l1djZ5U0szWmRNdW41Q0xvZWFjZmZhbnBIaXFkeWJsUU1jMTNETU5uUHdvS21yMmFSNDNnVjdIWHNGZ01hUjkxNFJV?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-04-12,2021-04-12 07:00:00,"Biocon arm gets GMP compliance certificate from MHRA, UK - Medical Dialogues","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon arm gets GMP compliance certificate from MHRA, UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-04-12,2021-04-12 07:00:00,"Biocon Pharma gets GMP compliance certificate from MHRA, UK - Express Pharma","<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxQX2dMT1dfTzlqQnZNbV9sa1ltS3dLWVRJOTlwY0ZiNjM2bjNNUVBDajYtR2VzczRJSlNYcFRqT0JjWUI3ZTc3OVo4SEFRX1ZXMkkwNEJ0YWFPb2t2dGpGbEZLa0NaNEtpMzdNZTZRLXY5TWVSNEZBVXVOZXRvQW50c3R5ajFlYUh3blFIbHdISGh2UdIBlwFBVV95cUxQMU85Ry1nSkh5S0VUTXg5UEY4Z3c0Z2ZYOVRZbUVkMmg0QXBHRUJFYjlna0hqSUw1YkJ5elpVMXpnUkhEbExfXzI5cER5VVpEdFVpZ2l1djZ5U0szWmRNdW41Q0xvZWFjZmZhbnBIaXFkeWJsUU1jMTNETU5uUHdvS21yMmFSNDNnVjdIWHNGZ01hUjkxNFJV?oc=5"" target=""_blank"">Biocon Pharma gets GMP compliance certificate from MHRA, UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxQX2dMT1dfTzlqQnZNbV9sa1ltS3dLWVRJOTlwY0ZiNjM2bjNNUVBDajYtR2VzczRJSlNYcFRqT0JjWUI3ZTc3OVo4SEFRX1ZXMkkwNEJ0YWFPb2t2dGpGbEZLa0NaNEtpMzdNZTZRLXY5TWVSNEZBVXVOZXRvQW50c3R5ajFlYUh3blFIbHdISGh2UdIBlwFBVV95cUxQMU85Ry1nSkh5S0VUTXg5UEY4Z3c0Z2ZYOVRZbUVkMmg0QXBHRUJFYjlna0hqSUw1YkJ5elpVMXpnUkhEbExfXzI5cER5VVpEdFVpZ2l1djZ5U0szWmRNdW41Q0xvZWFjZmZhbnBIaXFkeWJsUU1jMTNETU5uUHdvS21yMmFSNDNnVjdIWHNGZ01hUjkxNFJV?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-07-10,2021-07-10 07:00:00,'Christie fiction': Biocon chief slams Sebi order on Allegro Capital - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">'Christie fiction': Biocon chief slams Sebi order on Allegro Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-07-10,2021-07-10 07:00:00,'Christie fiction': Biocon chief slams Sebi order on Allegro Capital - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">'Christie fiction': Biocon chief slams Sebi order on Allegro Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-07-10,2021-07-10 07:00:00,'Christie fiction': Biocon chief slams Sebi order on Allegro Capital - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">'Christie fiction': Biocon chief slams Sebi order on Allegro Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxNeW1DV1lWZThkMm1mLWxEdjV3OWtRYXFRZ3B4Nlh0WVI2TVZYZi1pUVB0bXV1Q1JtUEZObjRaRkl6RGlVRER3d195U3V3LVVTMnc1cy0xSUs5dXFQdHNQVXJ4SERQdWJvb2YyNktsOU0wYXRkYldXazR2WWFHQWNGbWVzUjBwcjJoOGFnSmVydmpzX2Z0dGpHR1BoUlFQQlJleVNBZEhtLXZ6UXFWbnhLcmhoa3FiLURlMzFrTmt2bEF5N1NsbGVwcE52bmRCWGdi0gHWAUFVX3lxTFA4WW9GMVhVcWZNQVlsbHRoVkl3V2JWUGxNV1BGM1ZEUE5COVhGSWtESW9SXzBGZDVnUjV1TDlTSlBIeE94U21SdjhaOWN1U1BTSDF4bF94RXFPQlZtX1NPTmFUS1IzNlpBa0EyelVUUEszX2lGU2syRnZEQlB3T1VYZkxtT0ROdVFCNFUwSHI4QURseDNxLTR3ZF9kMHFmV0JyTy1PeUJmU1RlZVhMMDNIWmFrV0YwQXBmbHFHYVpaQW5aOW8wQzdsaGU3UkdncEJjNjhXZ1E?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-07-10,2021-07-10 07:00:00,'Christie fiction': Biocon chief slams Sebi order on Allegro Capital - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">'Christie fiction': Biocon chief slams Sebi order on Allegro Capital</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.0,0.0,neutral,1.0
2021-09-29,2021-09-29 07:00:00,"Veritas, SAM, K Law advise on Serum-Biocon merger - Law.asia","<a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5"" target=""_blank"">Veritas, SAM, K Law advise on Serum-Biocon merger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Law.asia</font>",https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2021-09-29,2021-09-29 07:00:00,"Veritas, SAM, K Law advise on Serum-Biocon merger - Law.asia","<a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5"" target=""_blank"">Veritas, SAM, K Law advise on Serum-Biocon merger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Law.asia</font>",https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2021-09-29,2021-09-29 07:00:00,"Veritas, SAM, K Law advise on Serum-Biocon merger - Law.asia","<a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5"" target=""_blank"">Veritas, SAM, K Law advise on Serum-Biocon merger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Law.asia</font>",https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2021-09-29,2021-09-29 07:00:00,"Veritas, SAM, K Law advise on Serum-Biocon merger - Law.asia","<a href=""https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5"" target=""_blank"">Veritas, SAM, K Law advise on Serum-Biocon merger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Law.asia</font>",https://news.google.com/rss/articles/CBMiZkFVX3lxTE9WMnpZYXRXYkMwbmtpLVUyekFSMmhXbVdOUVU4TFBYQXFKdWpDTGtjMDFmaC1TVVBRMEg5TXJ3U2I1R3djekZpRlBwRk1DYy1mV250Q0Q5dTNzODJkUk5RQmNRMk0tZw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.3062,0.3062,positive,1.0
2021-10-04,2021-10-04 07:00:00,Allegro Capital named in Pandora Papers: What was the Sebi order about? - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Allegro Capital named in Pandora Papers: What was the Sebi order about?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWXBmOS1IQ0RvcDczODFsY09LemN0RHloeEstVXJDV2pXTGlxQ09lRE5IejRSU1FjWlhzMWFDenNiV2NXV3J0YjNvYW53dThFSmF0TnY1N2hlZFRSYy1ZS1ladmF1MWpVN1RJWS1zYnR5VzlwbTMydDZkMFJDdUplOFE2dTNWR1lycXBSbVVBQnlWQlplSHBOajhaZnNUdzg0ZTRxcUJzUGE3RlRsTG9VS25mZkRRQV9WQnRDRzYwakNEeWRJV1ZtNUxpOHNIZ0lvd2xWWEI0WnTSAd4BQVVfeXFMUGp5V2sxWURTQmsyY2x3UHhmTVhVczV2ejVSanJ5RmMxNktiLTl6YUlBYjhUUGVTTkpFdEZqa1Q2MzJySkE4SDN4dzBxbUg3THlyM3NIYkZWTFFfN2hRcUM4OC1rVDBKMGVCXzdrX1pwYjNaVnNMemtwVTJHUW0xZFFIblJPTmduVXJYbjZ1MkhWQ0EwOEVUdFJDMVhDcEVWOGJyWi13Mjg3NUdpUUwzZU1IQ21SQjdXNEpPSWtrSXktUFZ1WVpQVFpPMWFyb1Y4a3JiUk9pdEJLa2xrSFVR?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Pandora Papers investigation to be monitored by multi-agency group, says Centre - Scroll.in","<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxNclgzb1VkZ2w4WWM2aXFGb1VtZHZsUGNQVlE4anF3MjZIa01UU2I3OHZzZk45WW1WTjhNUTBxVk1wQUtqQXZ5TmhnM3lWMVhYZmE3eWo0MXFnM2kxckItSTRNYkQtcEhWX1BycFN6WC1hMFpLd1U1aVI5eUFoUFZlVUpCR3JmUnAtenBYMFN5V2FJbzUzZnNIQldSaE1lNzhVaS0tRkRfWUFJcUxxRmZRelVIbEFXT3VTa0ZBQXc3a3FDTXIybmfSAcsBQVVfeXFMUGxqejB0S3EtU1hXLXpJVHBhZ3dJUm5rYjdZS3FNSmZUSWdGQ3VjWFpTb2h5bDktZlVjanBrbzRqZFVWSDlSaEpYdWxQZGM1QTBwZE1xX0lveDY3S2lLakEzNUdLS0ctc2NGcHkwQkM5TjU5ekNTMDJRTzZOT1NBVHgyOF9nZzhqeWJfYnptSHBhOFFlQ0lKa0pTc3g3Z29FOW5ibDRNMjRqc0lYM3BrbVY3aXZBUHIydVpWOXZFSmJSczBwbzZmdGNTelk?oc=5"" target=""_blank"">Pandora Papers investigation to be monitored by multi-agency group, says Centre</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Scroll.in</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,True,0.3062,0.3062,positive,1.0
2021-10-04,2021-10-04 07:00:00,Allegro Capital named in Pandora Papers: What was the Sebi order about? - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Allegro Capital named in Pandora Papers: What was the Sebi order about?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.3062,0.3062,positive,1.0
2021-10-04,2021-10-04 07:00:00,Allegro Capital named in Pandora Papers: What was the Sebi order about? - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOWXBmOS1IQ0RvcDczODFsY09LemN0RHloeEstVXJDV2pXTGlxQ09lRE5IejRSU1FjWlhzMWFDenNiV2NXV3J0YjNvYW53dThFSmF0TnY1N2hlZFRSYy1ZS1ladmF1MWpVN1RJWS1zYnR5VzlwbTMydDZkMFJDdUplOFE2dTNWR1lycXBSbVVBQnlWQlplSHBOajhaZnNUdzg0ZTRxcUJzUGE3RlRsTG9VS25mZkRRQV9WQnRDRzYwakNEeWRJV1ZtNUxpOHNIZ0lvd2xWWEI0WnTSAd4BQVVfeXFMUGp5V2sxWURTQmsyY2x3UHhmTVhVczV2ejVSanJ5RmMxNktiLTl6YUlBYjhUUGVTTkpFdEZqa1Q2MzJySkE4SDN4dzBxbUg3THlyM3NIYkZWTFFfN2hRcUM4OC1rVDBKMGVCXzdrX1pwYjNaVnNMemtwVTJHUW0xZFFIblJPTmduVXJYbjZ1MkhWQ0EwOEVUdFJDMVhDcEVWOGJyWi13Mjg3NUdpUUwzZU1IQ21SQjdXNEpPSWtrSXktUFZ1WVpQVFpPMWFyb1Y4a3JiUk9pdEJLa2xrSFVR?oc=5"" target=""_blank"">Allegro Capital named in Pandora Papers: What was the Sebi order about?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Pandora Papers investigation to be monitored by multi-agency group, says Centre - Scroll.in","<a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers investigation to be monitored by multi-agency group, says Centre</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Scroll.in</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2021-10-04,2021-10-04 07:00:00,"Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Offshore entities of Kiran Mazumdar Shaw’s husband have Biocon shares, $85 million; trust advisor banned by Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,0.3062,0.3062,positive,1.0
2021-10-04,2021-10-04 07:00:00,Allegro Capital named in Pandora Papers: What was the Sebi order about? - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Allegro Capital named in Pandora Papers: What was the Sebi order about?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2022-01-04,2022-01-04 08:00:00,Biocon announces merger of its arm with Serum Institute subsidiary - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon announces merger of its arm with Serum Institute subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-01-04,2022-01-04 08:00:00,Biocon Biologics approves scheme of merger by absorption of Covidshield Tech - India Infoline,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxOVkZqZG81RjZzcjFmN0Z1cVJqeV9aUDUtYThBajhVVERLdmU5anJ4MTZFdnFMNlJuMktpemNSM21EN293SEYzdW5seVRsOGI4QWFUSkNva0Z6VFRyb1l2ZWJCeXliZEdOQUxBWWRWZXkxYjlYS09rRXF4akhnc3RhdVE2WmI2SU1BRXBEdVN4X1RrMEZ2MVVKUmRqTUxycE9qTnBoNWV2MWZucFllUmdZUkRlSTU0d1JvdHY5ZUp4WjA2UVR0Nlk0RXZJenI?oc=5"" target=""_blank"">Biocon Biologics approves scheme of merger by absorption of Covidshield Tech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxOVkZqZG81RjZzcjFmN0Z1cVJqeV9aUDUtYThBajhVVERLdmU5anJ4MTZFdnFMNlJuMktpemNSM21EN293SEYzdW5seVRsOGI4QWFUSkNva0Z6VFRyb1l2ZWJCeXliZEdOQUxBWWRWZXkxYjlYS09rRXF4akhnc3RhdVE2WmI2SU1BRXBEdVN4X1RrMEZ2MVVKUmRqTUxycE9qTnBoNWV2MWZucFllUmdZUkRlSTU0d1JvdHY5ZUp4WjA2UVR0Nlk0RXZJenI?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.32985,0.32985,positive,1.0
2022-01-04,2022-01-04 08:00:00,Biocon announces merger of its arm with Serum Institute subsidiary - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon announces merger of its arm with Serum Institute subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-05-19,2022-05-19 07:00:00,CCI approves acquisition of majority stake in SMW Ispat Private Limited by OFB Tech Private Limited - orissadiary.com,"<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxNaWNLWkp1SE54cVFqVHc0NDZ3VnlWOFhzVU9BdFY3dEQwOU9GeklZSXhNdjZQcVJpSXk5NFE1VklUYkZuZW1QNWw3Vm1GaTNDTlJmSW5IcmUzTkdzUy1sQlZ4OGFHUHB2VzFXT3lsZmRqZnVjZTVjSFY1MVY1bUxqa3ZkQU9PU05pYm5PNWw2dVI5Z0tTZmxlamlWc056QW14REQtOFNabVN4QnEzbnpWUi1ZZ09tTFVWSDVVQXhtcFR5QQ?oc=5"" target=""_blank"">CCI approves acquisition of majority stake in SMW Ispat Private Limited by OFB Tech Private Limited</a>&nbsp;&nbsp;<font color=""#6f6f6f"">orissadiary.com</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxNaWNLWkp1SE54cVFqVHc0NDZ3VnlWOFhzVU9BdFY3dEQwOU9GeklZSXhNdjZQcVJpSXk5NFE1VklUYkZuZW1QNWw3Vm1GaTNDTlJmSW5IcmUzTkdzUy1sQlZ4OGFHUHB2VzFXT3lsZmRqZnVjZTVjSFY1MVY1bUxqa3ZkQU9PU05pYm5PNWw2dVI5Z0tTZmxlamlWc056QW14REQtOFNabVN4QnEzbnpWUi1ZZ09tTFVWSDVVQXhtcFR5QQ?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.07555714285714286,0.07555714285714286,neutral,1.0
2022-11-16,2022-11-16 08:00:00,Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics secures regulatory approvals for acquisition of Viatris' biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.34536666666666666,0.34536666666666666,positive,1.0
2022-11-29,2022-11-29 08:00:00,Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbkdQcDBWNE5RdHo0eV9rYzhFajFvanJRQm5obHF1cWZwRXJfTEUxTHRrZFJqUjdEZmdTUWdwR2EwWl81dmZaMHpfMEM0UENfX1FrZlF2VUZvdV9oNVdJUDR5TUVZcUpYRjJsUjVPaXF1am1NdFRyRzRyVFFBZXlVRGJkUGJoR0N6Qko3cFl1alQ4TE1BRjVXaHdpcGtCN1BsVmNxWUNydnBwWWU1UFVkUVdPdXVZTk5COTRlRzZsWW1aNlVaZXlLcmNGZ0ZGbWNNZ0E?oc=5"" target=""_blank"">Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbkdQcDBWNE5RdHo0eV9rYzhFajFvanJRQm5obHF1cWZwRXJfTEUxTHRrZFJqUjdEZmdTUWdwR2EwWl81dmZaMHpfMEM0UENfX1FrZlF2VUZvdV9oNVdJUDR5TUVZcUpYRjJsUjVPaXF1am1NdFRyRzRyVFFBZXlVRGJkUGJoR0N6Qko3cFl1alQ4TE1BRjVXaHdpcGtCN1BsVmNxWUNydnBwWWU1UFVkUVdPdXVZTk5COTRlRzZsWW1aNlVaZXlLcmNGZ0ZGbWNNZ0E?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,Biocon completes $3.34 billion acquisition of Viatris's biosimilar business - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon completes $3.34 billion acquisition of Viatris's biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2022-11-29,2022-11-29 08:00:00,Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOMlZWaFVhdmlOQl9WUEt2OExPLTl6bGxSeG4zc3ZJV2JoaUJ4VHFVMkM4d28tT0tPa0NjNjdQbnp1MUFjXzlLbHhUS2dhc3p6aUVpUjJMbGZXOFdRejRRYVF2MUtnQVZaX0hfcTRPNV9sOXk1TVpGZjJhOTBaSFFoaTluTFE1bUpITy05NXRZWWJ2Z0Q1UlNfRjlCQXZRWk9MbGN2LWtzVFVmR1g3eGZkbno0UVJqOHZXWVk5ZFY3WmUwZ25OY1MxSkpPMUZEUQ?oc=5"" target=""_blank"">Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOMlZWaFVhdmlOQl9WUEt2OExPLTl6bGxSeG4zc3ZJV2JoaUJ4VHFVMkM4d28tT0tPa0NjNjdQbnp1MUFjXzlLbHhUS2dhc3p6aUVpUjJMbGZXOFdRejRRYVF2MUtnQVZaX0hfcTRPNV9sOXk1TVpGZjJhOTBaSFFoaTluTFE1bUpITy05NXRZWWJ2Z0Q1UlNfRjlCQXZRWk9MbGN2LWtzVFVmR1g3eGZkbno0UVJqOHZXWVk5ZFY3WmUwZ25OY1MxSkpPMUZEUQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbkdQcDBWNE5RdHo0eV9rYzhFajFvanJRQm5obHF1cWZwRXJfTEUxTHRrZFJqUjdEZmdTUWdwR2EwWl81dmZaMHpfMEM0UENfX1FrZlF2VUZvdV9oNVdJUDR5TUVZcUpYRjJsUjVPaXF1am1NdFRyRzRyVFFBZXlVRGJkUGJoR0N6Qko3cFl1alQ4TE1BRjVXaHdpcGtCN1BsVmNxWUNydnBwWWU1UFVkUVdPdXVZTk5COTRlRzZsWW1aNlVaZXlLcmNGZ0ZGbWNNZ0E?oc=5"" target=""_blank"">Biocon Biologics Completes Acquisition of Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxQbkdQcDBWNE5RdHo0eV9rYzhFajFvanJRQm5obHF1cWZwRXJfTEUxTHRrZFJqUjdEZmdTUWdwR2EwWl81dmZaMHpfMEM0UENfX1FrZlF2VUZvdV9oNVdJUDR5TUVZcUpYRjJsUjVPaXF1am1NdFRyRzRyVFFBZXlVRGJkUGJoR0N6Qko3cFl1alQ4TE1BRjVXaHdpcGtCN1BsVmNxWUNydnBwWWU1UFVkUVdPdXVZTk5COTRlRzZsWW1aNlVaZXlLcmNGZ0ZGbWNNZ0E?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,Biocon completes $3.34 billion acquisition of Viatris's biosimilar business - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon completes $3.34 billion acquisition of Viatris's biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon Biologics completes $3.3 billion acquisition of Viatris' biosimilars business - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes $3.3 billion acquisition of Viatris' biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon concludes Viatris' $3 bn acquisition - VCCircle,"<a href=""https://news.google.com/rss/articles/CBMic0FVX3lxTE5CcllqOHJIeVZSMkJiSXY4ZTBDZzFGWHRtZnZCVHY0OWVaMEFuRzk1eFpJX2YxS1FqcGJYbUcwb0VvclRmNmNTaFpwLWNHQVpSUWZpbURMLUUwTkxHNVRXVHE2UUZKTTJwZ2hadFU1eDdudE0?oc=5"" target=""_blank"">Biocon concludes Viatris' $3 bn acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">VCCircle</font>",https://news.google.com/rss/articles/CBMic0FVX3lxTE5CcllqOHJIeVZSMkJiSXY4ZTBDZzFGWHRtZnZCVHY0OWVaMEFuRzk1eFpJX2YxS1FqcGJYbUcwb0VvclRmNmNTaFpwLWNHQVpSUWZpbURMLUUwTkxHNVRXVHE2UUZKTTJwZ2hadFU1eDdudE0?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon Biologics completes Acquisition of Viatris’ Global Biosimilars Business - The Financial World,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQOV9TVHdKS0FfdHVsNGpHdDZjLWNxajhLYjdwWm94VmlYMENfcTlqNDg2am0zU2VrMFBwQm1fQkw3WXJlVTVTNktNSmc3dHdBMmlFa0kxR0NRMXZieFNlMHFuYnFrVUZWN3RGSEl5dzRYZjFWT1RzclN4b3RxX1FBc1Y3S1F6Zk5zZnF6dndHak5sWE1Tbk5FSjFLS09naHdmd2RrbFFISWs0TFRUSlU2VWh3?oc=5"" target=""_blank"">Biocon Biologics completes Acquisition of Viatris’ Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Financial World</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxQOV9TVHdKS0FfdHVsNGpHdDZjLWNxajhLYjdwWm94VmlYMENfcTlqNDg2am0zU2VrMFBwQm1fQkw3WXJlVTVTNktNSmc3dHdBMmlFa0kxR0NRMXZieFNlMHFuYnFrVUZWN3RGSEl5dzRYZjFWT1RzclN4b3RxX1FBc1Y3S1F6Zk5zZnF6dndHak5sWE1Tbk5FSjFLS09naHdmd2RrbFFISWs0TFRUSlU2VWh3?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes acquisition of Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-12-01,2022-12-01 08:00:00,What’s behind Indian pharma cos’ global acquisition spree - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOS19iSDVDUGlZSFBaVDU4eWhxWVlEdERldlpvd3ZESmNRTmtwT0ZjYzZTbDRVajV2SHdDTWxYTkFRTXlteHZTTEtqN2pHWjhDcVRqODZ0ZDlnR2pIX1djU2tQWGw5bUp2dUdHQkFZMFVKbmRIeDhRU1ZZU200ei1STVBjTmVXLTNHVFd4bFlQeGk1cUJsUHZ5eW9VWXEzZkJjSzdveNIBsgFBVV95cUxPVGFQaVB1S1dLcEFRZFZtaE16ZjcxTjJYMGljMDNjeTFWTEExSUpLbC1MVzNzSWhIbF9jemg0ckxFNENEUkZPODlqTHN6UmpwcGUwNGVZQ09GQVdhX1RQY0VXYnY4cUJ4dTNvV2ZVQmNZc0cwVjZxY0tVbzR3clVTSzZSZDkxOVNwSUx2LWtBT3hxRG1aRzlDOHlQd1dBaHZWSk81Qm1yTkEwcURsdjYxYy13?oc=5"" target=""_blank"">What’s behind Indian pharma cos’ global acquisition spree</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOS19iSDVDUGlZSFBaVDU4eWhxWVlEdERldlpvd3ZESmNRTmtwT0ZjYzZTbDRVajV2SHdDTWxYTkFRTXlteHZTTEtqN2pHWjhDcVRqODZ0ZDlnR2pIX1djU2tQWGw5bUp2dUdHQkFZMFVKbmRIeDhRU1ZZU200ei1STVBjTmVXLTNHVFd4bFlQeGk1cUJsUHZ5eW9VWXEzZkJjSzdveNIBsgFBVV95cUxPVGFQaVB1S1dLcEFRZFZtaE16ZjcxTjJYMGljMDNjeTFWTEExSUpLbC1MVzNzSWhIbF9jemg0ckxFNENEUkZPODlqTHN6UmpwcGUwNGVZQ09GQVdhX1RQY0VXYnY4cUJ4dTNvV2ZVQmNZc0cwVjZxY0tVbzR3clVTSzZSZDkxOVNwSUx2LWtBT3hxRG1aRzlDOHlQd1dBaHZWSk81Qm1yTkEwcURsdjYxYy13?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,-0.08,-0.08,neutral,1.0
2022-12-01,2022-12-01 08:00:00,What’s behind Indian pharma cos’ global acquisition spree - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOS19iSDVDUGlZSFBaVDU4eWhxWVlEdERldlpvd3ZESmNRTmtwT0ZjYzZTbDRVajV2SHdDTWxYTkFRTXlteHZTTEtqN2pHWjhDcVRqODZ0ZDlnR2pIX1djU2tQWGw5bUp2dUdHQkFZMFVKbmRIeDhRU1ZZU200ei1STVBjTmVXLTNHVFd4bFlQeGk1cUJsUHZ5eW9VWXEzZkJjSzdveNIBsgFBVV95cUxPVGFQaVB1S1dLcEFRZFZtaE16ZjcxTjJYMGljMDNjeTFWTEExSUpLbC1MVzNzSWhIbF9jemg0ckxFNENEUkZPODlqTHN6UmpwcGUwNGVZQ09GQVdhX1RQY0VXYnY4cUJ4dTNvV2ZVQmNZc0cwVjZxY0tVbzR3clVTSzZSZDkxOVNwSUx2LWtBT3hxRG1aRzlDOHlQd1dBaHZWSk81Qm1yTkEwcURsdjYxYy13?oc=5"" target=""_blank"">What’s behind Indian pharma cos’ global acquisition spree</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOS19iSDVDUGlZSFBaVDU4eWhxWVlEdERldlpvd3ZESmNRTmtwT0ZjYzZTbDRVajV2SHdDTWxYTkFRTXlteHZTTEtqN2pHWjhDcVRqODZ0ZDlnR2pIX1djU2tQWGw5bUp2dUdHQkFZMFVKbmRIeDhRU1ZZU200ei1STVBjTmVXLTNHVFd4bFlQeGk1cUJsUHZ5eW9VWXEzZkJjSzdveNIBsgFBVV95cUxPVGFQaVB1S1dLcEFRZFZtaE16ZjcxTjJYMGljMDNjeTFWTEExSUpLbC1MVzNzSWhIbF9jemg0ckxFNENEUkZPODlqTHN6UmpwcGUwNGVZQ09GQVdhX1RQY0VXYnY4cUJ4dTNvV2ZVQmNZc0cwVjZxY0tVbzR3clVTSzZSZDkxOVNwSUx2LWtBT3hxRG1aRzlDOHlQd1dBaHZWSk81Qm1yTkEwcURsdjYxYy13?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,-0.08,-0.08,neutral,1.0
2022-12-12,2022-12-12 08:00:00,Biocon Biologics Completes $3 Billion Acquisition of Viatris’ Biosimilars - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSzFZdWoyeWFuWGdUamppTlpYZURWcWpSSXE1YnBGSGhPY2N5eFQtbTdwb1hNdnY3d1M3SElhdDRpZG1ld0hWMkYwcGJXZl90b3R4WUpiMEJfdzg1dl81QkJLYVRoR1RGWjNCcnJOOXJRX1ZPaG4tS0M4VmhETkFjT04tWlZHZEtJdFBaWmhhLTl6cF9keWVBakIzTGFNRzRsSWtkcVc4TlFYSG1tWU9SNnZUM1FTaDJxR0tV?oc=5"" target=""_blank"">Biocon Biologics Completes $3 Billion Acquisition of Viatris’ Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxOSzFZdWoyeWFuWGdUamppTlpYZURWcWpSSXE1YnBGSGhPY2N5eFQtbTdwb1hNdnY3d1M3SElhdDRpZG1ld0hWMkYwcGJXZl90b3R4WUpiMEJfdzg1dl81QkJLYVRoR1RGWjNCcnJOOXJRX1ZPaG4tS0M4VmhETkFjT04tWlZHZEtJdFBaWmhhLTl6cF9keWVBakIzTGFNRzRsSWtkcVc4TlFYSG1tWU9SNnZUM1FTaDJxR0tV?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-12-13,2022-12-13 21:10:38,Agricultural certification as a complementary tool for environmental law compliance - ScienceDirect.com,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE9Nd3kxVFIyTk5VUVRULVpldFZkaXJFS3NDWVRLVUhKaVdqalhTN1NhQktmUEFSUlNtUTlnMkdhT1dnNzRwdmZxTmxKWlpDSEl6NjVJUkNtUEM3STVRbUVFZzkwOWp1Uld6VnRQekdyRlRFRHpsaXc?oc=5"" target=""_blank"">Agricultural certification as a complementary tool for environmental law compliance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ScienceDirect.com</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE9Nd3kxVFIyTk5VUVRULVpldFZkaXJFS3NDWVRLVUhKaVdqalhTN1NhQktmUEFSUlNtUTlnMkdhT1dnNzRwdmZxTmxKWlpDSEl6NjVJUkNtUEM3STVRbUVFZzkwOWp1Uld6VnRQekdyRlRFRHpsaXc?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2023-02-01,2023-02-01 08:00:00,Biocon sells another 10% stake in Syngene to fund Viatris acquisition - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sells another 10% stake in Syngene to fund Viatris acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2023-02-10,2023-02-10 08:00:00,"Biocon raises Rs 2,250 crore from selling 10% stake in Syngene to fund Viatris acquisition - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon raises Rs 2,250 crore from selling 10% stake in Syngene to fund Viatris acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2023-08-11,2023-08-11 07:00:00,Biocon to close Viatris merger by FY24 end - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to close Viatris merger by FY24 end</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2023-08-11,2023-08-11 07:00:00,Biocon to close Viatris merger by FY24 end - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to close Viatris merger by FY24 end</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWlFLSm9QcXhSMkstOHBZV0dvLTloMjhWSXJxeW5ULTRGY3puY1F3bEZnbFFSQVFPV05fdm1OUEVscHVGMHBmcm9PQVdxYWROZEZiNVQwNzJRYjRUSnExMUxJcVVUbTVpQlNvT1NhZERyX0Rucm1KVXBvYzhRMjQ0eGpwejRnb2pkR05OT2JnRTdrRUhkbTJyU2U2MDZKV0VSemhSUGt3c0pTOTltNlBaUGRGal9lS1NmaWVMeUM4RUMySEI5ZXkwNkpWb2IzbDh0blRnZTI4LVA1ZzVUZktPTWJfWHdKd9IB6wFBVV95cUxPVFhBdzE0ZjRKYnJ4OGtmZkVMLUR5S2EwTHoyOF9JVnNRenI0NjlBYTFUc2pqSUJGUmNCREsxTFRQV3RrY01raE5jV193dFVyeE41X2NKd3lrRV9yMUxLLUl4MzBQUGM4LTVheERDcE1IMmg2MTZmQlFuU0lHVERZdzVrV0U5VGJ0SFBnQ0U2UXVmSlZ5dVZtQjZQdnQ4UTdLTWppaVNNWUxrUnlrb0lvOEpaWnI1aXdRaTJoM2pnTzVUaXhxcDczQ0RTREhUMVRtRUo5dU12WTgwZk1fVjJ6VVdLR2dGTXlCaURR?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Biocon Expands Footprint in the U.S. with $7.7 Million Acquisition of Eywa Pharma’s Manufacturing Facility - The Hindu,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPSkttTVNUamdaVC1NRTRDWC1sNGc0WWszcUk2YmVOUWY3NG12Y29XT0VzREVpdVdDa2ZrTEZId3EwcmxpbWVlSVJ6cXdkYy03bllCWmxTN0IyLXBLZGx4d0otc1J4R3dHM3otYVdCUmo2dFM1Z1Y3Ulh0THl2Z1hES0JRekYtV3FmMXM2UWNQb1phYXlkVU56UGtxanJlM2hjMTNr0gGqAUFVX3lxTE5mMnRTbDFEQjJ2dnEtVnh6cC01STFUMko0M0M4ZEctOURuSzViNGZNX1VFeVI5N25rSEQzZ1NIM205ZXI1NlVKNkowc3llVFctX19teWgydUtIZlhrbkJhWW1CeThRS1VLNHNDMjBzendNcGR4M0lwTVFRcXN5U3k0WVAyLWxvVjVvVS1ObXNXQ212bldCU0FnMkxZQjBrZlRqOXppZGlsWEdR?oc=5"" target=""_blank"">Biocon Expands Footprint in the U.S. with $7.7 Million Acquisition of Eywa Pharma’s Manufacturing Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxPSkttTVNUamdaVC1NRTRDWC1sNGc0WWszcUk2YmVOUWY3NG12Y29XT0VzREVpdVdDa2ZrTEZId3EwcmxpbWVlSVJ6cXdkYy03bllCWmxTN0IyLXBLZGx4d0otc1J4R3dHM3otYVdCUmo2dFM1Z1Y3Ulh0THl2Z1hES0JRekYtV3FmMXM2UWNQb1phYXlkVU56UGtxanJlM2hjMTNr0gGqAUFVX3lxTE5mMnRTbDFEQjJ2dnEtVnh6cC01STFUMko0M0M4ZEctOURuSzViNGZNX1VFeVI5N25rSEQzZ1NIM205ZXI1NlVKNkowc3llVFctX19teWgydUtIZlhrbkJhWW1CeThRS1VLNHNDMjBzendNcGR4M0lwTVFRcXN5U3k0WVAyLWxvVjVvVS1ObXNXQ212bldCU0FnMkxZQjBrZlRqOXppZGlsWEdR?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.10115,0.10115,positive,1.0
2023-09-02,2023-09-02 07:00:00,Biocon Expands Footprint in the U.S. with $7.7 Million Acquisition of Eywa Pharma’s Manufacturing Facility - The Hindu,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPSkttTVNUamdaVC1NRTRDWC1sNGc0WWszcUk2YmVOUWY3NG12Y29XT0VzREVpdVdDa2ZrTEZId3EwcmxpbWVlSVJ6cXdkYy03bllCWmxTN0IyLXBLZGx4d0otc1J4R3dHM3otYVdCUmo2dFM1Z1Y3Ulh0THl2Z1hES0JRekYtV3FmMXM2UWNQb1phYXlkVU56UGtxanJlM2hjMTNr0gGqAUFVX3lxTE5mMnRTbDFEQjJ2dnEtVnh6cC01STFUMko0M0M4ZEctOURuSzViNGZNX1VFeVI5N25rSEQzZ1NIM205ZXI1NlVKNkowc3llVFctX19teWgydUtIZlhrbkJhWW1CeThRS1VLNHNDMjBzendNcGR4M0lwTVFRcXN5U3k0WVAyLWxvVjVvVS1ObXNXQ212bldCU0FnMkxZQjBrZlRqOXppZGlsWEdR?oc=5"" target=""_blank"">Biocon Expands Footprint in the U.S. with $7.7 Million Acquisition of Eywa Pharma’s Manufacturing Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxPSkttTVNUamdaVC1NRTRDWC1sNGc0WWszcUk2YmVOUWY3NG12Y29XT0VzREVpdVdDa2ZrTEZId3EwcmxpbWVlSVJ6cXdkYy03bllCWmxTN0IyLXBLZGx4d0otc1J4R3dHM3otYVdCUmo2dFM1Z1Y3Ulh0THl2Z1hES0JRekYtV3FmMXM2UWNQb1phYXlkVU56UGtxanJlM2hjMTNr0gGqAUFVX3lxTE5mMnRTbDFEQjJ2dnEtVnh6cC01STFUMko0M0M4ZEctOURuSzViNGZNX1VFeVI5N25rSEQzZ1NIM205ZXI1NlVKNkowc3llVFctX19teWgydUtIZlhrbkJhWW1CeThRS1VLNHNDMjBzendNcGR4M0lwTVFRcXN5U3k0WVAyLWxvVjVvVS1ObXNXQ212bldCU0FnMkxZQjBrZlRqOXppZGlsWEdR?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.10115,0.10115,positive,1.0
2023-12-13,2023-12-13 08:00:00,"SAM, CAM act on acquisition of Derma and Nephrology biz units of Biocon Biologics by Eris Lifesciences - Bar and Bench","<a href=""https://news.google.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?oc=5"" target=""_blank"">SAM, CAM act on acquisition of Derma and Nephrology biz units of Biocon Biologics by Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bar and Bench</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-02-23,2024-02-23 08:00:00,Biocon receives a penalty of over Rs 3 crore in GST related issues - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives a penalty of over Rs 3 crore in GST related issues</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.3592,-0.3592,negative,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences enters Rs 30,000 cr injectables market with Biocon Biologics acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxNaHVfamJ6WjUwOHQ4TnhSajlRRlJUNGtoQW5uU3hVSzRvdl9MWmhLOEhsYVB0VGotck1tU24yTHE3QWtTUWNfTGlNYzY4TWcwODh4dzZmZmFjYWFmYjk0YmhtaEc4akM0bllVbHV1eHVxRUNnS1hWTlltXzExWXZ3b0lsbmhLb3FMUnVXeW8xX0gzN2lqX25iWC0zdU51a2R6OEN3LWpZR1hUN3B4SExCVmdkczRaWW9DTERKejZCa2dxUEUtMTBXYTJIUkxRYTBEMGl5RzlHY192VUg1emFteEowTXM0XzdTcTJLNElpa9IB9AFBVV95cUxNQ3UtUTBtZlFkNEEtQXRORGpRVTlIVzJyWkpLYXkwbFlIbzJzdldzWGlDaXJ1NDhSMWR5N3NSZ1F2Q1ZFalNlM2VPNjZYcTBkaFFhT2RSa1FpQ1AwY1puUnRnZjlzeHpmdnhkeE5hQzRIcDVHd0ZYRlZsX0xQT0I2bGd1a0RzcE1PVnZ4dGdkakIzdmpTZXNpM1BlX29aRno2c3YxR25YXzhma1pHMnBNOUxmSnlKb1JuSkJZOUxtTXQxaXJiNkNMNHBKQnplUEUzNnlDWUgxLV84Wkl5Um1jN2NmUkpDLUFJTFFsNWM2Tnd2UHJF?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-03-15,2024-03-15 07:00:00,"Eris Lifesciences Dives into INR 30,000+ Crore Injectables Market with Biocon Biologics' Acquisition - eHealth Magazine","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWUNTRk9ldU1fWXVvX2pCdkdBcUZjRjRsM3VhTERTcXZlVEcwdnVndlJRT2tjaE5fZ3RmN0xUdGE4N185SkJCZS14OFpDd2h3ZTNRVE0zM1dPOHhMLTVKd3dZend4TEhkdWU5TUFyTENLbnh3MGpKdWY2OUstUEZDVXQ3b1FlNklTdTFUZHBTdXJXYkNZYURNemdtRGhaZG9rUDllclhhSXFPZEFWNUh0WHZTNTNiNHB5YVFtR0ZRLW5FbjRaNFExbWxhUDBidzNHcXVTWA?oc=5"" target=""_blank"">Eris Lifesciences Dives into INR 30,000+ Crore Injectables Market with Biocon Biologics' Acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">eHealth Magazine</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxQWUNTRk9ldU1fWXVvX2pCdkdBcUZjRjRsM3VhTERTcXZlVEcwdnVndlJRT2tjaE5fZ3RmN0xUdGE4N185SkJCZS14OFpDd2h3ZTNRVE0zM1dPOHhMLTVKd3dZend4TEhkdWU5TUFyTENLbnh3MGpKdWY2OUstUEZDVXQ3b1FlNklTdTFUZHBTdXJXYkNZYURNemdtRGhaZG9rUDllclhhSXFPZEFWNUh0WHZTNTNiNHB5YVFtR0ZRLW5FbjRaNFExbWxhUDBidzNHcXVTWA?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-03-16,2024-03-16 07:00:00,"Sebi nod to T+0 settlement for limited stocks, eases norms for FPIs - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Sebi nod to T+0 settlement for limited stocks, eases norms for FPIs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.08329285714285714,0.08329285714285714,neutral,1.0
2024-05-03,2024-05-03 07:00:00,"NSE board approves 4:1 bonus issue, dividend of Rs 90 per share - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">NSE board approves 4:1 bonus issue, dividend of Rs 90 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.5303666666666667,0.5303666666666667,positive,1.0
2024-05-16,2024-05-16 07:00:00,DGGI begin Investigations into Pharma Companies for Fake ITC and Non-payment of GST under RCM - Studycafe,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxNQkZldTYxaVNyOUt2clNlWDhGSUNxNkN0b3pSbUUzMzc2Z2ZOYWQySGtabF94S0VERXdUQlV5VW9EeENZNmRGb2NNYzR1VC1iTnBmd0Q1VkpweXo2UU5VZ0JGOWR1U2FwbVlCMng2QkFuaW5pU1RjWTJNV3RjQ1BpTzdMdHRBa0F0VTZ4M2dHV21zalRVTS01OUt2OWtWb2U0SzlLSWNBeGVpUlNXSUY1OFRoRGszeHNJdzEwSzlmNGpxUVRy?oc=5"" target=""_blank"">DGGI begin Investigations into Pharma Companies for Fake ITC and Non-payment of GST under RCM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Studycafe</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxNQkZldTYxaVNyOUt2clNlWDhGSUNxNkN0b3pSbUUzMzc2Z2ZOYWQySGtabF94S0VERXdUQlV5VW9EeENZNmRGb2NNYzR1VC1iTnBmd0Q1VkpweXo2UU5VZ0JGOWR1U2FwbVlCMng2QkFuaW5pU1RjWTJNV3RjQ1BpTzdMdHRBa0F0VTZ4M2dHV21zalRVTS01OUt2OWtWb2U0SzlLSWNBeGVpUlNXSUY1OFRoRGszeHNJdzEwSzlmNGpxUVRy?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,-0.5342166666666667,-0.5342166666666667,negative,1.0
2024-06-19,2024-06-19 07:00:00,Kotak to part finance Matrix Pharma's acquisition of Viatris' API biz - The Pharma Letter,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOWVYyejBDRXNJNDhHUmNGbkxnZnplUnNubE9EZlhQT2NrV2RhZ2FOR3J6eGJobm5ka3UyeFNCak5pbzZZMnlGZU1PWWdPcjVsWGFrczYxU09NdUdtVXB1TUdEZ2VhaUVWbFFWcTZJVzhtZWpnS3Q2Z2tMYXpYNG5BdUl1OTdHN0lHMEVfUHY1bUVzMGJFU0lSamVtTkp5bzNidmZTLVdyTjMwSlpaWmc?oc=5"" target=""_blank"">Kotak to part finance Matrix Pharma's acquisition of Viatris' API biz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOWVYyejBDRXNJNDhHUmNGbkxnZnplUnNubE9EZlhQT2NrV2RhZ2FOR3J6eGJobm5ka3UyeFNCak5pbzZZMnlGZU1PWWdPcjVsWGFrczYxU09NdUdtVXB1TUdEZ2VhaUVWbFFWcTZJVzhtZWpnS3Q2Z2tMYXpYNG5BdUl1OTdHN0lHMEVfUHY1bUVzMGJFU0lSamVtTkp5bzNidmZTLVdyTjMwSlpaWmc?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,"Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans to expand margins to 25%, led by new products and markets: Group CEO Peter Bains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,True,0.3241545454545455,0.3241545454545455,positive,1.0
2024-08-18,2024-08-18 07:00:00,Health | Kiran Mazumdar-Shaw: Spearheading pharma innovation - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Health | Kiran Mazumdar-Shaw: Spearheading pharma innovation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,False,0.1909,0.1909,positive,1.0
2024-09-02,2024-09-02 07:00:00,"Dividend, Stock Split: These shares trade ex-date today; are you eligible? - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Dividend, Stock Split: These shares trade ex-date today; are you eligible?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.3023,0.3023,positive,1.0
2024-09-12,2024-09-12 07:00:00,Need innovation-driven value creation in biotech: Kiran Mazumdar-Shaw - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Need innovation-driven value creation in biotech: Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,False,0.3953,0.3953,positive,1.0
2024-09-12,2024-09-12 07:00:00,Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector - Press Trust of India,"<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxPRl9sYTRRNU5yRTVUV2EyVnU4THNsbHZBeGlVQWF5eWxxdnVzS2tGdUVDZlRyOVFwa3RqNVJkcDM5aWhJeTVEa1VSeUp3RnlYUnplZTcwak5qQjhPcFZKTTRVNUx5ZV93Wlc5MEROZXY1NzFlemFucVd4TGVMYko0VkpEOHRpcTdzWkEwSXZraHpCd29MYUstaXVuNTZ1RVQzLWpZV05EcURhZ2dzcnpaUThOT2FSOVoxTUxTbmJ5eFFnOE9aUDRkWGh1ZnhsYzR6?oc=5"" target=""_blank"">Kiran Mazumdar-Shaw calls for innovation-driven value creation in India's biotech sector</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Press Trust of India</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxPRl9sYTRRNU5yRTVUV2EyVnU4THNsbHZBeGlVQWF5eWxxdnVzS2tGdUVDZlRyOVFwa3RqNVJkcDM5aWhJeTVEa1VSeUp3RnlYUnplZTcwak5qQjhPcFZKTTRVNUx5ZV93Wlc5MEROZXY1NzFlemFucVd4TGVMYko0VkpEOHRpcTdzWkEwSXZraHpCd29MYUstaXVuNTZ1RVQzLWpZV05EcURhZ2dzcnpaUThOT2FSOVoxTUxTbmJ5eFFnOE9aUDRkWGh1ZnhsYzR6?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,False,0.4637,0.4637,positive,1.0
2024-09-27,2024-09-27 07:00:00,Meet Kiran Mazumdar-Shaw's niece Claire: An MIT grad making Indian innovation shine with $1 billion market - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Meet Kiran Mazumdar-Shaw's niece Claire: An MIT grad making Indian innovation shine with $1 billion market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,False,0.38511666666666666,0.38511666666666666,positive,1.0
2024-10-03,2024-10-03 07:00:00,"Rights issues, stock splits, capital raising on Oct 3: Key updates from Premier Polyfilm, Mittal Lifestyle, an - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxOT1Bfd3gzQVA5cTZncWhVd3FJbmZRajB5WDdWNWxQRVNvcFJqeGhoMkpJQzJmX2lDQ2daRlVUWEpWbDBfc24wMlhQZkdLSXhZWTJjSEx5cW1tMFhpODlzVldLaHEycmcycEliX1FwZ0pGTDAyU2FYUWdNZjdxaF9QNXZOSm9LMTZLa2FBaGV6ZU5QSzBKZHNNVHI2OHhqbEVta2VaanhFV2FQbHAzWkFWRDhQZGR1amhSaG1NbkRjelQ2Nkp3TnFteFp5SWw3bmp1dFhtbXVxVVJROWtPcE5xUTNkWHkwOWhiVDJJcWdCWHp4N3VVLUHSAfsBQVVfeXFMTWlteFR1bkV0cVhjY09kNmRWQmN1aTVrMlJDejdqSGZ1LV8wQVlnd0pRSEU5aGZGbGVPekI1Mkc1STFqekpQZ0YwU2wzOWFXY1lIbGxXSnRWSVB6cDJZSU9GYTNWbG44dUhsXzV0OTRWOVlaQ1JUNWlPSTFrOV9yVjJpX0tyMlNNYjJpSDZlS1hscnZjN3dIdUdLTzJNa3d0M29JUk9zN0xhLTlXSDBBRWRaXzdVZUNvMzgtcmN6QTFPS0RXdXFyUVBrUDQ3aGZndURlSC1PaHNCOTZQLTN6T2ZnVld5eEZoNVBpM1VyX1l5SFNvcFFBNldydzg?oc=5"" target=""_blank"">Rights issues, stock splits, capital raising on Oct 3: Key updates from Premier Polyfilm, Mittal Lifestyle, an</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.0,0.0,neutral,1.0
2024-12-22,2024-12-22 03:53:32,Biocon Completes Acquisition of Viatris’ Global Biosimilars Business - Contract Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbTVWa2RXLUhLRVVIcmZUZ1d3TU8yeDg0bjdEMU52dDFSSkVEbU9nT3lIaGlDa09ONHN0X3FXUTExa0FReTBabk9yeno3ZTEyaERtR1lBd1RDM0pqTkR3X2NCOU5vTTJnZEZYYlJYUklxdzFVVWRBS2VZVkdxM2Jydm5CWi1mcHJLNTMwU3E0eWUxaUlhYzg3VW5NTW1fd3huMUxiLXVJZnM?oc=5"" target=""_blank"">Biocon Completes Acquisition of Viatris’ Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Contract Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbTVWa2RXLUhLRVVIcmZUZ1d3TU8yeDg0bjdEMU52dDFSSkVEbU9nT3lIaGlDa09ONHN0X3FXUTExa0FReTBabk9yeno3ZTEyaERtR1lBd1RDM0pqTkR3X2NCOU5vTTJnZEZYYlJYUklxdzFVVWRBS2VZVkdxM2Jydm5CWi1mcHJLNTMwU3E0eWUxaUlhYzg3VW5NTW1fd3huMUxiLXVJZnM?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2024-12-24,2024-12-24 08:00:00,Rs 1000 cr IPO! Greaves Cotton EV arm files DRHP with SEBI - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Rs 1000 cr IPO! Greaves Cotton EV arm files DRHP with SEBI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2024-12-24,2024-12-24 08:00:00,Upcoming IPO: EV player Greaves Electric Mobility files DRHP with Sebi - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Upcoming IPO: EV player Greaves Electric Mobility files DRHP with Sebi</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,0.0,0.0,neutral,1.0
2025-01-08,2025-01-08 08:00:00,Markets regulator Sebi warns Ola Electric for violating disclosure norms - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Markets regulator Sebi warns Ola Electric for violating disclosure norms</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,False,-0.4158,-0.4158,negative,1.0
2025-01-16,2025-01-16 08:00:00,Goldman Sachs AIF Investment Manager Fined for Not Informing on Biocon Stake Acquisition - Goodreturns,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPTHZQb0IwclF1U1cySFdOS2htM29rck1tek9sM0xTYUdxLTl0eUtrRDB0Zm9FWWlxNmU1amllaDRIZ1d1aE9XSFp6M2RjdlNvRFFIbmlBbm9rZXVGUmcwVjRPd09Wbk1BUVROMm4tMVlsaS1jVTRYb051S29GZXZvUVdUOEdJbjh6SnlxeEFaS0hVdjBibV8tU3JuVQ?oc=5"" target=""_blank"">Goldman Sachs AIF Investment Manager Fined for Not Informing on Biocon Stake Acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxPTHZQb0IwclF1U1cySFdOS2htM29rck1tek9sM0xTYUdxLTl0eUtrRDB0Zm9FWWlxNmU1amllaDRIZ1d1aE9XSFp6M2RjdlNvRFFIbmlBbm9rZXVGUmcwVjRPd09Wbk1BUVROMm4tMVlsaS1jVTRYb051S29GZXZvUVdUOEdJbjh6SnlxeEFaS0hVdjBibV8tU3JuVQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-01-16,2025-01-16 08:00:00,Goldman Sachs AIF Investment Manager Fined for Not Informing on Biocon Stake Acquisition - Goodreturns,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPTHZQb0IwclF1U1cySFdOS2htM29rck1tek9sM0xTYUdxLTl0eUtrRDB0Zm9FWWlxNmU1amllaDRIZ1d1aE9XSFp6M2RjdlNvRFFIbmlBbm9rZXVGUmcwVjRPd09Wbk1BUVROMm4tMVlsaS1jVTRYb051S29GZXZvUVdUOEdJbjh6SnlxeEFaS0hVdjBibV8tU3JuVQ?oc=5"" target=""_blank"">Goldman Sachs AIF Investment Manager Fined for Not Informing on Biocon Stake Acquisition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Goodreturns</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxPTHZQb0IwclF1U1cySFdOS2htM29rck1tek9sM0xTYUdxLTl0eUtrRDB0Zm9FWWlxNmU1amllaDRIZ1d1aE9XSFp6M2RjdlNvRFFIbmlBbm9rZXVGUmcwVjRPd09Wbk1BUVROMm4tMVlsaS1jVTRYb051S29GZXZvUVdUOEdJbjh6SnlxeEFaS0hVdjBibV8tU3JuVQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxNa0NLaEFINGxrZVBST0JnNmEyWDhZVjlvVm5SejN3UlkwV1dNU19yOW1TVDZBSWtfTW5TbERQX3U3TEdZZ0Fua096eTZ0UjNfaFJ4dlloNXlNRGtaR3JuT2kteXljZExQTHFqVzd4aXBVRWRlREtPUU15bU83M2ZMd1B6blNaV0ZkeHFxUHNucmtfVS1XMUREVlBZYjBuNXZubmJxczhRVUpLZ0p1a1U2OTRreDhxam5EN2FwdFlzQU8tZ3lDOEpDN1pKOTVWbUZtVlJHRnNIM1BHYWFDcTl1eE9TWHBFRWhiSDNaQTkxdEh1MDFHYk1OdGVxZ3JqQdIBgwJBVV95cUxNQ0VpTTFId2pOS285c3pZb3hMamVLWDBUeXA5MldHU3Yta183U2YtM1VNRnd1dzNvWEdYZEtGLUlkaVl1dGt6VlIzOUdpWEpJWVBCM3FoMXRwVHNhTnJ3YkZJS1pSQVJ3cWJ3NHlDMzc2cmVRZ0xQVDFWZnlGT1pTNE1ENWVndVNPUzJRMHRQRXRjUnN3Z1FPLWNHU3hqcG9Ua1QzdGlDSnhESi1nbGduejlJYUl0dDdnYklXbk9nbUFTUFlKVGhNcU45dkVOSkJLWjZJeURLaVBwX3hfWjIwRk5DTllBSzdwRmxaNGJvQmh0RkgyaWdqY0ZPbU05WVprZmRJ?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon shares in focus after Q3 PAT drops 96% YoY, 1.5% additional stake acquisition in subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-31,2025-01-31 08:00:00,Competition Commission Slaps Rs40 Lakh Penalty on Goldman Sachs for Failing to Notify Investment in Biocon - Moneylife,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxQT2pQSTd3MkJRc0tEVkg0ZmVtWjZ3OXZ0eF8zdVJtNUp2S3BCWmtiU2p5Y3BHU3lnZkZobjFMRkhkSWR6NFJ6WVdvdDBlTHR2VjdZRnpaNTBXVWQ2TGV0REpJN042M2pHS2dYaVFvdHZoUlJrSnJEeDM1RGc2aTRGSzdsX2NEMEQ0NXExRzdkY3hjbVhRdGFMeG8tLXM3cXIzREdNc0ZZNFJVd0h4VmNjOUNXYl9ady1zZjdiM3BYbjJrbWxzYXpnV3MxeTJRXzZqQ1UwWHNfeGw3MWxCUVN2alFqbWY?oc=5"" target=""_blank"">Competition Commission Slaps Rs40 Lakh Penalty on Goldman Sachs for Failing to Notify Investment in Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneylife</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxQT2pQSTd3MkJRc0tEVkg0ZmVtWjZ3OXZ0eF8zdVJtNUp2S3BCWmtiU2p5Y3BHU3lnZkZobjFMRkhkSWR6NFJ6WVdvdDBlTHR2VjdZRnpaNTBXVWQ2TGV0REpJN042M2pHS2dYaVFvdHZoUlJrSnJEeDM1RGc2aTRGSzdsX2NEMEQ0NXExRzdkY3hjbVhRdGFMeG8tLXM3cXIzREdNc0ZZNFJVd0h4VmNjOUNXYl9ady1zZjdiM3BYbjJrbWxzYXpnV3MxeTJRXzZqQ1UwWHNfeGw3MWxCUVN2alFqbWY?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.4559,-0.4559,negative,1.0
2025-01-31,2025-01-31 08:00:00,CCI Imposes ₹40 Lakh Penalty On Goldman Sachs For Failure To Notify Investment In Biocon Biologics U/S... - Live Law,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CCI Imposes ₹40 Lakh Penalty On Goldman Sachs For Failure To Notify Investment In Biocon Biologics U/S...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live Law</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.5244212121212121,-0.5244212121212121,negative,1.0
2025-01-31,2025-01-31 08:00:00,Mayank Verma resigns as Compliance Officer of Biocon Limited - legal.economictimes.indiatimes.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Mayank Verma resigns as Compliance Officer of Biocon Limited</a>&nbsp;&nbsp;<font color=""#6f6f6f"">legal.economictimes.indiatimes.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.35310714285714284,-0.35310714285714284,negative,1.0
2025-02-04,2025-02-04 08:00:00,Failure to Notify Investment in Biocon Biologics u/s 6(2) of Competition Act: CCI Imposes ₹40 Lakh Penalty on Goldman Sachs [Read Order] - Taxscan,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxQTEI2QTkwNWNfTW9DUVNFNVV6NzRSUmhKWXBGUlVnbjlwUWQ1Nl9nOENlSk1ja0dtSWdRRlZ2ZEZPU2twSXFjR2pXNmxHY1R1c1NOT1NZekFKaW42ejhrSFNObTV6UXVjUWhjZnRDazlCb01xUkJPcUR1SExTSGJ1MG9OeEUyNlVLbG83cmd2QVNxZ1N3elJVX2I0b3ZkeEh5eGszWlk0Ym4zcTNDbWZOUW16MFIwNWZhLWhGZ0I4RQ?oc=5"" target=""_blank"">Failure to Notify Investment in Biocon Biologics u/s 6(2) of Competition Act: CCI Imposes ₹40 Lakh Penalty on Goldman Sachs [Read Order]</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Taxscan</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxQTEI2QTkwNWNfTW9DUVNFNVV6NzRSUmhKWXBGUlVnbjlwUWQ1Nl9nOENlSk1ja0dtSWdRRlZ2ZEZPU2twSXFjR2pXNmxHY1R1c1NOT1NZekFKaW42ejhrSFNObTV6UXVjUWhjZnRDazlCb01xUkJPcUR1SExTSGJ1MG9OeEUyNlVLbG83cmd2QVNxZ1N3elJVX2I0b3ZkeEh5eGszWlk0Ym4zcTNDbWZOUW16MFIwNWZhLWhGZ0I4RQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.5181166666666667,-0.5181166666666667,negative,1.0
2025-02-05,2025-02-05 08:00:00,Failure to Notify Investment in Biocon Biologics u/s 6(2) of Competition Act: CCI Imposes ₹40 Lakh Penalty on Goldman Sachs [Read Order] - Taxscan,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxOLUJXNjRlLTJObUp5Nmp4Ykl6T3p2bjF6QmVxMWZMejBSMHhuYTdmbTJTZm45RksyVnJtVkFoaDhGY0JlbThxUDVJT0dLYm4tVEVleGVCcEtvRktpSjZ6eW9iSmtHbDVQSE1xZmFoN0VBdHYzZkQtZFVHV1l1TkM4cVY4UDVpdl9ncEZYTnFkRlk1X2toVkFyVERHbzgweXZjVlM0Nktad29QS1FKTEpIYmZJbWp2MXU2SkE1UWpkX3U?oc=5"" target=""_blank"">Failure to Notify Investment in Biocon Biologics u/s 6(2) of Competition Act: CCI Imposes ₹40 Lakh Penalty on Goldman Sachs [Read Order]</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Taxscan</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxOLUJXNjRlLTJObUp5Nmp4Ykl6T3p2bjF6QmVxMWZMejBSMHhuYTdmbTJTZm45RksyVnJtVkFoaDhGY0JlbThxUDVJT0dLYm4tVEVleGVCcEtvRktpSjZ6eW9iSmtHbDVQSE1xZmFoN0VBdHYzZkQtZFVHV1l1TkM4cVY4UDVpdl9ncEZYTnFkRlk1X2toVkFyVERHbzgweXZjVlM0Nktad29QS1FKTEpIYmZJbWp2MXU2SkE1UWpkX3U?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.5181166666666667,-0.5181166666666667,negative,1.0
2025-02-10,2025-02-10 14:50:44,"Biocon Ranks Among Top 10 Global Employers, Recognised For Innovation By Science Magazine - BW Healthcare","<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRHB5MFo1Nk8xd0U2T05zcENXblI1dU9JMGl4UFoyd3B6bnhPYjhwUTRTd21uLU4zRUU2cUNPcXg2b084NGF4NzZaNnVpRElvd1NHZGNiZDdoTGFNY1d6NlVCdF9SSUR2OUhsYWNJZVQ1SDVIcE9pbnZsVWZuNXg4MXlnRFZmd0tadmJYQ1I3MXRUMjVUMzBwT21hVzdtdjNDb2ljTnBoUVV6M0ZpNmVvTVJDNG9kWVNrNnBEX2pLQ01peXh0ZFl4T0UxbGxfOFFuX05r?oc=5"" target=""_blank"">Biocon Ranks Among Top 10 Global Employers, Recognised For Innovation By Science Magazine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Healthcare</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxQRHB5MFo1Nk8xd0U2T05zcENXblI1dU9JMGl4UFoyd3B6bnhPYjhwUTRTd21uLU4zRUU2cUNPcXg2b084NGF4NzZaNnVpRElvd1NHZGNiZDdoTGFNY1d6NlVCdF9SSUR2OUhsYWNJZVQ1SDVIcE9pbnZsVWZuNXg4MXlnRFZmd0tadmJYQ1I3MXRUMjVUMzBwT21hVzdtdjNDb2ljTnBoUVV6M0ZpNmVvTVJDNG9kWVNrNnBEX2pLQ01peXh0ZFl4T0UxbGxfOFFuX05r?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,True,0.48915,0.48915,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon share price jumps over 2% during intraday day after its arm launches a new product for US market - Upstox,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxNYzB2OEZQVXNpNXpwdEJNRlVYWFlQak8yWkRuVFpHNVJhYnFmQzdneE5jZ3BpVDQxZlVvUWFUdWtQejFBVWU3VmdXcTNrVDJ6WHRMTGdqcUNHZnIwcTFKQTFTUzJnOTdxYVBmU2ZJQk5naHNJM2xmMlBjU2dscU52bWFwU3ZZOUJMb1hkR0t5Rk5SUVlZcW9ZeXVSQXVTNVpGcW5LMm1ONWhpcVh6Y3lrS1VNZDVWWHpTdmsxeG9EV3gzdG1JSFF1Wnl4MGo2VXhYZVFpbmhXTm0?oc=5"" target=""_blank"">Biocon share price jumps over 2% during intraday day after its arm launches a new product for US market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxNYzB2OEZQVXNpNXpwdEJNRlVYWFlQak8yWkRuVFpHNVJhYnFmQzdneE5jZ3BpVDQxZlVvUWFUdWtQejFBVWU3VmdXcTNrVDJ6WHRMTGdqcUNHZnIwcTFKQTFTUzJnOTdxYVBmU2ZJQk5naHNJM2xmMlBjU2dscU52bWFwU3ZZOUJMb1hkR0t5Rk5SUVlZcW9ZeXVSQXVTNVpGcW5LMm1ONWhpcVh6Y3lrS1VNZDVWWHpTdmsxeG9EV3gzdG1JSFF1Wnl4MGo2VXhYZVFpbmhXTm0?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,True,0.30880454545454544,0.30880454545454544,positive,1.0
2025-03-01,2025-03-01 08:00:00,"Record dates for dividends, bonus shares, stock splits next week: SBI Life, Anand Rathi Wealth among 11 shares - Full List - ET Now","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOSFVFa1d0emhxS3JQb3lBclZyaW5nUWJwSm52YnJodFRhR25qQkpwa25GZWJQakE4RC1YeGd6WURtMFpJRmdvcWVZYnU4TmxiQ21xMl90VGxmbTZoYkkwYVdUbUFxa0RLcng2SEJNWGJ0WVRaclBqMzV2eHZDb2U3THE0VW42ZEtqTU5zSXpyU29wVnRheUlvTXpuVDVBanpjQ0l1cXg1S2ZlcXdrekM4VTl4Z3VEM1JmbE9DaFpXa0ZBcTNEdUNCYW1RSDJBdnc4OGxaTnNEUjMwaDlBNWx5VkFJeTF6elI4X0NZRmVIcC1saHZ0UkpmUHczN2_SAYICQVVfeXFMTnJaUTBmZmJwZVlYTVJhZzhIclp6TmFhR1VQNE1ldzVQdzZDZUJhd1JiQUdpdV9DbGdRYU1hUTFwbFFEdGxSa2N1Y1ZmT3J3LWxBTXVBanp4dmJ5ZlJUck94M2RZeWtYWXdLUmJfOTR5YzI3UDZLeG5fR0xLcUhiYjNkWDF0RnVxdXZHSDFtY0h4QlZLUVcyYmlnWU1uc3VneUtWaUtpZi02eFpEbTNjTEdfb2RjT216enpQU05haFc1UWx6eFBKMmQyZ3d0dEZIT1RwM08wVlRmQVFtX1F2TlB4dnFSbmZmbmx4d3ZVMmhQanVvMEVfRUtuTEVuaVRuWTJ3?oc=5"" target=""_blank"">Record dates for dividends, bonus shares, stock splits next week: SBI Life, Anand Rathi Wealth among 11 shares - Full List</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxOSFVFa1d0emhxS3JQb3lBclZyaW5nUWJwSm52YnJodFRhR25qQkpwa25GZWJQakE4RC1YeGd6WURtMFpJRmdvcWVZYnU4TmxiQ21xMl90VGxmbTZoYkkwYVdUbUFxa0RLcng2SEJNWGJ0WVRaclBqMzV2eHZDb2U3THE0VW42ZEtqTU5zSXpyU29wVnRheUlvTXpuVDVBanpjQ0l1cXg1S2ZlcXdrekM4VTl4Z3VEM1JmbE9DaFpXa0ZBcTNEdUNCYW1RSDJBdnc4OGxaTnNEUjMwaDlBNWx5VkFJeTF6elI4X0NZRmVIcC1saHZ0UkpmUHczN2_SAYICQVVfeXFMTnJaUTBmZmJwZVlYTVJhZzhIclp6TmFhR1VQNE1ldzVQdzZDZUJhd1JiQUdpdV9DbGdRYU1hUTFwbFFEdGxSa2N1Y1ZmT3J3LWxBTXVBanp4dmJ5ZlJUck94M2RZeWtYWXdLUmJfOTR5YzI3UDZLeG5fR0xLcUhiYjNkWDF0RnVxdXZHSDFtY0h4QlZLUVcyYmlnWU1uc3VneUtWaUtpZi02eFpEbTNjTEdfb2RjT216enpQU05haFc1UWx6eFBKMmQyZ3d0dEZIT1RwM08wVlRmQVFtX1F2TlB4dnFSbmZmbmx4d3ZVMmhQanVvMEVfRUtuTEVuaVRuWTJ3?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.5524,0.5524,positive,1.0
2025-03-03,2025-03-03 08:00:00,HAL dividend 2025 payment date next week; check amount - ET Now,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSkNnMnNodkJWTk5DLVVlZ2V0eWNLbG9QN3M2MEVjRERfMjZGbnZVNjl5UnJja0NMSHZWY3lxNUxkb3VwbFNDZkM5S18tazhOYkthNWZiUG9hTlA0ZC1ISlpLaDBydHJNX0tVZjM1MTZHaWxienRaN3MzVzRrMmlGeHNid2hLMkJkTnl3RlZPYjU3aVJRWHhuNlI2alRnWGVRWXR4bXBINzTSAa4BQVVfeXFMUDIyV25sMHBjb3lLNE1NV1pkVlk4S29RUGtTWHY5QUk1d0VRNmZsNUY3b01pTFQxMmhuVFRzZUVOSmJ6dFJ1ZDhEek5MNGtQclVraXZCbkdkZ1NpOXJMWXdZSUpOOXVrN3Q0SGs4TXNsU1NORVMwMWVMMXlyNDVrLVU5bjBrUk9lVkNsRW5JU05oSjR0RzN4aUFjYzRaNUJDTVU3SG1wTm50M2RjZEpR?oc=5"" target=""_blank"">HAL dividend 2025 payment date next week; check amount</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSkNnMnNodkJWTk5DLVVlZ2V0eWNLbG9QN3M2MEVjRERfMjZGbnZVNjl5UnJja0NMSHZWY3lxNUxkb3VwbFNDZkM5S18tazhOYkthNWZiUG9hTlA0ZC1ISlpLaDBydHJNX0tVZjM1MTZHaWxienRaN3MzVzRrMmlGeHNid2hLMkJkTnl3RlZPYjU3aVJRWHhuNlI2alRnWGVRWXR4bXBINzTSAa4BQVVfeXFMUDIyV25sMHBjb3lLNE1NV1pkVlk4S29RUGtTWHY5QUk1d0VRNmZsNUY3b01pTFQxMmhuVFRzZUVOSmJ6dFJ1ZDhEek5MNGtQclVraXZCbkdkZ1NpOXJMWXdZSUpOOXVrN3Q0SGs4TXNsU1NORVMwMWVMMXlyNDVrLVU5bjBrUk9lVkNsRW5JU05oSjR0RzN4aUFjYzRaNUJDTVU3SG1wTm50M2RjZEpR?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.0,0.0,neutral,1.0
2025-03-11,2025-03-11 07:00:00,Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter - DSIJ,"<a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxObUhLem1NQmVmdTZYZlZFZnRjczRXR3RLVkZxaXRiWDdJaTdwdUdoOEJpckQ2X1FHMlk1M1dZZ182UTFCbC1lZDZJREE5UnF2RnJXdENjVWFzNVJXS3E4MTl0dEVxQ3pCWVV1UFZIS25Sb0tabzc2LU5KZUZPQ3QtZHJKWHNhdVlwMTBxTjByeWJRUmRDNXdTRnUxeXVyM3Z1QnJhYTRJS09WTDN2RW03QkV6YVlDWEhfaWpPZXdkdURmb3MyWXo4MmNBcTM1Nl8wQ3Z2Z041bXZvMmxsV2Vpa190RTBHcld5dlNxMHdLZ0Z4YVlJa2pTNThZbXVpbnBQVkdwckxSUFpQN002R0RPeUt2aGI3bDNn?oc=5"" target=""_blank"">Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DSIJ</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxObUhLem1NQmVmdTZYZlZFZnRjczRXR3RLVkZxaXRiWDdJaTdwdUdoOEJpckQ2X1FHMlk1M1dZZ182UTFCbC1lZDZJREE5UnF2RnJXdENjVWFzNVJXS3E4MTl0dEVxQ3pCWVV1UFZIS25Sb0tabzc2LU5KZUZPQ3QtZHJKWHNhdVlwMTBxTjByeWJRUmRDNXdTRnUxeXVyM3Z1QnJhYTRJS09WTDN2RW03QkV6YVlDWEhfaWpPZXdkdURmb3MyWXo4MmNBcTM1Nl8wQ3Z2Z041bXZvMmxsV2Vpa190RTBHcld5dlNxMHdLZ0Z4YVlJa2pTNThZbXVpbnBQVkdwckxSUFpQN002R0RPeUt2aGI3bDNn?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.24695,0.24695,positive,1.0
2025-03-11,2025-03-11 07:00:00,Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter - DSIJ,"<a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxObUhLem1NQmVmdTZYZlZFZnRjczRXR3RLVkZxaXRiWDdJaTdwdUdoOEJpckQ2X1FHMlk1M1dZZ182UTFCbC1lZDZJREE5UnF2RnJXdENjVWFzNVJXS3E4MTl0dEVxQ3pCWVV1UFZIS25Sb0tabzc2LU5KZUZPQ3QtZHJKWHNhdVlwMTBxTjByeWJRUmRDNXdTRnUxeXVyM3Z1QnJhYTRJS09WTDN2RW03QkV6YVlDWEhfaWpPZXdkdURmb3MyWXo4MmNBcTM1Nl8wQ3Z2Z041bXZvMmxsV2Vpa190RTBHcld5dlNxMHdLZ0Z4YVlJa2pTNThZbXVpbnBQVkdwckxSUFpQN002R0RPeUt2aGI3bDNn?oc=5"" target=""_blank"">Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DSIJ</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxObUhLem1NQmVmdTZYZlZFZnRjczRXR3RLVkZxaXRiWDdJaTdwdUdoOEJpckQ2X1FHMlk1M1dZZ182UTFCbC1lZDZJREE5UnF2RnJXdENjVWFzNVJXS3E4MTl0dEVxQ3pCWVV1UFZIS25Sb0tabzc2LU5KZUZPQ3QtZHJKWHNhdVlwMTBxTjByeWJRUmRDNXdTRnUxeXVyM3Z1QnJhYTRJS09WTDN2RW03QkV6YVlDWEhfaWpPZXdkdURmb3MyWXo4MmNBcTM1Nl8wQ3Z2Z041bXZvMmxsV2Vpa190RTBHcld5dlNxMHdLZ0Z4YVlJa2pTNThZbXVpbnBQVkdwckxSUFpQN002R0RPeUt2aGI3bDNn?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.24695,0.24695,positive,1.0
2025-03-25,2025-03-25 07:00:00,Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon - DSIJ,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQX0JPN21UcUUxcTlJUE54dzFUNUpDbmMyRjJoWnpjcHZJUzNTSmpCcC1kUXJTQ1lmZVA4b0llbXdhamF1N2RzMWhrbERWWUEyMzB3ZlpkTUhyS1YzLW5KUy13d3VqT3huR3N5MU1heXk0UWhEX1dYS3pfWkVzWjBwamFmU3VzajI2cVRnX0R0Q3BHWHh6b1hOM2dlaEwtUzZOQ1FUUDZGV2JnZ0p0Tmt0ZEt1ZEI5TE4tYVlDU0VWQXk5RFZ0dXhqUlpPQTczZkpndGdkaUZrS2hLVlQzTGZZ?oc=5"" target=""_blank"">Rs 65 Million Investment Sparks Interest in Renewable Energy Acquisition by Subsidiary of Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DSIJ</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxQX0JPN21UcUUxcTlJUE54dzFUNUpDbmMyRjJoWnpjcHZJUzNTSmpCcC1kUXJTQ1lmZVA4b0llbXdhamF1N2RzMWhrbERWWUEyMzB3ZlpkTUhyS1YzLW5KUy13d3VqT3huR3N5MU1heXk0UWhEX1dYS3pfWkVzWjBwamFmU3VzajI2cVRnX0R0Q3BHWHh6b1hOM2dlaEwtUzZOQ1FUUDZGV2JnZ0p0Tmt0ZEt1ZEI5TE4tYVlDU0VWQXk5RFZ0dXhqUlpPQTczZkpndGdkaUZrS2hLVlQzTGZZ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.42405,0.42405,positive,1.0
2025-03-30,2025-03-30 07:00:00,Upcoming dividend 2025: Navratna PSU stock to trade ex-date on April 2 - Shares up 212% in 2 years - ET Now,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxPOHV6X3RWaDZBcVpPNWRoUFh2X3NBdTBvN2tHZmQ1N3lia0M5NnFLRkk4bjVfRTVfS2tXRWpCWEI5Mk9YSlVUZzc1WEtGeW1lYVpCUGViS01Gc210Tlp6WElVekFOTkpjbmVVR1hQLUxZVXR1UjI4b3VYNkx5N2J3ZGNLamM5ci1SUTRJTks1SDBVSFRaVU5lOTdWcDNnWERPWDFwRU5ZMnk3VFNRLTM4QkRSOFpERzhMUGlIYmRtTlhIMm4tN3B5YUd1QmVFU0VDMHA4bkQyNHFvWFlKUG9F0gHkAUFVX3lxTFBoVjdZQUVPODJKQ1d6RHhseUtseW1uQnlfXy0zZHh3Y1hhZllid1BGN0ROSGFMYzRVeEFjX0Z5ajloUVRfMkpOcG9NcDBXcV94Q040NWI2dWJqTFR2NFp5SjgyQ08wZzV0TWpIYldkWHk4YU1TZlNFaVU5aFNvWTNwdXQ0M2RJdVl2VjYteFBvenhCMkE4dktIZmtDLTJKQW54SUdSUG5WaHdxektPc3ozekc3c1BKYUpXYWNuY0sxZzFOZUpIUW8wd0dqMzItTlhlMHpCQk9BUy1uX2pZcVhWYzljXw?oc=5"" target=""_blank"">Upcoming dividend 2025: Navratna PSU stock to trade ex-date on April 2 - Shares up 212% in 2 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxPOHV6X3RWaDZBcVpPNWRoUFh2X3NBdTBvN2tHZmQ1N3lia0M5NnFLRkk4bjVfRTVfS2tXRWpCWEI5Mk9YSlVUZzc1WEtGeW1lYVpCUGViS01Gc210Tlp6WElVekFOTkpjbmVVR1hQLUxZVXR1UjI4b3VYNkx5N2J3ZGNLamM5ci1SUTRJTks1SDBVSFRaVU5lOTdWcDNnWERPWDFwRU5ZMnk3VFNRLTM4QkRSOFpERzhMUGlIYmRtTlhIMm4tN3B5YUd1QmVFU0VDMHA4bkQyNHFvWFlKUG9F0gHkAUFVX3lxTFBoVjdZQUVPODJKQ1d6RHhseUtseW1uQnlfXy0zZHh3Y1hhZllid1BGN0ROSGFMYzRVeEFjX0Z5ajloUVRfMkpOcG9NcDBXcV94Q040NWI2dWJqTFR2NFp5SjgyQ08wZzV0TWpIYldkWHk4YU1TZlNFaVU5aFNvWTNwdXQ0M2RJdVl2VjYteFBvenhCMkE4dktIZmtDLTJKQW54SUdSUG5WaHdxektPc3ozekc3c1BKYUpXYWNuY0sxZzFOZUpIUW8wd0dqMzItTlhlMHpCQk9BUy1uX2pZcVhWYzljXw?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.26335,0.26335,positive,1.0
2025-04-28,2025-04-28 07:00:00,12.5% dividend payment declared on each stock Rs 10 FV by BSE 500 company; record date fixed - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">12.5% dividend payment declared on each stock Rs 10 FV by BSE 500 company; record date fixed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.025,0.025,neutral,1.0
2025-05-09,2025-05-09 07:00:00,Pidilite Inds gains after Q4 PAT rises 40% YoY to Rs 422 cr; declares dividend of Rs 20/sh - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Pidilite Inds gains after Q4 PAT rises 40% YoY to Rs 422 cr; declares dividend of Rs 20/sh</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.29295,0.29295,positive,1.0
2025-05-12,2025-05-12 07:00:00,Biocon to evaluate merger with biosimilars arm - Mint,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxPQUdlM09HOUVIai0xQUJIcmZkdFJzbXhoV3d3RVJEWFdUSmY5SnRZMUZJdThZc0R2bFR1OTBTMmUxMTViU3I3WWFJN0VDQU1zTjR2aWp1dWNfMVp6Ynh6QWJjelZJaEJKNU1UakhyR3VQRktZQ21mT1JZTVlxOF9QZWVkaXRjVFNmaGxlUmRiSXRtYnU1Z1hEX1p1M21TdUYycEg2ZXNPUHZOT0FWYjMyNTNMNGNkUlJxamF2NjA0UTBxeXV5aHBQREtKQ0tsS205U3kxSg?oc=5"" target=""_blank"">Biocon to evaluate merger with biosimilars arm</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPQUdlM09HOUVIai0xQUJIcmZkdFJzbXhoV3d3RVJEWFdUSmY5SnRZMUZJdThZc0R2bFR1OTBTMmUxMTViU3I3WWFJN0VDQU1zTjR2aWp1dWNfMVp6Ynh6QWJjelZJaEJKNU1UakhyR3VQRktZQ21mT1JZTVlxOF9QZWVkaXRjVFNmaGxlUmRiSXRtYnU1Z1hEX1p1M21TdUYycEg2ZXNPUHZOT0FWYjMyNTNMNGNkUlJxamF2NjA0UTBxeXV5aHBQREtKQ0tsS205U3kxSg?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-05-12,2025-05-12 07:00:00,Biocon to evaluate merger with biosimilars arm - Mint,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxPQUdlM09HOUVIai0xQUJIcmZkdFJzbXhoV3d3RVJEWFdUSmY5SnRZMUZJdThZc0R2bFR1OTBTMmUxMTViU3I3WWFJN0VDQU1zTjR2aWp1dWNfMVp6Ynh6QWJjelZJaEJKNU1UakhyR3VQRktZQ21mT1JZTVlxOF9QZWVkaXRjVFNmaGxlUmRiSXRtYnU1Z1hEX1p1M21TdUYycEg2ZXNPUHZOT0FWYjMyNTNMNGNkUlJxamF2NjA0UTBxeXV5aHBQREtKQ0tsS205U3kxSg?oc=5"" target=""_blank"">Biocon to evaluate merger with biosimilars arm</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPQUdlM09HOUVIai0xQUJIcmZkdFJzbXhoV3d3RVJEWFdUSmY5SnRZMUZJdThZc0R2bFR1OTBTMmUxMTViU3I3WWFJN0VDQU1zTjR2aWp1dWNfMVp6Ynh6QWJjelZJaEJKNU1UakhyR3VQRktZQ21mT1JZTVlxOF9QZWVkaXRjVFNmaGxlUmRiSXRtYnU1Z1hEX1p1M21TdUYycEg2ZXNPUHZOT0FWYjMyNTNMNGNkUlJxamF2NjA0UTBxeXV5aHBQREtKQ0tsS205U3kxSg?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-05-14,2025-05-14 07:00:00,"Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-05-14,2025-05-14 07:00:00,"Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s Kiran Mazumdar-Shaw looking at biosimilar unit merger, IPO plans on hold</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-05-15,2025-05-15 07:00:00,Biocon Eyes Fundraising Round Amid Discussions On Merger With Biosimilars Branch - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxObFEwcHZSenNoblZVTktsa0RGcVJ2TzgxMTc5U20zNHFTR3BteDF1ekpHME11S2xoVmFIdTJEU1ZKMzQzLUotU3NCNzhEWGxOaURXSFdkemZtYjEwcnJYUHR3eUF0V2lEVmEydFBOblNtRmZVTmkycmJVN0p0aFlxMUVQVU5PdUN3dUR4NHRSYWNnaWk2UVE2SnA5Z0gzZDAxa3ZJalF2RDAyNm9wa1FyajU2ZWFVeUpCWHdLRElEUEFILV9iN0FtN0hCMUlOOE9WcGc3LVlIQkVCbDVlaFlVMUNMSmg2WWNYd1pxcmFSeHFzZWpyMWhqSVRPUTVKeVZxTUkyZg?oc=5"" target=""_blank"">Biocon Eyes Fundraising Round Amid Discussions On Merger With Biosimilars Branch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxObFEwcHZSenNoblZVTktsa0RGcVJ2TzgxMTc5U20zNHFTR3BteDF1ekpHME11S2xoVmFIdTJEU1ZKMzQzLUotU3NCNzhEWGxOaURXSFdkemZtYjEwcnJYUHR3eUF0V2lEVmEydFBOblNtRmZVTmkycmJVN0p0aFlxMUVQVU5PdUN3dUR4NHRSYWNnaWk2UVE2SnA5Z0gzZDAxa3ZJalF2RDAyNm9wa1FyajU2ZWFVeUpCWHdLRElEUEFILV9iN0FtN0hCMUlOOE9WcGc3LVlIQkVCbDVlaFlVMUNMSmg2WWNYd1pxcmFSeHFzZWpyMWhqSVRPUTVKeVZxTUkyZg?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,-0.06666666666666667,-0.06666666666666667,neutral,1.0
2025-05-15,2025-05-15 07:00:00,Biocon Eyes Fundraising Round Amid Discussions On Merger With Biosimilars Branch - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxObFEwcHZSenNoblZVTktsa0RGcVJ2TzgxMTc5U20zNHFTR3BteDF1ekpHME11S2xoVmFIdTJEU1ZKMzQzLUotU3NCNzhEWGxOaURXSFdkemZtYjEwcnJYUHR3eUF0V2lEVmEydFBOblNtRmZVTmkycmJVN0p0aFlxMUVQVU5PdUN3dUR4NHRSYWNnaWk2UVE2SnA5Z0gzZDAxa3ZJalF2RDAyNm9wa1FyajU2ZWFVeUpCWHdLRElEUEFILV9iN0FtN0hCMUlOOE9WcGc3LVlIQkVCbDVlaFlVMUNMSmg2WWNYd1pxcmFSeHFzZWpyMWhqSVRPUTVKeVZxTUkyZg?oc=5"" target=""_blank"">Biocon Eyes Fundraising Round Amid Discussions On Merger With Biosimilars Branch</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxObFEwcHZSenNoblZVTktsa0RGcVJ2TzgxMTc5U20zNHFTR3BteDF1ekpHME11S2xoVmFIdTJEU1ZKMzQzLUotU3NCNzhEWGxOaURXSFdkemZtYjEwcnJYUHR3eUF0V2lEVmEydFBOblNtRmZVTmkycmJVN0p0aFlxMUVQVU5PdUN3dUR4NHRSYWNnaWk2UVE2SnA5Z0gzZDAxa3ZJalF2RDAyNm9wa1FyajU2ZWFVeUpCWHdLRElEUEFILV9iN0FtN0hCMUlOOE9WcGc3LVlIQkVCbDVlaFlVMUNMSmg2WWNYd1pxcmFSeHFzZWpyMWhqSVRPUTVKeVZxTUkyZg?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,-0.06666666666666667,-0.06666666666666667,neutral,1.0
2025-05-16,2025-05-16 07:00:00,Dividend of Rs 40 ANNOUNCED; smallcap company- Record date fixed - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Dividend of Rs 40 ANNOUNCED; smallcap company- Record date fixed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.025,0.025,neutral,1.0
2025-06-18,2025-06-18 00:25:30,Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50 - simplywall.st,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVTRjUTRtLWxfTE93b00wbHN6N0J4QjhuRmk1ZVBNZ3UwN1RHbnNnMFY4Yng3M3gtSVlxbEtvSXZxNmlEQlVJUHczaFBUcllQZnBZUFBNRHFKcFh3TDMyeWxqV1Y4T2E2WEtMVFZObWNTLTVGSUIzQkZrRFU2UF9CcXk3TDF2ZHp1VlVpejBOXzlVR1JtX3pSRUFjY1BpR3ZfbHc2ekE1V1FMZEdITElEZzlWQUl6N0cxY1hiOG5tTU9XT28xRDBNbNIBzgFBVV95cUxQMlFLbVdBcnJjNnJLcGQ1TmZ0RTJteVlrQ3haYzdLdkxzbFVVUEh2anZ1OXZwcE1pbzN3VnZrQTA1WTZnVmRGRjdUUm5wQ015cVlpTVBQbk1zSzdSUXRUbFBrci1XT25GLVJnYmkyTW9MQWYtWUU0ZGNDX1A5LUdPR3hhNlFZM3pyaFAtVlA1ems3WWNMVnY5azNKWU9ZOWM1dkN1T3RUOGhZek1KN2Y5ak1SV28zZllTR1hkTGdJRTNVZTZZVWYxalZUMFFfUQ?oc=5"" target=""_blank"">Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-18,2025-06-18 00:25:30,Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50 - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-18,2025-06-18 00:25:30,Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50 - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-18,2025-06-18 07:00:00,"Dividend stocks, right issue today: THESE shares will trade ex-date, do you own any? - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Dividend stocks, right issue today: THESE shares will trade ex-date, do you own any?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,False,0.47944285714285717,0.47944285714285717,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain - Stocktwits,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOMkx6MHhEY19Kb0htT3dVQURtMHlwUVJRTnRvYnZ4Q2VPQk1EQ0R5NmVNS2t2dUNUb0tQUFliQzR3U0k0VWZXZzVjQzQxdVl0VUdtSDgxMHdNX0ZMaUNtREpTak10YmFiZTEtMkNnTzZlNlRGYVJNM2R2LUZRWktySG1rNmtCV3k5QVZTZnVpb3lNSXR0R2FqbUdWR3g2TVYteFVFa2Z5VXpaM1RQZkhwZUZ1cjVTZUVGODBhYkZXSGRxcU1YM2RnaExyUXpmdw?oc=5"" target=""_blank"">Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Stocktwits</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOMkx6MHhEY19Kb0htT3dVQURtMHlwUVJRTnRvYnZ4Q2VPQk1EQ0R5NmVNS2t2dUNUb0tQUFliQzR3U0k0VWZXZzVjQzQxdVl0VUdtSDgxMHdNX0ZMaUNtREpTak10YmFiZTEtMkNnTzZlNlRGYVJNM2R2LUZRWktySG1rNmtCV3k5QVZTZnVpb3lNSXR0R2FqbUdWR3g2TVYteFVFa2Z5VXpaM1RQZkhwZUZ1cjVTZUVGODBhYkZXSGRxcU1YM2RnaExyUXpmdw?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain - MSN,"<a href=""https://news.google.com/rss/articles/CBMi8wFBVV95cUxQeVZDWm93RVRrUnhBVzE5SzFjZWQ1TnJwT1J1eG50TEI4bjBLclEwWElROW0xUHhxZmFDNTBSQzBtUEJpeW55V1NNRU9zdGE4MXVMMl9IeGRRd21wSUJHLXpOVHNFVXNNcmlNSUxiZmpHcnhWdEMtVjhvWm1hbWctOUxtTDNQNFEyZzZFRVNVS1FzbTRhS2ZScVBmaFZVVjN3ZEQwU2RQbnJxYXlYNjFTNnZwcnlJODNuZXNGM1JkREpJX1ZBZnBUbXVrSFJRSW5fYzFlRjFTSDFSQTRWMlJobG9TUVc3YUNLV0JlOVRaWUZ5Mzg?oc=5"" target=""_blank"">Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMi8wFBVV95cUxQeVZDWm93RVRrUnhBVzE5SzFjZWQ1TnJwT1J1eG50TEI4bjBLclEwWElROW0xUHhxZmFDNTBSQzBtUEJpeW55V1NNRU9zdGE4MXVMMl9IeGRRd21wSUJHLXpOVHNFVXNNcmlNSUxiZmpHcnhWdEMtVjhvWm1hbWctOUxtTDNQNFEyZzZFRVNVS1FzbTRhS2ZScVBmaFZVVjN3ZEQwU2RQbnJxYXlYNjFTNnZwcnlJODNuZXNGM1JkREpJX1ZBZnBUbXVrSFJRSW5fYzFlRjFTSDFSQTRWMlJobG9TUVc3YUNLV0JlOVRaWUZ5Mzg?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-19,2025-06-19 11:00:51,Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain - MENAFN.com,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxOUE9LS09nenZWYm9CQTN3WFQ1MGlKd3cxZUpuNHVxcG9hWGJfX2xQZmJxS0Q1M3ZPMTBFc0dTc01oMzhXWUZzbTJRQXpPUGRxTDZmeXhqakFmaC1mVVhtVndNMWxEZ3dleWJpdGo0eVJoTUFNa3RCLWg2RV9jQ2xKLXpGWDZ0TWhvYWJFaC1zak9PR2djNzZOeVZfbWpEOEY1VUtTc0dxLUZvdUhmSEpTQQ?oc=5"" target=""_blank"">Biocon Stock Rebounds: SEBI RA Ketan Mittal Warns That Short-Term Headwinds Remain</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MENAFN.com</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxOUE9LS09nenZWYm9CQTN3WFQ1MGlKd3cxZUpuNHVxcG9hWGJfX2xQZmJxS0Q1M3ZPMTBFc0dTc01oMzhXWUZzbTJRQXpPUGRxTDZmeXhqakFmaC1mVVhtVndNMWxEZ3dleWJpdGo0eVJoTUFNa3RCLWg2RV9jQ2xKLXpGWDZ0TWhvYWJFaC1zak9PR2djNzZOeVZfbWpEOEY1VUtTc0dxLUZvdUhmSEpTQQ?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,regulatory_compliance,7,False,True,-0.10115,-0.10115,negative,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon closes ₹4,500 crore QIP to boost innovation, expand global access - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon closes ₹4,500 crore QIP to boost innovation, expand global access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,True,0.46085,0.46085,positive,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon closes ₹4,500 crore QIP to boost innovation, expand global access - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon closes ₹4,500 crore QIP to boost innovation, expand global access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,research_development,7,False,True,0.46085,0.46085,positive,1.0
2025-06-23,2025-06-23 07:00:00,"Decision on merger with Biocon Biologics soon, says Siddharth Mittal - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdnlVU0UyVEdERzRuT2Ftcm1XNFpQUE5TN0I0Ymh6WjREUWVrcEU5dlNoQVJOZE8tTTdYdE1iN0Z4c0lsUG1xVEhlb0p6QnowSVI0djBTdnJuTEZySnotRV95bHFrU0hqelVqWjBiZndxTnpwX0RGLWFlaHktUUpoUkJ4UUZGMXdNT2NRQU9kdURydFBxS2lCRFFVaktDckRZenhESGN4a0t2dGFUTnlzS0hKSmIzVk5jUU1lZmhjSi1FU1dOQS1rZEpheDFtaWcyaDcxNFVhSFdqZ9IB3wFBVV95cUxPbHM5eDNPQmlEQkJ1TGdMbk80djdmQVV3dHdnQzlXMmJuUnZIeEEyWVUzWDBibmJvcmFlVFRnRmE5aVFJWnJhQVZMOXktcUxxVkVLZTJMX1laY1UycnJPS3Iza2NhdzZROEFWV1ltMTJVTEhOeGFoR29xbzVOdWxRSEFSNnRvQUdTaUdlVDljSEx3UDV6ZWh6eWx3UWVXSkZodW5GX0pPdHJNSlROeW1Od1NKcVJzekV4WEM2RU9mS3dDZWhPUEM1WGI2eDZ0cDFwUjBEeUp6ZmZtTjJzdnV3?oc=5"" target=""_blank"">Decision on merger with Biocon Biologics soon, says Siddharth Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOVGFtZXZaS0lXWnQ1SEZJeTV0RlNRN1NSUTZvVE1zT25Da3ptWHM1cUtGdzdkaTM0X0RiQVkyQVZneUNiTUROU2J3OGFNQjFwZTY4c05acU1qaVlWNHJoR2Y1bWx4YklFTklvdzlvTmE5VDdjRjlKS25xVms2VG5UN2NidFo2NFZxbDNIUXNxSDI5LU03M3I2WEV1T0s2SmtublVTV1JPNGFXT3F0cXMyWDlJQ2rSAbsBQVVfeXFMTkNOcTR3VEp2VjQydTd5WUc4RE1GLThKRXVFQmtibzJITHJxU2lHMXlCWVZ4eHZyNWJ1ZzZZQVNUeThPemh3UzZRX3huQms1bDZJMFFKY2tNR0pIYkRIaEpPNThRMERCdE80TkplVHp4aUxyN0RENlRaM1BIcnBEamdpbzUxczBOekZKcVFZT2ZsTXVKdGt4OVgwZi1kdlFfdmNMZ3RDNmw2SGYtdlBYNVVHdWpueGZxWTRHUQ?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOVGFtZXZaS0lXWnQ1SEZJeTV0RlNRN1NSUTZvVE1zT25Da3ptWHM1cUtGdzdkaTM0X0RiQVkyQVZneUNiTUROU2J3OGFNQjFwZTY4c05acU1qaVlWNHJoR2Y1bWx4YklFTklvdzlvTmE5VDdjRjlKS25xVms2VG5UN2NidFo2NFZxbDNIUXNxSDI5LU03M3I2WEV1T0s2SmtublVTV1JPNGFXT3F0cXMyWDlJQ2rSAbsBQVVfeXFMTkNOcTR3VEp2VjQydTd5WUc4RE1GLThKRXVFQmtibzJITHJxU2lHMXlCWVZ4eHZyNWJ1ZzZZQVNUeThPemh3UzZRX3huQms1bDZJMFFKY2tNR0pIYkRIaEpPNThRMERCdE80TkplVHp4aUxyN0RENlRaM1BIcnBEamdpbzUxczBOekZKcVFZT2ZsTXVKdGt4OVgwZi1kdlFfdmNMZ3RDNmw2SGYtdlBYNVVHdWpueGZxWTRHUQ?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2025-06-24,2025-06-24 07:01:46,"After a $3.3 bn acquisition, is it finally time to look at Biocon? - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">After a $3.3 bn acquisition, is it finally time to look at Biocon?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxOVGFtZXZaS0lXWnQ1SEZJeTV0RlNRN1NSUTZvVE1zT25Da3ptWHM1cUtGdzdkaTM0X0RiQVkyQVZneUNiTUROU2J3OGFNQjFwZTY4c05acU1qaVlWNHJoR2Y1bWx4YklFTklvdzlvTmE5VDdjRjlKS25xVms2VG5UN2NidFo2NFZxbDNIUXNxSDI5LU03M3I2WEV1T0s2SmtublVTV1JPNGFXT3F0cXMyWDlJQ2rSAbsBQVVfeXFMTkNOcTR3VEp2VjQydTd5WUc4RE1GLThKRXVFQmtibzJITHJxU2lHMXlCWVZ4eHZyNWJ1ZzZZQVNUeThPemh3UzZRX3huQms1bDZJMFFKY2tNR0pIYkRIaEpPNThRMERCdE80TkplVHp4aUxyN0RENlRaM1BIcnBEamdpbzUxczBOekZKcVFZT2ZsTXVKdGt4OVgwZi1kdlFfdmNMZ3RDNmw2SGYtdlBYNVVHdWpueGZxWTRHUQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,corporate_actions,7,False,True,0.0,0.0,neutral,1.0
2022-07-05,2022-07-05 07:00:00,Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's biologics arm gets EU GMP certificate for new facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxNR2Jqdm9tem52Mks1ckFrUlpWMnJiUXlYRDV4ak5NZFZ2elVOWXcyUFJ6RG1RT0ZPZXZHTUpqZVkweHpoMUpYOW1OOGxlenh2dzBvYU13dnZqek02aV9jUFB1VFRhT3NWZTB5WnlwU29ZbTZrUmliZ1JBSmNNdWtRZm9qb1ByNUNKZXZRY08zMFNCeG8tRzVlMzk5QmxHa2J1ekdCNDhneVdqTFptNlFCQkVYMGN1cDVJSlp4bEhpTXU5RHNFTU1NT0pLRVY5S1FG0gHWAUFVX3lxTE9uZng4UlpDT1lTNWFkT0hncF80UVNPVDgyaXBWRVVGTzhXTHc4aE1BZXNXSC1yMlhqa3NiNVVIUG84dDAxdFJxdzZFdW1LTlh1RVk4M0Q4Rk1PZWFEdDdCeGNyd0NOc0syWl9fUnNPZlEwVE0yZzF0QndwVnVtTkNxVFZQV0FXQjgwcTRuZzUzVkZzdjNybU9uZjdWQl93MEFjT25YZzY2emZvNGpselRXalFaUnRrRTQ1QVpCQlhLTDRLbEVkWTExVG8ybnlpY1VpT2p0ZHc?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,business_expansion,6,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2022-07-06,2022-07-06 07:00:00,Biocon Biologics new facility receives EU certification - Medical Buyer,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxNQ0hyNzJGU2lPVG00QUhZSXE3cDFNWk1JM0xzVVo3UUVYNmlVTGFNWGc1U3lFRzd4N2c0TE9LeHZaSFFFSEdMd0ViNDhCcnQ4MnFLTXdCSm55dWY3NnJUQllVb282clV0V0hfMHdja2g4enBMVWtyMW05VmJLc3lVLWFyLTl6VFFSa1pr?oc=5"" target=""_blank"">Biocon Biologics new facility receives EU certification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Buyer</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxNQ0hyNzJGU2lPVG00QUhZSXE3cDFNWk1JM0xzVVo3UUVYNmlVTGFNWGc1U3lFRzd4N2c0TE9LeHZaSFFFSEdMd0ViNDhCcnQ4MnFLTXdCSm55dWY3NnJUQllVb282clV0V0hfMHdja2g4enBMVWtyMW05VmJLc3lVLWFyLTl6VFFSa1pr?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,business_expansion,6,False,True,0.03409090909090909,0.03409090909090909,neutral,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi9AFBVV95cUxPV29uNmlhWDhxVGVncnIwY0tIWWNQVnp5VFdDelQyVWpLSEVDbTAwcldUcXFicUxGaDUwcF9TdzZmeE5XcU1tTUI5c1RnY0VjUmhEVVBBdmtPTy1WUkV5cVh5THBlQnZXSmdzZFNmYjVTSFBUMy1yZEF0V3l0akRQQW90QnlqUlU1cFpHUVhxOW1kbEJ6MnpOWkhKTUVfam9JM1JRc01mUXBCeDZOeVUtU1k3dzlYYnVvaXFqNHlHSkdCbTBhZ2Y5ZHJJUGx1TFlCYVpJUThGMF9BVHlqVGpPdFVHRlhlenBzZ0JfaVhtQ3htU0hp?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9AFBVV95cUxPV29uNmlhWDhxVGVncnIwY0tIWWNQVnp5VFdDelQyVWpLSEVDbTAwcldUcXFicUxGaDUwcF9TdzZmeE5XcU1tTUI5c1RnY0VjUmhEVVBBdmtPTy1WUkV5cVh5THBlQnZXSmdzZFNmYjVTSFBUMy1yZEF0V3l0akRQQW90QnlqUlU1cFpHUVhxOW1kbEJ6MnpOWkhKTUVfam9JM1JRc01mUXBCeDZOeVUtU1k3dzlYYnVvaXFqNHlHSkdCbTBhZ2Y5ZHJJUGx1TFlCYVpJUThGMF9BVHlqVGpPdFVHRlhlenBzZ0JfaVhtQ3htU0hp?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,business_expansion,6,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi9AFBVV95cUxPV29uNmlhWDhxVGVncnIwY0tIWWNQVnp5VFdDelQyVWpLSEVDbTAwcldUcXFicUxGaDUwcF9TdzZmeE5XcU1tTUI5c1RnY0VjUmhEVVBBdmtPTy1WUkV5cVh5THBlQnZXSmdzZFNmYjVTSFBUMy1yZEF0V3l0akRQQW90QnlqUlU1cFpHUVhxOW1kbEJ6MnpOWkhKTUVfam9JM1JRc01mUXBCeDZOeVUtU1k3dzlYYnVvaXFqNHlHSkdCbTBhZ2Y5ZHJJUGx1TFlCYVpJUThGMF9BVHlqVGpPdFVHRlhlenBzZ0JfaVhtQ3htU0hp?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi9AFBVV95cUxPV29uNmlhWDhxVGVncnIwY0tIWWNQVnp5VFdDelQyVWpLSEVDbTAwcldUcXFicUxGaDUwcF9TdzZmeE5XcU1tTUI5c1RnY0VjUmhEVVBBdmtPTy1WUkV5cVh5THBlQnZXSmdzZFNmYjVTSFBUMy1yZEF0V3l0akRQQW90QnlqUlU1cFpHUVhxOW1kbEJ6MnpOWkhKTUVfam9JM1JRc01mUXBCeDZOeVUtU1k3dzlYYnVvaXFqNHlHSkdCbTBhZ2Y5ZHJJUGx1TFlCYVpJUThGMF9BVHlqVGpPdFVHRlhlenBzZ0JfaVhtQ3htU0hp?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,business_expansion,6,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2023-09-29,2023-09-29 07:00:00,"Stock recommendations by share market analysts for September 29, 2023: Polycab India, DMart, Biocon & Just Dial - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock recommendations by share market analysts for September 29, 2023: Polycab India, DMart, Biocon & Just Dial</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2024-05-27,2024-05-27 07:00:00,Jefferies to Nuvama: These brokerage have raised NTPC target price post Q4 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Jefferies to Nuvama: These brokerage have raised NTPC target price post Q4</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,0.0,0.0,neutral,1.0
2024-05-30,2024-05-30 07:00:00,"Stock recommendations by analyst for May 30: HUDCO, Biocon and Action Construction Equipment - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock recommendations by analyst for May 30: HUDCO, Biocon and Action Construction Equipment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.03333333333333333,0.03333333333333333,neutral,1.0
2024-11-27,2024-11-27 08:00:00,"Stocks To Buy Today, Brokerages Recommendation: Coal India, Hyundai Motor India, Prestige Estates and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: Coal India, Hyundai Motor India, Prestige Estates and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,0.125,0.125,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTU5BMXV3bkxwcnRubjd2RU5yZk1TNVBJTW9LcUM5YTJGN240NWUxNnB5QVNJR2ZHV2FzMzNvVktMQk05VTFaaDdQNXNhN21EdkhvZGlVOXRuWjJHNnNjem9oa3M0YTFoS3NOLUFacDRvc050RS1RQnU0ODFMREUyUjFKbWRjRHdKVWFjRE9PMVprZjFCUHRvSWNvWGNyaktwak9ITWtTYmc1MUZxRnI5TG1GOGNXNVZRa1ZrZThyanRoQkc4V0lIdlc1ZzJEMzdoV3JVbUN2cG5XMTFFRTd0ZnRB0gHnAUFVX3lxTE9vVklhdHY3dENHbGlNaFh5enZoZHF0OGZENjBsb2Nxbml0UFRCeGpYVXpFeFVQYW5vOU8tTEMwUXJSQldXN0ZmdWxpcmFpeWxUVm5aVXhHcE5wQU1YVzVpS2I4QTJZYW4tNVFkenVWal9yVTlhbFgtYXN5U1c4UUlWbmcwRF91Y00xYzlqaTZRWGdRYTBhQU1KOHRCX3RHdGhwNkhJazczYlotVzJBUjNnWW1WaGdBMGpRZjlxMnNCT1JZbWZCUnJ4andpbno2SkNsTWZZZ2R1OXhuYjdjSnRnSXZVU2xrNA?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.0625,0.0625,neutral,1.0
2025-01-07,2025-01-07 08:00:00,"Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTU5BMXV3bkxwcnRubjd2RU5yZk1TNVBJTW9LcUM5YTJGN240NWUxNnB5QVNJR2ZHV2FzMzNvVktMQk05VTFaaDdQNXNhN21EdkhvZGlVOXRuWjJHNnNjem9oa3M0YTFoS3NOLUFacDRvc050RS1RQnU0ODFMREUyUjFKbWRjRHdKVWFjRE9PMVprZjFCUHRvSWNvWGNyaktwak9ITWtTYmc1MUZxRnI5TG1GOGNXNVZRa1ZrZThyanRoQkc4V0lIdlc1ZzJEMzdoV3JVbUN2cG5XMTFFRTd0ZnRB0gHnAUFVX3lxTE9vVklhdHY3dENHbGlNaFh5enZoZHF0OGZENjBsb2Nxbml0UFRCeGpYVXpFeFVQYW5vOU8tTEMwUXJSQldXN0ZmdWxpcmFpeWxUVm5aVXhHcE5wQU1YVzVpS2I4QTJZYW4tNVFkenVWal9yVTlhbFgtYXN5U1c4UUlWbmcwRF91Y00xYzlqaTZRWGdRYTBhQU1KOHRCX3RHdGhwNkhJazczYlotVzJBUjNnWW1WaGdBMGpRZjlxMnNCT1JZbWZCUnJ4andpbno2SkNsTWZZZ2R1OXhuYjdjSnRnSXZVU2xrNA?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.0625,0.0625,neutral,1.0
2025-01-07,2025-01-07 08:00:00,"Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: IGL, Zomato, Biocon, Hyundai Motor, Blue Star and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.0625,0.0625,neutral,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.31534999999999996,0.31534999999999996,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.31534999999999996,0.31534999999999996,positive,1.0
2025-01-14,2025-01-14 08:00:00,Pharma stock jumps 6% after upgrade in target price; Further upside of over 10% expected - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQb2xVeGdNOWtleFhwMTJkWHJQWlFadURkZG5OelM2aXNqTDlYaklwTUQ4N0hrbi1mWE4tSnJiQ1FCdzNWN0lsQ3lteHFfQ1dXNjU3THdGLWFHN0R2Qm9DYjl5akN6OTJZdkE5U3FRb3FZNkd2aXBfN1hDZkJ2SEhQVGJNeHY5enNVLWdfSHZBWmIzRmhUZDIwN0FiMDFmNnpTaE1oQVFGcXBzV0JlQXc?oc=5"" target=""_blank"">Pharma stock jumps 6% after upgrade in target price; Further upside of over 10% expected</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxQb2xVeGdNOWtleFhwMTJkWHJQWlFadURkZG5OelM2aXNqTDlYaklwTUQ4N0hrbi1mWE4tSnJiQ1FCdzNWN0lsQ3lteHFfQ1dXNjU3THdGLWFHN0R2Qm9DYjl5akN6OTJZdkE5U3FRb3FZNkd2aXBfN1hDZkJ2SEhQVGJNeHY5enNVLWdfSHZBWmIzRmhUZDIwN0FiMDFmNnpTaE1oQVFGcXBzV0JlQXc?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,-0.0125,-0.0125,neutral,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRHlBV0EtaGFUdWpmM25iS0NoY001UTRGVTNtNlNyelROWkppOU9YWW9zbTd1T052aFhKazNFS05naWNheGJlaV9yVDJTUU9SUzRkQy0zOHdkTkhFYmtFVG1aLU1WWnZuVlkyR21EOXM1SXlEajE4eTU4TFlTYjY3UmNYYXpvNmJ6Z1ZtMXFYVDRrYjFVYzVabEJjdm1JNmlCdHR6WVR4aW9KWS10SnN3bGZYMlhsWk5wbkstS0Z4aEtBSnQzdHF6R0FSVlpxLVN5Tm8wWTc1QUJaVFpvTFh2a0JBaULSAeoBQVVfeXFMT1JQOEdISlFLOG1ndWthc1cyZ2lsVWlGNXVmYVhER195aUdWQUdnejFIOUVGQ3p1cW5DZHlLLWhHOU92WkVuSk9sS1EyQzd0MW96dFNvckRNQmlma1c4bDE3LWQ4SE9leHZKTU5MVTgyOVVzVi1DaW9HRU5CUkxfaWhuekJLc1JRdWVtVUdzVVd3TUxob1FEVllqOFk1cFlzd3Q3cHUwX3pCcHhLeFNJVHR2Y19NOFFDME5aR1poTWJVVmdtWkgwa0t4azN1ZFRFVXNTWEYwbUNNOG5kbW5PVURQbUJxZnlRdXN3?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.31534999999999996,0.31534999999999996,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNU45QUtKNFU5UWRBRjlxcDdwTkxhRUducGdWLU11UW9IQVBTRGg2czVkbTNQdnh3cVk1cURwWUNjeDRPYm51QVZETnNTUFZkc09zWkNLcVNneWg5MzdISmF2bF9ERzFDb0kzR1o0LTlwRlRwMDJQcmJFbmM1blc2Zk10VXRfZnozQm1wbEdPNm1mMXRZN211WEpzNU1lYnVZckJkX3g1dnlpczZ0TXFBVjI4WmRhRmZLdGF5aGVBSDFESnpsMW04ak5mZ1g3OEc3NnI4enhjUkdKc1lVZmlmU2s5RdIB6AFBVV95cUxQVjNlWXdmdkRiWjgzOVF0TjhtTTZpemxnVGJVOVYxdU5yeUE0VWx1UGFQLXViakVwZm44UlNKbE9QSDJIT1dYbzdQVUgyZk5Yb1djeVJGeWlUWHB4SzdJdG96UXNjaXU2OTI4YWN2UGN4aUUyT1ZvVFpFVFpxTXdMRUhIYjFfZEQ5SmZjOVhlMHQzNGZLSkUzYUtybFhhaElUU25CZE1XcXRLX1FrcHlnTTREbm5mcW1oeG5OZVpfNzhNa2o1Wkw3ZnlWRjB2YktKR2VZelBlUzFLWnJ2M1VfeF83RkZxV0l1?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,Pharma stock jumps 6% after upgrade in target price; Further upside of over 10% expected - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQb2xVeGdNOWtleFhwMTJkWHJQWlFadURkZG5OelM2aXNqTDlYaklwTUQ4N0hrbi1mWE4tSnJiQ1FCdzNWN0lsQ3lteHFfQ1dXNjU3THdGLWFHN0R2Qm9DYjl5akN6OTJZdkE5U3FRb3FZNkd2aXBfN1hDZkJ2SEhQVGJNeHY5enNVLWdfSHZBWmIzRmhUZDIwN0FiMDFmNnpTaE1oQVFGcXBzV0JlQXc?oc=5"" target=""_blank"">Pharma stock jumps 6% after upgrade in target price; Further upside of over 10% expected</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxQb2xVeGdNOWtleFhwMTJkWHJQWlFadURkZG5OelM2aXNqTDlYaklwTUQ4N0hrbi1mWE4tSnJiQ1FCdzNWN0lsQ3lteHFfQ1dXNjU3THdGLWFHN0R2Qm9DYjl5akN6OTJZdkE5U3FRb3FZNkd2aXBfN1hDZkJ2SEhQVGJNeHY5enNVLWdfSHZBWmIzRmhUZDIwN0FiMDFmNnpTaE1oQVFGcXBzV0JlQXc?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,-0.0125,-0.0125,neutral,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 7% after HSBC upgraded stock to ‘buy’, raised target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxPNU45QUtKNFU5UWRBRjlxcDdwTkxhRUducGdWLU11UW9IQVBTRGg2czVkbTNQdnh3cVk1cURwWUNjeDRPYm51QVZETnNTUFZkc09zWkNLcVNneWg5MzdISmF2bF9ERzFDb0kzR1o0LTlwRlRwMDJQcmJFbmM1blc2Zk10VXRfZnozQm1wbEdPNm1mMXRZN211WEpzNU1lYnVZckJkX3g1dnlpczZ0TXFBVjI4WmRhRmZLdGF5aGVBSDFESnpsMW04ak5mZ1g3OEc3NnI4enhjUkdKc1lVZmlmU2s5RdIB6AFBVV95cUxQVjNlWXdmdkRiWjgzOVF0TjhtTTZpemxnVGJVOVYxdU5yeUE0VWx1UGFQLXViakVwZm44UlNKbE9QSDJIT1dYbzdQVUgyZk5Yb1djeVJGeWlUWHB4SzdJdG96UXNjaXU2OTI4YWN2UGN4aUUyT1ZvVFpFVFpxTXdMRUhIYjFfZEQ5SmZjOVhlMHQzNGZLSkUzYUtybFhhaElUU25CZE1XcXRLX1FrcHlnTTREbm5mcW1oeG5OZVpfNzhNa2o1Wkw3ZnlWRjB2YktKR2VZelBlUzFLWnJ2M1VfeF83RkZxV0l1?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares near Sept 2024 high as HSBC upgrades stock to buy; here's target price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.31534999999999996,0.31534999999999996,positive,1.0
2025-01-15,2025-01-15 08:00:00,"Stocks To Buy Today, Brokerages Recommendation: BSE, SBI Life Insurance, UltraTech Cement, Ambuja Cements and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: BSE, SBI Life Insurance, UltraTech Cement, Ambuja Cements and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi8wFBVV95cUxPWl80bzAweVZjZm5GNUFzaUZXVXhkZURQXy14aWtRVXZwd0RFZF9KN2RCNFJEUXdLeGhzRVFiSlRhYUYyVTlha3hSR0FsdVgyUWxMeTRaUmQ5RnNscXZZUHpwMUY5QjRHS1Z3SlVnamRYNG9iVW9jYVhOVjRiM0IycGtvYzlXbHY2b3hjM3lXNmpTa01YSkJVeU9NRFg0T0gzV05EM0NlNC12TTNFUVExV2VDczIySW9UWlJrVkRFMUxNV3BVdjNhbEVNRnZOdnFiMndmRGpmTTk5cFdGZ3FDSTVaOE96WEpxOWlxSlBZT2tMZmfSAfgBQVVfeXFMTVBmTUdONmFzUFZxNGZ1d0JRYkhjQnp0dmhGOUw2aEROWjlRVV9iZG9SNFdpdVBqbFZnTWk5eXA0WGJ4SUJ0UXFCQ0J6cTZJa2ZSZnFCem1WNjAtY1BvcWFnQjg5OEpzMm0zOGctUWtRMnZVODVjVEtZejJqUkhuQ3g1N2RPUVdvekhLQ25id29WX1hqeVhPOVVReGY5bjc2dWNXemJrelctLWxrT2Q4Q1JENEZ3YUJ2cmNmQzlCcjhvNHlrcXNvTGp3TEdDcEpxQlNUbXJKdXlETlV6QjdJbDRHYWFMcUZuUFNqRnF4TXNOdVVQc0lPUEg?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,0.125,0.125,positive,1.0
2025-01-16,2025-01-16 08:00:00,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.04,0.04,neutral,1.0
2025-01-16,2025-01-16 08:00:00,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.04,0.04,neutral,1.0
2025-01-16,2025-01-16 08:00:00,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.04,0.04,neutral,1.0
2025-01-16,2025-01-16 08:00:00,"Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Motilal Oswal Financial Services upgrades Biocon to Buy, target price Rs 430</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.04,0.04,neutral,1.0
2025-04-30,2025-04-30 07:00:00,"Stocks To Buy Today, Brokerages Recommendation: Patel Engineering, Engineers India, Biocon, Ambuja Cements, Trent and more - ET Now","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks To Buy Today, Brokerages Recommendation: Patel Engineering, Engineers India, Biocon, Ambuja Cements, Trent and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxPbGc2LXhrMnJBeEd5ZUdDMXJYTmxsdDMwWFBCMndxMGEwUHlEMUZzWHV2ZDZnRVktblBEUXlXR3lZX3Y3TmsyOHVpdlVfS2pBNGFUSC1EdVZXQ3VBd1I3NVhBelJrM1p2S1lndU5velJVaUFyZHphaWRjTmEtbi1US0Vrc2JZZlhlNVR6T1I3Rll5UWRKUzZ0T2p6Y0RMTTAxc21TVThyU2ptUkZWczBTa1REOElZbndNWldEbFpHSVR5ZkxISm9kRFJSS0QwX2RncEVTcEtFQkphcjJmZjVzNUMzT1ZMbVlXTmNTSzI2bDJIeFJzR25WQ1E1d2fSAYICQVVfeXFMTjVVdTg4TGhqY0VUMXRLS05pY2NzMFVSWUVTSHFkd1JMV2JkalhhOWc3S25fVDF3OG5GeTJmRkN3Z3AzOE9ObmJuYmdfaTlabWVLblUwSExEZnBLcTdiRWNRaVE2QXRGdXV5VnZXOWpZeUVLRUR0X0k5VzdxQkwwdkExczhPaVV5QkpOckUtalByVjAxaGh0RVk4VjFJOV9xV3RXNy1lVHg3VHZDSzJUSnc3TE8xNWdLeTA5Vll2X0U3YUY0VURZRkRCVHMxRXRQaTJKNVAxM0cyZDUxbWFWQmNxZl9seDExMlZ0ZnZmNUZiV2JwcmZHVWpTTUNOT0kxYkF3?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.125,0.125,positive,1.0
2025-05-07,2025-05-07 07:00:00,"Buy Biocon, target price Rs 351: Axis Securities - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy Biocon, target price Rs 351: Axis Securities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.21466666666666667,0.21466666666666667,positive,1.0
2025-05-07,2025-05-07 07:00:00,"Buy Biocon, target price Rs 351: Axis Securities - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy Biocon, target price Rs 351: Axis Securities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOZGlBNlAweWlmSE9lZHhZZkc1NjJrMk9jYzJiNDIwZkgzSHpfUEpXajY2QkxmS3pZeU5STU1WRnl4RG5ncXZRQmhJNDVraXh4VVAyMll4bDdYUTJxeUNqTEo1T1FqQWoxRUE2eHFVV1dvTEs1bjA0OFNLRk81WHR4dEFZRTQwTGs0N3dIa3J6dEN6cDFtRUpmdFhieFp3TTRYRm44N1k1Und2QmxZd2hfYzN1MGRDNnp3aXZxTVRR0gHDAUFVX3lxTE5aT2xUaV9LUHZjZ21SU3ZwLWtLQXAwNm9rX3NBQ0pvWFNEUU9UR29GTDhzTmpfeVBEN3pkODgzWE5FUWIxMWJoNFdkRlZ1cXNWNEJhdmF1VzF0UG52bk85aFdReG5KTjktWWdmNVdEbkFZYWVEbmNWaG8wR2dhV0JGcExCd2pFbEE1NFJsTHkzeFlsbllXV2NPd0wwUTFMdVpLUWE4bFpmeG91ZWQzZTVjR0kyN0RrYnRfZXRNd2NYVDFDVQ?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.21466666666666667,0.21466666666666667,positive,1.0
2025-05-07,2025-05-07 07:00:00,"Buy Biocon, target price Rs 351: Axis Securities - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy Biocon, target price Rs 351: Axis Securities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.21466666666666667,0.21466666666666667,positive,1.0
2025-05-07,2025-05-07 07:00:00,"Buy Biocon, target price Rs 351: Axis Securities - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy Biocon, target price Rs 351: Axis Securities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.21466666666666667,0.21466666666666667,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Top stocks to buy today: Stock recommendations for May 13, 2025 - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to buy today: Stock recommendations for May 13, 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxOekhubzhrRkhCLVFybEpjQjF0Tk14M1MtVGxaNE9aSFpYQ211T3IzOUhyd0FLellyQ09RSlViUmdxamF4eVkxcDljWFM2Z1V1MjBpN0twYmdiSzRFdzI0bDk5WkVrZ2dlLWkyRHNSSGk2eDM5UTRXVHFOOHVrQUlhZFc0SDV3SzRnNEVlemtWQjVtTjYxbC01amVLdXBRVWIzVGdpaWRPd3o2aGZkU1lNTWFVcnFiZ3doa29ETTlzRkFuZDE0akRBSWhfQ184M0JfQWp6bXpLTDFhUGJUbTZ5UdIB5gFBVV95cUxOODBtbDB3RnBvUTZsTkhoTlZtQXpKU2g3MWd4aTNCYU0tNGNnS2d1WWc3VTVnS051eFA1WWtuS1N6RTdsTDhmd1ExTVFyRzlKRnBQNzB4RHlHcjh4UGlIaFRneGN6OWlCWFROMHpOcG5LdWp1ZlpTYzZQaTkwckpVTjhxcUhTR1FxaUg4c0dLeTBuMTdpYkxvb2ZkeFpJWGowbjBoVFlnTUZYQzNnS1F0UFRsV0h0X09sdXZSdHVqRVBSTTgyVVFRakdhR1hiS2NYck9MNVhkR2FCT0k0VldXWTNnc25jdw?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,0.22615000000000002,0.22615000000000002,positive,1.0
2025-05-13,2025-05-13 07:00:00,"Top stocks to buy today: Stock recommendations for May 13, 2025 - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to buy today: Stock recommendations for May 13, 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,False,0.22615000000000002,0.22615000000000002,positive,1.0
2025-05-14,2025-05-14 03:41:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-14,2025-05-14 03:41:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-14,2025-05-14 03:41:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-14,2025-05-14 07:00:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-14,2025-05-14 07:00:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-14,2025-05-14 07:00:00,"I-Sec maintains Sell on Biocon, revises target price to Rs 270 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">I-Sec maintains Sell on Biocon, revises target price to Rs 270</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,market_rumors,5,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News - Comprehensive Company News,Biocon earnings,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News - Comprehensive Company News,Biocon profit,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News - Comprehensive Company News,Biocon investor call,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News - Comprehensive Company News,Biocon expansion,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-04-02,2015-04-02 07:00:00,Biocon's Syngene to build a plant in India - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5"" target=""_blank"">Biocon's Syngene to build a plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPSU84Z1BWUVRPLXBMcy1mZHVxbmFjQVNjaHNGemhSUWlWdFgwWTczekk1QmVGeUFmZ3BhQWU5NlpOQ2g3bm1PREFMU2RVbkc1VUlQRE00WEhXWkRGUmk4cGpuczVRSWVfcGtycnpSZzNmdEszeDBqb2EwVUVXU01TUHpENWJ1cmJLZlE?oc=5,Google News - Comprehensive Company News,Biocon new facility,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-09-28,2015-09-28 07:00:00,No easy way out for Biocon | Company Business News - Mint,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPTTVjcjg5dFdJU3ctcV9nNFRoQXUzQUdEeXBPRkcyWkpmRjh6ZEJlck5mSWx3WjJocTBQZ3pXRG03ZUFPNmpSS2VUNE5KSGFsRjJoXzYzSjhXNDhJSGFzcERleF8zTFNDV043MDNfNjYyTjBaNUVEMTZsYy1BVTExTGt6SnBkUFpld2hSdFNTTEZBd9IBnwFBVV95cUxPdjBkYm45cW1nb1hUWjEtdkdad3poQk9keFdTU2RQbGcwd2drbmhVbktDV3NqT0ZPemJ3aWxXYnlzMlRQb1ZmY3dBYUN1Z0hSMk9uUzhSaEJmQjR1TzBMa0xDS2pSd0JhdVZsV29YZ3MzeGxCeXlaLWFiT0dUNE5CMWtDX1loMGl4U3FQMUl1TGRhS25ZZHN6NEljVm1IN3M?oc=5"" target=""_blank"">No easy way out for Biocon | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPTTVjcjg5dFdJU3ctcV9nNFRoQXUzQUdEeXBPRkcyWkpmRjh6ZEJlck5mSWx3WjJocTBQZ3pXRG03ZUFPNmpSS2VUNE5KSGFsRjJoXzYzSjhXNDhJSGFzcERleF8zTFNDV043MDNfNjYyTjBaNUVEMTZsYy1BVTExTGt6SnBkUFpld2hSdFNTTEZBd9IBnwFBVV95cUxPdjBkYm45cW1nb1hUWjEtdkdad3poQk9keFdTU2RQbGcwd2drbmhVbktDV3NqT0ZPemJ3aWxXYnlzMlRQb1ZmY3dBYUN1Z0hSMk9uUzhSaEJmQjR1TzBMa0xDS2pSd0JhdVZsV29YZ3MzeGxCeXlaLWFiT0dUNE5CMWtDX1loMGl4U3FQMUl1TGRhS25ZZHN6NEljVm1IN3M?oc=5,Google News - Comprehensive Company News,Biocon management change,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.3148111111111111,0.3148111111111111,positive,1.0
2015-12-09,2015-12-09 08:00:00,NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxNa1FBaV9uRlBlZkpIUnpPTm1mUzUySHNTYk44MjZZUUpzU0RnZE5rUXd0NTNabXJKbGhtRU9ZQy1XWTRidVFKVVhGeS1EU09ueFJaakd0X25WRlJpZDlfNjAwSXM4ZURaTi0zX0dkUW91Sno4djJPMU5nY19UaXdMQWEtdzJpR0lSQVJTZklHbzRWVEU1MldqM05adHFQcFlWSFd0bm5HZG9hNTBqMC1CRWdXVFlTMHd2UWpjT0tEVlJJS2s0emNJV0ZRRHBWdEk?oc=5"" target=""_blank"">NeoBiocon Partners With Novartis to Offer Vildagliptin for Diabetics in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxNa1FBaV9uRlBlZkpIUnpPTm1mUzUySHNTYk44MjZZUUpzU0RnZE5rUXd0NTNabXJKbGhtRU9ZQy1XWTRidVFKVVhGeS1EU09ueFJaakd0X25WRlJpZDlfNjAwSXM4ZURaTi0zX0dkUW91Sno4djJPMU5nY19UaXdMQWEtdzJpR0lSQVJTZklHbzRWVEU1MldqM05adHFQcFlWSFd0bm5HZG9hNTBqMC1CRWdXVFlTMHd2UWpjT0tEVlJJS2s0emNJV0ZRRHBWdEk?oc=5,Google News - Comprehensive Company News,Biocon partnership,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-12-09,2015-12-09 08:00:00,NeoBiocon partners Novartis to launch diabetes drugs in UAE - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">NeoBiocon partners Novartis to launch diabetes drugs in UAE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon collaboration,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2015-12-28,2015-12-28 08:00:00,Biocon launches hepatitis-C drug in India | Company Business News - Mint,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQZUJtU09ubUk0WXdfY1dybWs1aWd4Z0pyTkFFejZjRkJ2ckl5N3NBc01KTTJTNjJSTUI3QjNMNV9DaXRRMHF0WE9QSk5rSlo5Z0VmbFVvTzRfbjI4d2wyZ1FSZDRKZ0hOZzloYnM5MVdNU25WbEJEc3hpQngwWHV0YW5VdFFGUnRtVkxuTURPZkJiM3R0eEZxekttWjZwRlg2Xzg5djVB0gGzAUFVX3lxTE14bXdndTVvVmJRMVhaTWVkRGt3OEQyR2RYel9OdDcta2Voa0tteGEwenhscEdHdDBvMjgxSEIyS2R3ckd0ZnNHemtNazktZHhUZ0cwMlE1T0diWVlkUkF6REU5WE90TDZqT1JuR3J6SWdSMVhRR2U0alpuNlAzTVRaM0Z3RDl2d3I5VnZJaDVVUjhqc3UxVnFZMjVTRGhnamgzZG43SExUUXFBMHNDNkNZa2hF?oc=5"" target=""_blank"">Biocon launches hepatitis-C drug in India | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQZUJtU09ubUk0WXdfY1dybWs1aWd4Z0pyTkFFejZjRkJ2ckl5N3NBc01KTTJTNjJSTUI3QjNMNV9DaXRRMHF0WE9QSk5rSlo5Z0VmbFVvTzRfbjI4d2wyZ1FSZDRKZ0hOZzloYnM5MVdNU25WbEJEc3hpQngwWHV0YW5VdFFGUnRtVkxuTURPZkJiM3R0eEZxekttWjZwRlg2Xzg5djVB0gGzAUFVX3lxTE14bXdndTVvVmJRMVhaTWVkRGt3OEQyR2RYel9OdDcta2Voa0tteGEwenhscEdHdDBvMjgxSEIyS2R3ckd0ZnNHemtNazktZHhUZ0cwMlE1T0diWVlkUkF6REU5WE90TDZqT1JuR3J6SWdSMVhRR2U0alpuNlAzTVRaM0Z3RDl2d3I5VnZJaDVVUjhqc3UxVnFZMjVTRGhnamgzZG43SExUUXFBMHNDNkNZa2hF?oc=5,Google News - Comprehensive Company News,Biocon licensing deal,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2016-01-27,2016-01-27 08:00:00,Biocon to conduct oral insulin trials on its own - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to conduct oral insulin trials on its own</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon clinical trial,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.09999999999999999,0.09999999999999999,neutral,1.0
2016-05-17,2016-05-17 07:00:00,Bristol-Myers Squibb pulls out of Biocon oral insulin pact - Fierce Biotech,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxOaldFczVRTnFEQ1pvb18teE8zX3Fib3NmS1g2U0p2eHg5c0JRNjR5Mm00ZHpOVnlNTDRTUVVqRXBkQUF1UE1zSUJzSGo4Q2xJZ1F2R0JLelZNSW92b2h0MlFfZklLYnRveVBvQXozWXg5aHBSaWFsUDV4dl9ZRXczSnlOUlhZSjZUUXJQMGVoOTgxU3pOUEs2TQ?oc=5"" target=""_blank"">Bristol-Myers Squibb pulls out of Biocon oral insulin pact</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Biotech</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxOaldFczVRTnFEQ1pvb18teE8zX3Fib3NmS1g2U0p2eHg5c0JRNjR5Mm00ZHpOVnlNTDRTUVVqRXBkQUF1UE1zSUJzSGo4Q2xJZ1F2R0JLelZNSW92b2h0MlFfZklLYnRveVBvQXozWXg5aHBSaWFsUDV4dl9ZRXczSnlOUlhZSjZUUXJQMGVoOTgxU3pOUEs2TQ?oc=5,Google News - Comprehensive Company News,Biocon partnership,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2016-10-21,2016-10-21 07:00:00,Biocon's Malaysia insulin plant will be ready for commercial production in H2 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5"" target=""_blank"">Biocon's Malaysia insulin plant will be ready for commercial production in H2</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5,Google News - Comprehensive Company News,Biocon investor call,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.3462,0.3462,positive,1.0
2016-10-21,2016-10-21 07:00:00,Biocon's Malaysia insulin plant will be ready for commercial production in H2 - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5"" target=""_blank"">Biocon's Malaysia insulin plant will be ready for commercial production in H2</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNLUFfeE9nVVRoc01XRW10U041OUVBaUJGam1iSW9yZ1JTT19LdE43NFNsZ2lJUWNUeVFOOVFXcVRLSmtNanM2dVF4ZTJnOE83VTZHMWVJbmxsVGUzbWloSTYtR3FzRGhrVlNEM0g5c1pxOEs2alQ4cmdnZkcwc05vQlhfZExPMlFpQjMzLWR3QzY3cEJ4cG9kaDBHTHZnbzBjOWxZN2tOeFhkZEJCQldISy1XQ25aTl9Z?oc=5,Google News - Comprehensive Company News,Biocon new facility,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.3462,0.3462,positive,1.0
2016-10-21,2016-10-21 07:00:00,Malaysian facility to be commercialised in H2 FY17: Biocon - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Malaysian facility to be commercialised in H2 FY17: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon new facility,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2016-12-13,2016-12-13 08:00:00,Major fire ravages Biocon subsidiary complex in India - Pharmafile,"<a href=""https://news.google.com/rss/articles/CBMihgFBVV95cUxPeXBHLVJjM0JkVnF1R08wY21naFdVQ09rSkUyTTE1MFh4X2pHSG1TZFFDWGNDNzRwcmhZcWlIbWljeHVLSDJJcmtOQUZSb2RYU0FxWGR0d2FqUmt0cXBVbGxLdUhGMjYxSlhFQVdNa2M2MHNraUxSZlo5djgtZUtuN0RrODZIQQ?oc=5"" target=""_blank"">Major fire ravages Biocon subsidiary complex in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmafile</font>",https://news.google.com/rss/articles/CBMihgFBVV95cUxPeXBHLVJjM0JkVnF1R08wY21naFdVQ09rSkUyTTE1MFh4X2pHSG1TZFFDWGNDNzRwcmhZcWlIbWljeHVLSDJJcmtOQUZSb2RYU0FxWGR0d2FqUmt0cXBVbGxLdUhGMjYxSlhFQVdNa2M2MHNraUxSZlo5djgtZUtuN0RrODZIQQ?oc=5,Google News - Comprehensive Company News,Biocon investigation,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,-0.3601375,-0.3601375,negative,1.0
2016-12-13,2016-12-13 08:00:00,Fire breaks out at Biocon’s research arm Syngene - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Fire breaks out at Biocon’s research arm Syngene</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Comprehensive Company News,Biocon investigation,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,-0.17,-0.17,negative,1.0
2016-12-23,2016-12-23 08:00:00,How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force - Forbes India,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTTFtVHBOWHprS29Mc29VTlFEZHNwcmFiUFlzY0pSbGJTS3JxU2FOYTE4MDB0WlJHVGM5UXluWWFWNTk5RS1UTlBoeW5lTGRBR1RKSUtDU0dMTnk3M2dsbEFyTDRFbjlINDZic2k4VTRyN1lmRzhrR0xfUUVmdjNqYkdacjNmNXI1X3ZKR2ZTRldRWEQ2cW9iQUQ4ZG1seDNaVk9qRFNvRTNSSUg5WVlwdVFIMUY2MXd2amprTE1sSDZRMHlJWkNpVg?oc=5"" target=""_blank"">How Biocon's Brewmaster Kiran Mazumdar-Shaw Made It A Global Force</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Forbes India</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTTFtVHBOWHprS29Mc29VTlFEZHNwcmFiUFlzY0pSbGJTS3JxU2FOYTE4MDB0WlJHVGM5UXluWWFWNTk5RS1UTlBoeW5lTGRBR1RKSUtDU0dMTnk3M2dsbEFyTDRFbjlINDZic2k4VTRyN1lmRzhrR0xfUUVmdjNqYkdacjNmNXI1X3ZKR2ZTRldRWEQ2cW9iQUQ4ZG1seDNaVk9qRFNvRTNSSUg5WVlwdVFIMUY2MXd2amprTE1sSDZRMHlJWkNpVg?oc=5,Google News - Comprehensive Company News,Biocon joint venture,Comprehensive Company News,2015-01-01_to_2016-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-03-03,2017-03-03 08:00:00,"Delhi High Court gives Biocon, Mylan green light to market blockbuster biosimilar for three cancers - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Delhi High Court gives Biocon, Mylan green light to market blockbuster biosimilar for three cancers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.47802222222222224,0.47802222222222224,positive,1.0
2017-03-03,2017-03-03 08:00:00,Herbalife joins hands with Biocon’s Syngene to open R&D centre - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Herbalife joins hands with Biocon’s Syngene to open R&amp;D centre</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.02727272727272727,0.02727272727272727,neutral,1.0
2017-03-03,2017-03-03 08:00:00,Herbalife joins hands with Biocon’s Syngene to open R&D centre - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Herbalife joins hands with Biocon’s Syngene to open R&amp;D centre</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.02727272727272727,0.02727272727272727,neutral,1.0
2017-03-06,2017-03-06 08:00:00,New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5"" target=""_blank"">New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.03563636363636364,0.03563636363636364,neutral,1.0
2017-03-06,2017-03-06 08:00:00,New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5"" target=""_blank"">New Delhi High Court Allows Marketing of Biocon-Mylan Biosimilar of Trastuzumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxNUllPX0NfUnlKVU1LcXRRNjRmRGg0R1E5cFhvekxrVXBOTFcySjU4Mlg5MzRKa1ZoNHhKbVNQMU1GTTdMX2ZEQzlHb0I0cDFEbHhGa1FLano1Umd3N21jS3FOWDJpU0p2Vmc4NXVkNkx5N1NBVXc4Xy12Y2I2UkREMlVoY195SENKNE1GYzBfNFdlSVdQQTVacUZDZEE0ckpha2Jad0ZwMVhGZ1Q3cXZVYllmNWtyUTE2LUs1MFNB?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.03563636363636364,0.03563636363636364,neutral,1.0
2017-07-25,2017-07-25 07:00:00,Is Biocon undervalued? - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMidkFVX3lxTE5ic2Fra2pqZE9RUzlKWHJQY0ducHZPZXQydjBHa29GdFMwWUduaHRTRnhOd29QTnV3RXJkRU5BZGFRYkt4SjNKVWduSVFZay1lZ0FZN01GMl9yYW9nUXZxbmxlU2Z1ZUM0bmZ0TWxJaENDbzhCQmfSAYMBQVVfeXFMUDZubEZfbnVRSVhpNjBTOEJVV0lXa0tSMEdzSFFWb25aOF95bFZhekxtWlFBQThnYzZ2aWdOQTM1d1d6Nkw0cnYwM2E4QUVNMVNoV1BQT0JrU2FEU0NVVEE1bmxkelh1VGZwdFdxYTFDaG4zY3lMdUhsVlFVQnRiR0Fsdmc?oc=5"" target=""_blank"">Is Biocon undervalued?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.com/rss/articles/CBMidkFVX3lxTE5ic2Fra2pqZE9RUzlKWHJQY0ducHZPZXQydjBHa29GdFMwWUduaHRTRnhOd29QTnV3RXJkRU5BZGFRYkt4SjNKVWduSVFZay1lZ0FZN01GMl9yYW9nUXZxbmxlU2Z1ZUM0bmZ0TWxJaENDbzhCQmfSAYMBQVVfeXFMUDZubEZfbnVRSVhpNjBTOEJVV0lXa0tSMEdzSFFWb25aOF95bFZhekxtWlFBQThnYzZ2aWdOQTM1d1d6Nkw0cnYwM2E4QUVNMVNoV1BQT0JrU2FEU0NVVEE1bmxkelh1VGZwdFdxYTFDaG4zY3lMdUhsVlFVQnRiR0Fsdmc?oc=5,Google News - FDA Journey + Company News,Biocon investor call,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-08-27,2017-08-27 07:00:00,CID probing fake offer letters sent to Biocon job aspirants - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CID probing fake offer letters sent to Biocon job aspirants</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.4402772727272727,-0.4402772727272727,negative,1.0
2017-09-06,2017-09-06 07:00:00,"Biocon, JDRF to conduct global study on oral insulin - The Hindu","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUkxDY0c0RHpUQkZzNHdnZEdRbmgzN05lbk9EUU1WMzhRZDZLSGI5bVcxdWItMjJvcjJyWElCT1l0UmNUS3dtODEtU1JEZ29WYl9NeWRkSjJESlpRZFBFT21KTXNNNkNiU0N2OHp5YjBqbV96WTUzVTVHNzZQcGxualR2UC1Id2xJODB6aVlvcWl1RjhkUUhfdU5sY3lMQVQzcGlwZUdFa0nSAa8BQVVfeXFMT1d2Q0pnazc5aTFRUjZYaXdRRHRJRFM3TkVhSVowMjBldFhGRHlyN0RDcE1wblBleUNHVnZmTG16R0RuUkxtNUpib1poQkhaYmlzbWJzR3AzOXR5MU5CTl9BREJxSGZPb1dRWC1kR05MUE9seWxYT1N0UWpVcFpzTnZPZlItR2V4dTd3cEh3TlBkYVdCaVhQQ2M2NWFjaGJLTjRIbUlSZFotdWF2cExGZw?oc=5"" target=""_blank"">Biocon, JDRF to conduct global study on oral insulin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxNUkxDY0c0RHpUQkZzNHdnZEdRbmgzN05lbk9EUU1WMzhRZDZLSGI5bVcxdWItMjJvcjJyWElCT1l0UmNUS3dtODEtU1JEZ29WYl9NeWRkSjJESlpRZFBFT21KTXNNNkNiU0N2OHp5YjBqbV96WTUzVTVHNzZQcGxualR2UC1Id2xJODB6aVlvcWl1RjhkUUhfdU5sY3lMQVQzcGlwZUdFa0nSAa8BQVVfeXFMT1d2Q0pnazc5aTFRUjZYaXdRRHRJRFM3TkVhSVowMjBldFhGRHlyN0RDcE1wblBleUNHVnZmTG16R0RuUkxtNUpib1poQkhaYmlzbWJzR3AzOXR5MU5CTl9BREJxSGZPb1dRWC1kR05MUE9seWxYT1N0UWpVcFpzTnZPZlItR2V4dTd3cEh3TlBkYVdCaVhQQ2M2NWFjaGJLTjRIbUlSZFotdWF2cExGZw?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-09-08,2017-09-08 07:00:00,Biocon's Malaysian arm gets EU certification for insulin facility - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Malaysian arm gets EU certification for insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-09-08,2017-09-08 07:00:00,Biocon gains as insulin facility in Malaysia gets GMP nod - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains as insulin facility in Malaysia gets GMP nod</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2017-09-11,2017-09-11 07:00:00,Biocon insulin plant in Malaysia wins EU manufacturing approval - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5"" target=""_blank"">Biocon insulin plant in Malaysia wins EU manufacturing approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxONzk5OUh6M19yUmNVOWdDY2JfN3BCbVBqZXdxMVZjN3pmNWpJeWUzejZfU1JkaG5PWEc0M3ZBeF8yb0pZZ2NhME82QWowcThmLWgwZVc5dllDRG1EYnB3TDdjaFZRRTFSSWh6X2dWVjc5aVY5eGQtQXNIMzFuSDRlSi1leFVWTFAwalppWWtlNV9hazNQUmdCSXM5VmU5d3ZIZG5jNVp3?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.54425,0.54425,positive,1.0
2017-10-10,2017-10-10 07:00:00,Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxPMVhKV0x1TlZBWjZlcWU3akVjTnJaWWh4dVZjc05PUHRlXzBLcmFLUUFPNFZSRWlsMDcxUEZhVEhBTEktam1hSmhzbjdULXd0ODFhajM1VW5RaWxCc1VRdzZkNFVzZ3lqYmxFOE5mS1Fha0VWZURPUEl2NTlmNTFWYXJmMWpiZk0wbWdEVlI3LUpRbFk4YVBXLW84SQ?oc=5"" target=""_blank"">Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxPMVhKV0x1TlZBWjZlcWU3akVjTnJaWWh4dVZjc05PUHRlXzBLcmFLUUFPNFZSRWlsMDcxUEZhVEhBTEktam1hSmhzbjdULXd0ODFhajM1VW5RaWxCc1VRdzZkNFVzZ3lqYmxFOE5mS1Fha0VWZURPUEl2NTlmNTFWYXJmMWpiZk0wbWdEVlI3LUpRbFk4YVBXLW84SQ?oc=5,Google News - FDA Journey + Company News,Biocon FDA warning letter,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-11-20,2017-11-20 08:00:00,Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOT01qREZtMVUzTnVhSks1WnZnRzE0WmZtaVlBNFBnS1JLQVJCTHZ2MWZoU2RXaGpTNHQ5NmdCR1dyMXg2Nl9Lc1RNRUdNbzF5LWZWMjY3eXo0bThiTzBJb0djNW4wUHFEa0w3eWNKbUJUcjU3OC1jUjZPV1RGXzdSSTVuQjVHVTNiQl9QYmhJOGY1Y2pSWDZuMUdTMnR1VkpUc2hzSU1KS184N2tRZG9QQVJLT1pEaGtpR2phRjdObmZSYmE1dXZv?oc=5"" target=""_blank"">Biocon and Mylan say their plant is good to go as FDA decision nears for their Herceptin copy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxOT01qREZtMVUzTnVhSks1WnZnRzE0WmZtaVlBNFBnS1JLQVJCTHZ2MWZoU2RXaGpTNHQ5NmdCR1dyMXg2Nl9Lc1RNRUdNbzF5LWZWMjY3eXo0bThiTzBJb0djNW4wUHFEa0w3eWNKbUJUcjU3OC1jUjZPV1RGXzdSSTVuQjVHVTNiQl9QYmhJOGY1Y2pSWDZuMUdTMnR1VkpUc2hzSU1KS184N2tRZG9QQVJLT1pEaGtpR2phRjdObmZSYmE1dXZv?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.5834833333333334,0.5834833333333334,positive,1.0
2017-11-21,2017-11-21 08:00:00,Biocon receives EIR from US FDA - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2017-12-08,2017-12-08 08:00:00,Biocon gets shareholders' nod for transfer of biosimilars business - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets shareholders' nod for transfer of biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-01-18,2018-01-18 08:00:00,"Biocon, Sandoz to Partner on Next Wave of Biosimilars - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5"" target=""_blank"">Biocon, Sandoz to Partner on Next Wave of Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.0125,-0.0125,neutral,1.0
2018-01-18,2018-01-18 08:00:00,"Biocon, Sandoz to Partner on Next Wave of Biosimilars - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5"" target=""_blank"">Biocon, Sandoz to Partner on Next Wave of Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.0125,-0.0125,neutral,1.0
2018-01-18,2018-01-18 08:00:00,"Biocon, Sandoz to Partner on Next Wave of Biosimilars - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5"" target=""_blank"">Biocon, Sandoz to Partner on Next Wave of Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPd28tNEdQSjdHaGlNUnp3eGlGZkpGa0JXcElOTk1lNkI1NUEycGk5T0NmNVp1b09zTHNrclN0aE9PaXNFbzBsRVZwa2tPRUoyUHVTanlibGw5NGM2bzQzZ19VaHZLYUhoX1hQUHF4LTdxYTc4QlJPS016WFVzWW5TVGdCVkJlRGVtVEtRMnRvYzM0M1Q3bGF1OWl3?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.0125,-0.0125,neutral,1.0
2018-02-23,2018-02-23 08:00:00,"Biocon to expand presence in Hyderabad, Syngene to set up R&D lab - The Quint","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQbFhMLWhCV2VlRFM2bWNfNHUwZ2M1cHRsZ1ZHRWphaW5lcF8tRkZpOGFnS08wTzdlUTFaSk5zcnlfTEdpbVpySkYwbmtvQUdLdEZfUEJIaGxOcEpUNm1EZ0NDd04tYkZvR3dKZkduT3BZcFYxeUZMVFBMMFdsRll6YlNDWkxXeGctOGo4eTJyQXFvQ2NScjNzREdmMkd2czF5dFgwaHBR0gGzAUFVX3lxTFBmRVZGbHI0UUtjSjRPbG5ISnM5X09rbW9KcURVMlJ0cXg4VzNENVktaVJBdXhLZi1HNWZ2QmpCaDJTY1VCSnN5eDZhOGp1Wjg5WVRLSDhuLXNld29EbGwzWUx4QkZzVUJKQnNvSjZFT3NOeG1pYXBZRzIxVmRlOGdwNk1LclRTZUpGSjc4dTJ6RjdpTkM2U2phalcxSWtZaC02eDFzVmFfcFhmQWNqeGw3UE53?oc=5"" target=""_blank"">Biocon to expand presence in Hyderabad, Syngene to set up R&amp;D lab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Quint</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQbFhMLWhCV2VlRFM2bWNfNHUwZ2M1cHRsZ1ZHRWphaW5lcF8tRkZpOGFnS08wTzdlUTFaSk5zcnlfTEdpbVpySkYwbmtvQUdLdEZfUEJIaGxOcEpUNm1EZ0NDd04tYkZvR3dKZkduT3BZcFYxeUZMVFBMMFdsRll6YlNDWkxXeGctOGo4eTJyQXFvQ2NScjNzREdmMkd2czF5dFgwaHBR0gGzAUFVX3lxTFBmRVZGbHI0UUtjSjRPbG5ISnM5X09rbW9KcURVMlJ0cXg4VzNENVktaVJBdXhLZi1HNWZ2QmpCaDJTY1VCSnN5eDZhOGp1Wjg5WVRLSDhuLXNld29EbGwzWUx4QkZzVUJKQnNvSjZFT3NOeG1pYXBZRzIxVmRlOGdwNk1LclRTZUpGSjc4dTJ6RjdpTkM2U2phalcxSWtZaC02eDFzVmFfcFhmQWNqeGw3UE53?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2018-02-24,2018-02-24 08:00:00,"Biocon to expand presence in Hyderabad, to set up R&D lab - The News Minute","<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxPY19XUnVSWVNpY2tLMDhud3NiRkFJdE5hbDNFemFjclRzcWN1SVRyMWVzVkRHaUtCSTdwdGJGa0w0MHpTUkNaVmVzNWx2T09iSFBwd2hzMXdfa2FGdExBMDBmUC0xb01hR3ZldUNYY085YWZmdl9oZ2U0cEsyRm4wb0V5aDFxVUxDaTdvONIBmgFBVV95cUxOUG15LXdEaG5DWTVGTEFrQTU4ZTZiNEhfMXlJTHJ6R2JNaWthZzU0MkJpT3dIVmJ4bzJhRjVWQlU5WnZFcVZieG9ERnRCeFBUN0syakJ6SHNPSGxQU0psMVExRVg1OGJ1ZkxpbnhOTVpCYVctbGhDcTR4bEpObzlZN0cwWFY5bkZScFhOOHRBLUdBX3hPQW5qc0RB?oc=5"" target=""_blank"">Biocon to expand presence in Hyderabad, to set up R&amp;D lab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxPY19XUnVSWVNpY2tLMDhud3NiRkFJdE5hbDNFemFjclRzcWN1SVRyMWVzVkRHaUtCSTdwdGJGa0w0MHpTUkNaVmVzNWx2T09iSFBwd2hzMXdfa2FGdExBMDBmUC0xb01hR3ZldUNYY085YWZmdl9oZ2U0cEsyRm4wb0V5aDFxVUxDaTdvONIBmgFBVV95cUxOUG15LXdEaG5DWTVGTEFrQTU4ZTZiNEhfMXlJTHJ6R2JNaWthZzU0MkJpT3dIVmJ4bzJhRjVWQlU5WnZFcVZieG9ERnRCeFBUN0syakJ6SHNPSGxQU0psMVExRVg1OGJ1ZkxpbnhOTVpCYVctbGhDcTR4bEpObzlZN0cwWFY5bkZScFhOOHRBLUdBX3hPQW5qc0RB?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2018-02-24,2018-02-24 08:00:00,Biocon to set up R&D unit in Hyderabad - The Hans India,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZkNOeC1WZk1fY0R6N29OOFowSUpmNTYxVG9FbmhDaGNickU0ZFRqSXhwN0VBWHYxcUZGdC1yTFJ0c0lPNHZlUFN3TWJmbTc2Q09OSzY4eldMZUxUVUpnUU9wU0ZXNlBMVDkyclZac2Nsa0RXdC1keTBQWXdVTnpWSnRhR1pwS1pyYjVhOGtrYkgxQjl5TzZ0R0E3REFTVjdmNEVkTk1JUlk4dw?oc=5"" target=""_blank"">Biocon to set up R&amp;D unit in Hyderabad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hans India</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZkNOeC1WZk1fY0R6N29OOFowSUpmNTYxVG9FbmhDaGNickU0ZFRqSXhwN0VBWHYxcUZGdC1yTFJ0c0lPNHZlUFN3TWJmbTc2Q09OSzY4eldMZUxUVUpnUU9wU0ZXNlBMVDkyclZac2Nsa0RXdC1keTBQWXdVTnpWSnRhR1pwS1pyYjVhOGtrYkgxQjl5TzZ0R0E3REFTVjdmNEVkTk1JUlk4dw?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-02-24,2018-02-24 08:00:00,"Biocon to expand presence in Hyderabad, to set up R&D lab - The News Minute","<a href=""https://news.google.com/rss/articles/CBMijAFBVV95cUxPY19XUnVSWVNpY2tLMDhud3NiRkFJdE5hbDNFemFjclRzcWN1SVRyMWVzVkRHaUtCSTdwdGJGa0w0MHpTUkNaVmVzNWx2T09iSFBwd2hzMXdfa2FGdExBMDBmUC0xb01hR3ZldUNYY085YWZmdl9oZ2U0cEsyRm4wb0V5aDFxVUxDaTdvONIBmgFBVV95cUxOUG15LXdEaG5DWTVGTEFrQTU4ZTZiNEhfMXlJTHJ6R2JNaWthZzU0MkJpT3dIVmJ4bzJhRjVWQlU5WnZFcVZieG9ERnRCeFBUN0syakJ6SHNPSGxQU0psMVExRVg1OGJ1ZkxpbnhOTVpCYVctbGhDcTR4bEpObzlZN0cwWFY5bkZScFhOOHRBLUdBX3hPQW5qc0RB?oc=5"" target=""_blank"">Biocon to expand presence in Hyderabad, to set up R&amp;D lab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.com/rss/articles/CBMijAFBVV95cUxPY19XUnVSWVNpY2tLMDhud3NiRkFJdE5hbDNFemFjclRzcWN1SVRyMWVzVkRHaUtCSTdwdGJGa0w0MHpTUkNaVmVzNWx2T09iSFBwd2hzMXdfa2FGdExBMDBmUC0xb01hR3ZldUNYY085YWZmdl9oZ2U0cEsyRm4wb0V5aDFxVUxDaTdvONIBmgFBVV95cUxOUG15LXdEaG5DWTVGTEFrQTU4ZTZiNEhfMXlJTHJ6R2JNaWthZzU0MkJpT3dIVmJ4bzJhRjVWQlU5WnZFcVZieG9ERnRCeFBUN0syakJ6SHNPSGxQU0psMVExRVg1OGJ1ZkxpbnhOTVpCYVctbGhDcTR4bEpObzlZN0cwWFY5bkZScFhOOHRBLUdBX3hPQW5qc0RB?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2018-04-17,2018-04-17 07:00:00,"We will continue to engage external consultants, Biocon assures USFDA - The Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">We will continue to engage external consultants, Biocon assures USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Indian Express</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.4063,0.4063,positive,1.0
2018-05-02,2018-05-02 07:00:00,Biocon gets 7 USFDA observations for Bengaluru drug facility - Mint,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5"" target=""_blank"">Biocon gets 7 USFDA observations for Bengaluru drug facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-05-02,2018-05-02 07:00:00,Biocon gets 7 USFDA observations for Bengaluru drug facility - Mint,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5"" target=""_blank"">Biocon gets 7 USFDA observations for Bengaluru drug facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxQY2dVQXVjY0w5S3RXV2x2Uy1qUlZKdTZUdUZCOUFCZG5VdUlmak1zWjBDenFVQzU5dHlpWkdfem1jN05oRzlOWGlGTkdnLTZNYVA4Z2ZlY194YktHMkxHbm16ZmJza25Vd0E2VmFtSG9tTjBJUFFMS1ZvdmN6R1lWNEN4OS1na2YwQi1CYmJGZzJLTkJOZVJiUzk1Nk5Ia24wRG9ocjlCRzBncEg2SFNjMHAxZ3dwamxMYlZIUllpOV8?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-05-18,2018-05-18 07:00:00,Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News - Mint,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOSHpON0JJcHFlTDZQQ3g3eGFfd2hXaHFPRXJva25Xc19ULWhtSHFDZUFFTG02N0pydlM3Y1Nqc3prVG5VcEh2MGVUSXJudEM4a0J2RlAyVWZOTkRHYWl4cFNoaUZUa0tkN3lHd28xdFg5N2JPbW9JU1ptWHBFQkRaSWpCQ0pOZHZyYWZ3ZjdGbi1BbThoU29aOFRSdEVTWDNYSXpjaWJ5Slg1VGpFVkpaQnlR0gG_AUFVX3lxTE1IS0xwUkNGUGVjOGhET1lQV05jVVNWcmp1T1FBQ2JOTGJjd3JoN243R1ZyTzJoUTB2OWxLTHJMLTVHMnQzTjNxZk5lZmlYMDN3cmZNWHRBVDFLWENMcDdRMWVla2Zmd240T3dUcXhvM3V0MWpaV2wtS0kyTGNlRlR2RVEyQjRMdVBiank2V3k2OVh1QWFfdlhjTGxtZUtCTHZhekFMY2pNanhFVTB0VGcyTGRsb1pLNDlvQl94Ym80?oc=5"" target=""_blank"">Biocon sells 1.88% stake in Syngene for Rs230 crore | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxOSHpON0JJcHFlTDZQQ3g3eGFfd2hXaHFPRXJva25Xc19ULWhtSHFDZUFFTG02N0pydlM3Y1Nqc3prVG5VcEh2MGVUSXJudEM4a0J2RlAyVWZOTkRHYWl4cFNoaUZUa0tkN3lHd28xdFg5N2JPbW9JU1ptWHBFQkRaSWpCQ0pOZHZyYWZ3ZjdGbi1BbThoU29aOFRSdEVTWDNYSXpjaWJ5Slg1VGpFVkpaQnlR0gG_AUFVX3lxTE1IS0xwUkNGUGVjOGhET1lQV05jVVNWcmp1T1FBQ2JOTGJjd3JoN243R1ZyTzJoUTB2OWxLTHJMLTVHMnQzTjNxZk5lZmlYMDN3cmZNWHRBVDFLWENMcDdRMWVla2Zmd240T3dUcXhvM3V0MWpaV2wtS0kyTGNlRlR2RVEyQjRMdVBiank2V3k2OVh1QWFfdlhjTGxtZUtCTHZhekFMY2pNanhFVTB0VGcyTGRsb1pLNDlvQl94Ym80?oc=5,Google News - FDA Journey + Company News,Biocon promoter stake,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-06-23,2018-06-23 07:00:00,Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-06-23,2018-06-23 07:00:00,Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-06-23,2018-06-23 07:00:00,Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for its Bengaluru facility producing sterile | Company Business News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2018-06-26,2018-06-26 07:00:00,FDA gives Biocon biosimilars plant clean bill of health - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5"" target=""_blank"">FDA gives Biocon biosimilars plant clean bill of health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.4520722222222222,0.4520722222222222,positive,1.0
2018-06-26,2018-06-26 07:00:00,FDA gives Biocon biosimilars plant clean bill of health - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5"" target=""_blank"">FDA gives Biocon biosimilars plant clean bill of health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.4520722222222222,0.4520722222222222,positive,1.0
2018-06-26,2018-06-26 07:00:00,FDA gives Biocon biosimilars plant clean bill of health - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5"" target=""_blank"">FDA gives Biocon biosimilars plant clean bill of health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQamJFdml3NUpCMXZDVTIta2ItSGlkQklqYlZYMXNSMFdjclIzd1Y0ZFRfcWowaHZQQkpOLXF6T2piN1hkTWVEMjM5NjJnV0FXTjJ1UHFDRnlvTzlKS0ZHZmF2R3ExNEcyNVZ6Mmh2WjJyRkFibjVZUzhhOThXeWtjR3o0eW5lWnZQaVpWdi1RNHdINWtKVUlTOFp0UQ?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.4520722222222222,0.4520722222222222,positive,1.0
2018-07-11,2018-07-11 07:00:00,Biocon puts arthritis drug on backburner - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon puts arthritis drug on backburner</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2018-12-04,2018-12-04 08:00:00,Biocon Foundation revives and inaugurates Hebbagodi Lake - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxNOVpwZjF0cUk2ZjJjLTdacVdOcTdFVS1VaFZtSWdfWG5LVG12eTY1TUxUOW5WbG1yOFF2aWZVSGc4YWpvcnlGRWxjTWJadEhmUkZCd1hwZW9vc3dLMnFUbGhjektvQXp6XzlTd2FJZ3pXdXRmcVNDM1FBMklGZ3hsRkpzSVZuNndZSm0zSlZLRdIBlAFBVV95cUxNb1o3dXQ1TGxRcHljZXZlcHdjZTBlZ2NZZXpMdXA2UWRjRmYxWUJOVEt6VWxNZ2lfd2RLTjQxa3pka1E2bDNfY196NkZ6bHBUM1M0T3BOZVN1eEYxUl83WTJEdzRJM0E4cW5WellRaEZwbW0zYmZmdEplT1c2dTdzc1NjZkc5RGxJZHJFYzIzclNhUG53?oc=5"" target=""_blank"">Biocon Foundation revives and inaugurates Hebbagodi Lake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxNOVpwZjF0cUk2ZjJjLTdacVdOcTdFVS1VaFZtSWdfWG5LVG12eTY1TUxUOW5WbG1yOFF2aWZVSGc4YWpvcnlGRWxjTWJadEhmUkZCd1hwZW9vc3dLMnFUbGhjektvQXp6XzlTd2FJZ3pXdXRmcVNDM1FBMklGZ3hsRkpzSVZuNndZSm0zSlZLRdIBlAFBVV95cUxNb1o3dXQ1TGxRcHljZXZlcHdjZTBlZ2NZZXpMdXA2UWRjRmYxWUJOVEt6VWxNZ2lfd2RLTjQxa3pka1E2bDNfY196NkZ6bHBUM1M0T3BOZVN1eEYxUl83WTJEdzRJM0E4cW5WellRaEZwbW0zYmZmdEplT1c2dTdzc1NjZkc5RGxJZHJFYzIzclNhUG53?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2019-01-28,2019-01-28 08:00:00,Biosimilars make Biocon stand apart - Mint,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5"" target=""_blank"">Biosimilars make Biocon stand apart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5,Google News - FDA Journey + Company News,Biocon earnings,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-01-28,2019-01-28 08:00:00,Biosimilars make Biocon stand apart - Mint,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5"" target=""_blank"">Biosimilars make Biocon stand apart</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxNUk1qa1EyeWNiQkpYcnkwSzlXR19zSWdkb3Nnc1UteTIwMTk4QmFWdDZtVXpXNG9weHE0RnVvTHRfVkJIY1I1ZlhhbXNqX0hmTUp3N1FnSkhTMGl3dW1mTU81R3JtT1Qyc2RYV0RXSkhMVlItRlpnNW05dmM2R2QtaUdCZ2lTVDBOMnZ6NTJkRVBlSnhQcklFcHFsaV94Z25WRndN0gGoAUFVX3lxTE5IOWFzdEVKbDh1cEkzclZrSjAwZ1JTRnBIU0NhRjhTMV9JM01uV3pIU0NkWDBDcUxXTXhUSUdOaGpQSnZnTXA0YXB1TGFxOHp6UzZ2bW53YjkzSFhuWXZDcnQwQVpVZWRJQ2dIb09TNVJ5ekxRWXNDQkc0V2MtUHRrcFhORE1TazNWMzFJOHhLOFNyRkkyZFMtcTFRT1VGMEFITHhVX1VadA?oc=5,Google News - FDA Journey + Company News,Biocon profit,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-03-07,2019-03-07 08:00:00,Biocon share price falls after USFDA issues six observations on Bengaluru facility - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price falls after USFDA issues six observations on Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2019-03-12,2019-03-12 07:00:00,Biocon biosimilar plant criticized again by the FDA - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5"" target=""_blank"">Biocon biosimilar plant criticized again by the FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2019-03-12,2019-03-12 07:00:00,Biocon biosimilar plant criticized again by the FDA - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5"" target=""_blank"">Biocon biosimilar plant criticized again by the FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2019-03-12,2019-03-12 07:00:00,Biocon biosimilar plant criticized again by the FDA - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5"" target=""_blank"">Biocon biosimilar plant criticized again by the FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPa3I5RS1UMDh2TldyQk5zQ2dycXF4Tl8zVXZabEVpNFAwd19hQThONUFRNHZFenF1VGJIcHZjMU9kdU4tR2NvRnBkZFc3bldKOWpxWldJN3F3WjVQVUROMDVzZjh5SmdiRDkybEpDaDBOdDBMYnBleVBBUld3LURlRUEzbmtXSE1LdTFfMmRrSnhXU3Vv?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2019-03-15,2019-03-15 07:00:00,FiercePharmaAsia—Gilead loses Riva to Glenmark; Biocon biosim plant; Akili-Shionogi pact - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxOaUlmSXNkd2xmVkRiX3BYbFFIaUltLWJ1NXIzckJJcjJGVG1raTh5WGcwQzFSNFZEWkM2TTlQa003WTN0OVdQSmctWmUyMlRhdlFOYWJ4T19mQ1NiUGpEX2w3b05QUWR5RC1iMk1pMlFNWVRndXJLUWp4MXpoZFFKcGRISDZrTktPRHpJYjJKZVZyRGVoSG5hZmJvQy00MUNrQWtqV0tMclZ2bGVuVk9hY0ZvQ1c2SmMzdTgtVnJlUnB6UWNQZkE?oc=5"" target=""_blank"">FiercePharmaAsia—Gilead loses Riva to Glenmark; Biocon biosim plant; Akili-Shionogi pact</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxOaUlmSXNkd2xmVkRiX3BYbFFIaUltLWJ1NXIzckJJcjJGVG1raTh5WGcwQzFSNFZEWkM2TTlQa003WTN0OVdQSmctWmUyMlRhdlFOYWJ4T19mQ1NiUGpEX2w3b05QUWR5RC1iMk1pMlFNWVRndXJLUWp4MXpoZFFKcGRISDZrTktPRHpJYjJKZVZyRGVoSG5hZmJvQy00MUNrQWtqV0tMclZ2bGVuVk9hY0ZvQ1c2SmMzdTgtVnJlUnB6UWNQZkE?oc=5,Google News - FDA Journey + Company News,Biocon FDA warning letter,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.3787,-0.3787,negative,1.0
2019-03-15,2019-03-15 07:00:00,FiercePharmaAsia—Gilead loses Riva to Glenmark; Biocon biosim plant; Akili-Shionogi pact - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxOaUlmSXNkd2xmVkRiX3BYbFFIaUltLWJ1NXIzckJJcjJGVG1raTh5WGcwQzFSNFZEWkM2TTlQa003WTN0OVdQSmctWmUyMlRhdlFOYWJ4T19mQ1NiUGpEX2w3b05QUWR5RC1iMk1pMlFNWVRndXJLUWp4MXpoZFFKcGRISDZrTktPRHpJYjJKZVZyRGVoSG5hZmJvQy00MUNrQWtqV0tMclZ2bGVuVk9hY0ZvQ1c2SmMzdTgtVnJlUnB6UWNQZkE?oc=5"" target=""_blank"">FiercePharmaAsia—Gilead loses Riva to Glenmark; Biocon biosim plant; Akili-Shionogi pact</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxOaUlmSXNkd2xmVkRiX3BYbFFIaUltLWJ1NXIzckJJcjJGVG1raTh5WGcwQzFSNFZEWkM2TTlQa003WTN0OVdQSmctWmUyMlRhdlFOYWJ4T19mQ1NiUGpEX2w3b05QUWR5RC1iMk1pMlFNWVRndXJLUWp4MXpoZFFKcGRISDZrTktPRHpJYjJKZVZyRGVoSG5hZmJvQy00MUNrQWtqV0tMclZ2bGVuVk9hY0ZvQ1c2SmMzdTgtVnJlUnB6UWNQZkE?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.3787,-0.3787,negative,1.0
2019-05-30,2019-05-30 07:00:00,Biocon Academy organises program in Quality Control Analytical - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOWmxRUElIelE3Vi0wY0lST05IYzdaVkpQbWxPTDgxSmFmWUhwMUxwOVNxbmhvR0w4cmNuR1NOYnROOGFIQWdpQVhTN3ByYkJKRTRQZDNHamUwR3NCWVgxSmJqQUNFd0JXZ0lUci1BZmZ1WmJpSzRvbTRaX0FVSF9Ed01sckU3bjFCZ182a0gwdlVfQ09hRl9rN2lrR1VuT2x4VnFtbnQwUHVFNWp5QmZoa2JZLV8?oc=5"" target=""_blank"">Biocon Academy organises program in Quality Control Analytical</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxOWmxRUElIelE3Vi0wY0lST05IYzdaVkpQbWxPTDgxSmFmWUhwMUxwOVNxbmhvR0w4cmNuR1NOYnROOGFIQWdpQVhTN3ByYkJKRTRQZDNHamUwR3NCWVgxSmJqQUNFd0JXZ0lUci1BZmZ1WmJpSzRvbTRaX0FVSF9Ed01sckU3bjFCZ182a0gwdlVfQ09hRl9rN2lrR1VuT2x4VnFtbnQwUHVFNWp5QmZoa2JZLV8?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-06-17,2019-06-17 07:00:00,Biocon board approves sale of branded formulations business to subsidiary - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon board approves sale of branded formulations business to subsidiary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.39651666666666663,0.39651666666666663,positive,1.0
2019-08-05,2019-08-05 07:00:00,India’s Biocon acquires Bio-Xcell’s facility for RM25 mil - The Edge Malaysia,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOemNYaEFPdU1HOFY2TEZNcVd3U0d5S01YaUhSc0ozR245MmlVUW1yTERPb1JPOExPQ3ByTVBCZWpyNUM4T2h3SkRpRFc0Z2NIZFUxVVNTdlFYclAwOC02NWpsQzRaQVZGMlFsWnhscW02MkZLV3lxU1l3b3BhOFhMX0xsWWxqcTVReW51Yy1sZw?oc=5"" target=""_blank"">India’s Biocon acquires Bio-Xcell’s facility for RM25 mil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Edge Malaysia</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOemNYaEFPdU1HOFY2TEZNcVd3U0d5S01YaUhSc0ozR245MmlVUW1yTERPb1JPOExPQ3ByTVBCZWpyNUM4T2h3SkRpRFc0Z2NIZFUxVVNTdlFYclAwOC02NWpsQzRaQVZGMlFsWnhscW02MkZLV3lxU1l3b3BhOFhMX0xsWWxqcTVReW51Yy1sZw?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-08-22,2019-08-22 07:00:00,Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5"" target=""_blank"">Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-08-22,2019-08-22 07:00:00,Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5"" target=""_blank"">Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNcDlJb3NGUlBpTmpDQ3A5cVc1UXg0OVgzTjBDZHluME1GMmNxYlk5Q2RYeGxwQ1JUWnd0bWJhamlFa3JMOGtlbDUyVTJ4ZnRLSU9PT01wMktXUmh2NEZkeHlwQ1pjLUFaNnVBQldMaW5qN2o3dHBRZU1mblo1VVhGcjA1VkM0TDhHM2NQcnBEeTFvQzY0VnRvRkxLRC1jTEVlQWfSAacBQVVfeXFMTWJpVXp3V1piSi1YQmRucWd1aHNEQkN1UU8yRGNRYll1RWJydldVcmo3SkpCalNRT2YzMDViekhLTzRCWEdTM1hGWmJia3BnMzMzaGxtTW9VQ084QTNFVkdDX0g5UWVFbGUxVl9fVnhhcVFmZGl1YlYzOExZRXJnN21iOXJ1SjFWOTNudThldm03Z3BWd1dzaXVLOWNiNHpXaFhPNXh2aFU?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-08-23,2019-08-23 07:00:00,Biocon Malaysia unit receives EU GMP certification - BioSpectrum Asia,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5"" target=""_blank"">Biocon Malaysia unit receives EU GMP certification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-08-23,2019-08-23 07:00:00,Biocon Malaysia unit receives EU GMP certification - BioSpectrum Asia,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5"" target=""_blank"">Biocon Malaysia unit receives EU GMP certification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOdFpTeWFhSktHWGd1QjM5N0hkSVRqa29fZWxfZ3RVQTRQVi1YcUF2VVJJd19FWC13QnpPUVpGTW5zaF9JcUtjWmpZWVdta2tCZ1UzMGRsSllRRTFNY21NZU1pTWZ2Mlc0TUItVzlZNHllN3Zmc0JQbHdFZnhVSGMtZTd4anBLLTZkYXVwVXVlMnpGNERVTHYxX2dmU3kzdkRyS2RJ?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-24,2019-09-24 07:00:00,Biocon subsidiary acquires research facility from Pfizer Healthcare - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires research facility from Pfizer Healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-24,2019-09-24 07:00:00,Biocon subsidiary acquires Pfizer's research facility - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires Pfizer's research facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-24,2019-09-24 07:00:00,Biocon subsidiary acquires research facility from Pfizer Healthcare - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires research facility from Pfizer Healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOUnRYUUdtRmRJV2JESjhvZmpMNWZoeW9pRnMtV2RibDFxNmFzX0RBQ0o1RTJDWUtfQzZSTHRWTWFzRjdlUmc0c19HVFNIekdUU3dfT3VCLVUxWTlEOFpFRkVfTWU0WXJTekRSWWlKQ2NZaDNOWjBBa2dUTkJQUlZmUGxEZmo3MjNuX1Z6Y0lRSDR2cmV3UndkTHBmMzNDclBIdEl0eTFuZzlVcktCVlVQV3kwRzlzNDdzVjAyRjNlUU5QdTFCUFo0RUZOME50TktaWm4zdjFaOGvSAd4BQVVfeXFMTmxwSmZtVS10SGs5b2h5akt4bldnUUh6ajFuU0Fqbk9CQ3M4d2tUZml3TVN5NlpHcl9CODJrbGNva2JiNElzNUhJdHVIbzRjNnJ6aWdIY1h1dzFzT29UdmY1OWFHdHNlVjZsOVFHTlN2Sm1HMU5XcnZMQWN1bnZ6TkRIREtkMi1HYVBoNnkyc2RZNmlyb2ZKMUVKRGZKaDl2bVVUdGxYbVVvSlYtMkdhR2ZfeUtxU1JlcENyY3BHOUlXekZxLUZqeTFFbmZtdTRZbmptQkFVaUc1dlRIRWZB?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-24,2019-09-24 07:00:00,Biocon subsidiary acquires research facility from Pfizer Healthcare - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires research facility from Pfizer Healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-24,2019-09-24 07:00:00,Biocon subsidiary acquires research facility from Pfizer Healthcare - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires research facility from Pfizer Healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-09-26,2019-09-26 07:00:00,Biocon subsidiary buys Chennai-based research facility from Pfizer Healthcare - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary buys Chennai-based research facility from Pfizer Healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-10-10,2019-10-10 07:00:00,"Biocon Biologics, Just - Evotec Biologics ink licensing pact for biosimilar asset - ET HealthWorld","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, Just - Evotec Biologics ink licensing pact for biosimilar asset</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNdlp0cVRxSE1XelgxSU9BY0xsNnItS3lUVS1NbVNYRjhJRHVhYlpncFVublB6MjJPYkdrRFhHcU1FcGRWeTUwOHBwVURCNkF2dmd0S1l3Rnc4MW5MZkh2ajJMV3gtQ29tdnVLX0VrM0MxR3pIWUpCOEVBQmgtRDBPN1hBYnNOeERCcHlsUXptcFF0bFEyUjhOTEpkcFBOZmoxRUF3TV9BQVlLdmNKZlhCWWlJTnlfMnZNY3lKTU9hQ0h1TzZzU0dPdDlWSFhTQ016b2RVcnJQSk9BalHSAeABQVVfeXFMTkR2bWdybjZMSEdwTkdUM1cxNzMxdGFtOEoxUk8xNjlHSnd4S1FtSXdWbGY5ZFMzU1hSVEhJQnFVZGJsQUlhZHhyMS1UTExMaU5vZW9ManQ3eEhVNW1Lc1I1c3p1aW5hZ0kwVWZYdWIyT0JLQzZ5RUtyOEJheUZwczMwaWhyV3VqOWZDRk5ER0xoLXZxMlpxaVlycFdwLVlUTTNkNHNVS293ajdNeDhfTjJxeXJUS0FjOWt3eWxhV19MZGNSWUZ6OE9CNzNNcmpoWU9lUWlCWldtNmV1b0oxV3U?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.1806,0.1806,positive,1.0
2019-10-24,2019-10-24 07:00:00,"Biocon CEO Arun Chandavarkar to retire on 30 Nov, CFO Mittal to replace himBioco - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon CEO Arun Chandavarkar to retire on 30 Nov, CFO Mittal to replace himBioco</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-10-25,2019-10-25 07:00:00,Biocon sets $1 billion target for biologics business - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sets $1 billion target for biologics business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxOLXJDbTJqamZNRHlPdjJJMElJSlVMdjBBZUVyckszcEEyVDY4dlM3WmRmSWhYbzYwbERVSk1JUG9RY3I5WTVXdjBmLXJTc0szQm50dXpnOWFaX1U2QTlGaVZMQnROVWhlMDNoR0FXU2RLSkc5SVI1aFFKQkxKWWJrckM2VW5sVHc2ekZrZUh3dEdRcDlXYmF6YTQ2NW9BSE5iVlNsWWxlam9fNllDV0NPaFRyeEVpLVhzVUVqeTF1TGNrRTBaRHpwR2h0NWlBamdt0gHWAUFVX3lxTE1vdE92V1dxRkNvRE9JclVpX1hXQzc2eVcxdzNVYUNKVHJIa01zUEN4dVp1UGFtNnp1Q2ZRZXVaajlFdUVGSzNaMmstblJtd0xVQTljSElvbzdHc0xHWUdwTUFJc3lXdmZUeUJ4OHZZM0V5Sl9JdWNXUHZyQ3ZtcWdRSzE4SzRZWlh2eTNJSUxPSWt1N2tNdm96RWZ2WWtydFlNT3NYUlVHQWRtZEctX3BqcDYyT1FRSVZxVFdUTW9yNm1CS3laSHRfamNGbnlJS2lYamhYalE?oc=5,Google News - FDA Journey + Company News,Biocon investor call,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-11-05,2019-11-05 08:00:00,Biocon's Biologics drug products facility gets nod from US FDA - ANI News,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5"" target=""_blank"">Biocon's Biologics drug products facility gets nod from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-11-05,2019-11-05 08:00:00,Biocon's Biologics drug products facility gets nod from US FDA - ANI News,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5"" target=""_blank"">Biocon's Biologics drug products facility gets nod from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2019-11-05,2019-11-05 08:00:00,Biocon's Biologics drug products facility gets nod from US FDA - ANI News,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5"" target=""_blank"">Biocon's Biologics drug products facility gets nod from US FDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxNUV9NN1NuaHpkTjkwN1hJWUdsLVlldmo5cU5ldTVTdjBVOUc0QmlPQ0hwVFB2WnpWOEdsa2tZOUNuYURJN2lxYnBuY1pVbnhmYVdSNE1hRml4ZFItbVFnN0RrbkpZMGtGd2g0QnlDdl9qWGdqUldTTVJTWlA3U3pjazYzdEJDakZ2Q190SG05cnRiTlhXQk9UVmdtWFlYMGxvMUgwRjR3QnBWclRncV9OekFR?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-01-06,2020-01-06 08:00:00,True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxQUWpKbDZNMkVodEVidDZUYVVfTUwyMFlfV2YySzBsak9xZmpOX25SV3JwWVU4UHFPS2VKX1M3X2l3UlJoT1FESFNldHEzWV9OeFZxT1Y2VEhhaVNYVmdQM05uZWtobkJOTHdGR0tWS2ZGRWo4UlNtYlloMUpETUVEM0VfaWl0R2tjOUZpV0VQU0pVNktta25zYTVUUGNUNTEtTU1mT2o2TUxBbTdibW5SLXRkZVE3MjVoeHF5b0x3MXN2YjBD?oc=5"" target=""_blank"">True North $100-Million Investment in Biocon Biologics Kicks Off New Fundraising Round</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxQUWpKbDZNMkVodEVidDZUYVVfTUwyMFlfV2YySzBsak9xZmpOX25SV3JwWVU4UHFPS2VKX1M3X2l3UlJoT1FESFNldHEzWV9OeFZxT1Y2VEhhaVNYVmdQM05uZWtobkJOTHdGR0tWS2ZGRWo4UlNtYlloMUpETUVEM0VfaWl0R2tjOUZpV0VQU0pVNktta25zYTVUUGNUNTEtTU1mT2o2TUxBbTdibW5SLXRkZVE3MjVoeHF5b0x3MXN2YjBD?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.23764393939393938,0.23764393939393938,positive,1.0
2020-01-06,2020-01-06 08:00:00,True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion - Mint,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxNbTdHLUo0Zkh1QS11dy1reFRDN2lZRTg4REdOMEZJYnJULXRtODQ5NWUyY1FyRTlVZGlOVjBKZVdlem5PY05UWjBURDVlUTBkajA1Y1U5OTY2TXhpcHJuNGJXNEh1cHlVb3NGQ3ZuaEJzbUhZbnNCWkxKQWc1T0c1TEFMaU9PNUxvSTZCelFXT1JkZ0Y4dm5FNkozQ1BZc1JfbUYwWUJ3SjNfLXZac1U5bkx0NUZaazBheVdVZzVRVERzX1ZwVUJEYnNfZkhDZ9IB0wFBVV95cUxPcUgwcnFxRUUxOVJkLS1kZFFfSkZ3REVLem5xMnh0dm52SVNadWwxSG5jOFJaTXAwc1kzRklNaGZyNUdrdUZpcVUzTUsxZG1pQ1JyR0V3aGtYb2xxVmNzRHRxaTNwcXJJN1FHS0dGN3daOUVaWU81LVlwV3c0RkVVdlF0d2Z4TkdqTTV0SmNIRUN6RGNUZ2cyZG9raU43ODd0am42NkNoQVprZGUySmFlNmJ1a0E1TDRFS2ZFdlQzSzd3b1lDZzZaVDlvMVRNZ0Z6QWRJ?oc=5"" target=""_blank"">True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.29825,0.29825,positive,1.0
2020-01-06,2020-01-06 08:00:00,True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake - ANI News,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWUlhMnJWMjlsLVJmRURQS2EtSHAtSm5oQ1VDemRWZ1B0VjhESHVwVlFkcUF0enZxc1BMQ0xwZU9rUVpINEFRRjRtNkhrY2FraF9RU01sTUxzdXBXVFRJYldtWmJ3WkoxVGVCclBTY3JtdURuSUZ5bkZwZk5lQUhSRkpzc3otRGJ5Ti1OcTVqN0YxOFMyWG9BQkIyemZ2ZGdPc0d5QUJfeW03MmJIRnpzbW1QX3d6UXA0T0F0MHFSWHdXcXQwUnhQUw?oc=5"" target=""_blank"">True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWUlhMnJWMjlsLVJmRURQS2EtSHAtSm5oQ1VDemRWZ1B0VjhESHVwVlFkcUF0enZxc1BMQ0xwZU9rUVpINEFRRjRtNkhrY2FraF9RU01sTUxzdXBXVFRJYldtWmJ3WkoxVGVCclBTY3JtdURuSUZ5bkZwZk5lQUhSRkpzc3otRGJ5Ti1OcTVqN0YxOFMyWG9BQkIyemZ2ZGdPc0d5QUJfeW03MmJIRnpzbW1QX3d6UXA0T0F0MHFSWHdXcXQwUnhQUw?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.29825,0.29825,positive,1.0
2020-01-06,2020-01-06 08:00:00,True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">True North to acquire 2.4% stake in Biocon Biologics at a valuation of $3 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.29825,0.29825,positive,1.0
2020-01-06,2020-01-06 08:00:00,Biocon Biologics Appoints M.B. Chinappa as Chief Financial Officer - BioSpace,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPSnkzUHpBTnpFWmNTdXFYNnFZSndMZ2RDc2NnMG1IYTZ3b0t6cHlFZmY4R0UtZFRYLTF4SjlrbTZGNU1rclNNZWpqeHRVT3ZaN1FRejN2NlV0S3QwVGZPdktKV2l2TmREc2Y1dDNfbDl3RkxCNkpyMkdVSWE5OW5qUjM4M1pIT3Q5Y1ZyQklxcmNfNHhv?oc=5"" target=""_blank"">Biocon Biologics Appoints M.B. Chinappa as Chief Financial Officer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpace</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPSnkzUHpBTnpFWmNTdXFYNnFZSndMZ2RDc2NnMG1IYTZ3b0t6cHlFZmY4R0UtZFRYLTF4SjlrbTZGNU1rclNNZWpqeHRVT3ZaN1FRejN2NlV0S3QwVGZPdktKV2l2TmREc2Y1dDNfbDl3RkxCNkpyMkdVSWE5OW5qUjM4M1pIT3Q5Y1ZyQklxcmNfNHhv?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-01-06,2020-01-06 08:00:00,Biocon Biologics appoints M.B. Chinappa as CFO - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxPNXYzQXp2VXJyekdWYm1mWEcwVGhWYjctb3B6M2I4cEtoSlF1ZVpMT1k3REhMUTBjcHA0YmhMNER0YzF0aDY3WXdaWm00alZBd0NqT2U3dllhVmE5M1VjWTJNUGFXRElNQmVWNlhOcXRBZXRIcnh4Si02cW1OamZ3WkdHT2hvSlpMV3RsWV82cUpmbkEta1poT0xMYnNSdw?oc=5"" target=""_blank"">Biocon Biologics appoints M.B. Chinappa as CFO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxPNXYzQXp2VXJyekdWYm1mWEcwVGhWYjctb3B6M2I4cEtoSlF1ZVpMT1k3REhMUTBjcHA0YmhMNER0YzF0aDY3WXdaWm00alZBd0NqT2U3dllhVmE5M1VjWTJNUGFXRElNQmVWNlhOcXRBZXRIcnh4Si02cW1OamZ3WkdHT2hvSlpMV3RsWV82cUpmbkEta1poT0xMYnNSdw?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-01-10,2020-01-10 08:00:00,"FiercePharmaAsia—Taiho, Otsuka, Chugai KRAS deals; Biocon biologics spinoff; Mark Alles' new title - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNbHdqcFdQVUlpR1k4RWNYXzc2NENGQWhVczlUckxlM04yYzl2SzFIeWkwR1MzbHAxUl9tcDdKeWRfaXRLZDF3ZExRQ0xRRXh0enhSd1oxNlczSVBUY3JLY0hYdXVHZzJQUGFZS3UyOFlsZUdCbnRzSTlFY2pmMEpVSFd2cXRIZXYtT0p2RjZZRzFpdFZSQnpTMmtpNzl5bW1KcWJPek1wTFk3RDBsV0w0dzhZQmFpY1p1NTJ1SWFzTW1hUjhHTFRj?oc=5"" target=""_blank"">FiercePharmaAsia—Taiho, Otsuka, Chugai KRAS deals; Biocon biologics spinoff; Mark Alles' new title</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNbHdqcFdQVUlpR1k4RWNYXzc2NENGQWhVczlUckxlM04yYzl2SzFIeWkwR1MzbHAxUl9tcDdKeWRfaXRLZDF3ZExRQ0xRRXh0enhSd1oxNlczSVBUY3JLY0hYdXVHZzJQUGFZS3UyOFlsZUdCbnRzSTlFY2pmMEpVSFd2cXRIZXYtT0p2RjZZRzFpdFZSQnpTMmtpNzl5bW1KcWJPek1wTFk3RDBsV0w0dzhZQmFpY1p1NTJ1SWFzTW1hUjhHTFRj?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2020-01-27,2020-01-27 08:00:00,FDA faults Biocon plant during preapproval review - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQSDUxYV9tN0xXSUhxSWpEWC1zVjVuOVE4dVQ5UkNjX0dJVWpBcWFfRV9NRVU4dVRSNXM3QWV3VnhGZWY5UUhaRzhqcTFyZ0lwbUdhVHRadGhtSWdZcERxUFVKRDA1RktYRWlBNVExUmZhMjJLcDc2NjU3Ym5VWUswdDFCaG01NVdyQ0Qzc2hWWGxlSmw1dFk4?oc=5"" target=""_blank"">FDA faults Biocon plant during preapproval review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxQSDUxYV9tN0xXSUhxSWpEWC1zVjVuOVE4dVQ5UkNjX0dJVWpBcWFfRV9NRVU4dVRSNXM3QWV3VnhGZWY5UUhaRzhqcTFyZ0lwbUdhVHRadGhtSWdZcERxUFVKRDA1RktYRWlBNVExUmZhMjJLcDc2NjU3Ym5VWUswdDFCaG01NVdyQ0Qzc2hWWGxlSmw1dFk4?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.36755,-0.36755,negative,1.0
2020-01-27,2020-01-27 08:00:00,FDA faults Biocon plant during preapproval review - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQSDUxYV9tN0xXSUhxSWpEWC1zVjVuOVE4dVQ5UkNjX0dJVWpBcWFfRV9NRVU4dVRSNXM3QWV3VnhGZWY5UUhaRzhqcTFyZ0lwbUdhVHRadGhtSWdZcERxUFVKRDA1RktYRWlBNVExUmZhMjJLcDc2NjU3Ym5VWUswdDFCaG01NVdyQ0Qzc2hWWGxlSmw1dFk4?oc=5"" target=""_blank"">FDA faults Biocon plant during preapproval review</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxQSDUxYV9tN0xXSUhxSWpEWC1zVjVuOVE4dVQ5UkNjX0dJVWpBcWFfRV9NRVU4dVRSNXM3QWV3VnhGZWY5UUhaRzhqcTFyZ0lwbUdhVHRadGhtSWdZcERxUFVKRDA1RktYRWlBNVExUmZhMjJLcDc2NjU3Ym5VWUswdDFCaG01NVdyQ0Qzc2hWWGxlSmw1dFk4?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.36755,-0.36755,negative,1.0
2020-01-28,2020-01-28 08:00:00,Biocon receives FDA Form 483 at Bangalore plant - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5"" target=""_blank"">Biocon receives FDA Form 483 at Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5,Google News - FDA Journey + Company News,Biocon FDA warning letter,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-01-28,2020-01-28 08:00:00,Biocon receives FDA Form 483 at Bangalore plant - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5"" target=""_blank"">Biocon receives FDA Form 483 at Bangalore plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxNSGtGWlpLUmZXWDVSN0paWXdyX3g4TEJvR3F4YmdWQXNWMEhqNzQ2SlhZNkgtZHFuT2IyRVQ2MkNMQm9YU1lqdE00ZDN0ZHI1QTlTb09uQnkyOFBNVUhCUE9vRnJwRHI4a09TVkllMFFNZGM3Z0FXVi1CU0xQWGFxTWhoMDFqeXpzdjVBY3BhOXptRzFY?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-02-08,2020-02-08 08:00:00,NCLT approves scheme of amalgamation of Biocon Research with Biocon Biologics - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">NCLT approves scheme of amalgamation of Biocon Research with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2020-02-22,2020-02-22 08:00:00,Biocon receives 3 USFDA observations for insulin facility in Malaysia - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives 3 USFDA observations for insulin facility in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-02-25,2020-02-25 08:00:00,Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag - The Edge Malaysia,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWJ1ZXdyekFvVl83TUtpNU5aZWZuTTM2eGhsa0JkQWl5bVp3aHoybm55T2U5SmZMb1UzamZfRDU4YklRY2ZMT0drU3FITE5sSU53a2FYX0dhaXY3UWM3Mk5JQWZwV1NQTXRldC16ZDZ4TG1USDE4S2EtTmNEYzRfM2ppSHNsb2l1aXYzYzZLalpPaFRvTWFhdElwTlM?oc=5"" target=""_blank"">Newsbreak: Sale of Malaysian Bio-XCell’s facility to Biocon hits a snag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Edge Malaysia</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxPVWJ1ZXdyekFvVl83TUtpNU5aZWZuTTM2eGhsa0JkQWl5bVp3aHoybm55T2U5SmZMb1UzamZfRDU4YklRY2ZMT0drU3FITE5sSU53a2FYX0dhaXY3UWM3Mk5JQWZwV1NQTXRldC16ZDZ4TG1USDE4S2EtTmNEYzRfM2ppSHNsb2l1aXYzYzZLalpPaFRvTWFhdElwTlM?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-03-11,2020-03-11 07:00:00,"Biocon, partner Mylan win patent litigation on insulin glargine device in US - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, partner Mylan win patent litigation on insulin glargine device in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.6258666666666667,0.6258666666666667,positive,1.0
2020-03-20,2020-03-20 07:00:00,Biocon receives EIR from USFDA for good manufacturing practice inspection - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives EIR from USFDA for good manufacturing practice inspection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.52515,0.52515,positive,1.0
2020-04-01,2020-04-01 07:00:00,FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.051550000000000006,0.051550000000000006,neutral,1.0
2020-04-01,2020-04-01 07:00:00,FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.051550000000000006,0.051550000000000006,neutral,1.0
2020-04-01,2020-04-01 07:00:00,FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.051550000000000006,0.051550000000000006,neutral,1.0
2020-04-01,2020-04-01 07:00:00,FDA Clears Biocon's Insulin Factory in Malaysia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5"" target=""_blank"">FDA Clears Biocon's Insulin Factory in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOckdFcFlnNU81Y0FqRkJGTXRnZVd3MHhwRW85eFQ5STFJUHVDTEhsN21VbXRVV0E3MjFfN3Jzc3l4dklwV21hc0ZIV3BsM2R1aHcyTW1FWk9zemYyUGJmd3k0d3RfdW1QN3h0NGN0cjZRQVNJWGZKMVdFZV9fTXdVTUJMczNzcFpRQjRXdXh4SQ?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.051550000000000006,0.051550000000000006,neutral,1.0
2020-04-07,2020-04-07 07:00:00,Biocon Investing $100 Million in New Fermentation-Based API Mfg Facility - DCAT Value Chain Insights,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQdktZU3hNdk5jbmRHZEE0ajIzbnZ2OVQtTzlkOGZMOVhaSkVpc1NXOVNUNEFUNTR5aVd2eTNXLU8xVkJ0d1JhcG1yYThoOUxkdGJtczI0SHhvMm9OM29JWWtCdGpDeG9ibDRQQTlWbmRvSUF6d2lZVlpNM05ZLXM2N0xfSnh2WjQ3UVVOc3JTSXVrd3lOQXZIQ3dXR0FtNzFteGlYWHVmRTNJNzl2MGJJ?oc=5"" target=""_blank"">Biocon Investing $100 Million in New Fermentation-Based API Mfg Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">DCAT Value Chain Insights</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQdktZU3hNdk5jbmRHZEE0ajIzbnZ2OVQtTzlkOGZMOVhaSkVpc1NXOVNUNEFUNTR5aVd2eTNXLU8xVkJ0d1JhcG1yYThoOUxkdGJtczI0SHhvMm9OM29JWWtCdGpDeG9ibDRQQTlWbmRvSUF6d2lZVlpNM05ZLXM2N0xfSnh2WjQ3UVVOc3JTSXVrd3lOQXZIQ3dXR0FtNzFteGlYWHVmRTNJNzl2MGJJ?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.33840454545454546,0.33840454545454546,positive,1.0
2020-04-14,2020-04-14 07:00:00,Mylan and Biocon Launch Pegfilgrastim Biosimilar in Australia - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxPZ2NOQXBwbHpnZm11dmw0Y0pXV3A4dTdkQi1XSjl5Ml9NREFtSGhMSDFEYmFZT01yQTdSLVlvZFpnVGhnYWVoWHZnaUJJUFF4eDNDLW1tcnIzT2todmQ0cklUY2NZeUlCTWRZZkhYWkpPNXRHVVE4ejVRUHRDYXJQRW5Ib3BZREJMbWw0NjhDRHY3NU1TTUdNMGJvdndnSVlVWGRfVzBR?oc=5"" target=""_blank"">Mylan and Biocon Launch Pegfilgrastim Biosimilar in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxPZ2NOQXBwbHpnZm11dmw0Y0pXV3A4dTdkQi1XSjl5Ml9NREFtSGhMSDFEYmFZT01yQTdSLVlvZFpnVGhnYWVoWHZnaUJJUFF4eDNDLW1tcnIzT2todmQ0cklUY2NZeUlCTWRZZkhYWkpPNXRHVVE4ejVRUHRDYXJQRW5Ib3BZREJMbWw0NjhDRHY3NU1TTUdNMGJvdndnSVlVWGRfVzBR?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2020-04-16,2020-04-16 07:00:00,Biocon Biologics gets EIR from US FDA for two manufacturing facilities - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPR1g0aXdVeWMySG5EQXpza3g0MXFlY2NEM1dMNVFjSWlrclJGdEtJOFY4and1b1FBdUt6Y2hLYVFnOU5CNjBJSHl3RHhXRkRscTJhOW53ZUZuV2h3QUlqN2Y2QXBpUDFib05ZS1JpSDgza3c4amRMckFOUFZzT2I0WGJxOUstSzFBd1M3dVIzdVcxWnVWZjNlVHJYSmttaTE0alHSAacBQVVfeXFMT0xlMkI0RXJRZFBER2RpWElhVDFGTkZBWXIwTlNiSkVyR0RERXR4c25SV2RjeENYdTNyeG00WE9fZTQweU5xWHVXZi0wU2NHVXRhUTBjRWZJQUtsa1BQZjIxeVBNMHNJT2ZZQXU5Mmh1cjNSOG1uMm5Ia1ZpZnFvRWVhMWVvM1RxM1c3ejk3djVxMkp2cWRodTZBRUtDVVA0Mnh6NjhqMHM?oc=5"" target=""_blank"">Biocon Biologics gets EIR from US FDA for two manufacturing facilities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPR1g0aXdVeWMySG5EQXpza3g0MXFlY2NEM1dMNVFjSWlrclJGdEtJOFY4and1b1FBdUt6Y2hLYVFnOU5CNjBJSHl3RHhXRkRscTJhOW53ZUZuV2h3QUlqN2Y2QXBpUDFib05ZS1JpSDgza3c4amRMckFOUFZzT2I0WGJxOUstSzFBd1M3dVIzdVcxWnVWZjNlVHJYSmttaTE0alHSAacBQVVfeXFMT0xlMkI0RXJRZFBER2RpWElhVDFGTkZBWXIwTlNiSkVyR0RERXR4c25SV2RjeENYdTNyeG00WE9fZTQweU5xWHVXZi0wU2NHVXRhUTBjRWZJQUtsa1BQZjIxeVBNMHNJT2ZZQXU5Mmh1cjNSOG1uMm5Ia1ZpZnFvRWVhMWVvM1RxM1c3ejk3djVxMkp2cWRodTZBRUtDVVA0Mnh6NjhqMHM?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-07-11,2020-07-11 07:00:00,Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients - ANI News,"<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxObUtnQ3pXNFpZRU5Da1c0Um5DX3hoSEV4MWlWazJ5Ulk1aGhoaTRXUktETzdmdG5aMVQ2dEZNWUkxZ2NaanFSNzBDQ0dyRjRpWVRMTHpMcnFfSldhV2RENlQxYUR4TFl3dkhZa2dwcnpIelRfSTlUSTh6LTdmc1J4cXVYR1cxSEdsQ093V1daMnFtN3dsMHE5MDdVR2lSbVBzaG5MTEk3Y2FXZlB2clhYYVdRblBXSE5EbmpsUi1vVWUzMi05Y3MtRW85ZW1NZWJKZVE?oc=5"" target=""_blank"">Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid-19 patients</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ANI News</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxObUtnQ3pXNFpZRU5Da1c0Um5DX3hoSEV4MWlWazJ5Ulk1aGhoaTRXUktETzdmdG5aMVQ2dEZNWUkxZ2NaanFSNzBDQ0dyRjRpWVRMTHpMcnFfSldhV2RENlQxYUR4TFl3dkhZa2dwcnpIelRfSTlUSTh6LTdmc1J4cXVYR1cxSEdsQ093V1daMnFtN3dsMHE5MDdVR2lSbVBzaG5MTEk3Y2FXZlB2clhYYVdRblBXSE5EbmpsUi1vVWUzMi05Y3MtRW85ZW1NZWJKZVE?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.31845,-0.31845,negative,1.0
2020-07-14,2020-07-14 07:00:00,"Biocon’s Covid-19 treatment drug costs Rs 8,000 a vial - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon’s Covid-19 treatment drug costs Rs 8,000 a vial</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-08-06,2020-08-06 07:00:00,Fact-checking during a pandemic: A response to Biocon and the Telegraph - Newslaundry,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Fact-checking during a pandemic: A response to Biocon and the Telegraph</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Newslaundry</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-08-06,2020-08-06 07:00:00,Fact-checking during a pandemic: A response to Biocon and the Telegraph - Newslaundry,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Fact-checking during a pandemic: A response to Biocon and the Telegraph</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Newslaundry</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-01,2020-09-01 07:00:00,"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5"" target=""_blank"">Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-01,2020-09-01 07:00:00,"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5"" target=""_blank"">Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-01,2020-09-01 07:00:00,"Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5"" target=""_blank"">Mylan, Biocon undercut insulin competitors on price with launch of Lantus copycat</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxPZ202Y2oxc25XczV1cGdDZ19UczNRTFlZTXM4T1JwQ0oxRmN2ZmxQSXhwUlZ6LVdvMUFZS3A5UmxfQWpVbG1sNXRROU9zdnZ0bUpxSlRsOW1POWZrSHpEOGVDUlJjeXNnQ1g5VGZidE10dEJqYlhXUXZIb05IZ1FzN0N5MEJqZUxfRV9UcTdIbS02T3hUUHN3VUxQT2l0VlRHNnlNNHpBdkI?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:46:27,Research saves lives. - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTFBqOGk3WE1wSDRGNTFINVo5eWFZQkVhc1p0M0RpMWdJeXFYdDZkLW9YaWpRTDJqenNtTjB6NmZPWGowY3RxYVZOelhxVHJJTW9QaVBvWlRPcw?oc=5"" target=""_blank"">Research saves lives.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiV0FVX3lxTFBqOGk3WE1wSDRGNTFINVo5eWFZQkVhc1p0M0RpMWdJeXFYdDZkLW9YaWpRTDJqenNtTjB6NmZPWGowY3RxYVZOelhxVHJJTW9QaVBvWlRPcw?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:46:27,Research saves lives. - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTFBqOGk3WE1wSDRGNTFINVo5eWFZQkVhc1p0M0RpMWdJeXFYdDZkLW9YaWpRTDJqenNtTjB6NmZPWGowY3RxYVZOelhxVHJJTW9QaVBvWlRPcw?oc=5"" target=""_blank"">Research saves lives.</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiV0FVX3lxTFBqOGk3WE1wSDRGNTFINVo5eWFZQkVhc1p0M0RpMWdJeXFYdDZkLW9YaWpRTDJqenNtTjB6NmZPWGowY3RxYVZOelhxVHJJTW9QaVBvWlRPcw?oc=5,Google News - FDA Journey + Company News,Biocon investigation,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:47:18,"Generics - delivering quality products to patients, partners & healthcare - Biocon","<a href=""https://news.google.com/rss/articles/CBMiVkFVX3lxTE0wSXBsUWxrcC1UUVlTOVJBaVNJVUs5SjdaRGF0a3lTa1hXcWNxaDZHMEh0VzVaUFY1NWVEblpQRmZCRXhMREhnMnllR21jUUxwbW1jYndR?oc=5"" target=""_blank"">Generics - delivering quality products to patients, partners & healthcare</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiVkFVX3lxTE0wSXBsUWxrcC1UUVlTOVJBaVNJVUs5SjdaRGF0a3lTa1hXcWNxaDZHMEh0VzVaUFY1NWVEblpQRmZCRXhMREhnMnllR21jUUxwbW1jYndR?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:48:36,Biocon Malaysia - Asia’s largest insulin manufacturing and R&D facility - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5"" target=""_blank"">Biocon Malaysia - Asia’s largest insulin manufacturing and R&amp;D facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5,Google News - FDA Journey + Company News,Biocon investor call,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:48:36,Biocon Malaysia - Asia’s largest insulin manufacturing and R&D facility - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5"" target=""_blank"">Biocon Malaysia - Asia’s largest insulin manufacturing and R&amp;D facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiV0FVX3lxTE1LZlJJMjFMeEZNbHZ0T09HTE5RM2x0WXAyajAtcnRHX2lES3pVS2dwMlRVMDJSMzYwMUg4SHZkRjFISGt4bm5OYzl2VDQ5WkxfS2lLeERzbw?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:49:33,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:49:33,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:49:33,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiakFVX3lxTE5jNmRpOU5sZXBpOVRrcnd2V2dORUZYNWd4SzRTLWtlTktEQU5SaktFdnJfSlFfeDdSYUE3cDVzcE9MeThPeHZFVWtLejNGZElpNm85Rks5bjBXZFhkV2VGcTQyaXEtbU9IWlE?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:50:25,Our work in Biosimilars - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiekFVX3lxTE1QVEpJcUd5aTJLV0FMeUNENlZpd2hObHNpa19FN0xZdzZRT3R5OUotSERrS3J5Z1J2eGtMbU9GRVdydXVHQjRqVXN5S0wxNlk3VmVTQndkZ0pCcTUxNHJXSUVEU240T0FrUkJVbFFYanRHNWQ4ZUFCQmdR?oc=5"" target=""_blank"">Our work in Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiekFVX3lxTE1QVEpJcUd5aTJLV0FMeUNENlZpd2hObHNpa19FN0xZdzZRT3R5OUotSERrS3J5Z1J2eGtMbU9GRVdydXVHQjRqVXN5S0wxNlk3VmVTQndkZ0pCcTUxNHJXSUVEU240T0FrUkJVbFFYanRHNWQ4ZUFCQmdR?oc=5,Google News - FDA Journey + Company News,Biocon merger,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:51:28,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5,Google News - FDA Journey + Company News,Biocon investor call,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 18:51:28,BOARD OF DIRECTORS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5"" target=""_blank"">BOARD OF DIRECTORS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxPWlU0Q1dfUmhJM3VySG1mTW83MjVYaWtxLURURWhicTlpd1JrX3lnZ0xxQlo4cFdZdWRfTHZpbXRGdFFlU2hJMnpvTXJYLWhKMVBGYW55R1gzcVlKbXotV0d0aXdpbTVuZGNWU0cxRV85WFR5RHk5MThBRHRyTWRYR1ktSWdVaUt5Qnc?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-09-05,2020-09-05 22:26:20,Creating a Safer Workplace - Biocon,"<a href=""https://news.google.com/rss/articles/CBMieEFVX3lxTFA5RzNxaVhsZDRQbFNiNGROVExlakM1a0ROU1RraTBoNXFhdXJsc2plRzN6YUdadlc4M2tyTjloRGc5VWhUMDJic3hPMGxTMFBjQlFIZmV1TEdjQTVQRUNONW13VU92eHFEeUkxR2M2OXc1MVBvX0UyNg?oc=5"" target=""_blank"">Creating a Safer Workplace</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMieEFVX3lxTFA5RzNxaVhsZDRQbFNiNGROVExlakM1a0ROU1RraTBoNXFhdXJsc2plRzN6YUdadlc4M2tyTjloRGc5VWhUMDJic3hPMGxTMFBjQlFIZmV1TEdjQTVQRUNONW13VU92eHFEeUkxR2M2OXc1MVBvX0UyNg?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.38915,0.38915,positive,1.0
2020-09-05,2020-09-05 22:27:09,An Environment of Change - Biocon,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxOZ3YyemVPWVdsV3dUQk5SUGhGMzZWN2dmbUdnRkdjeGp4YWtudkFuQ3kwUHVkanFOQlExYS1vcGwxVlJpZjNjOGtnWmYwMXhlZklXTmpuSU5lUW5OTWhqQmRGLUFtajQxY1RBOGE2M3YwRFJHdXRVYXY0bkl0ekY5ZF9OM3Q?oc=5"" target=""_blank"">An Environment of Change</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxOZ3YyemVPWVdsV3dUQk5SUGhGMzZWN2dmbUdnRkdjeGp4YWtudkFuQ3kwUHVkanFOQlExYS1vcGwxVlJpZjNjOGtnWmYwMXhlZklXTmpuSU5lUW5OTWhqQmRGLUFtajQxY1RBOGE2M3YwRFJHdXRVYXY0bkl0ekY5ZF9OM3Q?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-11-03,2020-11-03 07:20:13,LEADERSHIP TEAM - Biocon,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5"" target=""_blank"">LEADERSHIP TEAM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-11-03,2020-11-03 07:20:13,LEADERSHIP TEAM - Biocon,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5"" target=""_blank"">LEADERSHIP TEAM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5,Google News - FDA Journey + Company News,Biocon board meeting,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-11-03,2020-11-03 07:20:13,LEADERSHIP TEAM - Biocon,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5"" target=""_blank"">LEADERSHIP TEAM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxONGJBWUMwYXZfOW1rQUFBTFQtdTVNX1haMFhwQlNFa2REcHRXM1g4cHdkRXl1RGRlU0ttUzNkcEtQRDNQNXRDRFo3M2pRcnNVTG1JQk8ybGlueXJjLTNMUDRYbVZILWlBZWU1ZHg5TG5PMHRrN2lhWXhHbTJkQmEzNWtjYnRtUzdBYzBfVkg1ZXQyV0V1UVVxeg?oc=5,Google News - FDA Journey + Company News,Biocon compliance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-11-07,2020-11-07 08:00:00,Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQMDFlUkdleF82RG9IaDVLS1Jia1BIYnd3Wmc2MW5hMTJPVWQ1aUswN2tmcjdVeGx2emp6UWpIZ2s4cmhUenJ2bmhlSlAtRDVhNHVzUkdLc3FZUlNBQ1R6bTRKZGNuNWRIaEU1TDRnWWlMQTdTemlUeXJhNjNGUkpSc3lZU21PTVZnR2RabzVOUmRlUEJ0bUdfWl9xZlVxV1diVGJobw?oc=5"" target=""_blank"">Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxQMDFlUkdleF82RG9IaDVLS1Jia1BIYnd3Wmc2MW5hMTJPVWQ1aUswN2tmcjdVeGx2emp6UWpIZ2s4cmhUenJ2bmhlSlAtRDVhNHVzUkdLc3FZUlNBQ1R6bTRKZGNuNWRIaEU1TDRnWWlMQTdTemlUeXJhNjNGUkpSc3lZU21PTVZnR2RabzVOUmRlUEJ0bUdfWl9xZlVxV1diVGJobw?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-11-24,2020-11-24 08:00:00,Biocon to Procure Solar Via Open Access Under Group Captive Model From Hinduja Renewables - Mercomindia.com,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB5cEpNNENyODRjSURtM3FvU1lqRlIxaDdnTHhCMG5qcGNEWFp4M1hoNThhc19iSTNVMUVVNWdPdVc2cGt6VDB1eEZfVWNOcTNTdEJ3MG1xdTBHR3NLcUZkMDdteUJYYjA?oc=5"" target=""_blank"">Biocon to Procure Solar Via Open Access Under Group Captive Model From Hinduja Renewables</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mercomindia.com</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFB5cEpNNENyODRjSURtM3FvU1lqRlIxaDdnTHhCMG5qcGNEWFp4M1hoNThhc19iSTNVMUVVNWdPdVc2cGt6VDB1eEZfVWNOcTNTdEJ3MG1xdTBHR3NLcUZkMDdteUJYYjA?oc=5,Google News - FDA Journey + Company News,Biocon acquisition,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.04,0.04,neutral,1.0
2020-12-15,2020-12-15 08:00:00,Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents - Biocon,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNRThwS3dvaTM0ZzdxTEdPX1Z1dGxwQml3WHctbVRZX2lLdno5Z25qMnN4YUV0M2FNREdVN3BrUnFGeGgtU2hNQXlrYklUQ1FWNkQ0N1pHYnMzWjI4NlVMZDNLazY1aDM4bnBVcUNuV3dfYVY0eVVTY0lWZ3pFUjlBY01ZVzZUZW9hUjN4bUVqRV9JS2dBbjBCUnpwWlQ?oc=5"" target=""_blank"">Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNRThwS3dvaTM0ZzdxTEdPX1Z1dGxwQml3WHctbVRZX2lLdno5Z25qMnN4YUV0M2FNREdVN3BrUnFGeGgtU2hNQXlrYklUQ1FWNkQ0N1pHYnMzWjI4NlVMZDNLazY1aDM4bnBVcUNuV3dfYVY0eVVTY0lWZ3pFUjlBY01ZVzZUZW9hUjN4bUVqRV9JS2dBbjBCUnpwWlQ?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-12-15,2020-12-15 08:00:00,Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents - Biocon,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNRThwS3dvaTM0ZzdxTEdPX1Z1dGxwQml3WHctbVRZX2lLdno5Z25qMnN4YUV0M2FNREdVN3BrUnFGeGgtU2hNQXlrYklUQ1FWNkQ0N1pHYnMzWjI4NlVMZDNLazY1aDM4bnBVcUNuV3dfYVY0eVVTY0lWZ3pFUjlBY01ZVzZUZW9hUjN4bUVqRV9JS2dBbjBCUnpwWlQ?oc=5"" target=""_blank"">Biocon Biologics signs an MoU with CSSC in Tanzania for Mission 10 cents</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNRThwS3dvaTM0ZzdxTEdPX1Z1dGxwQml3WHctbVRZX2lLdno5Z25qMnN4YUV0M2FNREdVN3BrUnFGeGgtU2hNQXlrYklUQ1FWNkQ0N1pHYnMzWjI4NlVMZDNLazY1aDM4bnBVcUNuV3dfYVY0eVVTY0lWZ3pFUjlBY01ZVzZUZW9hUjN4bUVqRV9JS2dBbjBCUnpwWlQ?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-12-16,2020-12-16 08:00:00,"Biocon Biologics, CSSC collaborate for Mission 10 cents - Medical Dialogues","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics, CSSC collaborate for Mission 10 cents</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2020-12-28,2020-12-28 08:00:00,Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQbzVwVll6bHR6X1FhVXc3MkVTVjFwY29fSkV5X25lOWxkSWk1ajFPemtxVERURlVCTUhtUTBQTVlSVEhEU3lDQ3Mtd01hWUQ5Um11WHF0aDBYdHJDZUljSjkzMlRDTlM5c3hpdm9hNUVaekJQeHVYTzBkaGhDVFRhcjJhTk9EdWZVdk9qQXV5bGZ0cWkweDgzWDA2d1UzVEhkdGQ4M0huN2w5WVd1dFJQcTRENkVBWHJ5cHc?oc=5"" target=""_blank"">Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQbzVwVll6bHR6X1FhVXc3MkVTVjFwY29fSkV5X25lOWxkSWk1ajFPemtxVERURlVCTUhtUTBQTVlSVEhEU3lDQ3Mtd01hWUQ5Um11WHF0aDBYdHJDZUljSjkzMlRDTlM5c3hpdm9hNUVaekJQeHVYTzBkaGhDVFRhcjJhTk9EdWZVdk9qQXV5bGZ0cWkweDgzWDA2d1UzVEhkdGQ4M0huN2w5WVd1dFJQcTRENkVBWHJ5cHc?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.10115,0.10115,positive,1.0
2021-02-05,2021-02-05 08:00:00,Biocon Biologics to offer its oncology biosimilars in 30+ countries - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to offer its oncology biosimilars in 30+ countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-02-05,2021-02-05 08:00:00,Biocon Biologics to offer its oncology biosimilars in 30+ countries - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to offer its oncology biosimilars in 30+ countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-02-05,2021-02-05 08:00:00,Biocon Biologics to offer its oncology biosimilars in 30+ countries - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to offer its oncology biosimilars in 30+ countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-02-05,2021-02-05 08:00:00,Biocon Biologics to offer its oncology biosimilars in 30+ countries - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to offer its oncology biosimilars in 30+ countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-02-12,2021-02-12 08:00:00,Biocon Gains EU Authorization for Insulin Aspart Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5"" target=""_blank"">Biocon Gains EU Authorization for Insulin Aspart Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.26794999999999997,0.26794999999999997,positive,1.0
2021-02-12,2021-02-12 08:00:00,Biocon Gains EU Authorization for Insulin Aspart Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5"" target=""_blank"">Biocon Gains EU Authorization for Insulin Aspart Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.26794999999999997,0.26794999999999997,positive,1.0
2021-02-12,2021-02-12 08:00:00,Biocon Gains EU Authorization for Insulin Aspart Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5"" target=""_blank"">Biocon Gains EU Authorization for Insulin Aspart Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOVzZyVVhHdGh1QWt5RE94SEFyN19tV1JuWXcyRzdIWjNSTUFCR2d2SWRVa0tfZ055dXpQc1lfblhWbXgwWmNNTU8tNWc5R0R1YUlwcTdQUGVOcm9GcFpxQmNZRktqckxEaHp2YlpBRjBNdkRpcVE4TFp0MjJjWDJhaE9uMzdzejBLNzRmQTFjS1pEQ2F2ZDRZQ2dGUm9IVDQ1UGtR?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26794999999999997,0.26794999999999997,positive,1.0
2021-02-16,2021-02-16 08:00:00,"Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5"" target=""_blank"">Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.6750499999999999,0.6750499999999999,positive,1.0
2021-02-16,2021-02-16 08:00:00,"Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5"" target=""_blank"">Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.6750499999999999,0.6750499999999999,positive,1.0
2021-02-16,2021-02-16 08:00:00,"Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5"" target=""_blank"">Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.6750499999999999,0.6750499999999999,positive,1.0
2021-02-16,2021-02-16 08:00:00,"Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide - Biocon","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5"" target=""_blank"">Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPckQ3MmRZaWNHOFJRLWVUOHh5RnNYTHh0YldIYnJLbnJoMDU2TGpoc3J6Q3NvN2VOdU9fcjduQ2NqUjJ0VFJVaDNUWXZTeDh4aFVlUGdaZE1SNHliN3ZpejZSX0g2YTVKYzVaanVGcUVaWFhRczVBczVFdHdtdWYyWlkzY01OOEFYX1ZNMDFsU21SUDZDR24wZmRISHZsU0U2c0lxX3Z1LUkxQW1XdFU4c2JyM05iMEw1Um03UnE2Q2R2eTU4STd4R3pXZWtnZC1yLTF4Uk9yLWowdXpEUFUwbA?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.6750499999999999,0.6750499999999999,positive,1.0
2021-03-01,2021-03-01 08:00:00,Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer - Biocon,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxOM1BOZlpwRnd4OWxQMHJEYWRmUEpvdDFYYWk4VkgyR2o0eVhBbnhsTDhNTUdRY1ZzdFNqamhRVHVXVlNraFlJR3VROHVvUllzR2NvZXUyMzNGczgxWF9Qci00QXJub2h2RHlySWFmNk9qYVY1djBYSUlpamN4RmNvR3dmXzJoUkVleFdvSjVIRUh1WHRNNnlYMHhtOE9OZUNS?oc=5"" target=""_blank"">Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxOM1BOZlpwRnd4OWxQMHJEYWRmUEpvdDFYYWk4VkgyR2o0eVhBbnhsTDhNTUdRY1ZzdFNqamhRVHVXVlNraFlJR3VROHVvUllzR2NvZXUyMzNGczgxWF9Qci00QXJub2h2RHlySWFmNk9qYVY1djBYSUlpamN4RmNvR3dmXzJoUkVleFdvSjVIRUh1WHRNNnlYMHhtOE9OZUNS?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2021-03-01,2021-03-01 08:00:00,Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer - Biocon,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxOM1BOZlpwRnd4OWxQMHJEYWRmUEpvdDFYYWk4VkgyR2o0eVhBbnhsTDhNTUdRY1ZzdFNqamhRVHVXVlNraFlJR3VROHVvUllzR2NvZXUyMzNGczgxWF9Qci00QXJub2h2RHlySWFmNk9qYVY1djBYSUlpamN4RmNvR3dmXzJoUkVleFdvSjVIRUh1WHRNNnlYMHhtOE9OZUNS?oc=5"" target=""_blank"">Biocon Biologics Promotes Shreehas Tambe to Deputy Chief Executive Officer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxOM1BOZlpwRnd4OWxQMHJEYWRmUEpvdDFYYWk4VkgyR2o0eVhBbnhsTDhNTUdRY1ZzdFNqamhRVHVXVlNraFlJR3VROHVvUllzR2NvZXUyMzNGczgxWF9Qci00QXJub2h2RHlySWFmNk9qYVY1djBYSUlpamN4RmNvR3dmXzJoUkVleFdvSjVIRUh1WHRNNnlYMHhtOE9OZUNS?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2021-03-09,2021-03-09 08:00:00,"Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2021-03-09,2021-03-09 08:00:00,"Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries - ThePrint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-29,2021-03-29 07:00:00,Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil - Biocon,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5"" target=""_blank"">Biocon Pharma partners with Libbs Farmaceutica to launch generic formulations in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNd0Z1MkVteGsxUW5DNm8ydWFmQUtkVHY0dk1BSUxsLWN5N3QzWWFPYWZ1dHNDcnIxamkwTTlwMC0tWl8zNHc5NXFQOE1tY1dqWE5qcWpsUGY3R3puSVBJVDhCRmR6bndlRkFZUzZNYS1xbXZtNmpNdWZqZGEtRVhhUmVGLTZqMDBqd25OaC1CdFdINm1YUVB6N0pjZVlSY01yZlQ5ek9zU1JCMDN5ZjdPXw?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-30,2021-03-30 07:00:00,Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-30,2021-03-30 07:00:00,Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-30,2021-03-30 07:00:00,Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-03-30,2021-03-30 07:00:00,Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Libbs Farmaceutica to launch generic drugs in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-04-18,2021-04-18 07:00:00,"In chat with Anil Singhvi, analyst Vikas Sethi recommends Hikal, Biocon as top buys for big gains - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">In chat with Anil Singhvi, analyst Vikas Sethi recommends Hikal, Biocon as top buys for big gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon promoter stake,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.48915,0.48915,positive,1.0
2021-04-18,2021-04-18 07:00:00,"In chat with Anil Singhvi, analyst Vikas Sethi recommends Hikal, Biocon as top buys for big gains - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">In chat with Anil Singhvi, analyst Vikas Sethi recommends Hikal, Biocon as top buys for big gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.48915,0.48915,positive,1.0
2021-06-07,2021-06-07 07:00:00,"Sustainable, Safe and State-of-the-Art: Biocon Biologics’ New Bangalore Facility Receives Recognition - Jacobs","<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxQSXdaeTkxcVVKcmpjeEg0ZXZGQURZWi1Wcy1aVUk4QlJ4V1ZfUmxXbUZmczRRLVpmQnZlU0taLUM2LXN3Mi1wOVhzRHpVczhYVnlyV29idFJBaXZCU1RHWF9kdzBvTEFlVUdTVjlERUpGdEtqelcyYmtsLThKcHlkaWNmVHRDN3M3VURicXR0TjVWNURVUFJac1RzdlJFZUtCQVVxUFNYS1lZRTJOb2kxN2dna0VTdWc?oc=5"" target=""_blank"">Sustainable, Safe and State-of-the-Art: Biocon Biologics’ New Bangalore Facility Receives Recognition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Jacobs</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxQSXdaeTkxcVVKcmpjeEg0ZXZGQURZWi1Wcy1aVUk4QlJ4V1ZfUmxXbUZmczRRLVpmQnZlU0taLUM2LXN3Mi1wOVhzRHpVczhYVnlyV29idFJBaXZCU1RHWF9kdzBvTEFlVUdTVjlERUpGdEtqelcyYmtsLThKcHlkaWNmVHRDN3M3VURicXR0TjVWNURVUFJac1RzdlJFZUtCQVVxUFNYS1lZRTJOb2kxN2dna0VTdWc?oc=5,Google News - FDA Journey + Company News,Biocon new facility,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.4774227272727273,0.4774227272727273,positive,1.0
2021-06-07,2021-06-07 07:00:00,"Sustainable, Safe and State-of-the-Art: Biocon Biologics’ New Bangalore Facility Receives Recognition - Jacobs","<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxQSXdaeTkxcVVKcmpjeEg0ZXZGQURZWi1Wcy1aVUk4QlJ4V1ZfUmxXbUZmczRRLVpmQnZlU0taLUM2LXN3Mi1wOVhzRHpVczhYVnlyV29idFJBaXZCU1RHWF9kdzBvTEFlVUdTVjlERUpGdEtqelcyYmtsLThKcHlkaWNmVHRDN3M3VURicXR0TjVWNURVUFJac1RzdlJFZUtCQVVxUFNYS1lZRTJOb2kxN2dna0VTdWc?oc=5"" target=""_blank"">Sustainable, Safe and State-of-the-Art: Biocon Biologics’ New Bangalore Facility Receives Recognition</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Jacobs</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxQSXdaeTkxcVVKcmpjeEg0ZXZGQURZWi1Wcy1aVUk4QlJ4V1ZfUmxXbUZmczRRLVpmQnZlU0taLUM2LXN3Mi1wOVhzRHpVczhYVnlyV29idFJBaXZCU1RHWF9kdzBvTEFlVUdTVjlERUpGdEtqelcyYmtsLThKcHlkaWNmVHRDN3M3VURicXR0TjVWNURVUFJac1RzdlJFZUtCQVVxUFNYS1lZRTJOb2kxN2dna0VTdWc?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4774227272727273,0.4774227272727273,positive,1.0
2021-06-28,2021-06-28 03:27:36,Biocon's European play - Business Today,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNVG5tXzd3bC00V21MYm13dTJ4NlZ6NGVHeGNWVkRyZlZJSTFjUlBTbUEyOVM3NHlzS19KRDc0aHVWQzlza3BpckpXcFBZcVhpczdjTG9LYVRfS2Y0T29pMEJ5OVU1Y3VfSDhJY3laWUFoY1hLdFAxa2ZRNllSZXZWdXpTQnpHRFZaNjRsclQ1c1lfMEpnWHc?oc=5"" target=""_blank"">Biocon's European play</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNVG5tXzd3bC00V21MYm13dTJ4NlZ6NGVHeGNWVkRyZlZJSTFjUlBTbUEyOVM3NHlzS19KRDc0aHVWQzlza3BpckpXcFBZcVhpczdjTG9LYVRfS2Y0T29pMEJ5OVU1Y3VfSDhJY3laWUFoY1hLdFAxa2ZRNllSZXZWdXpTQnpHRFZaNjRsclQ1c1lfMEpnWHc?oc=5,Google News - FDA Journey + Company News,Biocon joint venture,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2021-06-28,2021-06-28 03:27:36,Biocon's European play - Business Today,"<a href=""https://news.google.com/rss/articles/CBMilgFBVV95cUxNVG5tXzd3bC00V21MYm13dTJ4NlZ6NGVHeGNWVkRyZlZJSTFjUlBTbUEyOVM3NHlzS19KRDc0aHVWQzlza3BpckpXcFBZcVhpczdjTG9LYVRfS2Y0T29pMEJ5OVU1Y3VfSDhJY3laWUFoY1hLdFAxa2ZRNllSZXZWdXpTQnpHRFZaNjRsclQ1c1lfMEpnWHc?oc=5"" target=""_blank"">Biocon's European play</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMilgFBVV95cUxNVG5tXzd3bC00V21MYm13dTJ4NlZ6NGVHeGNWVkRyZlZJSTFjUlBTbUEyOVM3NHlzS19KRDc0aHVWQzlza3BpckpXcFBZcVhpczdjTG9LYVRfS2Y0T29pMEJ5OVU1Y3VfSDhJY3laWUFoY1hLdFAxa2ZRNllSZXZWdXpTQnpHRFZaNjRsclQ1c1lfMEpnWHc?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2021-07-27,2021-07-27 07:00:00,Adagio and Biocon collaborate to develop antibody therapy for Covid-19 - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxPMjRCel8yQUFGYjM4RWM4YUZLckFhRENxM3FzX2dETzV1UGtXeF8teC1reVJqMjZ2NkFwdXphYXRkZ3B2RkxfMkwxSDFXSHJJSi01a0VzSFdDejFuRndBRUI3OGlYUGc0Rm1WMWJENW5vdnFtN0owU3dSSEZrRG5YY2hNV1k?oc=5"" target=""_blank"">Adagio and Biocon collaborate to develop antibody therapy for Covid-19</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxPMjRCel8yQUFGYjM4RWM4YUZLckFhRENxM3FzX2dETzV1UGtXeF8teC1reVJqMjZ2NkFwdXphYXRkZ3B2RkxfMkwxSDFXSHJJSi01a0VzSFdDejFuRndBRUI3OGlYUGc0Rm1WMWJENW5vdnFtN0owU3dSSEZrRG5YY2hNV1k?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-27,2021-07-27 07:00:00,Adagio and Biocon collaborate to develop antibody therapy for Covid-19 - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxPMjRCel8yQUFGYjM4RWM4YUZLckFhRENxM3FzX2dETzV1UGtXeF8teC1reVJqMjZ2NkFwdXphYXRkZ3B2RkxfMkwxSDFXSHJJSi01a0VzSFdDejFuRndBRUI3OGlYUGc0Rm1WMWJENW5vdnFtN0owU3dSSEZrRG5YY2hNV1k?oc=5"" target=""_blank"">Adagio and Biocon collaborate to develop antibody therapy for Covid-19</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxPMjRCel8yQUFGYjM4RWM4YUZLckFhRENxM3FzX2dETzV1UGtXeF8teC1reVJqMjZ2NkFwdXphYXRkZ3B2RkxfMkwxSDFXSHJJSi01a0VzSFdDejFuRndBRUI3OGlYUGc0Rm1WMWJENW5vdnFtN0owU3dSSEZrRG5YY2hNV1k?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,Semglee interchangeable,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee interchangeable,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-28,2021-07-28 07:00:00,Biocon’s Global Biosimilars Portfolio - Insulin Glargine - Biocon,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5"" target=""_blank"">Biocon’s Global Biosimilars Portfolio - Insulin Glargine</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9PR0hXTzc3UkJEN3lJRlJjM1VFcy0ybjF5ckRBTnZMNjFlUEl6b2syUE8xNDhVaUZWQlBIZ1hyQzNucnZxTE51Rmx5bUJGNlZzb0pFNktYbG9Rc0p4N3poX3ZvSGhRaVY5OWtQZVprYmY?oc=5,Google News - Market + Complete Company News,Semglee market launch,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,Semglee FDA application,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,Semglee FDA approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,Semglee regulatory approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,insulin glargine-yfgn FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - FDA Journey + Company News,Semglee biosimilar approval,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,Semglee FDA approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,Semglee regulatory approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,insulin glargine-yfgn FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-07-29,2021-07-29 07:00:00,"FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics - Drug Delivery Business","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5"" target=""_blank"">FDA approves insulin glargine biosimilar injection from Viatris, Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Drug Delivery Business</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxQS1RCclJpTVRmdUJNWUFybFlRbndWY1g3RTJPd0htSGZrYlpacHRTZGNJS1RlY01iaEN2am5SaXZoalZZM0l5aGlwQWRxSUNxX3lEb2hjQlhFZXB5Z20xMlRJZDhDMWkyT3JNR2pYTzVPUUtyU0VpRnNtV3dOWEJ0bTRTcWFzN3BfOVZNNVVuWTB2Ykt3YzNjOWZJdHBtQVhORWg1VG5NTEo0cVRaR0Z3SUFZOUV0WjcyVnc?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2021-09-16,2021-09-16 07:00:00,Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi6gFBVV95cUxQbkhiSU14WW1yd3pPWnpILUNpZTZJRGRRWkR5OTB5azAyOVpvenJLNVNJUW1Md3dqajZUYWIxSFB0R01GVW5zWmx2ZktPYjlYb3VfajI2anZUbFBielR1SXZUM1B6U2JKSHc3OGd5b21odGdNalRDTjY5dmlWWXdibk9wS2xBSmRuNEw3QjN5TWxFM2xQbnluMGhfUENTb0hqM014MXJmUTZIdXBVa1NDVWJJMTFxT2ZjdjZ4aG1JaXVhTWtzYmwzWU9WX0ZtbGxhZkM4eG5jM2pHUnBReERCeDM0cnN2NTJHUHfSAe8BQVVfeXFMUHMtQzFtMnFZZVhDSG03c3RNMjFCeFZVTzVscFpZTjBYYnJYbGpBczFtWlptTmhrakR4ZzYtTjRMUE9jVFNZdFRWZEZVTzJSUkUta0tYWjRUQnVjRGdqTDR5bC1LaUhTVl94a0JrdUpVQnRKM0llRXQ3VHZmajc4Q21HTU44bkx6Sm1RRFFKNWJKZGFHeGtiRzZTLUZTU0Y0Tk1rSV9PU3RHU1NzdkxwdlV2eEo5LXdKZW9PTkJWWHh1NGlNbndtRWNzUm9jS3RWVFZoalYwV0VkVDB2SEdxSlZfM281TVF2Z0lqNldVUEE?oc=5,Google News - FDA Journey + Company News,Biocon partnership,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0258,0.0258,neutral,1.0
2021-09-16,2021-09-16 07:00:00,Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Adar Poonawalla's Serum commits 100 million doses of vaccines for 15% stake in Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0258,0.0258,neutral,1.0
2021-09-24,2021-09-24 07:00:00,"New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products - Swarajyamag","<a href=""https://news.google.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?oc=5"" target=""_blank"">New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.014204545454545456,-0.014204545454545456,neutral,1.0
2021-09-24,2021-09-24 07:00:00,"New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products - Swarajyamag","<a href=""https://news.google.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?oc=5"" target=""_blank"">New Deal Between Serum Institute Of India And Biocon Covers Vaccines, Other Biotech Products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Swarajyamag</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.014204545454545456,-0.014204545454545456,neutral,1.0
2021-09-25,2021-09-25 07:00:00,USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA issues 6 observations after inspection of Biocon's Malaysian arm mfng facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - FDA Journey + Company News,Semglee FDA submission,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - FDA Journey + Company News,Biocon Semglee FDA,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - FDA Journey + Company News,Biocon FDA warning letter,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - FDA Journey + Company News,Biocon FDA inspection,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-09-29,2021-09-29 07:00:00,More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5"" target=""_blank"">More trouble for Biocon insulin plant in Malaysia as FDA flags 6 Form 483 observations</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxNZ1hSb0RESnZNRXdXM2doeUttV202Sl9tYTlsQktFX2RjYS1WblFkMm1rUFZuakh1cUpTWHctRE5UOFRwQmhOV0hUVl9iN2p0OVRhYWpIWEtUY2F4LWRteFhETHFBSmpaeVdLenZDc21vVURRWjRQWWpycml4ZG5wNlhHMjVtcm9GU3Z5NnpLRUFDMHB6Ni1nVXptNkxUR1hrVTBVYVRZS2lRaDVUZzY0UHNqOUs3dWtKWmJYZmRUZDBKU2xOMzRv?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.34609999999999996,-0.34609999999999996,negative,1.0
2021-10-05,2021-10-05 07:00:00,Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxNcTJXbHQyc0JVbUd5UDh4b01sWExtR194cXk4c1NZSVF2V3ZGVTdMbzVOeFA1UW5CeXVNYVBWeDlYX0VWNkxiQk9SMU1HQnMtX3NRN1BmRTVxNk1DbDkya2dHcjNhenJTUHB3cFNqaFlrZ1NRUHpNTk4yVUNtbG16QlZhRXg3TjhKSDQySWpESmJDVXI3SDQ4em9Rcm9HX29CeUJfaHhOVlpGeUx1Y3RIM1c2bXBtMXJFaVplZGdpRkxHTHdINGhqci1peWVQWjlYZVpLOUdZSVg4ZDlrX0HSAeMBQVVfeXFMTU5jbnlldHpBYVNyVTRoMWNRNDZLdGk0T3hMcW83SmNXczQtaFdpdkRfS2VGa2xudmlYMnVudXl0MGRsV0QyMWJ5OW9GeHdScmVTUmpIUkdNR1h4a1hvSG9pLTdyZ1RWNldmU2FxdFgzVEh2VmF3NG1aTnhVSGFjSWpQWGlSWDFmQVg1dGNuUW9JZUI3eGFUTGhqYnpOemxqMnI2VXpfTlQ4OC1wQ0RYOGs2c19jeVZ5aXFTVFE3WjlBa0s3WnBXbEJyalo0MGxQWEpVWUF1SDFBRGdoMnlmYnpiQlk?oc=5,Google News - FDA Journey + Company News,Biocon guidance,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.2575,0.2575,positive,1.0
2021-10-05,2021-10-05 07:00:00,Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNcTJXbHQyc0JVbUd5UDh4b01sWExtR194cXk4c1NZSVF2V3ZGVTdMbzVOeFA1UW5CeXVNYVBWeDlYX0VWNkxiQk9SMU1HQnMtX3NRN1BmRTVxNk1DbDkya2dHcjNhenJTUHB3cFNqaFlrZ1NRUHpNTk4yVUNtbG16QlZhRXg3TjhKSDQySWpESmJDVXI3SDQ4em9Rcm9HX29CeUJfaHhOVlpGeUx1Y3RIM1c2bXBtMXJFaVplZGdpRkxHTHdINGhqci1peWVQWjlYZVpLOUdZSVg4ZDlrX0HSAeMBQVVfeXFMTU5jbnlldHpBYVNyVTRoMWNRNDZLdGk0T3hMcW83SmNXczQtaFdpdkRfS2VGa2xudmlYMnVudXl0MGRsV0QyMWJ5OW9GeHdScmVTUmpIUkdNR1h4a1hvSG9pLTdyZ1RWNldmU2FxdFgzVEh2VmF3NG1aTnhVSGFjSWpQWGlSWDFmQVg1dGNuUW9JZUI3eGFUTGhqYnpOemxqMnI2VXpfTlQ4OC1wQ0RYOGs2c19jeVZ5aXFTVFE3WjlBa0s3WnBXbEJyalo0MGxQWEpVWUF1SDFBRGdoMnlmYnpiQlk?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.2575,0.2575,positive,1.0
2021-10-05,2021-10-05 07:00:00,Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2575,0.2575,positive,1.0
2021-10-05,2021-10-05 07:00:00,Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Pandora Papers' wrongly implicates husband's offshore trust: Biocon Chief Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2575,0.2575,positive,1.0
2021-10-06,2021-10-06 07:00:00,Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges - Fortune India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.38585,-0.38585,negative,1.0
2021-10-06,2021-10-06 07:00:00,Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges - Fortune India,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNaExQUW5oZHE3Q193Wkg2YURKclJ4d1JQMGhxS2F4N04tSnF6SXpMM2txMDhjNmpGN3czUlI3djBGVmQ2bG5yQ2VYOXRvVGVQamU1RkhIcTF4SnhNaEE4eEFEc1ZfcTNEUjZ0ai1vZ0s5UTBWRUhiM3BpYnFseUY2NUdzYzFTalp2YlY0VkVsYUlMUmNmbC1paVNFb3NfN3BISENVMEp3dEhvbmNMUmfSAbsBQVVfeXFMT3NZdTYzSGNGbXExOUVybjFCVzctTDRfc3RLUXF6dnNlNXJVTDNFWGRqYWFkNGZLMUtUTXVnRXZXSGs1ZFJiRllCcTlrZmxHR2ktVG0yVkhiSXY4RjMtdFZQRUpZMTFCRE1teWlHa2drVlZuTjlXSjBZeXVkMndoaUF4R2Z4UUl3enlVRFFXa3hnVzNtMEF0bXNqLWRDYzY2RXYyT3ZmMi1ZQU5PSWxUMmVYTGY0anVrbEhwdw?oc=5"" target=""_blank"">Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon sebi,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,-0.38585,-0.38585,negative,1.0
2021-10-06,2021-10-06 07:00:00,Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges - Fortune India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.38585,-0.38585,negative,1.0
2021-10-06,2021-10-06 07:00:00,Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges - Fortune India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon chief Kiran Mazumdar-Shaw denies 'Pandora Papers' charges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fortune India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.38585,-0.38585,negative,1.0
2021-10-20,2021-10-20 06:46:50,EHS Certifications - Biocon,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE1MOThWd3lXdVE4ZmpwLW82eFBtWXNwaXRqb2tPZk1nRDRFenNkZ0lfU2dUdnc3bUJib1BXX0l2UE5NYllqMEZtU3EwTWJQaW5OWHpYSjNfNkphVXFTLWU1ZEpBT3dZTmVFcExUNjBhaXRET29vbUF3M3NLZEk?oc=5"" target=""_blank"">EHS Certifications</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE1MOThWd3lXdVE4ZmpwLW82eFBtWXNwaXRqb2tPZk1nRDRFenNkZ0lfU2dUdnc3bUJib1BXX0l2UE5NYllqMEZtU3EwTWJQaW5OWHpYSjNfNkphVXFTLWU1ZEpBT3dZTmVFcExUNjBhaXRET29vbUF3M3NLZEk?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-10-20,2021-10-20 06:46:50,EHS Certifications - Biocon,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE1MOThWd3lXdVE4ZmpwLW82eFBtWXNwaXRqb2tPZk1nRDRFenNkZ0lfU2dUdnc3bUJib1BXX0l2UE5NYllqMEZtU3EwTWJQaW5OWHpYSjNfNkphVXFTLWU1ZEpBT3dZTmVFcExUNjBhaXRET29vbUF3M3NLZEk?oc=5"" target=""_blank"">EHS Certifications</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE1MOThWd3lXdVE4ZmpwLW82eFBtWXNwaXRqb2tPZk1nRDRFenNkZ0lfU2dUdnc3bUJib1BXX0l2UE5NYllqMEZtU3EwTWJQaW5OWHpYSjNfNkphVXFTLWU1ZEpBT3dZTmVFcExUNjBhaXRET29vbUF3M3NLZEk?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-11-29,2021-11-29 08:00:00,Joyeeta Chatterjee joins Biocon as VP - Human Resources - ETHRWorld.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Joyeeta Chatterjee joins Biocon as VP - Human Resources</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ETHRWorld.com</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon management change,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-11-29,2021-11-29 08:00:00,Joyeeta Chatterjee joins Biocon as VP - Human Resources - ETHRWorld.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Joyeeta Chatterjee joins Biocon as VP - Human Resources</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ETHRWorld.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxPOWJaeDhBY1lvSExPdThleUh6NklVdWlzWkkzQ1BiVUROd3pBSW9JcW5lM3lZXzg3LVBDZDBIaFdwa0xuemJwUmhFR0xrbWpQSjd6QW9JRVhLMVRxaU93b0ZUMGtyUlVQUWVsQUlBc3BxSVVoM2swSUU0SVh6enY5SjhLaDFURm9fVkZTUllMX053Nzg3ZVZ0UjFjeUljRktBb1p0R2dvbkl2MkdoVWYyRkRidnlpSWtZTjJveDJIQXJMbWhIMGlBakRSWHJNdjFKdGxYeVkxYlJNSV9oR1NEbzlqMjZZNk51VGNtMHU4MDJjaFlQY0R3ZWt30gGHAkFVX3lxTFBsSTFaVDNiRFI1VnBwVFBRY2NPMlgzbFNlNlJtNmJuUUx4WG4xcVVzWFdZTnpzQU9DRDVyRTcwWWczYkFVbFE0Y3dyaGpOUW1USF8tVXVpZWV5UVdZRnh6VXQ2VG15ZHZlWnJpNDJpdzV3dTdSb2FGVVlVMWdJdXFPSnhFajMtYlhOc3ZPVFRyam9LbVlWY0paRTNLRU4zVlBUNkdKMk15MDBaRGRrNURhZmk5aVJxS09hWk15U3ZPdHlNSWNIcFE5TWYyanpZU1N6LXVNTXBqcmZsbkVLc3BPNlRRN1BnLW1MUkM0VElZU21SMHdac1VhSVdScGNEdTFkU0JZNWRN?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon insider trading,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxPOWJaeDhBY1lvSExPdThleUh6NklVdWlzWkkzQ1BiVUROd3pBSW9JcW5lM3lZXzg3LVBDZDBIaFdwa0xuemJwUmhFR0xrbWpQSjd6QW9JRVhLMVRxaU93b0ZUMGtyUlVQUWVsQUlBc3BxSVVoM2swSUU0SVh6enY5SjhLaDFURm9fVkZTUllMX053Nzg3ZVZ0UjFjeUljRktBb1p0R2dvbkl2MkdoVWYyRkRidnlpSWtZTjJveDJIQXJMbWhIMGlBakRSWHJNdjFKdGxYeVkxYlJNSV9oR1NEbzlqMjZZNk51VGNtMHU4MDJjaFlQY0R3ZWt30gGHAkFVX3lxTFBsSTFaVDNiRFI1VnBwVFBRY2NPMlgzbFNlNlJtNmJuUUx4WG4xcVVzWFdZTnpzQU9DRDVyRTcwWWczYkFVbFE0Y3dyaGpOUW1USF8tVXVpZWV5UVdZRnh6VXQ2VG15ZHZlWnJpNDJpdzV3dTdSb2FGVVlVMWdJdXFPSnhFajMtYlhOc3ZPVFRyam9LbVlWY0paRTNLRU4zVlBUNkdKMk15MDBaRGRrNURhZmk5aVJxS09hWk15U3ZPdHlNSWNIcFE5TWYyanpZU1N6LXVNTXBqcmZsbkVLc3BPNlRRN1BnLW1MUkM0VElZU21SMHdac1VhSVdScGNEdTFkU0JZNWRN?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East - The New Indian Express,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01948051948051948,0.01948051948051948,neutral,1.0
2021-12-07,2021-12-07 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to sell medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - FDA Journey + Company News,Biocon collaboration,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialize speciality medicines in Middle East - Startup Story,"<a href=""https://news.google.com/rss/articles/CBMie0FVX3lxTE9pZ3B4bDRUcVpUVTBmdXhES2YzeXh3ZUZ2ME1OeW1vVkhCYXhQU0YyWWxjVlJVckxLWUVvMzVIS3VZWkhpbWZ0SlZYd1VqYjVIa1RZcnRGNXZYMHdHR3RPYWZMRHU0TkJ4c3kwVlEwNTZZcEFDbUhGSU10TQ?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialize speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Startup Story</font>",https://news.google.com/rss/articles/CBMie0FVX3lxTE9pZ3B4bDRUcVpUVTBmdXhES2YzeXh3ZUZ2ME1OeW1vVkhCYXhQU0YyWWxjVlJVckxLWUVvMzVIS3VZWkhpbWZ0SlZYd1VqYjVIa1RZcnRGNXZYMHdHR3RPYWZMRHU0TkJ4c3kwVlEwNTZZcEFDbUhGSU10TQ?oc=5,Google News - FDA Journey + Company News,Biocon licensing deal,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon expansion,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialize speciality medicines in Middle East - Startup Story,"<a href=""https://news.google.com/rss/articles/CBMie0FVX3lxTE9pZ3B4bDRUcVpUVTBmdXhES2YzeXh3ZUZ2ME1OeW1vVkhCYXhQU0YyWWxjVlJVckxLWUVvMzVIS3VZWkhpbWZ0SlZYd1VqYjVIa1RZcnRGNXZYMHdHR3RPYWZMRHU0TkJ4c3kwVlEwNTZZcEFDbUhGSU10TQ?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialize speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Startup Story</font>",https://news.google.com/rss/articles/CBMie0FVX3lxTE9pZ3B4bDRUcVpUVTBmdXhES2YzeXh3ZUZ2ME1OeW1vVkhCYXhQU0YyWWxjVlJVckxLWUVvMzVIS3VZWkhpbWZ0SlZYd1VqYjVIa1RZcnRGNXZYMHdHR3RPYWZMRHU0TkJ4c3kwVlEwNTZZcEFDbUhGSU10TQ?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma - ITP.net,"<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5"" target=""_blank"">Biocon to commercialise its speciality generic medicines in Middle East with Tabuk Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ITP.net</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNSG5FWGt1M0VpZXA5SDEzUHNxX2pvVUZzTmFuZnZvU0xHRGFpb0ZWUng3TnRLX0swc01wRy1kcHZiaW5ER3l1UHRUNUMxUXJXTjhoaklVWE5IcjhlV3l5ODhNVThUejI0bDJNSUk2WUc1X1NabWJWQjY3MGVHa0FycWRoMEpjM1JKeXNxZ0JPVDY4THVBS0FvTjA3aUk4Qko2Slg1U1JzY2hrMFpjYi1HQUVBTHd0akt5LXc?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-08,2021-12-08 08:00:00,Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East - ET HealthWorld,"<a href=""https://news.google.com/rss/articles/CBMi8AFBVV95cUxPMzVKNWlVemtRbHdXSC1qbHRkY0theGZNVnJQMWxUUTNaVW5OOXZNOFB0a0x4MWxwWXRGZ1pxZ3d3T0xiSzc1TzRDSzVuVEJZSW1SNGItTGRsaE5ETlVTbnN5ZGlocnFlN1llbHU1b3ZRYnlPemc3WnZWemZKYjM0OWJSZE9CMmJvclpTUzZuZHdEQjVPNHEtU2JEZnZUcEFoT0pPU05MR3R0QUR4bnNjTmNJT2YzdGtZNjZaUWk0d2RuejNGdDJHdlI1Umh1X0lBbWh5aFRyd21JTHRCSmhONWhpLTdXdXBsRXJQaGpSX2PSAfYBQVVfeXFMUE9oaklYTXFRTnE5a0k5cF8wcERPTElqWFlkRElQaEJjMWJOUmZtWS1iM3RvUXc4THpKU2laUHdoZFcxZ2xFb2dFeTFNT2NrbGp4ZlBBbTE5M04tdTJnNDBHVm1hQmJyQlN4cUFaMTZTYWtWRlNDNTJ5TGpKT0hwZDFTQ0FMQlhLNGN0Q2NDNEthcVdYbzJhNkJoM05tNmE2Tmhjd2ZXOUU0aFBWelR0RGlLam4yX1dJaGt4eFZpWEhMaEd3OG1KWnFJS3dZQWhVT2czejZWMzRBTzdHWFhZbmt4UU9yNnVRSDhoQW14Y2RlbnlLQVhB?oc=5"" target=""_blank"">Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2021-12-23,2021-12-23 08:00:00,Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon regulatory,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.23835,0.23835,positive,1.0
2021-12-23,2021-12-23 08:00:00,Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval - NDTV,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Says Clinical Study For Drug Itolizumab Initiated After Drug Regulator's Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NDTV</font>",https://news.google.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?oc=5,Google News - FDA Journey + Company News,Biocon clinical trial,FDA Journey + Company News,2017-01-01_to_2021-12-31,Other,Other,Other,1,False,True,0.23835,0.23835,positive,1.0
2022-01-05,2022-01-05 08:00:00,Serum’s Covidshield Technologies to merge with Biocon Biologics - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxNZG9sN2xJMl8zMjhZZ3NrSEVDZHk1ekU1UzN6T3JGc3FpTEVhc20tbWk3MUxqcnJ4bEFOYTVtSU0zSmxQa3NCSTFUN1hoRkRvR2RBWkFPdmJFcmZhRGJrNDllcUNoa3ptTTd4X2xoSFpYSjRubWFBQ0RZZHZ2Y0VtX1ZQWHRaX0xmQTBNWUdjbVNnb0VWcWRiSGZ4RTB0Y0VPQkN0OVF4M1A5bVB1VmZBSklSVDFuQWIwNkJ6b0Jhdw?oc=5"" target=""_blank"">Serum’s Covidshield Technologies to merge with Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxNZG9sN2xJMl8zMjhZZ3NrSEVDZHk1ekU1UzN6T3JGc3FpTEVhc20tbWk3MUxqcnJ4bEFOYTVtSU0zSmxQa3NCSTFUN1hoRkRvR2RBWkFPdmJFcmZhRGJrNDllcUNoa3ptTTd4X2xoSFpYSjRubWFBQ0RZZHZ2Y0VtX1ZQWHRaX0xmQTBNWUdjbVNnb0VWcWRiSGZ4RTB0Y0VPQkN0OVF4M1A5bVB1VmZBSklSVDFuQWIwNkJ6b0Jhdw?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-08,2022-01-08 00:39:13,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE5hMkU2eHdFWUtGR1VlRGN1YVJ3dXpyX2drUmlwYy1vM2RMdXg5TEY3Z0tWckM1bGZpWm5xVjZPdGhZME5sbmViX2FVZWYzVjlTX2taUWhCQXZQNDZodXI0MHlvVk5yYXp6?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30994090909090904,0.30994090909090904,positive,1.0
2022-01-14,2022-01-14 08:00:00,"Exclusive | Biocon, Mylan biosimilar deal in last leg; Serum Institute to buy additional stake of $500... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Exclusive | Biocon, Mylan biosimilar deal in last leg; Serum Institute to buy additional stake of $500...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMipgJBVV95cUxQUDF3T1JPOWFmc2VKZzRpbFl3c1REdmQxWVN3V2tVOUxXRmd1SmhmMHNDRGU0Nnl1c1NBWF80OFZLaVV0c1lvYjlKZnRWb29NYnVqX3lCU2xzem9aUHZzNWtxanZvdlV0M2dHWEh4eHBqTDR2ZlFaUWd5MVpfSTBXaGV2cmhraklnUTltVVh1Q2VKa0FtN3Q2eHJLZlNCMFBNOHdUNlJxVExhZ3YzcXFMQ1BJWG9hOWR5YUJqcWMxWm9IWHJxS0k1YmpkU3VPNGZYVUVLVnRvN0VoQWNkUmw4MG5LMkoydXNSQzBCbUdvN25iYjI1SVpjb2V1ajJUN3JHbWFtRkJPNGstWEZ3VDdjeEJFcElxNTZ4YXExbEFyNGtVVFNySUHSAasCQVVfeXFMTVM3Z21PRm5rWU5JZmhCcVRqZGotUEhad21zX2xQZjJKQXFWX012MEZRTGhmN3UtbUdfaXBzeTlabVRaMEpVVnNfYmdQeWdUWVhWTUlKUW5qZ0pnWmZsQXI5b2pQR3hfcE1fb1V0VEZzbmZDOHk4S01tX3hFdUZib18yVTR1Um1lX1BSb0FTZzhqZmxCeUNNNnQ0V2M0Mzl3c005OHFjSndZbWNVOV81SFVyaXNGVzJZRENVVkVaRWgtbHl4V0xFN2FHNDAxOWd5eXdnMVlOUzE0VjBDeVZoeFJUcHRISThUUG5qamc1VEViTVprNXAtTGJYTF91UzFxWnVoQXNiVlV1LW51VUk5NmlMWkRqb19Xd0VEakVITENBOXVrYmJJMUZYR2M?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.064,0.064,neutral,1.0
2022-01-14,2022-01-14 08:00:00,"Exclusive | Biocon, Mylan biosimilar deal in last leg; Serum Institute to buy additional stake of $500... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Exclusive | Biocon, Mylan biosimilar deal in last leg; Serum Institute to buy additional stake of $500...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.064,0.064,neutral,1.0
2022-01-26,2022-01-26 08:00:00,MRC Cleanrooms to design and build facility for Biocon - Cleanroom Technology,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQZ3RfQ1hKcTF6alhUZ3QzalZsVHlJYUJ6VG91YnNOcTRYZFZwbmo5ZE1faWtfVDUzcEpFLXAwVUVaaUEwZTFyRXRIQmkyOTZXQWhoRTBaSTlQalVLTk1DYUlCMllVRXkxX3lyYTJuYUxrMmk2RXJTV29uc0VsSEZPZzZNcmplc0VQdGNJR3hoTXFhSzd4Tk9yZA?oc=5"" target=""_blank"">MRC Cleanrooms to design and build facility for Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Cleanroom Technology</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxQZ3RfQ1hKcTF6alhUZ3QzalZsVHlJYUJ6VG91YnNOcTRYZFZwbmo5ZE1faWtfVDUzcEpFLXAwVUVaaUEwZTFyRXRIQmkyOTZXQWhoRTBaSTlQalVLTk1DYUlCMllVRXkxX3lyYTJuYUxrMmk2RXJTV29uc0VsSEZPZzZNcmplc0VQdGNJR3hoTXFhSzd4Tk9yZA?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-06,2022-02-06 14:59:52,Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTXdaNGlqSTYyOWFCb0VfQVFlOXo0elBoN2M1SEdrakNfZDAxUkxMV2tXaldTR3V5WFBoZEpRR1ozRUFOdmxRbHJTRnY1YmlDNnJBaTdZS2tiQWQwSC1WU3hyMW1DendMZ0pOVGpTdW9lOV9VYUxCZWdkak9FRWRYZTZEcG42Y3BiZENrU2RYWGp3TS0wUDBjTWpBZUoxaU1qTFF0RVd1YkZZaHM?oc=5"" target=""_blank"">Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTXdaNGlqSTYyOWFCb0VfQVFlOXo0elBoN2M1SEdrakNfZDAxUkxMV2tXaldTR3V5WFBoZEpRR1ozRUFOdmxRbHJTRnY1YmlDNnJBaTdZS2tiQWQwSC1WU3hyMW1DendMZ0pOVGpTdW9lOV9VYUxCZWdkak9FRWRYZTZEcG42Y3BiZENrU2RYWGp3TS0wUDBjTWpBZUoxaU1qTFF0RVd1YkZZaHM?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-06,2022-02-06 14:59:52,Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTXdaNGlqSTYyOWFCb0VfQVFlOXo0elBoN2M1SEdrakNfZDAxUkxMV2tXaldTR3V5WFBoZEpRR1ozRUFOdmxRbHJTRnY1YmlDNnJBaTdZS2tiQWQwSC1WU3hyMW1DendMZ0pOVGpTdW9lOV9VYUxCZWdkak9FRWRYZTZEcG42Y3BiZENrU2RYWGp3TS0wUDBjTWpBZUoxaU1qTFF0RVd1YkZZaHM?oc=5"" target=""_blank"">Biocon Enters Prestigious Dow Jones Sustainability Emerging Markets Index</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQTXdaNGlqSTYyOWFCb0VfQVFlOXo0elBoN2M1SEdrakNfZDAxUkxMV2tXaldTR3V5WFBoZEpRR1ozRUFOdmxRbHJTRnY1YmlDNnJBaTdZS2tiQWQwSC1WU3hyMW1DendMZ0pOVGpTdW9lOV9VYUxCZWdkak9FRWRYZTZEcG42Y3BiZENrU2RYWGp3TS0wUDBjTWpBZUoxaU1qTFF0RVd1YkZZaHM?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-27,2022-02-27 08:00:00,Biocon to Buy Viatris’ Biosimilars Assets for up to $3.335B - Bloomberg.com,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxNcW1QRDJfSFFhY2tkZDFFdkllZ0prdHpYNjhUUmNubmVaQkRmeEtWZy1KWi1fd0RJVWRCSzhVemQ3WkdyODdFel9OWTRkMHRuY2hOcmttR1F1NS03QmtVZHAxUkcxWTNZZ1JCRTdPRGxhVlNpV1JKUFhqWFRxLUdBRVlWU1BTVlhobnFodW1pc1IzclFURHNLOWEyZFQtNFQwYmNOOWlVQmVlS0xi?oc=5"" target=""_blank"">Biocon to Buy Viatris’ Biosimilars Assets for up to $3.335B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bloomberg.com</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxNcW1QRDJfSFFhY2tkZDFFdkllZ0prdHpYNjhUUmNubmVaQkRmeEtWZy1KWi1fd0RJVWRCSzhVemQ3WkdyODdFel9OWTRkMHRuY2hOcmttR1F1NS03QmtVZHAxUkcxWTNZZ1JCRTdPRGxhVlNpV1JKUFhqWFRxLUdBRVlWU1BTVlhobnFodW1pc1IzclFURHNLOWEyZFQtNFQwYmNOOWlVQmVlS0xi?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxPMXltMm1ZNVRwMWV1Z1ZvQXJhcE1NakVTZnoyb1cxcTlGOERmWUtjTXFRc2ptemZSY0o0blJSbUFnVTd0RExWUTRfRy1GQWM5dFJBenQ0bmlvZEFEVXRGVXNGckJ6N1ZYX09DRDhRU1l1QW1rTlVlQjFOSm5XOWJSVXJkTWNTdHdFQ1RmekRFNURXNzdlaldXaGpJV29DTzFBVnJTM2R3ZXZzRU9PTW81X0w2M2k4NFkwaDE4OUg1RkVpUmdJdTRBRzZ6WVFSVk1zTG9BcXVXMDJ5TkJJdW1Ybndkd0o0TDNiQU5ILQ?oc=5"" target=""_blank"">Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxPMXltMm1ZNVRwMWV1Z1ZvQXJhcE1NakVTZnoyb1cxcTlGOERmWUtjTXFRc2ptemZSY0o0blJSbUFnVTd0RExWUTRfRy1GQWM5dFJBenQ0bmlvZEFEVXRGVXNGckJ6N1ZYX09DRDhRU1l1QW1rTlVlQjFOSm5XOWJSVXJkTWNTdHdFQ1RmekRFNURXNzdlaldXaGpJV29DTzFBVnJTM2R3ZXZzRU9PTW81X0w2M2k4NFkwaDE4OUg1RkVpUmdJdTRBRzZ6WVFSVk1zTG9BcXVXMDJ5TkJJdW1Ybndkd0o0TDNiQU5ILQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to Acquire Viatris’ Biosimilars Assets - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to Acquire Viatris’ Biosimilars Assets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.08895,0.08895,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to acquire Viatris Inc’s biosimilars biz for USD 3.33 bn - Trade Brains,"<a href=""https://news.google.com/rss/articles/CBMiZEFVX3lxTE9ENzhxOVRwZUlrYnoyZDdoZHJIVHNCbkpNYXQ3NTd3VzZuYTFNeXdOWTdWczBJV1FYTUx2ODJkcVJoY05DZUk2am5oTVk3RmQzTlUtNkYwNnRDZS1rQmNTUXV0ZGc?oc=5"" target=""_blank"">Biocon Biologics to acquire Viatris Inc’s biosimilars biz for USD 3.33 bn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Trade Brains</font>",https://news.google.com/rss/articles/CBMiZEFVX3lxTE9ENzhxOVRwZUlrYnoyZDdoZHJIVHNCbkpNYXQ3NTd3VzZuYTFNeXdOWTdWczBJV1FYTUx2ODJkcVJoY05DZUk2am5oTVk3RmQzTlUtNkYwNnRDZS1rQmNTUXV0ZGc?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxPMXltMm1ZNVRwMWV1Z1ZvQXJhcE1NakVTZnoyb1cxcTlGOERmWUtjTXFRc2ptemZSY0o0blJSbUFnVTd0RExWUTRfRy1GQWM5dFJBenQ0bmlvZEFEVXRGVXNGckJ6N1ZYX09DRDhRU1l1QW1rTlVlQjFOSm5XOWJSVXJkTWNTdHdFQ1RmekRFNURXNzdlaldXaGpJV29DTzFBVnJTM2R3ZXZzRU9PTW81X0w2M2k4NFkwaDE4OUg1RkVpUmdJdTRBRzZ6WVFSVk1zTG9BcXVXMDJ5TkJJdW1Ybndkd0o0TDNiQU5ILQ?oc=5"" target=""_blank"">Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxPMXltMm1ZNVRwMWV1Z1ZvQXJhcE1NakVTZnoyb1cxcTlGOERmWUtjTXFRc2ptemZSY0o0blJSbUFnVTd0RExWUTRfRy1GQWM5dFJBenQ0bmlvZEFEVXRGVXNGckJ6N1ZYX09DRDhRU1l1QW1rTlVlQjFOSm5XOWJSVXJkTWNTdHdFQ1RmekRFNURXNzdlaldXaGpJV29DTzFBVnJTM2R3ZXZzRU9PTW81X0w2M2k4NFkwaDE4OUg1RkVpUmdJdTRBRzZ6WVFSVk1zTG9BcXVXMDJ5TkJJdW1Ybndkd0o0TDNiQU5ILQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics buys Viatris’ biosimilars business in $3.3 bln deal; Mazumdar-Shaw to continue as chairperson - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxNaHhReWZmTnBHUGJZaENIMGNVX3p5N1FCcWZTSFBMeG0xemNxX243SkNpcmx6LUtWSjJNVmdlbV85cG1weWkwWHo2aGp5VHRxeXpaeE1hbnM5dUg1UzV5cmlzOGk3Y2c5WERuX0cyVEY5N1BsRjh4ME1vMHhoTG1SYlFBMm9HT1pGMEstSlFmM0J6U0RTVGtTQ2ZiclY5WURqQVRTNXp4UGE0NUkzMnhweTI3MVN6Qkc2MkYyVnpOM2phVTRwX0llTndtNUlMT0wzQmRLbEVUY1pBLTZwdU5yOV84QUlzdHM4akNpYTRBZXlKUTM1dURaMldyUQ?oc=5"" target=""_blank"">Biocon Biologics buys Viatris’ biosimilars business in $3.3 bln deal; Mazumdar-Shaw to continue as chairperson</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxNaHhReWZmTnBHUGJZaENIMGNVX3p5N1FCcWZTSFBMeG0xemNxX243SkNpcmx6LUtWSjJNVmdlbV85cG1weWkwWHo2aGp5VHRxeXpaeE1hbnM5dUg1UzV5cmlzOGk3Y2c5WERuX0cyVEY5N1BsRjh4ME1vMHhoTG1SYlFBMm9HT1pGMEstSlFmM0J6U0RTVGtTQ2ZiclY5WURqQVRTNXp4UGE0NUkzMnhweTI3MVN6Qkc2MkYyVnpOM2phVTRwX0llTndtNUlMT0wzQmRLbEVUY1pBLTZwdU5yOV84QUlzdHM4akNpYTRBZXlKUTM1dURaMldyUQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to Acquire Viatris’ Biosimilars Assets - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to Acquire Viatris’ Biosimilars Assets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.08895,0.08895,neutral,1.0
2022-02-28,2022-02-28 08:00:00,Biocon Biologics to acquire Viatris’ biosimilars assets for $3.35 bn - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to acquire Viatris’ biosimilars assets for $3.35 bn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2022-02-28,2022-02-28 08:00:00,Viatris unloads biosimilar business to partner Biocon for $3.3B - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5"" target=""_blank"">Viatris unloads biosimilar business to partner Biocon for $3.3B</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPdDZLbV8tOWloQUJvQjh6SXJiT0ltM3ZHUnFtOWZDaDdzUlJTaS03bkFsOUFNdDd1OEFuczRUMWI4UUFvV0NaT3hYM0t6MGUxNFowbjR3VUxkc3JTdUlwNVFYNVBWRWVUcjhwdmd4QURpTWFFSUlLZ1lndUdHZXQxTG9IcVJ3cGhHLW9leUQwcUtrTC1l?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Viatris Sells Biosimilars Business to Biocon Biologics - AJMC,"<a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxNYnUwalhuNzU0alhEWWVHRXE3MF8zVUllOWpiNlh1M3NYTF93MUpPTEEwOFN4UHF6aThzQ1AxN3pFUXRTNzd0a2IwdVZBZDlQY3FaSl9oMVA2TXA1aWxCbnA4RnVlV2hiTWZXTzlRYjlmTERrU1JqUllJMWdJZG9lWlVxc0dmMkE?oc=5"" target=""_blank"">Viatris Sells Biosimilars Business to Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AJMC</font>",https://news.google.com/rss/articles/CBMihwFBVV95cUxNYnUwalhuNzU0alhEWWVHRXE3MF8zVUllOWpiNlh1M3NYTF93MUpPTEEwOFN4UHF6aThzQ1AxN3pFUXRTNzd0a2IwdVZBZDlQY3FaSl9oMVA2TXA1aWxCbnA4RnVlV2hiTWZXTzlRYjlmTERrU1JqUllJMWdJZG9lWlVxc0dmMkE?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Biocon Biologics Acquires Viatris’ Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5"" target=""_blank"">Biocon Biologics Acquires Viatris’ Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxNdGhMdGlEaFNyR2FraktxdWl3NzNaOTFZWlZDa2Nnb0RlNEZUS2I3RHJuRllsTUFad0ZpUTF2R1RMOWJRZjBXTDZ1WENEOGtaM2syRmwxbHlIX3NMZGRsUU9UelN1Q1htV0NEVnYxa1JpZmJwTkNSUTZKQm9xSElpTXJGOF8zeThzRzIwN2FVNlM5Q3lsMk1ld09LQjZJYnhoMTVQNGhKX29LcklDYUIxbVRJb082VmpiUXpyME1ZZ1RlNFJBUmo4Mlhn?oc=5"" target=""_blank"">Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxNdGhMdGlEaFNyR2FraktxdWl3NzNaOTFZWlZDa2Nnb0RlNEZUS2I3RHJuRllsTUFad0ZpUTF2R1RMOWJRZjBXTDZ1WENEOGtaM2syRmwxbHlIX3NMZGRsUU9UelN1Q1htV0NEVnYxa1JpZmJwTkNSUTZKQm9xSElpTXJGOF8zeThzRzIwN2FVNlM5Q3lsMk1ld09LQjZJYnhoMTVQNGhKX29LcklDYUIxbVRJb082VmpiUXpyME1ZZ1RlNFJBUmo4Mlhn?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Why the Biocon-Viatris deal has pleased no one | Stock Market News - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Why the Biocon-Viatris deal has pleased no one | Stock Market News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33666666666666667,0.33666666666666667,positive,1.0
2022-03-01,2022-03-01 08:00:00,Biocon Biologics Acquires Viatris’ Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5"" target=""_blank"">Biocon Biologics Acquires Viatris’ Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxNdGhMdGlEaFNyR2FraktxdWl3NzNaOTFZWlZDa2Nnb0RlNEZUS2I3RHJuRllsTUFad0ZpUTF2R1RMOWJRZjBXTDZ1WENEOGtaM2syRmwxbHlIX3NMZGRsUU9UelN1Q1htV0NEVnYxa1JpZmJwTkNSUTZKQm9xSElpTXJGOF8zeThzRzIwN2FVNlM5Q3lsMk1ld09LQjZJYnhoMTVQNGhKX29LcklDYUIxbVRJb082VmpiUXpyME1ZZ1RlNFJBUmo4Mlhn?oc=5"" target=""_blank"">Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxNdGhMdGlEaFNyR2FraktxdWl3NzNaOTFZWlZDa2Nnb0RlNEZUS2I3RHJuRllsTUFad0ZpUTF2R1RMOWJRZjBXTDZ1WENEOGtaM2syRmwxbHlIX3NMZGRsUU9UelN1Q1htV0NEVnYxa1JpZmJwTkNSUTZKQm9xSElpTXJGOF8zeThzRzIwN2FVNlM5Q3lsMk1ld09LQjZJYnhoMTVQNGhKX29LcklDYUIxbVRJb082VmpiUXpyME1ZZ1RlNFJBUmo4Mlhn?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-01,2022-03-01 08:00:00,Biocon Biologics Acquires Viatris’ Biosimilar Portfolio - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5"" target=""_blank"">Biocon Biologics Acquires Viatris’ Biosimilar Portfolio</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNWXlidXE5elVHajM4S1V5UklBSE5WVEFKM0pFSkp2X0hScjVLSUx5dFgzQWZZbXpCMDVzVXhmWmdIU09oN3drNHVnbHhCdDBwVUVKTmYxM0ZXVXYzSTMzTlRUZXU4dGlOY3kyYVpHcHJiWklvZjhpZkFKUFlOVTZ6UE9pRlBSZmh1MTBUVzduLWRiSU02TERJX0FxNHE?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2022-03-04,2022-03-04 07:08:22,Biocon Biologics to acquire Viatris’ biosimilar assets worth $3.34 billion - People Matters - HR News,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to acquire Viatris’ biosimilar assets worth $3.34 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42984999999999995,0.42984999999999995,positive,1.0
2022-03-18,2022-03-18 10:47:59,Transformational Deal to Acquire Viatris' Global Biosimilars Business - Biocon,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5"" target=""_blank"">Transformational Deal to Acquire Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-18,2022-03-18 10:47:59,Transformational Deal to Acquire Viatris' Global Biosimilars Business - Biocon,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5"" target=""_blank"">Transformational Deal to Acquire Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-18,2022-03-18 10:47:59,Transformational Deal to Acquire Viatris' Global Biosimilars Business - Biocon,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5"" target=""_blank"">Transformational Deal to Acquire Viatris' Global Biosimilars Business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQQ3RvSDIzeG1YSDUxSHBLM2VGZzlBVWhRMXJJd0tORDlkUGtOSTQ2eUJpX3dmazI1d3BvYVdqaTJVOWwtUXdwYWh0WDNsUXJtYmZLU0NENURoXzJ4V05QX2ZPT3ZPSG1WSTN2VGhQNDl1eHVvbEZYSXZVYVJRVUlwdE1ETUczUVQ2aE9sZzNwaGVXUU84NWgtOWotMUExQzlLRmV1Ul92bHRqeDhOZTA0?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-03-31,2022-03-31 07:00:00,Biocon chief Kiran Mazumdar-Shaw calls out growing religious divide in Karnataka - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon chief Kiran Mazumdar-Shaw calls out growing religious divide in Karnataka</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3954,0.3954,positive,1.0
2022-05-04,2022-05-04 07:00:00,Ireland regulator reports manufacturing deficiency at Biocon's plant - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Ireland regulator reports manufacturing deficiency at Biocon's plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-05-04,2022-05-04 07:00:00,Ireland regulator reports manufacturing deficiency at Biocon's plant - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Ireland regulator reports manufacturing deficiency at Biocon's plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-06-21,2022-06-21 07:00:00,Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval - outlookbusiness.com,"<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Biologics Denies Bribery Charge; Says Company Follows Regulatory Procedure For Product Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.1806,-0.1806,negative,1.0
2022-06-21,2022-06-21 07:00:00,Biocon denies allegation over bribery in DCGI office - Mint,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOaXNOWXVBSExVUFJzdXFnUXB0LU9JZEFYQ3hBV1FPU2xEWVpUbE5EelNTM2VvcWkyV3gtQXBNZGZvZlNXbkNuZGR1X044elJ4VWxSdF9fdnA4RjFLRW5od0FFZWpQdFJVR1k0MFJ3Tjh5bDVUN08tQTh2QjZhdDM0MEIzeDF1QzRadkMtVl9Jbm50alJtSlZITFpxZndZZUlLb2hrdnM1VGQ0dHU1YkdHYjJ30gG3AUFVX3lxTFBmZ0xXenFoUDdLd1o2YXFyR3dQU0ZSa1BzTzBqemtnVlJlMnVsVFFCNGpMeFJ4WUhoT3JOYlpXeXFIMGhTVlZ3WHM3Q0dlV1VtbUE4R0swWU5SU0drN3ItWEp5MXlzVFd2dktwMkh2a3ZOaW5CZGNZNmxiSWRod1RHY2JaSUdodnEzQXVCdE9DSU9oZ2RneTc2NFF6T0JTQm5pdUd3SmltVEEwLTNfZnZUM0ZwYVVIZw?oc=5"" target=""_blank"">Biocon denies allegation over bribery in DCGI office</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3404,-0.3404,negative,1.0
2022-06-21,2022-06-21 07:00:00,"CBI arrests officer for allegedly taking bribe from Biocon Biologics, company denies - The News Minute","<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI arrests officer for allegedly taking bribe from Biocon Biologics, company denies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.47368333333333335,-0.47368333333333335,negative,1.0
2022-06-21,2022-06-21 07:00:00,Biocon denies allegations it bribed regulator to waive diabetes drug's pivotal trial - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOTnpBcFZkY3lGQjZUODNQN0NWSUw5a29adnNXa3VTZkFodzhFT0kyMjNfVXJxS3AyX2Q3QTJlVEtiejRHWHRickZ0OXF4SFZVSXRVYk8yZDRmZkdsX00xT29QR2pPMGFOaWd5TG5HVklRa0sxVVpaNThUZU5BbG5HeEpqM09HaTVyU3BZUlV3Z0VZX0N3UlhxSE9Za3BKN1NuZUFLVThEckVYYzMtVUlBNnVB?oc=5"" target=""_blank"">Biocon denies allegations it bribed regulator to waive diabetes drug's pivotal trial</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxOTnpBcFZkY3lGQjZUODNQN0NWSUw5a29adnNXa3VTZkFodzhFT0kyMjNfVXJxS3AyX2Q3QTJlVEtiejRHWHRickZ0OXF4SFZVSXRVYk8yZDRmZkdsX00xT29QR2pPMGFOaWd5TG5HVklRa0sxVVpaNThUZU5BbG5HeEpqM09HaTVyU3BZUlV3Z0VZX0N3UlhxSE9Za3BKN1NuZUFLVThEckVYYzMtVUlBNnVB?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.17373333333333332,-0.17373333333333332,negative,1.0
2022-06-21,2022-06-21 07:00:00,Biocon subsidiary caught offering bribe to waive off trial of new drug - The Hindu,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxNU2Y0Y25ZUWZZTGs3d3lhVTN1eEVYYVdFREJwOGlqVmJvZk5wbENuWkNPdmgyN0M4cE54RndsZWUzdmZMSGZnSWVIcWl2VlJjQWs2VU1wV0hmODRtUjVFeFhYMS1rWTY1S3FLeHlEaFBlSDlPQ0lIQ3JmVWZ6VkZ0UHNYTzVLaTFGVHVHQkF2SGRHT29lS0VmQmw2LVdCdnBjUnI00gGqAUFVX3lxTFB5a19zQUV1NURoc3RfajQ3bk45b29tVEw3bEFTYjJGbHlad250cTNHWGEzLXRfbkJGSkRaU3lQZVJ3a0h1MU9jMkdId21ES21QRjJ1MW94NUpOcHZCcl9xZWdfQUU2Qld1eDl6YmNBMkg2VUZOTWRVcHh0YUJiUDdZMzRGdXN0S0hwRExPdHRTcmxYUE42bmk3Wk5BRnBmUGswZzF3STZjYnl3?oc=5"" target=""_blank"">Biocon subsidiary caught offering bribe to waive off trial of new drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxNU2Y0Y25ZUWZZTGs3d3lhVTN1eEVYYVdFREJwOGlqVmJvZk5wbENuWkNPdmgyN0M4cE54RndsZWUzdmZMSGZnSWVIcWl2VlJjQWs2VU1wV0hmODRtUjVFeFhYMS1rWTY1S3FLeHlEaFBlSDlPQ0lIQ3JmVWZ6VkZ0UHNYTzVLaTFGVHVHQkF2SGRHT29lS0VmQmw2LVdCdnBjUnI00gGqAUFVX3lxTFB5a19zQUV1NURoc3RfajQ3bk45b29tVEw3bEFTYjJGbHlad250cTNHWGEzLXRfbkJGSkRaU3lQZVJ3a0h1MU9jMkdId21ES21QRjJ1MW94NUpOcHZCcl9xZWdfQUU2Qld1eDl6YmNBMkg2VUZOTWRVcHh0YUJiUDdZMzRGdXN0S0hwRExPdHRTcmxYUE42bmk3Wk5BRnBmUGswZzF3STZjYnl3?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.14544545454545454,-0.14544545454545454,negative,1.0
2022-06-21,2022-06-21 07:00:00,CBI arrests Joint drug controller for allegedly taking Rs. 4 lakh bribe to clear Biocon Biologics’s diabetes injection; company denies - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMingJBVV95cUxNTUtOOTZURzhtUnN0dXA4Z2lmTzJfSmc1TXltTHg1anA1dExqeS1BMW5FSWR3Y21xY29lOEFIcUw4YnhfeFM5ZjFSeVVoSkFGWGlxcjY3NkUwMTZXUXNwNEFFYWxHWlh1Z2hSUXYtUGoxeFQtWktuZGppY01BbmVOOUJBN093QUVrSmtEUXZEelpTeDFGZjlhd1Y1clNnOFZVMG44Z19EYUctT3c4dkwtb3ZyMFVZSWppVEEyZkhwV3BHWjlRaTNCdDhKMTNqRGZSRjZrZ0ZTdkNKUDFhc1VDOFY1Wk54UmMxaWVjQ2lDX2QwNlRCaHNXVk5sek9QRERJQjVaWHJQbmQ1NjFobHg3bzNXVmlsYXRMaHhTZlpn?oc=5"" target=""_blank"">CBI arrests Joint drug controller for allegedly taking Rs. 4 lakh bribe to clear Biocon Biologics’s diabetes injection; company denies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMingJBVV95cUxNTUtOOTZURzhtUnN0dXA4Z2lmTzJfSmc1TXltTHg1anA1dExqeS1BMW5FSWR3Y21xY29lOEFIcUw4YnhfeFM5ZjFSeVVoSkFGWGlxcjY3NkUwMTZXUXNwNEFFYWxHWlh1Z2hSUXYtUGoxeFQtWktuZGppY01BbmVOOUJBN093QUVrSmtEUXZEelpTeDFGZjlhd1Y1clNnOFZVMG44Z19EYUctT3c4dkwtb3ZyMFVZSWppVEEyZkhwV3BHWjlRaTNCdDhKMTNqRGZSRjZrZ0ZTdkNKUDFhc1VDOFY1Wk54UmMxaWVjQ2lDX2QwNlRCaHNXVk5sek9QRERJQjVaWHJQbmQ1NjFobHg3bzNXVmlsYXRMaHhTZlpn?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3592,-0.3592,negative,1.0
2022-06-22,2022-06-22 07:00:00,Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-06-22,2022-06-22 07:00:00,Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5"" target=""_blank"">Product approvals legitimate: Biocon after CBI detains CDSCO officials in kickback case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOXzB3RUJSTENoQkRnaHZTekxaUmtDNlpZOGxqRDg4clhBQ3BhZXVsbTg0N0dnVktLS2pVRWFuVUxPelZJZ2gyZHN0TUI0eXRORldNTXdaSjNEcFVXRGdEWEpxM2h3N3IteFFBbWo1bHZDV1JLQmIxZlJfelN1Rm4wUnBqQUFOMkhyWDZGbFR5U2RiS1pBenVyMjhDYi1fMXJ2UDhDOUpjZ1hKZXdURVJUWXdFMTg2aHc5RUotUlN1NDVKUElGMW9YRzlRNmtXWDBzZGFhNnFYN2_SAd4BQVVfeXFMTnZWLVBGZldIc0FHMEt3ZjlTajhaMllXOWpxOGJOZG9YdG5XY1QwcEhZb2RyckJfdW44SU9raHJPRDNid21jNTBYcDhsd2VQRk5xdnM5LW1uQXM2YVRkcVRjMkRFR21Ob2JlUGRCSklFWFh6Z2xhYVBRS2RMYVB2UXd2UWs4enZEMEpYODdRa2c3bDVKVDhYVnlXNmVNNkh0azFjV2J3dlZGMkctd1YxTDNnWDIxOUZZMkFneEppWE1oam04aEN4ZXdnTUx5a1BrdDVPM0t2NU5PZVNKTllR?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-06-23,2022-06-23 07:00:00,"CBI arrests Biocon executive, four others in bribery case - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI arrests Biocon executive, four others in bribery case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.30469545454545455,-0.30469545454545455,negative,1.0
2022-06-23,2022-06-23 07:00:00,"CBI arrests Biocon executive, four others in bribery case - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI arrests Biocon executive, four others in bribery case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.30469545454545455,-0.30469545454545455,negative,1.0
2022-06-29,2022-06-29 07:00:00,Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to buy 26% stake in AMPYR Renewable Energy Resources Eleven</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2022-06-29,2022-06-29 07:00:00,Biocon bribery case: CBI moves Delhi HC for custody of accused officials - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bribery case: CBI moves Delhi HC for custody of accused officials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26335,-0.26335,negative,1.0
2022-06-29,2022-06-29 07:00:00,Biocon bribery case: CBI moves Delhi HC for custody of accused officials - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon bribery case: CBI moves Delhi HC for custody of accused officials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26335,-0.26335,negative,1.0
2022-06-30,2022-06-30 07:00:00,Biocon hires law firm for governance review after CBI arrests - Deccan Herald,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxOMU1Ta1pUNnFwTTBmSjJuZy1RNWhzR01pLTBVRFNRdEJCYTAxLTBYT0UxaFppUXo3SGJILTVDX0hPRkhkZUZucXVpQnpkY2VZd1dWbkFOaFVzMnZoZGhfZUJFYVY4OTlBeDFaMEk5UVpuWXp3LWV0Vll0RnhycnlRcmRlZWNfaVZDUTZjZzhpYW1ibjl6TFVTU2FJdmhkb1paTWdFRTlOMjlyeGYta2IyTmpR?oc=5"" target=""_blank"">Biocon hires law firm for governance review after CBI arrests</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Deccan Herald</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxOMU1Ta1pUNnFwTTBmSjJuZy1RNWhzR01pLTBVRFNRdEJCYTAxLTBYT0UxaFppUXo3SGJILTVDX0hPRkhkZUZucXVpQnpkY2VZd1dWbkFOaFVzMnZoZGhfZUJFYVY4OTlBeDFaMEk5UVpuWXp3LWV0Vll0RnhycnlRcmRlZWNfaVZDUTZjZzhpYW1ibjl6TFVTU2FJdmhkb1paTWdFRTlOMjlyeGYta2IyTmpR?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.28686666666666666,-0.28686666666666666,negative,1.0
2022-07-05,2022-07-05 07:00:00,Biocon Biologics receives EU GMP certification for its new biologics manufacturing facility in Bengaluru - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxNY0ZYcUZDcVNDTXl5QzhaR0NCUjl1dEZnNkZVN2dZckdtQ0wxeWxRNmRHN2tQWGw4R2JVSC10MXFsLWVLWHlUOVlodEVGNHpEd25tQUtQT0JMc1ZJQ0FBVm5tdGp2TWdRSkpXemtRazZvdXRPWWlwTmxid0VfeVFlcWp4NGR0N0NsdHBtQ29PTnUtX20yRHVtZVJsajA1RWdPbHpSanlrUk81UldhZDFHLVBoZERDd1E2bjVVYzl0NnFKWmdDWXdCWXQ2bk9ocVRCckRvcjdkWUVVbXpjRnU4WXd5V0Z1eHRwUzM4Y3RxRk9fSEZESTlBa2tn?oc=5"" target=""_blank"">Biocon Biologics receives EU GMP certification for its new biologics manufacturing facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxNY0ZYcUZDcVNDTXl5QzhaR0NCUjl1dEZnNkZVN2dZckdtQ0wxeWxRNmRHN2tQWGw4R2JVSC10MXFsLWVLWHlUOVlodEVGNHpEd25tQUtQT0JMc1ZJQ0FBVm5tdGp2TWdRSkpXemtRazZvdXRPWWlwTmxid0VfeVFlcWp4NGR0N0NsdHBtQ29PTnUtX20yRHVtZVJsajA1RWdPbHpSanlrUk81UldhZDFHLVBoZERDd1E2bjVVYzl0NnFKWmdDWXdCWXQ2bk9ocVRCckRvcjdkWUVVbXpjRnU4WXd5V0Z1eHRwUzM4Y3RxRk9fSEZESTlBa2tn?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2022-07-05,2022-07-05 07:00:00,"Biocon Biologics bags EU GMP certificate for its facility at Biocon Park, Bengaluru - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxPZzVKc2Y1aW42OFRGMFV0Rm02UjRnV0NYOU95Ym1xWVRqdE8tZjJoZnM5el9ZRWNYOHVpbERkN2VRM1ZhTldHT2NMc0UxRkVqS0p4bDdYMTYyaFJYeGNqejBpdXpyRUE2a3ByMDktM091MUg5N09hRkdXY0VDT1VsaW5aMnJJRmtrTENaUlNCeG9zeUk3SWJLLWxCZ3RodDJfankwSWdjbUFSeG1zdjFreDdrLVNsSzNqbWFQZ2JydE5Bd0ZVUGVtRDMySGttZE0?oc=5"" target=""_blank"">Biocon Biologics bags EU GMP certificate for its facility at Biocon Park, Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxPZzVKc2Y1aW42OFRGMFV0Rm02UjRnV0NYOU95Ym1xWVRqdE8tZjJoZnM5el9ZRWNYOHVpbERkN2VRM1ZhTldHT2NMc0UxRkVqS0p4bDdYMTYyaFJYeGNqejBpdXpyRUE2a3ByMDktM091MUg5N09hRkdXY0VDT1VsaW5aMnJJRmtrTENaUlNCeG9zeUk3SWJLLWxCZ3RodDJfankwSWdjbUFSeG1zdjFreDdrLVNsSzNqbWFQZ2JydE5Bd0ZVUGVtRDMySGttZE0?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-07-07,2022-07-07 07:00:00,Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru - Microbioz India,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxPMDl5Rk91T2ZWZUVYNTBCQUtVcmtWZTVjYTNxN01xbDV5Nkl0V01HRTJ5MWxQTVZhcllnZTBUQ2hQV0Z5eEdUd2x3d3pPeFRObFdpdFk4d0Q2ZGRob2YycG1aQ0pWdUh5blNDNHB4UlFKTXYzRDZkTTkyVGVYcUZmdTRjZmVKNXNPNVRWUDRXbzBOV0FpcTU2MEdXVUtvLXF3NDk4bGlfVzlxLUFEQ1gxdGxfdW5DbnJ5Q24waDhxUmJsQ2w4NXc3cXU3dmE?oc=5"" target=""_blank"">Biocon Biologics Receives EU GMP Certification for Its New Biologics Manufacturing Facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Microbioz India</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxPMDl5Rk91T2ZWZUVYNTBCQUtVcmtWZTVjYTNxN01xbDV5Nkl0V01HRTJ5MWxQTVZhcllnZTBUQ2hQV0Z5eEdUd2x3d3pPeFRObFdpdFk4d0Q2ZGRob2YycG1aQ0pWdUh5blNDNHB4UlFKTXYzRDZkTTkyVGVYcUZmdTRjZmVKNXNPNVRWUDRXbzBOV0FpcTU2MEdXVUtvLXF3NDk4bGlfVzlxLUFEQ1gxdGxfdW5DbnJ5Q24waDhxUmJsQ2w4NXc3cXU3dmE?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2022-07-18,2022-07-18 07:00:00,Biocon Briberygate: Company Used Middlewoman Guljit To Deliver Entire Bribe To Officials: CBI - newindian.in,"<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZTBOaTdKdHU0TXRqdHZYZ3NLWVdhLTktQnZScUpOOGRVUVFNZ2tySUQzZV90R0xqYm5xRF82dHFuemdpX0E5YTJiMUlkbkROZ01lazhwNU5iM2NiVlAtbjlRcEhldkx0UDVDaXZjMEZhNTEwY21QQVppRmUxY2FjWkpFdHAyRWZSWW53aVZ3YU01dVdJcm1RN1dRY05pQk1wWEhrRlpHTlRUMEdkd1pVS2JDTWhtWmVD?oc=5"" target=""_blank"">Biocon Briberygate: Company Used Middlewoman Guljit To Deliver Entire Bribe To Officials: CBI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newindian.in</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZTBOaTdKdHU0TXRqdHZYZ3NLWVdhLTktQnZScUpOOGRVUVFNZ2tySUQzZV90R0xqYm5xRF82dHFuemdpX0E5YTJiMUlkbkROZ01lazhwNU5iM2NiVlAtbjlRcEhldkx0UDVDaXZjMEZhNTEwY21QQVppRmUxY2FjWkpFdHAyRWZSWW53aVZ3YU01dVdJcm1RN1dRY05pQk1wWEhrRlpHTlRUMEdkd1pVS2JDTWhtWmVD?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.1909,-0.1909,negative,1.0
2022-07-22,2022-07-22 07:00:00,Biocon gets 3 USFDA observations for Hyderabad facility - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 3 USFDA observations for Hyderabad facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-08-25,2022-08-25 07:00:00,CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI files charge sheet in Rs 9 lakh Biocon Biologics bribery case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-08-25,2022-08-25 07:00:00,CBI files chargesheet in Biocon bribery case against five people - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxQMGFqTjRYeTQ3OG1HdjVpNFV1RmxLVDdUeUpVTHNOeU4xVGtpRDJSU3dwb05jbl9lUERXTUtxa25fa0JabVFMTXgzbDZoangwVEhzWkxhWVhJX2JEUEpyVk5sd3haN2t5aVdOLUNaeWFDRk5LWTNTRjV5NEdmQ3B1dGZVMndkRDFTRGZkcVl2TlgwN1A3TEE3TmIxZXpGaHQtQzFNQVRpaWRpQV9WZmloWlVvQ2ZUM3Y0bnVrNjlndGZpMkstMnNvaHdzOTJkQQ?oc=5"" target=""_blank"">CBI files chargesheet in Biocon bribery case against five people</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQMGFqTjRYeTQ3OG1HdjVpNFV1RmxLVDdUeUpVTHNOeU4xVGtpRDJSU3dwb05jbl9lUERXTUtxa25fa0JabVFMTXgzbDZoangwVEhzWkxhWVhJX2JEUEpyVk5sd3haN2t5aVdOLUNaeWFDRk5LWTNTRjV5NEdmQ3B1dGZVMndkRDFTRGZkcVl2TlgwN1A3TEE3TmIxZXpGaHQtQzFNQVRpaWRpQV9WZmloWlVvQ2ZUM3Y0bnVrNjlndGZpMkstMnNvaHdzOTJkQQ?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-08-25,2022-08-25 07:00:00,CBI files charge sheet in Biocon case - The Hindu,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxORHNtQzc4U29qUUtVT3BwTWVxbEdmSGVLblhGMkJwN3VONGU0LWVQdVVZaHlpR0E1Z0pULWxlRGZFUkZyMHR5di03YmNfWC1WWFpoVnU3Wk1LcEI4MlQtYTN1cG9qSVhpZ1c4ZWlONkRINHpYY2VFQWlDajRZUW9iR1dLMHV4N0JBVjB1UUlaVURKZlNoTjE4TTh0SWzSAaMBQVVfeXFMTUpLTmRLQVRQcDlVRGFRNFFsNElCNXRRX21KMEV5WllnQ2NHdTFIdTBhOTJ3SEdkMURHVWEyaVhsd2hKcDl6MnJqYlhMRXdrc3h5d2t5MC1SNHZWb1otbjJRY0xKQlpVc1cyWVlvbzZ4OEZOLWVkdHRMZWFZOWJ6SW1uYkc0RVE1c3BLbV9ha2JrZmR5d2JSZ1ZTb3JmVjl4cWM1WQ?oc=5"" target=""_blank"">CBI files charge sheet in Biocon case</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxORHNtQzc4U29qUUtVT3BwTWVxbEdmSGVLblhGMkJwN3VONGU0LWVQdVVZaHlpR0E1Z0pULWxlRGZFUkZyMHR5di03YmNfWC1WWFpoVnU3Wk1LcEI4MlQtYTN1cG9qSVhpZ1c4ZWlONkRINHpYY2VFQWlDajRZUW9iR1dLMHV4N0JBVjB1UUlaVURKZlNoTjE4TTh0SWzSAaMBQVVfeXFMTUpLTmRLQVRQcDlVRGFRNFFsNElCNXRRX21KMEV5WllnQ2NHdTFIdTBhOTJ3SEdkMURHVWEyaVhsd2hKcDl6MnJqYlhMRXdrc3h5d2t5MC1SNHZWb1otbjJRY0xKQlpVc1cyWVlvbzZ4OEZOLWVkdHRMZWFZOWJ6SW1uYkc0RVE1c3BLbV9ha2JrZmR5d2JSZ1ZTb3JmVjl4cWM1WQ?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-01,2022-09-01 07:00:00,"FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5"" target=""_blank"">FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-01,2022-09-01 07:00:00,"FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5"" target=""_blank"">FDA slaps Biocon following inspections of biosimilar production sites in India, Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNdzVWY0FTVzAwR3dkNkg1eVhFajNMRmpNaUlnRjM1MWh6TkhsVkt4c0JHcnZ4T29yRF9wdGFGSDMxYlR3ci1VWExnOFBlYk50a241NnhTbGtvb2FoNkQxSjZmVk05N2RQMDFOUDVZbXlHQTFjV2ZWS05fZ25EU3drTDhfMk81eWhrZlpncFFpdnlJbmdya2NQZUlNaFBmU3k0ZnVWaW9meFh0MkpDc2c?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-02,2022-09-02 07:00:00,Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOX0dTWERCNTJlTS1namhfVjZmdFhvQVdmZzFxdHBIeTBDenNmdlQ0RWxCOWxhaDJPcVlKQ0hOcjEzakhTdS1CVFV6SjYySDF0bHB2ZnpFVmVGQ2VGOExoREUxS1pxWFEtM2x0a0szWWZMYXc1b01xWldQRzkxT0pCRS1XbjEtak5IYzZ3c3NoZUhSYldDYW50N09OMUJEUmFDcUswUkYtOUV2ckNUby1ENGw4MkdwZmJrekNEX1V3?oc=5"" target=""_blank"">Fierce Pharma Asia—Biocon's biosimilar production faults; Fosun unit's PD-1 plan; Takeda-Finch IBD severance</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOX0dTWERCNTJlTS1namhfVjZmdFhvQVdmZzFxdHBIeTBDenNmdlQ0RWxCOWxhaDJPcVlKQ0hOcjEzakhTdS1CVFV6SjYySDF0bHB2ZnpFVmVGQ2VGOExoREUxS1pxWFEtM2x0a0szWWZMYXc1b01xWldQRzkxT0pCRS1XbjEtak5IYzZ3c3NoZUhSYldDYW50N09OMUJEUmFDcUswUkYtOUV2ckNUby1ENGw4MkdwZmJrekNEX1V3?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.36755,-0.36755,negative,1.0
2022-09-06,2022-09-06 07:00:00,"Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal. Should you buy? - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal. Should you buy?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-06,2022-09-06 07:00:00,"Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal. Should you buy? - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon divests over ₹1,220 crore stake in Syngene International in bulk deal. Should you buy?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-06,2022-09-06 07:00:00,"Biocon sells 5.4% stake in arm Syngene International for Rs 1,220 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sells 5.4% stake in arm Syngene International for Rs 1,220 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-07,2022-09-07 07:00:00,Biocon Sells 5.4% Stake in Arm Syngene International - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMjJwbVJnOC11bkltRVhrelZieWJ6QjJDX3dJQy1nRDdxaDBrcjBpZVc4TFUzbHZ6LUxHRUxKNW5XSktJcGxBc0ViYW9lWGtJRUNsYjhfNWNETFA3Q19MMkJrcmN5OVFFZkZRS1k0SG5rS2tyVnlGV25Za2NKOUtTYldmaDVfZWYw?oc=5"" target=""_blank"">Biocon Sells 5.4% Stake in Arm Syngene International</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxPMjJwbVJnOC11bkltRVhrelZieWJ6QjJDX3dJQy1nRDdxaDBrcjBpZVc4TFUzbHZ6LUxHRUxKNW5XSktJcGxBc0ViYW9lWGtJRUNsYjhfNWNETFA3Q19MMkJrcmN5OVFFZkZRS1k0SG5rS2tyVnlGV25Za2NKOUtTYldmaDVfZWYw?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-09-08,2022-09-08 07:00:00,CBI chargesheet in Biocon case raises questions about how India manages drug trials - ThePrint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CBI chargesheet in Biocon case raises questions about how India manages drug trials</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ThePrint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-10-05,2022-10-05 07:00:00,"'What a disgrace': Biocon boss, Mohandas Pai upset as Bengaluru's Swachh ranking drops 15 spots - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">'What a disgrace': Biocon boss, Mohandas Pai upset as Bengaluru's Swachh ranking drops 15 spots</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.25178333333333336,-0.25178333333333336,negative,1.0
2022-10-17,2022-10-17 07:00:00,Biocon in pact with Japan’s Yoshindo to commercialise two biosimilar assets - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon in pact with Japan’s Yoshindo to commercialise two biosimilar assets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.08895,0.08895,neutral,1.0
2022-10-17,2022-10-17 07:00:00,Why Biocon Share Price is Falling - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxPeGVoRUZhTTFXeUpkYUYydURtbnRJN1JPOVYxWXVPYzBCT2NOZjNJWU1tNFRJMDcwaUotQjF2UkVTVi1CcEZiT1lFRGwyeG1YWFU2RDBHZFJfbF8xLURuNTY5S0M0cVBCbWFxQ0h1S1BWSWtCdFdmRVgwdzhEcU9FZkFDenlZLUVCWEJXZkd1dUJjaDRSdDJicUVVVlQtWnFVOS01cDZn?oc=5"" target=""_blank"">Why Biocon Share Price is Falling</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxPeGVoRUZhTTFXeUpkYUYydURtbnRJN1JPOVYxWXVPYzBCT2NOZjNJWU1tNFRJMDcwaUotQjF2UkVTVi1CcEZiT1lFRGwyeG1YWFU2RDBHZFJfbF8xLURuNTY5S0M0cVBCbWFxQ0h1S1BWSWtCdFdmRVgwdzhEcU9FZkFDenlZLUVCWEJXZkd1dUJjaDRSdDJicUVVVlQtWnFVOS01cDZn?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.21075,0.21075,positive,1.0
2022-10-17,2022-10-17 07:00:00,Why Biocon Share Price is Falling - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxPeGVoRUZhTTFXeUpkYUYydURtbnRJN1JPOVYxWXVPYzBCT2NOZjNJWU1tNFRJMDcwaUotQjF2UkVTVi1CcEZiT1lFRGwyeG1YWFU2RDBHZFJfbF8xLURuNTY5S0M0cVBCbWFxQ0h1S1BWSWtCdFdmRVgwdzhEcU9FZkFDenlZLUVCWEJXZkd1dUJjaDRSdDJicUVVVlQtWnFVOS01cDZn?oc=5"" target=""_blank"">Why Biocon Share Price is Falling</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxPeGVoRUZhTTFXeUpkYUYydURtbnRJN1JPOVYxWXVPYzBCT2NOZjNJWU1tNFRJMDcwaUotQjF2UkVTVi1CcEZiT1lFRGwyeG1YWFU2RDBHZFJfbF8xLURuNTY5S0M0cVBCbWFxQ0h1S1BWSWtCdFdmRVgwdzhEcU9FZkFDenlZLUVCWEJXZkd1dUJjaDRSdDJicUVVVlQtWnFVOS01cDZn?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.21075,0.21075,positive,1.0
2022-10-24,2022-10-24 07:00:00,"John Shaw, former Vice Chairman of Biocon, passes away at age 73 - YourStory.com","<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTFBmM1dsWFZ5UV94b1g0VUUzOENUMFBoTnhtNi1FdFd6LTFfRGdZT2o0VnF1QmtLZnQwSFk0WnROaVFXQ3BsUmR3LTB6VGctYlRzRWFodnRyb3F4YlhmSG5jckoyNXFZaGxjc0xOZDk1RVVOWWJUelBCSVFJZDlzLTA?oc=5"" target=""_blank"">John Shaw, former Vice Chairman of Biocon, passes away at age 73</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTFBmM1dsWFZ5UV94b1g0VUUzOENUMFBoTnhtNi1FdFd6LTFfRGdZT2o0VnF1QmtLZnQwSFk0WnROaVFXQ3BsUmR3LTB6VGctYlRzRWFodnRyb3F4YlhmSG5jckoyNXFZaGxjc0xOZDk1RVVOWWJUelBCSVFJZDlzLTA?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-10-24,2022-10-24 07:00:00,"John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away - Unique Times","<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQbkhiNVJaNGZlUmJEaFhwWnFFblRveFFBcTB5UXlkSmoxVkNycmxLOXJXMGlpclVxUDFBOEJDRXpFQUswSExGUGZxVEJOUl9MYnBMSFVtWHRkV3luZ2dLVS1mTlRicEk1ZC1ueTBYbW9BTzdZVWFoZTlnOWpKNnJ3VTh5M1dKMzZFcGc3c3A1bzQ1M0ti?oc=5"" target=""_blank"">John Shaw, husband of Biocon chief Kiran Mazumdar Shaw, passes away</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Unique Times</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQbkhiNVJaNGZlUmJEaFhwWnFFblRveFFBcTB5UXlkSmoxVkNycmxLOXJXMGlpclVxUDFBOEJDRXpFQUswSExGUGZxVEJOUl9MYnBMSFVtWHRkV3luZ2dLVS1mTlRicEk1ZC1ueTBYbW9BTzdZVWFoZTlnOWpKNnJ3VTh5M1dKMzZFcGc3c3A1bzQ1M0ti?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.09375,0.09375,neutral,1.0
2022-10-25,2022-10-25 07:00:00,"Devastated to lose my husband, says Biocon founder Kiran Mazumdar-Shaw - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQQTdUeTl0a1FkYnRpZmM2ZnNiUDdIa0QyZ1MtU2hENzk3eEVvWXc4Z2xfXzNLNVkyTW9uRFF5U0N1VTNqdmNvTGxqM2ROMXUyU3VBMVQ3ZEtpdkdFelNmTkxWQzRSeEZaMGRNVDVyVTlseWQ5UjlCQU5VZEphTnlGSXl6Tk1WY2ZnMVV6RzJYYVRRLVdRNlVwdi00OV9NNEt2YzFwcDZKQ0JMQ3NIRUo0encwRjl6eS1vTFl6QV9nV2VyT0NWWjlvdA?oc=5"" target=""_blank"">Devastated to lose my husband, says Biocon founder Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiyAFBVV95cUxQQTdUeTl0a1FkYnRpZmM2ZnNiUDdIa0QyZ1MtU2hENzk3eEVvWXc4Z2xfXzNLNVkyTW9uRFF5U0N1VTNqdmNvTGxqM2ROMXUyU3VBMVQ3ZEtpdkdFelNmTkxWQzRSeEZaMGRNVDVyVTlseWQ5UjlCQU5VZEphTnlGSXl6Tk1WY2ZnMVV6RzJYYVRRLVdRNlVwdi00OV9NNEt2YzFwcDZKQ0JMQ3NIRUo0encwRjl6eS1vTFl6QV9nV2VyT0NWWjlvdA?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.42775,-0.42775,negative,1.0
2022-11-29,2022-11-29 08:00:00,BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5"" target=""_blank"">BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,Biocon raises $1.2 billion green loan to fund purchase of Viatris unit - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxQaEROUGFQUzQ0SU14ZUNDdF9sMTNuREZYYVFocVVPTjk4MU1mblBQQkRobW9xWHppbTJNYWI2QklRVEpScDRjUjFEaUgtMEs2SnJUSmZrQndQTkpadE5kemtkYnI2VTU5VmRMOGF6bTVEU1AxSkRCNnBJQ0hWem16S1pQTFBYZTlxWGhuREhEN0pfU1ZHZEE4ajFjSjRkWWV2UzRBaTNyMWZQbDBkR00wcGREaE5lM2pCS1hJbHdWWGNTNEJ1ZzBDbTF5T0hUcWdOS29IRjFuSzFZbWRaODBlV0NDbkZwMDhXZndBd25vbXBWVDFkc3EtSXZB0gH_AUFVX3lxTE1xdmNOcjVxVmhIZkE2WEIwZmtGT3ZOQmRrUG4xTGxiOFhGeVExM0xJQ0FDcklTWU5EakN3UFNleTZfcFN3RjFLOGJ1MjB2WkZTOXQ2cVZrVnRLY3psY3BjTWZJR3VEMXgzVXZ4eHZCaEllekxVZVFrZVdvaVljdUFqQldka0c5TU0zQmMxbzlSSDZhYjcwWHoxVTBLaG93Q09pUUk5LTVYcmhJZlF2OXRCWmJQeFlTNHZXazRLcGVxZE1URld6Rk9aeU9PdG5UX1FTd2VRNGJ2cmRuZU9RaG5lSUZYMWZzVjZleTBtVnY3MDYtbDNaM2h1TVpHMEZhQQ?oc=5"" target=""_blank"">Biocon raises $1.2 billion green loan to fund purchase of Viatris unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxQaEROUGFQUzQ0SU14ZUNDdF9sMTNuREZYYVFocVVPTjk4MU1mblBQQkRobW9xWHppbTJNYWI2QklRVEpScDRjUjFEaUgtMEs2SnJUSmZrQndQTkpadE5kemtkYnI2VTU5VmRMOGF6bTVEU1AxSkRCNnBJQ0hWem16S1pQTFBYZTlxWGhuREhEN0pfU1ZHZEE4ajFjSjRkWWV2UzRBaTNyMWZQbDBkR00wcGREaE5lM2pCS1hJbHdWWGNTNEJ1ZzBDbTF5T0hUcWdOS29IRjFuSzFZbWRaODBlV0NDbkZwMDhXZndBd25vbXBWVDFkc3EtSXZB0gH_AUFVX3lxTE1xdmNOcjVxVmhIZkE2WEIwZmtGT3ZOQmRrUG4xTGxiOFhGeVExM0xJQ0FDcklTWU5EakN3UFNleTZfcFN3RjFLOGJ1MjB2WkZTOXQ2cVZrVnRLY3psY3BjTWZJR3VEMXgzVXZ4eHZCaEllekxVZVFrZVdvaVljdUFqQldka0c5TU0zQmMxbzlSSDZhYjcwWHoxVTBLaG93Q09pUUk5LTVYcmhJZlF2OXRCWmJQeFlTNHZXazRLcGVxZE1URld6Rk9aeU9PdG5UX1FTd2VRNGJ2cmRuZU9RaG5lSUZYMWZzVjZleTBtVnY3MDYtbDNaM2h1TVpHMEZhQQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5"" target=""_blank"">BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-29,2022-11-29 08:00:00,BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS - Biocon,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5"" target=""_blank"">BIOCON BIOLOGICS ACQUIRES VIATRIS' GLOBAL BIOSIMILARS BUSINESS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPTVMtb0dZVHduMEs2UXFCczJ4SWNfZ1YwZV91cHMzajQyMW84V0xfdnpfV3dPQjZWcmpBd2FBRzd2WUc3LUxkeFhoXzhZb2g3VXVWRHFQNFlkVVhEVUhJR3BqTmdpbnNtNmt4N1JqekpSSDBfRE5felpjT0EzdXM5NnhlR0hyQWFEVXN2MG1B?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon subsidiary acquires Viatris pharma for $3 billion - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires Viatris pharma for $3 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaS11R2xwQl9LZ3dBaUY2XzR0UnoyLU1zZWwyX2xjSF8wc0hYRldhNjVuMGh5WTBtZDhVSE9oR0tXc0tYMW9vZGRzZk05OHhxT0hDOXB6Ukc3T25NMjItT1ZwX1cyNmtfcHM3bGRJZDd4dERvb0EyYnhEVk9zV0ZKN3MybDhJR1BtQWhLOERSb1VyNENwUGZlVGlBaGl3R2lUb3NRak1CS0l4VnZscnlpNjVvWUpCU2Q0RXVr0gHAAUFVX3lxTFBCRXBwTVh3YUxIR1ZQWWZVel9PSGE4a3lXWk1jWnpfVmtYRDBhWF8wUm5Sc1hlQWpRWmd0NnBfODQyTTg5STdwcFVaQXZuUHBZeEdlX3A0VVJ6c0x5U2FuNGZVZDhOMVJZR3NZRHhacVNQWFRlTzNXZURKdXJLSTh3Q2lKLWZ5clVoQ19memw0b05yaVRfeUJrc0szUXlxejBNLVpkU0ZvZTVDTjRnMC1ZbXJORFlrZUpkUFJISnVUWQ?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon subsidiary acquires Viatris pharma for $3 billion - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires Viatris pharma for $3 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-11-30,2022-11-30 08:00:00,Biocon subsidiary acquires Viatris pharma for $3 billion - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon subsidiary acquires Viatris pharma for $3 billion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-12-02,2022-12-02 08:00:00,Biocon And Zentiva Sign Liraglutide Deal For 30 European Countries - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdzQ3UDhKSnNoNzRLVVVGUDhxR2xFRERiekxDXzl3YmpnbS1wY1dTbi1RZnF3YU5naDBRY2hiLWkxWVJMUVFPbmdNMmlfdFNRVFdUT203bkRRSU5DRjl5ekplUzllUGpaSjZuV25VN1FxbkhPc1BnYnBWVXNCOHFSaUNsTk5ETWV3eE5aUmVDZ3NUNC1tSFlfekRTdmI5Ykx3REQ2UmZOY1YzUQ?oc=5"" target=""_blank"">Biocon And Zentiva Sign Liraglutide Deal For 30 European Countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxOdzQ3UDhKSnNoNzRLVVVGUDhxR2xFRERiekxDXzl3YmpnbS1wY1dTbi1RZnF3YU5naDBRY2hiLWkxWVJMUVFPbmdNMmlfdFNRVFdUT203bkRRSU5DRjl5ekplUzllUGpaSjZuV25VN1FxbkhPc1BnYnBWVXNCOHFSaUNsTk5ETWV3eE5aUmVDZ3NUNC1tSFlfekRTdmI5Ykx3REQ2UmZOY1YzUQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-12-15,2022-12-15 09:08:52,Board of Directors - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxOVDhCRXk1WTUyV0NITng0enZPQ241U09BMDE5RjkzU0EzYjZQdk4tUFRkemdnako3VEhlU21jbjBCdTlHRldyUU55d0h6a3pfTVFRMUFjR1FXek11X3ladEw5NUdmZVhsWWc4eWJKRFlwaC1JbjJ3RG41Z0h1VGxJb0RoR25fZ1Z1Vnc?oc=5"" target=""_blank"">Board of Directors</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxOVDhCRXk1WTUyV0NITng0enZPQ241U09BMDE5RjkzU0EzYjZQdk4tUFRkemdnako3VEhlU21jbjBCdTlHRldyUU55d0h6a3pfTVFRMUFjR1FXek11X3ladEw5NUdmZVhsWWc4eWJKRFlwaC1JbjJ3RG41Z0h1VGxJb0RoR25fZ1Z1Vnc?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2022-12-15,2022-12-15 09:08:52,Board of Directors - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiigFBVV95cUxOVDhCRXk1WTUyV0NITng0enZPQ241U09BMDE5RjkzU0EzYjZQdk4tUFRkemdnako3VEhlU21jbjBCdTlHRldyUU55d0h6a3pfTVFRMUFjR1FXek11X3ladEw5NUdmZVhsWWc4eWJKRFlwaC1JbjJ3RG41Z0h1VGxJb0RoR25fZ1Z1Vnc?oc=5"" target=""_blank"">Board of Directors</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiigFBVV95cUxOVDhCRXk1WTUyV0NITng0enZPQ241U09BMDE5RjkzU0EzYjZQdk4tUFRkemdnako3VEhlU21jbjBCdTlHRldyUU55d0h6a3pfTVFRMUFjR1FXek11X3ladEw5NUdmZVhsWWc4eWJKRFlwaC1JbjJ3RG41Z0h1VGxJb0RoR25fZ1Z1Vnc?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-01-12,2023-01-12 08:00:00,"FDA rejects Biocon insulin biosimilar over data, manufacturing concerns - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5"" target=""_blank"">FDA rejects Biocon insulin biosimilar over data, manufacturing concerns</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5,Google News - Market + Complete Company News,Semglee FDA submission,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3753,-0.3753,negative,1.0
2023-01-12,2023-01-12 08:00:00,"FDA rejects Biocon insulin biosimilar over data, manufacturing concerns - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5"" target=""_blank"">FDA rejects Biocon insulin biosimilar over data, manufacturing concerns</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxONmphTnpGZUFmQkphZmdhLTIzaTNlNTZVRUhndTlfbnM2OU9Ta3ZXMGFoMVY2UGRVV0VoODFvSHVhLXJOaDBGMUtpLTVsOUh6c1pOMlZwVW1XcUlxVUZKSC05c3BPQzV3a2F1cl94SVZUb0VTdUxFcjczV1ZGbld4am5TVkVvVEhaanktSU5TLUZzZ1F2NmsxQ19VRk1Ldw?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3753,-0.3753,negative,1.0
2023-01-23,2023-01-23 12:37:34,"Biocon Ltd Share Price Today, BIOCON Share Price NSE, BSE - Business Today","<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE92OG8yZ3NXdWFkNlA5VjcxeW1MTERWaVFlUzk0SktRbDRsUXpGQXlfYTV4U3U1N0xMcXdNRmFTUmUtY1ZYdTEtNDc0R01zakFKckdVRnFvelZKNkUzRGlud0ZPdXo3XzhlMnJNY1VVU3hHVlh5cW5yQUM4R24?oc=5"" target=""_blank"">Biocon Ltd Share Price Today, BIOCON Share Price NSE, BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE92OG8yZ3NXdWFkNlA5VjcxeW1MTERWaVFlUzk0SktRbDRsUXpGQXlfYTV4U3U1N0xMcXdNRmFTUmUtY1ZYdTEtNDc0R01zakFKckdVRnFvelZKNkUzRGlud0ZPdXo3XzhlMnJNY1VVU3hHVlh5cW5yQUM4R24?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.38915,0.38915,positive,1.0
2023-02-01,2023-02-01 08:00:00,Biocon sells 10% stake in Syngene via open market - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon sells 10% stake in Syngene via open market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04,0.04,neutral,1.0
2023-02-10,2023-02-10 08:00:00,"TheCSRUniverse Interview with Dr Anupama Shetty, Mission Director, Biocon Foundation - TheCSRUniverse","<a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxNNktqblJYT2pWS18zV01xZjhzTmR4MGFram5ZZXdVSjI5aURUb1otS3BCODlpeDdkQU5PZjNJN19Rd3NqMkZiMUhxNG1NX3dwQXhiazNXYWRUVUs4WmdTWWV4dHJGM2pnQmNfVWpLem42Z1lmQjJPTHltZEctcktrM3VpZ21WVWlfZUFuaDZsM2ctRXEyN2VsX1BIeXlScnJMWHktYURnNFIxVUFaSnV3WlRnalhYNW9tRW1ZQk95a1NhSHVXZE1WUXZDR3lfbWZiTkFsVXRSMjhEa1dGSkE4N0dVR0tFQXpQaWFCRTdaVEhwNkdTN2ZGR1hOTjg1RXpIdVZoUGlscHRPdDFQakEwdA?oc=5"" target=""_blank"">TheCSRUniverse Interview with Dr Anupama Shetty, Mission Director, Biocon Foundation</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TheCSRUniverse</font>",https://news.google.com/rss/articles/CBMikAJBVV95cUxNNktqblJYT2pWS18zV01xZjhzTmR4MGFram5ZZXdVSjI5aURUb1otS3BCODlpeDdkQU5PZjNJN19Rd3NqMkZiMUhxNG1NX3dwQXhiazNXYWRUVUs4WmdTWWV4dHJGM2pnQmNfVWpLem42Z1lmQjJPTHltZEctcktrM3VpZ21WVWlfZUFuaDZsM2ctRXEyN2VsX1BIeXlScnJMWHktYURnNFIxVUFaSnV3WlRnalhYNW9tRW1ZQk95a1NhSHVXZE1WUXZDR3lfbWZiTkFsVXRSMjhEa1dGSkE4N0dVR0tFQXpQaWFCRTdaVEhwNkdTN2ZGR1hOTjg1RXpIdVZoUGlscHRPdDFQakEwdA?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5"" target=""_blank"">FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5"" target=""_blank"">FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2023-02-14,2023-02-14 08:00:00,"FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5"" target=""_blank"">FDA Issues CRL for Biocon Biologics, Viatris Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxNZzBzUGxKcmloU1A4ai1QaGpYbkxMMGFwOXFKR096d2dtWlN1alhKaW5MZG5JZWQtb3R4SXlwb3ZLbDlhWDY1NHFWT3ZtVUZCY0xzRk5lb2ZHUUo0ekhoTXpYdW1BNF9KTnl2Wjl4aXRvQzZHTG9wUWx6ckJTbnhtMzhLbzVLVzhJUUFTZy0tVDdlckktYW95QUJuZ0JHZw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.025,-0.025,neutral,1.0
2023-02-22,2023-02-22 08:00:00,"Kotak's alternative investment fund pumps in ₹1,070 cr in Biocon. Details here - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Kotak's alternative investment fund pumps in ₹1,070 cr in Biocon. Details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-02-22,2023-02-22 08:00:00,"Kotak's alternative investment fund pumps in ₹1,070 cr in Biocon. Details here - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Kotak's alternative investment fund pumps in ₹1,070 cr in Biocon. Details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-02-28,2023-02-28 08:00:00,Integrated Core Strategies (Asia) buys Biocon shares worth ₹185 cr - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Integrated Core Strategies (Asia) buys Biocon shares worth ₹185 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.46754999999999997,0.46754999999999997,positive,1.0
2023-02-28,2023-02-28 08:00:00,Integrated Core Strategies (Asia) buys Biocon shares worth ₹185 cr - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Integrated Core Strategies (Asia) buys Biocon shares worth ₹185 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.46754999999999997,0.46754999999999997,positive,1.0
2023-03-08,2023-03-08 08:00:00,"Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-03-08,2023-03-08 08:00:00,"Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies - Business Today","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNT1l6bWM4RUpwXzBCd2FXWllvelhYQktRUFdkUVQ4OGY2YjBjRWpyNW1VOG04RlBpY0pVU25tYkszdU9MeExtaEE0STV3VzBxSzgwOWo0WWQ0NUtlU0Ntck95aDFGVk9hZkhFbmZmOENYZDFxR3ZIYzVjVlUyRnUtcTNCMm1CVmo3VjFZMlJILW9BN0YwaEVrU3pSTWFaaW8xNXFUWUxDNWdrU1hXMWlvaDRsZG5NWk9XZlpvRzBLbWFjOEJMdEVtUlA1T3ozalE4VEpyQnVzTjlEQmZkX2tyLVk3Z19ILWs4WHR3WnE0Z9IB9AFBVV95cUxNMnZSVHp1dU56WnFqTlM0UTl4NnNFSVdpYnRQM1E0VjJHcnZyd1FnN1d2YXI3Z2Q5RUNmeU95UG1Cdnp6aThmT0c4bW8wZVdkdmRtb2xJRGdiVFRoZ0o3TEV2VjAyNEt6ZnhfX1RCeUFZYmpFTjVYaFN5bGVXTDh0M1JIR2hLNFA1LVpFWUl1Ynp2LU11WWw5VFRfRmhKRjEtRnh4UVc2SGJqRVdfa0cxZDBLdHFhdFBJY2Q2S0x0QTNmUjBmUlk5U1RocWh0TzZENWdLUnM3aGEzWUFoQVlnaC1XU2Y1RC1SYnNfNTBJWUhMYnBC?oc=5"" target=""_blank"">Nykaa, Westlife Foodworld, Biocon: Should you invest in stocks of these 7 women-led companies</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-03-23,2023-03-23 07:00:00,Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times - Hindustan Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Kiran Mazumdar-Shaw retires from Infosys board - Hindustan Times</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Hindustan Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-03-29,2023-03-29 07:00:00,Biocon Biologics wins ‘ABEA: Bioprocessing Excellence in South Asia’ Award - The News Minute,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics wins ‘ABEA: Bioprocessing Excellence in South Asia’ Award</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The News Minute</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5821500000000001,0.5821500000000001,positive,1.0
2023-03-29,2023-03-29 07:00:00,Biocon Biologics wins Bioprocessing Excellence in South Asia Award at ABEA 2023 - Express Pharma,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics wins Bioprocessing Excellence in South Asia Award at ABEA 2023</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5869,0.5869,positive,1.0
2023-04-24,2023-04-24 07:00:00,Biocon to consider issuance of NCDs on private placement basis on April 26 - Mint,"<a href=""https://news.google.com/rss/articles/CBMizwFBVV95cUxOaW05Ni1pY25CS1djNEpyX18yaGlHTmdUZW9LblVPd1paMVc3Si1SMXZzdy1UNEpMd1FaNTQzdV9YT1lKcEY2RzRwbmJPQjd0UmdubFVaNE1kbTJiaHBGTUU4RndRUUNkeDc0MUp0T1ROSjVxeTVhRnFhY3BqLW4xVVAydlh1Wno3R3VBMmdmMWV0ajNMS1FIOTdNaUt5WFAxMEw0REVxdGpMU1BKYmRTQlFfc2dtREFkTjc4Mnd4QlEwVHBkdF9FQ2xsRGdJRm_SAdQBQVVfeXFMT2xqbVNxM19BeGJ4d1ZTb2tqdDllT1d3bzdiLWdnalVPUm9valUtQngtem5OaFFVWXJzMHRORHJiT0ZmNGt2cU1tZTFBamQ0N1dVQUNQWlNCMlVWUUJ0RW50LU9NSzgtOTNZeEJrMUpQVlI3TjdZbmpxZ2Q3bW9tS0JVQy10NUMzelo3eW1WVXo1MEhxT3Z1X21EcGVnRVBQbWVmbXlHU3dsN1Y5YUdkaEMxTjJ4VTNHZEp0Wl9wQzY0Z1FwZ0dCQlJEb1pHUDY5NFRLbUs?oc=5"" target=""_blank"">Biocon to consider issuance of NCDs on private placement basis on April 26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxOaW05Ni1pY25CS1djNEpyX18yaGlHTmdUZW9LblVPd1paMVc3Si1SMXZzdy1UNEpMd1FaNTQzdV9YT1lKcEY2RzRwbmJPQjd0UmdubFVaNE1kbTJiaHBGTUU4RndRUUNkeDc0MUp0T1ROSjVxeTVhRnFhY3BqLW4xVVAydlh1Wno3R3VBMmdmMWV0ajNMS1FIOTdNaUt5WFAxMEw0REVxdGpMU1BKYmRTQlFfc2dtREFkTjc4Mnd4QlEwVHBkdF9FQ2xsRGdJRm_SAdQBQVVfeXFMT2xqbVNxM19BeGJ4d1ZTb2tqdDllT1d3bzdiLWdnalVPUm9valUtQngtem5OaFFVWXJzMHRORHJiT0ZmNGt2cU1tZTFBamQ0N1dVQUNQWlNCMlVWUUJ0RW50LU9NSzgtOTNZeEJrMUpQVlI3TjdZbmpxZ2Q3bW9tS0JVQy10NUMzelo3eW1WVXo1MEhxT3Z1X21EcGVnRVBQbWVmbXlHU3dsN1Y5YUdkaEMxTjJ4VTNHZEp0Wl9wQzY0Z1FwZ0dCQlJEb1pHUDY5NFRLbUs?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-04-25,2023-04-25 07:00:00,"Serum Institute to invest $300 mn in Biocon's unit, provide access to 100 mn vaccine doses annually - Mint","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPQXdKM0lud1YzTXFrb2hQWXcwYUlHV3NxTHN0N1MzT0pxZkoyWV93aGFDLVlZMnlwODlzSGxCQUxxdW5vcWExVi1OejFEWm9pSkl2ODliNExfN25OM2dkYlNDMU8xdUEwVGFOY3VwQlBNVERCZDM0enhzUWt5Tnp3Y2RYRmlJNXVrNEhVbWRKdDhxd3k5clk3OXoxNTJvam5WQUZLeDJ5YlNYTnRndHJ4Wm9yNTQ3RG5wNC1XTGVfdS1FRF9ramt3aTJ6cEZ4Qko2X3Y2T3FKQdIB3AFBVV95cUxNbUlMaTQzZFRjVmdKdXZyaTU5cXNpQklNX3NpNXNWSktBNWd1SVNULTdUS1pVaks5eXNmaW4zYURXVW1XQ3VTWk9wa2lGODROMmNfNWpPYTJhSHozUzdmemR5ek9VZjJ6RjJoS2FpZkJHYzJhaHg3RFk1dzB5SzN2SHdCX3hDVWhRdWpzN05KSzVtMHRFSjVxa212ZmRYcEtGVGNfMEFRbUtrYWtiXzZxNVVMMnp5RDUzMkJqY1J1a2haTC12OEROT0Rfd1p0RHlLVURLV2JQeHk0eTls?oc=5"" target=""_blank"">Serum Institute to invest $300 mn in Biocon's unit, provide access to 100 mn vaccine doses annually</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-04-25,2023-04-25 07:00:00,Serum Institute to double its investment in Biocon unit to $300 million - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Serum Institute to double its investment in Biocon unit to $300 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-04-25,2023-04-25 07:00:00,Serum Institute doubles its stake in Biocon Biologics to $300M - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOWlA4YVE1QXIxMlRLRVQ2NnJmZmVZY2l2Y0lTUGt3NS1abWRzTGJlVXFNWUVISzNnTWVwY1FNNUZhRnBmNVRrSHhDcUF0bnVQaWVFUFJoMjVpNklQYWllcWkya09yc3BfUE9GWHpQTVZFamhsdEVnd1p3WXUtMm1nUFVlb1dxTmRCSlFxUXdpb2RZMnRCZ2dIQnkwZkZqV0k?oc=5"" target=""_blank"">Serum Institute doubles its stake in Biocon Biologics to $300M</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOWlA4YVE1QXIxMlRLRVQ2NnJmZmVZY2l2Y0lTUGt3NS1abWRzTGJlVXFNWUVISzNnTWVwY1FNNUZhRnBmNVRrSHhDcUF0bnVQaWVFUFJoMjVpNklQYWllcWkya09yc3BfUE9GWHpQTVZFamhsdEVnd1p3WXUtMm1nUFVlb1dxTmRCSlFxUXdpb2RZMnRCZ2dIQnkwZkZqV0k?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-04-25,2023-04-25 07:00:00,"Biocon-Serum deal: Won't raise stake for now but alliance not limited to Covid vaccines, says Adar Poonawalla - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon-Serum deal: Won't raise stake for now but alliance not limited to Covid vaccines, says Adar Poonawalla</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24115476190476193,0.24115476190476193,positive,1.0
2023-04-27,2023-04-27 07:00:00,Biocon approves NCD issue - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9oZjR2QTBYZUJmdFQwY0pZb2hVaW9fREtfb194NlozeFpUZmoybFozS1ZIVUctcXcyQTZNQlZmYnVsZ3VkZjlDb2tkODdKRTNCclpaSlo5TE1qWmFzeHhfd0NzWlF2UV9oVDIwQ3NRQ1lLT2ZES1haRllselQ5ZWPSAX9BVV95cUxPaGY0dkEwWGVCZnRUMGNKWW9oVWlvX0RLX29feDZaM3haVGZqMmxaM0tWSFVHLXF3MkE2TUJWZmJ1bGd1ZGY5Q29rZDg3SkUzQnJaWkpaOUxNalphc3h4X3dDc1pRdlFfaFQyMENzUUNZS09mREtYWkZZbHpUOWVj?oc=5"" target=""_blank"">Biocon approves NCD issue</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTE9oZjR2QTBYZUJmdFQwY0pZb2hVaW9fREtfb194NlozeFpUZmoybFozS1ZIVUctcXcyQTZNQlZmYnVsZ3VkZjlDb2tkODdKRTNCclpaSlo5TE1qWmFzeHhfd0NzWlF2UV9oVDIwQ3NRQ1lLT2ZES1haRllselQ5ZWPSAX9BVV95cUxPaGY0dkEwWGVCZnRUMGNKWW9oVWlvX0RLX29feDZaM3haVGZqMmxaM0tWSFVHLXF3MkE2TUJWZmJ1bGd1ZGY5Q29rZDg3SkUzQnJaWkpaOUxNalphc3h4X3dDc1pRdlFfaFQyMENzUUNZS09mREtYWkZZbHpUOWVj?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2023-04-28,2023-04-28 07:00:00,Biocon Biologics facility gets EU GMP certification for Bevacizumab - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics facility gets EU GMP certification for Bevacizumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-05-09,2023-05-09 07:00:00,Competition Commission gives nod to Edelweiss-Biocon Biologics deal - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Competition Commission gives nod to Edelweiss-Biocon Biologics deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-05-24,2023-05-24 07:00:00,Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-05-24,2023-05-24 07:00:00,Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-05-24,2023-05-24 07:00:00,Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-05-24,2023-05-24 07:00:00,Biocon surges 7% post-Q4 nos; should you buy now or wait for correction? - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon surges 7% post-Q4 nos; should you buy now or wait for correction?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-08,2023-06-08 07:00:00,API manufacturing facility in Bangalore receives GMP certificate: Biocon - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">API manufacturing facility in Bangalore receives GMP certificate: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-08,2023-06-08 07:00:00,API manufacturing facility in Bangalore receives GMP certificate: Biocon - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">API manufacturing facility in Bangalore receives GMP certificate: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-08,2023-06-08 07:00:00,API manufacturing facility in Bangalore receives GMP certificate: Biocon - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxOajZiUWJwUFJCS2wxQXZoeGZ5MFhlSUNjU3ZnUlE5V2s5R2VwaXV1ZWRRQ1RoLWI2N2JtMy1wQlB2XzFXc1otTUNodnFOSFBjTGhoUFBJNVBITVdNTktITGNRRmRXSFJyZzZTUTRZandKdUxOQmpRQTk1aHpmYXIxT3I4Q0UzXzQzSGNnRXp5OEFuT3NjX0ZKRUNyWnozZVF2SEcyTk1JcFlNUTJmUU5OZHFsVEY0WFI1N081YVoyeDFKM0Y1RVdGbG1yQzZVNVJidm1fWklpTdIB3AFBVV95cUxQWUY3TEJLalQ2WUJKcVpFSjRST2I0MUU0cE5rd01BUWNCb29DYmhYcW9SR2hqeDdlVnB6Ylo1T0FlMVh4V1JtX2RULUF3MDF2V3d3S0dDZTNXcEpmVVFPNzQ3YlNpMXBQS240YUd3OUJNT2cwdFAtbkFmeFoxeE1aWkhmSm9fX3l3dzhQVlFqQnNJdkRqSE96S2F1Q096RG1lZ1hNWmJXbXR3TGhOZWpGTWFiNjBRYTk4azF0d29mSEtsYnZfYXpqTmdsVHlBTDZLWVY2a3dYcjRqcGpx?oc=5"" target=""_blank"">API manufacturing facility in Bangalore receives GMP certificate: Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxOajZiUWJwUFJCS2wxQXZoeGZ5MFhlSUNjU3ZnUlE5V2s5R2VwaXV1ZWRRQ1RoLWI2N2JtMy1wQlB2XzFXc1otTUNodnFOSFBjTGhoUFBJNVBITVdNTktITGNRRmRXSFJyZzZTUTRZandKdUxOQmpRQTk1aHpmYXIxT3I4Q0UzXzQzSGNnRXp5OEFuT3NjX0ZKRUNyWnozZVF2SEcyTk1JcFlNUTJmUU5OZHFsVEY0WFI1N081YVoyeDFKM0Y1RVdGbG1yQzZVNVJidm1fWklpTdIB3AFBVV95cUxQWUY3TEJLalQ2WUJKcVpFSjRST2I0MUU0cE5rd01BUWNCb29DYmhYcW9SR2hqeDdlVnB6Ylo1T0FlMVh4V1JtX2RULUF3MDF2V3d3S0dDZTNXcEpmVVFPNzQ3YlNpMXBQS240YUd3OUJNT2cwdFAtbkFmeFoxeE1aWkhmSm9fX3l3dzhQVlFqQnNJdkRqSE96S2F1Q096RG1lZ1hNWmJXbXR3TGhOZWpGTWFiNjBRYTk4azF0d29mSEtsYnZfYXpqTmdsVHlBTDZLWVY2a3dYcjRqcGpx?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-09,2023-06-09 07:00:00,"Asian Paints, L&T Finance, HAL, Urja Global, Biocon are in Focus - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5"" target=""_blank"">Asian Paints, L&amp;T Finance, HAL, Urja Global, Biocon are in Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-09,2023-06-09 07:00:00,"Asian Paints, L&T Finance, HAL, Urja Global, Biocon are in Focus - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5"" target=""_blank"">Asian Paints, L&amp;T Finance, HAL, Urja Global, Biocon are in Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-06-09,2023-06-09 07:00:00,"Asian Paints, L&T Finance, HAL, Urja Global, Biocon are in Focus - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5"" target=""_blank"">Asian Paints, L&amp;T Finance, HAL, Urja Global, Biocon are in Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxNZnM0QnROdlg4RW9faVFCZGlXRFFwbHZUMGp2UHI0MEtzRHNxR2FQOWhaNmxqLWd3SE1iWWpxTzZUT1hiZWJPVHJsRHdsUVo3S0toNVFpQ3hGQnl3NkV3NTNLbzh4ZjNEV1o0bTJDelkyQXVid2N1UkU1SzNRU2c5SEdBVjJfSzJ6dnY0RWtjVE9sREk?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-07-03,2023-07-03 07:00:00,"After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States - Biocon","<a href=""https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5"" target=""_blank"">After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.6251357142857142,0.6251357142857142,positive,1.0
2023-07-03,2023-07-03 07:00:00,"After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States - Biocon","<a href=""https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5"" target=""_blank"">After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMi8gFBVV95cUxQNGlnUTZrU1BKeFdPT2xhblFnRkhReFlMT2Iwai16S3h3ZDN1QVRmU1Z0bjhzZ1BJa1ZkWkVxd2p0c0RtSVlaQkc5UC1uTGo5UENnZXVIeDczbDZ4VC1EbFZSOGtVVHY2c3NSOGtBOHZmb29va01rVTZlbFlWamZpTFJWbjF1U1dEMlVUNFloOWxXSWRmdlozUFRuT3lGcHlMcmtIX2pHUUFRWlNUYnNGV21lRDJmRnJxN2lUNExnSUE2RUFnWmNjRTVTTFVXSU1nOGFoZ2pmYjRwN0IzOGJsNUV1U016NUlGX0VtTURNcVV2Zw?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.6251357142857142,0.6251357142857142,positive,1.0
2023-07-04,2023-07-04 07:00:00,Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-07-04,2023-07-04 07:00:00,Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stelis sells Bengaluru facility to Biocon arm Syngene for Rs 702 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-07-05,2023-07-05 07:00:00,Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics expands footprint after taking over biosimilars business from Viatris in over 70 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.10115,0.10115,positive,1.0
2023-07-17,2023-07-17 05:07:26,Maninder Kapoor Puri joins Biocon as Head HR - People Matters - HR News,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxOX1JfVlZkUUtyZllRaHVrSm9wRVNaelludlVsRE9WWUNIb21JeVBldXhzOW5HVlNFMTVaYUxxb1N4TzQ2bkc5MTRGaHRHWXFIUUdiOHB3Y3VEVFl6eXBIM3I4YnlOakt4Nl9sNEs2a2tfaV9SYjdrV1ZKWmtQclotVDdkVjFhS0pscGhjcUhxMGo3OEtOQlZ6el93NlBCZ9IBnAFBVV95cUxOenlIV1Axc2Z2T1drMkVoSkZsLTlnRldTeEZ5UWF6MGVndURrbG56LWNzdFRQTGNMdVhBQXVoYnY0em4xVUtYVGZ3QkZGbW9WNEkyS0N0Q3JfOFJnNEVLY0dRSzk4OVYtVHJObUFxbDU0eXhMdjBqSkRHUW9WQlNEWDVEMWdoYTR6bEpGbENUYmh4Y3VwWXlaMjA1VVo?oc=5"" target=""_blank"">Maninder Kapoor Puri joins Biocon as Head HR</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxOX1JfVlZkUUtyZllRaHVrSm9wRVNaelludlVsRE9WWUNIb21JeVBldXhzOW5HVlNFMTVaYUxxb1N4TzQ2bkc5MTRGaHRHWXFIUUdiOHB3Y3VEVFl6eXBIM3I4YnlOakt4Nl9sNEs2a2tfaV9SYjdrV1ZKWmtQclotVDdkVjFhS0pscGhjcUhxMGo3OEtOQlZ6el93NlBCZ9IBnAFBVV95cUxOenlIV1Axc2Z2T1drMkVoSkZsLTlnRldTeEZ5UWF6MGVndURrbG56LWNzdFRQTGNMdVhBQXVoYnY0em4xVUtYVGZ3QkZGbW9WNEkyS0N0Q3JfOFJnNEVLY0dRSzk4OVYtVHJObUFxbDU0eXhMdjBqSkRHUW9WQlNEWDVEMWdoYTR6bEpGbENUYmh4Y3VwWXlaMjA1VVo?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0258,0.0258,neutral,1.0
2023-07-24,2023-07-24 07:00:00,Biocon Fell 2% After Malaysia Unit Gets 6 Notes From USFDA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxOMjM5S3RmYU4xcXd6X2k3RlR3OG45cWJiVVdmNmtYdUpadk1HcVBza2J2SFRFbFR2V0gwYVpGY2lwR29wcUJaMktuRXc2TnBMUnd1eUVSa2VGcTFsNVZNQUFyREhYS2tHYWw2M1psaGk2TkpGclQ3ZXpxdVpTZkU5UFl3b1loQmN0M2NtUm9NeVA?oc=5"" target=""_blank"">Biocon Fell 2% After Malaysia Unit Gets 6 Notes From USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxOMjM5S3RmYU4xcXd6X2k3RlR3OG45cWJiVVdmNmtYdUpadk1HcVBza2J2SFRFbFR2V0gwYVpGY2lwR29wcUJaMktuRXc2TnBMUnd1eUVSa2VGcTFsNVZNQUFyREhYS2tHYWw2M1psaGk2TkpGclQ3ZXpxdVpTZkU5UFl3b1loQmN0M2NtUm9NeVA?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-07-24,2023-07-24 07:00:00,Biocon Fell 2% After Malaysia Unit Gets 6 Notes From USFDA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxOMjM5S3RmYU4xcXd6X2k3RlR3OG45cWJiVVdmNmtYdUpadk1HcVBza2J2SFRFbFR2V0gwYVpGY2lwR29wcUJaMktuRXc2TnBMUnd1eUVSa2VGcTFsNVZNQUFyREhYS2tHYWw2M1psaGk2TkpGclQ3ZXpxdVpTZkU5UFl3b1loQmN0M2NtUm9NeVA?oc=5"" target=""_blank"">Biocon Fell 2% After Malaysia Unit Gets 6 Notes From USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxOMjM5S3RmYU4xcXd6X2k3RlR3OG45cWJiVVdmNmtYdUpadk1HcVBza2J2SFRFbFR2V0gwYVpGY2lwR29wcUJaMktuRXc2TnBMUnd1eUVSa2VGcTFsNVZNQUFyREhYS2tHYWw2M1psaGk2TkpGclQ3ZXpxdVpTZkU5UFl3b1loQmN0M2NtUm9NeVA?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-08-05,2023-08-05 07:00:00,Biocon Biologics announces leadership appointments - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxNWEVnMGVlcmRaclNrdnNEUmJYWG5lYVZHY1R0TGRCcUNwY3NaekppUlRtdU9VRWJzdnJQMThhWXcxZlU1M1lkRHlNcDdUaktQVW5UWU85NlBPMHlmWUwySEwzLTd6bHV3UmdhTllmLWxJVmI4OW43TDFKVmdRTnVwSnpxc2cyQ3hjaWpRZXhlSmw1REkxTVRSNHZxTmHSAaMBQVVfeXFMUFJIYTFwSkhCdXhaMUpqcndEWWtNSTBJbGp0YUFvNnVOSnE0VlNWYjQ2QXlXQjNnNUtNSkl3N2ljVmVhNUNsWlA5X3dFMm5ObTBsWDRpQndXdk9DMkNoS0NYZVE0dFRlYXJPMWlZM2xBSm5VMDh4cTVVcTdPS1ZRbi1IMWVMcjdOUzdkUlc1WTNCZmdyZnl2WWxncXVUaUVQTXFMTQ?oc=5"" target=""_blank"">Biocon Biologics announces leadership appointments</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxNWEVnMGVlcmRaclNrdnNEUmJYWG5lYVZHY1R0TGRCcUNwY3NaekppUlRtdU9VRWJzdnJQMThhWXcxZlU1M1lkRHlNcDdUaktQVW5UWU85NlBPMHlmWUwySEwzLTd6bHV3UmdhTllmLWxJVmI4OW43TDFKVmdRTnVwSnpxc2cyQ3hjaWpRZXhlSmw1REkxTVRSNHZxTmHSAaMBQVVfeXFMUFJIYTFwSkhCdXhaMUpqcndEWWtNSTBJbGp0YUFvNnVOSnE0VlNWYjQ2QXlXQjNnNUtNSkl3N2ljVmVhNUNsWlA5X3dFMm5ObTBsWDRpQndXdk9DMkNoS0NYZVE0dFRlYXJPMWlZM2xBSm5VMDh4cTVVcTdPS1ZRbi1IMWVMcjdOUzdkUlc1WTNCZmdyZnl2WWxncXVUaUVQTXFMTQ?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-08-11,2023-08-11 07:00:00,Biocon may list biosimilars business by 2025 first half - CEO - Reuters,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxQQnBDN2NoaDRiN3lPdjFLQXlnMXNTT0ZUUi01Zm5QVk50S19WLUhPRVRBR0FxYWt4NHBDT1k2Z1JoS1ltZ1JVOFhPcXlHVHFnQlpBRTRQc1F2aWhGenBsRldoMWxhUS1LOFNmenJscUpOTXNEMDltR2M3S2xqM19LdzJ0Q3dIZ3Q4OWVFTTZCcTdmai1mOEZKci1KUTU0ejdiNVNoNDZyY19RYmN4MkE?oc=5"" target=""_blank"">Biocon may list biosimilars business by 2025 first half - CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxQQnBDN2NoaDRiN3lPdjFLQXlnMXNTT0ZUUi01Zm5QVk50S19WLUhPRVRBR0FxYWt4NHBDT1k2Z1JoS1ltZ1JVOFhPcXlHVHFnQlpBRTRQc1F2aWhGenBsRldoMWxhUS1LOFNmenJscUpOTXNEMDltR2M3S2xqM19LdzJ0Q3dIZ3Q4OWVFTTZCcTdmai1mOEZKci1KUTU0ejdiNVNoNDZyY19RYmN4MkE?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01666666666666667,0.01666666666666667,neutral,1.0
2023-08-12,2023-08-12 07:00:00,Competition Commission of India clears Kotak-Biocon Biologics deal - legal.economictimes.indiatimes.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Competition Commission of India clears Kotak-Biocon Biologics deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">legal.economictimes.indiatimes.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.07655,0.07655,neutral,1.0
2023-08-12,2023-08-12 07:00:00,Competition Commission of India clears Kotak-Biocon Biologics deal - legal.economictimes.indiatimes.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Competition Commission of India clears Kotak-Biocon Biologics deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">legal.economictimes.indiatimes.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.07655,0.07655,neutral,1.0
2023-08-17,2023-08-17 07:00:00,"FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5"" target=""_blank"">FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.5258666666666667,-0.5258666666666667,negative,1.0
2023-08-17,2023-08-17 07:00:00,"FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5"" target=""_blank"">FDA again slams Biocon's troubled plant in Malaysia, citing 8 manufacturing shortfalls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxPYlVISGJQWWNUeXZnbXV0c21ZUTRoRGpFcVp4LWlia0ViWXZjSHh4UnlhbXhDUDlnaVRfV2F6QTh0czUtTFlhc3RaWUdWS1BSdzhzejVCd3g4c2ZsbDJzY2VEcWdYUDBlVW9Pa2cxRFlqWUUzUENaTWhYSFZMd2pXdml0Z0JaNlVzMndaNVJiX2xOR0JzelhHUWFXemp5VTFNeWtlUlh6Wld4QlBRaTVJbA?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.5258666666666667,-0.5258666666666667,negative,1.0
2023-09-01,2023-09-01 07:00:00,Biocon Appoints Nicholas Haggar As Additional Director In Non-Executive & Independent Director Category - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Appoints Nicholas Haggar As Additional Director In Non-Executive & Independent Director Category</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3053,0.3053,positive,1.0
2023-09-02,2023-09-02 07:00:00,Biocon acquires Eywa Pharma's US-based manufacturing facility for $7.7 mn - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon acquires Eywa Pharma's US-based manufacturing facility for $7.7 mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Biocon acquires Eywa Pharma's US-based plant for $7.7 million - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxNdW9aaE1FcVZuSW5xM2ZQWWxtdXZaLUh6eUJ0ZDZ3WU4xc3lRbGtkeS1MNkFUQlJ0Mkc0dndVYXNDdW1pSUZqazdCSW9Gd29oT2I4N3pTU0lRVHlDNzJXLXZBbExLU3hZaW56eFkyb2VNc3Z3RWUtbFpURzdNNkhXMXNtLWRDNFN0MXdFMVdTSzdEa0lPSlZrSTJING1UOUhBOFFCNzc1Y3hJUzBidFN0VG93U2xENEFwRUhUVXpRNWZmMGJSSnBfSi1vZk0zZXpSalRGeEllVTQ4MjZ5TDB3TjRGeTNjMkl5elltWNIB8gFBVV95cUxQdWthanUtZ2xMMF9BNWhPZ2pjTXJnaWtQcG5UblBOcUNMRkFvdWN5VnpSM2VHT0xJdVZMemxsTC1BVDIzN2RVSVJEcldLbV81X3QtY2lFaXQtNGo1M29NNXVJZlNONWxJMG5sSUhPdGxXVGdvcjVlUEhzRDFuV1RfUlhZZy1ZZXJweHY0c0F5cVozbkN3cDBlMjUtYjkxeEF2R2gycGg1V0tYYmpYclBhWEdSWUJtVUkzVU9TMVZLQzdEVnNreFFON1NIREFsMVZaR3RYb3B1dnZVSVRpV1ZybW9EYkZEblUwZFFaSV9YUy1idw?oc=5"" target=""_blank"">Biocon acquires Eywa Pharma's US-based plant for $7.7 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Kiran Mazumdar-Shaw founded Biocon acquires Eywa Pharma's manufacturing unit for $7.7 million - Indian Startup News,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxNTTlROWF6MG5JQ0R5R3NGSXB5OTFBbGUyWEZUUFVvakZZY3pNWTJrQzRtMmZ2ZUR0R0dPaDhaX1pFd1NHZFFQMUw3cHNUaXlNdEVORzNBT19kYV90TF81Qm01NW9lM1pIbWd4enFEZG9NZlN1Ylh2eXdJSGtZM1BiZDNZRFI4cWNTcld0RG54a2NLdkd1Y1pTOVFoclBYNEVGR1HSAaIBQVVfeXFMTU05UTlhejBuSUNEeUdzRklweTkxQWxlMlhGVFBVb2pGWWN6TVkya0M0bTJmdmVEdEdHT2g4Wl9aRXdTR2RRUDFMN3BzVGl5TXRFTkczQU9fZGFfdExfNUJtNTVvZTNaSG1neHpxRGRvTWZTdWJYdnl3SUhrWTNQYmQzWURSOHFjU3JXdERueGtjS3ZHdWNaUzlRaHJQWDRFRkdR?oc=5"" target=""_blank"">Kiran Mazumdar-Shaw founded Biocon acquires Eywa Pharma's manufacturing unit for $7.7 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Startup News</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxNTTlROWF6MG5JQ0R5R3NGSXB5OTFBbGUyWEZUUFVvakZZY3pNWTJrQzRtMmZ2ZUR0R0dPaDhaX1pFd1NHZFFQMUw3cHNUaXlNdEVORzNBT19kYV90TF81Qm01NW9lM1pIbWd4enFEZG9NZlN1Ylh2eXdJSGtZM1BiZDNZRFI4cWNTcld0RG54a2NLdkd1Y1pTOVFoclBYNEVGR1HSAaIBQVVfeXFMTU05UTlhejBuSUNEeUdzRklweTkxQWxlMlhGVFBVb2pGWWN6TVkya0M0bTJmdmVEdEdHT2g4Wl9aRXdTR2RRUDFMN3BzVGl5TXRFTkczQU9fZGFfdExfNUJtNTVvZTNaSG1neHpxRGRvTWZTdWJYdnl3SUhrWTNQYmQzWURSOHFjU3JXdERueGtjS3ZHdWNaUzlRaHJQWDRFRkdR?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Biocon Acquires A Manufacturing Facility Of Eywa Pharma - Free Press Journal,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjB5VVFfQWpLREdweWx5RXI3eWl0MHlTOV91blM1RGZMRVN1MURyMHFvelEzd1cwejQwMzh5VklvXzA0N3c4VXlVYmxscW1mQkNZalNsSTNlZFRBbVVTdm5MeFBpNVhuZTBkWnpLaDBUeDQ1Vy04NU03Y0oyVENUa0lPYWxfdk85VVkzTXNOdzF1bGkzMlQ5djV0WG7SAaIBQVVfeXFMT0U1cjZJaU9hRWREQ2JBQ3RvV2FYSGdqTllVQld3UVM4MHB4OXg4azZ4RE1KX3dmaVFnU1NQUFJYS0pHVmNwNXpHeGpyUmsyWnY1UXFqMEhxOE9VM3pvdzhVbGhGSXctTDdVa254U2pKRzduRm0weTZrRWNpRGptaU1XTjE2RDB6eUEwcGlIcVVLckE0M1V0dHR1b1ZaemFJVHhB?oc=5"" target=""_blank"">Biocon Acquires A Manufacturing Facility Of Eywa Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjB5VVFfQWpLREdweWx5RXI3eWl0MHlTOV91blM1RGZMRVN1MURyMHFvelEzd1cwejQwMzh5VklvXzA0N3c4VXlVYmxscW1mQkNZalNsSTNlZFRBbVVTdm5MeFBpNVhuZTBkWnpLaDBUeDQ1Vy04NU03Y0oyVENUa0lPYWxfdk85VVkzTXNOdzF1bGkzMlQ5djV0WG7SAaIBQVVfeXFMT0U1cjZJaU9hRWREQ2JBQ3RvV2FYSGdqTllVQld3UVM4MHB4OXg4azZ4RE1KX3dmaVFnU1NQUFJYS0pHVmNwNXpHeGpyUmsyWnY1UXFqMEhxOE9VM3pvdzhVbGhGSXctTDdVa254U2pKRzduRm0weTZrRWNpRGptaU1XTjE2RDB6eUEwcGlIcVVLckE0M1V0dHR1b1ZaemFJVHhB?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.35530000000000006,0.35530000000000006,positive,1.0
2023-09-02,2023-09-02 07:00:00,Biocon acquires Eywa Pharma's US-based manufacturing facility for $7.7 mn - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon acquires Eywa Pharma's US-based manufacturing facility for $7.7 mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Biocon acquires Eywa Pharma's US-based plant for $7.7 million - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon acquires Eywa Pharma's US-based plant for $7.7 million</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxNdW9aaE1FcVZuSW5xM2ZQWWxtdXZaLUh6eUJ0ZDZ3WU4xc3lRbGtkeS1MNkFUQlJ0Mkc0dndVYXNDdW1pSUZqazdCSW9Gd29oT2I4N3pTU0lRVHlDNzJXLXZBbExLU3hZaW56eFkyb2VNc3Z3RWUtbFpURzdNNkhXMXNtLWRDNFN0MXdFMVdTSzdEa0lPSlZrSTJING1UOUhBOFFCNzc1Y3hJUzBidFN0VG93U2xENEFwRUhUVXpRNWZmMGJSSnBfSi1vZk0zZXpSalRGeEllVTQ4MjZ5TDB3TjRGeTNjMkl5elltWNIB8gFBVV95cUxQdWthanUtZ2xMMF9BNWhPZ2pjTXJnaWtQcG5UblBOcUNMRkFvdWN5VnpSM2VHT0xJdVZMemxsTC1BVDIzN2RVSVJEcldLbV81X3QtY2lFaXQtNGo1M29NNXVJZlNONWxJMG5sSUhPdGxXVGdvcjVlUEhzRDFuV1RfUlhZZy1ZZXJweHY0c0F5cVozbkN3cDBlMjUtYjkxeEF2R2gycGg1V0tYYmpYclBhWEdSWUJtVUkzVU9TMVZLQzdEVnNreFFON1NIREFsMVZaR3RYb3B1dnZVSVRpV1ZybW9EYkZEblUwZFFaSV9YUy1idw?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2023-09-02,2023-09-02 07:00:00,Biocon Acquires A Manufacturing Facility Of Eywa Pharma - Free Press Journal,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjB5VVFfQWpLREdweWx5RXI3eWl0MHlTOV91blM1RGZMRVN1MURyMHFvelEzd1cwejQwMzh5VklvXzA0N3c4VXlVYmxscW1mQkNZalNsSTNlZFRBbVVTdm5MeFBpNVhuZTBkWnpLaDBUeDQ1Vy04NU03Y0oyVENUa0lPYWxfdk85VVkzTXNOdzF1bGkzMlQ5djV0WG7SAaIBQVVfeXFMT0U1cjZJaU9hRWREQ2JBQ3RvV2FYSGdqTllVQld3UVM4MHB4OXg4azZ4RE1KX3dmaVFnU1NQUFJYS0pHVmNwNXpHeGpyUmsyWnY1UXFqMEhxOE9VM3pvdzhVbGhGSXctTDdVa254U2pKRzduRm0weTZrRWNpRGptaU1XTjE2RDB6eUEwcGlIcVVLckE0M1V0dHR1b1ZaemFJVHhB?oc=5"" target=""_blank"">Biocon Acquires A Manufacturing Facility Of Eywa Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQcjB5VVFfQWpLREdweWx5RXI3eWl0MHlTOV91blM1RGZMRVN1MURyMHFvelEzd1cwejQwMzh5VklvXzA0N3c4VXlVYmxscW1mQkNZalNsSTNlZFRBbVVTdm5MeFBpNVhuZTBkWnpLaDBUeDQ1Vy04NU03Y0oyVENUa0lPYWxfdk85VVkzTXNOdzF1bGkzMlQ5djV0WG7SAaIBQVVfeXFMT0U1cjZJaU9hRWREQ2JBQ3RvV2FYSGdqTllVQld3UVM4MHB4OXg4azZ4RE1KX3dmaVFnU1NQUFJYS0pHVmNwNXpHeGpyUmsyWnY1UXFqMEhxOE9VM3pvdzhVbGhGSXctTDdVa254U2pKRzduRm0weTZrRWNpRGptaU1XTjE2RDB6eUEwcGlIcVVLckE0M1V0dHR1b1ZaemFJVHhB?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.35530000000000006,0.35530000000000006,positive,1.0
2023-09-04,2023-09-04 07:00:00,Biocon Generics purchases Eywa’s manufacturing facility in US - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOUDZwbDJ1WTBWOU02Y1RSeGNwSjBQZjBISWxKU2h3UEY1V08xMmtBbU1qN0piczNOSWs2dVd4YTFXbnVJNEV6cFFZTDNfZ1BJR3A2WXF1c21JVGtzbjVGZTl2TmVmbl91LXIwZnl5T2JMTW0wTlRLQzl2eTBBYkNnM0VXRUpHT18zMXB2MHU5VTB6Zw?oc=5"" target=""_blank"">Biocon Generics purchases Eywa’s manufacturing facility in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOUDZwbDJ1WTBWOU02Y1RSeGNwSjBQZjBISWxKU2h3UEY1V08xMmtBbU1qN0piczNOSWs2dVd4YTFXbnVJNEV6cFFZTDNfZ1BJR3A2WXF1c21JVGtzbjVGZTl2TmVmbl91LXIwZnl5T2JMTW0wTlRLQzl2eTBBYkNnM0VXRUpHT18zMXB2MHU5VTB6Zw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-04,2023-09-04 07:00:00,Biocon Generics purchases Eywa’s manufacturing facility in US - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOUDZwbDJ1WTBWOU02Y1RSeGNwSjBQZjBISWxKU2h3UEY1V08xMmtBbU1qN0piczNOSWs2dVd4YTFXbnVJNEV6cFFZTDNfZ1BJR3A2WXF1c21JVGtzbjVGZTl2TmVmbl91LXIwZnl5T2JMTW0wTlRLQzl2eTBBYkNnM0VXRUpHT18zMXB2MHU5VTB6Zw?oc=5"" target=""_blank"">Biocon Generics purchases Eywa’s manufacturing facility in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOUDZwbDJ1WTBWOU02Y1RSeGNwSjBQZjBISWxKU2h3UEY1V08xMmtBbU1qN0piczNOSWs2dVd4YTFXbnVJNEV6cFFZTDNfZ1BJR3A2WXF1c21JVGtzbjVGZTl2TmVmbl91LXIwZnl5T2JMTW0wTlRLQzl2eTBBYkNnM0VXRUpHT18zMXB2MHU5VTB6Zw?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMipAJBVV95cUxONkplbm56SHNtcElRSWN3cnpqMWo0MnZTc2dBcDcxSV9iNlFIZFFCbjV5dm42Sjd2cDVSclFvNHpJNTRMU3o0Wm1uYVFpV2VQZDN6SWtrTkpjcnpma0FSR1ByaXZHcVllM0VOdlF0RXhYSTBFSFd6VGUwaVlkQUduRkNuSUtDQ0RsbGdSUTBwelpoYTdwVGV6d1dob2NxWmRJMjYwZXJVVWZObTFHRzZKNWhZX0h2VFZZclJ5Yk14VndFZVRqSF9OWGdJaUNvYkZqS1hsNTVUbFVVVVBGWTgxMHNrclhDeC1fQlF4V3pwQ09JR0pVLWNlYV95dlAtU2V4ajl6M09ZRGxMMnFUYUozVHNSeVVwQXJFRzd6b0ZhRG1GWFg3?oc=5"" target=""_blank"">Biocon Biologics Continues to Expand Global Footprint, Completes Integration of Viatris Biosimilars' Business In North America Ahead of Schedule</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMipAJBVV95cUxONkplbm56SHNtcElRSWN3cnpqMWo0MnZTc2dBcDcxSV9iNlFIZFFCbjV5dm42Sjd2cDVSclFvNHpJNTRMU3o0Wm1uYVFpV2VQZDN6SWtrTkpjcnpma0FSR1ByaXZHcVllM0VOdlF0RXhYSTBFSFd6VGUwaVlkQUduRkNuSUtDQ0RsbGdSUTBwelpoYTdwVGV6d1dob2NxWmRJMjYwZXJVVWZObTFHRzZKNWhZX0h2VFZZclJ5Yk14VndFZVRqSF9OWGdJaUNvYkZqS1hsNTVUbFVVVVBGWTgxMHNrclhDeC1fQlF4V3pwQ09JR0pVLWNlYV95dlAtU2V4ajl6M09ZRGxMMnFUYUozVHNSeVVwQXJFRzd6b0ZhRG1GWFg3?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2023-09-06,2023-09-06 07:00:00,"Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5"" target=""_blank"">Biocon buys US plant for $7.7M, advances Viatris integration efforts and plots hires</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxQS2ZXTExvcEo5dDkxRXhueVhuM0cxMEpNaUtfWTZad2VmWTF3aXQ0NExwZXkzb0NWY1NhMWxXMmFXMDhmbkFKR184blV4QzJrSTB2bXRyTHJYZ0p0cDZ4OFlUZ2czNFhsNWJwSXRxOW1Ga3hvc0Vha3cycjBTdU0yNlBsaUFhYXhOOXI4UklSSXRrOGwwU1haZ0tUOHQtMlhxZU1vMzJBSUVIaUVJR2NZTmZTVQ?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-07,2023-09-07 07:00:00,Biocon Biologics completes integration of Viatris biosimilars business in North America - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris biosimilars business in North America</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-07,2023-09-07 07:00:00,Biocon Biologics may reveal details of its likely IPO post integration of the acquired biosimilar business - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics may reveal details of its likely IPO post integration of the acquired biosimilar business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-07,2023-09-07 07:00:00,Biocon Biologics completes integration of biosimilars biz - BizzBuzz,"<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxObURXcFZoS3VHc1ppNWtlT0dMV01FSXFnRnZ3TEo1QXZBOFRWczJVS0M5LTZmSkNuVnFYdkp1R3pIMy1oN0ZWWXBfQTM0U3J6b0tBZ1ZTdWp4UFRWUXJHVDNjMDUwTlhva0lGN2ZPRkpiV1ZfVmRWZ0lJalktVmxLVEYwUUpGMHJSSExvaFpGU0tyMUV1S253MDdfTnM2VUhPT3c?oc=5"" target=""_blank"">Biocon Biologics completes integration of biosimilars biz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxObURXcFZoS3VHc1ppNWtlT0dMV01FSXFnRnZ3TEo1QXZBOFRWczJVS0M5LTZmSkNuVnFYdkp1R3pIMy1oN0ZWWXBfQTM0U3J6b0tBZ1ZTdWp4UFRWUXJHVDNjMDUwTlhva0lGN2ZPRkpiV1ZfVmRWZ0lJalktVmxLVEYwUUpGMHJSSExvaFpGU0tyMUV1S253MDdfTnM2VUhPT3c?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-08,2023-09-08 07:00:00,Is Biocon making a comeback? - Finshots,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-08,2023-09-08 07:00:00,Is Biocon making a comeback? - Finshots,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-08,2023-09-08 07:00:00,Is Biocon making a comeback? - Finshots,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-08,2023-09-08 07:00:00,Is Biocon making a comeback? - Finshots,"<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5"" target=""_blank"">Is Biocon making a comeback?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Finshots</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBlMF9YTVZjZXNXa1N1RXl0elFxWWpTb3JNR0VjNlM2RFNjZklWblVhVF90MmNIV1pYdEV4UGlNQTZrdVR3YUZnejlFR01sSGVydkhFWi1KY3Vqd2I0VVhKa050TGtEM1E?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-15,2023-09-15 07:00:00,"Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5"" target=""_blank"">Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-15,2023-09-15 07:00:00,"Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5"" target=""_blank"">Biocon’s Syngene to invest Rs 788 Crore for campus expansion in Genome Valley, Hyderabad</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi4gFBVV95cUxOandPclBDMDhTdmpjZjBkWDFjS3JqV25La3FPanNES2F6WF9yRlpDUXViUkNNanFwRTFSZnRONnl4UmMzNDlvTGNfOFZMb0Q2VkNoUzB4azBkZlFfOGZpMGgyTUxHR3J0eHU5SlFjZmx2VHlyMUotTXpDQ2VoaDRvSmJEWkc4US1uRWdOQ0tmcGpSY3lEZTlOTXBLdDJ1UHg0V1hGMXIzaE5tVVJCY2lWVG1sRjA4QnV0LVQ5alNHVnlINGpVSlhCSGxKRUg5Z3hFWG1fVVRDYkwzb2EwU0lLdHhB?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-18,2023-09-18 07:00:00,Drugmaker Biocon appoints Peter Bains as group CEO effective immediately - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Drugmaker Biocon appoints Peter Bains as group CEO effective immediately</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxPaFRhYmdjc1hZazFUWWVaaTM4d1Job2Ixc1Y3dGNJdDZ3eWJOM3ZJaWtiQWppblhibDFkVW92YXV1cGtldW9Hd1ZlWi1BZ3pCalp3MG9OcS00NlZOa091NzdtRDBvOHdOMkxQX2s1YkozWWlVRU9Vd0RuczRLVVRZeU95Ymc5emE1RXNoZjIySEs1Y28yQTEyU1l2UGVxMnpqRkZnVEpNMzFyU0JIV0VzY0JYekxnVXFJSFE3NnQ4Z2xqNkk3OUJvR3NFcUREMV9TSjJSVEhTSkrSAd4BQVVfeXFMT2hVcklvQnlWd0tOYnJPUUI0d3lJNVhhYjVaNkY0MVVXRlVmanFXaFMwb2JqbE1QcFNvZ2pmNDVEVGp2SGNtZ2sxY09HVTZka1B5Z3JtbFlsX3M5WkN5SGFPTzBBWlNNNmpJUkc5UkpwX0ZPMzJXTDE4bmdBNmoxcnM2UU02UmxfQnBIVlFCcUZnZDJ0TGNoSmhNMzAtanBqVFA1V2UwMDBva1c3NFUxdDVkeE0zY2lkNFdreXFSdDlXWWxvMnJaZWl4WU0zZ3dIVWhRaTlPSTN6bXotNjNR?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.51755,0.51755,positive,1.0
2023-09-19,2023-09-19 07:00:00,Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-19,2023-09-19 07:00:00,Biocon appoints Peter Bains as Group CEO - Manufacturing Today India,"<a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPTnRjaGd5cmVaX3gwNjBHT05RUnVnYVE4R2RzYmFKUlpQRWRzTGhoMWEtR0ZyLU1hRzJaak42NG9fVGZXaTIyczZWZS1HUlBFOHpnT21iclNsNlkzclZkSkJFQ2QzMGZDdEpwSVEzVUdVUXUyc09qU1pCWTJZMlNqaG1oTHRiaFU?oc=5"" target=""_blank"">Biocon appoints Peter Bains as Group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Manufacturing Today India</font>",https://news.google.com/rss/articles/CBMihwFBVV95cUxPTnRjaGd5cmVaX3gwNjBHT05RUnVnYVE4R2RzYmFKUlpQRWRzTGhoMWEtR0ZyLU1hRzJaak42NG9fVGZXaTIyczZWZS1HUlBFOHpnT21iclNsNlkzclZkSkJFQ2QzMGZDdEpwSVEzVUdVUXUyc09qU1pCWTJZMlNqaG1oTHRiaFU?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-19,2023-09-19 07:00:00,Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-19,2023-09-19 07:00:00,Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-19,2023-09-19 07:00:00,Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5"" target=""_blank"">Biocon's Peter Bains jumps from the board to group CEO amid company's expansion push</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNU0FKNHRpaWJFTFJLRGhfOUxHY2hlNnJYR0hVQ0pTQTR1Q0IxUTZjanpnUUludVRWY2NVWDVQQnNTRHJ4VHEtdlhDRGpzUFJrYWJHQ2NuZmI3VU1tUHJyRmctY1Btbl84WWpiR2tObXJMWDVzY0F3a0x3X2l6T3R1Z2xVZGdYZEFQREdkQzAyVUJZM0RuTE8w?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-19,2023-09-19 08:07:41,Leadership rejigs at Biocon; Peter Bains named as Group CEO - People Matters - HR News,"<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNUWhhSFM4X1NrR0c1N1FvWDByM0tib25ha1pOMDBHdHF5cVFxeUpodHNNU1FrSmtSVVN4UTlKNDhPbW1FUUNjWlUwN0EwSGduTkEyMHZUY1lJTENucjJhVnpFMWdlMUdnNFZjaEhyRmlHR2x3WFUxbk1OMHQ5bVJxaml6MURWUE1XSmdlZmNSVUVfM09PQlB3SmVkcEU0aFRXSkRtWFVRQ1J0TGVmTVNRM9IBrwFBVV95cUxPd19IaGdVZ3RSczgtdUc3RlBOTjhWM1pPeU9rN2ZCZXcyZ2Z5MVhqSDJGY3hVOWN3WXNkU1RxTEs5R0RSdmJFdlFycUdNYkY3UzFzRVoxOE1rQ0ZNM3BfTENVZV9qeFRuSUNNQXAtUlh0UExEZUdNdzZLOElMYU5uNDFpRTlId05JQnFRblNMTU5vSUJoZmlXcVJsaGJYM0h4SWhKc1dIQmR2aWlVNGFv?oc=5"" target=""_blank"">Leadership rejigs at Biocon; Peter Bains named as Group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNUWhhSFM4X1NrR0c1N1FvWDByM0tib25ha1pOMDBHdHF5cVFxeUpodHNNU1FrSmtSVVN4UTlKNDhPbW1FUUNjWlUwN0EwSGduTkEyMHZUY1lJTENucjJhVnpFMWdlMUdnNFZjaEhyRmlHR2x3WFUxbk1OMHQ5bVJxaml6MURWUE1XSmdlZmNSVUVfM09PQlB3SmVkcEU0aFRXSkRtWFVRQ1J0TGVmTVNRM9IBrwFBVV95cUxPd19IaGdVZ3RSczgtdUc3RlBOTjhWM1pPeU9rN2ZCZXcyZ2Z5MVhqSDJGY3hVOWN3WXNkU1RxTEs5R0RSdmJFdlFycUdNYkY3UzFzRVoxOE1rQ0ZNM3BfTENVZV9qeFRuSUNNQXAtUlh0UExEZUdNdzZLOElMYU5uNDFpRTlId05JQnFRblNMTU5vSUJoZmlXcVJsaGJYM0h4SWhKc1dIQmR2aWlVNGFv?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0258,0.0258,neutral,1.0
2023-09-20,2023-09-20 07:00:00,New Group CEO is someone who understands Biocon's business synergy well: Kiran Mazumdar-Shaw - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMilwJBVV95cUxNNVZSaV9mMjRFMnF1clJZTjNYZ3YwT1dfdEJQaEs4ejlPVnlVajJWSzJxQURJQnFUb08tMEpMMGFJdjFFV0VyU25hS1JuTzNGRmdMaVlHb2psZkpjZ29zWlJZQmtuX3BINFJyWHVzTS13VWoxQVU0bzQxN1VkbFEyLUNQM3VOQW1wQ3lsTE5aR0pIY2wxZWhLYkpuSUhoLWlqQzh1VmZ6dFpYYVdVemtzaDBjd0dpX2oxaWx4QXJoVzFsNTItRmdrMGpmNU5UVXAzNmVkTUF1MWJ3em9Ja0w2SGFCeTlBS1p2RFhKeUtqZjBHU3JTWXdYTTJzNHNDVjV6OENlcmNEeEVmMTJTVkFrNnRENGdaeGPSAZwCQVVfeXFMTnFNWURtODFmOTgwaW1YdGZFQ0ZJSXA5Q0x3X3Baem1RRDdQNnlELVRVRHUxQnJjcllXY3NLd1JVak1ZMV81a3FUOE5NdTJOdFNDLWp5YXBTOWF4UmxmS196WjZVQ3dTVlJfbUNYNHBTRWdvWXBmbFlFMnFSVnJXNUtnZnZ6by1fdlYwOTlIXzlUV0lSSms0QjdXZE1Mc0gxUTB3NEtsREhyX19jUzBUTHRENGtmZE5ER3gwUFpFcGxxYVJTZkZhSUh5Ty16RDdDc1VUelZIOUZPSW9kOS0wZ0pCQzhPNkdXUVF6X05ndkxvb2stUFk3LVF4dExlX2FHMmZnRXBXUGs3b3ZXQUNRakM3dzhYcG9xZ0RWWmI?oc=5"" target=""_blank"">New Group CEO is someone who understands Biocon's business synergy well: Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3139954545454545,0.3139954545454545,positive,1.0
2023-09-20,2023-09-20 07:00:00,"Former executive of GSK, SyngenePeter Bains, is now Biocon’s group CEO - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Former executive of GSK, SyngenePeter Bains, is now Biocon’s group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-20,2023-09-20 07:00:00,"Former executive of GSK, SyngenePeter Bains, is now Biocon’s group CEO - Times of India","<a href=""https://news.google.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?oc=5"" target=""_blank"">Former executive of GSK, SyngenePeter Bains, is now Biocon’s group CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-09-22,2023-09-22 07:00:00,Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5"" target=""_blank"">Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2023-09-22,2023-09-22 07:00:00,Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5"" target=""_blank"">Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2023-09-22,2023-09-22 07:00:00,Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5"" target=""_blank"">Fierce Pharma Asia—Novartis and BeiGene's PD-1 breakup; Genentech's PeptiDream deal; Biocon's new CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOYXpoT3FBci1xdktEelhMWUcwWm1BRy1TRFcyODJJRW1fdmgxdU5oRzVsZnJpcHJJX1dqZE05cUxzdHFwSEZZaVZNWXEwOUJjOElqTzBqVjBMLUJWRVdBaEhWaWtzR2lDVWFUOXdDQmtuZGYwTWFoeTFWMlEzZHhKaC15OWVOcTg0cjNzdDA3eGcwQ1Z3MTZWN2prSjRxNnpTRnBkek1fUUgwRUxpZ2c?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2023-10-06,2023-10-06 07:00:00,Biocon partners with Canada's Juno Pharma for innovative diabetes and obesity treatment - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Canada's Juno Pharma for innovative diabetes and obesity treatment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxOQ2JaZ0IzOHVPa09XYWs3X3dyY0NOMHR3NS1UYUtkVFdzVkJaa1ZmUTFxOGlReUk3bDlodXhweXRnMWRqOVlpRlVGRmtCaGE4bjJzUU1pcGNqS1loY3lXMzVHTGJwYjlJSkE5MkJrTmxJY21FX1VYRE1VYnNRVHU3bVFCbFdNUmpSbTFfUGhNaEpjRVhrcTVZeENjS1dQcEt2ZmZ3RzR1Y1JjLTRIQzRaODhtSDJ3QXFURVhPM2dqa1l6cFdNX2FZLXBfak55eE9s0gHWAUFVX3lxTFB0U1MzbU5ybG9kSWJNSmFtSFZYaUNLN21LcXFTOEptZ01FM1Q3RFg1ZTJYMmFTZnBIRmlXZ0FXRXNyUWpyVkJOZHF1RUMxTV9ib0RoamFlcFNGVm1uNTBmalZrQWFoMnNnLU5TZlFnOG5VSVZVWnlRamtteldzMjJURDh2TEdCWGk4Z2dUSkVVWGhtbVlQWW9HT2ozWVdIR3gwb2VTQ1V3dXRZWDkxaDJQTUFGTGs3UjFlclR0N3hqaEY3WWdldWY3dnlxXzl2MzljSExZYnc?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5168166666666667,0.5168166666666667,positive,1.0
2023-10-06,2023-10-06 07:00:00,Biocon partners with Canada's Juno Pharma for innovative diabetes and obesity treatment - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Canada's Juno Pharma for innovative diabetes and obesity treatment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5168166666666667,0.5168166666666667,positive,1.0
2023-10-06,2023-10-06 07:00:00,"Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Juno Pharma ink pact for commercialisation of Liraglutide in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-10-13,2023-10-13 07:00:00,"Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjRYMUEwbm93MlRtcWQzd0JoWHRrUEpaRlZyZC1nODB4QjBBS0gzSVV4OFoyM003UkJDZ3ZDVF80Q29mbU53OS1qY2VTWFhacmNRUEFEemItdEZTc0Zndk9QZzA5Sm05ZUJaZVZvR19jUV9sNGJ2VGtwMEJieFZGbEJ5WjlQek1EbXhNNU43c3JZQlMzWFV3dEI1VEl2V29PV3VJaU9lemJFN2R4YVh5cjdaSkJfX0E?oc=5"" target=""_blank"">Fierce Pharma Asia—GSK, Zhifei's vaccine pact; BioNTech's latest China deal; Biocon's biosimilar rejection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxNMjRYMUEwbm93MlRtcWQzd0JoWHRrUEpaRlZyZC1nODB4QjBBS0gzSVV4OFoyM003UkJDZ3ZDVF80Q29mbU53OS1qY2VTWFhacmNRUEFEemItdEZTc0Zndk9QZzA5Sm05ZUJaZVZvR19jUV9sNGJ2VGtwMEJieFZGbEJ5WjlQek1EbXhNNU43c3JZQlMzWFV3dEI1VEl2V29PV3VJaU9lemJFN2R4YVh5cjdaSkJfX0E?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.10448333333333334,-0.10448333333333334,negative,1.0
2023-11-08,2023-11-08 08:00:00,Biocon to sell two non-core India business units to Eris Lifesciences - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to sell two non-core India business units to Eris Lifesciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxOSE1XUEtDWUJUUy1LN0lsY2JvTVk1TG9USkIxaUtETXR4UTFsNnl5QVhuZGJCYjRnVldoYmJmQnBkQ2I0LXhUVDNWTlFSX0hmcnd6eDhLSXdnVmQ5Z2p2RmpiOGRPTE42S3UzcmJja3NYbm1rVGpsOFNnVVZZY0hRODctZEt1Nzc4anA3WjFUcmhfdTFrc0NzTkdFSUIwS3JOWExmYXRIZ3pPYThZQUktcHdxMDdRQXNPdUZTb3VaTC0yMUtIeEZ0cFI5d2JIYTdpSVF1RmxYZ0tDNnVKcXU2ZdIB5gFBVV95cUxNaTZtb0ZpbWlyWXd4dkgycm90b0hGM1BYNW9HNFFCdVFjb1BLVEQtZ3pCaEZ4SFI1Mk1qcnJxRW42NHE3ZHQ0M1ZNX3h1VVZOLVlhS3UtLWFSV0FKZENGV1J2a2Zaa2VKQkxWX2hNd1hWVzFKSm4xUi0xUThHZWhSZWlCUmZqNTlPR1ZMQlJIdk9zazZoVXppdWVJUDJ0b095QWNMMTJKZVhYeWQ3OWtSbWpZTDUwLUE3cjNFWGJZeUVhQWgyVERWZHRCRUl0S1lpMTJkeC1lRlBQeDZiaS1OcGdoV2Zzdw?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-11-08,2023-11-08 08:00:00,"Eris to acquire nephro, derma units of Biocon Biologics - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris to acquire nephro, derma units of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-11-08,2023-11-08 08:00:00,"Eris Lifesciences acquires Biocon Biologics' nephro, derma units for Rs 366 crore - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon Biologics' nephro, derma units for Rs 366 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2023-11-08,2023-11-08 08:00:00,"Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris to buy derma, nephro units of Biocon Biologics for Rs 366 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-11-09,2023-11-09 08:00:00,Eris to buy Biocon arm’s brands in Rs 366 crore deal - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris to buy Biocon arm’s brands in Rs 366 crore deal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-11-30,2023-11-30 08:00:00,Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe - GlobeNewswire,"<a href=""https://news.google.com/rss/articles/CBMijAJBVV95cUxPbzlwdUdBTU5Ddml3eDJXc3Vad0Q2RkRiWmEtaXBKanlWSmozekxEX1VzUGMyZTZkWThCV3MyRGQ2QktablZpcS1pQkFNYnNaQlhiYVpFX1hfZFFWRlRqVU00OHVST3puMTNZMVc2MmRUU2ZSVC1LYzJHSk1CZWN2NUtuWG10Y1ZjVVBJTVBrdUtsVzE0cEFZaVVPaWVMd015QUxXenVnOEVHWDRZNndOOXlnNHoxM19oU1ZvcUN5cmNZSFZWY3pvMWotY2R3SU1RSGFpTE9zNXFrNnVwbkNkN1liaDF1YTRqcktPOUtTdV9FLVNMQUF6Qk9WaFF4RFc5ajJfNzJFcHRVTjhC?oc=5"" target=""_blank"">Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">GlobeNewswire</font>",https://news.google.com/rss/articles/CBMijAJBVV95cUxPbzlwdUdBTU5Ddml3eDJXc3Vad0Q2RkRiWmEtaXBKanlWSmozekxEX1VzUGMyZTZkWThCV3MyRGQ2QktablZpcS1pQkFNYnNaQlhiYVpFX1hfZFFWRlRqVU00OHVST3puMTNZMVc2MmRUU2ZSVC1LYzJHSk1CZWN2NUtuWG10Y1ZjVVBJTVBrdUtsVzE0cEFZaVVPaWVMd015QUxXenVnOEVHWDRZNndOOXlnNHoxM19oU1ZvcUN5cmNZSFZWY3pvMWotY2R3SU1RSGFpTE9zNXFrNnVwbkNkN1liaDF1YTRqcktPOUtTdV9FLVNMQUF6Qk9WaFF4RFc5ajJfNzJFcHRVTjhC?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.6253,0.6253,positive,1.0
2023-12-01,2023-12-01 08:00:00,Biocon integrates biosimilars business of Viatris in 31 countries - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxONUZqMzl4c01ocVZ4NjZjZGVNaDV3ODQxTUtNV1p2ZUlKOWtucUdYaVo1aGVOVjRsS3V3X1JhSV9UWTZRQmhXQU4yc1JpNnVqQi1vQ0pBX3NPaDJaUG9odGEzTnRzQ1RVcVRSN0M4WXA3bTZaZmlISy1rMDhjbjB5NWoxRW95WlVnU0FXX0tILXI5ZTAw?oc=5"" target=""_blank"">Biocon integrates biosimilars business of Viatris in 31 countries</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxONUZqMzl4c01ocVZ4NjZjZGVNaDV3ODQxTUtNV1p2ZUlKOWtucUdYaVo1aGVOVjRsS3V3X1JhSV9UWTZRQmhXQU4yc1JpNnVqQi1vQ0pBX3NPaDJaUG9odGEzTnRzQ1RVcVRSN0M4WXA3bTZaZmlISy1rMDhjbjB5NWoxRW95WlVnU0FXX0tILXI5ZTAw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-12-01,2023-12-01 08:00:00,Biocons subsidiary completes integration of Viatris biosimilars business; stock rises - Zee Business,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocons subsidiary completes integration of Viatris biosimilars business; stock rises</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-12-13,2023-12-13 08:00:00,Biocon's Bicara Therapeutics Ceases to Be Associate Company - Rediff MoneyWiz,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's Bicara Therapeutics Ceases to Be Associate Company</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-12-15,2023-12-15 08:00:00,Biocon Considers $1.5 Billion Sale Of Generic API Business To Cut Debt - outlookbusiness.com,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Considers $1.5 Billion Sale Of Generic API Business To Cut Debt</a>&nbsp;&nbsp;<font color=""#6f6f6f"">outlookbusiness.com</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3454,-0.3454,negative,1.0
2023-12-15,2023-12-15 08:00:00,Biocon considers selling generic API biz; turn into biosimilar major - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQMDdpQ1RuVXQzSGRKdlpIVGRuRlVTNkRRc2ZibFFzNlNoaHEzR2Fhb1Fma2I5UHBpejkzMkJBZnQ5QmVBQmpMaG1RaU5CMlg1aDc0a0R1SmdtZnZNNjYybVFOUUhEVzZ5elZOTzRNa25fblltNy1QTjVYMkRQMDdVM1dOQmwybmE0clFJbERnNDJod09BcGdabFFqYWI3SU1RNFRhcm9FTmlKVFZuZjFxT2Y4UkNISHdVNFVXU0JNNkhBWFNqM25lMnZaWENDcWJGNEHSAdcBQVVfeXFMTWJfdEdmWWluY3NXMGpBZmJidEo4SGx0bm1MUG5oMDlQTWZGLW1mZlZfcVk2Szd4YmFfTkg5bHBibHl1RzVtNGtJSlQ2VDU2S2w1WUxETEczdVR1WUwxWEVtdHRtLXdrUjBJb2ZWY3dTUDA4TkpqOUVVQzZwT094TVZoWExCTnlOc1FPN3E3VjA1TTVNX3A2cnFLQ0VBU0FSMGhHcjdPZ2xNZzFDZlBFWGw5V3pzZVpBQ2QyLTV6ZkZkcFRXNDBhcGFoUTBQREl6OEVsUVc4b2s?oc=5"" target=""_blank"">Biocon considers selling generic API biz; turn into biosimilar major</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.00625,0.00625,neutral,1.0
2023-12-18,2023-12-18 08:00:00,Biocon Biologics completes integration of Viatris' biosimilars business - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics completes integration of Viatris' biosimilars business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2023-12-22,2023-12-22 08:00:00,"Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxOY3NCNExkWGlxSFBPTDRJamx0MkFKbTZUanRORHRybWFKS0d3ZnhLUmdpWFBUYmJ3MXJXSHZ0ME9Od2xJQlo5VnE5WTZydlZ6b2hrS1lNRlRpcTBGaENPN3Zjd2NiUkgtTmN5Z2FIMkh0Q3RlcGtjaXhkbkFnamJhU2JzOThFV0NNX1JqZXBZYzhEZk9GM285NHBLTlI2bUZ1YVpmWDJkTkMza3YzUkl2aWdEbFpURTg4SDlNY0ZxdTVkNGJ6X016cUNuVmNaRnVfUGlV0gHYAUFVX3lxTE00alBqV2FWVHJIeXhTS0R5OVpHSEJ1ZkZ0SXAwdFJFeHJEcVR2T05TajVyZkxobkF6cThwbHptd1RqSHZiaGdWN3NGZXVrSkMtdjBYVXQtWlhweXJKU3ByekFuSUZjV1BvSFRPTHMzcnh5UndEMU1HdWVRQ0I2ckk0TS1CbEJ3OWpVZ2NKZ1lXOW1CcVR0aG82dnYzaWhKdi13cnhBYlp3ektRdHlPb2lSQ0Q0eWpYSF82U3YwdVQtRUw3VGh5cEFmd2UxdVg2TUgyb2Z4R1o0bw?oc=5"" target=""_blank"">Biocon Biologics, Sandoz ink deal to market immune disorder injection adalimumab in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.125,-0.125,negative,1.0
2023-12-26,2023-12-26 08:00:00,"Stocks to watch out for today: KPIT Tech, RIL, Tata Steel, Biocon and more - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch out for today: KPIT Tech, RIL, Tata Steel, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2023-12-26,2023-12-26 08:00:00,"Stocks to watch out for today: KPIT Tech, RIL, Tata Steel, Biocon and more - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch out for today: KPIT Tech, RIL, Tata Steel, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2024-01-04,2024-01-04 08:00:00,Why Biocon Share Price is Rising - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkhQOExicHF1a1ZIdDExSzdYamVkWHg2bnNLU3lhTV9BeFpxLU5kbXpUNVczSVE2dl9QZW1sMGRId0pCT21KWkcxd2UyMVNYUVVCZ2ZLd0FYdmRNOHRHdnA4d1d3ZGs5VE5tZlVHSjVUUTR4OXZxOXI0bXIyZlVDaXdCZnpzNnN0WXdOc0NJeTJjMHdzbzgwOVpGeGcxOWFWWjNiQQ?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxQTkhQOExicHF1a1ZIdDExSzdYamVkWHg2bnNLU3lhTV9BeFpxLU5kbXpUNVczSVE2dl9QZW1sMGRId0pCT21KWkcxd2UyMVNYUVVCZ2ZLd0FYdmRNOHRHdnA4d1d3ZGs5VE5tZlVHSjVUUTR4OXZxOXI0bXIyZlVDaXdCZnpzNnN0WXdOc0NJeTJjMHdzbzgwOVpGeGcxOWFWWjNiQQ?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-01-10,2024-01-10 10:35:14,“Biocon has challenged the premise of high quality = high price” - The Dollar Business,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ3ZaaUtibV8zSWg1c2lKWHEwcFlCczhwX1cwajBLSGNTdldNMXdtdm82WE1XeVBpdHpQeTV2czNRMEtpZTFwaWgxQTEzcDNMTU0zTmE3elFQXzYtazZ4Zll2ZHc1RFNTS3VrbTFNUHhaakRDZm9pSlV1NVhTY3NMRlJ0MjhZX2gybklrWHZ5LWh3eF9qWTdnZ0NzdUJTclBXTmN1SC1XUU1KSDA?oc=5"" target=""_blank"">“Biocon has challenged the premise of high quality = high price”</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Dollar Business</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ3ZaaUtibV8zSWg1c2lKWHEwcFlCczhwX1cwajBLSGNTdldNMXdtdm82WE1XeVBpdHpQeTV2czNRMEtpZTFwaWgxQTEzcDNMTU0zTmE3elFQXzYtazZ4Zll2ZHc1RFNTS3VrbTFNUHhaakRDZm9pSlV1NVhTY3NMRlJ0MjhZX2gybklrWHZ5LWh3eF9qWTdnZ0NzdUJTclBXTmN1SC1XUU1KSDA?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.03715,-0.03715,neutral,1.0
2024-02-06,2024-02-06 08:00:00,Biocon Gets USFDA Nod for Generic Anti-Cancer Drug - Rediff MoneyWiz,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxQMElXWm1HempwdmVrMG9YdWNxbWtzQ016eWVRbFZZalc1WHFGSGl6WTlXRjd2aDFvNUFCLVJGMXg2VUZDeGVLOFdQaDFkeEcxOER5WjFudTNGX3N1by1jaTQwT3JFR3g5NTU4MG5MejRkbTZjTWJSVVBZTHF0WVU0OUhIY2V1aUk2Uk5MTzhpSnRockp0UU9LVEpwTTJCODdxZ2lF0gGoAUFVX3lxTE1sbkJJbE5aUzhtejNYYkdZNlAzV3RJelpiVWxTbkthWTQ3ak1VdnVLYndYdzhRUnpFRHltM2pRX2ZsUUdhZGpRemV3NDlSdnRCQUJpeWNyaXp4OElGUDJEckk2S3BfLVE5LTEtOHpHWUZKU3JicEZXQ1RuR1dzUm1jaHV3UWpDUDJPbEtUZ290eW9iUmNkT3Z3alhXay1DaG5NRFNwUWtwRw?oc=5"" target=""_blank"">Biocon Gets USFDA Nod for Generic Anti-Cancer Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxQMElXWm1HempwdmVrMG9YdWNxbWtzQ016eWVRbFZZalc1WHFGSGl6WTlXRjd2aDFvNUFCLVJGMXg2VUZDeGVLOFdQaDFkeEcxOER5WjFudTNGX3N1by1jaTQwT3JFR3g5NTU4MG5MejRkbTZjTWJSVVBZTHF0WVU0OUhIY2V1aUk2Uk5MTzhpSnRockp0UU9LVEpwTTJCODdxZ2lF0gGoAUFVX3lxTE1sbkJJbE5aUzhtejNYYkdZNlAzV3RJelpiVWxTbkthWTQ3ak1VdnVLYndYdzhRUnpFRHltM2pRX2ZsUUdhZGpRemV3NDlSdnRCQUJpeWNyaXp4OElGUDJEckk2S3BfLVE5LTEtOHpHWUZKU3JicEZXQ1RuR1dzUm1jaHV3UWpDUDJPbEtUZ290eW9iUmNkT3Z3alhXay1DaG5NRFNwUWtwRw?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-08,2024-02-08 08:00:00,Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab - PR Newswire,"<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPRjd6eW8tSEtDTzEzVkIwTDNoUVphNHlYRzRlWldTOURzLWo4WlVPOS0wTkstbVhqLVNPQWx3WDFzQnNWdzk3MndhVzRMTUFWUnR1M2RZbEpkVmttd1o4NGNBVnhLQV9aZ08wTE1SdjVVNTN1V25kbzVDaFhYQ1hDd3J4TDlUN1JsaUo4OWt4dzgtcE1JcGs4UkZOWEJFRVpVYWNpTG1GTDUwTV9vTVp1OHFiXzcweHNWODdRRU5tVGItdG42VldGTVd0ek1PVk5SUjU3QmpadjUzWURvelRBbw?oc=5"" target=""_blank"">Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxPRjd6eW8tSEtDTzEzVkIwTDNoUVphNHlYRzRlWldTOURzLWo4WlVPOS0wTkstbVhqLVNPQWx3WDFzQnNWdzk3MndhVzRMTUFWUnR1M2RZbEpkVmttd1o4NGNBVnhLQV9aZ08wTE1SdjVVNTN1V25kbzVDaFhYQ1hDd3J4TDlUN1JsaUo4OWt4dzgtcE1JcGs4UkZOWEJFRVpVYWNpTG1GTDUwTV9vTVp1OHFiXzcweHNWODdRRU5tVGItdG42VldGTVd0ek1PVk5SUjU3QmpadjUzWURvelRBbw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-09,2024-02-09 08:00:00,Biocon Biologics partners with Sandoz Australia for cancer biosimilars - BioSpectrum Asia,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxPaE1SWEt2NTZXckhna3JRY2s0NXhhQUg1VkJnVDlFU0tpV1JJczRVMkdoMHNPY0hwMXQtaXFhY0Q4d0ZwcXRzSTkwLUpnS2l1UndueVNPRkZNX2hiakdGdExjMldFalFMcUZYdzNtUjZmZ1pFZjZWamJpaVdiV2FaamwtU2tGUG1zTnYzNkUxTnNWSGxuU1Y4QlU3M0VPUW1xZTlNUklBZFpLQ0U0ZF9NWHVYVWNCaG5QWUt5aEZR?oc=5"" target=""_blank"">Biocon Biologics partners with Sandoz Australia for cancer biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum Asia</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxPaE1SWEt2NTZXckhna3JRY2s0NXhhQUg1VkJnVDlFU0tpV1JJczRVMkdoMHNPY0hwMXQtaXFhY0Q4d0ZwcXRzSTkwLUpnS2l1UndueVNPRkZNX2hiakdGdExjMldFalFMcUZYdzNtUjZmZ1pFZjZWamJpaVdiV2FaamwtU2tGUG1zTnYzNkUxTnNWSGxuU1Y4QlU3M0VPUW1xZTlNUklBZFpLQ0U0ZF9NWHVYVWNCaG5QWUt5aEZR?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-02-09,2024-02-09 08:00:00,Biocon Biologics partners with Sandoz Australia to sell cancer drugs | Company News - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5"" target=""_blank"">Biocon Biologics partners with Sandoz Australia to sell cancer drugs | Company News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-02-09,2024-02-09 08:00:00,Biocon Biologics & Sandoz Partner for Biosimilar Cancer Treatments in Australia - Rediff MoneyWiz,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics & Sandoz Partner for Biosimilar Cancer Treatments in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-02-09,2024-02-09 08:00:00,Biocon subsidiary partners with Sandoz Australia - BusinessLine,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxQbXNxbW5XRm9JT192c2RJZXU1Z1FBdlFZUTFHVDlLendxcEZJSWthQXZlUkdTYXZfSUNVRTNVcjBDTWlYQW8tRERzeEx5LU1mczZORlp6X3NLU290WkVnWE1LdWstcFAwQnBMcFdjeFhnV21OejBEWGRJV285ZEM5UDlPSWdNVFNyZjZTNW1saDBpa2lSY05YRTItcDUxUWdNV3hadkduZ3JJUXo5NXZ1dXlSTTJHMVRUQkpvQUxTQW1lak5XWUHSAcwBQVVfeXFMUDFLdEZSM3NPVUwybTY2bnJvUVVDWmp5d1RqM05KVFpZOUFrVjlvWU5mN0dneUhOSENDVXdVYWpKQkMwY1JaMFdfMGl5UEU5ZDg4R0dGUmlESzUwUDRMS0pzSDEyTVpYck1HWVFvYWg3bnhLcm1RejNWdlplZFU4MGptOHhtZmd1WlphSFdfUGxmV0xnRTZZM21TZDF3U2RIZ2lZY0UxSS1nd0xpUHRUaWlnWjhWaGw2bVZ2UjF3ai1pQTU1dktlRXRqb1VN?oc=5"" target=""_blank"">Biocon subsidiary partners with Sandoz Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-09,2024-02-09 08:00:00,Biocon inks pact with Sandoz for sale of 2 biosimilar products in Australia - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxNYnhWdlZlZDBxdTVzUFZvSWtfTEJyRlo3czI5N004aF9jdGZ6eGtlbkJPV0tVd21QOGh2ZlNodmxPQ3ZtR1pIUjgwaVBXZDA5TTVDR3dTbzFlc3VVamEwMW5wWExoa1RqUkZ0N3ZDckpYYl92MGVZQTcxWmZSRDVnWG1xOG9uVFpXdXVacnNOVFFhSC1TcW1ESzNuV0hDbVpJcDZlRW5XdDlFck5GSUE1eXBWazVJakt0QkVQclRuY2M4Qzc3MTBtU3pBWGxheWk0cGRIRHdab3pCSlRo0gHiAUFVX3lxTE5fR19DZWRDU1NsWWRlTEpERW55cGNUYi1HU1J5WWxHSk1CMUdrTzlWeUNCUm8yQTJxcG1USDMyMHlTS2FhY0tGSWJ0aVp2Z2R2dHViZEFkWHNDU1lpZHVlYUN0M0N4MzVmamwweWdvN21vOWVQS3VsUDJvS0JKZG9JaWpoTk90NWRhQnJWZkNjTHlOemJ4Rnc1SFBwZF9pS2pIakJ1a2NOUDVtcWF2OGttRTlhcFptTmc0MW1PWTI1T1N4dHdzX2lkbENLaTE0LVBVMHdGLUFuVVNRU2cxbDRkZnc?oc=5"" target=""_blank"">Biocon inks pact with Sandoz for sale of 2 biosimilar products in Australia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-09,2024-02-09 08:00:00,Biocon Biologics partners with Sandoz Australia to sell cancer drugs | Company News - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5"" target=""_blank"">Biocon Biologics partners with Sandoz Australia to sell cancer drugs | Company News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNOTNKam9GSkN5alFOa0VRZS1qTEhuWk1HUGdwX0VwRFRpR3ZmZVBuaENfTGttX3hTeGRIUGhoMU42MWhzek5DdHYzUzF2enBHeHpvanB4VGhla0hSWHRrYVBwV1Z1RmJ3TUhLZzlnZFNqbW92QXl4RkRtTWxjOE5sM2hTWmVFeFRISFZLQUZMYjVSWXdZYzhMdi1nWmtmY2k1c1dRMHFGbklrQ2QtZWtqdTFLQUdKOG5TbzlMV09LTGJ1VERZUldYMDZBNlh0engwZ1lN?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-02-10,2024-02-10 08:00:00,FY25 to be year of consolidation for Biocon Biologics: CEO Tambe - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMiwAFBVV95cUxNS2x0M1JOM1EwUmZzZTl3UGdxU040U1Q3U1hUSEF1MDBEX3ViZl9veXZZbHJ4QmwxUmduVVBINUVSSnlxa0JJc1RFSWdmY0kxYmM1LUNUWHlUNDIyQ2ZkZmFEa095Q2Y0U05rS2JJTzdpNE9HLUFJaDA1VGE3cEpsQ2ZleVh2S2JVcVZHZDMwVDVCUERMZnRmYnVsT3htV0ZxYTBYdURpcm1UMjJTVWprWkR4TnlvYmlGX2VKNDVYY0w?oc=5"" target=""_blank"">FY25 to be year of consolidation for Biocon Biologics: CEO Tambe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMiwAFBVV95cUxNS2x0M1JOM1EwUmZzZTl3UGdxU040U1Q3U1hUSEF1MDBEX3ViZl9veXZZbHJ4QmwxUmduVVBINUVSSnlxa0JJc1RFSWdmY0kxYmM1LUNUWHlUNDIyQ2ZkZmFEa095Q2Y0U05rS2JJTzdpNE9HLUFJaDA1VGE3cEpsQ2ZleVh2S2JVcVZHZDMwVDVCUERMZnRmYnVsT3htV0ZxYTBYdURpcm1UMjJTVWprWkR4TnlvYmlGX2VKNDVYY0w?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-20,2024-02-20 08:00:00,"Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44325000000000003,0.44325000000000003,positive,1.0
2024-02-20,2024-02-20 08:00:00,"Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44325000000000003,0.44325000000000003,positive,1.0
2024-02-20,2024-02-20 08:00:00,"Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Coal India, Biocon, Coforge and more: Tuesday's top brokerage calls</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44325000000000003,0.44325000000000003,positive,1.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-02-21,2024-02-21 08:00:00,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdVdNV1gyZGVvandycWh4dE1tSkN0YnBOVVRrdW9HTE5sZDJlbHg1S0M3dndITWQtcDNoUjZYd1FvSS1scWJjVlFOcHFuZjhEdWtwUkI5ckhXRjJOZi1KV3p6NmdUN0VkWlRZeWNJd0dqUWdTaXh4LXloYmc5V3N2V29MaUFCbHB3bDhUZnh4MllOZkdrVzVrYnFBN2djcnRmaTFXOFZzYzlaR29NN2x4aDZKelYta0JSX0c3cEE0SVl3QWhnOGVDSWw4VmZhdHJMZ01oX1FXQdIB3AFBVV95cUxOWXVtQU5nYTY0MVMyVFNXcUdMSGhsY0E5ZmoxUXZlQ2FhaU8wdHlLc1NHTHI2UTc5Nmtka1ItUDBMTkJqYWRwZ0I3U0EyVkVPejJKT2FkM01qTEZGV0RiNVJGOG1iSV96elJuM1ZXVkJrdlJLU1ZVcTdLZXVFUFNNYlRNdDc2NHlkTGt5VnFMdWhhbEtwS1Jna3FxTVAyN0Y2YUdvSExDVzN4ZjNRRDk3aUJrUlp2R0dWWF9xVWVCSWhmZlpLQVlHNEpBcDhRZUpxelFUQmdfVGZyeUxB?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.2294,-0.2294,negative,1.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-02-21,2024-02-21 08:00:00,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.2294,-0.2294,negative,1.0
2024-02-21,2024-02-21 08:00:00,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdVdNV1gyZGVvandycWh4dE1tSkN0YnBOVVRrdW9HTE5sZDJlbHg1S0M3dndITWQtcDNoUjZYd1FvSS1scWJjVlFOcHFuZjhEdWtwUkI5ckhXRjJOZi1KV3p6NmdUN0VkWlRZeWNJd0dqUWdTaXh4LXloYmc5V3N2V29MaUFCbHB3bDhUZnh4MllOZkdrVzVrYnFBN2djcnRmaTFXOFZzYzlaR29NN2x4aDZKelYta0JSX0c3cEE0SVl3QWhnOGVDSWw4VmZhdHJMZ01oX1FXQdIB3AFBVV95cUxOWXVtQU5nYTY0MVMyVFNXcUdMSGhsY0E5ZmoxUXZlQ2FhaU8wdHlLc1NHTHI2UTc5Nmtka1ItUDBMTkJqYWRwZ0I3U0EyVkVPejJKT2FkM01qTEZGV0RiNVJGOG1iSV96elJuM1ZXVkJrdlJLU1ZVcTdLZXVFUFNNYlRNdDc2NHlkTGt5VnFMdWhhbEtwS1Jna3FxTVAyN0Y2YUdvSExDVzN4ZjNRRDk3aUJrUlp2R0dWWF9xVWVCSWhmZlpLQVlHNEpBcDhRZUpxelFUQmdfVGZyeUxB?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.2294,-0.2294,negative,1.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxQU21KZUFYSkJrNzJ2NW4tVFdGbWx0UlozYXlzSHlwRGRPUWFTVXByMXBWSXE3OUxXV010RWxzWm4tRXFyUEcxSk54STBzSGRILTJjcXdDWnEtZFpoT2ZCQk9IWGsxSmcwYTRYM2k5Y0M4VGJMRmlZeTBDaU9aM3NhdkVYVEs4M1dLUFNmRXd0SVdLOEcySHc5b0h6d1NjWVNXbm1yUlNGbnpHcWc4cFd4OTJhZi1TcnBqd01aYlpGYWx1YW1YcVBodW5kZ2JwTU84bDhPZllRajBmVU1STlHSAeMBQVVfeXFMTkdQVXVPa0pmcEZDT0wtcUEyS2VEQzVuQVlxNVBCUVRlNWgyQWhnSk10Nk9lSU90X0xhRDROeGlpRVVSamNnRmdscG9CV08yaWFBYXBzQUQ4X01JUWFhTUE4azNnTk0taXFhYmlsLWt3LTFSY0ozT1gyYmxXQldaLXFzS3UyRVZ2NkZxeVZ1a2dDU2FTdVUzQ2dNUWhObWdTd093eEg1b09UR2FMQ3FVVUlfUkRnUWx6YnJwQ1liOWZZWVVDSHp0WVV3NFZOcTdiQVNZa3Y4QnM1OWNJNDRianZZYzA?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-02-21,2024-02-21 08:00:00,"Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Jefferies downgrades Biocon to ‘underperform’, sees 11% downside; here's why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdVdNV1gyZGVvandycWh4dE1tSkN0YnBOVVRrdW9HTE5sZDJlbHg1S0M3dndITWQtcDNoUjZYd1FvSS1scWJjVlFOcHFuZjhEdWtwUkI5ckhXRjJOZi1KV3p6NmdUN0VkWlRZeWNJd0dqUWdTaXh4LXloYmc5V3N2V29MaUFCbHB3bDhUZnh4MllOZkdrVzVrYnFBN2djcnRmaTFXOFZzYzlaR29NN2x4aDZKelYta0JSX0c3cEE0SVl3QWhnOGVDSWw4VmZhdHJMZ01oX1FXQdIB3AFBVV95cUxOWXVtQU5nYTY0MVMyVFNXcUdMSGhsY0E5ZmoxUXZlQ2FhaU8wdHlLc1NHTHI2UTc5Nmtka1ItUDBMTkJqYWRwZ0I3U0EyVkVPejJKT2FkM01qTEZGV0RiNVJGOG1iSV96elJuM1ZXVkJrdlJLU1ZVcTdLZXVFUFNNYlRNdDc2NHlkTGt5VnFMdWhhbEtwS1Jna3FxTVAyN0Y2YUdvSExDVzN4ZjNRRDk3aUJrUlp2R0dWWF9xVWVCSWhmZlpLQVlHNEpBcDhRZUpxelFUQmdfVGZyeUxB?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.2294,-0.2294,negative,1.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxQU21KZUFYSkJrNzJ2NW4tVFdGbWx0UlozYXlzSHlwRGRPUWFTVXByMXBWSXE3OUxXV010RWxzWm4tRXFyUEcxSk54STBzSGRILTJjcXdDWnEtZFpoT2ZCQk9IWGsxSmcwYTRYM2k5Y0M4VGJMRmlZeTBDaU9aM3NhdkVYVEs4M1dLUFNmRXd0SVdLOEcySHc5b0h6d1NjWVNXbm1yUlNGbnpHcWc4cFd4OTJhZi1TcnBqd01aYlpGYWx1YW1YcVBodW5kZ2JwTU84bDhPZllRajBmVU1STlHSAeMBQVVfeXFMTkdQVXVPa0pmcEZDT0wtcUEyS2VEQzVuQVlxNVBCUVRlNWgyQWhnSk10Nk9lSU90X0xhRDROeGlpRVVSamNnRmdscG9CV08yaWFBYXBzQUQ4X01JUWFhTUE4azNnTk0taXFhYmlsLWt3LTFSY0ozT1gyYmxXQldaLXFzS3UyRVZ2NkZxeVZ1a2dDU2FTdVUzQ2dNUWhObWdTd093eEg1b09UR2FMQ3FVVUlfUkRnUWx6YnJwQ1liOWZZWVVDSHp0WVV3NFZOcTdiQVNZa3Y4QnM1OWNJNDRianZZYzA?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-02-21,2024-02-21 08:00:00,Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform' - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares: 2 reasons why Jefferies downgraded stock to 'underperform'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-02-29,2024-02-29 08:00:00,"With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5"" target=""_blank"">With J&amp;J settlement, Biocon Biologics gets a license to challenge Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.07655,0.07655,neutral,1.0
2024-02-29,2024-02-29 08:00:00,"With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US - Fierce Pharma","<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5"" target=""_blank"">With J&amp;J settlement, Biocon Biologics gets a license to challenge Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxQY2hCRXpYRld6OVhjbmZOU1ozRmY2WTU1R2NwbDNrSjdzbGRxbzhDNlVPZDBmUXpfcTRHeTZMelVIYzdMNWVrcnVLamNuallIeERwZ24zQVpiOWx5MmtTOUhfaW53ZTU3YVQ2UzV5TDdUMm1aX0poVnlDUzV4V2V6OTczZElkX3lTTmVfcUYtdFdCUi1LRmYySw?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.07655,0.07655,neutral,1.0
2024-02-29,2024-02-29 12:35:59,FDA hits Biocon insulin biosimilar with another CRL - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5"" target=""_blank"">FDA hits Biocon insulin biosimilar with another CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5,Google News - Market + Complete Company News,Semglee FDA application,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-02-29,2024-02-29 12:35:59,FDA hits Biocon insulin biosimilar with another CRL - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5"" target=""_blank"">FDA hits Biocon insulin biosimilar with another CRL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxPQ3NaT2g3Y0RhVFl5TWRtNXJ5YW9PcmstUVpqcFpLNHVxZWlqZEZwZ25kd3RtMlpWV2JMUHBVUkZrOWVoS0tMU0lBSjBQZVZKcHozdXk1bFRFSWpwWHdRLXhRanl0RV9xYjJHZkktb1ltelI5dEY1Um9mSXVpM21YRmtHaEpTTUplbmtPQWRSU3pBZFNsUzhsMFJR?oc=5,Google News - Market + Complete Company News,Biocon Semglee FDA,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-04,2024-03-04 01:55:31,Biocon investing $200m into second MAb plant in India - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOekJyTmdXMXBnMmdsWGtDQ1d5UEh0UE5tdXBqX0FuY25UUXhJRG9wa1dLU1dITzctbkEyVEt6WlJad2VmSmc0RlZ1UUJEVE5oVzJubnJMSUh1TkZOUkJBc29KZEloNW5WRk1HLWNaTVRuVENzUlRfaEFtejRKcjZVbWxPNTRIMlNHUldSbnMtaHpCLTRDTS12R0xMLWRCTDVaZ0Q1WVNB?oc=5"" target=""_blank"">Biocon investing $200m into second MAb plant in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxOekJyTmdXMXBnMmdsWGtDQ1d5UEh0UE5tdXBqX0FuY25UUXhJRG9wa1dLU1dITzctbkEyVEt6WlJad2VmSmc0RlZ1UUJEVE5oVzJubnJMSUh1TkZOUkJBc29KZEloNW5WRk1HLWNaTVRuVENzUlRfaEFtejRKcjZVbWxPNTRIMlNHUldSbnMtaHpCLTRDTS12R0xMLWRCTDVaZ0Q1WVNB?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-04,2024-03-04 08:00:00,Biocon Biologics secures Canada market entry date for YESAFILI - Industry News - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPS0FYNXZCX0kxYzNwRDl5Sm53SHhwa20xZXZWbmFxcGJ3akU2OUZxLU9oTng0V0FlOWJtQXN1XzQ4Qnd4aDVyZzNVWG5kR25lXy1GMUVIZzQ3U0ZYZDJ5SkN6MjJvOGZIUWdRbTRORGkyZDVSSl96Rk1LcWU4MlNJaGs4MVlpemEyVGQ3VnBXQUVybHo2UlVocmcyYWNqSmxxZjhlQXBNcktycU1ROE1mVThTRzdOaEllY0RIVnpPaw?oc=5"" target=""_blank"">Biocon Biologics secures Canada market entry date for YESAFILI - Industry News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxPS0FYNXZCX0kxYzNwRDl5Sm53SHhwa20xZXZWbmFxcGJ3akU2OUZxLU9oTng0V0FlOWJtQXN1XzQ4Qnd4aDVyZzNVWG5kR25lXy1GMUVIZzQ3U0ZYZDJ5SkN6MjJvOGZIUWdRbTRORGkyZDVSSl96Rk1LcWU4MlNJaGs4MVlpemEyVGQ3VnBXQUVybHo2UlVocmcyYWNqSmxxZjhlQXBNcktycU1ROE1mVThTRzdOaEllY0RIVnpPaw?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2024-03-04,2024-03-04 08:00:00,Biocon Biologics gets green light to launch Yesafili biosimilar in Canada - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets green light to launch Yesafili biosimilar in Canada</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.03333333333333333,0.03333333333333333,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMijgJBVV95cUxOOFBQaWFnNW9jQXY4TUpGeXdEQW1nUzVxWlN0NDVZWk1GcWFsRmVvaFFoeUJKMWJEZTc2ZTY4ckROLWxNV3pYdTY0WC1HdjFjY2g1cGVNY29rLVJncFNLa1R0eF84UDV6ZjR6T0JEcnlYZlZqdkVTRkQ2OGVUQ2pHOG5YS000SmY1RU1rUkhIZE53TDJIQ3dvNWhfV1ZVUnlKajlRWVViMldkZnVlSjZKYkliMENHY3ZuRmUzTGxkaXVVc0tlMjRBZTVQc1JzeWFtQ2JaSVN3OTR5T3NYUkFMMWRJdDNha09lWVN0cDYxQUp5NjBXQ3QyUHdMSW5UNF9mRm5waUNvZ3lxeXRXcWfSAZMCQVVfeXFMTmZnei0ycG1vRHBEMUF3Yy10UEJVQ0VwR0V1bWhDbGNFTGQwem1jdGVZaVcwV1hRb1JvUnZESUo0TXZxV3gwLWFwSkprVXFjcEJtZS1ubnFrOXBKUVpCbmpaTUFzTl9GNTBHSUlGeTNnUnZlUjNPZzNiRkNacGNnNkRSQm1BMHNiVTZZbHZZV1FJNjNaSWZmQWNzUDBXOFJWZlRxSVlqR1VkMVAtalRjMVN5WHVMM0FBSXkzQWRBY2lRdEtLRmxrTUc2N1NLVTkyZGtiTEIxWEtubVpCb0dBeDRZV3IwaUpzV29aQkZrT0YxYWVFRm5qVllVcW1QUVAxdkFfZ3ZOaVJjLTJfYjN2VmhuNmM?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04,0.04,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris to acquire Biocon Biologics’ India branded formulations business for ₹1,242 crore - The Hindu","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris to acquire Biocon Biologics’ India branded formulations business for ₹1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.com/rss/articles/CBMi9gFBVV95cUxPZ2F0dHluSW9XRGVLR0pGdm9QY2VUQ1gtalYwTmltb3FOSnJWNlRKSEc4U0hha2xxTUxEMmxHSzFqVmxqd0wxMURHRUt3X1pYWEZwRVBhSVhGcHhkWnBEaVRJUno2LTJ6d192YWtzZndQdDJMdzFfdnBGd0Q4dlc1N1Q1M3RvZng3QXh0aS1BZDZjWkdmYXp0cTJlVzFRb1IwakdpR2plckRKMEMwTGNvR2RvRUZRN2NITUhXMldheFpIcnBkbEVzNG9WeE1mc0tkUC1pZE9LVFBoc2tlNWswSVYwVW03RlY5NmNqTnM4cTJXY0NkOUHSAfwBQVVfeXFMT1JZX3prRWo3ME1mTnFPekN0Nmw3RHhRVTN6SWN1amxXWUw4TUJqRC1iWGZSUmVJRWhENlZwUVFMY2Q4UXBKSXhuaUxVdGVOWTBmcl9rd3YtMWViMVotOWpiR0RQY3lsOEhHT3R4TDBIenMzQ0NuZ2lGNS1lVENKbUxxYkwtc0tReXIxN0FkVDladXNwM0NpU2hwcGFtZGlTV1hlRVoxeVgwWFd0cm9zZXM0ZUpkeVgxWFFlRjlicEVJbWFvYlhYNjJ0WmJSaVFXdHYxLUh0czlnazNYVFNFWWcwdms3MFhLYU01N29QQW9hSl9yaExUXy0zcU9w?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04,0.04,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris to acquire Biocon Biologics’ India branded formulations business for ₹1,242 crore - The Hindu","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris to acquire Biocon Biologics’ India branded formulations business for ₹1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences acquires India-branded formulation business of Biocon Biologics for ₹1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business - VCCircle,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQVVRBS28yUTh6UUhSaVNxQXFxRXktRGlxSFlFa0o0dWk0NW9Qd3p5eGwxTW1jTU1VZUdJQVpKZFhIR1NNeWZrRW10ZDBBZGRXRUpYUWNGdHBLbU04ZlhDdjVLaEFINzBPTThvc213ZFNERjBra1gxc1BERnJFTHoxbk5xcVpSMDkxMnhlWUh0UjgxT3AwLUtQeFYxM3o0T256UlhLQmdB?oc=5"" target=""_blank"">ChrysCap-backed Eris Life acquires Biocon Biologics' India formulations business</a>&nbsp;&nbsp;<font color=""#6f6f6f"">VCCircle</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQVVRBS28yUTh6UUhSaVNxQXFxRXktRGlxSFlFa0o0dWk0NW9Qd3p5eGwxTW1jTU1VZUdJQVpKZFhIR1NNeWZrRW10ZDBBZGRXRUpYUWNGdHBLbU04ZlhDdjVLaEFINzBPTThvc213ZFNERjBra1gxc1BERnJFTHoxbk5xcVpSMDkxMnhlWUh0UjgxT3AwLUtQeFYxM3o0T256UlhLQmdB?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris Lifesciences acquires Biocon Biologics’ India branded formulation biz for Rs 1,242 Cr - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxQQVN4NFB4X0owLUNsUE41ejJ4VkM2WDh4ZjE3QVpscF9PUENVVERIcFVuZEtid3lGWDdhSGRqT3U3d2hCaHpORUl0eHFfMms0X3ZFcE84QkY4d1k1TEE1d2lLSXZORVViYllRRF9qQXpGVkZjWExhWkhadWhCZURhRkR0M2d4dU5mWkYyUGFsX2c1bFFURzFOdGVjQm9MSHdzU0lQRTNYNUhuRTlOZEsyeWZZSjlWWm9SVjFGOHY2Q0pmd3VESzI5My1nNmdTZXh1RVJtcTJjNA?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon Biologics’ India branded formulation biz for Rs 1,242 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxQQVN4NFB4X0owLUNsUE41ejJ4VkM2WDh4ZjE3QVpscF9PUENVVERIcFVuZEtid3lGWDdhSGRqT3U3d2hCaHpORUl0eHFfMms0X3ZFcE84QkY4d1k1TEE1d2lLSXZORVViYllRRF9qQXpGVkZjWExhWkhadWhCZURhRkR0M2d4dU5mWkYyUGFsX2c1bFFURzFOdGVjQm9MSHdzU0lQRTNYNUhuRTlOZEsyeWZZSjlWWm9SVjFGOHY2Q0pmd3VESzI5My1nNmdTZXh1RVJtcTJjNA?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon Biologics signs 10-year supply deal with Eris Lifesciences for Rs 1242 crore - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxPY0xfT1FZWHF0RWZUYndHb2pDdEJlX2I2VDlkNWdkMDBxTXFCalhwa2hqcTRWVXk2WjQ3b2twbE1GQWRpS3ZnSEhXcUN4YmpBMTdWUnZvZ2FQRXRYT3YxcGEwa1lBMV9Zb0pBOXZlTWtvVGM3c0tvTEMxV0FzTVZrSGtNVEw4bTdCdVZyWndRTkVyNHRMUk9MdWZadURyQkQySU4yRVZWb2YzVUpVLV9BUXpHeThneWZMOVkxeXpSaXptYVI5SzRUV0hkZWhQaHdGMkFic0hYVjlHMkFCczF3Y9IB5gFBVV95cUxQb25TU0dGd0VvNFd6bUwxd1lkd2ZtU3k2cm1PN1p0VWZXZnp4T3FjVzRRcDNIaVVGdlBqUm5qeVV4bW9tVkdDVXg1OEdBLVNrYUZ4UUxBckhxQ05LeXRwY0ZMd2NENmwtNHVEYVViSmgydUJFU0xnZWRSZUNNVXprVG12RHk5OEZhOE1Rblp6ZlZ2TnJxelhhWDBfSmYxSkl3X3ozQXJrZGdvT2hHYjhFWnFmSXB0bEFENnVFOFBKWi1EUnc4ZkJiNEJIU3hVSnc4YmVjRmVDS0hRalNBeUhlMEFHLW9oZw?oc=5"" target=""_blank"">Biocon Biologics signs 10-year supply deal with Eris Lifesciences for Rs 1242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access - BW Businessworld,"<a href=""https://news.google.com/rss/articles/CBMixgFBVV95cUxPYnYxTWtBNERFZTdYbWVuaGkwV2x4UkJ4SHlDdmdWSnBrbTR1dGRxbmhHRHpWTUl2TzQ4WkphenloYm9IR3d1eUk5bi0xSUxUOTg2SDRzNFZTU2dxVVBJRmZxTWZqa1M5Qk1LR1pXNG9tQmVsd3VOdnlmQWxhMGl6RGNJNm92NTV1ci1qY2ZTbnh1ZDMwVnYwNG5PQlhHWl82anktMEpBa3hPUE5MUGVqV0pWaDAzQ2FDWmJxSThqR2loYWRfeFE?oc=5"" target=""_blank"">Biocon Biologics Signs 10-year Deal With Eris Lifesciences To Expand Patient Access</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxPYnYxTWtBNERFZTdYbWVuaGkwV2x4UkJ4SHlDdmdWSnBrbTR1dGRxbmhHRHpWTUl2TzQ4WkphenloYm9IR3d1eUk5bi0xSUxUOTg2SDRzNFZTU2dxVVBJRmZxTWZqa1M5Qk1LR1pXNG9tQmVsd3VOdnlmQWxhMGl6RGNJNm92NTV1ci1qY2ZTbnh1ZDMwVnYwNG5PQlhHWl82anktMEpBa3hPUE5MUGVqV0pWaDAzQ2FDWmJxSThqR2loYWRfeFE?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris buys India formulation biz of Biocon Biologics for Rs 1,242 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon continues to divest with $150M sale of insulin and other brands to Eris - Fierce Pharma,"<a href=""https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5"" target=""_blank"">Biocon continues to divest with $150M sale of insulin and other brands to Eris</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Fierce Pharma</font>",https://news.google.com/rss/articles/CBMiqgFBVV95cUxNaHZnblh3SFlBc2lMV2h6SmRZVGNVd2V4TTFDQ3ZGZVVWSkVVR1FpZGU2RERBRkhUTU5XQm9taUJjVzlPckNod3NvNVl4SGN0UjZhRUxRSmoyQ1FSSW1HXzUzREV4Wkw3VjMtd0JRdUgzMC1EZngtZTVJYUQtVGZ6V3BrT2MzV00wS1hkaHA2RkhfX01SdHI1Nmgxd0hjWFJFYW80WlUtX0RYdw?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-03-14,2024-03-14 07:00:00,Biocon to sell branded formulations biz to Eris Lifesciences for $150 mn - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to sell branded formulations biz to Eris Lifesciences for $150 mn</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-14,2024-03-14 07:00:00,"Biocon share price target 2024: Pharma company bags Rs 1,242 cr deal; Time to BUY? - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price target 2024: Pharma company bags Rs 1,242 cr deal; Time to BUY?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2024-03-14,2024-03-14 07:00:00,"Biocon share price target 2024: Pharma company bags Rs 1,242 cr deal; Time to BUY? - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price target 2024: Pharma company bags Rs 1,242 cr deal; Time to BUY?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2024-03-15,2024-03-15 07:00:00,Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxPLUs4c2ROSXF4TzAzdTBSRHRZdDJrSjg3NHNyLWUyZnlDdWtJWkpBRkZ1YVpCc0RXRGxsYmF5MTM2ZmY4eFdIRFJGMGd3T2dvZVFZS1ZickZseUVsOVhtX2tNcVJMV0sxR3FMOEUwWF9VVE9hMnQwalA4UWhmOW5PLUhMQnF5MGZ4MlNmX0t6b0RUQzE1QTVKTVFTUWVwWDBITDNNcmY1d1ExaUVHeGd5NFNPalE0bmFHUW1rM0RjWVZxRmtVV3RyODU4cjFjM05Ocm05S1ppc2JQcGR2U2t2SndNczdhbVUtSXEzatIB8gFBVV95cUxQd0JUWTZlOFNQdzdnVktMZk8zM0RZazVKTVdMWEhXbWJ1S1ZXMUo1NEVlNVh2dm81dzNZOEtuVkJXcG1ZSFBuRV9SX1V3NGR3VlBodVNNS1MxbEFpQ05kaEJOZ245bVlTZ3UxVXhiRXhXbzctS0dvWGhpU3ZUZ0hDaV9VQlZyZFN3QmNfMmM5NHljbTdkMlZVZ1hLVWJVMG9xVjhiX2VkcnJuNm12Zkw4Rms2UkQ1bG5vQklQV2NKNzJkMUxtZU5hNWZmT043X0w4M1VPYllPdHNINTJpdHZsZ3lqa1d3UWQ3VmZSQUdNdlkwdw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26335,-0.26335,negative,1.0
2024-03-15,2024-03-15 07:00:00,"Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr - Mint","<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxQY0ZUYUs5ZEtYVzZxV2xTUVY3dml3V3Q1cS1zMnF0U3VWWDhEZWNPOHYtQmdXeFJUU3JwMWVEeFlwcW9KRVBjbzJYOGZDSTh2UXZ6ak8wZTNzeGxNSDhmaGlFYlc5dlNaNkg1N3JBaE55TWd4UUxLUldwWVdaU00xeWM1WGdTQUZsaU1WcGZkVXdRTy0zSG41QzB4Rm8yMkVkUUw4Zlc2aG5oX3VKeWtua2VkOGoxajVFWk5Cd08wTU1VYlEwTzRoOEc2YUVnREdEa3fSAdcBQVVfeXFMTm5ESUdHOE9aZ3dRTGRvQXBjUzV2QXlIZnd2R0ZjdjdWTFZkX2E1d3gxNENkTnJSWjl3ejc2VTVVX0Z5V2lEUTRYZXNxai11NGJZdUUzZmJLYVp3VWVrWG9tRHE2TGJyVjE5djg2cVdGZUl1Y0NQdXhxa0FiT0ZCZ0lDR0ZfTzZQSVlBNm1leUJNTm9CM2Q4Q0tOQ3JfazY0ekxWWVBfSkFPbkI5QmRHc0xXSmIyc0JKa2lXUWlmbFhXMTJCUjY3RWJ5bHcybXk3c044Q3BUdGM?oc=5"" target=""_blank"">Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-15,2024-03-15 07:00:00,"Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-15,2024-03-15 07:00:00,"Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.1462,0.1462,positive,1.0
2024-03-15,2024-03-15 07:00:00,"Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to sell India branded formulations biz to Eris Lifesciences for ₹1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-15,2024-03-15 07:00:00,"Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics CEO terms Eris Lifesciences deal as enabling, not restricting</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.1462,0.1462,positive,1.0
2024-03-17,2024-03-17 07:00:00,"Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr - Indian Pharma Post","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-17,2024-03-17 07:00:00,"Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr - Indian Pharma Post","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eris Lifesciences buys India formulation business of Biocon Biologics for Rs. 1,242 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-03-18,2024-03-18 07:00:00,"Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr - Value Research","<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2024-03-18,2024-03-18 07:00:00,"Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr - Value Research","<a href=""https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5"" target=""_blank"">Eris Lifesciences acquires Biocon's branded division for Rs 1,242 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",https://news.google.com/rss/articles/CBMiwgFBVV95cUxPQmF6TktFMlR2ZWJXZWUtQXZodzVQUk1mZDdxSmR0Uy1Lc0pVUl9ZUGpzWWFpVlVSRFF0MFF0SVUtaWZRUWhBUW5YSkxTd3QwZHdyRU96eTZYcC1lVGx1ZmtCeS1lbjFhOEdTMW1PMHBGamo0TkU5c3IwV0NiSG80UWVYMk1wMWppZ0N3YjdqeVQ1cUdIWm40TUNIVkkwdFlxTldzT2RZRmwtN2w5UWJuOUFEaWI5OTdDZGtTOWNsTEFfQQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.17,0.17,positive,1.0
2024-03-28,2024-03-28 07:00:00,"Biocon to obtain approval for diabetes drug, Liraglutide in UK - Indian Pharma Post","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to obtain approval for diabetes drug, Liraglutide in UK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.36755,0.36755,positive,1.0
2024-04-09,2024-04-09 07:00:00,"Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - PharmaVoice","<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5"" target=""_blank"">Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaVoice</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5,Google News - Market + Complete Company News,Semglee biosimilar approval,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-09,2024-04-09 07:00:00,"Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - PharmaVoice","<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5"" target=""_blank"">Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaVoice</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5,Google News - Market + Complete Company News,Semglee market share,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-09,2024-04-09 07:00:00,"Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future - PharmaVoice","<a href=""https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5"" target=""_blank"">Biosimilar uptake appears to finally be on the upswing, and Biocon Biologics is betting on the sector’s future</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PharmaVoice</font>",https://news.google.com/rss/articles/CBMimwFBVV95cUxQVnV5ZXhReV9pVTMzSHpjN0ZDaUpKa0VaZHNxQzU2LUpMUnVQbnU3WG5rTkkzYzJ3ZEdfMHJIamF4aWwtcDNEN2taMXdocDRoY0duYkxTVkQwV1VKSDZ5U2NYMHEyaWNac3NYOGFEa0FrODIzRTBDV2M1ZElpSERCeng4SEhPYmxTX1ZMdHNPTnNJdlB5V3d6d3Jqbw?oc=5,Google News - Market + Complete Company News,Semglee commercial success,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-12,2024-04-12 07:00:00,Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5"" target=""_blank"">Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31074999999999997,0.31074999999999997,positive,1.0
2024-04-12,2024-04-12 07:00:00,Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5"" target=""_blank"">Will Biocon Lead Indian Pharma's Rare 'Patent Cliff' Opportunity</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxNMkZ0QUdwbEZjelpWVDk3bm1kd2I5ZmtTT19SZjZ1YkM4VjdSTXlsakt2ZFA4ekdBZGxlM3VOQVBNcExhUDg3aEl4MHU4ZTh4SkZnSF9nX05GTVpFaTI5emUzYVo2RWdfWFBVNGxJbGRvNm9wVTVfVUMyb1BJQkxKbGw4XzVnblN3YWtRM3VoZE1fYWx4b1lsOXAtY2pCX0lOMkRpOWRLSTRGTlF1OEswXzZoWHdvR0xCb2ZmQS1KZjlnZU1mbmdiYko0cWRibjMyZGdTWE5VSjBoUzNGOWc?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31074999999999997,0.31074999999999997,positive,1.0
2024-04-17,2024-04-17 07:00:00,Biocon partners Biomm SA to commercialise it's diabetes drug in Brazil - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners Biomm SA to commercialise it's diabetes drug in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-17,2024-04-17 07:00:00,Biocon inks licensing pact with Biomm for diabetes management drug Semaglutide in Brazil - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxPQzhDVnp0dU1wN3VwRnhHdlRpZ3BpQlppU0JJNXpmOWg4SlphYldpTHBjVl9uN3ppdTNmNmtXZ0tvenNla1hkSHVvdW93YUZRWEZ3UGMyMnBrN0IyUzY2WGtGQlZtYXg1bGNBWVNWQms1cU1iNkxOUkJfYzJFbUFtLUk5aFFPQTV6VkN2M2V4UE5LVlE1VXc0dmhvWkphc3BxdjExbmxBUGQ0YU5nc2pTTXU1eVAzX1FtVThmRUpzcHFSSnBVNEdUQm55dktNaDNSR3BpQ3o1Z3hYZWpmbU44VWQ1R0_SAeoBQVVfeXFMT3pxeXl0c1V0d0ppb21qQmM1ZnBsSlI4T2d6UkFWeERqWEgyNkZVdmVQZjI3R21PUTV3bngxN1BmdGdqUkl6MHZQZkI1bUtHYlZfc0RUMWtkQlVVOFk3U0E5NjBLNkJCT3Zpdk0tTlZWSk1tWUFjNEtOVk5oVWNfYnFLNWlnX0FYS0kyd3JDZUNaNkRocmlVb1NkZlJUaFpzc3FjWkljblJPZTFDUXQ4bmN1T0FFVG1KMlo5YXZ3cDZKajdWYW5ScE51UVFfRFdpZC1iZkY0THNOSmQzTGRiejhYYWNGd0FiaTl3?oc=5"" target=""_blank"">Biocon inks licensing pact with Biomm for diabetes management drug Semaglutide in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxPQzhDVnp0dU1wN3VwRnhHdlRpZ3BpQlppU0JJNXpmOWg4SlphYldpTHBjVl9uN3ppdTNmNmtXZ0tvenNla1hkSHVvdW93YUZRWEZ3UGMyMnBrN0IyUzY2WGtGQlZtYXg1bGNBWVNWQms1cU1iNkxOUkJfYzJFbUFtLUk5aFFPQTV6VkN2M2V4UE5LVlE1VXc0dmhvWkphc3BxdjExbmxBUGQ0YU5nc2pTTXU1eVAzX1FtVThmRUpzcHFSSnBVNEdUQm55dktNaDNSR3BpQ3o1Z3hYZWpmbU44VWQ1R0_SAeoBQVVfeXFMT3pxeXl0c1V0d0ppb21qQmM1ZnBsSlI4T2d6UkFWeERqWEgyNkZVdmVQZjI3R21PUTV3bngxN1BmdGdqUkl6MHZQZkI1bUtHYlZfc0RUMWtkQlVVOFk3U0E5NjBLNkJCT3Zpdk0tTlZWSk1tWUFjNEtOVk5oVWNfYnFLNWlnX0FYS0kyd3JDZUNaNkRocmlVb1NkZlJUaFpzc3FjWkljblJPZTFDUXQ4bmN1T0FFVG1KMlo5YXZ3cDZKajdWYW5ScE51UVFfRFdpZC1iZkY0THNOSmQzTGRiejhYYWNGd0FiaTl3?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-17,2024-04-17 07:00:00,Biocon inks licensing pact with Biomm for diabetes management drug Semaglutide in Brazil - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxPQzhDVnp0dU1wN3VwRnhHdlRpZ3BpQlppU0JJNXpmOWg4SlphYldpTHBjVl9uN3ppdTNmNmtXZ0tvenNla1hkSHVvdW93YUZRWEZ3UGMyMnBrN0IyUzY2WGtGQlZtYXg1bGNBWVNWQms1cU1iNkxOUkJfYzJFbUFtLUk5aFFPQTV6VkN2M2V4UE5LVlE1VXc0dmhvWkphc3BxdjExbmxBUGQ0YU5nc2pTTXU1eVAzX1FtVThmRUpzcHFSSnBVNEdUQm55dktNaDNSR3BpQ3o1Z3hYZWpmbU44VWQ1R0_SAeoBQVVfeXFMT3pxeXl0c1V0d0ppb21qQmM1ZnBsSlI4T2d6UkFWeERqWEgyNkZVdmVQZjI3R21PUTV3bngxN1BmdGdqUkl6MHZQZkI1bUtHYlZfc0RUMWtkQlVVOFk3U0E5NjBLNkJCT3Zpdk0tTlZWSk1tWUFjNEtOVk5oVWNfYnFLNWlnX0FYS0kyd3JDZUNaNkRocmlVb1NkZlJUaFpzc3FjWkljblJPZTFDUXQ4bmN1T0FFVG1KMlo5YXZ3cDZKajdWYW5ScE51UVFfRFdpZC1iZkY0THNOSmQzTGRiejhYYWNGd0FiaTl3?oc=5"" target=""_blank"">Biocon inks licensing pact with Biomm for diabetes management drug Semaglutide in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxPQzhDVnp0dU1wN3VwRnhHdlRpZ3BpQlppU0JJNXpmOWg4SlphYldpTHBjVl9uN3ppdTNmNmtXZ0tvenNla1hkSHVvdW93YUZRWEZ3UGMyMnBrN0IyUzY2WGtGQlZtYXg1bGNBWVNWQms1cU1iNkxOUkJfYzJFbUFtLUk5aFFPQTV6VkN2M2V4UE5LVlE1VXc0dmhvWkphc3BxdjExbmxBUGQ0YU5nc2pTTXU1eVAzX1FtVThmRUpzcHFSSnBVNEdUQm55dktNaDNSR3BpQ3o1Z3hYZWpmbU44VWQ1R0_SAeoBQVVfeXFMT3pxeXl0c1V0d0ppb21qQmM1ZnBsSlI4T2d6UkFWeERqWEgyNkZVdmVQZjI3R21PUTV3bngxN1BmdGdqUkl6MHZQZkI1bUtHYlZfc0RUMWtkQlVVOFk3U0E5NjBLNkJCT3Zpdk0tTlZWSk1tWUFjNEtOVk5oVWNfYnFLNWlnX0FYS0kyd3JDZUNaNkRocmlVb1NkZlJUaFpzc3FjWkljblJPZTFDUXQ4bmN1T0FFVG1KMlo5YXZ3cDZKajdWYW5ScE51UVFfRFdpZC1iZkY0THNOSmQzTGRiejhYYWNGd0FiaTl3?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-18,2024-04-18 07:00:00,Biocon signs licensing and supply deal for diabetes drug in Brazil - Pharmaceutical Business review -,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPMDFLOWs1V3Q0ZnRxTWtZeExwTFNlcy1GOV8tYVU5Z3lrcGVfTk1MZ21PVVRrRVRod2RvX2RqRW10bFd3T1NGXzFtcTlNZklaZ0oxN2NwOFF6Z0VtWFhjODRqdkE3dGF5cEhkbnQxYTdySWIwN1hORkh3R1lEQ1BBczBfNmpHaDZTRklkaXN3?oc=5"" target=""_blank"">Biocon signs licensing and supply deal for diabetes drug in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Business review -</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPMDFLOWs1V3Q0ZnRxTWtZeExwTFNlcy1GOV8tYVU5Z3lrcGVfTk1MZ21PVVRrRVRod2RvX2RqRW10bFd3T1NGXzFtcTlNZklaZ0oxN2NwOFF6Z0VtWFhjODRqdkE3dGF5cEhkbnQxYTdySWIwN1hORkh3R1lEQ1BBczBfNmpHaDZTRklkaXN3?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-18,2024-04-18 07:00:00,Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxPVm5sVkswLVYzbDBqR3VBeTg0TEpjRFA3UHlsTkIwemxTQTNrV1lDenFyZDhNX2pVS1BGQU9WR09PWVplSGdiSzhTWUhJM0MyWFgyZ0l2cGNWOVIyanB1d00ycnNydmdrSDBxTFRtY0l3TE9NZEJyS2Myd2ZCak1CZ0huZjl0b050OVp6bHZCR3ZPQVpUWC03cGRZVkJXNXBnYWtiWUNxZ3ZUX21CZ3hUQzgwNlVQNFktdmxlLVB6cS1LYVprekV4aE03emdzTjdWaEJON1pBZVbSAd4BQVVfeXFMTVJJR2VYUjJ0LTI5d3ozOEJWS0JaRWJmdjhxcmQtNG9VWk9WR2x3akNOOVlHNjRPZE9fY2x5RkxhUEo1WmIwRG5yS1RrNjJSN3E4SlNYeHVLNEJ3bkxSWGxFMU9jd2hUOUZSZEt2bGtZb2dzVTV0VmdZN1AtSVEzQ09rYVlab2kyaVJ0OEs4WXh5UUNSSllHU3JvOC1rNFgxSVBVTC15TTRJVFhDUFNwSlB1VmNqbk1rQTJXZVg1Qm12dHN3cHRYY0htaFdONmtQUmZNQ2lPZHQ1Uy0tZlV3?oc=5"" target=""_blank"">Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-18,2024-04-18 07:00:00,Biocon signs licensing and supply deal for diabetes drug in Brazil - Pharmaceutical Business review -,"<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxPMDFLOWs1V3Q0ZnRxTWtZeExwTFNlcy1GOV8tYVU5Z3lrcGVfTk1MZ21PVVRrRVRod2RvX2RqRW10bFd3T1NGXzFtcTlNZklaZ0oxN2NwOFF6Z0VtWFhjODRqdkE3dGF5cEhkbnQxYTdySWIwN1hORkh3R1lEQ1BBczBfNmpHaDZTRklkaXN3?oc=5"" target=""_blank"">Biocon signs licensing and supply deal for diabetes drug in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Business review -</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxPMDFLOWs1V3Q0ZnRxTWtZeExwTFNlcy1GOV8tYVU5Z3lrcGVfTk1MZ21PVVRrRVRod2RvX2RqRW10bFd3T1NGXzFtcTlNZklaZ0oxN2NwOFF6Z0VtWFhjODRqdkE3dGF5cEhkbnQxYTdySWIwN1hORkh3R1lEQ1BBczBfNmpHaDZTRklkaXN3?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-18,2024-04-18 07:00:00,Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxPVm5sVkswLVYzbDBqR3VBeTg0TEpjRFA3UHlsTkIwemxTQTNrV1lDenFyZDhNX2pVS1BGQU9WR09PWVplSGdiSzhTWUhJM0MyWFgyZ0l2cGNWOVIyanB1d00ycnNydmdrSDBxTFRtY0l3TE9NZEJyS2Myd2ZCak1CZ0huZjl0b050OVp6bHZCR3ZPQVpUWC03cGRZVkJXNXBnYWtiWUNxZ3ZUX21CZ3hUQzgwNlVQNFktdmxlLVB6cS1LYVprekV4aE03emdzTjdWaEJON1pBZVbSAd4BQVVfeXFMTVJJR2VYUjJ0LTI5d3ozOEJWS0JaRWJmdjhxcmQtNG9VWk9WR2x3akNOOVlHNjRPZE9fY2x5RkxhUEo1WmIwRG5yS1RrNjJSN3E4SlNYeHVLNEJ3bkxSWGxFMU9jd2hUOUZSZEt2bGtZb2dzVTV0VmdZN1AtSVEzQ09rYVlab2kyaVJ0OEs4WXh5UUNSSllHU3JvOC1rNFgxSVBVTC15TTRJVFhDUFNwSlB1VmNqbk1rQTJXZVg1Qm12dHN3cHRYY0htaFdONmtQUmZNQ2lPZHQ1Uy0tZlV3?oc=5"" target=""_blank"">Biocon signs deal with Biomm SA to commercialise diabetes drug in Brazil</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-04-18,2024-04-18 07:02:14,BIOCON TIES UP WITH A BRAZILIAN COMPANY FOR GENERIC OZEMPIC (SEMAGLUTIDE). - ICICI Direct,"<a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxNd3FoY3hyMWRQUk9oT3o1R2JNTDQzQ0todGQ2ZU00cTRQNlRhcXdPNjFSWU5FcGVfYVQ5YjVZLUFzN2ZweVN0YWc4cjZObENwbVpCS3lUckxRaXVHN1dnLTBDY0QtTzhQUnZBSjdOWGJYOHdHcktWSWYzXzV1SE5QZlU0LXFJRVZUcWZPMFpsdEU1ZWxLbXNuX1FMSElibTA4cmJ4eHpfOFREQkdFX2FpV3c5b2VOWG1xNEtvbThGcmFJYmZMdUhDbXlB?oc=5"" target=""_blank"">BIOCON TIES UP WITH A BRAZILIAN COMPANY FOR GENERIC OZEMPIC (SEMAGLUTIDE).</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ICICI Direct</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxNd3FoY3hyMWRQUk9oT3o1R2JNTDQzQ0todGQ2ZU00cTRQNlRhcXdPNjFSWU5FcGVfYVQ5YjVZLUFzN2ZweVN0YWc4cjZObENwbVpCS3lUckxRaXVHN1dnLTBDY0QtTzhQUnZBSjdOWGJYOHdHcktWSWYzXzV1SE5QZlU0LXFJRVZUcWZPMFpsdEU1ZWxLbXNuX1FMSElibTA4cmJ4eHpfOFREQkdFX2FpV3c5b2VOWG1xNEtvbThGcmFJYmZMdUhDbXlB?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0125,0.0125,neutral,1.0
2024-04-24,2024-04-24 07:00:00,Biocon shares up 13% in a month; here's what analysts say - Business Today,"<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxQQzdSMGgySHZNR2gyWGpBSzJkVURLVjc3V2tEY2dRTWd4Z1doS3NFakVUSVFycGhQX0JRWjlkWDlPemFTOWhBQktHNGVsRlJ3T2p4dmI0MjVRamltMElUYlI5ZnRyOGVRSlprUGFlbTZXNTVJa09BUnpfSTFpeGNRNVIyQVUwSERrWVo4NWNWVUFFT1RMQ056SHN0SUlUNi12alF6djBtSFJvQmNfUUZ3SllFUjdMZjg2aE1uZmlEbzlBZ3BkMGhkNdIBzgFBVV95cUxPZXMyWWY1TVU1LTBTbXpEMmpBM242UkNfazZlVmdMR2tBUkg5dEw0M0NZellTYk5QbEFPbFBERmZPZklxXzhXaTd3ODMwR1hhSzk3aHlzNFNlQWNmRG1iNmxtczA0ZUhTSllqWHpBSmtnREloOE9XdFZmc2F3YW43b01XZkRvR3U0bjVyUC05WEd6eWJNSEZjNFMtSTc5V1hnX09TNTM0R0lndWxKRFZLX0hldmVxUHVfOUtZa0tGcGF4aGJGcWdpOHh0Uktqdw?oc=5"" target=""_blank"">Biocon shares up 13% in a month; here's what analysts say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-04-24,2024-04-24 07:00:00,Biocon shares up 13% in a month; here's what analysts say - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 13% in a month; here's what analysts say</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-05-02,2024-05-02 07:00:00,"Stock market today: Biocon, Vodafone Idea stocks under F&O ban list on Thursday — May 2 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock market today: Biocon, Vodafone Idea stocks under F&amp;O ban list on Thursday — May 2</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.401,-0.401,negative,1.0
2024-05-13,2024-05-13 07:00:00,"Biocon inks supply, distribution pact with Medix for chronic weight management drug in Mexico - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks supply, distribution pact with Medix for chronic weight management drug in Mexico</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-05-15,2024-05-15 07:00:00,"BEL, Bosch, NHPC and Biocon | Stocks that may gain up to 5-6% in the short term - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">BEL, Bosch, NHPC and Biocon | Stocks that may gain up to 5-6% in the short term</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxOMWdieHBSWnRDa2IzVm94TFdSMUo2Z3dpQ1l5SWxzWXc2Sk9INnFvQXVmWDlSZk5mNVMxakdadDhTdE1pSXRiNEdyalUyZ0hmYUZvc1dhZG1fVFNyY2swbzhqYlRDSktpd2FCaWZkM3dDRHBZUHYxRjVFM25lQU9ST3NwZEpUMzRKem8wS3BEak5JUmJETTFYaHhOWnlmVktYYVRmVDdOOVFHblVucVYwWjJ30gG3AUFVX3lxTFBKQkd3RGFoTEpWYVdlNFN2U084N1hvVm9nT0tkZ1RDd0RqeUpDOEI0SV9UbkpMenpBZi1kLUhpVmFFS0VnaU5aNldBcHUzTVpyNTRfLXdMNlRhc0VpTTJYWTN6ZHByNjg0VTVPZGM2THZDQmtRMXZEYXA1bzdWLW1rQVRFV2diaGM2NUVnME5RSXZCV05sV0cweFFFbU1DaVd2X2lzMnp0OVQwOW9PR0ZlLXlWcmlZMA?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.38915,0.38915,positive,1.0
2024-05-16,2024-05-16 07:00:00,"Stock market today: Biocon, LIC Housing Finance, Piramal Enterprises, ZEE among 12 stocks under F&O ban list on May 16 - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock market today: Biocon, LIC Housing Finance, Piramal Enterprises, ZEE among 12 stocks under F&amp;O ban list on May 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.401,-0.401,negative,1.0
2024-05-17,2024-05-17 07:00:00,"Stocks To Buy Today, Share Price Target: M&M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more - ET Now","<a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxQMzRvZm5GNmdlSDRKNC1OYUl3N1RUMFFGZFNXeWVXd09samNKRy1JMWlEVkp4RzMxRmZ5TjBpUU93OUs2M09hWTB0akI0a0VHNVg0Qm9TS1AtQi1Ddk92Y0tIakdySVNLenBSS1JqdkJqUUdhYWVTdzE5WWpyd2xROW9LUmppc2NSOWJVUEdlMVBEcEFZZ2RIZFQ0dDVlTGxneGVvc2dKMXFCMDhmZnQxYnJyVXpkUF9CeHhwS0FNbl8tZHBuQnhyNGpFaXB6eDQ2aklWM2J0UTlKQ1VqNTlWVVNDb2o4Uk1hV2szMnJ4bUZPeDRFMFRGM0c4cndNOUXSAYQCQVVfeXFMUDV1TDlxR0JsQ19YU0p6cUw4dFZ6WGJmVW5kbTg2TF9nUzJUaFJJQXJEWjlFNUxDNUZhN01NRi1kZHVIcXRrRzRBQTFXVVItcHhId1F0akthV21LRjhRY3VhMEhkRWJpMy1iVU1CbDFmZ2FWQ0dqRGNrRDltT1lsaE5iVTNxaW9xam45VmNSQW03a3FPWTdwdGtiZnRiQ1hQYTZZOVhYNmdwNy1CeGhuaWM2N2Z6SVpvN21sSVJaNjJPTS1mcTdZbXFPeGtENHF5anRNdEF5SV9sUDJ0UTJmRFItcEU0S29Wd0tTQndyQ19oNmRrc0RMSllzbm54ckZQakNqeW0?oc=5"" target=""_blank"">Stocks To Buy Today, Share Price Target: M&amp;M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.38835,0.38835,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Stocks To Buy Today, Share Price Target: M&M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more - ET Now","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks To Buy Today, Share Price Target: M&amp;M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.38835,0.38835,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Stocks To Buy Today, Share Price Target: M&M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more - ET Now","<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks To Buy Today, Share Price Target: M&amp;M, Biocon, Naukri, LIC Housing Finance, Mankind Pharma and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.38835,0.38835,positive,1.0
2024-05-17,2024-05-17 07:00:00,"Traders Diary: Buy, sell or hold strategy on Infosys, Larsen and Toubro, Mahindra & Mahindra, Bharat Electronics, Biocon, over a dozen other stocks today - Zee Business","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxOOXdQQk5JYTJ1UkNHMWw1T0FiS1BBVHVZV0RFbTdnaXZwa0FNR3o0VzVSeXVpZFJuSG1BUnVBc3VvRmdrSUJ3MkdGQ2F1ZktuOWxCbDRqMHAzU2M1TVdvdWxzVnFmMk9OaWl6bld4MkVwMVFrWm5IdUx2eFhtclpra0NBYkFDdWxEbGhzUGF0YThZeVNHOHQ5NlJzSHQ2QlhNTjJMQ0FFX2ROQTJPZ2VTUHk5eTdfRWRQaHJLVmN3TWhzc2VtLTR3NGJWNVdwRE10SWJ4OXV0b2VQWk5oS29ZT1J1WDRTQW_SAewBQVVfeXFMTVlzamZHYTlBLVluc25fd2ZTbENROXpVNVA2M2VORlQxVkZlc2MyRnBMX3hOY1NJTTBaN2JaTnJEZ1NyTkdQdXJSVlNsR0RiTVRDT1BEc1cxaGt1LXUwUlcwOUd1VjFZclN0d2lmeHlGYkZIZ2tMT250SUt0QmZHNzZYYUstQnQwb3IyZGMzX2tTVUV4Sy13aGxaMnlJYTBERFVzemVpTVN3TlZ5cDU1aWpKLVVXaHViRmpMcFY5VHdOUXRTeWlZMWQyMlRQLV9SSWxIdUdpbV9ydXB4VTl6M3BUSFFHb0pld2R1eFU?oc=5"" target=""_blank"">Traders Diary: Buy, sell or hold strategy on Infosys, Larsen and Toubro, Mahindra & Mahindra, Bharat Electronics, Biocon, over a dozen other stocks today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxOOXdQQk5JYTJ1UkNHMWw1T0FiS1BBVHVZV0RFbTdnaXZwa0FNR3o0VzVSeXVpZFJuSG1BUnVBc3VvRmdrSUJ3MkdGQ2F1ZktuOWxCbDRqMHAzU2M1TVdvdWxzVnFmMk9OaWl6bld4MkVwMVFrWm5IdUx2eFhtclpra0NBYkFDdWxEbGhzUGF0YThZeVNHOHQ5NlJzSHQ2QlhNTjJMQ0FFX2ROQTJPZ2VTUHk5eTdfRWRQaHJLVmN3TWhzc2VtLTR3NGJWNVdwRE10SWJ4OXV0b2VQWk5oS29ZT1J1WDRTQW_SAewBQVVfeXFMTVlzamZHYTlBLVluc25fd2ZTbENROXpVNVA2M2VORlQxVkZlc2MyRnBMX3hOY1NJTTBaN2JaTnJEZ1NyTkdQdXJSVlNsR0RiTVRDT1BEc1cxaGt1LXUwUlcwOUd1VjFZclN0d2lmeHlGYkZIZ2tMT250SUt0QmZHNzZYYUstQnQwb3IyZGMzX2tTVUV4Sy13aGxaMnlJYTBERFVzemVpTVN3TlZ5cDU1aWpKLVVXaHViRmpMcFY5VHdOUXRTeWlZMWQyMlRQLV9SSWxIdUdpbV9ydXB4VTl6M3BUSFFHb0pld2R1eFU?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-05-17,2024-05-17 07:00:00,"Stocks to watch: M&M, Vedanta, HAL, Vi, Biocon, PB Fintech, Crompton Greaves - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: M&amp;M, Vedanta, HAL, Vi, Biocon, PB Fintech, Crompton Greaves</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-05-18,2024-05-18 07:00:00,"Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Acceleration of biosimilar business, debt reduction to be key priorties in FY25: Biocon Chief</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26620000000000005,-0.26620000000000005,negative,1.0
2024-05-20,2024-05-20 07:00:00,"Biocon to invest ₹2,200 crore in capex in the next 2 years - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to invest ₹2,200 crore in capex in the next 2 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-05-20,2024-05-20 07:00:00,"Biocon to invest ₹2,200 crore in capex in the next 2 years - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon to invest ₹2,200 crore in capex in the next 2 years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-05-24,2024-05-24 07:00:00,"Biocon signs licensing, supply deal for obesity drug in South Korea - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon signs licensing, supply deal for obesity drug in South Korea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-05-24,2024-05-24 07:00:00,"Biocon inks licensing, supply pact with South Korea's Handok for chronic weight management product - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks licensing, supply pact with South Korea's Handok for chronic weight management product</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-05-24,2024-05-24 07:00:00,"Biocon signs licensing, supply deal for obesity drug in South Korea - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon signs licensing, supply deal for obesity drug in South Korea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-06-04,2024-06-04 07:00:00,"Stocks to watch: M&M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: M&amp;M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31035,0.31035,positive,1.0
2024-06-04,2024-06-04 07:00:00,"Stocks to watch: M&M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: M&amp;M Finance, Dr Reddy's, Welspun, Biocon, JP Associates, Zee</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31035,0.31035,positive,1.0
2024-06-11,2024-06-11 07:00:00,Biocon appoints Mukesh Kamath as interim CFO - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxNalJ3cVAyZFFXcVA1X2MxNjI2bk5EZXdSNTUySHAyY1BBVWFfN1gteEhoQUV1RjVqa053aG81aldFUFVSZ0FxZ0FmVXZTR1VZeGZpR3hrTU1Bd2NUS2xUNnVOTG94amI5Rk5waEJsUm1OSU5fMTFnMG53QlZZUHE0bmk5ZEQ1VEFzeDdQMEZKeXFXSHRwa3B1cm1aaFI4UFNuYmR2OXNWNA?oc=5"" target=""_blank"">Biocon appoints Mukesh Kamath as interim CFO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxNalJ3cVAyZFFXcVA1X2MxNjI2bk5EZXdSNTUySHAyY1BBVWFfN1gteEhoQUV1RjVqa053aG81aldFUFVSZ0FxZ0FmVXZTR1VZeGZpR3hrTU1Bd2NUS2xUNnVOTG94amI5Rk5waEJsUm1OSU5fMTFnMG53QlZZUHE0bmk5ZEQ1VEFzeDdQMEZKeXFXSHRwa3B1cm1aaFI4UFNuYmR2OXNWNA?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-06-13,2024-06-13 07:00:00,"Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel - Medical Dialogues","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon appoints Mukesh Kamath as Interim CFO, Key Managerial Personnel</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-06-20,2024-06-20 07:00:00,"Biocon searches for partner to test generic Wegovy, Ozempic in China - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon searches for partner to test generic Wegovy, Ozempic in China</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-06-22,2024-06-22 07:00:00,Biocon gets 4 observations from USFDA for Andhra Pradesh facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets 4 observations from USFDA for Andhra Pradesh facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-06-24,2024-06-24 07:00:00,Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4016409090909091,0.4016409090909091,positive,1.0
2024-06-24,2024-06-24 07:00:00,EMA approves Biocon’s new mAbs facility in India - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxPZURmTkhlN0xkTjRXSFE5am5iVFdMRkNNVUdZZWFfU1hGbUNCUmlHcUJWN3FUOXJmeVVBcmRESmNRZC14MFlKTEd4Q2gtMnJzUmhhM2wzSVZlUTdrbTRFRHlld3J4Q2dXWkhBZkhBNjFRRlNyTFdDMVJkVzMyVVpMb3VXc9IBiAFBVV95cUxPUWZZUUx1b0JrVXlYTmpONGh4SU8wOHZjWU5maWtRa0Myb2pJQk9LTDJ0MXdzTUo3YjRqdXJxdl90TnI0SXVNdWVPbVVDdkFNam9wak5IZ0M4MlZkVV83R0FqT2JJRkpvSUNscUhiSzBxU2dOOEVnRTV2aXQ5NDMySC1sam1iVXdJ?oc=5"" target=""_blank"">EMA approves Biocon’s new mAbs facility in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMigwFBVV95cUxPZURmTkhlN0xkTjRXSFE5am5iVFdMRkNNVUdZZWFfU1hGbUNCUmlHcUJWN3FUOXJmeVVBcmRESmNRZC14MFlKTEd4Q2gtMnJzUmhhM2wzSVZlUTdrbTRFRHlld3J4Q2dXWkhBZkhBNjFRRlNyTFdDMVJkVzMyVVpMb3VXc9IBiAFBVV95cUxPUWZZUUx1b0JrVXlYTmpONGh4SU8wOHZjWU5maWtRa0Myb2pJQk9LTDJ0MXdzTUo3YjRqdXJxdl90TnI0SXVNdWVPbVVDdkFNam9wak5IZ0M4MlZkVV83R0FqT2JJRkpvSUNscUhiSzBxU2dOOEVnRTV2aXQ5NDMySC1sam1iVXdJ?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.37530454545454545,0.37530454545454545,positive,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-06-24,2024-06-24 07:00:00,Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon mAns facility approved by EMA to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.31845,-0.31845,negative,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.41300454545454546,0.41300454545454546,positive,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to manufacture cancer drug in India - AP7AM,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxQbk9MSm5aVEZpQkpsb3R2RnhkcklLUEkwbHV6MF9YQ25wcVE2aHpXWUt0RjFYNlIySTB0Wkx2Wm5iQ01STTNHS1NwTjdJelNqU3hwM3QtTmdKUVpWVl9MckI3c01VUHl4QnNuZzNZMHAzS29YMGgzUmtOMW15cnFYWV9xNFFXaDZ0c1NTLVJOeml0YVJWcmNTYlMyMUXSAaIBQVVfeXFMT3dKMnFVWlVmeE1haGJsVXhkMUd4U0t5YUt6QlNjeHcyeUpZTXFsT2JlZ0EwaE9ELTIwWktfM3NZdlJfNWJLc3pqdGNrNjg3aElTT3l5WURrNzhhckc5WVFIakhpU1BuYVM2M1ZMSlR6akl3RXlST0Z6V3FOMGFwVnFHZDJtZlp3aThPVW5oZHJJN2wxbHMwcWZoeWx0WUw3VFNB?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">AP7AM</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxQbk9MSm5aVEZpQkpsb3R2RnhkcklLUEkwbHV6MF9YQ25wcVE2aHpXWUt0RjFYNlIySTB0Wkx2Wm5iQ01STTNHS1NwTjdJelNqU3hwM3QtTmdKUVpWVl9MckI3c01VUHl4QnNuZzNZMHAzS29YMGgzUmtOMW15cnFYWV9xNFFXaDZ0c1NTLVJOeml0YVJWcmNTYlMyMUXSAaIBQVVfeXFMT3dKMnFVWlVmeE1haGJsVXhkMUd4U0t5YUt6QlNjeHcyeUpZTXFsT2JlZ0EwaE9ELTIwWktfM3NZdlJfNWJLc3pqdGNrNjg3aElTT3l5WURrNzhhckc5WVFIakhpU1BuYVM2M1ZMSlR6akl3RXlST0Z6V3FOMGFwVnFHZDJtZlp3aThPVW5oZHJJN2wxbHMwcWZoeWx0WUw3VFNB?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-06-24,2024-06-24 07:00:00,Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon mAns facility approved by EMA to manufacture cancer drug in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET HealthWorld</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.31845,-0.31845,negative,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab used in cancer treatment - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab used in cancer treatment</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics Expands European Manufacturing Capabilities with EMA Approval - KNN India,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxNMTFfUUNZU3BrV1NNSmRDdDlQWEQ4UW1wemlkajgySlNsOUx5YmlaQWNsNnBGMnpFOHVxQVBrSHJEckJreF91VlJVSzBybnYwdC1EeGNZYjl6V0w2VXdaRHdsRTJ1Ukl6c3IwV3diZEIyTmU5N1MyQzlLTDVVSGNHMUhBbHR5S3VOV0xpM2p0NGd5Z0MybVhoQXZ0M3FEZnpVdG1nTHgxWXBWTUhGZzM2ano3T1FvcDNfMHlXRDM0eG5kMlc3T3czZ1JMUEVfNHNCX21FcTF2OA?oc=5"" target=""_blank"">Biocon Biologics Expands European Manufacturing Capabilities with EMA Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">KNN India</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxNMTFfUUNZU3BrV1NNSmRDdDlQWEQ4UW1wemlkajgySlNsOUx5YmlaQWNsNnBGMnpFOHVxQVBrSHJEckJreF91VlJVSzBybnYwdC1EeGNZYjl6V0w2VXdaRHdsRTJ1Ukl6c3IwV3diZEIyTmU5N1MyQzlLTDVVSGNHMUhBbHR5S3VOV0xpM2p0NGd5Z0MybVhoQXZ0M3FEZnpVdG1nTHgxWXBWTUhGZzM2ano3T1FvcDNfMHlXRDM0eG5kMlc3T3czZ1JMUEVfNHNCX21FcTF2OA?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2997,0.2997,positive,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant - YourStory.com,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOeHgtSnZ3Qy00NUN4NTVuUnlvOWt3MzFrNmU5QkxsQzhlWUdRejhZaWZZeEwtcXFFc2tqUlpQX0EyTElJc1BDWVdWaFc1bWZsX21qd0kyclZwX3RobVpmM1g1SWdtcHBVOXF1YmZsMnd1NG5WeWpfWVJwUGFKakhvSVAySFJZcUpRZjNIbUx3MkZyYTNjTGFvUGJn?oc=5"" target=""_blank"">Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant</a>&nbsp;&nbsp;<font color=""#6f6f6f"">YourStory.com</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOeHgtSnZ3Qy00NUN4NTVuUnlvOWt3MzFrNmU5QkxsQzhlWUdRejhZaWZZeEwtcXFFc2tqUlpQX0EyTElJc1BDWVdWaFc1bWZsX21qd0kyclZwX3RobVpmM1g1SWdtcHBVOXF1YmZsMnd1NG5WeWpfWVJwUGFKakhvSVAySFJZcUpRZjNIbUx3MkZyYTNjTGFvUGJn?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-06-24,2024-06-24 07:00:00,EMA approves Biocon’s new mAbs facility in India - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMigwFBVV95cUxPZURmTkhlN0xkTjRXSFE5am5iVFdMRkNNVUdZZWFfU1hGbUNCUmlHcUJWN3FUOXJmeVVBcmRESmNRZC14MFlKTEd4Q2gtMnJzUmhhM2wzSVZlUTdrbTRFRHlld3J4Q2dXWkhBZkhBNjFRRlNyTFdDMVJkVzMyVVpMb3VXc9IBiAFBVV95cUxPUWZZUUx1b0JrVXlYTmpONGh4SU8wOHZjWU5maWtRa0Myb2pJQk9LTDJ0MXdzTUo3YjRqdXJxdl90TnI0SXVNdWVPbVVDdkFNam9wak5IZ0M4MlZkVV83R0FqT2JJRkpvSUNscUhiSzBxU2dOOEVnRTV2aXQ5NDMySC1sam1iVXdJ?oc=5"" target=""_blank"">EMA approves Biocon’s new mAbs facility in India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMigwFBVV95cUxPZURmTkhlN0xkTjRXSFE5am5iVFdMRkNNVUdZZWFfU1hGbUNCUmlHcUJWN3FUOXJmeVVBcmRESmNRZC14MFlKTEd4Q2gtMnJzUmhhM2wzSVZlUTdrbTRFRHlld3J4Q2dXWkhBZkhBNjFRRlNyTFdDMVJkVzMyVVpMb3VXc9IBiAFBVV95cUxPUWZZUUx1b0JrVXlYTmpONGh4SU8wOHZjWU5maWtRa0Myb2pJQk9LTDJ0MXdzTUo3YjRqdXJxdl90TnI0SXVNdWVPbVVDdkFNam9wak5IZ0M4MlZkVV83R0FqT2JJRkpvSUNscUhiSzBxU2dOOEVnRTV2aXQ5NDMySC1sam1iVXdJ?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.37530454545454545,0.37530454545454545,positive,1.0
2024-06-24,2024-06-24 07:00:00,Biocon Biologics Receives EMA Approval for New Biosimilar Facility - newskarnataka.com,"<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5"" target=""_blank"">Biocon Biologics Receives EMA Approval for New Biosimilar Facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newskarnataka.com</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxOVkg4Z2c3bWp6N2pCTzVxMlBUXzNHTkIwNjgzRmZHazhsdExKNV9sYjQ5Q3NJWm5KbXpBMUk5MHRUbWlSZUxWOEc5Um1ETzZLMTBLWk9ZXzI4MUU1aDVuV2pxTnBfR3V5M01BUlJreFVpVjRxdkllY1FIcldSQ2ZvanNnVm1yQ1Rzb1gzZm9LTUFSa3hwNEw3YUh2dno5WUJBcVByc3hSc1dmbGRRMTV3?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.41300454545454546,0.41300454545454546,positive,1.0
2024-06-30,2024-06-30 07:00:00,Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own? - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxQbFB4b0hnNjF6UzRsWDAzZUk4YThmdnVZaGRma3B1ZkMwTmlSMzZGa0tPTmRuOFJCa0JId1hId21LY2hjQ2d5Q3hjZ2ZmSnQ3SmdUVXBIajEtNWZ2c1VJeUhJbUgxdHRTcHpIWmNpa1RfMkU0X2VON2xaUHhTZlcxODhucUNFdEFrM2NxZ0lyazU1M2V5eGx3NXR1YWFLLU44bktycEVIeWktRVdhSXlsMWVOQkZlaDdaZUxDS3VjT3dWS3oxTUZIRGRRSGlxVG1HX2Y0OGZIN1lDWTJUUllXSkVIdVdFNjRHVm1OcDA0Wk1BOG5XUDJ2TXBPa3BrX1XSAYQCQVVfeXFMT3hNMDV0aGFIYlVuU2tMZWlrN0VmZ1lDNENldGVsdmNwM2txeUItWjZ3cDN3c2UwYkZQNkl3alA1SU5HVFBOZG1zTlhSaUlaSTBEM3Y2TmJuY3dnS1pDbHR1MnpYLXVOMnBqcXNGNkJ2OHljYW4taHh3WU50VFRIVlcxTU4tQTluTmV0ZE82N0ZWWnFDcEt6LXpNVDJXSGFSOTFsZFVxWkY3elZQVWkwU3pkUDJNRmpsQTI2NEJ1MndRcnpjNlY0RVNGUWpULXU5NVNyNG5GZFV1TnFfaWJ6Qm5GNzhwdzd0SEhPMWtGcmVodWw3b2lyTXpNNVNYczdCcVlsTGg?oc=5"" target=""_blank"">Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.40035,0.40035,positive,1.0
2024-06-30,2024-06-30 07:00:00,Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own? - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.40035,0.40035,positive,1.0
2024-07-03,2024-07-03 07:00:00,Biocon expanded plant approved to make Avastin biosimilar - BioProcess International,"<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFZKNTFGZXZKVHl1cjZwQkJjeWtkS0pUcjFnU21Hd3A5ZGNZc05oWkxvRHkxNFRwT3ZzX1E2aGVvUFJob0tDRmcyNWNHY0RxbmVNREZHNUFOanpIbWo4WXA0SHFvaXJRZFdyek9kU0JabXJkRkpwbGJ2TnNHZk0xS3BlMG1Kb04yalpBeWZIXzFlRnMtQnpKbU1SM1R6R3NCR0FER1pVcFF5Z2t6?oc=5"" target=""_blank"">Biocon expanded plant approved to make Avastin biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioProcess International</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFZKNTFGZXZKVHl1cjZwQkJjeWtkS0pUcjFnU21Hd3A5ZGNZc05oWkxvRHkxNFRwT3ZzX1E2aGVvUFJob0tDRmcyNWNHY0RxbmVNREZHNUFOanpIbWo4WXA0SHFvaXJRZFdyek9kU0JabXJkRkpwbGJ2TnNHZk0xS3BlMG1Kb04yalpBeWZIXzFlRnMtQnpKbU1SM1R6R3NCR0FER1pVcFF5Z2t6?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2024-07-05,2024-07-05 07:00:00,Biocon Biologics Mulls Raising Up to $540 Million in Rupee Bonds - Bloomberg.com,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxOLVZMMVFGVXpTck80OFRNVmZDVmZJck0yUkRLTjE5dFk5clQxOVR1bnltcGp3SkQyQUViam9OZUhxNGU4Wl90cUtLcF9jSk5WOXE2ZmJNWm92TDBjMVRld2QxRjM0MTd3aVM3dUxYY2pnYUdoZkxqUjB5YWF3UzNiQ3FaR1l0R01laVVLRVRLMXRCMmZ2djktZTdxbk0yQnM1eUtaajkxa1RWMVlPekJQbVd2ME0?oc=5"" target=""_blank"">Biocon Biologics Mulls Raising Up to $540 Million in Rupee Bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bloomberg.com</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxOLVZMMVFGVXpTck80OFRNVmZDVmZJck0yUkRLTjE5dFk5clQxOVR1bnltcGp3SkQyQUViam9OZUhxNGU4Wl90cUtLcF9jSk5WOXE2ZmJNWm92TDBjMVRld2QxRjM0MTd3aVM3dUxYY2pnYUdoZkxqUjB5YWF3UzNiQ3FaR1l0R01laVVLRVRLMXRCMmZ2djktZTdxbk0yQnM1eUtaajkxa1RWMVlPekJQbVd2ME0?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-07-06,2024-07-06 07:00:00,Kiran Mazumdar-Shaw: Pioneering Biotech Entrepreneur and Global Leader in Biocon Limited and Biocon Biologics Limited since 1978 - foundermagazine.in,"<a href=""https://news.google.com/rss/articles/CBMi6wFBVV95cUxOajNNdWNVbFB4TV9zT0diMmtPYjQzUVlUOVVSTjhVUWszSU50OHAzZ1pHYjN0UjNuNkxxM2xMSWV1T21IUjlsWGVMN2t6bGd1WnFhbmdlTzFiczRzQ0ZySDB0aWxVd3dodXFtZFpmWVNuSXFnWUpsbEx6Q3hOVjN5bWZXbHVvSG5hRUR3bVFQUXd1SnhHNE00UVF0ckY2dHBBWUNZcUFpNnN5My0zR2pHM2RVY21HcGszS3ZCWkFwOEVPdW1RalZRdHRyNUNnOFFBaF9ScHBobFlLVGUyb0Q2anQ3Vlk0QTN2RkVj?oc=5"" target=""_blank"">Kiran Mazumdar-Shaw: Pioneering Biotech Entrepreneur and Global Leader in Biocon Limited and Biocon Biologics Limited since 1978</a>&nbsp;&nbsp;<font color=""#6f6f6f"">foundermagazine.in</font>",https://news.google.com/rss/articles/CBMi6wFBVV95cUxOajNNdWNVbFB4TV9zT0diMmtPYjQzUVlUOVVSTjhVUWszSU50OHAzZ1pHYjN0UjNuNkxxM2xMSWV1T21IUjlsWGVMN2t6bGd1WnFhbmdlTzFiczRzQ0ZySDB0aWxVd3dodXFtZFpmWVNuSXFnWUpsbEx6Q3hOVjN5bWZXbHVvSG5hRUR3bVFQUXd1SnhHNE00UVF0ckY2dHBBWUNZcUFpNnN5My0zR2pHM2RVY21HcGszS3ZCWkFwOEVPdW1RalZRdHRyNUNnOFFBaF9ScHBobFlLVGUyb0Q2anQ3Vlk0QTN2RkVj?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3608081632653061,-0.3608081632653061,negative,1.0
2024-07-08,2024-07-08 07:00:00,"Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report - Medical Dialogues","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics plans to raise Rs 4,000-4,500 crore via local bonds: Report</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-07-19,2024-07-19 07:00:00,Biocon Biologics establishes North American HQ in Bridgewater - NJBIZ,"<a href=""https://news.google.com/rss/articles/CBMihwFBVV95cUxPMVlsVHJ2ZDRKd3NwaUtRX3JvSWhjbDBDLWJ2SkZONklFcXJwaXdFTkJKNkNuSi0zTDFnbWh1dmZfQ045N25GQW0wekdzUW5keWpObEw0WW85eU5sX0NQV0VySmQ4bkNzemJpMGtXVkRMWmFsUFpiRkRGZEF3NGFyMDQ0Y2d4blU?oc=5"" target=""_blank"">Biocon Biologics establishes North American HQ in Bridgewater</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NJBIZ</font>",https://news.google.com/rss/articles/CBMihwFBVV95cUxPMVlsVHJ2ZDRKd3NwaUtRX3JvSWhjbDBDLWJ2SkZONklFcXJwaXdFTkJKNkNuSi0zTDFnbWh1dmZfQ045N25GQW0wekdzUW5keWpObEw0WW85eU5sX0NQV0VySmQ4bkNzemJpMGtXVkRMWmFsUFpiRkRGZEF3NGFyMDQ0Y2d4blU?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-07-22,2024-07-22 07:00:00,Black paint smeared on Biocon board after Kiran Mazumdar-Shaw opposes Karnataka job Bill. Video - Hindustan Times - Hindustan Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Black paint smeared on Biocon board after Kiran Mazumdar-Shaw opposes Karnataka job Bill. Video - Hindustan Times</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Hindustan Times</font>",https://news.google.com/rss/articles/CBMi6wFBVV95cUxPV045YUNWc3lHRHdweWU2UkhVREh3QXhZSjRTRVFLQW5xOS16ajNmenZmRHJlVHJSMmpCUDg2X1o3TEszYXM0YlFCWGItNWJocmhxNnI3bGNJblRzY3BCcTdzNzBpTGFmb3ZpMU85XzliWkJBY2MtUWZHbkg1X1dhdGRWcmV6SDdqRkFHYTJ4NUk1RFJLNU1ob3V4ZFFfeEloRHp1UnNEdEFMUF9TcU00RmUza3VvNHo1MFU3WXpKdUFoTEw2ai1xai13QW9TYUZET2haRzdXWHREdHFrRUVucUJNZkpOYWVudzhn0gHwAUFVX3lxTE0zNFpvbTI5Y0YtdFZLTEhqX2dBdlRRZURtbUd6Zk1LV0dWQzRWZnJlVTlMdS1TanBhVEVkNFM5MC1ydmo1bWlSV2JRRHpLUy1sTzJuaEVQbm8tQkN0OFBMY2NOYXJxclpfRklhXzY2UlBiV0lndXJCQUk0YURITEpRSi1fWk1YSmg1M0tlQmZaSlJQLUx2MlI0dG5OOUxZRkZPek9fYmVGMzF5TUhhVTZVTXBkUjZYYnV1NFNaMTcwdnp6bEdGUWlGU0lPZWhVekNTcWdkTzlMX3F3UkhBR3BHTjdjT3p2X0VTSWdpaDJpbQ?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-07-26,2024-07-26 07:00:00,"Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxQNTdDY1ZNWnBBYm44ZHpRWFBBVTBkc05IYjRFemF3RF9sOU9Qak02UDdJQVQ2eHRma1dValFxeXBVYnR2R2VMY0NaRElZc3huZTNSX3FVNm1IRkREVGxtTnRBZmxhQkJsdnVFcUU5NEs4ckx5dzNOLXpPWTJvVy1fWEo3MmtVb2d1YXVpT0hDZTdMWnVQSS14VjA1dlVRNWRxcHZuMExpLVVHdW5jUEJMTjh5cFdHQWxXRS04UmlObDhPN0N5T3lPd0huMGMwQdIB0wFBVV95cUxNaENoRDVjZjZCZjBxTHFVakFOTDNrN1dFZnBidnI3Skl0WktHOVl2dThmMkFPWnRHdDNLNFhnT0J1NzZfUUlyLUdITXo5S196NjNyYWQ4TFlGMm1EYnVfQWgzZEVuZGRsaHdmSHNCZ1Ixd2s1allIamNhend4aGp6dmd0a2lGOEQzTkhUcHQzOHp5NURxbFhsbnNvUDFvaGVhd2x4TVlvWE9SR1Rsc3hhZTNzRlZ2ZUJjXy0xWWFWb0JWX1dwU0NUSF9ndzduRFFLSDJJ?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.27115,-0.27115,negative,1.0
2024-07-26,2024-07-26 07:00:00,"Biocon Shares Surge 3% on Rs 4,000 Crore QIP Plan to Reduce Debt - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNRDdTRFgzN2FocWVDQ2t2SUZJckU2OVNwV3EwZmxYaGZ5dldVTHFEbndud01BSmxWQkJ6cVBkYlRLcnZ1cE1SNjlxQkJFdWpiNWlJclY5VnFMUEZBWXZYbVhwY0FfcklYNllvVll3d2ZYUkVhTFhtM1cxQ3hGc2s1SDdXX0lpWkNBV3BwQUs2Nm9EdFN5bkNV?oc=5"" target=""_blank"">Biocon Shares Surge 3% on Rs 4,000 Crore QIP Plan to Reduce Debt</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNRDdTRFgzN2FocWVDQ2t2SUZJckU2OVNwV3EwZmxYaGZ5dldVTHFEbndud01BSmxWQkJ6cVBkYlRLcnZ1cE1SNjlxQkJFdWpiNWlJclY5VnFMUEZBWXZYbVhwY0FfcklYNllvVll3d2ZYUkVhTFhtM1cxQ3hGc2s1SDdXX0lpWkNBV3BwQUs2Nm9EdFN5bkNV?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.11315,0.11315,positive,1.0
2024-07-26,2024-07-26 07:00:00,"Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.27115,-0.27115,negative,1.0
2024-07-26,2024-07-26 07:00:00,"Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans a ₹4,000 crore QIP to pare debt — Exclusive</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.27115,-0.27115,negative,1.0
2024-07-26,2024-07-26 07:00:00,"Biocon aims to raise Rs 4,000 crore through QIP next month, reports CNBC-TV18 - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxPdEhzd2JieDNidmpHelNRYW9mdU12R3RhMDBuZU5sUFA1b01TRDRWZmtfMThwaU15S0ZIejJ6QmlwUlF3M18yZTJPLWFqbGpaSEJKbUpla0ZYWHMzVVVkTWx0LUJIS0pLYThvYy1EUkJzLXU1bk83cDMzZjMxQmM3bTk3U05KTnNYanItbDNBM2Ria2hFQUVZUUpfeS1yQdIBowFBVV95cUxPaTdISDd6dnpnMDRfaV9BcUNsQVZLejdNSUhEWjd2ZDVRQlM2dVd6a1VXMHFfRGs3aEFGaXdiSVRuQk0yeTR0M1lBWXVidzBCNG1lNEJ0Z0VZUjZxNTY3TElVYi15UDJ1alA1WUJfdWNDdk44d3o0MnJ3SktaYjFFbzNHQnBPU1o5bm0tNlJ0WU5faldxOWYyX3YxaTBZVDZta3pr?oc=5"" target=""_blank"">Biocon aims to raise Rs 4,000 crore through QIP next month, reports CNBC-TV18</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxPdEhzd2JieDNidmpHelNRYW9mdU12R3RhMDBuZU5sUFA1b01TRDRWZmtfMThwaU15S0ZIejJ6QmlwUlF3M18yZTJPLWFqbGpaSEJKbUpla0ZYWHMzVVVkTWx0LUJIS0pLYThvYy1EUkJzLXU1bk83cDMzZjMxQmM3bTk3U05KTnNYanItbDNBM2Ria2hFQUVZUUpfeS1yQdIBowFBVV95cUxPaTdISDd6dnpnMDRfaV9BcUNsQVZLejdNSUhEWjd2ZDVRQlM2dVd6a1VXMHFfRGs3aEFGaXdiSVRuQk0yeTR0M1lBWXVidzBCNG1lNEJ0Z0VZUjZxNTY3TElVYi15UDJ1alA1WUJfdWNDdk44d3o0MnJ3SktaYjFFbzNHQnBPU1o5bm0tNlJ0WU5faldxOWYyX3YxaTBZVDZta3pr?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-07-29,2024-07-29 07:00:00,"Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus - Firstpost","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Firstpost</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-07-29,2024-07-29 07:00:00,"Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus - Firstpost","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch: Ultratech Cements, Maruti Suzuki, Biocon, Dr Reddy's and BHEL shares in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Firstpost</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-07-30,2024-07-30 07:00:00,Biocon Foundation and IISc organise conference on 'Artificial Intelligence in Oral Cancer' - BioSpectrum India,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOLVA0NWpVMi1QRkdaWTJsQjJlVUtSbFFCcko4UzNlS05RUEI5YUJGOVRoZl9mYXZybmhPXzVSQUpodjlBdW4wblNURmlZM3lmNk1xTjVOajlzTE0zN09aY2hrOGJiQlNoTk9rT0h0T1R1TnVld2o4TGJYS251dVUyeU5nMFJSOWdadHNtVERudy1YQktDb09aUE5qX2ZVWXo0bG9TZkx3bXRBb3dHUXpaZmpva3hpTkVjUk9QY25MbmhtYzMyT29zdnc3STJ3RzZIM2pyUXhCR0Q?oc=5"" target=""_blank"">Biocon Foundation and IISc organise conference on 'Artificial Intelligence in Oral Cancer'</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOLVA0NWpVMi1QRkdaWTJsQjJlVUtSbFFCcko4UzNlS05RUEI5YUJGOVRoZl9mYXZybmhPXzVSQUpodjlBdW4wblNURmlZM3lmNk1xTjVOajlzTE0zN09aY2hrOGJiQlNoTk9rT0h0T1R1TnVld2o4TGJYS251dVUyeU5nMFJSOWdadHNtVERudy1YQktDb09aUE5qX2ZVWXo0bG9TZkx3bXRBb3dHUXpaZmpva3hpTkVjUk9QY25MbmhtYzMyT29zdnc3STJ3RzZIM2pyUXhCR0Q?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.09884999999999998,-0.09884999999999998,neutral,1.0
2024-07-31,2024-07-31 07:00:00,Biocon Foundation and IISc organise OCTF conference on AI in oral cancer - Express Healthcare,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation and IISc organise OCTF conference on AI in oral cancer</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Healthcare</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.32985,-0.32985,negative,1.0
2024-08-05,2024-08-05 07:00:00,Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gets US FDA report after Vizag facility scan; no more regulatory action needed</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.29335,-0.29335,negative,1.0
2024-08-09,2024-08-09 07:00:00,"Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi6gFBVV95cUxNbUl2NlJvWEpaRHBrNWM2M291UHlqQTh1Y2IxRERxVmRCRjlIdEQ0M011MW5NZVlFZzY4M0dOQXZZWVUweHVua3FLQUdvSWZYeTlteUVkN3hPdTdMYXI5LThiMC03TDJya1VDM1NST0p2UVFaZWFXZ015Z182WlFHV2JTRUt4UGFTVVJESXpxcEJTUmN5Y2g5V0xlSXVHWlAzcW1Kd20zYUJoWU9EQVJxcC1hYk84d3RwN2NNRGZJNjczT21vVldJYTVWbHBlRXZTSU9zRE5LQndmN0dmNm5lVmpJeDJmU1dkQUHSAe8BQVVfeXFMTVpfZ3hBSWI3N2E3aWMyUDhmT2FhbFR1elJiWGNhUGY2d2xrVkxnMUZKdjBLMFpFMmlSdG43S3VsaEpLLWNNM2xDN0VEY19nUlFIaC1ZNG9HS3QyN3ZhU2x6UWplZ3MxUVhjMzJpLU5xYXhDMW1Odm90Y05LRFVULXJKcHBKMkNaT0VZeGg1ZDFhRDlOWkdITXpwdlprVHlrU2VjU1ZPazFpeFk5dUcxZXlJM3BtZzR2aEI2ZWNkaGJmQjlKNTJQTnRYUHRRc2puWlVVdFJFMFpwQmdabW5BQThOQWZxbmY5Y0kxWTFabE0?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,"Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi6gFBVV95cUxNbUl2NlJvWEpaRHBrNWM2M291UHlqQTh1Y2IxRERxVmRCRjlIdEQ0M011MW5NZVlFZzY4M0dOQXZZWVUweHVua3FLQUdvSWZYeTlteUVkN3hPdTdMYXI5LThiMC03TDJya1VDM1NST0p2UVFaZWFXZ015Z182WlFHV2JTRUt4UGFTVVJESXpxcEJTUmN5Y2g5V0xlSXVHWlAzcW1Kd20zYUJoWU9EQVJxcC1hYk84d3RwN2NNRGZJNjczT21vVldJYTVWbHBlRXZTSU9zRE5LQndmN0dmNm5lVmpJeDJmU1dkQUHSAe8BQVVfeXFMTVpfZ3hBSWI3N2E3aWMyUDhmT2FhbFR1elJiWGNhUGY2d2xrVkxnMUZKdjBLMFpFMmlSdG43S3VsaEpLLWNNM2xDN0VEY19nUlFIaC1ZNG9HS3QyN3ZhU2x6UWplZ3MxUVhjMzJpLU5xYXhDMW1Odm90Y05LRFVULXJKcHBKMkNaT0VZeGg1ZDFhRDlOWkdITXpwdlprVHlrU2VjU1ZPazFpeFk5dUcxZXlJM3BtZzR2aEI2ZWNkaGJmQjlKNTJQTnRYUHRRc2puWlVVdFJFMFpwQmdabW5BQThOQWZxbmY5Y0kxWTFabE0?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-08-09,2024-08-09 07:00:00,"Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Ola Electric, LIC, Eicher Motors, GAIL, Sobha, SAIL, Biocon and SJVN</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-08-17,2024-08-17 07:00:00,"ICICI Bank, IEX, Biocon: Axis Direct recommends buying these 5 stocks for 5-15 days | Check targets - Zee Business","<a href=""https://news.google.com/rss/articles/CBMimAJBVV95cUxPeEFtNU9fTWlKbkFhajYzUnl2a2pvVFdXQnN6bGxYUUUtVjVZNzlGWncwQl91MzhndUlyRUo3cDN1QkZHOUtUekVrRXdqQW8xc2FwbkthY2x1OXRFbV96bUNJaHp5NDNOcHAzQmtZb3o0UWkyWllTcjhJd0F1OE82VDZzNThpXzJjNWZ1QVlYVzNxdTl0M294WENVZ0wtOXpLVjBhRm10LUl2TEN0R184V245OS1YNVdZc1d3OEFsZUxNQ2VsRW9Yc0dJNzF6MzNMWVFDSHRWWFpkc283MmVDZHMyNlB0ei0xdjNHQVc3el9RSVAxN2U4WUtDWUthR2huUG1VN2R3MEdxUm1mV0I1WUZOdWpua2ZQ?oc=5"" target=""_blank"">ICICI Bank, IEX, Biocon: Axis Direct recommends buying these 5 stocks for 5-15 days | Check targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMimAJBVV95cUxPeEFtNU9fTWlKbkFhajYzUnl2a2pvVFdXQnN6bGxYUUUtVjVZNzlGWncwQl91MzhndUlyRUo3cDN1QkZHOUtUekVrRXdqQW8xc2FwbkthY2x1OXRFbV96bUNJaHp5NDNOcHAzQmtZb3o0UWkyWllTcjhJd0F1OE82VDZzNThpXzJjNWZ1QVlYVzNxdTl0M294WENVZ0wtOXpLVjBhRm10LUl2TEN0R184V245OS1YNVdZc1d3OEFsZUxNQ2VsRW9Yc0dJNzF6MzNMWVFDSHRWWFpkc283MmVDZHMyNlB0ei0xdjNHQVc3el9RSVAxN2U4WUtDWUthR2huUG1VN2R3MEdxUm1mV0I1WUZOdWpua2ZQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24408333333333332,0.24408333333333332,positive,1.0
2024-08-29,2024-08-29 07:00:00,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - Newswire Canada","<a href=""https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTnV2VjJzMWxWcUZzckZYbWZEbkExNENNUE5mY3BwVk1VYllJZk8wVmZ2NWpsY1hkcVZKbF9ibnk0aldIeDFqa29BaEpTWXhCT0I0WGlKS3dmSTBLb0xndi1kV2Jma0dRbU90cG5XbzlMdGRWQ3VmRWZwY3BrbFcxVi1xd3dLcWxIUUo3VW5RVWxXd3U3WVlFbkhZVUZTVl9yZTJldHZjUUZwMlphNm9MQUNWbXl4TG5iaG5fM3hLR1c1QjRjbnRnOEhEeDJDeEd4eWNlOTVTZFpQRTRxSm5nMjN5NmI4ekNHS0w1a3ZYbWIwWkFSRi0tRTlLMDl4QQ?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Newswire Canada</font>",https://news.google.com/rss/articles/CBMi_gFBVV95cUxQTnV2VjJzMWxWcUZzckZYbWZEbkExNENNUE5mY3BwVk1VYllJZk8wVmZ2NWpsY1hkcVZKbF9ibnk0aldIeDFqa29BaEpTWXhCT0I0WGlKS3dmSTBLb0xndi1kV2Jma0dRbU90cG5XbzlMdGRWQ3VmRWZwY3BrbFcxVi1xd3dLcWxIUUo3VW5RVWxXd3U3WVlFbkhZVUZTVl9yZTJldHZjUUZwMlphNm9MQUNWbXl4TG5iaG5fM3hLR1c1QjRjbnRnOEhEeDJDeEd4eWNlOTVTZFpQRTRxSm5nMjN5NmI4ekNHS0w1a3ZYbWIwWkFSRi0tRTlLMDl4QQ?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2024-08-29,2024-08-29 07:00:00,"Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxPR0hCT1RPc3EzTzc5ZFNycUN1VFlTa3FvR1NvVU9LN3Uya1dqamZjMjNrWDloVnBDSVF6VmFQUmxpS1FQT2d1X1k0TzRsdjVlbkpvQURralVGUU5mcDVlNWdqRjBuWjNwekZ6T3NVY1ZodFZPVVBGdVhkM1B4Vmt6ZTFvVXZ0c3c1OXRHNzdNcnhiSzdKcll1dVRnOFk1TTZSSllfbTlaT1RPY3FSZ0VLelo4X0RaalZ0cFRRUEVJZGZaQmVMZVVfS3Y3QVJNTzJRWU9BWDJmYlZaX2ttZVhQOEtTQTBUOFJVdGVrdnI4Y3plemx6SjVHWWJKR0wyZ0k?oc=5"" target=""_blank"">Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara®, in Europe, UK, Canada, and Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi_wFBVV95cUxPR0hCT1RPc3EzTzc5ZFNycUN1VFlTa3FvR1NvVU9LN3Uya1dqamZjMjNrWDloVnBDSVF6VmFQUmxpS1FQT2d1X1k0TzRsdjVlbkpvQURralVGUU5mcDVlNWdqRjBuWjNwekZ6T3NVY1ZodFZPVVBGdVhkM1B4Vmt6ZTFvVXZ0c3c1OXRHNzdNcnhiSzdKcll1dVRnOFk1TTZSSllfbTlaT1RPY3FSZ0VLelo4X0RaalZ0cFRRUEVJZGZaQmVMZVVfS3Y3QVJNTzJRWU9BWDJmYlZaX2ttZVhQOEtTQTBUOFJVdGVrdnI4Y3plemx6SjVHWWJKR0wyZ0k?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2024-08-30,2024-08-30 07:00:00,"Biocon receives FDA report, can start supplies to US from Vizag facility - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon receives FDA report, can start supplies to US from Vizag facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-08-31,2024-08-31 07:00:00,"Biocon is targeting to be a gender parity company by 2030, says Kiran Mazumdar Shaw - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon is targeting to be a gender parity company by 2030, says Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-01,2024-09-01 07:00:00,"Stock Radar: Maruti Suzuki, TVS Motor, SJVN, RailTel, Biocon, Gujarat Gas, Tata Motors in focus on Monday - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxNTkh0R3NIWHdEemJhb2FjRjk4Qk9yQ0hBLVZ1cHlMMGxlTU5JT2Y2WmY5c0Y1S0gwRWpoWktFUFNrSXB6YnZlUlp2ZUhVWnZfYk5wLWpNSXVONGpnMHNNMDU5T0p3Nl91Yk1ESDQ3MlRvNHVIQ3BzQllEOFBtWWtwbG9nUWVSYmo4R2tIT0RvMXJTZVpvU3AyTHlQeFVuSGJ4Vzlsb3FFSWhCTkZMUzh5MmNWNHJneklkUzBHNTFXNjhydEpDNDRnRmFBM2xvZVFWS2prOEZSZVU5cW0xVDBHeXBWc0E1WXZ3WlBSelVKNk1uLWlqeFHSAfsBQVVfeXFMUFM2VVc3RHItLVlIVldXd29UNHdmVVhTUTVsWUtlTWZTaWxmVjZjNGoyZzhSNmNVTXVheGZPd3g0ZkFUbmxNY0czckhPY29SSFNvS0U4TGlWVTRJQXdoc2pBeEl0YmVhU1psQ2xmeEdfclpQQkxGRm1UUWdVRnFvdTY2dDlMbHo1WXZxeWYzMnRiSzRMR3lmYU1WUjZSemM1cTZoUzlMV3lDODc5NkhzS2pvTUpuNTF0aXRMUmo1bXc5b3FJRjBlRDc3aVpWeVZRbTdscmtNdk1NdFBobDlVYkV2NmpHSWJzdDBTbVlwUWNtWXR3cDZYWEJrdXM?oc=5"" target=""_blank"">Stock Radar: Maruti Suzuki, TVS Motor, SJVN, RailTel, Biocon, Gujarat Gas, Tata Motors in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-01,2024-09-01 07:00:00,"Stock Radar: Maruti Suzuki, TVS Motor, SJVN, RailTel, Biocon, Gujarat Gas, Tata Motors in focus on Monday - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMi9gFBVV95cUxNTkh0R3NIWHdEemJhb2FjRjk4Qk9yQ0hBLVZ1cHlMMGxlTU5JT2Y2WmY5c0Y1S0gwRWpoWktFUFNrSXB6YnZlUlp2ZUhVWnZfYk5wLWpNSXVONGpnMHNNMDU5T0p3Nl91Yk1ESDQ3MlRvNHVIQ3BzQllEOFBtWWtwbG9nUWVSYmo4R2tIT0RvMXJTZVpvU3AyTHlQeFVuSGJ4Vzlsb3FFSWhCTkZMUzh5MmNWNHJneklkUzBHNTFXNjhydEpDNDRnRmFBM2xvZVFWS2prOEZSZVU5cW0xVDBHeXBWc0E1WXZ3WlBSelVKNk1uLWlqeFHSAfsBQVVfeXFMUFM2VVc3RHItLVlIVldXd29UNHdmVVhTUTVsWUtlTWZTaWxmVjZjNGoyZzhSNmNVTXVheGZPd3g0ZkFUbmxNY0czckhPY29SSFNvS0U4TGlWVTRJQXdoc2pBeEl0YmVhU1psQ2xmeEdfclpQQkxGRm1UUWdVRnFvdTY2dDlMbHo1WXZxeWYzMnRiSzRMR3lmYU1WUjZSemM1cTZoUzlMV3lDODc5NkhzS2pvTUpuNTF0aXRMUmo1bXc5b3FJRjBlRDc3aVpWeVZRbTdscmtNdk1NdFBobDlVYkV2NmpHSWJzdDBTbVlwUWNtWXR3cDZYWEJrdXM?oc=5"" target=""_blank"">Stock Radar: Maruti Suzuki, TVS Motor, SJVN, RailTel, Biocon, Gujarat Gas, Tata Motors in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-02,2024-09-02 07:00:00,"Stocks to Watch: Eicher, MSIL, NBCC, Biocon, Insecticides India, KIMS - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Eicher, MSIL, NBCC, Biocon, Insecticides India, KIMS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-02,2024-09-02 07:00:00,"Stocks to Watch: Eicher, MSIL, NBCC, Biocon, Insecticides India, KIMS - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Eicher, MSIL, NBCC, Biocon, Insecticides India, KIMS</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-05,2024-09-05 07:00:00,Why Biocon Share Price is Rising - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOb1VTNGotRFpobWVFdTVJTndHNTExRGJ0V2NZbTE5NVN6cVZnUlV1RnVSWmMxWS14WjEtNEVxVlRaLUFjUVdwTFFhSjFkWjUxOElXN1FDc0ZGWkYtUWJCYjlzYUpQTTJOemNjSDI5b09faEdDWXFfOXFhYjFoNk1welN4bDJYdC1vVzk5YVYyZ1RFaGVURGZuSXNJcEdkSTJHY0dxMw?oc=5"" target=""_blank"">Why Biocon Share Price is Rising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOb1VTNGotRFpobWVFdTVJTndHNTExRGJ0V2NZbTE5NVN6cVZnUlV1RnVSWmMxWS14WjEtNEVxVlRaLUFjUVdwTFFhSjFkWjUxOElXN1FDc0ZGWkYtUWJCYjlzYUpQTTJOemNjSDI5b09faEdDWXFfOXFhYjFoNk1welN4bDJYdC1vVzk5YVYyZ1RFaGVURGZuSXNJcEdkSTJHY0dxMw?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-09-05,2024-09-05 07:00:00,"Buy IEX, Bharti Airtel and Biocon shares, suggests LKP Securities - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy IEX, Bharti Airtel and Biocon shares, suggests LKP Securities</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2024-09-05,2024-09-05 07:00:00,"Biocon, Syngene International among 5 stocks with long buildup - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi4AFBVV95cUxNR3VUamZRanF6Vl80WHZ1WDJMUExneEFXYUhja29fQ2JKMDdORHZJT2p2alBrUUFpcHo3TGVrNUpwZGdnZWRDME9SSXVQQkI0c3Uzdm0tdDhJWWNHdFlmbC1BMEIwRTRvNF82VlItMldNQmZQQzBuakpHUzdzYVNWbDY2UVJWd3p0RnMtU1hSWWtQQWR0NUVOWUh5VDhRZTJxd3JQeE1Td0M0TUdJX3o0T0hVZmlKVzdxVVAzblN6RUk3U2xWS3JLSjl6MmNMd1ZQQXExemdDaWVTcTRaYkh0Sw?oc=5"" target=""_blank"">Biocon, Syngene International among 5 stocks with long buildup</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxNR3VUamZRanF6Vl80WHZ1WDJMUExneEFXYUhja29fQ2JKMDdORHZJT2p2alBrUUFpcHo3TGVrNUpwZGdnZWRDME9SSXVQQkI0c3Uzdm0tdDhJWWNHdFlmbC1BMEIwRTRvNF82VlItMldNQmZQQzBuakpHUzdzYVNWbDY2UVJWd3p0RnMtU1hSWWtQQWR0NUVOWUh5VDhRZTJxd3JQeE1Td0M0TUdJX3o0T0hVZmlKVzdxVVAzblN6RUk3U2xWS3JLSjl6MmNMd1ZQQXExemdDaWVTcTRaYkh0Sw?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.021428571428571432,0.021428571428571432,neutral,1.0
2024-09-12,2024-09-12 07:00:00,"'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQcXFBNGtJNW1KSUpfNFotekoxR200OG50eHVIaGVtMUtibDBON1NyUDJLNzZtZlowVzFqN3psajlydW0weEd3WWYwdGxPWE5CWW9XZmNlZkw0ZWFMVzF4b3R4UWxHSEluMktWNTBycWVycTlGVFZILWczUTdMUEhUQWRhTFFPMnhRQWRvYlljUUxwNTYyRDhQa2cyOWtxTko5SVpGUEgycGtrRVRBYkpDWjJvM0dMdzlERGJ5TU5JYm9icE9laWZ3OF9JaDhPS29aYlN1YW5QT19HYy1tU1Nv0gHkAUFVX3lxTE81Z0FaUzNscWZfOVA5NVhOemJwZUlqWm5aWkRnV2lWRXdrdXJ6OGNub2I3cmlGR3ZHZXdteE5aejFHVWFRZFpOOTJvTGZPcEpvVHVYMEtWZHAzblRXalMwaXFHY0I3ZGNaVTEzWmJvYTFzUjVRN1B3STExX1dTNERfMEJmZXFUSkNOQVI5YVJkLXFvX1NvZWJTejd5cFl1STZ3SlY1YTg0SXlkUnFHYWxVb2g4cFB5cHNlOFZEdmV1SDllMmVrdl9HYmJjdk1YQXRmNEMyNG5XX200LTk4SHhYMzNfeA?oc=5"" target=""_blank"">'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-12,2024-09-12 07:00:00,"'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">'I’ve built this business to last, not for sale', says Biocon's Kiran Mazumdar-Shaw on sellout rumours</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-14,2024-09-14 07:00:00,Biocon Biologics is planning to raise $950 million through overseas bonds - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics is planning to raise $950 million through overseas bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-09-14,2024-09-14 07:00:00,Biocon Biologics is planning to raise $950 million through overseas bonds - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics is planning to raise $950 million through overseas bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxNZ2tyNVN1ZllvRW5jaURaSnBKY0ZGaEJlVnBwcVpqdlhJSGZvdFJoMW9sQXI5RS1GcHpqM0pfdkhjSk4wOWtyc3ZoZU9FZHc3R1FMdWJuVFhPSGd3YmVvRmJoajZ3Z2JzcUtLZ2J1dS10MnFKdHljb0k2b0tOTTBxSnJhLUdvVGlibERIa01qc3RzU0M0amJ5SXJOQWF5UzB2SlVkRm90RFljU29MdF9ENzN5bFExRkJhR2t4ekZVRkFrQW9BX0czT2Z0RHJ4WG1tMnY3ckJnVdIB3AFBVV95cUxQd0lWeDU2QWlVTGJuaGdXUkM4SXBUYVBCbklpVk5RdGxwQ1VuRkZXYlBIRWdrMy1tVHpLYXVVR3BjZU5Na0FJLVBtMm5hdkhMVWNtMVl1d2hfUzFCaGpMbDJzV0ZvaTdyLXdhTXlmdEpEeXJ0SkYyWkdzYjJiVEZ3c2tVbUhWWlExWlZjN04wQTdybTFMeTBxWFNYb2c0blNTQXY3a2dJdnpNNkZ4aENGOWh5M3dJZE41OTRIcnYydERnQmJPS2FpSFJHVWxBdldtNmJsTWJfdldHQTZH?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-09-14,2024-09-14 07:00:00,Biocon Biologics is planning to raise $950 million through overseas bonds - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics is planning to raise $950 million through overseas bonds</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-09-18,2024-09-18 07:00:00,Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-09-18,2024-09-18 07:00:00,Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-09-18,2024-09-18 07:00:00,Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-09-18,2024-09-18 07:00:00,Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5"" target=""_blank"">Biocon Share Price Could be in Focus Tomorrow as LIC Raises Stake to 5.02 Percent</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxOQXhPUFNFemJIMjhSTTFzcVlBYUloTElqVU5OR1BIcjRxMVFWNm5Lbzg5RWFXLWVOOENpMnBUT2pnVFZicFFwUzNsYmJJTjdVYUYyZUwxT3dtQXNJUC15RERJdnRYNlN0QWxqb1BGOUhZaWZLSUlySUR3dTFZdF93blBpQTBfSkZjaG5Zd0xtUXd4QkdHN1ZHNWZEZ1hDYXc?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-09-26,2024-09-26 07:00:00,"Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing Co - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing Co</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-09-26,2024-09-26 07:00:00,Biocon Partners with Tabuk Pharmaceuticals to Launch GLP-1 Products in the Middle East - India Infoline,"<a href=""https://news.google.com/rss/articles/CBMiygFBVV95cUxNM1FVSXZkZ0g5Q01RU1pXSmRKalF1OHhrc0NKeWxtcDFxZmZRTkswZEZyR3BSU0tkYlhhODhsVzg5N0VtcUFraU5mREViZElWRGw0aWptWE1NaTBNWlVsa3VEaDhQRElJaDAteVRlTW9YQXFUZkNySlVlbTJTMFZDTUwyekZpaWN4RExibjYydm84d0FQM3Q5RHFMTElTRHhqUHJ6aG94RUpYcUh0OWxGRnd6YVNtZWExU2tZVEVZbDVBdUlKNnJ6ZnZn?oc=5"" target=""_blank"">Biocon Partners with Tabuk Pharmaceuticals to Launch GLP-1 Products in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxNM1FVSXZkZ0g5Q01RU1pXSmRKalF1OHhrc0NKeWxtcDFxZmZRTkswZEZyR3BSU0tkYlhhODhsVzg5N0VtcUFraU5mREViZElWRGw0aWptWE1NaTBNWlVsa3VEaDhQRElJaDAteVRlTW9YQXFUZkNySlVlbTJTMFZDTUwyekZpaWN4RExibjYydm84d0FQM3Q5RHFMTElTRHhqUHJ6aG94RUpYcUh0OWxGRnd6YVNtZWExU2tZVEVZbDVBdUlKNnJ6ZnZn?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-26,2024-09-26 07:00:00,"Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxNdW1ySWNtMm9Gdk1UUmVVa3I4ZG1sbkc2MmFvMWtyd3poeTFqUWJSbGE0c3N5ZXd2S2h5Zk9YUVozYjZTcGR5UC1RVWpVdXBVUXRTdUV3NTMwVE8xcDVncDhyQmNBMXotNEY4TUNiVm1SWVhvVjlvVVFIYUtQdTB6Uks5NFpMblQ4SWUyUFRHdGJrRzdKRGtScUZIOW11clptZHJVeHVlUzI4aTBUbDNTSXBzSVM3ZWk5d2c3X2FRcFZibHRVRmdTRUFGQ2wyc29CS0FtMDRNWnVfd9IB3wFBVV95cUxPMUR3eVhBaFU4S0d2dzV0MXFCV24wd3lDY3pzTzMxbjJvYnRONWVGUkpVVTgzMWtXLWQyMG1TNXdKb19EU2xOS3NkT1lESklkWE5WYkhmSzI0N1ZybVlTb2NPazFmMjdYaG03Sll0M0FCVVlMcXV3ejg0ZmxRYjdRbVRkbnI2YzZEVXJGUk1UaEEyWWlFN0JpYUZFY3ZiWE5zQ1B6SlFWM3E0Um13RGVNeXdIaGxnaW9nQjlWaUFLRVV1OWZxN1NJVk5FaXQ3TXRoaXhncTFGTjMzT2xzbkI0?oc=5"" target=""_blank"">Biocon inks licensing, supply pact with Tabuk Pharmaceutical Manufacturing</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon and Tabuk partner to launch GLP-1 products in Middle East - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxNeWVzUmh6NTJzMWczeFR6QUR5U3FxbHZDaDVjVG1BbXVSdFJLMGlDa1BlRm0xa2xaMVVTVlNrNFZ6VEZKVEJ5UHNibGZmMWk1WXpVQ2toQlFtcE9wLWcwM1FYTUw0ai1BVFdTUF9TbDRMSDNoRlozdUhCVXFZNXVNQzZEeW0?oc=5"" target=""_blank"">Biocon and Tabuk partner to launch GLP-1 products in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxNeWVzUmh6NTJzMWczeFR6QUR5U3FxbHZDaDVjVG1BbXVSdFJLMGlDa1BlRm0xa2xaMVVTVlNrNFZ6VEZKVEJ5UHNibGZmMWk1WXpVQ2toQlFtcE9wLWcwM1FYTUw0ai1BVFdTUF9TbDRMSDNoRlozdUhCVXFZNXVNQzZEeW0?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon partners with Tabuk to commercialize its Glucagon-like peptide-1 products in the Middle East - Indian Pharma Post,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon partners with Tabuk to commercialize its Glucagon-like peptide-1 products in the Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxNUmNRaEdLaTlmbWpaakhHMjhiYS1NcFdJZDBWWGpmTVpvTkZjcS1uSFo4eWdmd1oyN2NKOGRjR1FCcGYxeVktUGxWT1Y4RWNSdnlQbklYRFhGaU9SUjNVSmFUVXlZeldBWC14YWd4SF9hWDBjWDVzemdkSzZnZUV3MXdWdlBITDdzc28xR3dNR05RbWtkWGM4bjlIV19OTTZEeGVESDk3bDg2c2IwU2VpQVkxcV8yeHZMNVpNVjlpNE04QjVEMjA2UUE1RmdqSFdtZXFVd1NBOV9taWPSAeIBQVVfeXFMTktTa0RXM2ZQVzctTjh6UUF4OVVsaE9SbTlVdWhtaEtJRmo3cnBaV1Fxbk05VWh5Z25BR2J3OTQxeC1RZmN0djE0M3lIc1VLNnFHTkNzcjJLUl9IeEswdUVDQ0lwTVRXVzJ5TC1WQWlEeElEaFhBZTBJZExCbW1BaFBTYkNyX3dhalJyTXBieUtjLXExWjd0ZVl0VlBCdkdVWXJOSEdaeXd2SGtjZEtoVjE0YXoyeUtTOVFQZFBvbVFBdWpSR0R3T0REN0tLZDBJWUc2dE9mcEM5NXBxYktvM0lmdw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon partners with Tabuk Pharmaceuticals to market GLP-1 products - Manufacturing Today India,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNUxQUldQUEhWZzdOVFA5VmQxcEk2YzdlT2NPWXRlTmpSX0hwamVSTmphQVpRcGpFSWRqdVJjeW0yTEMyVWdSSHZBNmRRUl9ZeF9PUGZ3dVFnNWppZ2pSbU1uWmlPeGJIS1VuWWxmUG53cnRmZlpNZDRZUERpdmJ3X3lzYVV4Zml0ZWU4SmVrcGdnbDUzdDN0NkdhVTNNaWphT3dfcFBxeTVENzA?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to market GLP-1 products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Manufacturing Today India</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNUxQUldQUEhWZzdOVFA5VmQxcEk2YzdlT2NPWXRlTmpSX0hwamVSTmphQVpRcGpFSWRqdVJjeW0yTEMyVWdSSHZBNmRRUl9ZeF9PUGZ3dVFnNWppZ2pSbU1uWmlPeGJIS1VuWWxmUG53cnRmZlpNZDRZUERpdmJ3X3lzYVV4Zml0ZWU4SmVrcGdnbDUzdDN0NkdhVTNNaWphT3dfcFBxeTVENzA?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon and Tabuk partner to launch GLP-1 products in Middle East - Pharmaceutical Technology,"<a href=""https://news.google.com/rss/articles/CBMihAFBVV95cUxNeWVzUmh6NTJzMWczeFR6QUR5U3FxbHZDaDVjVG1BbXVSdFJLMGlDa1BlRm0xa2xaMVVTVlNrNFZ6VEZKVEJ5UHNibGZmMWk1WXpVQ2toQlFtcE9wLWcwM1FYTUw0ai1BVFdTUF9TbDRMSDNoRlozdUhCVXFZNXVNQzZEeW0?oc=5"" target=""_blank"">Biocon and Tabuk partner to launch GLP-1 products in Middle East</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Pharmaceutical Technology</font>",https://news.google.com/rss/articles/CBMihAFBVV95cUxNeWVzUmh6NTJzMWczeFR6QUR5U3FxbHZDaDVjVG1BbXVSdFJLMGlDa1BlRm0xa2xaMVVTVlNrNFZ6VEZKVEJ5UHNibGZmMWk1WXpVQ2toQlFtcE9wLWcwM1FYTUw0ai1BVFdTUF9TbDRMSDNoRlozdUhCVXFZNXVNQzZEeW0?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon partners with Tabuk Pharmaceuticals to market GLP-1 products - Manufacturing Today India,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNUxQUldQUEhWZzdOVFA5VmQxcEk2YzdlT2NPWXRlTmpSX0hwamVSTmphQVpRcGpFSWRqdVJjeW0yTEMyVWdSSHZBNmRRUl9ZeF9PUGZ3dVFnNWppZ2pSbU1uWmlPeGJIS1VuWWxmUG53cnRmZlpNZDRZUERpdmJ3X3lzYVV4Zml0ZWU4SmVrcGdnbDUzdDN0NkdhVTNNaWphT3dfcFBxeTVENzA?oc=5"" target=""_blank"">Biocon partners with Tabuk Pharmaceuticals to market GLP-1 products</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Manufacturing Today India</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxQNUxQUldQUEhWZzdOVFA5VmQxcEk2YzdlT2NPWXRlTmpSX0hwamVSTmphQVpRcGpFSWRqdVJjeW0yTEMyVWdSSHZBNmRRUl9ZeF9PUGZ3dVFnNWppZ2pSbU1uWmlPeGJIS1VuWWxmUG53cnRmZlpNZDRZUERpdmJ3X3lzYVV4Zml0ZWU4SmVrcGdnbDUzdDN0NkdhVTNNaWphT3dfcFBxeTVENzA?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-27,2024-09-27 07:00:00,Biocon's Kiran Mazumdar-Shaw rings Nasdaq bell for niece's Bicara Therapeutics' Billion-Dollar debut - Storyboard18,"<a href=""https://news.google.com/rss/articles/CBMi4wFBVV95cUxNUzk1eldvX2wycldHVUxyZ3NlY0F2SF9USXBZbkxJd2xKVVZSaFpFWldzdTN3UjRRQlpJNFlqMmZoZ1prSmxIZjRhRUFFN29ETWJFNURJT0xNRElLQTItRWNxYlFPcm5kX2hfRFFxOW9zXzNOR2xXQXRmLTRXZXBkT0pIZGdGaG5jZE5Md01hUmNvOEk1WnZjcFNDSnFCUDAyelNDbDRpbVdVSU5KNG5TMlRFRUdhZ0Z4QWpBeEVlWFpLTjJOVGcyd05IcXpOblhpZDlSXzJXRTlTQ0M5YkdYTVNQNA?oc=5"" target=""_blank"">Biocon's Kiran Mazumdar-Shaw rings Nasdaq bell for niece's Bicara Therapeutics' Billion-Dollar debut</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Storyboard18</font>",https://news.google.com/rss/articles/CBMi4wFBVV95cUxNUzk1eldvX2wycldHVUxyZ3NlY0F2SF9USXBZbkxJd2xKVVZSaFpFWldzdTN3UjRRQlpJNFlqMmZoZ1prSmxIZjRhRUFFN29ETWJFNURJT0xNRElLQTItRWNxYlFPcm5kX2hfRFFxOW9zXzNOR2xXQXRmLTRXZXBkT0pIZGdGaG5jZE5Md01hUmNvOEk1WnZjcFNDSnFCUDAyelNDbDRpbVdVSU5KNG5TMlRFRUdhZ0Z4QWpBeEVlWFpLTjJOVGcyd05IcXpOblhpZDlSXzJXRTlTQ0M5YkdYTVNQNA?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-28,2024-09-28 07:00:00,U.S. FDA issues 4 observations to Biocon API facility in Bengaluru - The Hindu,"<a href=""https://news.google.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?oc=5"" target=""_blank"">U.S. FDA issues 4 observations to Biocon API facility in Bengaluru</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-29,2024-09-29 07:00:00,"Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-29,2024-09-29 07:00:00,"Stocks to watch on September 30: BSE, PNB, Zomato, metal stocks, Biocon, Reliance Infra - Upstox","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxObkdDSVZzMXNvLTlLNXRmSlJJQWRsSlVfNVpVY2tJWGplLVI1R3ZnZ3o1WWhHbkU4Q3g0RjBLb1hsVTNhcmltQjR2Ni12OFpDbjA4NmY4UENCVnduMFdDMS1YTjFwRWNCSHhWVHlfWnlHNW1fak5acnZhZlY3YU1LX2FrN1VIRHFINUNTZzM5Q1RtYldJdE96RE54bXFab3NsTVZpWE1STkxXNTBLdmk5ZHRIeWRGRjVQejFqaFg3dFBnMExtZEtRTjVnUTRxakVGT0tzX3pWMA?oc=5"" target=""_blank"">Stocks to watch on September 30: BSE, PNB, Zomato, metal stocks, Biocon, Reliance Infra</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxObkdDSVZzMXNvLTlLNXRmSlJJQWRsSlVfNVpVY2tJWGplLVI1R3ZnZ3o1WWhHbkU4Q3g0RjBLb1hsVTNhcmltQjR2Ni12OFpDbjA4NmY4UENCVnduMFdDMS1YTjFwRWNCSHhWVHlfWnlHNW1fak5acnZhZlY3YU1LX2FrN1VIRHFINUNTZzM5Q1RtYldJdE96RE54bXFab3NsTVZpWE1STkxXNTBLdmk5ZHRIeWRGRjVQejFqaFg3dFBnMExtZEtRTjVnUTRxakVGT0tzX3pWMA?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-29,2024-09-29 07:00:00,"Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxNY3hxZjJZWXhzUXM0VFNKdTd1dWpjWFUwM1kwVzZrVjJycjAwZGNpN3VkM3prUGNtYUZvelE3MGF3RTE5VzVNc09MVU5rR1ZweEFMREhzRm9ETTFGTkV5LWdsT1hDTkdMUlBGZm9yQUhIUWM0SlhvNmktMEpiMlkxUml1UDY4Tnpvd1BpdWw4U2o1dVpFOVBsenpNcmZURmpucmxGcXRsbGplazBWZGZtRUFES0hjOU4wa05VRUo3ZTY5endvTDc0OXQwMGVEc1Ezcld6c081N3JmVVVXa1V4bV95TU52eW9QR0NhcNIB8gFBVV95cUxPeWhkLWRpZU5nZ3RpLTNkMlNxTHpFN2prWUxPbWN1bkI4Z0RLU0o5U3pER2oxcEVoRXI0d3hMeXN2aG5Nc2RVeDVRRUVweW9sbWlQZ0dYeklaaTRHdks1a2VMLTZGMFFFTlBPc1c3VWktdE5kanJvM3ppejNSeW9Ca3dKREF4OXNhNGx0SnNQNjBwRDhLaG9DdFVOejU4YzA4bWpKckE2cVpzZG1UTGRDdWJMSGtaM25fUWRQLXBydUJpMVdVWHl4eGQ1T2NOQ1RyNDlZdmp5bFVOOUFSSUx3T3N4bm9CMU9kOTFrLXBBeVpHdw?oc=5"" target=""_blank"">Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-29,2024-09-29 07:00:00,"Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Welspun Enterprises, Zomato, BSE, Apollo Hospitals, Biocon, Lupin in focus on Monday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-09-30,2024-09-30 07:00:00,"Stocks to Watch: IDFC First Bank, PNB, Dr Reddy's, REC, RIL, Welspun Enterprises, Biocon, and more - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: IDFC First Bank, PNB, Dr Reddy's, REC, RIL, Welspun Enterprises, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2024-09-30,2024-09-30 07:00:00,Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares drop 2% after USFDA issues 4 observations for Bengaluru API facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.09246666666666667,0.09246666666666667,neutral,1.0
2024-10-03,2024-10-03 07:00:00,Biocon Biologics refinances $1.1 Billion long term debt - Healthcare News - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMitwFBVV95cUxORWVSa3MzSlFEVkJzZzdLbWkyR0dLdXNEaEZwZkdzbVhidXN6U01XX1dRVjhFRWRjM0V5RlZ5Q1pidWlLVTFsdWs0ZThRY1NGNVNacGJ3alVOcUJxWm8wamV1b3dJSmQ5cm9NX0c0NFJhYVgzR0dkdnowTUFBUW1oLWlCRWluVDhZLXNTYTlRMTEzb0daS2JrMnBCcEY1aElsWWtkTGYzdHZtZGthUW9XTEFkNE92Ums?oc=5"" target=""_blank"">Biocon Biologics refinances $1.1 Billion long term debt - Healthcare News</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxORWVSa3MzSlFEVkJzZzdLbWkyR0dLdXNEaEZwZkdzbVhidXN6U01XX1dRVjhFRWRjM0V5RlZ5Q1pidWlLVTFsdWs0ZThRY1NGNVNacGJ3alVOcUJxWm8wamV1b3dJSmQ5cm9NX0c0NFJhYVgzR0dkdnowTUFBUW1oLWlCRWluVDhZLXNTYTlRMTEzb0daS2JrMnBCcEY1aElsWWtkTGYzdHZtZGthUW9XTEFkNE92Ums?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3228666666666667,-0.3228666666666667,negative,1.0
2024-10-03,2024-10-03 07:00:00,Biocon Biologics refinances 1.1 billion debt through US dollar bonds and new syndicated facility - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics refinances 1.1 billion debt through US dollar bonds and new syndicated facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.23892727272727277,-0.23892727272727277,negative,1.0
2024-10-03,2024-10-03 07:00:00,"Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics refinances $1.1 bn debt through bonds, syndicated facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOZklmb3hLbEJqaWdiN0x0cEJ6NXJZb242TmxBOFZfc2VnRDVhdy1iVnp6cUQ0Q0thU3VMMklPUkl4Q3dSUWxUSnhOejJ4SUItMUFJNzJFdlJUS3ZvZ0wyT3dwdkdDdW90RVZFbXpVcU1sckNJZUxnOXJTWUdtWkxZczVzMzNfM1ktbEE5NVl5V1VrazFENDg0b0czSDdEaFNDYWlwTFk1ZDJnOFBXQXpGa3JvWWNoUk1Rc25xOUs2amdGNUkxdXo5REZSNjl6UlZ5eFk5R2JPNULSAd4BQVVfeXFMUEJGbjlwVDltakt0MmItalVMQVJrT1JMRDdBQ2lXSm9sdlZ2N1h0c09tY2R1cWl2RlhfRXFWNndkMG9UZlUzMEhJaVJqaElhRFU3WVBIQkpXTWhGcW9QY2paVXl0X2tQcGVGSGJkZlFhbmljVnh3b1dXcmpPSDBvMW16ZWJ2d0ozUkJjaTc4QXA0alUtaUhPU0o3X3NLRnRxaHhKWjdQZFFfSndpUmxESVh0aFBjaHlYeS1lcGtWQm52QkpRSFZkYXM2ejJkV3JkVEJsb3JkTkNfbW0wRVh3?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2024-10-03,2024-10-03 07:00:00,Biocon Biologics refinances $1.1 billion debt via debut dollar bonds and syndicated facility - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics refinances $1.1 billion debt via debut dollar bonds and syndicated facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2024-10-04,2024-10-04 07:00:00,"Biocon Biologics refinances US$ 1.1 billion debt through USD bonds, new syndicated facility - Indian Pharma Post","<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxNcHFmUVRBNDRhWVZSci1pTl8wM0luVlNBeTRkREhfZDFpSUJ6VmJ1X2tfNGllLVRFMmpwYVR3SkFubmhvVFZBWVpJQmF2Y29wcHZDekpnUzhZQW4xOWhpcnphRzlOZEhaVl95dWxJUnI4aGpOc1Z2Y0MzbDJESi1INFBVV0RoYm9kbi1EVV9LSDhSTVhod203VDE5WGwzOHl6RTIzVnFYS25Ic3VMUmFScWhLMHJTNWdzX3BsM1RCSFc3SW1FY2RvN1FRZF8?oc=5"" target=""_blank"">Biocon Biologics refinances US$ 1.1 billion debt through USD bonds, new syndicated facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxNcHFmUVRBNDRhWVZSci1pTl8wM0luVlNBeTRkREhfZDFpSUJ6VmJ1X2tfNGllLVRFMmpwYVR3SkFubmhvVFZBWVpJQmF2Y29wcHZDekpnUzhZQW4xOWhpcnphRzlOZEhaVl95dWxJUnI4aGpOc1Z2Y0MzbDJESi1INFBVV0RoYm9kbi1EVV9LSDhSTVhod203VDE5WGwzOHl6RTIzVnFYS25Ic3VMUmFScWhLMHJTNWdzX3BsM1RCSFc3SW1FY2RvN1FRZF8?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26074545454545456,-0.26074545454545456,negative,1.0
2024-10-17,2024-10-17 07:58:44,Biocon And Mylan's Fulphila And Insulin Plans On Track - insights.citeline.com,"<a href=""https://news.google.com/rss/articles/CBMimAFBVV95cUxPZXl5VnR1SGlyQ3AxTDlQcUxPSnJfLXBoa3NBXzVIWVF0OHo2enhVMi1hRVU0U1J6d0lGeFVmR1oteEppMWpyYWxpMEtqckxxUkFMWUtHTkg4V3hKYk9mNEFJNVpqUWpwSTZJSXlfYWtLdzU3UV9vemYtTGh1T1VzZnIySk5GVFFkRXB4MXpKSXBlaFJ5NG1VZw?oc=5"" target=""_blank"">Biocon And Mylan's Fulphila And Insulin Plans On Track</a>&nbsp;&nbsp;<font color=""#6f6f6f"">insights.citeline.com</font>",https://news.google.com/rss/articles/CBMimAFBVV95cUxPZXl5VnR1SGlyQ3AxTDlQcUxPSnJfLXBoa3NBXzVIWVF0OHo2enhVMi1hRVU0U1J6d0lGeFVmR1oteEppMWpyYWxpMEtqckxxUkFMWUtHTkg4V3hKYk9mNEFJNVpqUWpwSTZJSXlfYWtLdzU3UV9vemYtTGh1T1VzZnIySk5GVFFkRXB4MXpKSXBlaFJ5NG1VZw?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-24,2024-10-24 07:00:00,"HSBC on Biocon: Reduce call, sees 7.8% downside from current share price - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxOamVvZ0tFRVVhUUpxNDFpRzdmWHM3ZHhYNm9sRm13TmU1c0JrYS13S0EzQUpSWUdpTjlKVlRlX1dXZVNFOWdFQzhFMUV4TUZROHhXYkJiNk94SldnLTEzZVR3VjRXYnBnSk54S0U2dDdJcDNQOHkxQlViVEtGVUJ1d2ctQUE1NUZMZzJMMkRuTmNUYmpMWFRMZ3VjSVZRNC1iVWxBYVYwbzJNVzVfS3ZFZV9ON1ZVU24ySjV4clFoSQ?oc=5"" target=""_blank"">HSBC on Biocon: Reduce call, sees 7.8% downside from current share price</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxOamVvZ0tFRVVhUUpxNDFpRzdmWHM3ZHhYNm9sRm13TmU1c0JrYS13S0EzQUpSWUdpTjlKVlRlX1dXZVNFOWdFQzhFMUV4TUZROHhXYkJiNk94SldnLTEzZVR3VjRXYnBnSk54S0U2dDdJcDNQOHkxQlViVEtGVUJ1d2ctQUE1NUZMZzJMMkRuTmNUYmpMWFRMZ3VjSVZRNC1iVWxBYVYwbzJNVzVfS3ZFZV9ON1ZVU24ySjV4clFoSQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.05135,0.05135,neutral,1.0
2024-10-27,2024-10-27 07:00:00,"BBMP engineers need to design roads scientifically, like ELCITA: Biocon's Kiran Mazumdar-Shaw - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxOM1NXRWcwcFBDdmNfYW93dDJGUFplLU84S0NWbDdFZS1HLVYtQnBsbDBGNjRPVVBYNU9QU3ROYTdzal9ycXB2SXdsWWY4UEN2M1lncHZtMGp6U0RybmJIQkxrYk1LelN0ZEllVGhQWVE0R2RHaV9qVFhSY0ZsaDRfZzR0blVTa3lGTVVial9XV3J6Yk9lQmI3NG1IUi1uRmpSS3VkcTd2ampTZ0xtb1BvWlJXU3hTZjZLWDc4N29HS0xBQ1JwWDJ2Q0M1RXItcHBSWDFKcVN2SVVlTjFr0gHiAUFVX3lxTE56S0piQk9TZTF6bW1nMm5PcmJFbTlWdFJDdUtKZHNBMS1QRzJlR3Nxb09kcERMYzd6ZU1WMFZnbzBKQ1VLdDkzSG9hYlNGM0RYdWRRalROSmhkUm50MmV4X003WFdnaTJtdFV0dHlXNVMxU2FlODZsLXBteVRTOUZGRHBJNnpqN2dDVzhVVlR5RTVqTE0td3RBQ090Tm1QWmUxVHFKVDhpVEdnVFU5LVZrV3NzVW5mRlhfU2IyTHpYdmktSHkzTVZiajR6Z1FWbHg1YzFYUkJhNDhMczUxOGxyU3c?oc=5"" target=""_blank"">BBMP engineers need to design roads scientifically, like ELCITA: Biocon's Kiran Mazumdar-Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2024-10-29,2024-10-29 07:00:00,Biocon and Dr. Reddy's Lab make it to 'Science' magazine's Top Employers List again - The New Indian Express,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon and Dr. Reddy's Lab make it to 'Science' magazine's Top Employers List again</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3181727272727273,0.3181727272727273,positive,1.0
2024-10-30,2024-10-30 07:00:00,"L&T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31 - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">L&amp;T, Tata Power, Biocon, DCM Shriram, IRB Infrastructure, Wipro and more: Stocks to watch on October 31</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.16666666666666666,0.16666666666666666,positive,1.0
2024-10-30,2024-10-30 07:00:00,Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNaXRPZW5zOE84Vl9nMy05Mm95WVd2Rk1fLXpzOFdKdG1icnB1NjZUMVRTaXVoM1dLRnM3SG5FTHJ1Nk13cGlTSHBpdlljbHNWbWhTQ3F6ZWxKekZIN0QxYVJhbDVZblBqRmpVT3NUX1g3YjJEbDBFX2pNb1pJZWZTZ3U3UWt3TGRPTUJOaEtVSXFzTGppdThGLVhBZFN4X0tY0gGmAUFVX3lxTE0wa0ZjTmpOV1dOMUtMb3lCTjNzbFBLTjRzRERlVlBKaXRZUWZhYW5QLUVnaXAyejJYck4yUFFVUFgwdVlWUzhBRDgzaVd2cHhndUFLMlNvaURuN3hUUG9uS1J6TEZncXc5VjZla3FPM2gta2tZNEVmRzctdk83M0xMQTE1STNqM1RfcUJkRXVKM1VZeENtVGhmM0tXc09YRlZ4VC1XcXc?oc=5"" target=""_blank"">Biocon and Dr Reddy’s featured in Science Magazine’s Top Employers List</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxNaXRPZW5zOE84Vl9nMy05Mm95WVd2Rk1fLXpzOFdKdG1icnB1NjZUMVRTaXVoM1dLRnM3SG5FTHJ1Nk13cGlTSHBpdlljbHNWbWhTQ3F6ZWxKekZIN0QxYVJhbDVZblBqRmpVT3NUX1g3YjJEbDBFX2pNb1pJZWZTZ3U3UWt3TGRPTUJOaEtVSXFzTGppdThGLVhBZFN4X0tY0gGmAUFVX3lxTE0wa0ZjTmpOV1dOMUtMb3lCTjNzbFBLTjRzRERlVlBKaXRZUWZhYW5QLUVnaXAyejJYck4yUFFVUFgwdVlWUzhBRDgzaVd2cHhndUFLMlNvaURuN3hUUG9uS1J6TEZncXc5VjZla3FPM2gta2tZNEVmRzctdk83M0xMQTE1STNqM1RfcUJkRXVKM1VZeENtVGhmM0tXc09YRlZ4VC1XcXc?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.35756666666666664,0.35756666666666664,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Stocks in news: Tata Investment, Tata Power, L&T, Wipro, Biocon - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Tata Investment, Tata Power, L&amp;T, Wipro, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth... - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQN2JzbTRua1dFYnp4dE1HTjRFOFBZQmRkRW1iVzU4N1pnVHctMURYaVpUdXhkSC1YNzJYWnItT2hkNV9KUnhnallOVjVfa0FEaTJ1SUY3Z3JsSjVkZlVwbzlzOGZMUkJRaWdzWFpxcTJJWWFyb3BNY3IwdXZ6Yk1JSzlFUV9qSkFINkJXTTR0RUxZdzBEMXljZ2xYZ214QkpqczBQcEdET19sN1pjdjlEdzJZOU5JSVoxak15SFItcUl6RVhNZ0VlbmRjRXlraGVPNkxkSVBGbWxOVlFBeW5zRm9admU2ZTVXWXN4cDMtU0xyN090c3prZkc5LVdmVzdDSEh6RE5ieFh4ZFlmLTBZ0gGUAkFVX3lxTE9pM0tGQ3ZsX2hqQmFBbWFOWHJPSm45THFneFZ3Y2V6QWhQelk0MUliYThvVE5vcGUtb21MR2ZSal9hQkI2aEphU1pNM1lDa0hDX1A1MVU3YVE4c3BwWnJXOV8wb2VLeTRuNVlneHRlSkNvQ2lzS0FpVUdKUzItZGdwbUZSeEZQLUdGYkJJT05oY0NlUVgwbTZVZ053U1BwYzlQWXNDQUk3dXBPck4wTTlkcnp3SzRDV3JqUFNxNUpWWUZVTW5qb1NScUFwRll3cGZQcGpGRTJzV3dhYktnVkxyUk1KTEQ5RlRRaVNhNUxaeDR1SWZqUDRrLXB5NXpwOHZodDNWOV9TRlN5djJaNmdqMkpKeQ?oc=5"" target=""_blank"">Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Stocks to Watch, Oct 31: Biocon, L&T, Tata Power, RVNL, Zydus Wellness - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Oct 31: Biocon, L&amp;T, Tata Power, RVNL, Zydus Wellness</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMiywFBVV95cUxORDNkaFFNaHhMX0piblhWMzNrZlF2X200UTRvcThuNDFRa2N3UnBaRXJhdk8zZ19jRzBWZHBTT3IzbnRkdVBfRXVOUFpYY092RlFTbm9Ib2dDNEdnQ0ZUYV9fdjRkS2Zuek9aNEwxY2t4MC12N24xNnN2OHlUVDZJVm9QTU0wZ3RhZUhlMFM4dzVUYUpSM2hsVlFfdERtakNLWE04bk14MjNXMW93RUhRRHFJRFByZzAwNWpNWW1aRTdlUlBEVFVyR2I0VdIB0AFBVV95cUxQWkViVlIycVFEVUhIQTQ0ZDUyYTNDZ2FMaEpodzdiaGU0SEp6N3g5Sk9sWjh0bHVoOUtaUzZVWHZLU1JFc0VQek1MeEZuRVRhLW5MSVhSemhwOGtiMkJYV1JVZEh4YVFFZTRkekdNU0psUzFiaDJyOFhNZi1oWFhHLWEwY2hZaTItbmlEd2xETTJBdXlVRkVnVzdIcUFSdVRMcmQ3dUU5bC14YmVyckVDXzcyeGVJcUpfWFB5LXByaUl4dU0tWXhvNlFfYUZMR3dN?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2202,0.2202,positive,1.0
2024-10-31,2024-10-31 07:00:00,"Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Stocks To Watch: Tata Power, Wipro, Biocon, RVNL, Adani Green, Biocon, And Others - News18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch: Tata Power, Wipro, Biocon, RVNL, Adani Green, Biocon, And Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.06666666666666667,-0.06666666666666667,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Wipro, Biocon , IRB Infrastructure Developers , Larsen & Toubro, Tata Power Company In Focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Should you buy, sell or hold L&T, Tata Power, Biocon, other stocks now? - Zee Business","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMzdtcmdYQjNWcXAydU1BUGdVMC1hejJydHdYTm5yR3dQT0JmUmRNZ0xRRWNWUVk2SG5uejAwdGt2LVRUaUItSTVCX0RNTEllQldzRjBwWEZPbXRNVTZSZDVid21Fdkpncmk0N2dmclRrNzJSUFk0azhiejZiWElFSGswZ09BdVZYMHRsQjRiYVRya2dHTUxvaGF1NDVUbnpyRDhUdWdnNWNkNnVSUEZsWG5kamJUYUt40gG-AUFVX3lxTE5qTEs3enRybzlZbEFTSFh2RnNXTi1iVVFaZVZYT3RsT2dWV2llQ1Y0WFNya1RCU0VLZGNiUXBNZU1adFBwLVpRQ09wRUlvbWV4QzZzRWRkSVg1V2tPckIxUUFwaHV3RW5NNDU0dmR0Qm80M28tVURCN2wwWG02YmZwbzhWLWFic3VSQmtVTl8tZERqREs2ZkdfekFKeWRRSFlCTXFxcFMyLUNRLUxQY252TFhvcGlFMHA4Q2VPSmc?oc=5"" target=""_blank"">Should you buy, sell or hold L&amp;T, Tata Power, Biocon, other stocks now?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMzdtcmdYQjNWcXAydU1BUGdVMC1hejJydHdYTm5yR3dQT0JmUmRNZ0xRRWNWUVk2SG5uejAwdGt2LVRUaUItSTVCX0RNTEllQldzRjBwWEZPbXRNVTZSZDVid21Fdkpncmk0N2dmclRrNzJSUFk0azhiejZiWElFSGswZ09BdVZYMHRsQjRiYVRya2dHTUxvaGF1NDVUbnpyRDhUdWdnNWNkNnVSUEZsWG5kamJUYUt40gG-AUFVX3lxTE5qTEs3enRybzlZbEFTSFh2RnNXTi1iVVFaZVZYT3RsT2dWV2llQ1Y0WFNya1RCU0VLZGNiUXBNZU1adFBwLVpRQ09wRUlvbWV4QzZzRWRkSVg1V2tPckIxUUFwaHV3RW5NNDU0dmR0Qm80M28tVURCN2wwWG02YmZwbzhWLWFic3VSQmtVTl8tZERqREs2ZkdfekFKeWRRSFlCTXFxcFMyLUNRLUxQY252TFhvcGlFMHA4Q2VPSmc?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.041666666666666664,-0.041666666666666664,neutral,1.0
2024-10-31,2024-10-31 07:00:00,"Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Larsen & Toubro, Biocon, Tata Power, DCM Shriram, Godavari Biorefineries, Yatharth...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-04,2024-11-04 08:00:00,Briefs: Sun Pharmaceutical Industries and Biocon Biologics - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOMzhkTlZfN3RYcnRsaWNOa0xISjBhbDl4RkVIVVRFYTJJTHZaZ2gxZzRON1Z6REh0RDN5TWwwSDdfMXotb2pHc00ydlNuZ0xuSDBmS2lmWWZTbjFpZENmeTJ3OGVaQmkzbUYxN3duOVJxZUVBZVhpcnZjYy12YjJMb2lvZDM0ZGxVS19iaHVYUVpIbnBvLW5uc0JNc3hISlNoRFZR0gGqAUFVX3lxTE5QaTQzREFZTlZIbVdXVmZQVVN3SHNTQXpxYzBYeVVGaHpYODJIOHdWdm9MUVcxSkJuTjNFZHo1RGVRa2UxUFFUTHRUYVUtMW95ZkNKaHJWTFhpc1N5aS0zWmRLWjJ6T0ppdmtDSFdTaTRUdjJfZkJvdjN3RGtCdWpiZDQ2Q2llWlNyMHRDR2RSbkhLYzAtc2llQzhSNlhDN0g3cUtsWFJRdkxR?oc=5"" target=""_blank"">Briefs: Sun Pharmaceutical Industries and Biocon Biologics</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOMzhkTlZfN3RYcnRsaWNOa0xISjBhbDl4RkVIVVRFYTJJTHZaZ2gxZzRON1Z6REh0RDN5TWwwSDdfMXotb2pHc00ydlNuZ0xuSDBmS2lmWWZTbjFpZENmeTJ3OGVaQmkzbUYxN3duOVJxZUVBZVhpcnZjYy12YjJMb2lvZDM0ZGxVS19iaHVYUVpIbnBvLW5uc0JNc3hISlNoRFZR0gGqAUFVX3lxTE5QaTQzREFZTlZIbVdXVmZQVVN3SHNTQXpxYzBYeVVGaHpYODJIOHdWdm9MUVcxSkJuTjNFZHo1RGVRa2UxUFFUTHRUYVUtMW95ZkNKaHJWTFhpc1N5aS0zWmRLWjJ6T0ppdmtDSFdTaTRUdjJfZkJvdjN3RGtCdWpiZDQ2Q2llWlNyMHRDR2RSbkhLYzAtc2llQzhSNlhDN0g3cUtsWFJRdkxR?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-11,2024-11-11 08:00:00,Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.53585,0.53585,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.53585,0.53585,positive,1.0
2024-11-11,2024-11-11 08:00:00,USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMisgFBVV95cUxQMy1WRGVmS29vVFh1NFVFNmVNV3ZGaWRfdC1JNGRFVGFGWUZLdTN5blBsOFZ6Ry1JNXpPX1FtMU9NS1VxMU5tRjBpT280YmRsMzZUUkVaYnRnY1Q0NUFyQ0JUYkJfTHVmUjhXOW9oX2lYaFB6RnVfRzZEeHNlYjFqaEljd3l6M1ByX1dLNVVWRS1YcW9EYkF5QzN5ck51RmhieEMtSWdBdklvMkNmZnRvekZB?oc=5"" target=""_blank"">USFDA grants ‘VAI’ tag to Biocon’s Bengaluru facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxQMy1WRGVmS29vVFh1NFVFNmVNV3ZGaWRfdC1JNGRFVGFGWUZLdTN5blBsOFZ6Ry1JNXpPX1FtMU9NS1VxMU5tRjBpT280YmRsMzZUUkVaYnRnY1Q0NUFyQ0JUYkJfTHVmUjhXOW9oX2lYaFB6RnVfRzZEeHNlYjFqaEljd3l6M1ByX1dLNVVWRS1YcW9EYkF5QzN5ck51RmhieEMtSWdBdklvMkNmZnRvekZB?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.21075,0.21075,positive,1.0
2024-11-11,2024-11-11 08:00:00,"Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMingJBVV95cUxORlBVM3AtcVZERC1WR3V5SGl2eWN0S1ZVZ29GR2IyYjJGUUNYS0ZtdVpfdnVrR0IyUDhTTlZtenFadDFwWXEyQU5kRnRBUnJIOUVkeVFIcTVnU2xLYVJXY1lUWFdBSGRkV0tMa1lock1ENnpHQlFyUjNDSlF4cFlhVGt5cDdSdE1EUDdNelpnVk5YNjBMVkNmUjNQZExqanFwR3cwVFQ3dW1rUEdSV2dKaHRnMzhGbHRzMjZVQWROOEoydWxnN1FSQS0wRmQtUlczZVZCY1RlZjVvVnlWMDZuVTVSQjRqU0hoQ3RHWjJiandUQVNKV2JlcnNIejgtNGxFLV9aRk1PWHFxQlRnR2FIcE16MGMwdVFteHRERFhn?oc=5"" target=""_blank"">Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMingJBVV95cUxORlBVM3AtcVZERC1WR3V5SGl2eWN0S1ZVZ29GR2IyYjJGUUNYS0ZtdVpfdnVrR0IyUDhTTlZtenFadDFwWXEyQU5kRnRBUnJIOUVkeVFIcTVnU2xLYVJXY1lUWFdBSGRkV0tMa1lock1ENnpHQlFyUjNDSlF4cFlhVGt5cDdSdE1EUDdNelpnVk5YNjBMVkNmUjNQZExqanFwR3cwVFQ3dW1rUEdSV2dKaHRnMzhGbHRzMjZVQWROOEoydWxnN1FSQS0wRmQtUlczZVZCY1RlZjVvVnlWMDZuVTVSQjRqU0hoQ3RHWjJiandUQVNKV2JlcnNIejgtNGxFLV9aRk1PWHFxQlRnR2FIcE16MGMwdVFteHRERFhn?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.148,-0.148,negative,1.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA classifies Bengaluru site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share jumps 6% on USFDA's 'VAI' tag to Bengaluru facility; details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action - Free Press Journal,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Rockets Up More Than 8% On NSE After US FDA Classifies Bengaluru Facility As Voluntary Action</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Free Press Journal</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.53585,0.53585,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 8.5% as USFDA classifies Bengaluru unit as VAI - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 8.5% as USFDA classifies Bengaluru unit as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-11-11,2024-11-11 08:00:00,Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 5% after USFDA clears Bengaluru unit as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMixgFBVV95cUxOa25IcFR1TjBvQVh0RGVLSC0zOExtanJUMHZ5bExjTkpzQWZLdHdLQUdIRVNkS19qWnpXbnBWWGJJOXdWdkttT2ZLamotSlV3WWFva1oxVDFjN205RThSYTJuX29RSzAwX2FicHl0ZUNuOFJrczlVT01lYVA2UW9paExrNzNJNG94RHFlWGVQY0ljdzQyVVZxbEZRclUyMmVpcHFJWlI1VEJTRGJyREY2MDhQRElGM2l1MG1UMlM0c0YxQmxjbVHSAcsBQVVfeXFMTmxlZ09TRmVweFZuQWJ1eTBqZGRNV1Zlb0dMU21QcEJtNFFkZDJ1ZXJrX3VYb0EyOUVEenhyZEJ3Ylo1SEQtd1lqeWFYRk5RM1hHYk41dzdLQTMwWGFrY2NoWHVMMUxLV2UtX1E4UFdKWmF2Q29IZnptQTFBdV9TQldDeFJ2ZldqcVF5YW95MFNRbUtXdUlFR251eUNzbUU2VFFYVWppYldNRWpHeTZyMjk1R2gzMHpLSlBTVklKbWE0aXdtMW5la2R1Rjg?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2024-11-14,2024-11-14 08:00:00,Buy Biocon; target of Rs 400: Sharekhan - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQNnd5TGRzMl9UVjU4U0lOOE1jZ0Y5eTA2Rms2SGIwa1dPV09lU1U1V2N1VFlmWWJJR0YwakNBWUVCOHNfZi1UUDE1X2hFckNNOGlHRENCeWlqb0lfQmkxV2Uxbk1wNldrZ09DQmpKMXdaZVVPSmlDMnpmcEtBMW8xS3lOTFNRNVd3b2dCZXBRZllVb3pNZFhsd3dWbzkwbkpJbGZNbmpn0gGrAUFVX3lxTFB6NXpZdDlWUkdYNExXc3JSODU4elp1M005azE5V3NUYlJXQWctYjI1ODkxRlpKZ2oycW1WZjBfOGtzMWlTcW54RDNKS0dESnJEYkdKU2owMkNqbTJNeFlWdUhHMkpsVlQxT2pLQUo5cXBDdjVQS25zM2JtcWRsbzNKb2tITTFibDRmbUNKVXd5TUlnOFJvODRJN0hwTjBrN1lwVkNpLVVMd3lrQQ?oc=5"" target=""_blank"">Buy Biocon; target of Rs 400: Sharekhan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQNnd5TGRzMl9UVjU4U0lOOE1jZ0Y5eTA2Rms2SGIwa1dPV09lU1U1V2N1VFlmWWJJR0YwakNBWUVCOHNfZi1UUDE1X2hFckNNOGlHRENCeWlqb0lfQmkxV2Uxbk1wNldrZ09DQmpKMXdaZVVPSmlDMnpmcEtBMW8xS3lOTFNRNVd3b2dCZXBRZllVb3pNZFhsd3dWbzkwbkpJbGZNbmpn0gGrAUFVX3lxTFB6NXpZdDlWUkdYNExXc3JSODU4elp1M005azE5V3NUYlJXQWctYjI1ODkxRlpKZ2oycW1WZjBfOGtzMWlTcW54RDNKS0dESnJEYkdKU2owMkNqbTJNeFlWdUhHMkpsVlQxT2pLQUo5cXBDdjVQS25zM2JtcWRsbzNKb2tITTFibDRmbUNKVXd5TUlnOFJvODRJN0hwTjBrN1lwVkNpLVVMd3lrQQ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-14,2024-11-14 08:00:00,Buy Biocon; target of Rs 400: Sharekhan - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQNnd5TGRzMl9UVjU4U0lOOE1jZ0Y5eTA2Rms2SGIwa1dPV09lU1U1V2N1VFlmWWJJR0YwakNBWUVCOHNfZi1UUDE1X2hFckNNOGlHRENCeWlqb0lfQmkxV2Uxbk1wNldrZ09DQmpKMXdaZVVPSmlDMnpmcEtBMW8xS3lOTFNRNVd3b2dCZXBRZllVb3pNZFhsd3dWbzkwbkpJbGZNbmpn0gGrAUFVX3lxTFB6NXpZdDlWUkdYNExXc3JSODU4elp1M005azE5V3NUYlJXQWctYjI1ODkxRlpKZ2oycW1WZjBfOGtzMWlTcW54RDNKS0dESnJEYkdKU2owMkNqbTJNeFlWdUhHMkpsVlQxT2pLQUo5cXBDdjVQS25zM2JtcWRsbzNKb2tITTFibDRmbUNKVXd5TUlnOFJvODRJN0hwTjBrN1lwVkNpLVVMd3lrQQ?oc=5"" target=""_blank"">Buy Biocon; target of Rs 400: Sharekhan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQNnd5TGRzMl9UVjU4U0lOOE1jZ0Y5eTA2Rms2SGIwa1dPV09lU1U1V2N1VFlmWWJJR0YwakNBWUVCOHNfZi1UUDE1X2hFckNNOGlHRENCeWlqb0lfQmkxV2Uxbk1wNldrZ09DQmpKMXdaZVVPSmlDMnpmcEtBMW8xS3lOTFNRNVd3b2dCZXBRZllVb3pNZFhsd3dWbzkwbkpJbGZNbmpn0gGrAUFVX3lxTFB6NXpZdDlWUkdYNExXc3JSODU4elp1M005azE5V3NUYlJXQWctYjI1ODkxRlpKZ2oycW1WZjBfOGtzMWlTcW54RDNKS0dESnJEYkdKU2owMkNqbTJNeFlWdUhHMkpsVlQxT2pLQUo5cXBDdjVQS25zM2JtcWRsbzNKb2tITTFibDRmbUNKVXd5TUlnOFJvODRJN0hwTjBrN1lwVkNpLVVMd3lrQQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-21,2024-11-21 08:00:00,Accumulat Biocon; target of Rs 376: Geojit Financial Services - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Accumulat Biocon; target of Rs 376: Geojit Financial Services</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-21,2024-11-21 08:00:00,Accumulat Biocon; target of Rs 376: Geojit Financial Services - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Accumulat Biocon; target of Rs 376: Geojit Financial Services</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-22,2024-11-22 08:00:00,"Biocon EPS estimates cut by 38% by Nuvama who sees challenges for Sun Pharma, Cipla - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOSTNfWm95VlNjbHBZa3dSTU9SSFNPd3dka0hhTW01TVUzR3BfajVrQ19tU0EwX0hMaENyQUdKcmpIRGFJWDNSS1hoalppaVZKQWprSHEwQXVkNFRnc3VveV83MjViQkxUWmNGVVVKWVVTQU5MS0VaSEZuNFN6aDlMOTVVVGhPWmpJVTItQm5vMGQ3bEVONmF3SzhZcl9vMUgybV9uMDZidHU2THFQVGJBNFl4LU9XcEtRcC1IdzR30gHDAUFVX3lxTE45bDlCRVp3a05nTHhGUkwtRUJINjNxNWJBbzlnbEtlZXYtTWMwRmpUUV9SZVhGNXROeU9rcGxrRUF0MF9qSGZpdXQ0czJkc1c0MUZiWkJRcVV5TktjWndQWV9HVkFMVGwweHhXNE5oRnBQUWY3THFscGJSTWlPandKR0k3R0pweUg2d3dpM3hUNUtoM2w5T0FhOThqR0JyNTZBdk9LZWo4NWd3VjAtX1BkY1NENlAxcUhldHU5NjltenhLcw?oc=5"" target=""_blank"">Biocon EPS estimates cut by 38% by Nuvama who sees challenges for Sun Pharma, Cipla</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.1909,-0.1909,negative,1.0
2024-11-27,2024-11-27 08:00:00,"Biocon Biologics, Diabetes Africa collab over nurses project in Ethiopia - Business Standard","<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxOak1hYXZUNVBNM2M3MndiODZrdkhGX3ZCWG1kbDdaZG51Z2MxRWhvUmdXUjBvZUxKR28xTThFeHY5dFZNN2dVYmg0TENlUkxpalFacE1xWVhDNjYtQzU1QXJ4czRPdjNxUDMybmZfNjA2TGM5bGE3aDZMUGxEdDU2c09PQ2JkZ2FjWjBIbGM1aXVtWmhVVVBuNkZsYVBCVEliTjF3V3hxNTE0QmRiNVFuSnJzVWVZMGJOQ1Z4NkNWMDhCODJSV0dpYXBfeG_SAdIBQVVfeXFMTUFDYmt1MHl2U2pyNnJXNUxhSTF2V2cwS0xQMl9IZ3J6Y1FXX2RlTlF6SWkxYmNEa2k4MTkxYmZObDE3WkgxYjBINFg5T2tBNm5IWEdEbGdsWVpiS2luSTJLcmUwRlRFLVVOTWVyT1FfMlktLVR1QVNPNlNzRGg3WUlYeW4wbXo0Vl94N2pfdlFNNmxIalIwbDJmSEFNTWV1d21JaWg4QkpWWnQ3UEpFYWcxU3BVVHlpemh6T0dLRy1Na2h3eDBONHdrejhSMEZFTmJR?oc=5"" target=""_blank"">Biocon Biologics, Diabetes Africa collab over nurses project in Ethiopia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxOak1hYXZUNVBNM2M3MndiODZrdkhGX3ZCWG1kbDdaZG51Z2MxRWhvUmdXUjBvZUxKR28xTThFeHY5dFZNN2dVYmg0TENlUkxpalFacE1xWVhDNjYtQzU1QXJ4czRPdjNxUDMybmZfNjA2TGM5bGE3aDZMUGxEdDU2c09PQ2JkZ2FjWjBIbGM1aXVtWmhVVVBuNkZsYVBCVEliTjF3V3hxNTE0QmRiNVFuSnJzVWVZMGJOQ1Z4NkNWMDhCODJSV0dpYXBfeG_SAdIBQVVfeXFMTUFDYmt1MHl2U2pyNnJXNUxhSTF2V2cwS0xQMl9IZ3J6Y1FXX2RlTlF6SWkxYmNEa2k4MTkxYmZObDE3WkgxYjBINFg5T2tBNm5IWEdEbGdsWVpiS2luSTJLcmUwRlRFLVVOTWVyT1FfMlktLVR1QVNPNlNzRGg3WUlYeW4wbXo0Vl94N2pfdlFNNmxIalIwbDJmSEFNTWV1d21JaWg4QkpWWnQ3UEpFYWcxU3BVVHlpemh6T0dLRy1Na2h3eDBONHdrejhSMEZFTmJR?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-11-27,2024-11-27 08:00:00,"Analysts recommend buying Syngene, M&M, Ashok Leyland, Biocon, Birlasoft, Polycab and selling MCX - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Analysts recommend buying Syngene, M&amp;M, Ashok Leyland, Biocon, Birlasoft, Polycab and selling MCX</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2024-11-27,2024-11-27 08:00:00,Biocon - Bullish Momentum: 3 stocks with White Marubozu Pattern on Nov 26 - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxQM2FnVEpKR2ljenFIY2JUVmtraVYxMkNoUXFDVUxjeGlvcXZvcnk0Z3l4NlBnQk4yMmVpMURKVF9vemZ3d01nQXJqOF83YjdXZFpyeHotVkVERE5HWW1tblZHRE9aQXNhSHpCOVd5LUZ5RjVCNk9qTV9jXzVPenVQcjFiU2VjbVRYcEVCWDRBRjlyeUgtamJPMFFvTTFXd0VVTE9Ob195dmpNNllTMTJQbW55WnZlUDh0dnF5UHQ0TGZMRGdYZ1Rqa2NhNzdZT0JQWjBvRU9rRzA5QQ?oc=5"" target=""_blank"">Biocon - Bullish Momentum: 3 stocks with White Marubozu Pattern on Nov 26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2gFBVV95cUxQM2FnVEpKR2ljenFIY2JUVmtraVYxMkNoUXFDVUxjeGlvcXZvcnk0Z3l4NlBnQk4yMmVpMURKVF9vemZ3d01nQXJqOF83YjdXZFpyeHotVkVERE5HWW1tblZHRE9aQXNhSHpCOVd5LUZ5RjVCNk9qTV9jXzVPenVQcjFiU2VjbVRYcEVCWDRBRjlyeUgtamJPMFFvTTFXd0VVTE9Ob195dmpNNllTMTJQbW55WnZlUDh0dnF5UHQ0TGZMRGdYZ1Rqa2NhNzdZT0JQWjBvRU9rRzA5QQ?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.09999999999999999,0.09999999999999999,neutral,1.0
2024-11-28,2024-11-28 08:00:00,"Stocks to Buy Today: Analysts see upside in RIL, LIC Housing Finance, HDFC Bank, Indus Towers, BEL and Biocon - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Buy Today: Analysts see upside in RIL, LIC Housing Finance, HDFC Bank, Indus Towers, BEL and Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-01,2024-12-01 08:00:00,Biocon Biologics gets US nod to launch Stelara biosimilar - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets US nod to launch Stelara biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2024-12-01,2024-12-01 08:00:00,USFDA gives nod to Biocon Biologics’ biosimilar to treat Crohn’s disease - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxPVWwzdTBmZkFFSkdYdEZ6bFdoZ0ZEQWV0dUFhX21mcDNYUjBya1FuOGtKbXAxVm5pVEQyak1YazNwSUhXeG5qT2dzTHdnTlR3OERfNTZ3Y3JFZHRVSlU3M2xVUGhyaTRLNDdRSHZ2d3BOUFc2Qkp6ZG1ROFh1dW9CV2xFNG4wR3dBWkNUVFNFU2l0SWJJbTl1NndHdHZoMnRaanJ6X3FCNU10ODVmZ1pFdVpmTGV4cUI2QWJMT1lUYnRDOGJxV2hKTkExQ2o?oc=5"" target=""_blank"">USFDA gives nod to Biocon Biologics’ biosimilar to treat Crohn’s disease</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxPVWwzdTBmZkFFSkdYdEZ6bFdoZ0ZEQWV0dUFhX21mcDNYUjBya1FuOGtKbXAxVm5pVEQyak1YazNwSUhXeG5qT2dzTHdnTlR3OERfNTZ3Y3JFZHRVSlU3M2xVUGhyaTRLNDdRSHZ2d3BOUFc2Qkp6ZG1ROFh1dW9CV2xFNG4wR3dBWkNUVFNFU2l0SWJJbTl1NndHdHZoMnRaanJ6X3FCNU10ODVmZ1pFdVpmTGV4cUI2QWJMT1lUYnRDOGJxV2hKTkExQ2o?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2024-12-02,2024-12-02 08:00:00,Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxPLWJqbC1hYmZCQldmTkczbERvbmV3Ry1tMGpCVVVZOWEzX0liWGh5Yzk4cGhYX1plaVI4c1hHbjlfdG5FM29vQWFLMlhicVNEMDlaZ2laeVkyWEZHMVFWQkJhU3FYbm1RZjJEOVRpNWFMaGFETko3bnFMNGh1a2lkanZhUjVGNGZybXlnb0RmMmRoQTF4cTRFdmIzb09LNTloOUtXdF84YTBtWUNCWEhoaVBzUXZhM2tJWkNnOGNGOFlhSEtwWHQw0gHMAUFVX3lxTFBuVm5PX1N5YkxVYWpvdzIyQTduWGROQnFwUVVWanJUZ2tUS0JRdUdKcjJKLWZqMGhJODM4MzVHRE14eDlUTG93Uk8ycmR4T2lGbGJVY3Zpb200VEJHUUpUaWVKakpFa3JHaTdTdVBSR3c0bUZoZ3JMS1VJNC16STFTWXpjSzNMNzlvVERxdlNhaG9MQWZLN1JJbDVKclpjeE9UYnY0N3JsQzk0UGpnUjM5eUFvOW4wYjBNdld6bDJ3dThOaDNORVlLLWk0eA?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-02,2024-12-02 08:00:00,Biocon shares rise 4% after US FDA approves Yesintek - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise 4% after US FDA approves Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4158,0.4158,positive,1.0
2024-12-02,2024-12-02 08:00:00,"U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&J's Stelara® (Ustekinumab) - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxOeDZCWEZ5d1dmanYtSHlFcEFLN2NSaGRjZThjcXZFUklGZW5RdWJaNldORUsyWV9ZRWhSMFNmNUR6dTBnSWdqaUFkbThYYWcxaHFzZGI2bDktLXI2NE82NHlPZTVuRG1Xb0FTZEMtdENoVkpOUmkxcjhRdGdoOXJpNFNtZWVJNDRUY3NCMzhNaDctVlBsV2JNVUJ2SnN0aW81ME1xdmFJck5MQm0tamNlWXlaYWw0YnV4WGpONk9OdVFQV3pzdklRdGhYem55TXlfeHpqZHVtOGdSNzlFcmc?oc=5"" target=""_blank"">U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&amp;J's Stelara® (Ustekinumab)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxOeDZCWEZ5d1dmanYtSHlFcEFLN2NSaGRjZThjcXZFUklGZW5RdWJaNldORUsyWV9ZRWhSMFNmNUR6dTBnSWdqaUFkbThYYWcxaHFzZGI2bDktLXI2NE82NHlPZTVuRG1Xb0FTZEMtdENoVkpOUmkxcjhRdGdoOXJpNFNtZWVJNDRUY3NCMzhNaDctVlBsV2JNVUJ2SnN0aW81ME1xdmFJck5MQm0tamNlWXlaYWw0YnV4WGpONk9OdVFQV3pzdklRdGhYem55TXlfeHpqZHVtOGdSNzlFcmc?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2024-12-02,2024-12-02 08:00:00,"FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek - Center for Biosimilars","<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics Ustekinumab Biosimilar, Yesintek</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxOMVVUc0JjMzRfeWZuWUJWS1B5cl9XQi1CZ3ZkZVVJVHEtR3hrbHRKUnpRR25lSzJyQjJqc2VCVlo2N2QwZk0yUkZWY1I4dDNObkFDVEN3Z3hMdXNTNGNuY0lQZ3B4VXFRUm9kNWIzdlc4ZnJSVGNOVGlINHk5MjNJVXNfb1FOYmd5UTNFSkpHU1l5bUl6ZUNPUzdoTzlKVmQtTXppNFhB?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30484999999999995,0.30484999999999995,positive,1.0
2024-12-02,2024-12-02 08:00:00,Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-02,2024-12-02 08:00:00,"Top stock picks | Mazagon Dock Ship, Sumitomo Chemical, GSFC, Bata, Biocon and JK Cement on the radar - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMirAFBVV95cUxNd1NGM29wb0NDTkduVTVVbDlXdktqUUZjek83LVpNdXU2NzRJdU4xcVV6clZDenBrM3Nud1BlcnktekY1NnZBSVctbU02bERXM2k1V1pJLVJzM1RzckpGMEw3V3BGQW5Ia2l1R21zZ0lHNE1KbDVVdDY4WjFMSzlueXZFUjVsRnpUZ2M4Vjlza3BaNnhqTjJiUm10QWxLZHh2OFVvbjJnS054RmNX0gGyAUFVX3lxTE1aQ1hKOG11TEhLeWR5MmxxU2xmRUViZ2tTU1RSeHpudnBYeE80MmxVY203X0hNWE40bHdISWlsdWFqNUVUWEozVkIyWjdxX19UUzhBR1g4TURFQWlMTkx6Q3F2WDduUlZZNXpqMER2dXU0S1FrX3Naa1h5QS1TcWRoVlVOU1R5UU1JWHBjWFdrME95ZVBuN1Zra1NRUTMxSTE1dnN2a2VtQXpVUXBoSmM4N2c?oc=5"" target=""_blank"">Top stock picks | Mazagon Dock Ship, Sumitomo Chemical, GSFC, Bata, Biocon and JK Cement on the radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMirAFBVV95cUxNd1NGM29wb0NDTkduVTVVbDlXdktqUUZjek83LVpNdXU2NzRJdU4xcVV6clZDenBrM3Nud1BlcnktekY1NnZBSVctbU02bERXM2k1V1pJLVJzM1RzckpGMEw3V3BGQW5Ia2l1R21zZ0lHNE1KbDVVdDY4WjFMSzlueXZFUjVsRnpUZ2M4Vjlza3BaNnhqTjJiUm10QWxLZHh2OFVvbjJnS054RmNX0gGyAUFVX3lxTE1aQ1hKOG11TEhLeWR5MmxxU2xmRUViZ2tTU1RSeHpudnBYeE80MmxVY203X0hNWE40bHdISWlsdWFqNUVUWEozVkIyWjdxX19UUzhBR1g4TURFQWlMTkx6Q3F2WDduUlZZNXpqMER2dXU0S1FrX3Naa1h5QS1TcWRoVlVOU1R5UU1JWHBjWFdrME95ZVBuN1Zra1NRUTMxSTE1dnN2a2VtQXpVUXBoSmM4N2c?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.48705,0.48705,positive,1.0
2024-12-02,2024-12-02 08:00:00,Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises 3% after its arm gets US FDA nod for psoriasis drug YESINTEK</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxPLWJqbC1hYmZCQldmTkczbERvbmV3Ry1tMGpCVVVZOWEzX0liWGh5Yzk4cGhYX1plaVI4c1hHbjlfdG5FM29vQWFLMlhicVNEMDlaZ2laeVkyWEZHMVFWQkJhU3FYbm1RZjJEOVRpNWFMaGFETko3bnFMNGh1a2lkanZhUjVGNGZybXlnb0RmMmRoQTF4cTRFdmIzb09LNTloOUtXdF84YTBtWUNCWEhoaVBzUXZhM2tJWkNnOGNGOFlhSEtwWHQw0gHMAUFVX3lxTFBuVm5PX1N5YkxVYWpvdzIyQTduWGROQnFwUVVWanJUZ2tUS0JRdUdKcjJKLWZqMGhJODM4MzVHRE14eDlUTG93Uk8ycmR4T2lGbGJVY3Zpb200VEJHUUpUaWVKakpFa3JHaTdTdVBSR3c0bUZoZ3JMS1VJNC16STFTWXpjSzNMNzlvVERxdlNhaG9MQWZLN1JJbDVKclpjeE9UYnY0N3JsQzk0UGpnUjM5eUFvOW4wYjBNdld6bDJ3dThOaDNORVlLLWk0eA?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-05,2024-12-05 08:00:00,"Biocon Electric Launches New Range of Switches, Expands Nationwide - Up18 News","<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxPbVNxVEJXSTV6Q2xEd2g5RXFJTFIzeXdzNWN4MUdIYndsQ3RQaUM2dTB6VWJiXzB6a194eHNqakc3ME1OMmlJcXFPZUtoR1NiT1BVQkpkd0lYakNvWmdVU1hlWk5XT3BZeWE5YVJIQUUzLXkzLWt2amJIVmxuQWNOWkJPTEoxczhKenZTamUtYk8?oc=5"" target=""_blank"">Biocon Electric Launches New Range of Switches, Expands Nationwide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Up18 News</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxPbVNxVEJXSTV6Q2xEd2g5RXFJTFIzeXdzNWN4MUdIYndsQ3RQaUM2dTB6VWJiXzB6a194eHNqakc3ME1OMmlJcXFPZUtoR1NiT1BVQkpkd0lYakNvWmdVU1hlWk5XT3BZeWE5YVJIQUUzLXkzLWt2amJIVmxuQWNOWkJPTEoxczhKenZTamUtYk8?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.14660454545454546,0.14660454545454546,positive,1.0
2024-12-08,2024-12-08 08:00:00,"Stocks to watch on December 9: CEAT, Paytm, Biocon, Godrej Consumer, Bajaj Healthcare, L&T, Uno Minda, UltraTech Cement, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMikgJBVV95cUxQWUFDN2piVXYzVE5fRDktcnRmNDNzcVJUTmd5a051cVRNSDR5dWtBck82by1BZHRnN0ZCVXk1bWg4OXg3andrM1BLMDZUX0o5MVM1dG13OGhRc2R6RktQS0xKbFNPZjBSTkl2enZoMmNQUERNX2VsYnF1YkJZa3k1ZGJ2d0NQdnZnSWY1ZHQ2WWFFeXBuSkxDMlc2enNzRnpDWl8wYVZIbmloMWlMMGZkWng3THNOaWhycWZzRUt2eWF3emVXYlg1Y1hEaklNZ0NkeUpROFMwYlhBdVlnZ0N0X1g1VHNNdzd1d1c5U3BJYk9Xcnd0cGNoN2hNOFFzbGYya1BqS2FXdzVTb252Y0tDbFpB?oc=5"" target=""_blank"">Stocks to watch on December 9: CEAT, Paytm, Biocon, Godrej Consumer, Bajaj Healthcare, L&amp;T, Uno Minda, UltraTech Cement, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMikgJBVV95cUxQWUFDN2piVXYzVE5fRDktcnRmNDNzcVJUTmd5a051cVRNSDR5dWtBck82by1BZHRnN0ZCVXk1bWg4OXg3andrM1BLMDZUX0o5MVM1dG13OGhRc2R6RktQS0xKbFNPZjBSTkl2enZoMmNQUERNX2VsYnF1YkJZa3k1ZGJ2d0NQdnZnSWY1ZHQ2WWFFeXBuSkxDMlc2enNzRnpDWl8wYVZIbmloMWlMMGZkWng3THNOaWhycWZzRUt2eWF3emVXYlg1Y1hEaklNZ0NkeUpROFMwYlhBdVlnZ0N0X1g1VHNNdzd1d1c5U3BJYk9Xcnd0cGNoN2hNOFFzbGYya1BqS2FXdzVTb252Y0tDbFpB?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2024-12-09,2024-12-09 08:00:00,"Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2024-12-09,2024-12-09 08:00:00,Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMijwFBVV95cUxOczhmWjJSd1RHU19RZGVDSENtM29Xc21VRUpIWkt4NFg3dTZiX3IyeUQ3cUFLZkMxLXJOOW9VSDVaYnhINjI0SWNtQTJ3cHh5V3RRQm9LbjdLWGR6SWZaRzdGQjBJN3FiTTc0QmRjeUlua1J6dGdKN2pjV3NhdWpObTVsMFRGNmpwWlBRdWhTQQ?oc=5"" target=""_blank"">Biocon Shares Slump 4% as Bengaluru API Unit Gets VAI Tag</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMijwFBVV95cUxOczhmWjJSd1RHU19RZGVDSENtM29Xc21VRUpIWkt4NFg3dTZiX3IyeUQ3cUFLZkMxLXJOOW9VSDVaYnhINjI0SWNtQTJ3cHh5V3RRQm9LbjdLWGR6SWZaRzdGQjBJN3FiTTc0QmRjeUlua1J6dGdKN2pjV3NhdWpObTVsMFRGNmpwWlBRdWhTQQ?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2024-12-09,2024-12-09 08:00:00,"Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Wipro, Paytm, RITES, Welspun Corp, CEAT, Biocon, JSW Energy & Suven Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2024-12-09,2024-12-09 08:00:00,"Stock Radar: Welspun Corp, Biocon, Paytm, Easy Trip Planners, Suven Pharma, NLC India, JSW Energy in focus... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Welspun Corp, Biocon, Paytm, Easy Trip Planners, Suven Pharma, NLC India, JSW Energy in focus...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5645444444444444,0.5645444444444444,positive,1.0
2024-12-10,2024-12-10 08:00:00,Syngene Intl stock jumps 3% after promoter Biocon likely offloads Rs 706 cr worth stake - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Syngene Intl stock jumps 3% after promoter Biocon likely offloads Rs 706 cr worth stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.27075,0.27075,positive,1.0
2024-12-10,2024-12-10 08:00:00,Syngene Intl Stock Jumps 3% As Promoter Biocon Likely Offloads ₹706 Cr Stake - Samco,"<a href=""https://news.google.com/rss/articles/CBMiywFBVV95cUxQVmNmMjBJc3pBeWM4Y2NfLUFTUURDMmFNMXhuNUJjT2l3TTNXLWRWRFl6dnYyNDdoTnhDNnRucWlvRnlMMmFHX0lGbmRadzB3ZUpUWFRndVdYM2hiM0F4NTNCNUJLTUEwRjBFNzFEQzd4MFBmbU1kQjMyTFRsZDFaQXhodEQtRFF3c3lRZmFWYk8yX3Y1N3N0TlY3cFBVOHFFQnVMVHhoQUk0dmRGVFVNQ0lIdDZxZ0w1T0xxY09CSi1fVGVGbUNTU2dTVQ?oc=5"" target=""_blank"">Syngene Intl Stock Jumps 3% As Promoter Biocon Likely Offloads ₹706 Cr Stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiywFBVV95cUxQVmNmMjBJc3pBeWM4Y2NfLUFTUURDMmFNMXhuNUJjT2l3TTNXLWRWRFl6dnYyNDdoTnhDNnRucWlvRnlMMmFHX0lGbmRadzB3ZUpUWFRndVdYM2hiM0F4NTNCNUJLTUEwRjBFNzFEQzd4MFBmbU1kQjMyTFRsZDFaQXhodEQtRFF3c3lRZmFWYk8yX3Y1N3N0TlY3cFBVOHFFQnVMVHhoQUk0dmRGVFVNQ0lIdDZxZ0w1T0xxY09CSi1fVGVGbUNTU2dTVQ?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-10,2024-12-10 08:00:00,Promoter Biocon sells 1.19% stake in Syngene International - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Promoter Biocon sells 1.19% stake in Syngene International</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-15,2024-12-15 08:00:00,"Reliance Industries, Bharat Forge, Biocon and more: Top stocks to watch out for on December 16 - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Reliance Industries, Bharat Forge, Biocon and more: Top stocks to watch out for on December 16</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44575,0.44575,positive,1.0
2024-12-15,2024-12-15 08:00:00,"Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR2g4b08xYkE3QTRHZXhjVkY3MWE4eEJMLVM0dS15RTR1c1dyYkdubkJWbFcwcmtRYnJ0SGU1WE5jWUlhRTY5SHBHbnpZRUNJc1pvVVpvblRFa0JKTkxRTjhWUVhaenJFYTdOWFRxVVFXTXdqTUtTLVI1SlZtX2hIYWlGYm5pVnA4NlBvV2VBZ3NYTlBveW16UkprYmxJTHRPMV9EUUtpZG9ndmwyS0FYSlZZU3FqeGs2Zm53a25STGZ1TGo4WlRXNG55NGRGNHZZVVAteXg4QUZoLTM2MHJlQkxfc0ZuejVoT0h6RGRGMHNITU9TTm1kYnNhZWs?oc=5"" target=""_blank"">Stocks to watch on December 16: Reliance Industries, Dixon Tech, Vedanta, Biocon, 63 Moons, Godrej Agrovet, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi_AFBVV95cUxOR2g4b08xYkE3QTRHZXhjVkY3MWE4eEJMLVM0dS15RTR1c1dyYkdubkJWbFcwcmtRYnJ0SGU1WE5jWUlhRTY5SHBHbnpZRUNJc1pvVVpvblRFa0JKTkxRTjhWUVhaenJFYTdOWFRxVVFXTXdqTUtTLVI1SlZtX2hIYWlGYm5pVnA4NlBvV2VBZ3NYTlBveW16UkprYmxJTHRPMV9EUUtpZG9ndmwyS0FYSlZZU3FqeGs2Zm53a25STGZ1TGo4WlRXNG55NGRGNHZZVVAteXg4QUZoLTM2MHJlQkxfc0ZuejVoT0h6RGRGMHNITU9TTm1kYnNhZWs?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2024-12-15,2024-12-15 08:00:00,'Amazing discovery': Biocon's Kiran Mazumdar-Shaw says THIS drug will disrupt dentistry for sure - Business Today,"<a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxPQl9RTlM0UENCQlliOXlURlkzRkN1bm5JUHVSRjh1eU50X0ZPYVZwZkl4Q004Z29uOWZSLXVOWF93SkZIR1E1ZktoVWVnc3g2WS03cWt6aXkteEpmMjJ3bDR3bElRX2k0OGZyeGQ0V1oxeF92QUFxQkZHTzJkdTk1WDAxaHVIc1FfMldXWUhQUHZCT1FYN3A5RUg0WFpCRnpDS1FiYmVGX1c0ZHUxMjE5Qmhtb3RNdURIYzNtb2ZRT1pQLWFYY1NpMFItNlNrUUFSYzNqUkY4eFVQLUFxb3c5VGdZazFkUdIB6wFBVV95cUxPYm5uVjBtZVJHLU5tYU5ub1Z2OVRUeWRRODBBYWFVLU9jRWlHWHZTQ3hqa1Y1V3ZuY3JSaGNmUUFUdWo4RkdZa1Mta0xVMV9OTy11c09pX20wamRBRGsyaEZ2WjZSXzZ4bnNmTHBZbVhwWEI1N0dKRWxXNDBWWTlYZzF3azdSMXIzLUZNZ2Z6VmExbmZObmotLWc2QkhhaW5IS3RSeGl3S2YxVVRBSDRpNmRsX0xwb1RLYVRSSUpDc2JVdzBiX1gxM09fVURVYVl5R3dRcm9Ld3dCMU5GQ1RMcWZmc0VFUzYtVWt3?oc=5"" target=""_blank"">'Amazing discovery': Biocon's Kiran Mazumdar-Shaw says THIS drug will disrupt dentistry for sure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi5gFBVV95cUxPQl9RTlM0UENCQlliOXlURlkzRkN1bm5JUHVSRjh1eU50X0ZPYVZwZkl4Q004Z29uOWZSLXVOWF93SkZIR1E1ZktoVWVnc3g2WS03cWt6aXkteEpmMjJ3bDR3bElRX2k0OGZyeGQ0V1oxeF92QUFxQkZHTzJkdTk1WDAxaHVIc1FfMldXWUhQUHZCT1FYN3A5RUg0WFpCRnpDS1FiYmVGX1c0ZHUxMjE5Qmhtb3RNdURIYzNtb2ZRT1pQLWFYY1NpMFItNlNrUUFSYzNqUkY4eFVQLUFxb3c5VGdZazFkUdIB6wFBVV95cUxPYm5uVjBtZVJHLU5tYU5ub1Z2OVRUeWRRODBBYWFVLU9jRWlHWHZTQ3hqa1Y1V3ZuY3JSaGNmUUFUdWo4RkdZa1Mta0xVMV9OTy11c09pX20wamRBRGsyaEZ2WjZSXzZ4bnNmTHBZbVhwWEI1N0dKRWxXNDBWWTlYZzF3azdSMXIzLUZNZ2Z6VmExbmZObmotLWc2QkhhaW5IS3RSeGl3S2YxVVRBSDRpNmRsX0xwb1RLYVRSSUpDc2JVdzBiX1gxM09fVURVYVl5R3dRcm9Ld3dCMU5GQ1RMcWZmc0VFUzYtVWt3?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.57595,0.57595,positive,1.0
2024-12-15,2024-12-15 08:00:00,'Amazing discovery': Biocon's Kiran Mazumdar-Shaw says THIS drug will disrupt dentistry for sure - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">'Amazing discovery': Biocon's Kiran Mazumdar-Shaw says THIS drug will disrupt dentistry for sure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.57595,0.57595,positive,1.0
2024-12-16,2024-12-16 08:00:00,"Stocks in news: Zinka Logistics, RIL, Bharat Forge, Biocon, Lupin, Afcons Infra & Auro Pharma - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Zinka Logistics, RIL, Bharat Forge, Biocon, Lupin, Afcons Infra & Auro Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-16,2024-12-16 08:00:00,"Stock Radar: Lupin, Aurobindo Pharma, JK Paper, Navin Fluorine, Afcons Infrastructure, 63 Moons, Biocon in... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Lupin, Aurobindo Pharma, JK Paper, Navin Fluorine, Afcons Infrastructure, 63 Moons, Biocon in...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32235,0.32235,positive,1.0
2024-12-16,2024-12-16 08:00:00,Biocon Chief Kiran Mazumdar-Shaw conferred Jamsetji Tata Award by Indian Society for Quality - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Chief Kiran Mazumdar-Shaw conferred Jamsetji Tata Award by Indian Society for Quality</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3953,0.3953,positive,1.0
2024-12-16,2024-12-16 08:00:00,"Stocks in news: Zinka Logistics, RIL, Bharat Forge, Biocon, Lupin, Afcons Infra & Auro Pharma - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Zinka Logistics, RIL, Bharat Forge, Biocon, Lupin, Afcons Infra & Auro Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2024-12-24,2024-12-24 08:00:00,"Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock settles 5% higher after US drug regulator clears Bengaluru API facility unit, stock up 35% YTD</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.15988333333333332,0.15988333333333332,positive,1.0
2024-12-24,2024-12-24 08:00:00,BIOCON AND ZENTIVA RECEIVE DE CENTRALIZED PROCEDURE APPROVAL FOR LIRAGLUTIDE - Capital Market,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxPNjAxMXd6UmJuUTdFOFlvazBsRUpxbS00b2h1dktVWklFalM2Y1BTY2JfMTBXUTZzaHVMTERqZkFCNnl5TlpzRGhjbG1YYTJfRDhOYUpOME5SdmdNSUZQamdSMHBCdHdPb09mcjRmaWx5a0ZOLVZUbTFuWjV4U21hNWJQMmFnSGtlU2E0WW5qSUZzTXZPYTh3TkhmbVdubWNnXzBpWlJkb1RsbS1fdHczelE0eW4yN0NfRHpTT2d2czBrNkRiNlp0djdLUFRLeUktTnhteHNBcThzVXJp?oc=5"" target=""_blank"">BIOCON AND ZENTIVA RECEIVE DE CENTRALIZED PROCEDURE APPROVAL FOR LIRAGLUTIDE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Capital Market</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxPNjAxMXd6UmJuUTdFOFlvazBsRUpxbS00b2h1dktVWklFalM2Y1BTY2JfMTBXUTZzaHVMTERqZkFCNnl5TlpzRGhjbG1YYTJfRDhOYUpOME5SdmdNSUZQamdSMHBCdHdPb09mcjRmaWx5a0ZOLVZUbTFuWjV4U21hNWJQMmFnSGtlU2E0WW5qSUZzTXZPYTh3TkhmbVdubWNnXzBpWlJkb1RsbS1fdHczelE0eW4yN0NfRHpTT2d2czBrNkRiNlp0djdLUFRLeUktTnhteHNBcThzVXJp?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4128,0.4128,positive,1.0
2025-01-02,2025-01-02 13:37:52,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30880454545454544,0.30880454545454544,positive,1.0
2025-01-02,2025-01-02 13:37:52,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30880454545454544,0.30880454545454544,positive,1.0
2025-01-02,2025-01-02 13:37:52,Biocon Share Price Today - Biocon Stock Price Live NSE/BSE - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5"" target=""_blank"">Biocon Share Price Today - Biocon Stock Price Live NSE/BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTFA4a1hVcUZVOVJvSEtkdFJxR29EdG1wVUR0amFNQlBaenhvS2FGUjhYZ2tDekpVMTBaeDVkRm5KT0JERTZYT1lQYVRHWk51akZPaDM2ckxuUzZmVzFURnVtZWtJaVU3UzJxT0J0ZUtrVVU?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30880454545454544,0.30880454545454544,positive,1.0
2025-01-03,2025-01-03 08:00:00,"Stocks to Watch Today: Bharti Airtel, Hero MotoCorp, Biocon, Wockhardt, RITES, DMart, V2 Retail, Bank of... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Bharti Airtel, Hero MotoCorp, Biocon, Wockhardt, RITES, DMart, V2 Retail, Bank of...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.401,0.401,positive,1.0
2025-01-03,2025-01-03 08:00:00,"STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others - MarketSmith India","<a href=""https://news.google.com/rss/articles/CBMixAJBVV95cUxPQTJwMnJmOWVmZHhGbzNiUHBsbGhpVXZhYUhMMURXTndSck1KWDI4MzBPVUNBbU9RamRYM0tWOHpxX1p4Q2V2ZWpMemNZaXpFQmw4dC0yQk1mOTV3SXRYTEttSkt1TG40eWwza01LSUdaWm1oMmk5LWg3X1QzanJOT2NjRGszV2pUYUhiV2tWVHU2OW9RbmpyRDdLLVdqcWs1aHlHR3ZNT1ZpVlgyUk1NVkotajE1ZlB1NXowSW5lZG1paHItaHZrYVB1eU1Fb1lvRXFXeU5mdVRDZjgyYWJVdXhkY2lZVFhOWDktcGFkNWx4cTdHLVRZcWZCUkZ0dUxUcVp5U2UxZnBGUC1XVDFFQTNROWhMclBFa0drYVBYbGlRNUFnZUNFYi1zd3phLW0tWkJOaHV3ellmX05CZ29lMDE2Skk?oc=5"" target=""_blank"">STOCKS IN NEWS: ITC, Afcons Infrastructure Ltd, KPI Green Energy, Wockhardt, Indian Railway Finance Corporation, Pricol, Biocon, Citichem India Ltd, Rites, Honasa Consumer Ltd, Varun Beverages ltd, Indian Oil Corporation and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketSmith India</font>",https://news.google.com/rss/articles/CBMixAJBVV95cUxPQTJwMnJmOWVmZHhGbzNiUHBsbGhpVXZhYUhMMURXTndSck1KWDI4MzBPVUNBbU9RamRYM0tWOHpxX1p4Q2V2ZWpMemNZaXpFQmw4dC0yQk1mOTV3SXRYTEttSkt1TG40eWwza01LSUdaWm1oMmk5LWg3X1QzanJOT2NjRGszV2pUYUhiV2tWVHU2OW9RbmpyRDdLLVdqcWs1aHlHR3ZNT1ZpVlgyUk1NVkotajE1ZlB1NXowSW5lZG1paHItaHZrYVB1eU1Fb1lvRXFXeU5mdVRDZjgyYWJVdXhkY2lZVFhOWDktcGFkNWx4cTdHLVRZcWZCUkZ0dUxUcVp5U2UxZnBGUC1XVDFFQTNROWhMclBFa0drYVBYbGlRNUFnZUNFYi1zd3phLW0tWkJOaHV3ellmX05CZ29lMDE2Skk?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.18028333333333335,0.18028333333333335,positive,1.0
2025-01-03,2025-01-03 08:00:00,"Stocks in news today: Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC & PB Fintech - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-03,2025-01-03 08:00:00,"Stocks to Watch Today: Bharti Airtel, Hero MotoCorp, Biocon, Wockhardt, RITES, DMart, V2 Retail, Bank of... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Bharti Airtel, Hero MotoCorp, Biocon, Wockhardt, RITES, DMart, V2 Retail, Bank of...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.401,0.401,positive,1.0
2025-01-03,2025-01-03 08:00:00,"Stocks in news today: Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC & PB Fintech - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: Bharti Airtel, IRFC, Varun Beverages, RITES, Biocon, NHPC & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-07,2025-01-07 08:00:00,Biocon Biologics marks one year as global biosimilars enterprise - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics marks one year as global biosimilars enterprise</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.37895,0.37895,positive,1.0
2025-01-07,2025-01-07 08:00:00,Explained: Why Biocon share price jumped over 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price jumped over 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43% - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43125,0.43125,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon Share Price Surges 7.22% to Rs 384.50 on BSE - Analytics Insight,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5"" target=""_blank"">Biocon Share Price Surges 7.22% to Rs 384.50 on BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Analytics Insight</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar - Bernama,"<a href=""https://news.google.com/rss/articles/CBMiWkFVX3lxTE9LWTN2S0h5R1NUQWpaZHpXUnBEZmZVbmp1WXpZaU1WdV9DZ3VOU2dpMi1kT3JlTEo2OGxSVGR1cllhOWY1Sm1IS0VyNER2eUw4VzBoNEgxdXFmUQ?oc=5"" target=""_blank"">Biocon Biologics Is Committed To Business Development In Malaysia - PM Anwar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bernama</font>",https://news.google.com/rss/articles/CBMiWkFVX3lxTE9LWTN2S0h5R1NUQWpaZHpXUnBEZmZVbmp1WXpZaU1WdV9DZ3VOU2dpMi1kT3JlTEo2OGxSVGR1cllhOWY1Sm1IS0VyNER2eUw4VzBoNEgxdXFmUQ?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5"" target=""_blank"">Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43% - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Explained: Why Biocon share price jumped over 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price jumped over 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxNZnY5eVRqQl85aXQxU21SV0ZQek04aHpZZURBOS12a3VzRGFkY2Z2aGlLbzlnODhxN3hucGVhRGtmaTBPTHRtS1hSZFRyTVFCTHlTN1hSaXh1bW1SZUc4eGpvR00xaEtudV9xZWhXamZRdU5ubFVvbzg5NG9IbHAtRXhxVnZHNGtrVDAxLWMxNUpXa0tubG0tOUN0SEhQM0NfblQwbG5yMWNPa0lnSTVvSDhWZTBiM1NKYzZ0ZXNmMGNSeU9ScHFZSTRHQk96QdIB0wFBVV95cUxOTHRHOFNNT0U3NDZzeHA4VG9iSUYzT2Jla1NJcUdPRjlhb0VwMFNCckFNM1lwY0E1Q21zNW9sMktZaVpoTkxNRWszdVJtSkFub3pqeVNVYXljWVZVem1iNFNhdFotaVNHWWVrM21VMnUxREJEWjhxS2p4M2pIZ1U0aHMwUEJWeGdZZWNISVpBOG5UZFVfSzQ2eEIwVkFObWlabEtHSFlHSHh5T01pWVZMUzhKbldmTWl6TFl6WnVySEd5ZkdNb094MFV1SEpnZS1jamVZ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon Share Price Surges 7.22% to Rs 384.50 on BSE - Analytics Insight,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5"" target=""_blank"">Biocon Share Price Surges 7.22% to Rs 384.50 on BSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Analytics Insight</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxPbE9hNG53M1BEU3JjajAyNlY4ZndMMjJBaFdLaThaRGFNazRWdTZkZTk5ZUU3SjJZempINEpyZ0hlMVJQenlHNTdCZjNGbFFRYk12bUNrMlFpamUwY1pCN3FVOUFZckxqejJZZXVtcDZKZ0ZEYVlPWk9mMHZNYm1JZzk0c29sSU1Bd0ExaWcyUjdiZ9IBnwFBVV95cUxQcnBNbG5hMU1Ua3RLSWtLb1RyYUdBV2ZTQ3g1Wnk2TVF5dkJNMjF1XzZSelJORHJmZXl2WlFNYm5naXBFR2sxeEFaUXEwaURuTXZLN2ZqT0ZwM0RfQTdUMFRJQWNTV3ozSkc3dmFESDlEQjJPRkhQQ0lpMmR4NjA5bV9xT3RZSENWdlQ2SG1tRXUtdW43VllPYlB1Z0JMaVU?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5"" target=""_blank"">Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.37895,0.37895,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5"" target=""_blank"">Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43% - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares zoom 8% after Jefferies upgrade to 'hold', price target lifted by 43%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Explained: Why Biocon share price jumped over 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price jumped over 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxNRmh1NDBrcXMxTjlwcmRFcVZYV09PVldPcmFBWVRZNllzZ1RiM1BabHczbUk4NjNham5FcmNPd0FpOHNBaFZ6SEtYbkQyN1RZSmZFcnlZSmMxbnp6ZnpqdjVjMVU0WGZzNmpNcm5LSjlfTGRrelBnLVFvQ19jc0ZMX1RhbVZsdnFZZ1p5bl9VU1pPanZoQmsyalpkNk9HMnhoUlltRnV0U0RRZUFYNWc5bnBSMzFuZXpMVThkS21BVmhWdk9MY3FWVGtUa0NnUjdoS2V6eDZfd9IB3AFBVV95cUxQYURhSHVDZXZlRW96ZDQ4OUQzZ1MyQlZKdDEtWVc0dC1ucWNyRDgzbUlpcVZwX0t4UFB5YjF2MVV3LThqNHB5cE1mRVNRc3J4QjFIdGRNY01Ka0RUa3FvaHRjOEtmOTNzc1V1ZUF5WHY5cjhEWENzZXNmX2JST2xQYXBDVGdVME5nRXJmS1JYa1NxaHY3Y3FoZmdZMW9iaXhMaTBYUjlabWRKQWZQRHowOExwMTB1dllPYjRqRU50WDV1Z19iUXRXNnlDbEJCOHlJSkhOLXRZY0hTTlcx?oc=5"" target=""_blank"">Biocon share rises 4% as arm gets Japan's PMDA approval for Psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43125,0.43125,positive,1.0
2025-01-07,2025-01-07 08:00:00,"Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5"" target=""_blank"">Why are Zomato, Biocon and ONGC shares buzzing today? By Invezz</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxOWmVSc250X0lMTldQcjd1b2NEUUd6Z21paWFDNDU4UFNqMHJVN2xhU2hHSGdhQzVZWGdjTjhjY2QzajBrTWloY2tmcjVOWkZYVjV2WUJDckhUUVkyeS0tXzNzbTNmS2JmZHlkNktwZXVTQ1F2T2RCY2lSS3NveE80TXRxc0h0d2xsQUtDUDJpWmYtYXM?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3023,0.3023,positive,1.0
2025-01-07,2025-01-07 08:00:00,Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5"" target=""_blank"">Biocon’s Share Price Soars Following Jefferies Upgrade and Regulatory Approval</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxOcEQzSWd0LU5iZmkyMjFqLVpodzdyWVBVc3JhbjhoMHNBRUViYlB3aS14YmRicF80VDU3d01QUGF1M0tPcnpXMGs2UWZONmljTHlKOW02MkhoYzc0WXlxR0huRmpiM1ZqdGtnMXFqN05hYTZEeXg1cWtKZ2pZRTZfai1WajlpUzBUX2NFcHNuNXdEMUdhaUFMRkR1bFhLTEoyOWU3b0RTWGMxXzVvU0E?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.37895,0.37895,positive,1.0
2025-01-08,2025-01-08 08:00:00,Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43445,0.43445,positive,1.0
2025-01-08,2025-01-08 08:00:00,Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug - IPO Central,"<a href=""https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5"" target=""_blank"">Biocon Biologics Secures Japan PMDA Approval For Psoriasis Drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IPO Central</font>",https://news.google.com/rss/articles/CBMicEFVX3lxTE9QNWtGQ1N6NS14MF9UWTlDdDdrbGt4VDZUTmZYcTM4b3Ntel9BYXBSRXRYdWZWZjlnNzQzOW03dDZyejgwcmFONUIwR1JLTXFieWRaQzVNeFFBRmkxSGs4dTJ5Q21qdDZTVUd3UHkzM3E?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43445,0.43445,positive,1.0
2025-01-08,2025-01-08 08:00:00,"Analysts recommend buying Maruti, Bajaj Finserv, Biocon, SBI Life, JK Cement and selling Bosch, Tata Power - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Analysts recommend buying Maruti, Bajaj Finserv, Biocon, SBI Life, JK Cement and selling Bosch, Tata Power</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxOTUVUTGwtLXBDOGJrV1dfV2E1aFg4UVdyemNrZF9ROVRiWUg1VVV2QlZHZFhXN0hqNGZHMkdYbTVFTnlrUlliSC1KMXJUbFA2ZXhUS1M2ZVd5YXR0NXdnVGJUU0FVRlJ0Y3MyWTNVSjlYal9UTU9zSXhXQkJsVkNib3Y2LS1BRURmZEsxSmtOcURObnZRUHNlRVJSZlluMjlnRUkxcnNrSERRM2JNSGpiVjctU0dqbEZzbVlZZkJ4cFJfTlFLbnBwMmRleElSOFZYMWdZOTNhRHY0UW1VR3fSAeMBQVVfeXFMTmhvMGJLOEtMV1ZqTV84THNOd05aNTdtZTlxaU1rajdpNGlOV1R5WUpkblVMM2M4bG52Slp0NEd3MFU3Y2djVzZwbGthSXA2UFR1VWxxVTFnLURGbWdaUmJLOGJ4WlBvMHowOE12a1FRTUZ6dzVER2NJbGwxWENrc1MweFNRZTdreFVaSU43N0lZLUJaSzF2dzlUS2dvejM0VWstZ0hwNlRkbzFfb3BqaVQ5WF9oNnRacWZDMnlTeUIzNmFKSHpvVTMzNG5lOEY1OTJWRGttOXc0TDF1VldDQmJXOG8?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4253,0.4253,positive,1.0
2025-01-08,2025-01-08 08:00:00,"Persistent Systems, Biocon among 5 stocks witnessing long unwinding - Bearish Trends - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxQWmVHbUtPc2FRYm1UWUd6MHhsSVpOQkE0QnFRZzNKRTdBZ1JPLXdnMjFaLWZYVTJ4a3Eya3Zpc1h6LTdpNUVfMFRQQ0hlSE05cURNaDQzMGs3VzBKUVdveWg5OF8wN0tCTmpWdHkxLWRtUFdlZDJObDVWWEd1SFVkZDBMTS1OX3J2cjF0djNzdTV5aWNadnVrb3NIVDRLeHJWOEFjbElpYTZTRWNSQ3lDNzhwYVFqdDdSaGE4eG90alFGekFtOVBQZTY0dkFNWklXNjFTbWpCaExLMTJNVlpWSXdWMW1UdVNS?oc=5"" target=""_blank"">Persistent Systems, Biocon among 5 stocks witnessing long unwinding - Bearish Trends</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxQWmVHbUtPc2FRYm1UWUd6MHhsSVpOQkE0QnFRZzNKRTdBZ1JPLXdnMjFaLWZYVTJ4a3Eya3Zpc1h6LTdpNUVfMFRQQ0hlSE05cURNaDQzMGs3VzBKUVdveWg5OF8wN0tCTmpWdHkxLWRtUFdlZDJObDVWWEd1SFVkZDBMTS1OX3J2cjF0djNzdTV5aWNadnVrb3NIVDRLeHJWOEFjbElpYTZTRWNSQ3lDNzhwYVFqdDdSaGE4eG90alFGekFtOVBQZTY0dkFNWklXNjFTbWpCaExLMTJNVlpWSXdWMW1UdVNS?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.030000000000000006,0.030000000000000006,neutral,1.0
2025-01-10,2025-01-10 08:00:00,Future Proofing Supply Chains For Global Success – The Biocon Way - Logistics Insider,"<a href=""https://news.google.com/rss/articles/CBMinAFBVV95cUxON3NnTnZ0dVhYNmFfZjkzZXhzQnVHS0VsdWtwZWlGYmdxZ29iU1BQbXk1TFl1MVlpSC1MUVp2VjBOMU5ITkphbEJmYUlSanUxcXo3QWdhcjRXX2tMTFl0Uk16Tm52U3p1T1JiOW1LUzRtWlBvaDNBUTZfa2JJYlBYdncxekg5Ui1TcndUOHRNM2JPbG1Hc2IxbklsM0s?oc=5"" target=""_blank"">Future Proofing Supply Chains For Global Success – The Biocon Way</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Logistics Insider</font>",https://news.google.com/rss/articles/CBMinAFBVV95cUxON3NnTnZ0dVhYNmFfZjkzZXhzQnVHS0VsdWtwZWlGYmdxZ29iU1BQbXk1TFl1MVlpSC1MUVp2VjBOMU5ITkphbEJmYUlSanUxcXo3QWdhcjRXX2tMTFl0Uk16Tm52U3p1T1JiOW1LUzRtWlBvaDNBUTZfa2JJYlBYdncxekg5Ui1TcndUOHRNM2JPbG1Hc2IxbklsM0s?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4563,0.4563,positive,1.0
2025-01-12,2025-01-12 08:00:00,"Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4453666666666667,0.4453666666666667,positive,1.0
2025-01-12,2025-01-12 08:00:00,"Stocks to Watch: DMart, NLC India, HEG, Biocon, Interarch Building, Standard Glass, Waaree Energies,... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: DMart, NLC India, HEG, Biocon, Interarch Building, Standard Glass, Waaree Energies,...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-12,2025-01-12 08:00:00,"Stocks to Watch: DMart, NLC India, HEG, Biocon, Interarch Building, Standard Glass, Waaree Energies,... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: DMart, NLC India, HEG, Biocon, Interarch Building, Standard Glass, Waaree Energies,...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-12,2025-01-12 08:00:00,Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know - Upstox,"<a href=""https://news.google.com/rss/articles/CBMilAJBVV95cUxOWkdvaVNRTTNvcEwybG4zMlplQjBkV2cxOEdMdWhkcWppOHo0cGlWeDJTZEdOUV9Tcm96ZUNLT2dQb2h1U1FWdDJsSHdyOEJ6eVVHalFodVBaaE16MERnUjdxWV9KejhjZ19pV3ltVGJVZGRJV1h6QzdMUEdIVVd1RHJrSlRZQTRDRlJqSkE3ZDRkaVdRc3RndkktQ05VTk9RYjZhSWhGaWtvWmJzY0JuaHZ3OHRRcmVBYzBPbF9OcFpSeE1uY2w5Y09wWnVpQllkODlkNWxxT1RqV3ZIeVBvMGp4YkdBVWZOQmVFci00ZFZ2YkFnUU01MHdlOUQzVFBEN2x2T1pqUDJ0V3licEIyMk93bTM?oc=5"" target=""_blank"">Biocon shares jump 4% as USFDA classifies Biocon Biologics site in Malaysia as voluntary action indicated; all you need to know</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMilAJBVV95cUxOWkdvaVNRTTNvcEwybG4zMlplQjBkV2cxOEdMdWhkcWppOHo0cGlWeDJTZEdOUV9Tcm96ZUNLT2dQb2h1U1FWdDJsSHdyOEJ6eVVHalFodVBaaE16MERnUjdxWV9KejhjZ19pV3ltVGJVZGRJV1h6QzdMUEdIVVd1RHJrSlRZQTRDRlJqSkE3ZDRkaVdRc3RndkktQ05VTk9RYjZhSWhGaWtvWmJzY0JuaHZ3OHRRcmVBYzBPbF9OcFpSeE1uY2w5Y09wWnVpQllkODlkNWxxT1RqV3ZIeVBvMGp4YkdBVWZOQmVFci00ZFZ2YkFnUU01MHdlOUQzVFBEN2x2T1pqUDJ0V3licEIyMk93bTM?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-01-12,2025-01-12 08:00:00,"Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks To Watch For January 13: Avenue Supermarts, PCBL, Biocon, Waaree Energies and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4453666666666667,0.4453666666666667,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock soars 4% after USFDA clears Malaysia unit, ends regulatory hurdles</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.07655,0.07655,neutral,1.0
2025-01-13,2025-01-13 08:00:00,Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility - Mint,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxNNFNtTGxYS2tiZUtvRjJTaTg2WDk4cmcyRWxPM0x5eUwxandFX3h2ZjJ1eFdiV1ozWmd3SnEyNEp6OEQ1ZUNZTS04WGlZVzJiTzdQSmNuUGFVTno2NnQwdUE4dkhnZVJORUVtc20tdVBLVmxJS3JTdGpMamhTNk5NYlY5R3ktd0IxNE1xNGktTWg3QXJOekJZRm1JcjBpWlBnV2ZVWFh3d2xBSHBUYWhVYmRGbVk5M25fZ2ZBb3puMkN0dHExdjFMcjFFM2I1MnAtWTBHeEl3cG16bWVnQmfSAeMBQVVfeXFMTkdHUGhTLVE4SmFnVWNueTFYTmNLLTljQWhxZWJQSWJBMU1JblMteHFCcXpua2xnNTgyUWZ1Z0ZqaURNaWJLWV9fSjVfUHAyVU9mR1NtOU9ldTlCRjNrOXBFcEtNUjdENnI2QWpSOS1HMU42NHNwaG02OEdjeFpLVkRSMG93dEl3NkpkU252TUlPNkY0aGp6b21UTmJBSHg1THFJQUd5cHFFcGdMYXctSkphRjVpQm1GVXYzR3FaQ25VMFV6amF2N29MQXpwUG9IWUpEbzYyT3RDSlhybmxtME15bHc?oc=5"" target=""_blank"">Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,Explained: Why Biocon share price climbed over 4% in early trade today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon share price climbed over 4% in early trade today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-01-13,2025-01-13 08:00:00,Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxONlVvR0V1R01idEpaRDJuem5SdUROSmZPci1fdHE4WGdXVHg4X3BaUnZpWEgwc1Q0R2NOMEd6Z0RXZS0wRjFMTFE0SlZXb3kycWRKYTJiemw0clFraDdPaXNUQURVbThKcHRjTlFYQjBla1YwVWE3bFBodHhjYng1YkhKbkJ4bVdsMGw3TVdBU2hlY3V5ZDQwVmVIaFZFSmQ3cFNWeXBNOHZxVDFBUDEyRVBTU2puWU9ub2hHZGNkUWZuaGRsUWdtNXRERmE4Y0EwVmpFTDA5OVFpWWZFTmgtMm8wSi3SAeoBQVVfeXFMTzNRSm1GSUcyVnJVX2ExMGVoS1piMnFpd2F0dENjV3hhQnFmZ3FjLVVHS085Q25Dc0ZPTnEwVjhEMVdjeV9zR0JFMjFWNmVHOVl3eXk5NzFZbmdzZ3d0ZlBncGh5eVAtMld4aDM0UzZQOUxnU0dvRDVjU2VWc3ItVkpYcXg0OEQ5QkJKTWp0cFNUSXN6ZUYzbjVETU90cUVuSjR5THh5X0Vob0dFUnV5UHlmcmU0WllWUWhPc0dtVmZFTzhPRWRzY3VsVE9JUndWaEd6Z2k1dUFucFMxTWROWklTWFdIb2F0bGhB?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-13,2025-01-13 08:00:00,Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 4% after USFDA gives VAI tag to its Malaysia unit</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44035,0.44035,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today","<a href=""https://news.google.com/rss/articles/CBMi8wFBVV95cUxOcVhua29SWlQxVml1NDRQSXM1V21EZXdmNnMzSGpyVWd4aVN5czVfZG5XVXZ1TVN0dkNJVklfVUh2VWxzLWZyQ1BLcldjb3NxQjZvSHhWZ0JPVVRWRkVCVGJqT3p3QmlVOC1LenFjdm96WUpUWkZibmxaM1c3QXpKUzVWUVIwc0FVc2p4RFg1b3Jud3JUMWhaT1VrMDhqMmpQb2pOTTRWZTlqalUzLWFhcm5jVldpZUkyVWVmcjlEZjRwV0x1QTFmN2g4TV84SU9rbG45MWZFMWhGc2hjUGRRbVVTRl85dE5VNVEtclJlczJCTEnSAfgBQVVfeXFMTVRTNzZwb19WUGVPejBGQVlva0tyVkpYdnRmNklTazdPNlVkd3BsWmN6MEV2TmExeGZJazVvVHpFLXFPZkZsTnFjbnRGdWhtSEdaYnpLMFhJMEhXcXdOLVRpd3lBbHg5Skd5MDI5bmVWWFVzLXpaQnlOdGU4UDBiS05MLTRnU09XYTUxMlI5UEFuS2MxYnZtVS1tNnpDTVRldUo5ejU5T2s0OVNXbUQweVBOY0t3YlJFX0hrazQ5MEhLS0VjMWdWcnlZYXVLUV9hRXNqRTFKbkhreEVKOS1BaS1JUWh6S00zODREZDBZU3lYOVNqLVg1WDA?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Top stocks to watch in trade today: DMart, PCBL, Biocon, Just Dial, Waaree Energies and more - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxNb05VYzhYR3VNUFJvZzBGNHp2ZGdsOE5vdFFHcXY1czdQdDgtNjBCaWZEaGk5MXdFcnEtVDhIMW5GRUxqb1ViSU1IOGJ2RmFUQ1BjMk9xTFdiVGZ0VnJrV182V2UwVlVUSEdBR05RWmJZV0VOaWxJbVZZZjMyMUNWbGNYLU85YjE5eWRQOG92U2x4NGU4UmlBaGJ3MHEtYWFNZXJxazlXbXZ6RlJoNkdDbW1XLVpTMENTNEJEREhUR3ZZa3U5MUc4cWVSQkIwdkdfbE90U1A0SQ?oc=5"" target=""_blank"">Top stocks to watch in trade today: DMart, PCBL, Biocon, Just Dial, Waaree Energies and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxNb05VYzhYR3VNUFJvZzBGNHp2ZGdsOE5vdFFHcXY1czdQdDgtNjBCaWZEaGk5MXdFcnEtVDhIMW5GRUxqb1ViSU1IOGJ2RmFUQ1BjMk9xTFdiVGZ0VnJrV182V2UwVlVUSEdBR05RWmJZV0VOaWxJbVZZZjMyMUNWbGNYLU85YjE5eWRQOG92U2x4NGU4UmlBaGJ3MHEtYWFNZXJxazlXbXZ6RlJoNkdDbW1XLVpTMENTNEJEREhUR3ZZa3U5MUc4cWVSQkIwdkdfbE90U1A0SQ?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4453666666666667,0.4453666666666667,positive,1.0
2025-01-13,2025-01-13 08:00:00,Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Stocks in news: HCL Tech, DMart, Adani Wilmar, IOB, Ola Electric, ICICI GIC, Biocon & PCBL - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: HCL Tech, DMart, Adani Wilmar, IOB, Ola Electric, ICICI GIC, Biocon & PCBL</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,"USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI - Indian Pharma Post","<a href=""https://news.google.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?oc=5"" target=""_blank"">USFDA classifies Biocon Biologics Johor Bahru site, Malaysia as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,Buy Biocon; target of Rs 430: Motilal Oswal - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5"" target=""_blank"">Buy Biocon; target of Rs 430: Motilal Oswal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,Biocon Share Price Surges Following Positive USFDA Classification - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQT0djZkxkcXVaQXJTZ01UTmZ6QzVkQ3ZRX0dyb2liQ1l5ekdYemlQdE9WOEhJMXBNOGZmU1VCQnJ0RkNhdi03a0Z6SVIxVVdnUXBWdC1neFMyeHk3THhaVmJvLUpxdkRMcVh6bnZIYm0wN0RkVEpxWDN2bEtiVjREaVV2S0lpSWsyajY5TWZ0T0paaURKRjZ6cmZTYVJVQQ?oc=5"" target=""_blank"">Biocon Share Price Surges Following Positive USFDA Classification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQT0djZkxkcXVaQXJTZ01UTmZ6QzVkQ3ZRX0dyb2liQ1l5ekdYemlQdE9WOEhJMXBNOGZmU1VCQnJ0RkNhdi03a0Z6SVIxVVdnUXBWdC1neFMyeHk3THhaVmJvLUpxdkRMcVh6bnZIYm0wN0RkVEpxWDN2bEtiVjREaVV2S0lpSWsyajY5TWZ0T0paaURKRjZ6cmZTYVJVQQ?oc=5,Google News - Market + Complete Company News,Biocon compliance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4909545454545455,0.4909545454545455,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,Biocon shares in focus after Malaysia unit gets clearance from the USFDA - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-13,2025-01-13 08:00:00,Buy Biocon; target of Rs 430: Motilal Oswal - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5"" target=""_blank"">Buy Biocon; target of Rs 430: Motilal Oswal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,US FDA classifies Biocon Biologics site as VAI - Express Pharma,"<a href=""https://news.google.com/rss/articles/CBMiggFBVV95cUxPOXliSi1SaXVLQWNkZ00yRTlqLXlXUTlnRjY5V3I1XzQ1aDhDSzRJemQ4R3lZOFBjYXpOejdaS2l3aFFlSWU2WWNjeHZMRm1yckpmbEJqRkZ4MU5mSHZDVXpacDRzRmZfb1pZaUEtLVR6a3F6MzNvOUo1ckpUaFNTd3B30gGHAUFVX3lxTE1LWi1faURNMm5CTDg1dnk3UkNpeTFwQmtpU1N6dmRCRlhuZDkzRUdla3FJV0tsNHktQmE3Y2d5bUdKSDBkM2h2YkJaeC1JMEcwYkpxU2w4Mm5ObkxNVm9UQThWTk9UdWljSWZvQTQxYkFTSnRPMFlzTnkyNHd2UnhTTXNIdU12aw?oc=5"" target=""_blank"">US FDA classifies Biocon Biologics site as VAI</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Express Pharma</font>",https://news.google.com/rss/articles/CBMiggFBVV95cUxPOXliSi1SaXVLQWNkZ00yRTlqLXlXUTlnRjY5V3I1XzQ1aDhDSzRJemQ4R3lZOFBjYXpOejdaS2l3aFFlSWU2WWNjeHZMRm1yckpmbEJqRkZ4MU5mSHZDVXpacDRzRmZfb1pZaUEtLVR6a3F6MzNvOUo1ckpUaFNTd3B30gGHAUFVX3lxTE1LWi1faURNMm5CTDg1dnk3UkNpeTFwQmtpU1N6dmRCRlhuZDkzRUdla3FJV0tsNHktQmE3Y2d5bUdKSDBkM2h2YkJaeC1JMEcwYkpxU2w4Mm5ObkxNVm9UQThWTk9UdWljSWZvQTQxYkFTSnRPMFlzTnkyNHd2UnhTTXNIdU12aw?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,Biocon Share Price Surges Following Positive USFDA Classification - theafricalogistics.com,"<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxQT0djZkxkcXVaQXJTZ01UTmZ6QzVkQ3ZRX0dyb2liQ1l5ekdYemlQdE9WOEhJMXBNOGZmU1VCQnJ0RkNhdi03a0Z6SVIxVVdnUXBWdC1neFMyeHk3THhaVmJvLUpxdkRMcVh6bnZIYm0wN0RkVEpxWDN2bEtiVjREaVV2S0lpSWsyajY5TWZ0T0paaURKRjZ6cmZTYVJVQQ?oc=5"" target=""_blank"">Biocon Share Price Surges Following Positive USFDA Classification</a>&nbsp;&nbsp;<font color=""#6f6f6f"">theafricalogistics.com</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxQT0djZkxkcXVaQXJTZ01UTmZ6QzVkQ3ZRX0dyb2liQ1l5ekdYemlQdE9WOEhJMXBNOGZmU1VCQnJ0RkNhdi03a0Z6SVIxVVdnUXBWdC1neFMyeHk3THhaVmJvLUpxdkRMcVh6bnZIYm0wN0RkVEpxWDN2bEtiVjREaVV2S0lpSWsyajY5TWZ0T0paaURKRjZ6cmZTYVJVQQ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4909545454545455,0.4909545454545455,positive,1.0
2025-01-13,2025-01-13 08:00:00,Buy Biocon; target of Rs 430: Motilal Oswal - Moneycontrol,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5"" target=""_blank"">Buy Biocon; target of Rs 430: Motilal Oswal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxOWUdqbWdzWFNKc1dKOXBqMTNSUmtTNkZlajdsWlR1bXFVWUd6RG9FZm5JMHBXWTNjcEs1eG9wbGgxeUF0MzNNZmhqd0FsekVqV3lLbGp3Tk1yeGJPSXVVYVAzWFZVeGtHb0FtZHpVdEhrTlBvTUhtdjNRWEQxb2RBYlZVRTJBUjdfZDk0dHFlaTFPQ3dkNTZCRzRwSVFEOXJCSGxSWUl1T1jSAa4BQVVfeXFMT0REN2t0UGRNMldULUFwQ21FaEM5Snd2d3A4blo3enBMTmcxVG80Zjl4V2JtSVN0RnI3T00wZU52dmU1NXp2b05lSGhIazBRR2ZVbXZyS0pkUWVoTXd6b3ZyQ2V2SWdETUV6T1p2cktBVi0wUENNRmtwTG8xUlJRLVlVcXlwTGk5c2dqUTM4SDRNNnJqN3NpME9oX09mbnBqOW9pRUg4X1hQSi1wU2dn?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-13,2025-01-13 08:00:00,Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxONlVvR0V1R01idEpaRDJuem5SdUROSmZPci1fdHE4WGdXVHg4X3BaUnZpWEgwc1Q0R2NOMEd6Z0RXZS0wRjFMTFE0SlZXb3kycWRKYTJiemw0clFraDdPaXNUQURVbThKcHRjTlFYQjBla1YwVWE3bFBodHhjYng1YkhKbkJ4bVdsMGw3TVdBU2hlY3V5ZDQwVmVIaFZFSmQ3cFNWeXBNOHZxVDFBUDEyRVBTU2puWU9ub2hHZGNkUWZuaGRsUWdtNXRERmE4Y0EwVmpFTDA5OVFpWWZFTmgtMm8wSi3SAeoBQVVfeXFMTzNRSm1GSUcyVnJVX2ExMGVoS1piMnFpd2F0dENjV3hhQnFmZ3FjLVVHS085Q25Dc0ZPTnEwVjhEMVdjeV9zR0JFMjFWNmVHOVl3eXk5NzFZbmdzZ3d0ZlBncGh5eVAtMld4aDM0UzZQOUxnU0dvRDVjU2VWc3ItVkpYcXg0OEQ5QkJKTWp0cFNUSXN6ZUYzbjVETU90cUVuSjR5THh5X0Vob0dFUnV5UHlmcmU0WllWUWhPc0dtVmZFTzhPRWRzY3VsVE9JUndWaEd6Z2k1dUFucFMxTWROWklTWFdIb2F0bGhB?oc=5"" target=""_blank"">Biocon shares surge over 4% after Malaysia unit gets clearance from the USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rally 5% as USFDA clears Malaysia unit; brokerages upgrade ratings, targets</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-01-13,2025-01-13 08:00:00,"BofA maintains buy on Biocon, check target share price here - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxNU1VlLVZQeDZYMDhsb2RKaVhkN0tNRGk5VUx6bmdnY3dFV2l3MU9oMjFIMm1BZFRfbXBmVm5xenB3TmVpNVhjNjVGcWVzR1JFZzVsWFdERlp6NnB0LUd2Uko5WklmNXB4aTZVaDh5VXVWNmFYUTNjMFlWZGRIWGRqNFJFY3c2c09fN3pHRG9rM005bzluLUd4eDNQUkc4N3dqZlJENjcxWFFPOG00ZDZObg?oc=5"" target=""_blank"">BofA maintains buy on Biocon, check target share price here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxNU1VlLVZQeDZYMDhsb2RKaVhkN0tNRGk5VUx6bmdnY3dFV2l3MU9oMjFIMm1BZFRfbXBmVm5xenB3TmVpNVhjNjVGcWVzR1JFZzVsWFdERlp6NnB0LUd2Uko5WklmNXB4aTZVaDh5VXVWNmFYUTNjMFlWZGRIWGRqNFJFY3c2c09fN3pHRG9rM005bzluLUd4eDNQUkc4N3dqZlJENjcxWFFPOG00ZDZObg?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-13,2025-01-13 08:00:00,"Stocks To Watch: HCL Tech, Dmart, Biocon, Waaree Energies, Power Grid, And Others - News18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch: HCL Tech, Dmart, Biocon, Waaree Energies, Power Grid, And Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.21075,0.21075,positive,1.0
2025-01-14,2025-01-14 08:00:00,HSBC sees Biocon share price rallying up to Rs 430; stock surges 5% - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-14,2025-01-14 08:00:00,Explained: Why Biocon shares surged 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon shares surged 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxQNlIyMU0wb1RkZkJBNUJsX3hWYWtGbDFiNkRxWWtZeWVGSkpLR2MyZU9kaHhPVzdSUlJGSHA4NnVnN3dxMVpaN3Fybm5zZFM1YnktU2RJNm53bWphMldjQWdBWlVyR1BJOFh5MURaSVJaTkJRY1dtQm1ua2FndTZCN3pFS0ZYY0RvYlJSU19jOTVsQlBhZnNFY08teWFRX3BCNmtZU1VZSEJfV2UyT2ZEdzNGOEhOWjRJNjdVeWFHZzV1bnUxVkljQUFaZnczRmxSZElFMGVNOVdUM2s2ams2U9IB5gFBVV95cUxNTTdBRWFYNG9LYXVQall1WURySW9aWmlNNmE1NDF0RmdxaEpvSGRwWVRxWkRQZ1FaMl9CZVd6M1R2T0VYUU9KejZmTUNaR3RzT2x6SG5oazJzdS16TF9yNjZYV2taUWRPZFV0YTM0Xzl4YUZYQ05CVGQzNXRCQmZYMVQyR01hTEROOEtRcnNuUW9JbGpMeEl1cHM2akltaDNtT2tweVpWOGltR2hSSHBhYklxakxxTFVzRFJPbXJpTnd3bFVDWlRxU3VlSjNINXlON3VHTHhQWVVBaWtDN3I1U1NjNjlXUQ?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4201,0.4201,positive,1.0
2025-01-14,2025-01-14 08:00:00,HSBC sees Biocon share price rallying up to Rs 430; stock surges 5% - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-14,2025-01-14 08:00:00,Explained: Why Biocon shares surged 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon shares surged 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5"" target=""_blank"">Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-14,2025-01-14 08:00:00,"Stocks To BUY Today, Jan 14 For Intraday: Biocon, BSE, RIL, HCL Tech and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today, Jan 14 For Intraday: Biocon, BSE, RIL, HCL Tech and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4201,0.4201,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxPNWVzMjFKeTVpZFZwaGZDQWU3X2gtOXlNQWJYSkpwSXRfaWoybm1vek96RVBvRHZyLVVaZHZSdW95bXFKWXFlQWF0UWtCTm45QmpQM1prRFFuV25FbzhvMlktSVZNck5yMFo4SDlSZFp0M0wwb2JaTF9QcXF0QzFnN3RING9nWGt4bzNYbGhmYThjOEl0S0Ztamd2Y2lxMDdDdTVaWFM5ZVN2MFpWY1dBYlo3RTFHNEVhYTI0cThNQ0JWaWllYUY5ZnVfbXVBLUc2dmfSAdcBQVVfeXFMTnpSVlRCZTRMNUdXRk9TOGxRdTYxODQzVTE1dTlyeVhNb0tFV3FVUFZjYnZHRHZtQ3loRjN3OTBKOXV2emx4V0M0MWFNVS1aTXVCaS16QkpGVjZyZ0tMMUp0S20zaUpkN1laR0NSM2IyYjliZlk5bE5FTzhpTTd2aVNJQmdvM0Ffb2twY21LQ083M0JFQVJGRUpLSUdDOE1hYmZuVE9FSzNBb0xCcEE2SVQzWkRwN1dMNUFyYnhrME9OR2JVdXowNlk0U0oxdDRzUlFPbW50LVE?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Should you buy United Spirits, Shree Cement, BSE, Biocon, other stocks? - Zee Business","<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVnZSQWRCMS01RTFLWEFtLUNjYk1kYms3TDFob3BuTkxvc2g1OWhBMmNBZTVsOG1XTEI0cXVybTZwRWczZU1tOWpFN1kxOVZzYzhJWDhaMFJiVTNnbVIwTGw0UEpBc2toNjZwVDl5eHFmZVY2VmJpcW1RSGFhOGhSUkl1bXhaWWNOQzhXV056YUhOeWs4Wlc3SzJ4eGx4ZHZkOU52YWx4Z3RGVFVveVBzVjdoaEtTQzlCc0g2Xzg2SEVRNnc?oc=5"" target=""_blank"">Should you buy United Spirits, Shree Cement, BSE, Biocon, other stocks?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxPVnZSQWRCMS01RTFLWEFtLUNjYk1kYms3TDFob3BuTkxvc2g1OWhBMmNBZTVsOG1XTEI0cXVybTZwRWczZU1tOWpFN1kxOVZzYzhJWDhaMFJiVTNnbVIwTGw0UEpBc2toNjZwVDl5eHFmZVY2VmJpcW1RSGFhOGhSUkl1bXhaWWNOQzhXV056YUhOeWs4Wlc3SzJ4eGx4ZHZkOU52YWx4Z3RGVFVveVBzVjdoaEtTQzlCc0g2Xzg2SEVRNnc?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3234833333333333,0.3234833333333333,positive,1.0
2025-01-14,2025-01-14 08:00:00,HSBC sees Biocon share price rallying up to Rs 430; stock surges 5% - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi1gFBVV95cUxPTnc3N1RGUGRKM2l1eFFOR20tTGIwYzdPeHo4czRzQldqQ2ExaF9EOEtWR0dLaGp3c1U3bmZFdDVfcVJzTzd4Q1hydDJ0clFiTFJhV0hNNUpUTXNfVlp3N0I3S0RQZEN6N2xxSHhmdmY5WXE2X1BfczR5SEJSTzZBSG1meGlvTzJDblphSFFqMzItSjZyREdZQkprRlpCeDJGZnZDd3BxaWo0X2U3NUlMbGFJdDdSVnBqb3dsb1lvd180MlZhazZvSTI4V0NpVEs2bGsxUzVB0gHbAUFVX3lxTE03WGswa2JVMlRGV0JVZml5WUF1WU9TVE5WWk9xSTVaeEh5dXdwU1FnOXBRTW1PUDFJVEk5eDh4WlF1T0Z5VkV2Y0VCRmV1YTBDQi1HSzh4SFc0MTR0YkYzQ2tONFBTamFHSXFFQUJZZEQ3UWJuaXU2RmYwRjgxN0lsU2JBbUxobnZHWGhRWlBON0VscmJQcnNEUTZCMnc2bDktTHFJRmVQT0lhVENZUkU0bWRFbWVheHB4dWtaRE9ZSU1pdVowdUpDVzc5OE9CQzhKNE5ORmhzR09TMA?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,Explained: Why Biocon shares surged 7% today - India Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Explained: Why Biocon shares surged 7% today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-14,2025-01-14 08:00:00,Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares surge 4% after HSBC upgrade to 'buy' on hopes of operational turnaround</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxQNlIyMU0wb1RkZkJBNUJsX3hWYWtGbDFiNkRxWWtZeWVGSkpLR2MyZU9kaHhPVzdSUlJGSHA4NnVnN3dxMVpaN3Fybm5zZFM1YnktU2RJNm53bWphMldjQWdBWlVyR1BJOFh5MURaSVJaTkJRY1dtQm1ua2FndTZCN3pFS0ZYY0RvYlJSU19jOTVsQlBhZnNFY08teWFRX3BCNmtZU1VZSEJfV2UyT2ZEdzNGOEhOWjRJNjdVeWFHZzV1bnUxVkljQUFaZnczRmxSZElFMGVNOVdUM2s2ams2U9IB5gFBVV95cUxNTTdBRWFYNG9LYXVQall1WURySW9aWmlNNmE1NDF0RmdxaEpvSGRwWVRxWkRQZ1FaMl9CZVd6M1R2T0VYUU9KejZmTUNaR3RzT2x6SG5oazJzdS16TF9yNjZYV2taUWRPZFV0YTM0Xzl4YUZYQ05CVGQzNXRCQmZYMVQyR01hTEROOEtRcnNuUW9JbGpMeEl1cHM2akltaDNtT2tweVpWOGltR2hSSHBhYklxakxxTFVzRFJPbXJpTnd3bFVDWlRxU3VlSjNINXlON3VHTHhQWVVBaWtDN3I1U1NjNjlXUQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4201,0.4201,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5"" target=""_blank"">Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-14,2025-01-14 08:00:00,"Stocks To BUY Today, Jan 14 For Intraday: Biocon, BSE, RIL, HCL Tech and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today, Jan 14 For Intraday: Biocon, BSE, RIL, HCL Tech and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,HSBC sees Biocon share price rallying up to Rs 430; stock surges 5% - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC sees Biocon share price rallying up to Rs 430; stock surges 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon extends rally, up 6% in 2 days on HSBC, Motilal Oswal 'Buy' upgrade</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxPNWVzMjFKeTVpZFZwaGZDQWU3X2gtOXlNQWJYSkpwSXRfaWoybm1vek96RVBvRHZyLVVaZHZSdW95bXFKWXFlQWF0UWtCTm45QmpQM1prRFFuV25FbzhvMlktSVZNck5yMFo4SDlSZFp0M0wwb2JaTF9QcXF0QzFnN3RING9nWGt4bzNYbGhmYThjOEl0S0Ztamd2Y2lxMDdDdTVaWFM5ZVN2MFpWY1dBYlo3RTFHNEVhYTI0cThNQ0JWaWllYUY5ZnVfbXVBLUc2dmfSAdcBQVVfeXFMTnpSVlRCZTRMNUdXRk9TOGxRdTYxODQzVTE1dTlyeVhNb0tFV3FVUFZjYnZHRHZtQ3loRjN3OTBKOXV2emx4V0M0MWFNVS1aTXVCaS16QkpGVjZyZ0tMMUp0S20zaUpkN1laR0NSM2IyYjliZlk5bE5FTzhpTTd2aVNJQmdvM0Ffb2twY21LQ083M0JFQVJGRUpLSUdDOE1hYmZuVE9FSzNBb0xCcEE2SVQzWkRwN1dMNUFyYnhrME9OR2JVdXowNlk0U0oxdDRzUlFPbW50LVE?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-14,2025-01-14 08:00:00,"Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5"" target=""_blank"">Stocks to buy in 2025: AB Capital, Biocon among 5 stocks that could give 20-40% return</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi6wFBVV95cUxOQjJRR0lDX2RLWEN6YWVmN2J6cHpyTE1sdHhzSTdQNTJJdnFiR1hMX2lSSkU0b19zZVJUSllLU0lfb3R4YjB5cEFUVTlKajhfUS1zWUJnSEFHWHJvWE5kbXBSRnJQcVJqV0ZfeEJWdEMycy1RNWJpdU43S2JVdTdzWHFnQWxnemFOdDhSdFBCZlBnMFB1TEJyV2NEM3J3YTJNUm85WGZocTJhZEFQcE9WQ0otUmRUdTk5cDliWXZ4clZlMUFEbk4yVG8yVURNbWpzMEJQcEJWVmdRSHRhcFQyVFd3SjFSc09VWEJJ?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-15,2025-01-15 08:00:00,"Stocks To BUY Today, Jan 15, Intraday: IRFC, Indus Towers, Biocon, JM Financial and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today, Jan 15, Intraday: IRFC, Indus Towers, Biocon, JM Financial and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMizwFBVV95cUxOeWVxajJrN0s1dmtXLUVVNUdpdlloTlpfX2lCZWFZWWw4cUdHTWlidXdGMklYVUZCd0Zob25VZFRVNlJkVGZlcVNMNUVLWHVaQi0wTVZvai1YZl82TzVtd2xzZnNpSUZUa2d0WFJUSENBV295X1NwWTVhTFBQTlFDSktmYnVyOFViUzRUN1FtWlNQRkJIeVlrMWdmbnZ1YndyVk9MY001TjVqbmdGLWI2cmtJZmdqUmVKeVRxTk9nQUdONzNEM3d2TXVUa2RudWPSAdQBQVVfeXFMT283MnUyak04RTI5ZkNrekRGaUdEMFdTNS1vV0tTSHdscW9ud3VISnh0QXNQc1d4THlxd1lqbUhTOHFmRzVEeUVoakFVU0pod2Zld0FwV0JHZzNqbmU2b2doeVcxSTBrMXBabDhhY2tlZnBkVEpEaGhNdFd4UndSTE1qX0FLLWtzM0JadnBTdU9hQ1h4OExRLW5UcTc2dXJHTFpYMkdvTkpvNTBOWHFyNDJTdlY0Nk01b1czbW44dlQ2SDNLeDlIR2o2aVk3MlR6N3pwQlM?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0625,0.0625,neutral,1.0
2025-01-16,2025-01-16 08:00:00,CCI fines Goldman Sachs manager Rs 40 lakh over Biocon deal failure - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">CCI fines Goldman Sachs manager Rs 40 lakh over Biocon deal failure</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3080777777777778,-0.3080777777777778,negative,1.0
2025-01-16,2025-01-16 08:00:00,Biocon Share Price Trades Close to 52-week Highs; Bullish Breakout Target at Rs 405 - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQX1d3cVZ4VlhMZ3BKVUk2Ym1qWFVXcFFndGxycGd0dTEweDJnTU1vejB5QjYxTTlrVGxTVmJhNnZXYUtoa2x2Y0JUZ1FfdGlNQV80cGRiaG9PWE1PenJwbjU1MXNLMDBTNnZZVHNBM3VHTWxWbWt5dDJHYmVxUlBxRkRncVVZOExxTjc3eVdhc2x4NWpYQnVpakJ0TktDUlVvRWhNcw?oc=5"" target=""_blank"">Biocon Share Price Trades Close to 52-week Highs; Bullish Breakout Target at Rs 405</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxQX1d3cVZ4VlhMZ3BKVUk2Ym1qWFVXcFFndGxycGd0dTEweDJnTU1vejB5QjYxTTlrVGxTVmJhNnZXYUtoa2x2Y0JUZ1FfdGlNQV80cGRiaG9PWE1PenJwbjU1MXNLMDBTNnZZVHNBM3VHTWxWbWt5dDJHYmVxUlBxRkRncVVZOExxTjc3eVdhc2x4NWpYQnVpakJ0TktDUlVvRWhNcw?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-16,2025-01-16 08:00:00,Biocon Share Price Trades Close to 52-week Highs; Bullish Breakout Target at Rs 405 - topnews.in,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxQX1d3cVZ4VlhMZ3BKVUk2Ym1qWFVXcFFndGxycGd0dTEweDJnTU1vejB5QjYxTTlrVGxTVmJhNnZXYUtoa2x2Y0JUZ1FfdGlNQV80cGRiaG9PWE1PenJwbjU1MXNLMDBTNnZZVHNBM3VHTWxWbWt5dDJHYmVxUlBxRkRncVVZOExxTjc3eVdhc2x4NWpYQnVpakJ0TktDUlVvRWhNcw?oc=5"" target=""_blank"">Biocon Share Price Trades Close to 52-week Highs; Bullish Breakout Target at Rs 405</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxQX1d3cVZ4VlhMZ3BKVUk2Ym1qWFVXcFFndGxycGd0dTEweDJnTU1vejB5QjYxTTlrVGxTVmJhNnZXYUtoa2x2Y0JUZ1FfdGlNQV80cGRiaG9PWE1PenJwbjU1MXNLMDBTNnZZVHNBM3VHTWxWbWt5dDJHYmVxUlBxRkRncVVZOExxTjc3eVdhc2x4NWpYQnVpakJ0TktDUlVvRWhNcw?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-17,2025-01-17 08:00:00,"Tech analysts see upside in SRF, LTTS, Biocon, RIL and Apollo Hospitals - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Tech analysts see upside in SRF, LTTS, Biocon, RIL and Apollo Hospitals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-20,2025-01-20 08:00:00,"Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21? - TradingView","<a href=""https://news.google.com/rss/articles/CBMimwJBVV95cUxONlJ0aEFlMkU2M3Q5S012TDBaSGgtSng2UVJRMVFQLUltbHRYNFFuSXBmSTBOb2ZZQVRKZzlHSkhaU2Z6cm5HQzU4VzFLV1dKNlVfc2VKaDVuUHkxdWpyWXNhQWdINU1sa2JKOWUydTZEUVpreEhXZGNOYXRMM1N5UnByLXczX1JMQmNuSy1XMWZCRzgzRjl2RHNpT1RCYzBVblpkNEQyVkZ4QWVvSUR4cmRhaDd2RnR2OGJmb3JqMmhpejRUSHVPOUlkUXNCVXlJRGpYOWd2Qkl1NGNkcUlNNHNlTzhKaWJiVkRLODI2dVN0NEZqcC1WMmlCTkVJNko1R0NDZi1QQUllR1lVMGZPcHZjdmhJQUdEV29R?oc=5"" target=""_blank"">Trade Spotlight: How should you trade IRCTC, Bajaj Finance, Bajaj Auto, Biocon, Redington, Divis Laboratories, and others on January 21?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMimwJBVV95cUxONlJ0aEFlMkU2M3Q5S012TDBaSGgtSng2UVJRMVFQLUltbHRYNFFuSXBmSTBOb2ZZQVRKZzlHSkhaU2Z6cm5HQzU4VzFLV1dKNlVfc2VKaDVuUHkxdWpyWXNhQWdINU1sa2JKOWUydTZEUVpreEhXZGNOYXRMM1N5UnByLXczX1JMQmNuSy1XMWZCRzgzRjl2RHNpT1RCYzBVblpkNEQyVkZ4QWVvSUR4cmRhaDd2RnR2OGJmb3JqMmhpejRUSHVPOUlkUXNCVXlJRGpYOWd2Qkl1NGNkcUlNNHNlTzhKaWJiVkRLODI2dVN0NEZqcC1WMmlCTkVJNko1R0NDZi1QQUllR1lVMGZPcHZjdmhJQUdEV29R?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMixAFBVV95cUxOYWFWM3FKZFl5ZGNEYVgtc1VMaVo4b3dfbm9zc0FrWl9aUk1vendaQmZ6RWxKcURHenJ1OU94T2hORndfTUJtek9VMV9iNmlHWEc5MVJUT240OFpCT056SkRtSWwycFNTbTQtYTlmY2tqV2JGZkhEMlU2UWU1RU1Oc3djYi1Nb3V5SUtxbUVGMlktclFoZWkxa28yT2p2VEFmOEQtazZXcE1ta1BueWU2SUFBcWxYSWhQMFMwNXhKUlNGTjQ5?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMixAFBVV95cUxOYWFWM3FKZFl5ZGNEYVgtc1VMaVo4b3dfbm9zc0FrWl9aUk1vendaQmZ6RWxKcURHenJ1OU94T2hORndfTUJtek9VMV9iNmlHWEc5MVJUT240OFpCT056SkRtSWwycFNTbTQtYTlmY2tqV2JGZkhEMlU2UWU1RU1Oc3djYi1Nb3V5SUtxbUVGMlktclFoZWkxa28yT2p2VEFmOEQtazZXcE1ta1BueWU2SUFBcWxYSWhQMFMwNXhKUlNGTjQ5?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-20,2025-01-20 08:00:00,"India's Biocon urges government to exempt cancer, rare-disease drugs from tax in budget - Reuters","<a href=""https://news.google.com/rss/articles/CBMivwFBVV95cUxPbzJWdFBsbUYwZGFtWmJfaVlQUDdkRGg5TGl4UG9JRm9yMnJ6VVlaaGREd3o5TFlyVjB5UU5DRTE2V2JlNUNWNV9sZU03Qy16Q1RNN3hBUEp1VzJad2hKNkZBRDdqNjQ1bUpQcTFrZkxfRW9tVkVBeGxtN1BuTmZuQlVNbHd0Y21JUnlpV2Y2bEl5cTNaMEdQSjlkMFBaODJLOU9CR1NDbjAxd2wxVWI1MjMwcHlBQ0pmcE1qNzdlUQ?oc=5"" target=""_blank"">India's Biocon urges government to exempt cancer, rare-disease drugs from tax in budget</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Reuters</font>",https://news.google.com/rss/articles/CBMivwFBVV95cUxPbzJWdFBsbUYwZGFtWmJfaVlQUDdkRGg5TGl4UG9JRm9yMnJ6VVlaaGREd3o5TFlyVjB5UU5DRTE2V2JlNUNWNV9sZU03Qy16Q1RNN3hBUEp1VzJad2hKNkZBRDdqNjQ1bUpQcTFrZkxfRW9tVkVBeGxtN1BuTmZuQlVNbHd0Y21JUnlpV2Y2bEl5cTNaMEdQSjlkMFBaODJLOU9CR1NDbjAxd2wxVWI1MjMwcHlBQ0pmcE1qNzdlUQ?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.4201,-0.4201,negative,1.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-20,2025-01-20 08:00:00,Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5"" target=""_blank"">Breakout Stocks: How to trade Biocon & BSE on Tuesday? - Market Summary</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2AFBVV95cUxOaC15Z3lQSlp3MnpBN2Ewd0ZhWVctZEJXaGR1YUJ6eE5icjZFVi1obXF4RS1Rc3E2eVk5UzZHM1EzMjRPcVA0dzN5amhXckpUSmFTNjRpVms0RWlBNGd5Y19PQUZaeUVhOVgzc0l2YUVVYUE0ZGpMNG9Qb1lMVDRXX0VKWUJVZElUclAwS0d3NFBkYzh6WUVXZEtjc2gtRTFkYTFhTmpHOEZtT0t1T1NUNC0zX3I0NWwxZlZtdnBWZmlucVpja19hTDNqbVB1VC1hVUpHWUhFTjQ?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-01-21,2025-01-21 08:00:00,Stock Radar: Biocon offers fresh buying opportunity; stock hits 52-week high in January - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Radar: Biocon offers fresh buying opportunity; stock hits 52-week high in January</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5084944444444444,0.5084944444444444,positive,1.0
2025-01-21,2025-01-21 08:00:00,"Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-21,2025-01-21 08:00:00,"Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating downgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-21,2025-01-21 08:00:00,"Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To BUY Today for Intraday, Jan 21: ONGC, Biocon, GICRE, Zomato, Paytm, Dixon Tech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-22,2025-01-22 08:00:00,Biocon stock is poised for a fresh breakout soon; is it time to buy? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock is poised for a fresh breakout soon; is it time to buy?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49934999999999996,0.49934999999999996,positive,1.0
2025-01-22,2025-01-22 08:00:00,Biocon stock is poised for a fresh breakout soon; is it time to buy? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock is poised for a fresh breakout soon; is it time to buy?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49934999999999996,0.49934999999999996,positive,1.0
2025-01-22,2025-01-22 08:00:00,Biocon stock is poised for a fresh breakout soon; is it time to buy? - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon stock is poised for a fresh breakout soon; is it time to buy?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49934999999999996,0.49934999999999996,positive,1.0
2025-01-23,2025-01-23 08:00:00,Biocon gains 3% after board to mull raising funds via commercial papers - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 3% after board to mull raising funds via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2025-01-23,2025-01-23 08:00:00,Biocon gains 3% after board to mull raising funds via commercial papers - Business Standard,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxOY3RaNmJhZlBpMVZoa2JtT3B5RE5neU8xOGF4OG40blVJeEFTWmNRaG0wVXgzNmlpc0hzRDA2dkpLaXZ4ejRGSTJFRkExYXVtNlplS3djeklBdVBkTlpVTF9MUmRLN1pTTUVsRkJ2WV96Y1Y1Tlc3U3NydTdQbG4wWU5tTlp3WGZxWUtZbVdISTJ4SGFOSXBiQ2JSSHRNYnhMVVBZOWNEUEFKa2YwUGdZdzRERWhJQ1NJTElHeGZ0ckxOdS1CQTVydW1wYkpEcWhiV3dZ0gHYAUFVX3lxTFB5eFkwelhDMWlpeUNGSWtCb0hxZ2J6MXVwNzRaM21Obl9NRC1zbHVnNDBfeEU0ZEQ5cFFWTzNzeTdMd3FUNDg3bVoyVTFwZlUyczNOV2hKWjd5elJuaHlRQjN6MW91LWxYMGtyRzVmbkZlMlNFQkpQYlpMYVpJU2JUVjQzQ0NWN1ZXNkVQZGxSN0VPZmhMVEJCb2k4NUtmd3ZwYm1uMmdxV3ZLUE5BRmQ1T0h1QVNZc2JBclh5X0d3RVJ0dzh1UUpiWEw3UHhCeVNWVlpGa05Ebg?oc=5"" target=""_blank"">Biocon gains 3% after board to mull raising funds via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2025-01-23,2025-01-23 08:00:00,Biocon gains 3% after board to mull raising funds via commercial papers - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 3% after board to mull raising funds via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2025-01-27,2025-01-27 08:00:00,Biocon board approves raising Rs 570 cr via issuance of commercial papers - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon board approves raising Rs 570 cr via issuance of commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.36984999999999996,0.36984999999999996,positive,1.0
2025-01-27,2025-01-27 08:00:00,Biocon achieves 6 point increase in its S&P Global ESG score to 69 for 2024 - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon achieves 6 point increase in its S&amp;P Global ESG score to 69 for 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2025-01-27,2025-01-27 08:00:00,"Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Eicher Motors, Tata Consumer, Biocon & Chambal Fertilisers: 4 stock picks by SMC Global</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-27,2025-01-27 09:20:41,Biocon’s ESG Excellence: S&P Global ESG Score Reaches 69 for 2024 - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbXVCaUVZVFUwa1ZGT3M4OUhBX0p5aHRvUUVIblVPalc1RExEcWdtTDhuMkZENTRNZkxXZXBFb1hlejNQLTRobnhHSTJDOVhncndpYTdZbFJESnZZbnl2WTE3YnJfSkc0cWRtVjNua2JhcXNOR2VWQjA3MUtNRE16VG9xRVc0Q3pwb3dkUDlRaGJiN29PZVVGMVMzUk03VUdVS1RoV0VnRFduWUE?oc=5"" target=""_blank"">Biocon’s ESG Excellence: S&amp;P Global ESG Score Reaches 69 for 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbXVCaUVZVFUwa1ZGT3M4OUhBX0p5aHRvUUVIblVPalc1RExEcWdtTDhuMkZENTRNZkxXZXBFb1hlejNQLTRobnhHSTJDOVhncndpYTdZbFJESnZZbnl2WTE3YnJfSkc0cWRtVjNua2JhcXNOR2VWQjA3MUtNRE16VG9xRVc0Q3pwb3dkUDlRaGJiN29PZVVGMVMzUk03VUdVS1RoV0VnRFduWUE?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43125,0.43125,positive,1.0
2025-01-27,2025-01-27 09:20:41,Biocon’s ESG Excellence: S&P Global ESG Score Reaches 69 for 2024 - Biocon,"<a href=""https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbXVCaUVZVFUwa1ZGT3M4OUhBX0p5aHRvUUVIblVPalc1RExEcWdtTDhuMkZENTRNZkxXZXBFb1hlejNQLTRobnhHSTJDOVhncndpYTdZbFJESnZZbnl2WTE3YnJfSkc0cWRtVjNua2JhcXNOR2VWQjA3MUtNRE16VG9xRVc0Q3pwb3dkUDlRaGJiN29PZVVGMVMzUk03VUdVS1RoV0VnRFduWUE?oc=5"" target=""_blank"">Biocon’s ESG Excellence: S&amp;P Global ESG Score Reaches 69 for 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Biocon</font>",https://news.google.com/rss/articles/CBMiqwFBVV95cUxNbXVCaUVZVFUwa1ZGT3M4OUhBX0p5aHRvUUVIblVPalc1RExEcWdtTDhuMkZENTRNZkxXZXBFb1hlejNQLTRobnhHSTJDOVhncndpYTdZbFJESnZZbnl2WTE3YnJfSkc0cWRtVjNua2JhcXNOR2VWQjA3MUtNRE16VG9xRVc0Q3pwb3dkUDlRaGJiN29PZVVGMVMzUk03VUdVS1RoV0VnRFduWUE?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.43125,0.43125,positive,1.0
2025-01-28,2025-01-28 08:00:00,Biocon approves raising Rs 570 cr - BizzBuzz,"<a href=""https://news.google.com/rss/articles/CBMif0FVX3lxTE9la2xJYnV1aDVrUmw5ZVE2Z3RBWFBDMDNtRFMzcTZiQTczaDZWeGlHYkZNeXJqR096MWxGcXRoT2RuVlFIUTVvMlpYbXV4MUZBODVvQkRpY1hucmh6M016aHlYWVZpX3JJYkpPb0Z6TDJzYk9WX3pOX2tUZ0tINEk?oc=5"" target=""_blank"">Biocon approves raising Rs 570 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMif0FVX3lxTE9la2xJYnV1aDVrUmw5ZVE2Z3RBWFBDMDNtRFMzcTZiQTczaDZWeGlHYkZNeXJqR096MWxGcXRoT2RuVlFIUTVvMlpYbXV4MUZBODVvQkRpY1hucmh6M016aHlYWVZpX3JJYkpPb0Z6TDJzYk9WX3pOX2tUZ0tINEk?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2025-01-29,2025-01-29 08:00:00,"Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMimgJBVV95cUxQRUduekV6UkpSczVVNFdqaXRvVTAyLW5Ya0EtbDRkNm5UVEpSTjBWbHNuS0czWEZrb1d5aWpYb3BZWUxERlJWUWFoS2hGRDlTUEREZDZFdU5GSDZpRG9OT3plTm9wbWF3dW5Ta0htVk81Y3A0enNsR1dITllrdkNNZjNTczJHWEhZVFlHNkRWeTFfMlJfbENhQjJCOXo3R0xvUlZoVUhIUmtUeXZvRk5INnltbE9NY01BTEF5ZVRNcEFDekcxbjNXOHNwZmN6bnZ1TDZxamIwTVVGOTR6SXhuYlV0OFc4UU9CRWsydU5JbEZhZFlWR28wb094TndweHQ5V2ZkWVZSYmVNZmVDdHVMR19POVdYX2Q0Q2c?oc=5"" target=""_blank"">Stocks to watch, January 30: Biocon, GAIL, Blue Star, Bajaj Finance, L&amp;T, Tata Motors, Adani Enterprises, Bajaj Finserv, Raymond, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMimgJBVV95cUxQRUduekV6UkpSczVVNFdqaXRvVTAyLW5Ya0EtbDRkNm5UVEpSTjBWbHNuS0czWEZrb1d5aWpYb3BZWUxERlJWUWFoS2hGRDlTUEREZDZFdU5GSDZpRG9OT3plTm9wbWF3dW5Ta0htVk81Y3A0enNsR1dITllrdkNNZjNTczJHWEhZVFlHNkRWeTFfMlJfbENhQjJCOXo3R0xvUlZoVUhIUmtUeXZvRk5INnltbE9NY01BTEF5ZVRNcEFDekcxbjNXOHNwZmN6bnZ1TDZxamIwTVVGOTR6SXhuYlV0OFc4UU9CRWsydU5JbEZhZFlWR28wb094TndweHQ5V2ZkWVZSYmVNZmVDdHVMR19POVdYX2Q0Q2c?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0625,0.0625,neutral,1.0
2025-01-30,2025-01-30 08:00:00,"Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&T, Biocon, Tata Consumer and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5"" target=""_blank"">Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&amp;T, Biocon, Tata Consumer and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&T, Biocon, Tata Consumer and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5"" target=""_blank"">Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&amp;T, Biocon, Tata Consumer and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-30,2025-01-30 08:00:00,"Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&T, Biocon, Tata Consumer and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5"" target=""_blank"">Stocks to watch, January 31: ONGC, Nestle, Vedanta, L&amp;T, Biocon, Tata Consumer and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxNUURFcHhBWHEtZ3kydlE2M3U1R3U3T09oRDVqQldyRnNKbWVna1BJdDVkTmhBSDF0Z3l0dldCeVdZbk9EZzU0dXpSM2dGX0UtaUVmLVFFeDUyeGZNWERLcUNDNW9DM0M4WkdyVUFDeTE2d3ZrMzZNTjRRT2tWWllSajBYSl9wRGtvYUc5eTMxWnQ2R2xWbkpWb2p4WUVTa3BtRmo5NHM5dkdSaVdjNk8yb2Q1YkZaRDNjLS1raEhuRXZja0Y5WVB0TUItSWZGS3F3Uk1aeE5qV2tLUEt2SjBmNDJLQlJPbS16bTJhWkh3Zw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-01-30,2025-01-30 08:00:00,Biocon’s S&P Global ESG Score improves to 69 for 2024 - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNTQ0SF80UDNwQmctcFZkcjlCczNhV2dkY1l0Y2FyMFBJQ2dzR0ZMaXRKQ1ZwSzZRU2Zya1pzM3FCdTNvNWxjZnpnVWppVm5uOC1pOUV6Nl9DY2NySGxKcWVrM19Ia0d1YVQ1emRIYzNfWFJRaV81NHh6NlZPbmxQd0hMdDVzQTVDT19KWHVpVTVrSGFjNjc1Qm5aVEhUUVhCRG9tMXJYV0_SAa8BQVVfeXFMT3Bydzkzdl9nTnh5MjdOLTN4T00zV1pFSk5Kd004d2Q2aXBZZFBiNnkwQk1jNGd1Rk5XS2xNd0w5a0cwVzdxODN5NjUyZi1sQ2RIX3Fmd2x5bzNyQm5TUWNDU2tMM09tdVZqZElfZUU0bHUzSXZ5Wmo1N1NUdzJHMUpDeVVkQ1ZfdHBickJDOXk2NXhnbksxeERjTHNxVTFCWEkwYUZoUFJtdndHVnZTQQ?oc=5"" target=""_blank"">Biocon’s S&amp;P Global ESG Score improves to 69 for 2024</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMiqAFBVV95cUxNNTQ0SF80UDNwQmctcFZkcjlCczNhV2dkY1l0Y2FyMFBJQ2dzR0ZMaXRKQ1ZwSzZRU2Zya1pzM3FCdTNvNWxjZnpnVWppVm5uOC1pOUV6Nl9DY2NySGxKcWVrM19Ia0d1YVQ1emRIYzNfWFJRaV81NHh6NlZPbmxQd0hMdDVzQTVDT19KWHVpVTVrSGFjNjc1Qm5aVEhUUVhCRG9tMXJYV0_SAa8BQVVfeXFMT3Bydzkzdl9nTnh5MjdOLTN4T00zV1pFSk5Kd004d2Q2aXBZZFBiNnkwQk1jNGd1Rk5XS2xNd0w5a0cwVzdxODN5NjUyZi1sQ2RIX3Fmd2x5bzNyQm5TUWNDU2tMM09tdVZqZElfZUU0bHUzSXZ5Wmo1N1NUdzJHMUpDeVVkQ1ZfdHBickJDOXk2NXhnbksxeERjTHNxVTFCWEkwYUZoUFJtdndHVnZTQQ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,"Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree... - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMiqAJBVV95cUxPRWZ0bl9vVTFDUENveXFzMnZLX1pwY2tZOGZQWFp4Smd2TE5OSloxNGRWQjNITHJWTU13a2dUUlNxUlRXUWJZZDBNMGw5WWdWU2M4d2FmTkJzNG1oRVUtbnZINGVYaFhHeW50Z2lKRC1rY2tjaFBPTXVWbHlMUUh0bTYyOEQ3eFpKdEpBVk1MWTFUYlRNWkc1bWFFdzZRMlltM2o2TVYwSGxjZXBabzZQWExUeHZzMXVXRG5kVjhHRlE3cXRJS3l4SkFMSUdaUUlQR3QyOEc4LUNCWmtWQmRmV0JOUDkwTlhzemc5cXM1bV9rY3JnMUY2QTBfbWhJV1Y2ZE5jZU9zWG1wTGpQT3Z3REtPVjRFbmVRVWl5NU5RM3Y3dm9FMXRFWdIBrgJBVV95cUxNVGtxa2JRNVJyQnFCN3c2ei1KOFVEVGJvUzFYOVJqSkdrMmhld2xTZXRtbmJpR092VzlqcEhwenpBLTlKX05lQlFxNUp3MllFcVUzNC1NNXctUGVha1YycXFtWVlxYndMQmdOeFRGNVlLMk1zSnRhcFRNRlkwOHh3QTBHbDUtd3pYbzZiUlhsTlBwWmRTU0p3VnRReG1QRDBMZ19QNFh3NFF5OEVhdlUtbllfZG9PN3JPMV9FWVVqNDUxMWI3a1h1TkFsdERQTWhTYzRCMUIwOFh2UFdjVU85QWxMSGFxM2kzQXZyc1N0SEEzUTRQLVBSaFZqdlBobTh5TV9Ydy1qN0dPSDZrRDc0SzlMUC1UV3pOVkZ4NUREazBkVzFXREUtVElZVVJtdw?oc=5"" target=""_blank"">Stocks to Watch Today: Larsen and Toubro, Wipro, PB Fintech, Biocon, IRCON, Kalyan Jewellers, Shree...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5"" target=""_blank"">Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar - financialexpress.com","<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5"" target=""_blank"">Biocon Share Price Today Highlights, 31 Jan, 2025: Biocon on the radar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxNZ3JUcnhKdVdRczAwMUxSZTBHOUVuZm5PZ3E0QlFNa0dtMU04Y0x2aDRkUVZFa0Q1ZC1CM3VDdkVCVEc5R0g2a0JPampTMi1HcllOMjlRTFpHSjRtUUZFaEk2RWQ3dGpJa25QNm1KWjh4cTFpU3E0cjBnaWdjVGxHX3RPRVdpNi13dWdtSDFJdmJCVUpfU05obmszUHhac0k?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-01-31,2025-01-31 08:00:00,"Stocks in news today: L&T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: L&amp;T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,"Stocks to Watch, Jan 31: L&T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch, Jan 31: L&amp;T, Biocon, BoB, CCI, Kalyan Jewellers, Aavas Fin</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-01-31,2025-01-31 08:00:00,"Stocks in news today: L&T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news today: L&amp;T, JSW Steel, Wipro, Bank of Baroda, Biocon, Kalyan & PB Fintech</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-01,2025-02-01 08:00:00,Biocon Biologics sees diversified global expansion offsetting US localisation risks - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics sees diversified global expansion offsetting US localisation risks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.1366,-0.1366,negative,1.0
2025-02-03,2025-02-03 08:00:00,Watch Biocon Group on Business Outlook - Bloomberg.com,"<a href=""https://news.google.com/rss/articles/CBMikAFBVV95cUxNTUJYb2FYWFBGZUdKejB1ajhMcGdfaUxBbXRxV1FZZmhqd3VoaUoxR2FVY0VmNlo1ZnNxZFR2QndycDN0X0NGeTJZcWhDbUdnS2FRemU5Z3FIbktNejFlc0NraXZmc2Nna2pScTVkRnh6cUo0XzBTSkRULUtJVm5Nb1FyVk4zNDB6Y09QWGxIQUw?oc=5"" target=""_blank"">Watch Biocon Group on Business Outlook</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Bloomberg.com</font>",https://news.google.com/rss/articles/CBMikAFBVV95cUxNTUJYb2FYWFBGZUdKejB1ajhMcGdfaUxBbXRxV1FZZmhqd3VoaUoxR2FVY0VmNlo1ZnNxZFR2QndycDN0X0NGeTJZcWhDbUdnS2FRemU5Z3FIbktNejFlc0NraXZmc2Nna2pScTVkRnh6cUo0XzBTSkRULUtJVm5Nb1FyVk4zNDB6Y09QWGxIQUw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-11,2025-02-11 08:00:00,Biocon's growth formula: Generics & biosimilars - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's growth formula: Generics & biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-02-11,2025-02-11 08:00:00,Biocon's growth formula: Generics & biosimilars - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's growth formula: Generics & biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-02-13,2025-02-13 08:00:00,Biocon Expands in Biosimilars with Viatris Deal | - Chemical Industry Digest,"<a href=""https://news.google.com/rss/articles/CBMifkFVX3lxTFBVZndibEFrQVVqVDdJWkdZUkowSzFGc1BtRlBEVU45WFhnZjd5cFBPTzY0Nm5ub1VaVk4yWk5FMGtUNTE5WVVndE5ISTRzVlFPQllOYXF4N2tlSUhLNnlRYVhVRXpfbmlWaUEwQUdmcjNQdHNyWWtHbTFUWUxxUQ?oc=5"" target=""_blank"">Biocon Expands in Biosimilars with Viatris Deal |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",https://news.google.com/rss/articles/CBMifkFVX3lxTFBVZndibEFrQVVqVDdJWkdZUkowSzFGc1BtRlBEVU45WFhnZjd5cFBPTzY0Nm5ub1VaVk4yWk5FMGtUNTE5WVVndE5ISTRzVlFPQllOYXF4N2tlSUhLNnlRYVhVRXpfbmlWaUEwQUdmcjNQdHNyWWtHbTFUWUxxUQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.10115,0.10115,positive,1.0
2025-02-13,2025-02-13 08:00:00,University of Glasgow announces New Postgraduate study with Biocon work placement during delegation visit to india - Passionate In Marketing,"<a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOG96RTI2YVJ5V2Zoam9iSlJPa3J6ZktoRkhWdUxETHR3UnMtVjBKMDJRdGtfdXlZR0tSRHZvVUxtbnQxSFBlXzZiNklKTV93R2dlNkJLQzlodDg4cFlSbVVXVnZuOHA4cElmbXlGNU1RZ2pXQkpjNFVaNUR6OTk4MjNOeU9QT0FIN05TM3ZEYmQ4RUFlcUdSLU1uNndzUS1RYUt0YXhpV0JXUWhBN1VZdFFBendXc25kQ3VWRkJxX21iS21kbV9rR3NIOTluU3M0eUNrUV9ZaF9PS3NZaVl1ZC0ydnlxbzRa?oc=5"" target=""_blank"">University of Glasgow announces New Postgraduate study with Biocon work placement during delegation visit to india</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Passionate In Marketing</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOG96RTI2YVJ5V2Zoam9iSlJPa3J6ZktoRkhWdUxETHR3UnMtVjBKMDJRdGtfdXlZR0tSRHZvVUxtbnQxSFBlXzZiNklKTV93R2dlNkJLQzlodDg4cFlSbVVXVnZuOHA4cElmbXlGNU1RZ2pXQkpjNFVaNUR6OTk4MjNOeU9QT0FIN05TM3ZEYmQ4RUFlcUdSLU1uNndzUS1RYUt0YXhpV0JXUWhBN1VZdFFBendXc25kQ3VWRkJxX21iS21kbV9rR3NIOTluU3M0eUNrUV9ZaF9PS3NZaVl1ZC0ydnlxbzRa?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29119090909090906,0.29119090909090906,positive,1.0
2025-02-13,2025-02-13 08:00:00,University of Glasgow announces New Postgraduate study with Biocon work placement during delegation visit to india - Passionate In Marketing,"<a href=""https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOG96RTI2YVJ5V2Zoam9iSlJPa3J6ZktoRkhWdUxETHR3UnMtVjBKMDJRdGtfdXlZR0tSRHZvVUxtbnQxSFBlXzZiNklKTV93R2dlNkJLQzlodDg4cFlSbVVXVnZuOHA4cElmbXlGNU1RZ2pXQkpjNFVaNUR6OTk4MjNOeU9QT0FIN05TM3ZEYmQ4RUFlcUdSLU1uNndzUS1RYUt0YXhpV0JXUWhBN1VZdFFBendXc25kQ3VWRkJxX21iS21kbV9rR3NIOTluU3M0eUNrUV9ZaF9PS3NZaVl1ZC0ydnlxbzRa?oc=5"" target=""_blank"">University of Glasgow announces New Postgraduate study with Biocon work placement during delegation visit to india</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Passionate In Marketing</font>",https://news.google.com/rss/articles/CBMi6AFBVV95cUxPOG96RTI2YVJ5V2Zoam9iSlJPa3J6ZktoRkhWdUxETHR3UnMtVjBKMDJRdGtfdXlZR0tSRHZvVUxtbnQxSFBlXzZiNklKTV93R2dlNkJLQzlodDg4cFlSbVVXVnZuOHA4cElmbXlGNU1RZ2pXQkpjNFVaNUR6OTk4MjNOeU9QT0FIN05TM3ZEYmQ4RUFlcUdSLU1uNndzUS1RYUt0YXhpV0JXUWhBN1VZdFFBendXc25kQ3VWRkJxX21iS21kbV9rR3NIOTluU3M0eUNrUV9ZaF9PS3NZaVl1ZC0ydnlxbzRa?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29119090909090906,0.29119090909090906,positive,1.0
2025-02-15,2025-02-15 08:00:00,Biocon founder Kiran Mazumdar-Shaw on how API supply chain can shift from China to India - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon founder Kiran Mazumdar-Shaw on how API supply chain can shift from China to India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-15,2025-02-15 08:00:00,Biocon founder Kiran Mazumdar-Shaw on how API supply chain can shift from China to India - Business Today,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon founder Kiran Mazumdar-Shaw on how API supply chain can shift from China to India</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi8gFBVV95cUxOak1WaHZFQmxVenducnFxbzh0bVBWOG5WNWdwNEdSYnJCWF9McmVHa3k5eWJtSEppdFlrOEp1X2g1WTQ1TUFlVUNsNFYxM2k0Z1plQnppSTNld0QtZUMxcUNSclRQREk2VGF1TUtxRlQ4LUthcllXVUhEZW1mWTVXdy0zaTM0ekZScXltbk5GdUE4eTBTdk80Z3hkZFFGMW5lWURsX0VaMDBJeFFkQUxiRHc4SG41XzNUSkdXNEZRMGxGRmpUY0Nnc242SW1XaTNTQ2Z0OHU4R1ZROUhJV3J3X2dEUG1hNXdiR241a3V5TVEzQdIB9wFBVV95cUxQUHluOFJMSEVZaWVSZFZmdkpRSEFrSUJGYTlqd0l5Nmc5bUpIcE1BZXRCamdoOU1sTFB2RTU1RXhwYU5maUwwSzlmYlV2bXFRR3lrZ2diemV3MW5vTlF4YkVwdFo1WXU2VzkwbVlJbEZLV1JTNGdncTZoVzdva19KTEg5aEw0Z19uZlUxcGFHcEFfVldveVFkcGt2cTk3dHBkZDI1QnpiMWJELV9EaEtvTW5CemFmZmpXNWxXcTBhZVVkQTR0R1p0NTRoYWJ2LU9TWWYyQXpwWjFtRVdRZ1Y2RHZWSjFpNFh0S2VVbXQteEpwN3EzRXEw?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-20,2025-02-20 08:00:00,Does Biocon (NSE:BIOCON) Have A Healthy Balance Sheet? - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Does Biocon (NSE:BIOCON) Have A Healthy Balance Sheet?</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5232166666666667,0.5232166666666667,positive,1.0
2025-02-21,2025-02-21 08:00:00,India can overtake China in drug discovery: Biocon chief - Times of India,"<a href=""https://news.google.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?oc=5"" target=""_blank"">India can overtake China in drug discovery: Biocon chief</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Times of India</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-24,2025-02-24 08:00:00,CCI fines Goldman Sachs AIM over Biocon investment notice - Law.asia,"<a href=""https://news.google.com/rss/articles/CBMiWEFVX3lxTE55djliTm50Z0JaNF95cE1kc0pRUHVIRjUybWRvanFHbElINFdCZXZMVlNMV0xtSElxMGk0LU5uZEtOZ29nWHhKdl85WFhOZGNCU3lDNndzOHk?oc=5"" target=""_blank"">CCI fines Goldman Sachs AIM over Biocon investment notice</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Law.asia</font>",https://news.google.com/rss/articles/CBMiWEFVX3lxTE55djliTm50Z0JaNF95cE1kc0pRUHVIRjUybWRvanFHbElINFdCZXZMVlNMV0xtSElxMGk0LU5uZEtOZ29nWHhKdl85WFhOZGNCU3lDNndzOHk?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-02-25,2025-02-25 08:00:00,"Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: ONGC, NTPC, SBI Life, Manappuram Finance, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-02-25,2025-02-25 08:00:00,Biocon share price in focus after arm launches product in US for autoimmune diseases - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price in focus after arm launches product in US for autoimmune diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQUx3X3ExR1BnalFST0g4TFBILV9VaHExRjBJeGlXWHE3d0lwZ1ZsTVVBSmpZTUR6TnpCSlVfeW91STgxdXgyN19Xemk4OVlQNWZaejBiSndBT0pvUUFvVnpQRnpRWEo3V1dRZExFZ0xkSi1JUHFlVDIxQmRBQUtZaWw5OWx5QjNCdUR2Wnh6NG8zY2Y1WHVjdWpsX1BXVFB3cEY5VnVxS3BOdHZxTjhfSXJ4cExQVTlMLWlUUmNjN3NsS3ZmVnZfQkRTSlp0bEVnOHBLUDJFb1BFcmltQ1hSSEVvRHVrZlBPQ21XbUJCbFQtVlJMRUFNUWVB0gH_AUFVX3lxTFA1OUY4TjREUHBrX2gybHVLWlFLSDVZeHc0blNYUTZvdG5UR3IxWE9iUjBGNEE3Y1FxVWlJWlcwYVNXX0NWc0NHOUdjVTlYTUZZd3VaUFNFWHlmcm9ZaksyMXBlOV9RVlRmQzU5WkRxeXVZNU1SbVQzeUZMVVhPa09vZGltem40V0lGaGlpSzFJQUYyblduOFdlNDNCNVZRVTZ5YXcxS181YXlPTVhLYzlWMjdBOFBqV0doM1VIMGZxX3lPc2ZzRmZLWmxZYkdXdmN6bXYxblBvb0xWb251cXVtZGFKNlBhQmlFUXI5dV9pSlJKZ1B2OV9XVjNxUUdoWQ?oc=5"" target=""_blank"">Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQUx3X3ExR1BnalFST0g4TFBILV9VaHExRjBJeGlXWHE3d0lwZ1ZsTVVBSmpZTUR6TnpCSlVfeW91STgxdXgyN19Xemk4OVlQNWZaejBiSndBT0pvUUFvVnpQRnpRWEo3V1dRZExFZ0xkSi1JUHFlVDIxQmRBQUtZaWw5OWx5QjNCdUR2Wnh6NG8zY2Y1WHVjdWpsX1BXVFB3cEY5VnVxS3BOdHZxTjhfSXJ4cExQVTlMLWlUUmNjN3NsS3ZmVnZfQkRTSlp0bEVnOHBLUDJFb1BFcmltQ1hSSEVvRHVrZlBPQ21XbUJCbFQtVlJMRUFNUWVB0gH_AUFVX3lxTFA1OUY4TjREUHBrX2gybHVLWlFLSDVZeHc0blNYUTZvdG5UR3IxWE9iUjBGNEE3Y1FxVWlJWlcwYVNXX0NWc0NHOUdjVTlYTUZZd3VaUFNFWHlmcm9ZaksyMXBlOV9RVlRmQzU5WkRxeXVZNU1SbVQzeUZMVVhPa09vZGltem40V0lGaGlpSzFJQUYyblduOFdlNDNCNVZRVTZ5YXcxS181YXlPTVhLYzlWMjdBOFBqV0doM1VIMGZxX3lPc2ZzRmZLWmxZYkdXdmN6bXYxblBvb0xWb251cXVtZGFKNlBhQmlFUXI5dV9pSlJKZ1B2OV9XVjNxUUdoWQ?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon share price up 2% as arm launches Yesintek in US; check details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price up 2% as arm launches Yesintek in US; check details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon share price up 2% as arm launches Yesintek in US; check details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price up 2% as arm launches Yesintek in US; check details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon share price in focus after arm launches product in US for autoimmune diseases - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price in focus after arm launches product in US for autoimmune diseases</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-02-25,2025-02-25 08:00:00,Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQUx3X3ExR1BnalFST0g4TFBILV9VaHExRjBJeGlXWHE3d0lwZ1ZsTVVBSmpZTUR6TnpCSlVfeW91STgxdXgyN19Xemk4OVlQNWZaejBiSndBT0pvUUFvVnpQRnpRWEo3V1dRZExFZ0xkSi1JUHFlVDIxQmRBQUtZaWw5OWx5QjNCdUR2Wnh6NG8zY2Y1WHVjdWpsX1BXVFB3cEY5VnVxS3BOdHZxTjhfSXJ4cExQVTlMLWlUUmNjN3NsS3ZmVnZfQkRTSlp0bEVnOHBLUDJFb1BFcmltQ1hSSEVvRHVrZlBPQ21XbUJCbFQtVlJMRUFNUWVB0gH_AUFVX3lxTFA1OUY4TjREUHBrX2gybHVLWlFLSDVZeHc0blNYUTZvdG5UR3IxWE9iUjBGNEE3Y1FxVWlJWlcwYVNXX0NWc0NHOUdjVTlYTUZZd3VaUFNFWHlmcm9ZaksyMXBlOV9RVlRmQzU5WkRxeXVZNU1SbVQzeUZMVVhPa09vZGltem40V0lGaGlpSzFJQUYyblduOFdlNDNCNVZRVTZ5YXcxS181YXlPTVhLYzlWMjdBOFBqV0doM1VIMGZxX3lPc2ZzRmZLWmxZYkdXdmN6bXYxblBvb0xWb251cXVtZGFKNlBhQmlFUXI5dV9pSlJKZ1B2OV9XVjNxUUdoWQ?oc=5"" target=""_blank"">Biocon shares in focus after subsidiary launches biosimilar alternative to Stelara in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQUx3X3ExR1BnalFST0g4TFBILV9VaHExRjBJeGlXWHE3d0lwZ1ZsTVVBSmpZTUR6TnpCSlVfeW91STgxdXgyN19Xemk4OVlQNWZaejBiSndBT0pvUUFvVnpQRnpRWEo3V1dRZExFZ0xkSi1JUHFlVDIxQmRBQUtZaWw5OWx5QjNCdUR2Wnh6NG8zY2Y1WHVjdWpsX1BXVFB3cEY5VnVxS3BOdHZxTjhfSXJ4cExQVTlMLWlUUmNjN3NsS3ZmVnZfQkRTSlp0bEVnOHBLUDJFb1BFcmltQ1hSSEVvRHVrZlBPQ21XbUJCbFQtVlJMRUFNUWVB0gH_AUFVX3lxTFA1OUY4TjREUHBrX2gybHVLWlFLSDVZeHc0blNYUTZvdG5UR3IxWE9iUjBGNEE3Y1FxVWlJWlcwYVNXX0NWc0NHOUdjVTlYTUZZd3VaUFNFWHlmcm9ZaksyMXBlOV9RVlRmQzU5WkRxeXVZNU1SbVQzeUZMVVhPa09vZGltem40V0lGaGlpSzFJQUYyblduOFdlNDNCNVZRVTZ5YXcxS181YXlPTVhLYzlWMjdBOFBqV0doM1VIMGZxX3lPc2ZzRmZLWmxZYkdXdmN6bXYxblBvb0xWb251cXVtZGFKNlBhQmlFUXI5dV9pSlJKZ1B2OV9XVjNxUUdoWQ?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-02-25,2025-02-25 08:00:00,"SBI Card, NTPC, NTPC Green, Biocon, other scrips to track on Tuesday - Zee Business","<a href=""https://news.google.com/rss/articles/CBMingFBVV95cUxPS0FKR2o5Q29NU1NlWjFQay1MQy1kNVFjM01RendMTGFYM2ctOUFLSnktMExHOEZmc3BoQ0U4NWhJSnN5X3c2M0k5TTZOSWVPN090b0M1QnBEWGNtMExJdHNLN0RFcFhIdHVuWU9ReWtIS1JMMERoS0g1NEhqRWtLMnQ1MlZFNmFHeVQ4SXFWXzNwRjRISHIyakRCVTcyZ9IBowFBVV95cUxPUzZwTWViOGszUmZiSFp3RFlsODhYa1VoRENZUXNDeHhGRVUzRGNSV0RVM2x5MW9MeVpUU2dTMWNmajV4YUtvRnIwbDNkZ1Q3U3B3dWNZcTF2Z3FwWlpUMzNBV0RhZjdhSWtJZF8zazhxYzV4VG9pVEFOdklCeTYxR01tTG9xTTFwdE9WdkFiRHZSY2lDa2kxaUVyaWNYdTFoMV9J?oc=5"" target=""_blank"">SBI Card, NTPC, NTPC Green, Biocon, other scrips to track on Tuesday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.com/rss/articles/CBMingFBVV95cUxPS0FKR2o5Q29NU1NlWjFQay1MQy1kNVFjM01RendMTGFYM2ctOUFLSnktMExHOEZmc3BoQ0U4NWhJSnN5X3c2M0k5TTZOSWVPN090b0M1QnBEWGNtMExJdHNLN0RFcFhIdHVuWU9ReWtIS1JMMERoS0g1NEhqRWtLMnQ1MlZFNmFHeVQ4SXFWXzNwRjRISHIyakRCVTcyZ9IBowFBVV95cUxPUzZwTWViOGszUmZiSFp3RFlsODhYa1VoRENZUXNDeHhGRVUzRGNSV0RVM2x5MW9MeVpUU2dTMWNmajV4YUtvRnIwbDNkZ1Q3U3B3dWNZcTF2Z3FwWlpUMzNBV0RhZjdhSWtJZF8zazhxYzV4VG9pVEFOdklCeTYxR01tTG9xTTFwdE9WdkFiRHZSY2lDa2kxaUVyaWNYdTFoMV9J?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.065,-0.065,neutral,1.0
2025-02-25,2025-02-25 08:00:00,"Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: NTPC, LIC, Biocon, ONGC, SBI Life, UPL, SBI Card, IREDA & Welspun Corp</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-02,2025-03-02 08:00:00,"Biocon Foundation marks 20 years of
transforming lives - The New Indian Express","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation marks 20 years of
transforming lives</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The New Indian Express</font>",https://news.google.com/rss/articles/CBMitwFBVV95cUxNU0Vfbjc3N3ZFVVVIVnhFaE1MTkpsSXR0QTFjczBGYnp6ZUlpSFVwTjFiZU1JYmIxR2hIOGw0QzVoQXRCR213aktEUGtneERvaEVsdjdlSElEbjRYdmw2WlYyaWJZYnd5cWpyUTU0R3JBRXVHUG1tcDh5eXdSU0hPWTBBTVNHbjRTQXNFM29YaWpieUNQWXhKSGc1MVVkQTgwTDRwVGl1MV9ESi16VXNvbTJVWU1BMWvSAcQBQVVfeXFMUEtGa0Nia1NXd2hkM0MxQUU2R2hhQzJGRHdZcGVjTWRFZUxpXzhsWkFTZWQ1WEpaQ1FPS21MdHFoNVNyWC03QmtQS01uUFB5ZlVySThkYTVRR1paaFBXZDhROGtPYzJ6ejJYNTc0QjRCMlhLTGQtQVUyNjJUVzNkdV9udVQ4QWlZSm54d1VCdlRUSUFJUThSVFJvazFXMTdrSHdVWW1VcGpnRzdoSzR3M2Q5cFZZdXUwMjNocU5ROFBrbU8xUA?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.04545454545454545,0.04545454545454545,neutral,1.0
2025-03-04,2025-03-04 08:00:00,"Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid, JSW Energy, Welspun Specialty, Rail Vikas Nigam in focus on 5 March - TradingView","<a href=""https://news.google.com/rss/articles/CBMilgJBVV95cUxNcHRTeGJqLWtIeXlmVlBocWlKbzdwQWZtNUZpd0VWWV9GbkxZcXpIeXNrMG5BT2VUZ3NpTUV2c2JuXzhGcnpCNTkxaVczVEZVSzRrdlZYbVlpSDJBU3lDRDg0SndYdXQ2NXFCdDByV1FqTWJ6bGRZOXpZc3dzWkNTNjF1eVQxXzJtdXJDOUNhX0F0YnlRTDlFV2RYWWtsbXpUWVZPZW5RQ1hGcy1xamFVcWNmZlBmNjJ3YnJDRU1vdnZFZGdmazhlT3A0RWZCd2tZSTFqazhyc3JFRVBJTWJ1eTBoM3JVTDU5cnlkRk8yZDVaQjR0SmpTRlBnS2lrN3I3SFVTWWRfdE1EaEdvQndwYUNfQlY2Zw?oc=5"" target=""_blank"">Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid, JSW Energy, Welspun Specialty, Rail Vikas Nigam in focus on 5 March</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMilgJBVV95cUxNcHRTeGJqLWtIeXlmVlBocWlKbzdwQWZtNUZpd0VWWV9GbkxZcXpIeXNrMG5BT2VUZ3NpTUV2c2JuXzhGcnpCNTkxaVczVEZVSzRrdlZYbVlpSDJBU3lDRDg0SndYdXQ2NXFCdDByV1FqTWJ6bGRZOXpZc3dzWkNTNjF1eVQxXzJtdXJDOUNhX0F0YnlRTDlFV2RYWWtsbXpUWVZPZW5RQ1hGcy1xamFVcWNmZlBmNjJ3YnJDRU1vdnZFZGdmazhlT3A0RWZCd2tZSTFqazhyc3JFRVBJTWJ1eTBoM3JVTDU5cnlkRk8yZDVaQjR0SmpTRlBnS2lrN3I3SFVTWWRfdE1EaEdvQndwYUNfQlY2Zw?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-03-05,2025-03-05 08:00:00,Here's why Biocon share price popped 3% in trade on March 5; details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Here's why Biocon share price popped 3% in trade on March 5; details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-03-05,2025-03-05 08:00:00,Biocon shares up 3% after US FDA nod for key cancer drugs - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 3% after US FDA nod for key cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.33530000000000004,-0.33530000000000004,negative,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33089999999999997,0.33089999999999997,positive,1.0
2025-03-05,2025-03-05 08:00:00,Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxQMUpYaG9BaDdSYWE1ODBNdmpDRzRGMm9fOWd3NW5LX2Mwd2FXR0cyUUZGMnN3UHNDVjl2X0w5VmVNT2VDeWRFejlmbExhdDhZWGFkM0t4RHFrMjNjM0RzR2VWQVJZMlB2RWFrWU02NmIyakhyR0ttUkZfaVJnbnAzcXVSbGk3eFdCT09TRlRaMU50a05Bc3dV?oc=5"" target=""_blank"">Biocon Shares Shot Up 3% on Securing Final Approvals from USFDA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxQMUpYaG9BaDdSYWE1ODBNdmpDRzRGMm9fOWd3NW5LX2Mwd2FXR0cyUUZGMnN3UHNDVjl2X0w5VmVNT2VDeWRFejlmbExhdDhZWGFkM0t4RHFrMjNjM0RzR2VWQVJZMlB2RWFrWU02NmIyakhyR0ttUkZfaVJnbnAzcXVSbGk3eFdCT09TRlRaMU50a05Bc3dV?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3953,0.3953,positive,1.0
2025-03-05,2025-03-05 08:00:00,Stocks To Watch: From Biocon to Ola Electric- Here’s a list of 10 stocks in news today - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxPRlpoYTZFS19zcmd5VGYxaFFDN2FQYXpqQjlvenh2bGFoSy1DTnpKZTNDY04yTmF0bGZURWF6Rms4cUZsbHJNelgzbUNwaXY2SjU2UmNSRl9tRnNONk4ta0pmLVpqOE1QdC1wVF9tYzZoTHc3SDdJT3JLMWhkUTVJR2ppRklKZlZQczlseFlJWTl6dXpxWFlsd01oRVE3eFBSYU1RV1ZJSGlISXJ2NnZvNU5YSHFiQnB4RFBjODNDWGhWN1NCNmhlb0p5SzQ?oc=5"" target=""_blank"">Stocks To Watch: From Biocon to Ola Electric- Here’s a list of 10 stocks in news today</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxPRlpoYTZFS19zcmd5VGYxaFFDN2FQYXpqQjlvenh2bGFoSy1DTnpKZTNDY04yTmF0bGZURWF6Rms4cUZsbHJNelgzbUNwaXY2SjU2UmNSRl9tRnNONk4ta0pmLVpqOE1QdC1wVF9tYzZoTHc3SDdJT3JLMWhkUTVJR2ppRklKZlZQczlseFlJWTl6dXpxWFlsd01oRVE3eFBSYU1RV1ZJSGlISXJ2NnZvNU5YSHFiQnB4RFBjODNDWGhWN1NCNmhlb0p5SzQ?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks in news: Power Grid, ONGC, Coforge, Adani Wilmar, Grasim, ABB India, Ola Electric & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Power Grid, ONGC, Coforge, Adani Wilmar, Grasim, ABB India, Ola Electric & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33089999999999997,0.33089999999999997,positive,1.0
2025-03-05,2025-03-05 08:00:00,Biocon shares up 3% after US FDA nod for key cancer drugs - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 3% after US FDA nod for key cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.33530000000000004,-0.33530000000000004,negative,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Biocon, PFC among top 9 trading ideas for 5 March 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33089999999999997,0.33089999999999997,positive,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid, JSW Energy, Welspun Specialty, Rail Vikas... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Biocon, Coforge, GE Vernova, Power Grid, JSW Energy, Welspun Specialty, Rail Vikas...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-03-05,2025-03-05 08:00:00,"Stocks in news: Power Grid, ONGC, Coforge, Adani Wilmar, Grasim, ABB India, Ola Electric & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks in news: Power Grid, ONGC, Coforge, Adani Wilmar, Grasim, ABB India, Ola Electric & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42405,0.42405,positive,1.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42405,0.42405,positive,1.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics and Civica, Inc. collaborate to expand insulin Aspart access in US - BioSpectrum India","<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOV0VEUGR5enBGdExFMFRHTUNYQUQtR1pxNTVPN2NpWFNnLWVscjlCWEF0aUNPaHdhNkZOSXlLREwxVEVsMDk5OWllTEJ0STcxVEQ5NXZSc19CRlpnbkJQT0lXLVBjMm10MWw3d19IUC05TW12bFhWSVRmak1Ec0EzYjZoZlc5azV2XzdWMl9GWDZnQWJheURnZ2lldTNUWnNKeEJ5dV9jbUhsMDFjZWdXTnMxeGxVdEhJYm5ZUmJHYV9aazFwd1l6NFNQTlBzdw?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. collaborate to expand insulin Aspart access in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BioSpectrum India</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOV0VEUGR5enBGdExFMFRHTUNYQUQtR1pxNTVPN2NpWFNnLWVscjlCWEF0aUNPaHdhNkZOSXlLREwxVEVsMDk5OWllTEJ0STcxVEQ5NXZSc19CRlpnbkJQT0lXLVBjMm10MWw3d19IUC05TW12bFhWSVRmak1Ec0EzYjZoZlc5azV2XzdWMl9GWDZnQWJheURnZ2lldTNUWnNKeEJ5dV9jbUhsMDFjZWdXTnMxeGxVdEhJYm5ZUmJHYV9aazFwd1l6NFNQTlBzdw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2025-03-06,2025-03-06 08:00:00,Biocon Biologics to supply insulin Aspart drug substance to Civica for US market - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics to supply insulin Aspart drug substance to Civica for US market</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,"Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March - TradingView","<a href=""https://news.google.com/rss/articles/CBMinAJBVV95cUxPcHZaU1ZidmNJN1dwYVhPLUpFVE5CWXJHYkZOLXB5eUpqMXJQbEVQNmRlVmM2SUZYR2xnekR1MEI1eDR4Ry1RUHNnTTVTY1B6X3dYb1otTVFjbFdTYmJ5MmgtMWVYWk9fTUZNVE9jMnlDY3hsS19VWTBFd1RiZS11TkxXWDB6TE5PVkREcklVaERlQWJGYUhZUmstNHRqY3drRGk2SHE2NHFkMlUyUldMcmNTUHdmZGdPUHIxUUhmVHdBeWJJS244MGdkTHJqWUZLRm9hbWpxcEtYQlh2dTRwbXdNUC15UkQ5MzNERnU4T2NVS0dFdDlabGF5Z2ZkNjZaT00zOEdjYl9IOU40WXE5ZXlER3ZJeTd0NFQ5Uw?oc=5"" target=""_blank"">Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMinAJBVV95cUxPcHZaU1ZidmNJN1dwYVhPLUpFVE5CWXJHYkZOLXB5eUpqMXJQbEVQNmRlVmM2SUZYR2xnekR1MEI1eDR4Ry1RUHNnTTVTY1B6X3dYb1otTVFjbFdTYmJ5MmgtMWVYWk9fTUZNVE9jMnlDY3hsS19VWTBFd1RiZS11TkxXWDB6TE5PVkREcklVaERlQWJGYUhZUmstNHRqY3drRGk2SHE2NHFkMlUyUldMcmNTUHdmZGdPUHIxUUhmVHdBeWJJS244MGdkTHJqWUZLRm9hbWpxcEtYQlh2dTRwbXdNUC15UkQ5MzNERnU4T2NVS0dFdDlabGF5Z2ZkNjZaT00zOEdjYl9IOU40WXE5ZXlER3ZJeTd0NFQ5Uw?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States - PR Newswire","<a href=""https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5"" target=""_blank"">Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States</a>&nbsp;&nbsp;<font color=""#6f6f6f"">PR Newswire</font>",https://news.google.com/rss/articles/CBMi5wFBVV95cUxNeVFmRjZpczFvYk5IZEg2dUJnNjFDV2JlcXhQOTloM2ktQWtVdnZQeG91QWd4bTEtVFpjRlh2ZUwzWlVDaDdIYkh2WVh3ZE9xQU9TeDQ0ZkgxM1I3UGg0R3lJWmFNRktFVU9BeHlfczRSczFuYTZTMmU1blIwdFNhejB6R1VFWTFZUDJncFB3WTdiRHp6YU9CY1I1cHl0T1RFZEFsWWxqXy1aQlJ2Und2dWlLaXZnOGxaUE0yWjJkWWtZVjRtN0Y0OG9zMmdoM2o1aGJtbzlUZmc1SWdQX1NnaS1ORy1CeVU?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42405,0.42405,positive,1.0
2025-03-06,2025-03-06 08:00:00,"Biocon Biologics, Civica partner to expand Insulin Aspart access in the US - Business Standard","<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxPdGdybHB3N2Vob0ZYQ1NPNkdBSkhfNmpxdHJoVzN2S2FXWEpTZFNNQzdFRGZqZWttTjEtZm1GSWMwb21WVnE4OWdiYV9NV25vNzZNeXJla2RaYW82T2ptV2RzODQ4X2lSaE9HbEdlcnBVR2I4WGdjTU5ZeHZydW42TW1UeFVUQjRPVVUyUWxTTnpTNVJpWXp3SnJYRnpEQkhHVGxXWHZ2bFgwZ1Z0ZGQtMDFrWVlzZHlxYnJ3Yld2a2dBdFB4YkIyM1UwZUVfUDVwUGYzQ0JfNzJWUdIB3wFBVV95cUxPYUJicWliWmFLdkRrOUd5Yko1cWQ1ZU1IZHYzcERvekg0S1RWODhiOElCVjl0cEpqdlpoUWp6ZDRUTmI2b2JFaFc4Q1Q4WlJ0bkNDZ2k0SVVuck10eXptZ3o1TC1FaTVTR3ZBT3dyanF4Qm9fMXdKVkNTLVVhbFRXQk9HSzFrTWxfeWxQU2hkT1JvOFdGcjdmaVlaMzNwU3QyZTd3LUFxQ2RaWFpTWG5sdG13WkYyRkRNNjU1bkZaUHNOcHhiUWVkRmRsMEQyOG9FQmtUYUc3MkM5UDlFZF9J?oc=5"" target=""_blank"">Biocon Biologics, Civica partner to expand Insulin Aspart access in the US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2025-03-06,2025-03-06 08:00:00,"Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March - TradingView","<a href=""https://news.google.com/rss/articles/CBMinAJBVV95cUxPcHZaU1ZidmNJN1dwYVhPLUpFVE5CWXJHYkZOLXB5eUpqMXJQbEVQNmRlVmM2SUZYR2xnekR1MEI1eDR4Ry1RUHNnTTVTY1B6X3dYb1otTVFjbFdTYmJ5MmgtMWVYWk9fTUZNVE9jMnlDY3hsS19VWTBFd1RiZS11TkxXWDB6TE5PVkREcklVaERlQWJGYUhZUmstNHRqY3drRGk2SHE2NHFkMlUyUldMcmNTUHdmZGdPUHIxUUhmVHdBeWJJS244MGdkTHJqWUZLRm9hbWpxcEtYQlh2dTRwbXdNUC15UkQ5MzNERnU4T2NVS0dFdDlabGF5Z2ZkNjZaT00zOEdjYl9IOU40WXE5ZXlER3ZJeTd0NFQ5Uw?oc=5"" target=""_blank"">Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMinAJBVV95cUxPcHZaU1ZidmNJN1dwYVhPLUpFVE5CWXJHYkZOLXB5eUpqMXJQbEVQNmRlVmM2SUZYR2xnekR1MEI1eDR4Ry1RUHNnTTVTY1B6X3dYb1otTVFjbFdTYmJ5MmgtMWVYWk9fTUZNVE9jMnlDY3hsS19VWTBFd1RiZS11TkxXWDB6TE5PVkREcklVaERlQWJGYUhZUmstNHRqY3drRGk2SHE2NHFkMlUyUldMcmNTUHdmZGdPUHIxUUhmVHdBeWJJS244MGdkTHJqWUZLRm9hbWpxcEtYQlh2dTRwbXdNUC15UkQ5MzNERnU4T2NVS0dFdDlabGF5Z2ZkNjZaT00zOEdjYl9IOU40WXE5ZXlER3ZJeTd0NFQ5Uw?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-07,2025-03-07 08:00:00,"Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-07,2025-03-07 08:00:00,"Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-07,2025-03-07 08:00:00,"Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Indigo, Infosys, Blue Star, Biocon, Britannia, 63 Moons</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-03-07,2025-03-07 08:00:00,"Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-07,2025-03-07 08:00:00,"Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to Watch: TCS, Power Grid, BEL, IndiGo, Biocon, RVNL, Quess Corp, RITES & Laurus Labs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-07,2025-03-07 08:00:00,"Biocon Share Price Today, March 7: Stocks of Biocon Limited Rise by 1.04% in Early Trade, Check Latest - LatestLY","<a href=""https://news.google.com/rss/articles/CBMi-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?oc=5"" target=""_blank"">Biocon Share Price Today, March 7: Stocks of Biocon Limited Rise by 1.04% in Early Trade, Check Latest</a>&nbsp;&nbsp;<font color=""#6f6f6f"">LatestLY</font>",https://news.google.com/rss/articles/CBMi-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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.15206020408163268,0.15206020408163268,positive,1.0
2025-03-10,2025-03-10 07:00:00,Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3165904761904762,0.3165904761904762,positive,1.0
2025-03-10,2025-03-10 07:00:00,Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3165904761904762,0.3165904761904762,positive,1.0
2025-03-10,2025-03-10 07:00:00,Biocon shares in focus after successful results of Yesintek in Phase 3 - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after successful results of Yesintek in Phase 3</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.64005,0.64005,positive,1.0
2025-03-10,2025-03-10 07:00:00,Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3165904761904762,0.3165904761904762,positive,1.0
2025-03-10,2025-03-10 07:00:00,"Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-10,2025-03-10 07:00:00,Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3165904761904762,0.3165904761904762,positive,1.0
2025-03-10,2025-03-10 07:00:00,"Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-10,2025-03-10 07:00:00,"Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: JSW Steel, Coal India, ONGC, Tata Power, RailTel, BHEL, Concor, Lupin & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-03-17,2025-03-17 07:00:00,"Johor to become Asia's biggest insulin hub, with Biocon's RM1.1bil investment boost - NST Online","<a href=""https://news.google.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?oc=5"" target=""_blank"">Johor to become Asia's biggest insulin hub, with Biocon's RM1.1bil investment boost</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NST Online</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.20095,0.20095,positive,1.0
2025-03-17,2025-03-17 07:00:00,"Johor to become Asia's biggest insulin hub, with Biocon's RM1.1bil investment boost - NST Online","<a href=""https://news.google.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?oc=5"" target=""_blank"">Johor to become Asia's biggest insulin hub, with Biocon's RM1.1bil investment boost</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NST Online</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.20095,0.20095,positive,1.0
2025-03-19,2025-03-19 07:00:00,Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs - The Independent Singapore News,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxNc2NZTDFZTVhJUkxOVFhUQ2FjTnlaQkF0aC0xQmNad2MzVzl0dWJ6R244SzU3QmdPeXdvMzI0bllTYXhEQVQtLWc0M2huU1hBb290Qmt0Y2tkVDZPeFFLX21iZGZIWndTd0RwVDcxQXl6TFBDRzZxWHNwRUFqODhsaWk2b3M5WGx1alFvN3JtaXVUZ0VGdjF1SWN3bGVHMmd1YU1RRlRUdlZHYm9QaG04TWRLb3BhRWRTNUJQTWRBNmhzc3E0eE1TNW9RMmx0ZkwwS2U2aE5zZjRlNGVWSzlB?oc=5"" target=""_blank"">Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Independent Singapore News</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxNc2NZTDFZTVhJUkxOVFhUQ2FjTnlaQkF0aC0xQmNad2MzVzl0dWJ6R244SzU3QmdPeXdvMzI0bllTYXhEQVQtLWc0M2huU1hBb290Qmt0Y2tkVDZPeFFLX21iZGZIWndTd0RwVDcxQXl6TFBDRzZxWHNwRUFqODhsaWk2b3M5WGx1alFvN3JtaXVUZ0VGdjF1SWN3bGVHMmd1YU1RRlRUdlZHYm9QaG04TWRLb3BhRWRTNUJQTWRBNmhzc3E0eE1TNW9RMmx0ZkwwS2U2aE5zZjRlNGVWSzlB?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-03-19,2025-03-19 07:00:00,Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs - The Independent Singapore News,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxNc2NZTDFZTVhJUkxOVFhUQ2FjTnlaQkF0aC0xQmNad2MzVzl0dWJ6R244SzU3QmdPeXdvMzI0bllTYXhEQVQtLWc0M2huU1hBb290Qmt0Y2tkVDZPeFFLX21iZGZIWndTd0RwVDcxQXl6TFBDRzZxWHNwRUFqODhsaWk2b3M5WGx1alFvN3JtaXVUZ0VGdjF1SWN3bGVHMmd1YU1RRlRUdlZHYm9QaG04TWRLb3BhRWRTNUJQTWRBNmhzc3E0eE1TNW9RMmx0ZkwwS2U2aE5zZjRlNGVWSzlB?oc=5"" target=""_blank"">Johor to become Asia’s largest insulin hub with Biocon’s RM2.7B investment; expansion to create over 300 high-skilled jobs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Independent Singapore News</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxNc2NZTDFZTVhJUkxOVFhUQ2FjTnlaQkF0aC0xQmNad2MzVzl0dWJ6R244SzU3QmdPeXdvMzI0bllTYXhEQVQtLWc0M2huU1hBb290Qmt0Y2tkVDZPeFFLX21iZGZIWndTd0RwVDcxQXl6TFBDRzZxWHNwRUFqODhsaWk2b3M5WGx1alFvN3JtaXVUZ0VGdjF1SWN3bGVHMmd1YU1RRlRUdlZHYm9QaG04TWRLb3BhRWRTNUJQTWRBNmhzc3E0eE1TNW9RMmx0ZkwwS2U2aE5zZjRlNGVWSzlB?oc=5,Google News - Market + Complete Company News,Biocon new facility,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-03-20,2025-03-20 07:00:00,Johor’s Insulin Hub: Biocon’s RM1.1 Billion Expansion Strengthens Asia’s Biotech Leadership - Batam News Asia,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOV3VWR3BhbEIxWFlkelEtMEo5N2o4RllEVFEtNnZodERrYW5GWFljaGlDbWd0Y0FGMWg0eGJEQmVac2FLZVp0ZGl6MmZpRHZqeXc3NXpmRlJBVkNxeFVRcnlVc3BORnRwRWhIVUdlN0hfclhDX1pWVFFNT3V3WmxMUXhTYklvSnZncXJucG1oNVJDYTE1U2pLRGRzSml5dWFUQ21vZjNzZ29HWF9rOEVnZmxTR0g0Zmk3QkVlelQtNWMzZ3M?oc=5"" target=""_blank"">Johor’s Insulin Hub: Biocon’s RM1.1 Billion Expansion Strengthens Asia’s Biotech Leadership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Batam News Asia</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxOV3VWR3BhbEIxWFlkelEtMEo5N2o4RllEVFEtNnZodERrYW5GWFljaGlDbWd0Y0FGMWg0eGJEQmVac2FLZVp0ZGl6MmZpRHZqeXc3NXpmRlJBVkNxeFVRcnlVc3BORnRwRWhIVUdlN0hfclhDX1pWVFFNT3V3WmxMUXhTYklvSnZncXJucG1oNVJDYTE1U2pLRGRzSml5dWFUQ21vZjNzZ29HWF9rOEVnZmxTR0g0Zmk3QkVlelQtNWMzZ3M?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3592,0.3592,positive,1.0
2025-03-20,2025-03-20 07:00:00,Johor’s Insulin Hub: Biocon’s RM1.1 Billion Expansion Strengthens Asia’s Biotech Leadership - Batam News Asia,"<a href=""https://news.google.com/rss/articles/CBMiwwFBVV95cUxOV3VWR3BhbEIxWFlkelEtMEo5N2o4RllEVFEtNnZodERrYW5GWFljaGlDbWd0Y0FGMWg0eGJEQmVac2FLZVp0ZGl6MmZpRHZqeXc3NXpmRlJBVkNxeFVRcnlVc3BORnRwRWhIVUdlN0hfclhDX1pWVFFNT3V3WmxMUXhTYklvSnZncXJucG1oNVJDYTE1U2pLRGRzSml5dWFUQ21vZjNzZ29HWF9rOEVnZmxTR0g0Zmk3QkVlelQtNWMzZ3M?oc=5"" target=""_blank"">Johor’s Insulin Hub: Biocon’s RM1.1 Billion Expansion Strengthens Asia’s Biotech Leadership</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Batam News Asia</font>",https://news.google.com/rss/articles/CBMiwwFBVV95cUxOV3VWR3BhbEIxWFlkelEtMEo5N2o4RllEVFEtNnZodERrYW5GWFljaGlDbWd0Y0FGMWg0eGJEQmVac2FLZVp0ZGl6MmZpRHZqeXc3NXpmRlJBVkNxeFVRcnlVc3BORnRwRWhIVUdlN0hfclhDX1pWVFFNT3V3WmxMUXhTYklvSnZncXJucG1oNVJDYTE1U2pLRGRzSml5dWFUQ21vZjNzZ29HWF9rOEVnZmxTR0g0Zmk3QkVlelQtNWMzZ3M?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3592,0.3592,positive,1.0
2025-03-24,2025-03-24 07:00:00,Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon gains 2% on US FDA nod for ANDA Norepinephrine Bitartrate Injection</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.29295,0.29295,positive,1.0
2025-04-02,2025-04-02 07:00:00,Biocon's board to mull fund raising plans on 4 April - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's board to mull fund raising plans on 4 April</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-02,2025-04-02 07:00:00,"Peter Bains steps down as Group CEO of Biocon, to serve Syngene's MD & CEO - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Peter Bains steps down as Group CEO of Biocon, to serve Syngene's MD & CEO</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.03888888888888889,-0.03888888888888889,neutral,1.0
2025-04-02,2025-04-02 16:15:05,"Biocon CEO Peter Bains resigns, board to discuss next steps - People Matters - HR News","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5"" target=""_blank"">Biocon CEO Peter Bains resigns, board to discuss next steps</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26335,-0.26335,negative,1.0
2025-04-02,2025-04-02 16:15:05,"Biocon CEO Peter Bains resigns, board to discuss next steps - People Matters - HR News","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5"" target=""_blank"">Biocon CEO Peter Bains resigns, board to discuss next steps</a>&nbsp;&nbsp;<font color=""#6f6f6f"">People Matters - HR News</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxPdVQxaktUS3FuNFd3aXhwTXlRTUMzUUw2RTVzRFNIeTlTcWotWnlUZ0xJRlc0a0xsRWw0X3VVU2R2RHQyanlnSFB3RDhqcUpYSFRoVkwzMEpEZ0NvbGViNHdnam9yQWRUUVN5U0pYSVVJSGVmY1JwMjl0cmhYUnRYQmNWaTMzYlZ6UVZOTXk4OU4tV1paX3dFY2NRVGZFdlJ5cC1KUXc1UDlxQWxfWFHSAawBQVVfeXFMTXppWGEtNEpQSF8wak42Tkw2c3NycXc0WTdKdC1kUW9rT2NINndnWkVpZ3RzUkp3OXRCY21mNWxtOU9jSUZremxZbWxmeEE4NnFmQk05NUZpcVVIT0pTZk1MVDdHaGpvYVViN0VUN1k4OVZYUFgxSHZQVFhaNkNfU2VrdHBnazQyM29SWWFTaFZDVGNmS1YtajZRTHdOanB1WEs1ay1leUFjdFhUSQ?oc=5,Google News - Market + Complete Company News,Biocon management change,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.26335,-0.26335,negative,1.0
2025-04-04,2025-04-04 07:00:00,"Biocon, Cipla: Nifty Pharma down 6% as US eyes possible tariffs on sector - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon, Cipla: Nifty Pharma down 6% as US eyes possible tariffs on sector</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30392407407407407,0.30392407407407407,positive,1.0
2025-04-07,2025-04-07 05:06:39,Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMizgFBVV95cUxOcXFqX0swdFhkdF9WWFY5OWM1M1cyUEptNEdPYmpvN1JMUy14TlBIRGdxNGN5SWwxamNGNEtPc3A0b0NaS2duZXpFNi1hTXJlNktqdHRQaXZyRXhmcUthdDBZUDBnWDNOeXQ1YTA2aGZFUU1pTGc4WGtzYjdiRlB6SmNQRlRYcEdTbDNiYmZjX0VPclpKREQ0YXN4WlJmVTZWbFRYTlVoZ2w3Q0hsNjJqV0Fma3pyd3RYN256bXdsUS03anpHSWxoZ0FnbkhiZw?oc=5"" target=""_blank"">Biocon Faces Increased Volatility Amid Broader Pharmaceuticals Sector Decline</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMizgFBVV95cUxOcXFqX0swdFhkdF9WWFY5OWM1M1cyUEptNEdPYmpvN1JMUy14TlBIRGdxNGN5SWwxamNGNEtPc3A0b0NaS2duZXpFNi1hTXJlNktqdHRQaXZyRXhmcUthdDBZUDBnWDNOeXQ1YTA2aGZFUU1pTGc4WGtzYjdiRlB6SmNQRlRYcEdTbDNiYmZjX0VPclpKREQ0YXN4WlJmVTZWbFRYTlVoZ2w3Q0hsNjJqV0Fma3pyd3RYN256bXdsUS03anpHSWxoZ0FnbkhiZw?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.24695,0.24695,positive,1.0
2025-04-07,2025-04-07 07:00:00,Biocon to raise up to Rs 600 crore - Medical Dialogues,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPejlRUzBLTTRJZXNZVXdSU3hibWxLNlM0MHkyX1pQd3ByVU41R1EwRWcwTWFsQnpFbjRJVm5HRWFETGZLYU5PeS05cFBFS0piZjN3ci1lc3dWSkxuX0xyRXJHNEFSTmN2d1pHZ3hHT3gzNXZsTTVmWXN2UjlaNDZmd1o5dFFlZXI3OFhpVllMeHpSSlVD0gGaAUFVX3lxTE9GS3hEX1lBemZQYUpheFcwVWJWaUc1d1FtTTZqWkRpWF83NlJLbzVtWE9DdkNleWtjUng3S2dCX0R3cS1wWEhmempWSy14VjVhV25ndmZhNHFOanZTOVBDeDIwbkJYeUZnak5QZmxoNzc5TUdXNXpULUphWjZNOFJpNnRpcVdYRXRkOWNSdTBhVzZKd19VRXhwT3c?oc=5"" target=""_blank"">Biocon to raise up to Rs 600 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPejlRUzBLTTRJZXNZVXdSU3hibWxLNlM0MHkyX1pQd3ByVU41R1EwRWcwTWFsQnpFbjRJVm5HRWFETGZLYU5PeS05cFBFS0piZjN3ci1lc3dWSkxuX0xyRXJHNEFSTmN2d1pHZ3hHT3gzNXZsTTVmWXN2UjlaNDZmd1o5dFFlZXI3OFhpVllMeHpSSlVD0gGaAUFVX3lxTE9GS3hEX1lBemZQYUpheFcwVWJWaUc1d1FtTTZqWkRpWF83NlJLbzVtWE9DdkNleWtjUng3S2dCX0R3cS1wWEhmempWSy14VjVhV25ndmZhNHFOanZTOVBDeDIwbkJYeUZnak5QZmxoNzc5TUdXNXpULUphWjZNOFJpNnRpcVdYRXRkOWNSdTBhVzZKd19VRXhwT3c?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-07,2025-04-07 07:00:00,Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers - Business Upturn,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSzBNSWNTOURZX2pCZEZPNFlZaEd2VkllaVJTWTBEQjFSSHdNdmNTcHhNMVFxWkZNelczVGtYd0tWRW9lZUdwZkxGME5mTjFhS0c1Tm5DMkdEbmdybUVnU1dNMnFWeDFDa0NHLUNXOG01QjJjd3BjaDM3bTZWU3ZKVUJXMnpzdmRtLVFSalB3cC1QZE81UmZfVFVkRjNKUnZGVmNPay03Y1hfVHh3SjVZeVJUM1BkdzVOZ1p5dXRkSEEyYTZYX0QxazlaTloyRG5VMl9CMVRKNlp3N2FE?oc=5"" target=""_blank"">Biocon shares drop over 6% today; Board approves Rs 600 crore fundraise via commercial papers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxPSzBNSWNTOURZX2pCZEZPNFlZaEd2VkllaVJTWTBEQjFSSHdNdmNTcHhNMVFxWkZNelczVGtYd0tWRW9lZUdwZkxGME5mTjFhS0c1Tm5DMkdEbmdybUVnU1dNMnFWeDFDa0NHLUNXOG01QjJjd3BjaDM3bTZWU3ZKVUJXMnpzdmRtLVFSalB3cC1QZE81UmZfVFVkRjNKUnZGVmNPay03Y1hfVHh3SjVZeVJUM1BkdzVOZ1p5dXRkSEEyYTZYX0QxazlaTloyRG5VMl9CMVRKNlp3N2FE?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-04-09,2025-04-09 07:00:00,"Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs - Zee Business","<a href=""https://news.google.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?oc=5"" target=""_blank"">Pharma Stocks Crash: Gland, Aurobindo, Biocon, Sun Pharma slump up to 6% as Trump eyes import tariffs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Zee Business</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.32985,-0.32985,negative,1.0
2025-04-10,2025-04-10 07:00:00,"Biocon Share Price Target 2025, 2030, 2050 - shareprice-target.com","<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5"" target=""_blank"">Biocon Share Price Target 2025, 2030, 2050</a>&nbsp;&nbsp;<font color=""#6f6f6f"">shareprice-target.com</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30484999999999995,0.30484999999999995,positive,1.0
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon Biologics' Bevacizumab Biosimilar - Center for Biosimilars,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5"" target=""_blank"">FDA Approves Biocon Biologics' Bevacizumab Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Center for Biosimilars</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOLXg5SmhvUG5XNFdIOUhnbUZIaEgzSnZjR01VRlhRTzVrQnBNX2NpakRSZ2lLejRPWm1WaUM0TEhTTFh0Z0xSVEUtVnMxOTJZVWNhTVM0cExOM0ltUktxTGtBam9VX3A1V1lLdzVXRDlHU3BGSjl6dlozTEplUjRFTkNyVGY5X3V5Y0laRHA5TXljbGlfSHRiWmdB?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.30484999999999995,0.30484999999999995,positive,1.0
2025-04-10,2025-04-10 07:00:00,FDA Approves Biocon’s Avastin Biosimilar - Managed Healthcare Executive,"<a href=""https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5"" target=""_blank"">FDA Approves Biocon’s Avastin Biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Managed Healthcare Executive</font>",https://news.google.com/rss/articles/CBMikgFBVV95cUxOMHFSOXp6VmFjWTRHYV9uai1FV1FVcHB6dHgxT25ZWVBVem55cUtYMmRRa19pUEhjQUNNeUw2aE9qaDJtLVlkMWdRaUU1d1FEbm9IbWp5NHdkUndJZm44Nnlja0hfd0VFT1c0WVdLOExtaU5PYlJjWnZsM2c4dDN3YkxhVzNvUkM3a0R0cEVmaDJidw?oc=5,Google News - Market + Complete Company News,Biocon investigation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2025-04-10,2025-04-10 07:00:00,"Biocon Share Price Target 2025, 2030, 2050 - shareprice-target.com","<a href=""https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5"" target=""_blank"">Biocon Share Price Target 2025, 2030, 2050</a>&nbsp;&nbsp;<font color=""#6f6f6f"">shareprice-target.com</font>",https://news.google.com/rss/articles/CBMiZ0FVX3lxTFAwLXM3RlFST2hYUVBnTUx6ZVJMY3M3V2hfWFhxMG80ZHRfMGNfSFJZN21vWEhxY3dmbnk2eVRsNGFwajBXb09NbnByeGtTRVBuajN0SkRZWFdIUDJyNXBQQVB3RWdOdDg?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-04-11,2025-04-11 07:00:00,"Stocks To Watch Today: TCS, Biocon, Anand Rathi, BHEL & Sun Pharma - Republic World","<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNcEthUjduV0twNDRabEt6aFZVMGhHNlZMMHhFX0xvR3h2Zkhjd1dhcTFnMmtLUHA5TkdURHZEal9TdU5sbl9aUzU3Wi1kOXM1SFplTWVxaWRhQ0dZY1FOSm1KYVJZSzFNdXd6dFpyRXNVQ3NmdkNwX1pCNEg5QUhRLVZ3NEFMTnJmS18wY1d6bzlaQUxoamVpLU1uTTRreEhW?oc=5"" target=""_blank"">Stocks To Watch Today: TCS, Biocon, Anand Rathi, BHEL & Sun Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxNcEthUjduV0twNDRabEt6aFZVMGhHNlZMMHhFX0xvR3h2Zkhjd1dhcTFnMmtLUHA5TkdURHZEal9TdU5sbl9aUzU3Wi1kOXM1SFplTWVxaWRhQ0dZY1FOSm1KYVJZSzFNdXd6dFpyRXNVQ3NmdkNwX1pCNEg5QUhRLVZ3NEFMTnJmS18wY1d6bzlaQUxoamVpLU1uTTRreEhW?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-04-11,2025-04-11 07:00:00,Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares jump 5.5% as USFDA clears biosimilar Cancer drug JOBEVNE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.35015,-0.35015,negative,1.0
2025-04-11,2025-04-11 07:00:00,Biocon shares rally nearly 6% after unit receives USFDA nod for cancer drug - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2gFBVV95cUxPbXQ4VjBnbm9FZmJkSUdqa0I5SVVPSFBha3BMR0xqNU9PRnRpRjZvSWtMNlU1OVh5aVUxNEk1RmEzRmdnQ2JGdGZMaFlSZkQwUGZGWlAya1hOdVVHNDFrTXlCQWk2TlEtTTczdjdBVnZvai1QSnFZRmlUTDMwSExLVG1jTmUxQ1VpUXN3N1pRU0dBbzEzODFXbkxuZncwbTNvcFpoamVnWEN4OTNZdUFGWHhpWVhRQzV3eHA3Q3ZUS2R3NTl2SVVfWC1WNW1PZDFfVUExYUhSR0MtQdIB3wFBVV95cUxOLVdHSlZEd2kyS0NRdFEybS1falpSN183LWVvUVJ3ZGJsRlBkVzVFdU1Dc1Ayb0wtQ3k5aEpWcy1yWFFqX2Rhb25OelJBNkx0TkhUbzlMbTZqQ1VRUFBXVlhRQlhmVk0weUJxc3VoaHU1UWxXVHJiMmlDUjVYaEY5VmJmVTIzLUtuR0FhQms3U0wxSHFtdzZJMTdaODZxWEpkREUwV1ZXSmNxUDg5U01PODFrRlFZb3JZTlNoVjVEeloyeHhFZXFCekF5VUptY1RQYzBjci1BMzM1Y3N1Q0hn?oc=5"" target=""_blank"">Biocon shares rally nearly 6% after unit receives USFDA nod for cancer drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3153,-0.3153,negative,1.0
2025-04-11,2025-04-11 07:00:00,Biocon Share Price Today: Stock Up Nearly 6% - Here's Why - Republic World,"<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5"" target=""_blank"">Biocon Share Price Today: Stock Up Nearly 6% - Here's Why</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOYjhqZlpuaHdaMEZLVnNhNzFRdl82ek9JX2xBcnZEMHkwVTdEUDBuaEFNc2xvX3NFbXNoQk1hY2dOa0hMT2h0cDYySnhLOHQ3cDg4ZFY5clhvZDRXT0puMUYya1RRQ09JVG84b0kzNEZfOFRUcFJUMC1zN1liN3RIODNfcUtGTzJWUDFWNGwyTDk0RWxqNTRHdkZ0RnBSaGlEYUNHUg?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2966833333333333,0.2966833333333333,positive,1.0
2025-04-11,2025-04-11 07:00:00,Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne - BW Businessworld,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxPZUtFR0NsSWtqazN0N2FPVUlhTENiTWlwVllZMmFJQWY0UmpHTjJoeHZacFp3czZQcVBfOXNSV2o3d1V3VVFfaHdDZWMxYllPclY2TWtLeEIzZ2c5R0FqeG1DRGs5MGh2cGZZV1Nna05yN2Y2bDk2SUNDYlZyVXJkZXgtYWlpenQ3eG5EbXdJV1BCM0tGUE1BekxZeEE5dzJrLUtR?oc=5"" target=""_blank"">Biocon Stock Soars 4% On USFDA Nod For Cancer Drug Jobevne</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BW Businessworld</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxPZUtFR0NsSWtqazN0N2FPVUlhTENiTWlwVllZMmFJQWY0UmpHTjJoeHZacFp3czZQcVBfOXNSV2o3d1V3VVFfaHdDZWMxYllPclY2TWtLeEIzZ2c5R0FqeG1DRGs5MGh2cGZZV1Nna05yN2Y2bDk2SUNDYlZyVXJkZXgtYWlpenQ3eG5EbXdJV1BCM0tGUE1BekxZeEE5dzJrLUtR?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.43445,-0.43445,negative,1.0
2025-04-11,2025-04-11 07:00:00,"TCS, GAIL, Tata Steel, JSW Steel and Biocon Share Price in Focus; Expect Volatile Session for NSE - topnews.in","<a href=""https://news.google.com/rss/articles/CBMiswFBVV95cUxPOUhyNzNSZkJFSlJSTVJnOHhmNkhLTF84ZktZZ21UMzdFcDgxN2V2OUhZQUpYNzlLLWxSRnVhZjcwQTFEOTQzRUhlb1JJWExLSXRxRTU5UXhoWHdDRDVqRkYzOHJNTlVqZXUzQXU1d3MzRUdiY0tQTWNIVDFJUTR3NEtRMV9JRmdvVEpycU5jY0FFWGpITU1kRnUwSTZNLVE1VkE3Y3JNa2NfQXNvWHQ5bVFMaw?oc=5"" target=""_blank"">TCS, GAIL, Tata Steel, JSW Steel and Biocon Share Price in Focus; Expect Volatile Session for NSE</a>&nbsp;&nbsp;<font color=""#6f6f6f"">topnews.in</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPOUhyNzNSZkJFSlJSTVJnOHhmNkhLTF84ZktZZ21UMzdFcDgxN2V2OUhZQUpYNzlLLWxSRnVhZjcwQTFEOTQzRUhlb1JJWExLSXRxRTU5UXhoWHdDRDVqRkYzOHJNTlVqZXUzQXU1d3MzRUdiY0tQTWNIVDFJUTR3NEtRMV9JRmdvVEpycU5jY0FFWGpITU1kRnUwSTZNLVE1VkE3Y3JNa2NfQXNvWHQ5bVFMaw?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-04-11,2025-04-11 07:00:00,"Stocks To Watch Today: TCS, Biocon, Anand Rathi, BHEL & Sun Pharma - Republic World","<a href=""https://news.google.com/rss/articles/CBMioAFBVV95cUxNcEthUjduV0twNDRabEt6aFZVMGhHNlZMMHhFX0xvR3h2Zkhjd1dhcTFnMmtLUHA5TkdURHZEal9TdU5sbl9aUzU3Wi1kOXM1SFplTWVxaWRhQ0dZY1FOSm1KYVJZSzFNdXd6dFpyRXNVQ3NmdkNwX1pCNEg5QUhRLVZ3NEFMTnJmS18wY1d6bzlaQUxoamVpLU1uTTRreEhW?oc=5"" target=""_blank"">Stocks To Watch Today: TCS, Biocon, Anand Rathi, BHEL & Sun Pharma</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMioAFBVV95cUxNcEthUjduV0twNDRabEt6aFZVMGhHNlZMMHhFX0xvR3h2Zkhjd1dhcTFnMmtLUHA5TkdURHZEal9TdU5sbl9aUzU3Wi1kOXM1SFplTWVxaWRhQ0dZY1FOSm1KYVJZSzFNdXd6dFpyRXNVQ3NmdkNwX1pCNEg5QUhRLVZ3NEFMTnJmS18wY1d6bzlaQUxoamVpLU1uTTRreEhW?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-11,2025-04-11 07:00:00,"Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to watch today, April 11: TCS, Tata Motors, Infosys, NBCC, SJVN, Vedanta, Gensol Engineering, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-11,2025-04-11 07:00:00,"Stock Alert: TCS, Coromandel Intl, JSW Energy, Biocon, Jindal Stainless Steel - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock Alert: TCS, Coromandel Intl, JSW Energy, Biocon, Jindal Stainless Steel</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4325,0.4325,positive,1.0
2025-04-15,2025-04-15 07:00:00,Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US - Mint,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price jumps 4% as subsidiary secures market entry for Yesafili in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi5AFBVV95cUxNdkRKVWVfd1JxM09sN2IwZnVwcERkMnBHaTZUSTBZTFlnLXFuTThldjA5Z2NhQmY1NVcxTENMZHlxWl9YeDIySmJybFRhQnJOUjJfRklKRmRQQXV4bkc3d01PcURsS1BlelYwbVB6cHpMUVV6cExZYWdMSXFtU19DQnlQZ3poczNVNG1NZTBVaG1RZXM3NVQzUzdCX04zS1FsaDhnVEl2OHd6S2o5a0JsVVFLM1YzNEdYSWxHaE03S1JJeHo1ZmIwQnV1VjUxV2NISU1XWHhOQ25SVGZ6MXJndzZ0N0fSAeoBQVVfeXFMTkF6RjczdU12eVRWUG54VjA1YlRZeHJ5ay11ZWtob3h4elB3aXVIYm9ETS16QTA1amdfYkVkNzJSVmM3eDYtcl8tb2tERFNrMi1uajRucHRiX3hoYUJTSWZzYk9HajZrb1AycWNUcDRleG53NnFlVU04NGRTUC1PSk9FckpBRl9yZjEyNGx1d3E4MDQ3aEhYVFE3SjAzSTJVLWpKdFhwVmJkY3FMYUpDVlQtVVhxTS01MG9ITkFGVUQxVDB6ODRmMXMwNEstVmFmOFZwc2RsQS03RWViQWNhWkhuZldBZjFncy1R?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3953,0.3953,positive,1.0
2025-04-15,2025-04-15 07:00:00,"Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026 - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics signs deal, gets market entry for Yesafili in US by 2026</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-15,2025-04-15 07:00:00,Biocon Biologics secures market entry for Yesafili in US - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMUFnWmVqN0ZnTVJUS1o0MW8wc3d0X1ktUjg3OU5BUTduamlQQmV4RjREamw4alJNdDlqVE8yWEREYTJ5V1N4U2xPZW5uc2Zad3Q1Z1RQcFVhZm1QRzdock9lSUxHNWtKQVFKVWZBZmlIcVE3VTZ3OWRUalV4OHJ1T2pvMG9Ga2RUb21rczVBWFRxMFdBTjNCd0VwTFA0NGxYZ1lLM19FSkgtNTdra1pWUjhJdlUteGJuWTFKQW94UDkzdDZtSHl0WmJ2RHFDMFlKUDMtZNIB2gFBVV95cUxQNU1HVFdFdXdseVhOWTZqSFFnVzJFWU1KNjFGNjNfUnQ3VS1YUFUwbkZ2NmZWbmxZdVdaRjlaWkVpLUg0QW5sQ1lJcWhIOFFEYUV4V0JlNk05blJhUVByV3ZwVU9oWktaVFhEcE5XTnlWdGd6Q0FHUDRNaFYzemkteDBBMExINlp6NTVUYm5PbzRRQkNIUzdzQk80V0daYkd2eXFKTVVqelBtREZzUHo4ekR0R3pkV3c1ZUg4clJXQnUzMERPR01FZjVDc2hlenZuLXNGaUZ1TlZOZw?oc=5"" target=""_blank"">Biocon Biologics secures market entry for Yesafili in US</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.34536666666666666,0.34536666666666666,positive,1.0
2025-04-17,2025-04-17 07:00:00,"Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk - newstrail.com","<a href=""https://news.google.com/rss/articles/CBMivAFBVV95cUxQZkg1ZDhNTWdBSVdqQ213SFBZMFNjNkdtbXU0YzdSWnhuaS1NU01FTHdyaEs1Q3RpQldjdVpYNVl0d2hIa3lZWTlDekxYQXFvWmM1eDVNNHpkdWJydlVrSkVZMGl5bGZkLVp3Wjk5MFlxRTk3cU1Yc1VhdkkzRFlIb3o0ZFdMWXN1bm9mckFvQXY0OGZ5dGM2OC15YlZXQm9TaEtFcHpFU3FhQkREcDZjd2xaaU5YQVlNcloySQ?oc=5"" target=""_blank"">Type 1 Diabetes Market Set to Witness Significant Growth by 2025-2032 | Biocon Ltd., Novo Nordisk</a>&nbsp;&nbsp;<font color=""#6f6f6f"">newstrail.com</font>",https://news.google.com/rss/articles/CBMivAFBVV95cUxQZkg1ZDhNTWdBSVdqQ213SFBZMFNjNkdtbXU0YzdSWnhuaS1NU01FTHdyaEs1Q3RpQldjdVpYNVl0d2hIa3lZWTlDekxYQXFvWmM1eDVNNHpkdWJydlVrSkVZMGl5bGZkLVp3Wjk5MFlxRTk3cU1Yc1VhdkkzRFlIb3o0ZFdMWXN1bm9mckFvQXY0OGZ5dGM2OC15YlZXQm9TaEtFcHpFU3FhQkREcDZjd2xaaU5YQVlNcloySQ?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.51415,0.51415,positive,1.0
2025-04-17,2025-04-17 07:00:00,Biocon Biologics deal for Yesafili commercialization - The Pharma Letter,"<a href=""https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcXFZamxIT3hmZ2MxZTN0VEU0ZEtWbjlDQ2NIbFlLMVR2QzBLZDlLT1NXXzFNLVp3NU5TLXRHRzhYM0hMMG5xZFJTMXNYRTVBMmlGQlhxQVo4WUl5elVNWG5yOFJrTUNmQ2x6cUl3TGxMWW1VcGVtdUxwc1FNZG95d0lRaXVOdlNQcGhz?oc=5"" target=""_blank"">Biocon Biologics deal for Yesafili commercialization</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Pharma Letter</font>",https://news.google.com/rss/articles/CBMiiwFBVV95cUxNcXFZamxIT3hmZ2MxZTN0VEU0ZEtWbjlDQ2NIbFlLMVR2QzBLZDlLT1NXXzFNLVp3NU5TLXRHRzhYM0hMMG5xZFJTMXNYRTVBMmlGQlhxQVo4WUl5elVNWG5yOFJrTUNmQ2x6cUl3TGxMWW1VcGVtdUxwc1FNZG95d0lRaXVOdlNQcGhz?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-23,2025-04-23 07:00:00,"Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxOclNIU0U2bHNQWnZoRU1aTTdqOWZfLVVWUGZXUU0yd0pLLVU4MFlPeTdJT3RacEIzWDc5Q05SWHFPdFlfT2JtWWRkRk1Xb1kxQ21rTXlwMFpqdXZOM01TeWlzUUc0NFNvT1I0TWpjQlVEYXZoakJNaDBYYm9hMXdhaEgxRkZhUUVjV1M4ZVhmOTVIRzl2clJGbUtvM05WdndrQXZtY3RrQzVrMlRkR3E3aUlrVUVveFlUVVJMSlFjeFA3Y0h3cXdRb1VhRFh5amNXREHSAdcBQVVfeXFMTU1mREtUaXBFMWFKRExEb043TEhfRmJMd2tMVVI1eGRJQ25PUmcyUEtkNnNZZ1ZVdHR2Y2VUcXRZMDE0VWY3U05WZXVnY3paNkYxam5sUlA0NGE2OXNSeWE2cGI4NHJQeUlzejV3S1A3ZkJoODlYX1FvajZEOVB0MFFnaGtwb2YtMi1JWUZENUxoTHEwQVdVc1Q4bnowTU5JeG5TeGJacVZKUmtpcEp1c2tRanNfdUc0OEp5S0xZYURzNUtXLWRFNHN0aDY1eUNVRzRJWkVvWUE?oc=5"" target=""_blank"">Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion - CNBC TV18","<a href=""https://news.google.com/rss/articles/CBMiyAFBVV95cUxPOXpmQU1TMWRoTTl0LWZhWThnSGxiejdscXRCZTlCTUxFVE96aF9iVXpETVVuZ3VEQVVSQ1FaVWwwblpGdFY0amlROW5SZTVDcnNyQUhvNWNQa1p4UTlubEgyS1c4bm53ZWZZLS1JcGUteHltU09TTlNzSlBkNllQUElkNThNM09lNzZLTWFlcGdOMElxUXVhcUozV09sYUdsYll6bW8taUpNVmlSNjNiSHU0cFZKRXRHSUJob0dxOWctellHR1YyV9IBzgFBVV95cUxPa3IzVUZHdHk0QWJJT3NCaUNuSE5nWElNSk9jTzN1WTRmZ1BhUGpuN0tLcmJPMlQwZW1VY2Q2Z1N3SG5hQlBLVGVMRk91aDMxVEpJU2d2djZpTnFZd0huQ2h6Vl9OMnlxREVOdnhqc1k5b2kzaWNxTGVRZnFGUHhlZEpHUzlvWlQxWGhKcGxuQU9WaXlWTzJKbkJPbkRXSVYxTERlVERrM1VPSm9IbXpzNk9MNks5LVNoaXZKb1hCMEJ1ZXR4YnVuTjlpeUw4UQ?oc=5"" target=""_blank"">Biocon board approves fundraise of up to ₹4,500 crore, plans share capital expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4158,0.4158,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Board of Biocon approves fund raising up to Rs 4,500 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Board of Biocon approves fund raising up to Rs 4,500 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Bajaj Housing Finance, LTIMindTree, Biocon: How to trade these 3 buzzing stocks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-23,2025-04-23 07:00:00,"Eris Lifesciences, Lupin and Biocon shares in focus as Novo Nordisk exits Rs 800 crore Human Mixtard brand, says report - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMi_wFBVV95cUxNamJpUnRZUmRIeUpEdGdLUUFIQ2pEWE1XZEJLWVN1MGZmajJzVGNZMU44N0Vva2ppdWlsaFZWNE9NYVl4ZmI0a2VhUDV3VFUtZWJ2YkFHbWtwdEdLT21yZTdWcEMxMUNkUFQzN294Mi1ia1FoT0ZOR1F5N252U2pFYUttRy12T0hoVTFMUjhveVVxeHBPNm95WVdMTVowUFRpN2h2MTluMWxEXzROSTlGeUJoTjNQZVZPQW14cngtVEZJODNiSldaS0xGUEpkYTRHOTJMakQ2aDdnT0s1Nzd5S0FYSUw2UzhJMGU1XzdoSWtJUGYtVDE4QmhhbGNEYUk?oc=5"" target=""_blank"">Eris Lifesciences, Lupin and Biocon shares in focus as Novo Nordisk exits Rs 800 crore Human Mixtard brand, says report</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMi_wFBVV95cUxNamJpUnRZUmRIeUpEdGdLUUFIQ2pEWE1XZEJLWVN1MGZmajJzVGNZMU44N0Vva2ppdWlsaFZWNE9NYVl4ZmI0a2VhUDV3VFUtZWJ2YkFHbWtwdEdLT21yZTdWcEMxMUNkUFQzN294Mi1ia1FoT0ZOR1F5N252U2pFYUttRy12T0hoVTFMUjhveVVxeHBPNm95WVdMTVowUFRpN2h2MTluMWxEXzROSTlGeUJoTjNQZVZPQW14cngtVEZJODNiSldaS0xGUEpkYTRHOTJMakQ2aDdnT0s1Nzd5S0FYSUw2UzhJMGU1XzdoSWtJUGYtVDE4QmhhbGNEYUk?oc=5,Google News - Market + Complete Company News,Biocon brokerage report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Board of Biocon approves fund raising up to Rs 4,500 cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Board of Biocon approves fund raising up to Rs 4,500 cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2025-04-23,2025-04-23 07:00:00,"Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: LTIMindtree, Bajaj Housing Finance, Biocon, 360 ONE WAM and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.11365,0.11365,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.48246666666666665,0.48246666666666665,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi7AFBVV95cUxPYm9keG0xMGxNR3lUZHlrTXFGXzJrWFlBcVlJNVdrVHBReVJQN2hyLVFUX1pyMW1IYnZnOGtneHNPNzR1Mkd0dFl5N2xYc3ZsLXJUS3ZhejdFZ3RpNWREcEFtdE9IQVdrM2g2MFV6ZkNrc3NLal8tYndlQkJORVdqSk9nNVljM3d6dUkyZDBIVEx5MWUzczR1X3RqTlF6Uk80azRzZWtKdzVNQ2t0Z2Q5d0UwdC1ITXlMLW9KN0hpalNCSTRXYURvMkx2MFdtWWFqcE1NTl9xWGN5cmdKVFkwVVo2Q0pxR2FnY2Z6MtIB8gFBVV95cUxPZG4tQW55Yk9VYnFEVnZOalRoUU9WLTZZZDY2SHhSUUxRS1hQYjZmQ09zYkFoTGJmekhKaG9hci1MNF9EbHZzMmhFQXg2WUYyYjlMNlJsdWFyYkhWT3lxYTFtY09FYXBQUDhMOUNpRy1MUzlVVXdPWDM3bWRlY1IzN19KU2NzWHVRZm5uOVJ2ZlFOSThpd1ZQWWRzVzdjaVpTZ015UmNtTDBCRnl3VzlIMVFKdUxxcUM0ZnBobmIydDNrcnFkbk5wQWZhYlgwODNqQUlINXVMSGdSSE5kcU5ISHZGcm9TSjBuUFRjN0UwS0hSUQ?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.11365,0.11365,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan - India Infoline","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdhVjBNSmRzQ0tFLUVRWmZKTWRVVHJYU1BMX2dLTXVwc3I0Q00yeFUwRVR0WlBKbkpLSExzbk1UX3FjM2hfNjhEakpFWklZdmRPUDMyS3l3OXRha3NkYThtUFZkNWdpb2gwYjQ3RkQzaENhd1NZY3RZNUp0YjZydVU1TTM2d0R1ekJmZDdsblNyYmRHZlphUkNmVlVZcmVjMkJVZw?oc=5"" target=""_blank"">Biocon to Raise ₹4,500 Crore; Approves Capital Expansion Plan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNOUdhVjBNSmRzQ0tFLUVRWmZKTWRVVHJYU1BMX2dLTXVwc3I0Q00yeFUwRVR0WlBKbkpLSExzbk1UX3FjM2hfNjhEakpFWklZdmRPUDMyS3l3OXRha3NkYThtUFZkNWdpb2gwYjQ3RkQzaENhd1NZY3RZNUp0YjZydVU1TTM2d0R1ekJmZDdsblNyYmRHZlphUkNmVlVZcmVjMkJVZw?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.32985,0.32985,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more - Groww","<a href=""https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5"" target=""_blank"">Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares fall 3% after board approves fundraise of up to Rs 4,500 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.48246666666666665,0.48246666666666665,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Biocon's board OKs to raise Rs 4,500-cr - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's board OKs to raise Rs 4,500-cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-04-24,2025-04-24 07:00:00,"Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more - Groww","<a href=""https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5"" target=""_blank"">Stocks to Watch Today, 24th April 2025: LTIMindtree, Bajaj Housing Finance, Tata Consumer Products, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Groww</font>",https://news.google.com/rss/articles/CBMia0FVX3lxTE5rVW9HSjVvNDBvVmpiMkZCaEtfZi02OGpmdS00X0ZxVVpQTEUxRHBqc015bVN4TWJTTjBHMmFSaGpUckVsLUdKcWhoeWgxTkRzSzV1NFhSVGVTUjJTWHl3TFBEaE44V19wX1Zj?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-04-24,2025-04-24 07:00:00,"Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon - Business Today","<a href=""https://news.google.com/rss/articles/CBMi7AFBVV95cUxPYm9keG0xMGxNR3lUZHlrTXFGXzJrWFlBcVlJNVdrVHBReVJQN2hyLVFUX1pyMW1IYnZnOGtneHNPNzR1Mkd0dFl5N2xYc3ZsLXJUS3ZhejdFZ3RpNWREcEFtdE9IQVdrM2g2MFV6ZkNrc3NLal8tYndlQkJORVdqSk9nNVljM3d6dUkyZDBIVEx5MWUzczR1X3RqTlF6Uk80azRzZWtKdzVNQ2t0Z2Q5d0UwdC1ITXlMLW9KN0hpalNCSTRXYURvMkx2MFdtWWFqcE1NTl9xWGN5cmdKVFkwVVo2Q0pxR2FnY2Z6MtIB8gFBVV95cUxPZG4tQW55Yk9VYnFEVnZOalRoUU9WLTZZZDY2SHhSUUxRS1hQYjZmQ09zYkFoTGJmekhKaG9hci1MNF9EbHZzMmhFQXg2WUYyYjlMNlJsdWFyYkhWT3lxYTFtY09FYXBQUDhMOUNpRy1MUzlVVXdPWDM3bWRlY1IzN19KU2NzWHVRZm5uOVJ2ZlFOSThpd1ZQWWRzVzdjaVpTZ015UmNtTDBCRnl3VzlIMVFKdUxxcUM0ZnBobmIydDNrcnFkbk5wQWZhYlgwODNqQUlINXVMSGdSSE5kcU5ISHZGcm9TSjBuUFRjN0UwS0hSUQ?oc=5"" target=""_blank"">Top Stocks to watch: Bajaj Finance, Adani Green, TCPL, LTIMindTree, BPCL, Bajaj Housing & Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.11365,0.11365,positive,1.0
2025-04-26,2025-04-26 07:00:00,Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.45781818181818185,0.45781818181818185,positive,1.0
2025-04-26,2025-04-26 07:06:40,Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health - Medical Dialogues,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics receives EMA Committee positive opinions for Biosimilar Denosumab for bone health</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Medical Dialogues</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.45781818181818185,0.45781818181818185,positive,1.0
2025-04-28,2025-04-28 07:00:00,Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares up 2% on positive opinions for biosimilar Denosumab in Europe</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5212575757575758,0.5212575757575758,positive,1.0
2025-04-28,2025-04-28 07:00:00,Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars - Samco,"<a href=""https://news.google.com/rss/articles/CBMiowFBVV95cUxOTGVIWFZQWWdWWDNCSnlKbDR3X2FIWHJpTzVRNUplcXc5YW5KMUZaYnF6MmM2RWl0UG9yVWFBMFAxcWFsT3FKbEhiTUNZZ2VGUjZMSE9aZ2hncjlETjBoV2NoXzVMR1pYcUFJTmtuY0FRc2NQT1ltdGNWT08yZGluNXNkU3RSYmZhR3V3Z1Ffb0VsRV9QYnFDUWNlY3B3dkxhbldJ?oc=5"" target=""_blank"">Biocon Shares Rise 2% Following Positive CHMP Opinion For Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Samco</font>",https://news.google.com/rss/articles/CBMiowFBVV95cUxOTGVIWFZQWWdWWDNCSnlKbDR3X2FIWHJpTzVRNUplcXc5YW5KMUZaYnF6MmM2RWl0UG9yVWFBMFAxcWFsT3FKbEhiTUNZZ2VGUjZMSE9aZ2hncjlETjBoV2NoXzVMR1pYcUFJTmtuY0FRc2NQT1ltdGNWT08yZGluNXNkU3RSYmZhR3V3Z1Ffb0VsRV9QYnFDUWNlY3B3dkxhbldJ?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4909545454545455,0.4909545454545455,positive,1.0
2025-04-28,2025-04-28 07:00:00,"Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5"" target=""_blank"">Zydus Lifesciences, Biocon, and Aurobindo Pharma Shares Rise on Fresh Regulatory Approvals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiugFBVV95cUxNU1ZBMkczS3B4SWZ5WGVoVzBWcmNqUHdkTU53MXdTSFVBaWdMMFZyUW42NE5NRjc4Z0NudGItQnNqdFVEc3lkZmpQVF96RFlnY0dpdlkzRkphRkZTUkNKd2xOSEJvdXpMaW9Wc3VmOGJLeEdndmpmQjFhakpfbTlvRWJiRDBiMTNwSE9rcVVRa1ZJREdXYkVyb3MydkYyNkU2RzJyN2NEN0hBNHNMUVRvejctem5uVUt6SkE?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49529999999999996,0.49529999999999996,positive,1.0
2025-05-05,2025-05-05 07:00:00,Biocon Share Price Today Up 5% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxQQkYtelFiLXlMRUhBMjExZm83Ri1PajU0alZITjNpVkhHem1mMDkyWW1oRzB2RHMwNTU2Y0dSUGVQRUJtejlGTlZHX1NIeDBJWVBFSzR5eXFQVWxreHRKRE5ranNWekR1a20tQTFSWmNGSXVveTlkTER0Nms3cVFpaTluMWhMRWZsNUF6TkM0cUp5R0Js?oc=5"" target=""_blank"">Biocon Share Price Today Up 5%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxQQkYtelFiLXlMRUhBMjExZm83Ri1PajU0alZITjNpVkhHem1mMDkyWW1oRzB2RHMwNTU2Y0dSUGVQRUJtejlGTlZHX1NIeDBJWVBFSzR5eXFQVWxreHRKRE5ranNWekR1a20tQTFSWmNGSXVveTlkTER0Nms3cVFpaTluMWhMRWZsNUF6TkM0cUp5R0Js?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-07,2025-05-07 07:00:00,"Buy Tata Motors, Paytm, Biocon, HUL & sell Coal India, ABB India, says analyst - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Buy Tata Motors, Paytm, Biocon, HUL & sell Coal India, ABB India, says analyst</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMiswFBVV95cUxPaS1oXzhqNzVKbDBKTGpPT2ZSUzV5WTJUaUJHc3pqdGE0OUlmVHBQanV6RnBrUFVnRndqZ0JqSXFPZXZwNWJndDdIN0M5bENDVnlkY1FFTENzT3JnWi1pYzdCWHdkS1ZKVXo5cTB3amxGUzFRVkpyaWt2U1h1MTk0NGVpVVlsMk45dTd6aFVJeUJ5NmxjTnFYQzgyMkRjX1V5UkFBNk5UYUx2YUg0MjRrWkYyMNIBuAFBVV95cUxPMTVOUkxsTDNNZXZfcDcxMDc0TTJKNkFkMjBsRmJZa0RUSkMyQkpsZ25LNWk5NzVNaUNIMVlESlZtaVh4SnUzNzduajZVTnotd1pqd2t0THI2c1htckNlZlRzeGw1ZEdqRDQ4N1Y0cHlNWGhaTUJPQ3Z1dmNmN295b2ZGVVo0OEx2eHVwTC1UOURmdmdaQXdlZVg5dlZzM055MGhiVmsxS1ZoSjlXX1IwSVRVVFlfSW9z?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-07,2025-05-07 07:00:00,"Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more - Upstox","<a href=""https://news.google.com/rss/articles/CBMijwJBVV95cUxQR3MxT3p0TVdES0FqMnNYZlQ1N3FlTy1KTmYyanVHczVuS1FBM21VcWNOQUpfODFBVTlmaFB0aW5CZmRCQnVVNnBOcW40dVNGTXJ5WEpVNGpuZk1wdl9LQ2Z4dVNoX1VfbUFZZjdEUnhoT1dUdDlPMUVxVFdETC1BSUEzUGxZZmZFQWdyWE5oWFBBeGhFNDd2bDF1cE9kU0ZRU1Jnc2cwOUZCOWpnZ291ZTdGLWFHRDZuSEQ1RTN1dmtUbGNhXy1tMXFObVViMlBDaEtQVFV6V1I2cDlpMm93dWRKejZra0U1dG9yOFgyZGlYUGNxdEZiTEl3YTBpc3RQVHotc3p4VHZKVzI4amNv?oc=5"" target=""_blank"">Stocks to Watch, May 8: Pidilite Industries, Asian Paints, L&amp;T, Titan, MCX, Britannia, Canara Bank, Bharat Forge, Biocon, and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijwJBVV95cUxQR3MxT3p0TVdES0FqMnNYZlQ1N3FlTy1KTmYyanVHczVuS1FBM21VcWNOQUpfODFBVTlmaFB0aW5CZmRCQnVVNnBOcW40dVNGTXJ5WEpVNGpuZk1wdl9LQ2Z4dVNoX1VfbUFZZjdEUnhoT1dUdDlPMUVxVFdETC1BSUEzUGxZZmZFQWdyWE5oWFBBeGhFNDd2bDF1cE9kU0ZRU1Jnc2cwOUZCOWpnZ291ZTdGLWFHRDZuSEQ1RTN1dmtUbGNhXy1tMXFObVViMlBDaEtQVFV6V1I2cDlpMm93dWRKejZra0U1dG9yOFgyZGlYUGNxdEZiTEl3YTBpc3RQVHotc3p4VHZKVzI4amNv?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0625,0.0625,neutral,1.0
2025-05-09,2025-05-09 07:00:00,Biocon targets high-teens generics growth in FY26 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon targets high-teens generics growth in FY26 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon shares in focus as Q4 PAT soars 153% YoY - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus as Q4 PAT soars 153% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon Q4 PAT zooms 154% YoY to Rs 344 crore - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Q4 PAT zooms 154% YoY to Rs 344 crore</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-09,2025-05-09 07:00:00,"Stocks To Watch: Titan, Swiggy, Paytm, Kalyan Jewellers, Biocon, Zee, And Others - News18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch: Titan, Swiggy, Paytm, Kalyan Jewellers, Biocon, Zee, And Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-09,2025-05-09 07:00:00,Biocon targets high-teens generics growth in FY26 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon shares in focus as Q4 PAT soars 153% YoY - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus as Q4 PAT soars 153% YoY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-05-09,2025-05-09 07:00:00,Biocon targets high-teens generics growth in FY26 - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5"" target=""_blank"">Biocon targets high-teens generics growth in FY26</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMipgFBVV95cUxQRDRmVUdTd1VOOWEzSjg0YmcwME4wQkMtMHVCSV9tempUQV9yYnBxdzZnU3JsMlRobmItTzhaVV90cEZ1NXJDR05wSEI4MnNDdTA4Ty1IaXg1RGh1YWt0VHdnYUI2NHg3bDV1ZnUwbUVBV0kycERVWloxRUM5ZUxLbW9TY2M3Wk1KdG1ONEYwZzFaQXhBWU04bHVSZVo2SThWQ1ZzRlFB0gGrAUFVX3lxTE1kX096dXk0UGlnR3U1Q2s2SWs5OC1oa0hkc1k1U0VrdHNMOG1Ka1BDdktMQ2EyNDRJXzR4Yktmb01JcFRTc0xfckR1d0E3WkNrY1FDNXp3XzRZWG5GNFRpa09JRXdMOFJmUVcwRlRWc2YzeWtsczZwcVFISmFZTGRJSFBNN1BhUWtVeVNTQ000X3AzdmN6azBQX2cybDVNMG5Pd2V6Q2Nrb1M4dw?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Analysts recommend buying Biocon, Tata Motors, BEL & selling Chambal Fertilisers, Adani Green - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Analysts recommend buying Biocon, Tata Motors, BEL & selling Chambal Fertilisers, Adani Green</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.25620000000000004,0.25620000000000004,positive,1.0
2025-05-09,2025-05-09 07:00:00,"Top stocks to watch: Titan, L&T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Top stocks to watch: Titan, L&amp;T, BPCL, Suzlon, Paytm, Lupin, Britannia, MCX India, Biocon</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMi4AFBVV95cUxOVVJCTl85cW1oNm5FNXhRQ08tcC1hV2FyMEtRRmFqX3QyZ1hNbmFqUGh3bTZJa3d4SmU3cG1qbW1pdEtpcFZzQ040bVdRa0JjTk9ETnEtd1FXSkQ2QnVRUTZ2SUpDOGFZbzgwMjQ2T3BSWFo2aFlOOENFWUh2ZlhIU1g5MS1USlFJN3dYa2t1bjFfd3h0Q25scEUwN041UkJWaTBlU2prVldkNjd2alIzMHMxNjh5WHRYUnZSYWdCQmNiMVM0VjdSTW9wb3NwdDFDR3pVOXNWUFhrN3lvOVNELdIB5gFBVV95cUxOZm5kNV95T3c2UUlPZm0ybEh3N3Z2Nms2aVZka09meldrNDhJd2prRHlpVFI0WjdDRF9XZnhkd0lnV2dVSDAtNGV1TFF5V0VGTTFTcnF0Ujg1dkh5cjNYNzE2WTJ1VEhBMzZ1azdiaFhYeUMwRkVaaExEVl9BN3NfbEZ6SmJqWEVXUTRuRUVPMmwzcW5sU3gxSV9FNGVpSUNPcjJBdzVWV09mbkVIT1B2RVNoYUpvbVU1ajU3RHJyY281TUliLWFCdUFGQUZ2WUMxeWdOVHRqQlhmalhMeDFyMi1PQ2VjUQ?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.22615000000000002,0.22615000000000002,positive,1.0
2025-05-10,2025-05-10 07:00:00,Biocon plans $150-million capex in two years - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans $150-million capex in two years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-10,2025-05-10 07:00:00,Biocon plans $150-million capex in two years - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans $150-million capex in two years</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-12,2025-05-12 07:00:00,Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150 - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42205,0.42205,positive,1.0
2025-05-12,2025-05-12 07:00:00,Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-12,2025-05-12 07:00:00,Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150 - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Dip 2.36% in Today's Trade; Among Top Losers in NIFTY MIDCAP 150</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42205,0.42205,positive,1.0
2025-05-12,2025-05-12 07:00:00,Biocon Share Price Today Down 3% - Equitymaster,"<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxOVXYtRlp6WUhDSy1wdTFhZW5hWGZxZlJDSXlLZjlIbFNkSjNnRGM0YUtJTnk3ODZTY2MtQWlDODZQdkZySE5fRmg3NXNQTU5aNEZGUW5GZGNvVVhFSVRFeS1IV3YydklycEhWOUpyUWQ2d1dyQ0V2dm8yalpOZlRMQVRPc1NiYzlIZUJWazNfOEo1WHBU?oc=5"" target=""_blank"">Biocon Share Price Today Down 3%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitymaster</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxOVXYtRlp6WUhDSy1wdTFhZW5hWGZxZlJDSXlLZjlIbFNkSjNnRGM0YUtJTnk3ODZTY2MtQWlDODZQdkZySE5fRmg3NXNQTU5aNEZGUW5GZGNvVVhFSVRFeS1IV3YydklycEhWOUpyUWQ2d1dyQ0V2dm8yalpOZlRMQVRPc1NiYzlIZUJWazNfOEo1WHBU?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.21149814814814813,0.21149814814814813,positive,1.0
2025-05-12,2025-05-12 07:00:00,Expect a 'soft-landing' for Indian pharma: Biocon's Kiran Mazumdar-Shaw on Trump's drug order - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Expect a 'soft-landing' for Indian pharma: Biocon's Kiran Mazumdar-Shaw on Trump's drug order</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-12,2025-05-12 07:00:00,Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy - CNBC TV18,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxQeWtveXgzRUJEa29YTkY5clJyZmtCNlQtYUxqM3RwcGRKQmpVYjJJNzdtekJtWG1XSGlKNXZ6X2VhNVp3VXpKektDc0k2dFJfb2dUZVJ4SWRzOXV1UERURXZUYWt4MDF1TVVXNWk3ZE8yZDFqejlsOG9jRnJqQ0lXbkc0V29zU09aazh2Snh4eEdRdjNkaFlGd2xiREtZd3RoV2tTejNyYnNNSU5FMFNNSVVwcVI1MnB3Y1N6ZmFn0gHDAUFVX3lxTE1pczNzeW44N01kUFlmbmo0TFVZUmJHcGtHTDYwRkl5cm80UklxRlZobEFpTnVZTlBRVlZ6d01LTG1LYmRZdG1tcXlTTEtjVmd0WDRFNE5FbFc1ZHVPVnpNR29CX3JVbEQzd2d3WURQUTNldFllWl9LcDhGSHljVE1WYVo2NDBFWVliZ1duNUItd2syaU54ZlM0LWtKVkFqaGIzS0d3R1JIWFA2VGpYZXFqbTlDanZxdGRkSkxnbHdEYVMtUQ?oc=5"" target=""_blank"">Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-12,2025-05-12 07:00:00,Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares decline even though analysts see up to 30% upside on stock — Should you buy</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-13,2025-05-13 11:31:34,Biocon to Invest $200 Million This Year in Growth and Expansion - IndiaMedToday,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5"" target=""_blank"">Biocon to Invest $200 Million This Year in Growth and Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-13,2025-05-13 11:31:34,Biocon to Invest $200 Million This Year in Growth and Expansion - IndiaMedToday,"<a href=""https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5"" target=""_blank"">Biocon to Invest $200 Million This Year in Growth and Expansion</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMikwFBVV95cUxORENXejRyMEVWVm1lOGtCenU1amV2LVBTTkJyWVZ1TE5RVnY3WHdkMWdFcEdCYW84d1hFeDFHem1uMFlsenYyZ0ZtVFlwb2lUTFl6NHJLWGNLQ1JSSUtZZ1E0cm1FNUhKMXprNk9UQWUxMi1ReVNVamtENHVFSzJGd2ZycHVJT1gyYmZsOTUyUzEwVkk?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-14,2025-05-14 07:00:00,Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr - Indian Pharma Post,"<a href=""https://news.google.com/rss/articles/CBMinwFBVV95cUxPaTZCaWZvc3BwTkJMWjV3N2ZYeE1YUkVWUjdaY3BmMWc1MEVzRzlQMDZIcDJsdVNQOU9JYzNwSWhIMEYyNlUtRFhlVUFlalp5TklESmZtQWJrbWUxbWprRnNmVzVvMmY2bm8zZlhobU1XMUxGaEN3YXZyQkR3OGJPUzVpNVVVZVdjTXVreWVIYWVnSkMzYW1BcXBBb0oyVUXSAaYBQVVfeXFMUDN2b0lrb3FGeDg1ZVE4WF9NZnlJaDZkdmNwczlVU2RvN3pLZEJlbHJtS29CT1lqY3Y1NmVqdGZmUnFmQ2xMbkoycTZpcmFySmxxZXgzdXVoLTFfU1g2b2Z5VXBVODZjX2wtTEFrNW16UWgzMHVhcDZwVEhSYXdTamdzUnZvXzlpNktwV2tWLXh6RjhjcVlkQWZsTS1QRklJazJtYUJwdw?oc=5"" target=""_blank"">Biocon Q4 FY25 consolidated PAT jumps 153% to Rs. 344 Cr</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Indian Pharma Post</font>",https://news.google.com/rss/articles/CBMinwFBVV95cUxPaTZCaWZvc3BwTkJMWjV3N2ZYeE1YUkVWUjdaY3BmMWc1MEVzRzlQMDZIcDJsdVNQOU9JYzNwSWhIMEYyNlUtRFhlVUFlalp5TklESmZtQWJrbWUxbWprRnNmVzVvMmY2bm8zZlhobU1XMUxGaEN3YXZyQkR3OGJPUzVpNVVVZVdjTXVreWVIYWVnSkMzYW1BcXBBb0oyVUXSAaYBQVVfeXFMUDN2b0lrb3FGeDg1ZVE4WF9NZnlJaDZkdmNwczlVU2RvN3pLZEJlbHJtS29CT1lqY3Y1NmVqdGZmUnFmQ2xMbkoycTZpcmFySmxxZXgzdXVoLTFfU1g2b2Z5VXBVODZjX2wtTEFrNW16UWgzMHVhcDZwVEhSYXdTamdzUnZvXzlpNktwV2tWLXh6RjhjcVlkQWZsTS1QRklJazJtYUJwdw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-14,2025-05-14 07:00:00,Biocon Shares Experience Price Rise of 2.11% During Today's Session - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Experience Price Rise of 2.11% During Today's Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-14,2025-05-14 07:00:00,Biocon Shares Experience Price Rise of 2.11% During Today's Session - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Experience Price Rise of 2.11% During Today's Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-14,2025-05-14 07:00:00,Biocon Unveils Investment Plan to Drive Growth | - Chemical Industry Digest,"<a href=""https://news.google.com/rss/articles/CBMifEFVX3lxTE1fWlhuZUZPUlZROTc3UVVtdlVlVm1zZkJfdHJUU2VZNkdoSF9OMXZqMHFMdThSRmJqQ0c2WVh3V0daaGxPZlJEeDRHNVRjUUh6cU45Rkg4SFppa1lLandXSEhvc0dQS0hEZmE3RjBTY2hHYUlFbjBWeGtocjc?oc=5"" target=""_blank"">Biocon Unveils Investment Plan to Drive Growth |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",https://news.google.com/rss/articles/CBMifEFVX3lxTE1fWlhuZUZPUlZROTc3UVVtdlVlVm1zZkJfdHJUU2VZNkdoSF9OMXZqMHFMdThSRmJqQ0c2WVh3V0daaGxPZlJEeDRHNVRjUUh6cU45Rkg4SFppa1lLandXSEhvc0dQS0hEZmE3RjBTY2hHYUlFbjBWeGtocjc?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.31845,0.31845,positive,1.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi5AFBVV95cUxPUGxyQUNJcEtjcVNxY0pnaWJHbUNad3pJN3VTMU9qWUpPOV9jWE1lM1Yya3ZONmptZnZ4cDZYakZpYlBDNlBxcmZfWFh3bXZHb0hHWmZoWHhxblNSb1ctSnBoRDNNTEVKNVhLSGk3U0ZFUVJnaEdJbXUzZWhCeHFRdzgzMlZ3UndXZkZDLU1pd0xYMkFZUWVVQkgyaU95Nkd5eXlMTGx2SWRjX1Z2NE9SOWEycVV3aHRJWmFIcGRzU3NUSFN3eklIbDZLSTBvbS1vdFFmZkhVOXF5a3lDbFVzTk1ySFHSAeoBQVVfeXFMTmRSeGcyYVZWNGxLOHFLYzJlSmw1VzFta2FTZmxkV2lsclBETjZfay1JZjQzRk5PRy1va2hHNzU4WXNNMTY5MFhrTHplQmFELUE2SmZZZ1Z6cjBoeW94Z1pHVDM1U1NpV05KSWdMSzVmLVhiS2FzRjNOY1lnYWs0OXVyQ2RrV0h3ZVpLUlMyU0hRdDFlNW96dmtnd0NKNnR3X3ZyNXdaZFhzdVNJT08yUUtVbDdEYXVqUU1MdTZaR0F5M3F3VjJNb0ptbGJZcEdpclRwOVcxYV9oYllJMkpxbUJGOThGcTNmRm9n?oc=5"" target=""_blank"">Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans ₹4,500-cr QIP to raise stake in Biologics unit: Kiran Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxNRnJYNUVobDhfY2Jic3MzbWZ6MXJtTHhOME1TazN2bkFtc20zMTlzRng0STZCb3VTNUlzbXU0UEs1TE1GS2F4MjJ5clN1dWNNWEpDVXpNelZzR0wtdlFkTmVqb2NxaTBQLXRuaGFEb2EtYmF4amc0TG5abXVzc3IxWnlfanV2NnZVVFJZYkdBVjZKektUby1ZZjhJY19fVlJXSHNHMU9NMmhMQ210Q2lz?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxNRnJYNUVobDhfY2Jic3MzbWZ6MXJtTHhOME1TazN2bkFtc20zMTlzRng0STZCb3VTNUlzbXU0UEs1TE1GS2F4MjJ5clN1dWNNWEpDVXpNelZzR0wtdlFkTmVqb2NxaTBQLXRuaGFEb2EtYmF4amc0TG5abXVzc3IxWnlfanV2NnZVVFJZYkdBVjZKektUby1ZZjhJY19fVlJXSHNHMU9NMmhMQ210Q2lz?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com UK","<a href=""https://news.google.com/rss/articles/CBMirwFBVV95cUxQV1otMUE3TDdjWU5OSHNwN0NTaXhaTmJXWGtRNl9MX1lxUm5lVDdLTFJLYlJzYzkzdmdaRXZqLUh2YnpoQXp0aWZmcXdpdG9wXzlzTlE5bmxlV2t6aXRWMG1mQ0xZdndnODB2T0cyZmtxZFQydEMyUHJsMGFSdGdaYmJtOVI1Vms1RHJhMFU3cEFiM0xqcmRBay1CMTVxSEtPTVN0NXB3am13WDc3ZU1N?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com UK</font>",https://news.google.com/rss/articles/CBMirwFBVV95cUxQV1otMUE3TDdjWU5OSHNwN0NTaXhaTmJXWGtRNl9MX1lxUm5lVDdLTFJLYlJzYzkzdmdaRXZqLUh2YnpoQXp0aWZmcXdpdG9wXzlzTlE5bmxlV2t6aXRWMG1mQ0xZdndnODB2T0cyZmtxZFQydEMyUHJsMGFSdGdaYmJtOVI1Vms1RHJhMFU3cEFiM0xqcmRBay1CMTVxSEtPTVN0NXB3am13WDc3ZU1N?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-15,2025-05-15 07:00:00,"Investec sets Biocon stock Buy rating, INR400 target By Investing.com - Investing.com","<a href=""https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5"" target=""_blank"">Investec sets Biocon stock Buy rating, INR400 target By Investing.com</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com</font>",https://news.google.com/rss/articles/CBMisAFBVV95cUxQeC1nM0E1aWVqdmNRX1dybWE0cFU3M1ozMVRGV1hzYl9iT1djWnNvT3RjVmVVaEtjcHRIZGVPZWpubU5kLWlQdzJOV3FtQXloTUhPcjM1anpvek1hYUQ2ZmQyZHdCNlhqUjkwN29JV2RRenpYTWk3NFhmS0ZHRzNlVmVyb19jV0hhOFM5dXZQVnNVMkpLNkQ0TVZ6R0d6aXpwNnl4cUhkQVFBbC1QV0JMeA?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-16,2025-05-16 11:57:15,"Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake - IndiaMedToday","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5"" target=""_blank"">Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3737333333333333,0.3737333333333333,positive,1.0
2025-05-16,2025-05-16 11:57:15,"Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake - IndiaMedToday","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5"" target=""_blank"">Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3737333333333333,0.3737333333333333,positive,1.0
2025-05-16,2025-05-16 11:57:15,"Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake - IndiaMedToday","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5"" target=""_blank"">Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5,Google News - Market + Complete Company News,Biocon acquisition,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3737333333333333,0.3737333333333333,positive,1.0
2025-05-16,2025-05-16 11:57:15,"Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake - IndiaMedToday","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5"" target=""_blank"">Biocon Eyes ₹4,500 Crore QIP to Clear Debt and Boost Biologics Stake</a>&nbsp;&nbsp;<font color=""#6f6f6f"">IndiaMedToday</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxNb1pfT241RkVGV01zME5LbG5CQjlkb1E4Vk5NazVqem53UmlzRzY2dlp1RjZkXzVza1hzZ2JoUHpFd2JOZnowRVpWSUJOazNWbTNqeGljVmZ1RjJDX1VmeksybGRVN2s5OEpGcEJ3U2ZfbzhzbXVKLS1qa3QtQ0JwY1BBU0U0NUI4d1V0WjJ5N2xrdDZBVFVlLWFvOWhhbXFoRTlSUg?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3737333333333333,0.3737333333333333,positive,1.0
2025-05-20,2025-05-20 07:00:00,Biocon Eyes Robust Growth as All Segments Gain Momentum | - Chemical Industry Digest,"<a href=""https://news.google.com/rss/articles/CBMiiAFBVV95cUxON1I0c3dSdEdpYURZek1IZy1JUjNwZnloaHMyTVVCaWcwd1lLREdlcUUzb1dxTGI4MHdNa29TZjludzFnWTRockNDeDBEeTRBaGJ4aUFvTV9ienY1cVg5V01vOEh1Sm1DYl85aG1tZ2hYUndzRExYQWpPcHBlM21GdHYxVzFCRUpL?oc=5"" target=""_blank"">Biocon Eyes Robust Growth as All Segments Gain Momentum |</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Chemical Industry Digest</font>",https://news.google.com/rss/articles/CBMiiAFBVV95cUxON1I0c3dSdEdpYURZek1IZy1JUjNwZnloaHMyTVVCaWcwd1lLREdlcUUzb1dxTGI4MHdNa29TZjludzFnWTRockNDeDBEeTRBaGJ4aUFvTV9ienY1cVg5V01vOEh1Sm1DYl85aG1tZ2hYUndzRExYQWpPcHBlM21GdHYxVzFCRUpL?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.47065,0.47065,positive,1.0
2025-05-21,2025-05-21 07:00:00,"Stocks in Focus: IRCON International, United Breweries, Biocon, and Others - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5"" target=""_blank"">Stocks in Focus: IRCON International, United Breweries, Biocon, and Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-05-21,2025-05-21 07:00:00,"Stocks in Focus: IRCON International, United Breweries, Biocon, and Others - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5"" target=""_blank"">Stocks in Focus: IRCON International, United Breweries, Biocon, and Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiogFBVV95cUxPNktoaU1NVDJNR1FQWk82SUlzbmFZQU9BUm13X1NSZmg4NFpNYlFQZlJFb1h0QjhJWUtPYXU5M2dib2tJTTNSMTZkUkVXOGF1WHI4SFNQbXE2ZTNtdHcxVklCY1M2eUE3cUVRMGIxb0JCWWNIbWxGdVJhVzQ3RDFnNGpaUmhBMm9LZll6alhMb2swaG54LXFKYzl4QkxCZFlUa0E?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-05-21,2025-05-21 07:00:00,Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares gain 2% as Japan partner launches Ustekinumab biosimilar</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44035,0.44035,positive,1.0
2025-05-21,2025-05-21 07:00:00,Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-21,2025-05-21 07:00:00,Biocon shares zoom ~2% after drug launch in Japan - India Infoline,"<a href=""https://news.google.com/rss/articles/CBMilwFBVV95cUxNSjZrRWU2MHpyLXcwWmp6MFpfei1UZ3NJaWE4Z0tQM1JZd21YTWlmUkViaEZIbjFFcUtxV2F5YnBYVW9JSmhJZ1B6dWZOYTBpdXlxclQ5S2xta0ZvWllhRVBuOVJrMWxSWFNDUlRCR2FVTUdqaE50S0JrRWxqbm9hYzFTT1BxU2N1a0huaEpTLWpDU19RVlQ4?oc=5"" target=""_blank"">Biocon shares zoom ~2% after drug launch in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Infoline</font>",https://news.google.com/rss/articles/CBMilwFBVV95cUxNSjZrRWU2MHpyLXcwWmp6MFpfei1UZ3NJaWE4Z0tQM1JZd21YTWlmUkViaEZIbjFFcUtxV2F5YnBYVW9JSmhJZ1B6dWZOYTBpdXlxclQ5S2xta0ZvWllhRVBuOVJrMWxSWFNDUlRCR2FVTUdqaE50S0JrRWxqbm9hYzFTT1BxU2N1a0huaEpTLWpDU19RVlQ4?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-21,2025-05-21 07:00:00,Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares rise after subsidiary launches psoriasis treatment drug in Japan</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon licensing deal,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-22,2025-05-22 07:00:00,Biocon Shares Decline by 2.05% in Today's Trading Session - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Shares Decline by 2.05% in Today's Trading Session</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-05-22,2025-05-22 07:00:00,Biocon Biologics gets six-month extension of insulin supply in Malaysia - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Biologics gets six-month extension of insulin supply in Malaysia</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-05-26,2025-05-26 07:00:00,Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share rises as arm secures UK MHRA nod for plaque psoriasis drug</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3953,0.3953,positive,1.0
2025-05-26,2025-05-26 07:00:00,Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA - Equitypandit,"<a href=""https://news.google.com/rss/articles/CBMimgFBVV95cUxOVlJZQ2Q4MXpNRkhId0ZHZzZpaTFXSkozWlBfLTRBTzRfZG9maGs2ckQ4eHVPZzQzUXFIOGh1QjFXQmpETFBnV1NEdlhmZXk2NEt4a2VaQkdMVWlHMkdMSklOLUxqTU9aTlN5ZHJFaEdVM1QtNUZCRElQZkU5Mm1fQngxRFZWWVRQanhSeGtIUV9SWWczbnA2R0ZB?oc=5"" target=""_blank"">Biocon Shares Gain 1% as Subsidiary Secures Approval from UK MHRA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMimgFBVV95cUxOVlJZQ2Q4MXpNRkhId0ZHZzZpaTFXSkozWlBfLTRBTzRfZG9maGs2ckQ4eHVPZzQzUXFIOGh1QjFXQmpETFBnV1NEdlhmZXk2NEt4a2VaQkdMVWlHMkdMSklOLUxqTU9aTlN5ZHJFaEdVM1QtNUZCRElQZkU5Mm1fQngxRFZWWVRQanhSeGtIUV9SWWczbnA2R0ZB?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4819,0.4819,positive,1.0
2025-05-30,2025-05-30 03:58:33,Biocon's Valuation Upgrade Highlights Strong Financial Metrics Amid Debt Challenges - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNlhrRER5a1BFRFhKcVB5LURUbmFpdmVhU2JTLUI5eGc1VUxVaFVkenR0d0Z3N3gyYUtLcDNRU21qUnZiRTNzeFE1V3czZ3FreklZcU1fb3h0NVg5UjN6R3gtTnhQTWNqbjZfQmlteFQ2NXdlSG1sX0tEdmRHazA3eVRMakpNYUlDX0tQYUF5clE2VzdrSUl4VGhjOGRaTDRaVWNseUtmZDYxclI5bTh1UXIzdC1CREhjM0JENm0tRXdQWmF2WTVCZ0lCRllEV0I1ZTRZ?oc=5"" target=""_blank"">Biocon's Valuation Upgrade Highlights Strong Financial Metrics Amid Debt Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi0wFBVV95cUxNNlhrRER5a1BFRFhKcVB5LURUbmFpdmVhU2JTLUI5eGc1VUxVaFVkenR0d0Z3N3gyYUtLcDNRU21qUnZiRTNzeFE1V3czZ3FreklZcU1fb3h0NVg5UjN6R3gtTnhQTWNqbjZfQmlteFQ2NXdlSG1sX0tEdmRHazA3eVRMakpNYUlDX0tQYUF5clE2VzdrSUl4VGhjOGRaTDRaVWNseUtmZDYxclI5bTh1UXIzdC1CREhjM0JENm0tRXdQWmF2WTVCZ0lCRllEV0I1ZTRZ?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3068666666666667,0.3068666666666667,positive,1.0
2025-06-02,2025-06-02 07:00:00,"Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea - Upstox","<a href=""https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5"" target=""_blank"">Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-02,2025-06-02 07:00:00,Biocon Targets 'Diabesity': Biocon's Kiran Mazumdar Shaw Sees Massive Opportunity in GLP-1 Drugs for Diabetes and Obesity - Prameyanews,"<a href=""https://news.google.com/rss/articles/CBMi3gFBVV95cUxOcjE3MHlkUzZVMGFFck14M1ZiNWVIQW44WHNnOWttVW1tS21uS09vZE4zUERDb1NSQ251ZTAtOTNnRDlIeFpqOFY0VjhXWGxNVkpYOEJmV29rUVpobVBaSjRyVEwxNXBoS0RiT3Y4cnN6REYtY1dQeEpBZ2h0REpCYW5OMGpRRDhTc3lTMlFhdmU0bTdqZHJJTUtiRnd0ZXB2eXh2RHA3eGJzc1AyYkpwTFFYSGtDaS11TDdWM2FNQURUNklaRlZHV2k0b2d2RXoxaEFxbEhFWHpTbXBUZGc?oc=5"" target=""_blank"">Biocon Targets 'Diabesity': Biocon's Kiran Mazumdar Shaw Sees Massive Opportunity in GLP-1 Drugs for Diabetes and Obesity</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Prameyanews</font>",https://news.google.com/rss/articles/CBMi3gFBVV95cUxOcjE3MHlkUzZVMGFFck14M1ZiNWVIQW44WHNnOWttVW1tS21uS09vZE4zUERDb1NSQ251ZTAtOTNnRDlIeFpqOFY0VjhXWGxNVkpYOEJmV29rUVpobVBaSjRyVEwxNXBoS0RiT3Y4cnN6REYtY1dQeEpBZ2h0REpCYW5OMGpRRDhTc3lTMlFhdmU0bTdqZHJJTUtiRnd0ZXB2eXh2RHA3eGJzc1AyYkpwTFFYSGtDaS11TDdWM2FNQURUNklaRlZHV2k0b2d2RXoxaEFxbEhFWHpTbXBUZGc?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-06-02,2025-06-02 07:00:00,"Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June - TradingView","<a href=""https://news.google.com/rss/articles/CBMiuAJBVV95cUxQRFpvWHAwam5MVmQ2di1pYTYwWkY2aWtQWXlzS19qNHRRekhsTHVfYllfUzlWM0RrY2lVUkEyV1JRNjNwbmh5QS12cTdjNTlSS0pNQ1lpdjFSVGZrVllSYXBSWmxXX1JfeW80QTlwZmlqOGh5NkpuZE1yVkp5NHNwV05wNTdROVVJZ3YzQ1Rva19FZ0hPYmJaSzcybExNYmpwYy0wM2I0dEY1Q3dHZ2JYOEpERE1nWG42Z1dMcTIwZ09JVVNJQ2V4aVd5WjVSWjFMR2x3Y1J3T05jTjRrX0tpOW1HOXJ3azlVSFFnT3EySEF1MGhmeTNzak12ek5ObFB3bVdneXcwbDR5WVpLX2dNalFwdGRpeEItdjJHZjVBZGZYdmplVHA0LW9Qakl6OFJ0eHRXOVY0RU4?oc=5"" target=""_blank"">Stocks to Watch Today: HCL Technologies, Zinka Logistics, Biocon, Torrent Power, Jindal Stainless, Frontier Springs, Prostarm Info Systems in focus on 3 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMiuAJBVV95cUxQRFpvWHAwam5MVmQ2di1pYTYwWkY2aWtQWXlzS19qNHRRekhsTHVfYllfUzlWM0RrY2lVUkEyV1JRNjNwbmh5QS12cTdjNTlSS0pNQ1lpdjFSVGZrVllSYXBSWmxXX1JfeW80QTlwZmlqOGh5NkpuZE1yVkp5NHNwV05wNTdROVVJZ3YzQ1Rva19FZ0hPYmJaSzcybExNYmpwYy0wM2I0dEY1Q3dHZ2JYOEpERE1nWG42Z1dMcTIwZ09JVVNJQ2V4aVd5WjVSWjFMR2x3Y1J3T05jTjRrX0tpOW1HOXJ3azlVSFFnT3EySEF1MGhmeTNzak12ek5ObFB3bVdneXcwbDR5WVpLX2dNalFwdGRpeEItdjJHZjVBZGZYdmplVHA0LW9Qakl6OFJ0eHRXOVY0RU4?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.06666666666666667,0.06666666666666667,neutral,1.0
2025-06-02,2025-06-02 07:00:00,Biocon in a position to be dominant player in diabetes-obesity space: Kiran Mazumdar Shaw - Moneycontrol,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon in a position to be dominant player in diabetes-obesity space: Kiran Mazumdar Shaw</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Kiran Mazumdar Shaw,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-02,2025-06-02 07:00:00,"Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea - Upstox","<a href=""https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5"" target=""_blank"">Stocks to Watch, June 3: Mphasis, oil-linked stocks, Torrent Power, Biocon, Zinka Logistics, Man Industries, Grasim, Vodafone Idea</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMijAJBVV95cUxNSEFGZkRtSHk0SmJ4Q3dSalloTG5jU3QySmJqYUR6QTdveG94UWhKdUdhNFpJWWJSOXlmY2RzUFpFLVRrcmRJVHk0emw5ZUc4WU5mMW9rN0UtSUc3VFpJMzM0Z0s1ejBtUF9zZUZPSm5aaG9JV2dBc0lNRzBOSFRROG13bnBDNVp2QUNON3h1c0dtcHhvbXhXQjFCMGpNT0pVYXR3ZHhZSmxybkFpLUt2cDdmRHdYdXVrRkR3Y0VNZDd2Y1VpV2piX3BmRVgxeDhwa0I2aFp2T3ZtSHEyTXZ1Rmk0SFoxLXVSTk5pS3Rac01KUWZ1V19ITFpOcC1tSDM5TWZDdnliWm5jNElN?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-03,2025-06-03 07:00:00,Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here - Business Standard,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-03,2025-06-03 07:00:00,Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after CDSCO nod for diabetes drug Liraglutide</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-06-03,2025-06-03 07:00:00,"Stocks To Watch: ITC, HCL Tech, Biocon, Vodafone Idea, Torrent Power, And Others - News18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch: ITC, HCL Tech, Biocon, Vodafone Idea, Torrent Power, And Others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">News18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon joint venture,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-03,2025-06-03 07:00:00,"Stocks to watch on June 3: Biocon, PTC India Financial, HCL Tech, Yes Bank, Maruti, Reliance Infra, Aptus Value, Zinka Logistics, Adani Group in focus - Business Upturn","<a href=""https://news.google.com/rss/articles/CBMinwJBVV95cUxObHAtNTJaTGVjYnpRZVQ4ajUzeDJiSk15QkZ2b1FDeDFocFZ6RXU0V0Q5dEtmNnVjb3FwejZkamhXNEJhbFNpN0pFNzdpSlpDdTdoWHBUVlV4M0hfYUFLVF9fc3hnR0FiN1RDa01qaUY1TTIzQW8tMUV1MmdZZ2dMbFZuajVES3c4MU40bXI3YXBhTlhTbzQ0YTFEcURkcmlzQm5PanVZelNScmlWRFVWZzZTTWNPd2YzYUI0UzM3STQtRjRZQUVXY2k0LTZCZmx0YWY0YlhIXzdabTNBYjdZWkhOQzA4MjgxSGthTHZla0wxX2JuVndsRjR4aVRySFNCRmx1UnluSHFzQ3l1bEpfcFZZdmJ5M0R4WTFJUXduTQ?oc=5"" target=""_blank"">Stocks to watch on June 3: Biocon, PTC India Financial, HCL Tech, Yes Bank, Maruti, Reliance Infra, Aptus Value, Zinka Logistics, Adani Group in focus</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Upturn</font>",https://news.google.com/rss/articles/CBMinwJBVV95cUxObHAtNTJaTGVjYnpRZVQ4ajUzeDJiSk15QkZ2b1FDeDFocFZ6RXU0V0Q5dEtmNnVjb3FwejZkamhXNEJhbFNpN0pFNzdpSlpDdTdoWHBUVlV4M0hfYUFLVF9fc3hnR0FiN1RDa01qaUY1TTIzQW8tMUV1MmdZZ2dMbFZuajVES3c4MU40bXI3YXBhTlhTbzQ0YTFEcURkcmlzQm5PanVZelNScmlWRFVWZzZTTWNPd2YzYUI0UzM3STQtRjRZQUVXY2k0LTZCZmx0YWY0YlhIXzdabTNBYjdZWkhOQzA4MjgxSGthTHZla0wxX2JuVndsRjR4aVRySFNCRmx1UnluSHFzQ3l1bEpfcFZZdmJ5M0R4WTFJUXduTQ?oc=5,Google News - Market + Complete Company News,Biocon market speculation,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42405,0.42405,positive,1.0
2025-06-06,2025-06-06 07:00:00,"Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins - TradingView","<a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5"" target=""_blank"">Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01515151515151515,0.01515151515151515,neutral,1.0
2025-06-06,2025-06-06 07:00:00,"Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins - TradingView","<a href=""https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5"" target=""_blank"">Biocon, Wockhardt, Eris to double insulin output, as global drugmakers scale back to focus on GLP-1, new generation insulins</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMikAJBVV95cUxQZTEySHRBVFhWYkdaOVFwQmlmRnlmT1N6Z1doQ3I5VXc0LUZNdEVUT0RrZ0RuVmNsY3c4WUo3M0dFN04xaHg0RnRONFEwSzZfOFFrQzNhUmRhS3NSYk5IZmoxQWN2Y0dfR2JZSzIwWDl5OUtaSDlVLWl5UDc0djlsMW5PSEdtMGpzLWgtejZDbHJOSUJVOXo4UzQyTk1hc2RqbDFsdDlYWER6Nml4UDE5Qko2Q29ZQTI3RGNnOEJlVC14OHVqamZKOWo2S183Q0xuWmdxVTE4V2REdkxmMlg3OUpVQ1VrYkp5eDROOEYzVjBNV1RWX0lGdFRwTy14MjNQYTcwV3VBb2VKbFk5b1RPSw?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.01515151515151515,0.01515151515151515,neutral,1.0
2025-06-09,2025-06-09 07:00:00,Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMixwFBVV95cUxOdG1XN3J2Y0V6dFg2aFlDanhCSkJvWlBoUVlsOHhpOFhQQ1JpeGxmM1Y4NFRzRUJqYmxaYXpjcTNjQkNvZk4xLTlRSFItdkxUZ1o5NWtKcmYzUWJqcVZzTElUQkxsUU5BS0IzclA1QV9IX0xfN292UnNHOXFGa0dHdGYwUXk3Ymc5VVdNd3pSWHF2Z195SWdJaTZhb1FiSGlRYmwzS1E4Nk5ncDdHZHI2VVcxWGFZTzJRV1FPbnBOS3pRcGxmVFVN?oc=5"" target=""_blank"">Biocon's Stock Rebounds Amidst Broader Market Optimism and Small-Cap Gains</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxOdG1XN3J2Y0V6dFg2aFlDanhCSkJvWlBoUVlsOHhpOFhQQ1JpeGxmM1Y4NFRzRUJqYmxaYXpjcTNjQkNvZk4xLTlRSFItdkxUZ1o5NWtKcmYzUWJqcVZzTElUQkxsUU5BS0IzclA1QV9IX0xfN292UnNHOXFGa0dHdGYwUXk3Ymc5VVdNd3pSWHF2Z195SWdJaTZhb1FiSGlRYmwzS1E4Nk5ncDdHZHI2VVcxWGFZTzJRV1FPbnBOS3pRcGxmVFVN?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42775,0.42775,positive,1.0
2025-06-09,2025-06-09 07:00:00,Biocon Foundation partners with NCBS and BeST Cluster to support 25 women in STEM - The Hindu,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Foundation partners with NCBS and BeST Cluster to support 25 women in STEM</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Hindu</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.7983333333333333,0.7983333333333333,positive,1.0
2025-06-10,2025-06-10 07:00:00,Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUWpVOUZkZGZHMW5nSTZPXzBSc2RyTEdFXzJGb19hdURuWDFtYzVmclhWVnR2UDZWbGhMQ2UtbkluNUlxZkVTV2VQYkdocXpHWGI5OG1MUUY0cW13SVEwVlFSa3Z5N0Zwd1E5M3pEMTc1cnF4TV93cUg1LW83Ml9vNTlQcTQxVnhiZUctNy1NQkhqVzNxTWNqRHNUekM4UzFxRktXNDNEX25CRWp3Zngzd1hOM25HdE5MUUtPazNaVE5PTTJBRzZYVlA0M2dsQlNOX2Q0VFNXR3VqS2RuQ2Vj?oc=5"" target=""_blank"">Biocon Faces Mixed Technical Signals Amidst Market Performance Challenges</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi3wFBVV95cUxQUWpVOUZkZGZHMW5nSTZPXzBSc2RyTEdFXzJGb19hdURuWDFtYzVmclhWVnR2UDZWbGhMQ2UtbkluNUlxZkVTV2VQYkdocXpHWGI5OG1MUUY0cW13SVEwVlFSa3Z5N0Zwd1E5M3pEMTc1cnF4TV93cUg1LW83Ml9vNTlQcTQxVnhiZUctNy1NQkhqVzNxTWNqRHNUekM4UzFxRktXNDNEX25CRWp3Zngzd1hOM25HdE5MUUtPazNaVE5PTTJBRzZYVlA0M2dsQlNOX2Q0VFNXR3VqS2RuQ2Vj?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0386,0.0386,neutral,1.0
2025-06-10,2025-06-10 07:00:00,"Analysts recommend buying Torrent Power, Havells, BHEL, Biocon and Apollo Hospitals - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Analysts recommend buying Torrent Power, Havells, BHEL, Biocon and Apollo Hospitals</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-06-11,2025-06-11 07:00:00,"NIFTY MIDCAP 150 Sees Oil India, CRISIL, and Biocon Among Top Gainers - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">NIFTY MIDCAP 150 Sees Oil India, CRISIL, and Biocon Among Top Gainers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.5273166666666667,0.5273166666666667,positive,1.0
2025-06-11,2025-06-11 07:00:00,"Analysts recommend buying GAIL, Nalco, Biocon, LIC Housing Finance, Aarti Industries & Birlasoft - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Analysts recommend buying GAIL, Nalco, Biocon, LIC Housing Finance, Aarti Industries & Birlasoft</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3062,0.3062,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon guidance,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025 - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi5gFBVV95cUxNcW43cFFuZXZvVTJCbE5ROWRUbVlBRXB3cE5STEMtc2NfNkFRX1k1V1NsSGt4RGIzZENwbEJvZ3dCdTNxUGRpa3ZSbGNTRTVjNGQ5U2lsSlctYWR1TnQ3bjJ2eEkzX01BR0xtSjN2dm5nNGxLemVfb1E4VUdWZ3U1R2hibWgtekZwNTN3S0xRZWxjZHhDTkpERHNybnRFd0NWSmk4WGxKUnlCZ01jMFZmSThNa3NNREc4OVlOdHlrTm42Zm5iU3VzNHFsWXh6U1c2eHdKR2dsaC1UeHhrLXZTWlFjOWFnZ9IB6wFBVV95cUxObFcwZmVnUjZudUFrLUQwR21lR3h4WjE4U0NCMjl6VHZ1cU9JLTFIMjVhZE5QdGhVTjkwOFlsQzFmM0xwa1BHOHZiTHhqaEI1QkNyMklneVVqalN0TEFwU2JOOHhReGdvaGdiR2dWT2NUNHphd0x6bzdaWi1WR2ZYNEk5cmZSOEZWd2I5YXhUQTRZTm1IVFc1ampmSnFtUDN1aHNkbzNQRXhUeFZ1OHctejJ6b0RLNmhjZTZpUENWcWRFc2tVUzdrWHREb254X0wxLU5laFV5Z292ZTNWZE9YRm5hcUNreHl4UlVJ?oc=5"" target=""_blank"">Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33089999999999997,0.33089999999999997,positive,1.0
2025-06-12,2025-06-12 07:00:00,Stock to buy today: Biocon (₹354.30) – BUY - BusinessLine,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Stock to buy today: Biocon (₹354.30) – BUY</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-12,2025-06-12 07:00:00,Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5"" target=""_blank"">Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44847474747474747,0.44847474747474747,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-06-12,2025-06-12 07:00:00,"""Top Stock Picks for June 12: Infosys, GAIL, Kotak Bank & Biocon Highlighted by Analysts"" - BizzBuzz","<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMWd0ZzVmTm9BR0tPWmdFUzFuWkdfTHJZX3R4YmdVN3FaNHJLdzhVRlBRWG5HT2NfN2NsUzFyQWVfZ01pLVlGMzhQblZZYWZjd3UxdVhiN3RQaTYxMG9ZT1hWZE5EcE9KTzFJNDJETGxRR0Q1TUp3eU9PTjM1dkJxeWRkOFhpcE5wWm9MLThvcmZuQ0h6MGhXRm5talRkcVMxc3FzVDU1TEZaRlNMMlQxLS13WTloWDEzMUl5ajNhQzcwZlp5aEw3TGZMLXFjMXdF?oc=5"" target=""_blank"">""Top Stock Picks for June 12: Infosys, GAIL, Kotak Bank & Biocon Highlighted by Analysts""</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMWd0ZzVmTm9BR0tPWmdFUzFuWkdfTHJZX3R4YmdVN3FaNHJLdzhVRlBRWG5HT2NfN2NsUzFyQWVfZ01pLVlGMzhQblZZYWZjd3UxdVhiN3RQaTYxMG9ZT1hWZE5EcE9KTzFJNDJETGxRR0Q1TUp3eU9PTjM1dkJxeWRkOFhpcE5wWm9MLThvcmZuQ0h6MGhXRm5talRkcVMxc3FzVDU1TEZaRlNMMlQxLS13WTloWDEzMUl5ajNhQzcwZlp5aEw3TGZMLXFjMXdF?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26781666666666665,0.26781666666666665,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today (June 12): Infosys, L&T, Biocon and more - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today (June 12): Infosys, L&amp;T, Biocon and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.com/rss/articles/CBMiygFBVV95cUxQaTVxUXMxYnplZXgxYURBN0RGSjJpS1d2ZGw5MEpXSkdfVnhrTlZ0LWxBLU1PX1RBdFhNVkJoSlF4SWNqUjR6dG5paFk0YUhxNjZDUVZzdG5oeGUtQmtlQTVnOTFwSVlFUzNmOGF0TjdtWjhtVndaR0lTYzlJQnB5MFJpNktmb3dxcVZRY3FGTEJIZjFwZDFLRFFCY3lXbzB2eTQxX3A5R00ybVVrVmFlbnFNV2JuNDVhSnVTRTB6OEtVSW9VZm1vdTJB0gHPAUFVX3lxTFBVT3ZfZUU3RVRBeFE4Ni1Cc1VaZzhaOE5PMU53ZTUtX05iZWg3RGU4cFNSd1lKQktmN1JCdmxwdl9SaE5GMlFPUjdzWWNWb0hEZnZLTGJzMjNWNkF1QTdPZlhaaEoyX0JuMkhqTWgyUmI5dmFQQ3FsQnhVTi10eTU0NWFnSmt4X0Q3SHkteVZDaEJvYlRuczdBQVlMLUI1bDEtbjctNnYwY2tCQkFYVDVIOVlRSlVXWEhrRG9nWi1aQ1VzWUZSY1ZhNlByNnpadw?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.125,0.125,positive,1.0
2025-06-12,2025-06-12 07:00:00,"Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025 - The Economic Times","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to buy today: Infosys, Biocon among top 7 trading ideas for 12 June 2025</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.33089999999999997,0.33089999999999997,positive,1.0
2025-06-12,2025-06-12 07:00:00,"""Top Stock Picks for June 12: Infosys, GAIL, Kotak Bank & Biocon Highlighted by Analysts"" - BizzBuzz","<a href=""https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMWd0ZzVmTm9BR0tPWmdFUzFuWkdfTHJZX3R4YmdVN3FaNHJLdzhVRlBRWG5HT2NfN2NsUzFyQWVfZ01pLVlGMzhQblZZYWZjd3UxdVhiN3RQaTYxMG9ZT1hWZE5EcE9KTzFJNDJETGxRR0Q1TUp3eU9PTjM1dkJxeWRkOFhpcE5wWm9MLThvcmZuQ0h6MGhXRm5talRkcVMxc3FzVDU1TEZaRlNMMlQxLS13WTloWDEzMUl5ajNhQzcwZlp5aEw3TGZMLXFjMXdF?oc=5"" target=""_blank"">""Top Stock Picks for June 12: Infosys, GAIL, Kotak Bank & Biocon Highlighted by Analysts""</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BizzBuzz</font>",https://news.google.com/rss/articles/CBMi0AFBVV95cUxQMWd0ZzVmTm9BR0tPWmdFUzFuWkdfTHJZX3R4YmdVN3FaNHJLdzhVRlBRWG5HT2NfN2NsUzFyQWVfZ01pLVlGMzhQblZZYWZjd3UxdVhiN3RQaTYxMG9ZT1hWZE5EcE9KTzFJNDJETGxRR0Q1TUp3eU9PTjM1dkJxeWRkOFhpcE5wWm9MLThvcmZuQ0h6MGhXRm5talRkcVMxc3FzVDU1TEZaRlNMMlQxLS13WTloWDEzMUl5ajNhQzcwZlp5aEw3TGZMLXFjMXdF?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26781666666666665,0.26781666666666665,positive,1.0
2025-06-12,2025-06-12 07:00:00,Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5"" target=""_blank"">Biocon - Positive Breakout: These 6 stocks close cross above their 200 DMA</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi2wFBVV95cUxQYUdTQmNzOEtCWUdZNnhHNW5zcThvajUweDV4eXZxNlJxdm9udUFoUEVPWmt1RkpkMEhPMW5ISVNHbEVwTl9DVk02bGhtcTNwTXQwMWZYaW5lSm5Ga3lfYnNrajdjcUxiazBRbzh6ZVVuS2dXcXB1X2FMUWFwQ3lZbnBTaDRoQ3RPZlRNZ0hUUDlBM1lnWmNlelNrc1pwTjdVSjgtWkdpWVFzanlhUzdhSmtneXhOQ0JMbE5fZkhPS1pBREZBRFRlQVdITU9MQllVYm85SFZueTB6Sm8?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44847474747474747,0.44847474747474747,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising - Upstox","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5"" target=""_blank"">Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.19668333333333332,0.19668333333333332,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising - Upstox","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5"" target=""_blank"">Biocon QIP: Firm sets floor price of ₹340.2 per share for ₹4,500 crore fundraising</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxOdVhpdzNsams2VzFjemNKanJhN0d0Z01sUXNNRFFVektrbjJxRUJFa2FXSTljUHNScGxCQ21LcW1CU0NLd0VsR0gydjRvNnlkdTk4ZGxUYjhZcVpMTktUWnU4RlJkamhhZ0dwX0pjbGdScjE1RzEwc1RFTFh1SGphaE1WT1JGQjNybnpOeGdvYzJ1bWl2WmVwSWUwb05nVG1yZDF6Unk0Ul9KUzh3b0JiS1Z6UGh5SWFpZjJQWXRESWtUaGd1WEQtaXBnTVVHNWtXRDVTQw?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.19668333333333332,0.19668333333333332,positive,1.0
2025-06-16,2025-06-16 07:00:00,F&O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June - Mint,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5"" target=""_blank"">F&amp;O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5,Google News - Market + Complete Company News,Biocon investor call,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-16,2025-06-16 07:00:00,Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon sets floor price of Rs 340.2 per share for Rs 4,500 cr QIP - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxOV2Vna1dOTU0yRl9JdFBRQmdLdVl2bUNBR1o0OVpaa2xFY2dybm5aSTRuRUNidWZJT3JYY0VpUnd2eWZjMGdGaGZxRG9Jek1USGJQNjFrMmMyYlpOUGRiSTJtNUh2Y3ZXcExKTEpiQ3lYd09OV1dBMTZhM0VJNUE4MTk0ekdGc3NnXzRVMXNvZEpaQkIwUVFaNm5uVk1aQkY4eTMxdHRiUE5MZ19sWnRlTm54c3U0Z1A5c0lFdG5SblloLTl3QjZ6d2pJa0FYQUFXbDNLY9IB2gFBVV95cUxPTEpXVWNvVk03TFFKQXE1VUozSVg1Y3o1OFNRbEZwMDBac2xKYkZCX1F5TV8zLU1UUzYzQjdOWkVXWVVDWFFUV1FmclladXNyaFlMYU5TRGxydURaSkxHcXhZUmFFVldQOTRibGhaanlsQ0FxRWg4eFU2Q2xSejFDVS00TlA4NXl0cEFqRHpZVG5mZnRkM09NYzZfd25wOEpORWRvTk9oOWhRVjM2dUVSMGNjaFdZYlNIR1o3N2Z3Nk1Dend3WTNzYU5zN0NpdDE2b2gwVEZtMFJ4UQ?oc=5"" target=""_blank"">Biocon sets floor price of Rs 340.2 per share for Rs 4,500 cr QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-06-16,2025-06-16 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN,"<a href=""https://news.google.com/rss/articles/CBMi0wJBVV95cUxQc1BFSncwNTVSMVhZeDhiYVYxQVRHREc3bFBndFFLQW5IS2JGMTZNeV9NdTRoZmhZNmtldnVmTkhWejAwWGNWNnVyX2h0ZVQzQzg2MXJONG0wVTlESnU5bGJ3aWJFZDJocjZ0UGc3TkRZcm1qaXFYc0ZMbWFvc2JvRGFiSThiOUhaVmxzSkl2OTZVRVE4eU40VmVoVWxFM1haQ0pZSXlYU091cWlmSUtaN2RhTGNFdDd6SUNIM2tuSTI3SzJIal9YVS11M3BLb2NpakJhdWFFd0dWN044RFl2MjQzenB0NUUwcFN5M2FuTGprdVJ3cmUtNUt5OFRXOFFuWERkd2dSSXJnaWtPSC0yd2o2Nnp3VVl3bU9KRTQ4RndfeXAxclgwdmxKLVhkbnVsLVowZmE5RE12MXFtbFBkME9vS1FQX2VweldnekNNaXFVN0k?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMi0wJBVV95cUxQc1BFSncwNTVSMVhZeDhiYVYxQVRHREc3bFBndFFLQW5IS2JGMTZNeV9NdTRoZmhZNmtldnVmTkhWejAwWGNWNnVyX2h0ZVQzQzg2MXJONG0wVTlESnU5bGJ3aWJFZDJocjZ0UGc3TkRZcm1qaXFYc0ZMbWFvc2JvRGFiSThiOUhaVmxzSkl2OTZVRVE4eU40VmVoVWxFM1haQ0pZSXlYU091cWlmSUtaN2RhTGNFdDd6SUNIM2tuSTI3SzJIal9YVS11M3BLb2NpakJhdWFFd0dWN044RFl2MjQzenB0NUUwcFN5M2FuTGprdVJ3cmUtNUt5OFRXOFFuWERkd2dSSXJnaWtPSC0yd2o2Nnp3VVl3bU9KRTQ4RndfeXAxclgwdmxKLVhkbnVsLVowZmE5RE12MXFtbFBkME9vS1FQX2VweldnekNNaXFVN0k?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-16,2025-06-16 07:00:00,F&O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June - Mint,"<a href=""https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5"" target=""_blank"">F&amp;O Strategy: Manappuram Finance to Biocon— Rupak De suggests buy or sell strategy for THESE stocks - 16 June</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxOMVFETXg0TnVQTjlmY0FRRElpbTBPNjhWSW9qc0U0WUd5Rkd6VTZYaUdoUE1UUFhMQmt0c3VscGczMnNrWjJPMmhWYkRHeVhfekNqZkk0QWp4UzV5c2NFeXBoRThvOV94Z1Z3OTNDYW0yRkZ1SHJLMG5nLWJvenIyQXZWSU13amJGQWtZUldqX1pmQ1RNMHFMZ1o5eVFNcFpPWFQxU0tIZWF3VDFQNnNQMmNTYW0ySmhPQlU0RmJpUXVKWDVoODRVVEVJU0Q2aV9nS2tTc3FseXVERHhUdW9DaUVObERIYzhnaDZFMHNYbFdmM3N0QmVNRC0zbnUtUFBFbmhLNw?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.13333333333333333,-0.13333333333333333,negative,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon opens QIP offering, sets floor price at Rs 340.20 per share - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon opens QIP offering, sets floor price at Rs 340.20 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.148,0.148,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon plans to launch QIP shortly to raise up to Rs 4,500 crore; Kotak, Goldman Sachs, BofA likely... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon plans to launch QIP shortly to raise up to Rs 4,500 crore; Kotak, Goldman Sachs, BofA likely...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon merger,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon launches ₹4,500 crore QIP, sets floor price at ₹340.20/share - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches ₹4,500 crore QIP, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.13333333333333333,-0.13333333333333333,negative,1.0
2025-06-16,2025-06-16 07:00:00,"Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc - Upstox","<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5"" target=""_blank"">Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share - Mint","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after board opens up QIP fundraising on 16 June, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMihAJBVV95cUxNY19pa3hZV2JyaU40bnlKQ0JpbzB4eUZydi1ieng0aHduWDNwaHVnZF83Unh1NzFkUjBOUlBjZURSM1RhNGtELXRtQ3BvUEVtdTBaVGJEQVZGNTFhUXc0ZWQyRS02Sk5wc1E1YnZKaUE1NWxwcDhJb3J6VlI1ZnJsdHAxMDNid05SdnVxYVd3ZWMxNF9vYUpkckcta0hTbGJ4NGZkRkdoNUlQTTlFdFZHeXVZejg1UjZsUi1vdHBscE1uX3lRMEc3N2RIcnhrbVJXR0xXaEU3MnItVHNaMWU1a2M0c3FIYlVMWkNTd0ZBcjRjUGpqYmtIWWRNOXJnZkZpVTVjYtIBigJBVV95cUxNSWJJYzhVd1VpaDRtSzB2TXdaeDIxYU1sRkN2V212ekwzbmd5N0VaOTBDYThLcklNNGtIbFhoa0lIWXg0SURSVWxPRTFjdEdMUGRNN3ZaTHZlQnl2X0ZFdHpUWmFHRXRKWHJIbHQtUHgyWmJpVkYyR0U4MEpoLW5sSWpXZS0zUXYxSkZSYXctRlJKQ0lWenQ0NjE0V2hCenpuS25KNjA3aDlOMnNqdmEyMXFZbUx6dmc0Wl82M1ZZTWh6VE1CcEFlMklVeVYzWGpPWUdXUkNncXhONXFnQzBXazBQTWMzOTRXeFc0czExWWRmN2dTWVJDYXd5M1BkZ3pGdnhnQnJtVnRMdw?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-16,2025-06-16 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN,"<a href=""https://news.google.com/rss/articles/CBMivgFBVV95cUxOSGNtd3JhVm9lT19QWnJIVVBHLTlJeE9JZGdlR0lTdTRhWGZmVGVUQXZWdFo1VFZZUzdZVEFjNWJpRlNyenh4WXQtRXR1RUI4RkI0WlNKTFlfdnRjN2toVV9VWnJXV0dyM1h4NjZyMklZUjYxZkJMSC1iYjVKQ1hKQk9jNGZ3SFhPaFQ4Q2RwVWtBR2R2Q2xMX0NxemEtQ3BaakVzUzR1dElkQ0ZDUjBkUG9zdGViWVdRa2lmWnNR?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMivgFBVV95cUxOSGNtd3JhVm9lT19QWnJIVVBHLTlJeE9JZGdlR0lTdTRhWGZmVGVUQXZWdFo1VFZZUzdZVEFjNWJpRlNyenh4WXQtRXR1RUI4RkI0WlNKTFlfdnRjN2toVV9VWnJXV0dyM1h4NjZyMklZUjYxZkJMSC1iYjVKQ1hKQk9jNGZ3SFhPaFQ4Q2RwVWtBR2R2Q2xMX0NxemEtQ3BaakVzUzR1dElkQ0ZDUjBkUG9zdGViWVdRa2lmWnNR?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc - Upstox","<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5"" target=""_blank"">Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others - MSN","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon launches ₹4,500 crore QIP, sets floor price at ₹340.20/share - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon launches ₹4,500 crore QIP, sets floor price at ₹340.20/share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon opens QIP offering, sets floor price at Rs 340.20 per share - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon opens QIP offering, sets floor price at Rs 340.20 per share</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.148,0.148,positive,1.0
2025-06-16,2025-06-16 07:00:00,"Biocon sets floor price of Rs 340.2 per share for Rs 4,500 crore QIP - NewsDrum","<a href=""https://news.google.com/rss/articles/CBMipwFBVV95cUxPTDdnYXo0aXZSWVVGNGdhZDhaT09VaFg4aHp3RkhFTTRnbGRBb2hYckh5NHVHczZjRUVJSzJRMUljUmtCMkViQ2daZ0FWUlctTnM4eWl0MnNYTmYyVGhBd1VZMTQ1dGUzRlViMnBWU0hFdkJ1UGQ0OVQ2aUY5Ynk5bW9mQTR0NW9JQnFtUnpzY3pHbWgzbTZaUkJfd0JDbUpXRGVBaURtZ9IBpwFBVV95cUxPTDdnYXo0aXZSWVVGNGdhZDhaT09VaFg4aHp3RkhFTTRnbGRBb2hYckh5NHVHczZjRUVJSzJRMUljUmtCMkViQ2daZ0FWUlctTnM4eWl0MnNYTmYyVGhBd1VZMTQ1dGUzRlViMnBWU0hFdkJ1UGQ0OVQ2aUY5Ynk5bW9mQTR0NW9JQnFtUnpzY3pHbWgzbTZaUkJfd0JDbUpXRGVBaURtZw?oc=5"" target=""_blank"">Biocon sets floor price of Rs 340.2 per share for Rs 4,500 crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">NewsDrum</font>",https://news.google.com/rss/articles/CBMipwFBVV95cUxPTDdnYXo0aXZSWVVGNGdhZDhaT09VaFg4aHp3RkhFTTRnbGRBb2hYckh5NHVHczZjRUVJSzJRMUljUmtCMkViQ2daZ0FWUlctTnM4eWl0MnNYTmYyVGhBd1VZMTQ1dGUzRlViMnBWU0hFdkJ1UGQ0OVQ2aUY5Ynk5bW9mQTR0NW9JQnFtUnpzY3pHbWgzbTZaUkJfd0JDbUpXRGVBaURtZ9IBpwFBVV95cUxPTDdnYXo0aXZSWVVGNGdhZDhaT09VaFg4aHp3RkhFTTRnbGRBb2hYckh5NHVHczZjRUVJSzJRMUljUmtCMkViQ2daZ0FWUlctTnM4eWl0MnNYTmYyVGhBd1VZMTQ1dGUzRlViMnBWU0hFdkJ1UGQ0OVQ2aUY5Ynk5bW9mQTR0NW9JQnFtUnpzY3pHbWgzbTZaUkJfd0JDbUpXRGVBaURtZw?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-16,2025-06-16 07:00:00,Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks - Mint,"<a href=""https://news.google.com/rss/articles/CBMi_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?oc=5"" target=""_blank"">Stocks to buy for short term: From Swiggy to Biocon— Jigar Patel of Anand Rathi suggests 3 stock picks</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Mint</font>",https://news.google.com/rss/articles/CBMi_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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-16,2025-06-16 07:00:00,"Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc - Upstox","<a href=""https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5"" target=""_blank"">Stocks to Watch, June 17: Tanla Platforms, Vishal Mega Mart, Biocon, NTPC, Sona BLW, Bata India, ZEEL, Hindustan Zinc</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Upstox</font>",https://news.google.com/rss/articles/CBMi-wFBVV95cUxQSDJXanZISklrci1JeXhlX3lfRGpaT29jQmpoOEwyS1JfUU8xUW5ZdUtLNWtNQmFRYW8zRGwzVXB1OEI4eU03bkNuMlpya282elB6Mmt2bmE0VDZDQ2NKOUtlZmt6ckRqX0lnM0dYTVplYnVqTDlDWkxXZE1wLUZoazFfM1dUVWJlUTRKMW9qcWdBQm44bUlPanJDZElSOXJ4dkFzY1cxU01VMGNmVmNWX0d4RU01YjlZeEFCZTNpYmpXZFFqX2lCSnpPdFNnZEJkMkE4MDNnNkFxeExqbkp3R3Z2T1dYQWMtakVjb1JzRHluRGtsWGQzSktINA?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 02:23:27,"Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17 - Republic World","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5"" target=""_blank"">Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 02:23:27,"Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17 - Republic World","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5"" target=""_blank"">Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 02:23:27,"Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17 - Republic World","<a href=""https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5"" target=""_blank"">Stocks to Watch Today: Biocon, Zee, NTPC, Hyundai & ONGC Among Key Movers On June 17</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Republic World</font>",https://news.google.com/rss/articles/CBMiuAFBVV95cUxNMWh1RW02eDZZU3AySzE4bGVNb3lUVFpNcGNUTi13TFBZSXVmMGkyZnNwdF91YmdYZmQyMHBIMDJSTDdDaUhKREZtcVlJZm9JRVUtNUNFZWpvdnd1MFREem5tWkgycHljaUljTkZYOXhBcUNTR0M5QlJEZFJlMkdCY2pHdXVDYi1iQmFKMERsU2pYSFRJS2hfZm16N3N0N0VqMjlfNHpyTjBzaFVOdlFKZ2VVNy1EUzg1?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Biocon share price rises over 1% after Rs 4,500 crore QIP - Value Research","<a href=""https://news.google.com/rss/articles/CBMipAFBVV95cUxOemw3S0k5bllxWnRxZFJNblRwSTduRzhJQmo2ZzlLbWNUQ1JvYjNGWV9QR1dzX2wzQ1NnMmRFNzhLckNncGEtU1ZCbEFkOE53M0ZzQ1pwQXo5ZXlXV0FPOWEtcE1DS0I1Q1daQVVGSTdoREJ0c3JzLUVHd0duQl9QUHk4UXpnSDV2WHJBeUdBMjE5LUQwN09zbjBLXzhiSHpaemJIeA?oc=5"" target=""_blank"">Biocon share price rises over 1% after Rs 4,500 crore QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Value Research</font>",https://news.google.com/rss/articles/CBMipAFBVV95cUxOemw3S0k5bllxWnRxZFJNblRwSTduRzhJQmo2ZzlLbWNUQ1JvYjNGWV9QR1dzX2wzQ1NnMmRFNzhLckNncGEtU1ZCbEFkOE53M0ZzQ1pwQXo5ZXlXV0FPOWEtcE1DS0I1Q1daQVVGSTdoREJ0c3JzLUVHd0duQl9QUHk4UXpnSDV2WHJBeUdBMjE5LUQwN09zbjBLXzhiSHpaemJIeA?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.35015,0.35015,positive,1.0
2025-06-17,2025-06-17 07:00:00,Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details - ET Now,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon QIP floor price: Rs 4500 crore fundraise by BSE 200 pharma company - details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others - ET Now","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks To Watch Today On June 17: Biocon, Vishal Mega Mart, NTPC, TCS, Sona Comstar, and others</a>&nbsp;&nbsp;<font color=""#6f6f6f"">ET Now</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch Today: Vishal Mega Mart, Biocon, TCS, Mastek, HCL Tech, ICICI Bank, Tanla Platforms, Zee... - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch Today: Vishal Mega Mart, Biocon, TCS, Mastek, HCL Tech, ICICI Bank, Tanla Platforms, Zee...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.com/rss/articles/CBMirgJBVV95cUxOXzJ3MW80ay1oNmVKSkhqZExheHNOVUgyZll3YWkyZEpmeVBqYW9VZTNtZEpFV1gtbmM2VFFDS05iUWdKRjFVY0taSHRKemZKQWJrTG42ak05UDlWbGlIcHYwMHNKR0lGbGhHMGdiYU51azIxRllaNGw4ckMtSDkzRk10N0tFNlB1TTktV3NSTU5qMnFVbjl1bHpNZkMycFh0REE1Nm5hVVVSRms1bWZLaWpJNkswTUlGNjdvRlBUSmczV2RlV1pLbEQxQVhsTGwzb1dLckZYSE9mdEdOMjlaX3pJN1NJV2oxMnNmNy00SV9lYzdiSkp6c0MtUVcxZXZScUVmVUxKTkVxRkx6amJ3TlBpODNoRmpHTld4TUg3eG9UZzFVdFF4LVJ0SmF4QdIBswJBVV95cUxQRV9lREQ0MmpiOXJTNlFaak96NkpEQkxWSUNEaE5VWmt1eHoxb205dnV4WDEzZVRVR3VNOFplcXFGU2JSZHJ3bTlvaWlHbVU5TmdkN3BrMXRub0dvQjh2SzVsbThRano4ajE0c0g4d21rcl9UQ3F5U3EwaHZXMDlQRlJ4SHg1UXNrMjdKekN3Q2pSX2RsRE5GNUdLTnBxMFlkZkpIcjQxMU5zcDdkc3FLUklKM2o1clFBcHRsQXc5VnBlanRhRjczQ21MUkJDMjMwQ0JGVFlBWWJ6NXB5VUxhTGpGVGpaWFBteWFnMTFnZGhJSVo3T2tzejFxdlFMN0thSnd4Y3ZOd3pXZXRuU1RnM0tWdUJzMWpZVnctSGRpVWtfYlkwM2NoQk81SlZiTUlhOHZZ?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Stocks to Watch: Biocon, NTPC, Zee Entertainment, Tanla Platforms and more</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4654,0.4654,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Watch out for these stocks today: Zee, PNB, ICICI Bank, Macrotech Developers, Biocon, Vishal Mega Mart, Bata, SIL, Marine Electrical - BusinessLine","<a href=""https://news.google.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?oc=5"" target=""_blank"">Watch out for these stocks today: Zee, PNB, ICICI Bank, Macrotech Developers, Biocon, Vishal Mega Mart, Bata, SIL, Marine Electrical</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessLine</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers - Live India","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5"" target=""_blank"">Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live India</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3574454545454545,0.3574454545454545,positive,1.0
2025-06-17,2025-06-17 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - The Economic Times,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch Today: Vishal Mega Mart, Biocon, TCS, Mastek, HCL Tech, ICICI Bank, Tanla Platforms, Zee... - Moneycontrol","<a href=""https://news.google.com/rss/articles/CBMirgJBVV95cUxOXzJ3MW80ay1oNmVKSkhqZExheHNOVUgyZll3YWkyZEpmeVBqYW9VZTNtZEpFV1gtbmM2VFFDS05iUWdKRjFVY0taSHRKemZKQWJrTG42ak05UDlWbGlIcHYwMHNKR0lGbGhHMGdiYU51azIxRllaNGw4ckMtSDkzRk10N0tFNlB1TTktV3NSTU5qMnFVbjl1bHpNZkMycFh0REE1Nm5hVVVSRms1bWZLaWpJNkswTUlGNjdvRlBUSmczV2RlV1pLbEQxQVhsTGwzb1dLckZYSE9mdEdOMjlaX3pJN1NJV2oxMnNmNy00SV9lYzdiSkp6c0MtUVcxZXZScUVmVUxKTkVxRkx6amJ3TlBpODNoRmpHTld4TUg3eG9UZzFVdFF4LVJ0SmF4QdIBswJBVV95cUxQRV9lREQ0MmpiOXJTNlFaak96NkpEQkxWSUNEaE5VWmt1eHoxb205dnV4WDEzZVRVR3VNOFplcXFGU2JSZHJ3bTlvaWlHbVU5TmdkN3BrMXRub0dvQjh2SzVsbThRano4ajE0c0g4d21rcl9UQ3F5U3EwaHZXMDlQRlJ4SHg1UXNrMjdKekN3Q2pSX2RsRE5GNUdLTnBxMFlkZkpIcjQxMU5zcDdkc3FLUklKM2o1clFBcHRsQXc5VnBlanRhRjczQ21MUkJDMjMwQ0JGVFlBWWJ6NXB5VUxhTGpGVGpaWFBteWFnMTFnZGhJSVo3T2tzejFxdlFMN0thSnd4Y3ZOd3pXZXRuU1RnM0tWdUJzMWpZVnctSGRpVWtfYlkwM2NoQk81SlZiTUlhOHZZ?oc=5"" target=""_blank"">Stocks to Watch Today: Vishal Mega Mart, Biocon, TCS, Mastek, HCL Tech, ICICI Bank, Tanla Platforms, Zee...</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers - Live India","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5"" target=""_blank"">Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live India</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5,Google News - Market + Complete Company News,Biocon board meeting,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3574454545454545,0.3574454545454545,positive,1.0
2025-06-17,2025-06-17 07:00:00,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxNTUlPVGpvS3BwWGd1TW1JSGZKcW15SndQbTlTdWNUS21lWVAxS1ZoWGFYQ1VKR0RDcTlLWW1mS2w2azFTUUZvY3c4ZTlINEpmLUV3ZmcyU1BZbkR4WklYd1hubVc3V3BWLWxMY25VUVpxWTcwck5mN1VHTXJnVVU1c0trYVA5ekJSMjZRSTE1NjZaMnpuVVI3dkxyZEpIcUZ0aTNsZ0sxYV9HZk5IN3R2TmVFTVBiTVgxbV9NMlpBM2lzRUdwQUFvMlZhNms3Skk3UlJ2cERHUnZPcTNJ0gHiAUFVX3lxTFB6OFdKRHp3Z1BxaEhvdGFObnhjUzBnVk5BX0xLZjYzR00zTURqU3B0ZHhneExhdUVqYWhkTHVNcllNTmhsS3Vsc3FMSHF4VFpnRDNOdXdvYm0wdmZXTGh4UUFsRmRqckhacGgwN1gxcTRkUUs3NGYycWpCT3pTOVRmQVl2OTlMWWZHbXIyWDJpSmFObngzNmYtcFRJRTNmd0YzeWVHOFdfUHRuMTMxUWNISk5mLW5xSEZzaVJuSTJGcy12b2NWcW1KanQzSkhKNzFBYjh6ZkJQVUZvX0VCX3ZBOFE?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxNTUlPVGpvS3BwWGd1TW1JSGZKcW15SndQbTlTdWNUS21lWVAxS1ZoWGFYQ1VKR0RDcTlLWW1mS2w2azFTUUZvY3c4ZTlINEpmLUV3ZmcyU1BZbkR4WklYd1hubVc3V3BWLWxMY25VUVpxWTcwck5mN1VHTXJnVVU1c0trYVA5ekJSMjZRSTE1NjZaMnpuVVI3dkxyZEpIcUZ0aTNsZ0sxYV9HZk5IN3R2TmVFTVBiTVgxbV9NMlpBM2lzRUdwQUFvMlZhNms3Skk3UlJ2cERHUnZPcTNJ0gHiAUFVX3lxTFB6OFdKRHp3Z1BxaEhvdGFObnhjUzBnVk5BX0xLZjYzR00zTURqU3B0ZHhneExhdUVqYWhkTHVNcllNTmhsS3Vsc3FMSHF4VFpnRDNOdXdvYm0wdmZXTGh4UUFsRmRqckhacGgwN1gxcTRkUUs3NGYycWpCT3pTOVRmQVl2OTlMWWZHbXIyWDJpSmFObngzNmYtcFRJRTNmd0YzeWVHOFdfUHRuMTMxUWNISk5mLW5xSEZzaVJuSTJGcy12b2NWcW1KanQzSkhKNzFBYjh6ZkJQVUZvX0VCX3ZBOFE?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3300166666666666,0.3300166666666666,positive,1.0
2025-06-17,2025-06-17 07:00:00,"Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers - Live India","<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5"" target=""_blank"">Stocks to Watch on June 17: Zee Entertainment, NTPC, Reliance Industries, Biocon, Tanla Platforms Among Key Movers</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Live India</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxPbV9jYUpLUXdfbTBlb245YWJKM214VUwwQTFTMERLeXl1S2NpUlNHdlFXM0RMajA3Yml5U0FveU93TG9hLS1aVlRSZ2FzcWhSRW03SkhkQXRGLUpERGVNNzROY19qbG43WEJqUloxV293UFNEZnl0dnZPUkNRbnVoRmR5WjFkUXQ0Z2d4cnZZMVl5UDd4VEdoeG1PVVBoX0d4ckVueW1GZXFRYzFjOEE4MXhuS3d4WFNMQ2pHTmNuamVORmN0al9MMW10eFZJTlJNd1l2OExpUQ?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3574454545454545,0.3574454545454545,positive,1.0
2025-06-17,2025-06-17 09:44:31,"Stocks To Watch Today: Zee Entertainment, Biocon, Vishal Mega Mart, Hindustan Zinc, NTPC - MSN","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxNb29Ma0hmTmdIUnZRRVoyWmRtWWpFZlJLOC1fblhqNEFlOW1mTnY2V1dXV2x0QWZFb09md0ZUbnk1Z0h4WkJfdEt2alNIT0ZpMnRkYzdya0xXZE4zelJUMkd5R2FISkphUWZPN3dtSkFRLVFOeE1MV2F0RzE3ZHByQ0JkZzVMSTJUelhIa0tZMk1ac2I0STlRQ2cyeTJQM3pQM0tLM3dUbkJ4VEE3bmZSb2ZEemtHMGJLTWM4aDFGazcxRi02UzNDVjhUcjdiYW9CMUxwOFhvX3NTbG1p?oc=5"" target=""_blank"">Stocks To Watch Today: Zee Entertainment, Biocon, Vishal Mega Mart, Hindustan Zinc, NTPC</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxNb29Ma0hmTmdIUnZRRVoyWmRtWWpFZlJLOC1fblhqNEFlOW1mTnY2V1dXV2x0QWZFb09md0ZUbnk1Z0h4WkJfdEt2alNIT0ZpMnRkYzdya0xXZE4zelJUMkd5R2FISkphUWZPN3dtSkFRLVFOeE1MV2F0RzE3ZHByQ0JkZzVMSTJUelhIa0tZMk1ac2I0STlRQ2cyeTJQM3pQM0tLM3dUbkJ4VEE3bmZSb2ZEemtHMGJLTWM4aDFGazcxRi02UzNDVjhUcjdiYW9CMUxwOFhvX3NTbG1p?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-06-17,2025-06-17 09:44:31,"Stocks To Watch Today: Zee Entertainment, Biocon, Vishal Mega Mart, Hindustan Zinc, NTPC - MSN","<a href=""https://news.google.com/rss/articles/CBMi3AFBVV95cUxNb29Ma0hmTmdIUnZRRVoyWmRtWWpFZlJLOC1fblhqNEFlOW1mTnY2V1dXV2x0QWZFb09md0ZUbnk1Z0h4WkJfdEt2alNIT0ZpMnRkYzdya0xXZE4zelJUMkd5R2FISkphUWZPN3dtSkFRLVFOeE1MV2F0RzE3ZHByQ0JkZzVMSTJUelhIa0tZMk1ac2I0STlRQ2cyeTJQM3pQM0tLM3dUbkJ4VEE3bmZSb2ZEemtHMGJLTWM4aDFGazcxRi02UzNDVjhUcjdiYW9CMUxwOFhvX3NTbG1p?oc=5"" target=""_blank"">Stocks To Watch Today: Zee Entertainment, Biocon, Vishal Mega Mart, Hindustan Zinc, NTPC</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMi3AFBVV95cUxNb29Ma0hmTmdIUnZRRVoyWmRtWWpFZlJLOC1fblhqNEFlOW1mTnY2V1dXV2x0QWZFb09md0ZUbnk1Z0h4WkJfdEt2alNIT0ZpMnRkYzdya0xXZE4zelJUMkd5R2FISkphUWZPN3dtSkFRLVFOeE1MV2F0RzE3ZHByQ0JkZzVMSTJUelhIa0tZMk1ac2I0STlRQ2cyeTJQM3pQM0tLM3dUbkJ4VEE3bmZSb2ZEemtHMGJLTWM4aDFGazcxRi02UzNDVjhUcjdiYW9CMUxwOFhvX3NTbG1p?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon earnings,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.22860714285714284,-0.22860714285714284,negative,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.22860714285714284,-0.22860714285714284,negative,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.22860714285714284,-0.22860714285714284,negative,1.0
2025-06-19,2025-06-19 07:00:00,"Nifty Ends Below 24,800, Midcaps Sink: Swiggy, Biocon Gain In A Volatile Session By Stocktwits - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxPNlRhamVzSEhkWDdvQ0hDWlNidWNhMzdaeGE4VkpOVnI1dWJBWkw5TzFnb2tVTjhDclR6UkUwSTV5RGJoSkJ0eDJheXh2SE9qX21KZG5DRHZaSmgyNElKdXVhWjRxMU9aZjRSZUsydElTOE1iVi1mUHBuTmdmSVZYZk9tZXlUd2ZlNGVwT1REWlVWTGh2M1NQQUdOdkxVTTJJZThFZ1hMZHpON2k2TkJZaTE0RFFaMV9MdGh4TEJlSVd4bnZIUXF4WlZDLU0?oc=5"" target=""_blank"">Nifty Ends Below 24,800, Midcaps Sink: Swiggy, Biocon Gain In A Volatile Session By Stocktwits</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxPNlRhamVzSEhkWDdvQ0hDWlNidWNhMzdaeGE4VkpOVnI1dWJBWkw5TzFnb2tVTjhDclR6UkUwSTV5RGJoSkJ0eDJheXh2SE9qX21KZG5DRHZaSmgyNElKdXVhWjRxMU9aZjRSZUsydElTOE1iVi1mUHBuTmdmSVZYZk9tZXlUd2ZlNGVwT1REWlVWTGh2M1NQQUdOdkxVTTJJZThFZ1hMZHpON2k2TkJZaTE0RFFaMV9MdGh4TEJlSVd4bnZIUXF4WlZDLU0?oc=5,Google News - Market + Complete Company News,Biocon profit,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42955,0.42955,positive,1.0
2025-06-19,2025-06-19 07:00:00,"HSBC maintains 'buy' on Biocon shares after Rs 4,500 crore QIP boost, stock gains 2% - Moneycontrol","<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC maintains 'buy' on Biocon shares after Rs 4,500 crore QIP boost, stock gains 2%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Moneycontrol</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4559,0.4559,positive,1.0
2025-06-19,2025-06-19 07:00:00,HSBC retains its positive stance on Biocon citing a key near-term trigger - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC retains its positive stance on Biocon citing a key near-term trigger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4464545454545455,0.4464545454545455,positive,1.0
2025-06-19,2025-06-19 07:00:00,"Nifty Ends Below 24,800, Midcaps Sink: Swiggy, Biocon Gain In A Volatile Session By Stocktwits - Investing.com India","<a href=""https://news.google.com/rss/articles/CBMizAFBVV95cUxPNlRhamVzSEhkWDdvQ0hDWlNidWNhMzdaeGE4VkpOVnI1dWJBWkw5TzFnb2tVTjhDclR6UkUwSTV5RGJoSkJ0eDJheXh2SE9qX21KZG5DRHZaSmgyNElKdXVhWjRxMU9aZjRSZUsydElTOE1iVi1mUHBuTmdmSVZYZk9tZXlUd2ZlNGVwT1REWlVWTGh2M1NQQUdOdkxVTTJJZThFZ1hMZHpON2k2TkJZaTE0RFFaMV9MdGh4TEJlSVd4bnZIUXF4WlZDLU0?oc=5"" target=""_blank"">Nifty Ends Below 24,800, Midcaps Sink: Swiggy, Biocon Gain In A Volatile Session By Stocktwits</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Investing.com India</font>",https://news.google.com/rss/articles/CBMizAFBVV95cUxPNlRhamVzSEhkWDdvQ0hDWlNidWNhMzdaeGE4VkpOVnI1dWJBWkw5TzFnb2tVTjhDclR6UkUwSTV5RGJoSkJ0eDJheXh2SE9qX21KZG5DRHZaSmgyNElKdXVhWjRxMU9aZjRSZUsydElTOE1iVi1mUHBuTmdmSVZYZk9tZXlUd2ZlNGVwT1REWlVWTGh2M1NQQUdOdkxVTTJJZThFZ1hMZHpON2k2TkJZaTE0RFFaMV9MdGh4TEJlSVd4bnZIUXF4WlZDLU0?oc=5,Google News - Market + Complete Company News,Biocon insider trading,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.42955,0.42955,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next</a>&nbsp;&nbsp;<font color=""#6f6f6f"">simplywall.st</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon analyst report,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.22860714285714284,-0.22860714285714284,negative,1.0
2025-06-19,2025-06-19 07:00:00,HSBC retains its positive stance on Biocon citing a key near-term trigger - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC retains its positive stance on Biocon citing a key near-term trigger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4464545454545455,0.4464545454545455,positive,1.0
2025-06-19,2025-06-19 07:00:00,Biocon Experiences Revision in Its Score Amid Broader Market Declines - MarketsMojo,"<a href=""https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUDhUOXRycnlvVWlCbUotOVhBRVcyRWdVRHhnQ3ZJN1EtX0VOVXNiQVhINGRrTF9nVjRVY0g1YXRFblo1bUxxYkxnSjhSTDFDc0ZWZzhRVVNmOV9na3pSc0xfSTRUYnhSUzg3a3BsQUdLSDRlSVFMQk4wOXcyVDUxcHctZDJRMi1CeU1CSmNVVm9wdy1KNklNaUxGWldGc21tSW9qazktWWE0UjJzZjBNTFFDOE5fbDBCZkhRaGs1QkkzS3RxVU9rWGpXaEFBTW93MFE?oc=5"" target=""_blank"">Biocon Experiences Revision in Its Score Amid Broader Market Declines</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MarketsMojo</font>",https://news.google.com/rss/articles/CBMi0gFBVV95cUxOUDhUOXRycnlvVWlCbUotOVhBRVcyRWdVRHhnQ3ZJN1EtX0VOVXNiQVhINGRrTF9nVjRVY0g1YXRFblo1bUxxYkxnSjhSTDFDc0ZWZzhRVVNmOV9na3pSc0xfSTRUYnhSUzg3a3BsQUdLSDRlSVFMQk4wOXcyVDUxcHctZDJRMi1CeU1CSmNVVm9wdy1KNklNaUxGWldGc21tSW9qazktWWE0UjJzZjBNTFFDOE5fbDBCZkhRaGs1QkkzS3RxVU9rWGpXaEFBTW93MFE?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-19,2025-06-19 07:00:00,HSBC retains its positive stance on Biocon citing a key near-term trigger - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">HSBC retains its positive stance on Biocon citing a key near-term trigger</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon target price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.4464545454545455,0.4464545454545455,positive,1.0
2025-06-19,2025-06-19 22:11:41,"Biocon rises post fundraise plan, analyst cautions long-term risks | Tap to know more | Inshorts - Inshorts","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon rises post fundraise plan, analyst cautions long-term risks | Tap to know more | Inshorts</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Inshorts</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon sebi,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.08028333333333335,-0.08028333333333335,neutral,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon announces closure of QIP, check details - Business Today","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon announces closure of QIP, check details</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Today</font>",https://news.google.com/rss/articles/CBMixwFBVV95cUxPUWZHRVhMZUpPWTQzdmk2dzFJcVJXdlNSVXhwd2l0bmJzaXlQWU5faWVXNFdjeTIxdHByM2hkeGZzOGdDbzF6X19rSUZLd1BTTjF6em5Bc3U4azNrTzlGY2doWHU5OWdSUjhveml2Vk9yc0FTby1wXzBPWUU5YTBoUTNNSzlfOURabkJQX2loTnBFaGpVVDU1Ti0yOUJjaVRweHNsOEpuX1A5M3RtM1IxZzV2SEVzQ3pDUEUtQ2V0QkJJSktqaUFB0gHMAUFVX3lxTE5kVGFvOWx5Q0V3SEp3azhCLWNtXzQtVDBCLUsyNE1OaU1pMG9GWXc2Q001UnZJRW9vd0JZbldqYUxHcHNxLWtRZExPZWwtMFJqaWlJZ2xieEd4ejR2LTV6cndMVnRzUjJ3UWRYUDI1S25XaWlRZVVuNjRmWDAzX2tGeUNFelRfbm1NRUl1cC1jWHZkdUUwTXdGNUt1bFYxSVFRd2JwcWMzUjg5X1I3a0d2Q0Jxb2FJUF84TDFUNVgtN0lSUDdsc2Njc2I4Xw?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon raises ₹4,500 crore through its QIP — Here are the funds who were allocated shares - CNBC TV18","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon raises ₹4,500 crore through its QIP — Here are the funds who were allocated shares</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.148,0.148,positive,1.0
2025-06-20,2025-06-20 07:00:00,"BIOCON Outlook for the Week (June 30, 2025 – July 04, 2025) - Equitypandit","<a href=""https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KVkdnRUhKcHA0b200cHpzZmZIQWlVakxTWm9GZ2x5TVRqU25vb1ZTUkNRMkhpRWFCdG5UZlIxNkRmb0dxMXQ3M2F3eHU2SzZzRmZ5N0tkNmRjTTloOWdXUEx4X2ZiSzRw?oc=5"" target=""_blank"">BIOCON Outlook for the Week (June 30, 2025 – July 04, 2025)</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Equitypandit</font>",https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KVkdnRUhKcHA0b200cHpzZmZIQWlVakxTWm9GZ2x5TVRqU25vb1ZTUkNRMkhpRWFCdG5UZlIxNkRmb0dxMXQ3M2F3eHU2SzZzRmZ5N0tkNmRjTTloOWdXUEx4X2ZiSzRw?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon Raises Rs 4,500 Cr via QIP - Rediff MoneyWiz","<a href=""https://news.google.com/rss/articles/CBMijgFBVV95cUxOVldmb2VCWkJQRkZLSFRsbUFIWWJoSkJ1Q25CZE9EblMyTnFyUm9zMTNKOE9PVUtVNVFtUDFzZjVSdzhBM1JSc2VGS2dxRzNJQnVoa0FkQ093SFB3YlI2Sk1wVWNGR2Q3V251bk1iY2hpNmxnLUtkWEN2aGxwRURyV1QwbWoxLWVXQnUxSkhR0gGTAUFVX3lxTE9ja2szRXhMVkNjZC1oTXBTTGlCaTB0TzhJUmthMEhNVFdtWTFrRFd6MVUyaGVrQkRKZlF4Vm5zUjQ4c1JLdmI1OUVrbUhEc1MzMGEzczNMMFJtYmNoSGQ4U1NFOHY2UHdOZmo5dXVDTGFSSElRblJ5VENGUTFPZnk3c0cxYzJpREVPV003U1ZSMDlJWQ?oc=5"" target=""_blank"">Biocon Raises Rs 4,500 Cr via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Rediff MoneyWiz</font>",https://news.google.com/rss/articles/CBMijgFBVV95cUxOVldmb2VCWkJQRkZLSFRsbUFIWWJoSkJ1Q25CZE9EblMyTnFyUm9zMTNKOE9PVUtVNVFtUDFzZjVSdzhBM1JSc2VGS2dxRzNJQnVoa0FkQ093SFB3YlI2Sk1wVWNGR2Q3V251bk1iY2hpNmxnLUtkWEN2aGxwRURyV1QwbWoxLWVXQnUxSkhR0gGTAUFVX3lxTE9ja2szRXhMVkNjZC1oTXBTTGlCaTB0TzhJUmthMEhNVFdtWTFrRFd6MVUyaGVrQkRKZlF4Vm5zUjQ4c1JLdmI1OUVrbUhEc1MzMGEzczNMMFJtYmNoSGQ4U1NFOHY2UHdOZmo5dXVDTGFSSElRblJ5VENGUTFPZnk3c0cxYzJpREVPV003U1ZSMDlJWQ?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-20,2025-06-20 07:00:00,"Biocon raises Rs 4,500 crore via QIP - MSN","<a href=""https://news.google.com/rss/articles/CBMilAFBVV95cUxPNUhVQ2hZQzZyNDljT1FhbUd1YjNOZllLY2I1SmVYRjh5RnRvVWZ3bTBzLU4tZnZqZUJYZDR1ZUpPc2xpVzhYaU9RTW5FNjZ5VGlsOFhVdFhES2NIeFVMZWVIX1B0MlZ6cjJFczFBNGY5eDFoS1I5emUxZ2JpSW4wMW9rM0h4OERxSjQtRmx3RkJQVzlB?oc=5"" target=""_blank"">Biocon raises Rs 4,500 crore via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.com/rss/articles/CBMilAFBVV95cUxPNUhVQ2hZQzZyNDljT1FhbUd1YjNOZllLY2I1SmVYRjh5RnRvVWZ3bTBzLU4tZnZqZUJYZDR1ZUpPc2xpVzhYaU9RTW5FNjZ5VGlsOFhVdFhES2NIeFVMZWVIX1B0MlZ6cjJFczFBNGY5eDFoS1I5emUxZ2JpSW4wMW9rM0h4OERxSjQtRmx3RkJQVzlB?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-20,2025-06-20 07:00:00,"Stocks to watch today: Oswal Pumps, Biocon, United Spirits, Sai Life Sciences - India Today","<a href=""https://news.google.com/rss/articles/CBMihwJBVV95cUxOMkMtZm5ZTERsd3Q4ZmdXVTFvOVpKMV9iNHVJOG15SFZpM3YzSzRUNG8wZ05ORDkwLVh2dllTOTZqanVQYWZpQk40SzN0OFgxcC1tdEh5d1k0UV93Y2VHS3lKWUQ1VDh4bDZJWUVGTnEyX28tV3ZqT0NvX2FkS0o0ZW1DSmpKcnFhSk1SdERXVWdQWjhaeDRpeE5uRHNndWNmdG02R0M5SDVXMnNEU2luMGt5YjBlR2twSEoyMlJZV2UyRWdId1BBemlQcDZ0VnlOd1F3VU1SaHhnSjNaZGpMWUhGWnJ4ZnJzU2pzVVF2WEZzdHA0SHh4M0FLU01sc3M4ZkEzMUp3RdIBjAJBVV95cUxOZEs0c0NScXd3dk5XdThBSWZoRVI2MzBFNjVVb0x4UWV3U3FDZ3E3d0dfRXp6aE5ZMzQ1dldyQ19rWUhoOVMtZ3JSRmJMVnZwVmgzQk1EbFAzX3c2ZnZ6bTJaWjBLeXdtcUpFdWUxWEVfUm5zNmFEVFkxVEhPNjdRQ3dtbjdMWmsxcVZzclVDYkdONVlvWF9sTW5jelFMbi0xR2E3S3Z6SUxhZDE3aUNnY19yejU1VEhzUjNxV0lrLTlMR1VOalFmbkdWTUFmWGVQMlhnLVN1Q09XR2JZQUxBN3Zxb0VoOGlXcFBnYjVhWHd4UnU3dHd3aDV1alY4ZXJJMWM0bHRWaTI3MVZ3?oc=5"" target=""_blank"">Stocks to watch today: Oswal Pumps, Biocon, United Spirits, Sai Life Sciences</a>&nbsp;&nbsp;<font color=""#6f6f6f"">India Today</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.3404,0.3404,positive,1.0
2025-06-20,2025-06-20 07:00:00,Biocon - Positive Breakout: These 4 stocks cross above their 200 DMAs - The Economic Times,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcm9hQ1RfT2tJVEh6eU5fUjVyYVlzenk2emY2d2YwcXlQeks5aHlFbDMzQU1fSUx5dXM4MHQwcF9JRmdQNWt5NWJTelJjLXN2bXdrZWNsWkI5azlnb25qd2IwMzQ0UDhBb1BxZVliaGNkS1Rpb3ZQN0dhQUdsVjRROGd5SWtsYTJzdW84eTZJd2hwZGJRN0ZZRDNMZFpWUHBjQldDT0tibmlnMTRuYTVjSXV2ZW5KOEpLMmUtZ014akNDT0hSbno3RUFnRDgxdXVXUTljdA?oc=5"" target=""_blank"">Biocon - Positive Breakout: These 4 stocks cross above their 200 DMAs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPcm9hQ1RfT2tJVEh6eU5fUjVyYVlzenk2emY2d2YwcXlQeks5aHlFbDMzQU1fSUx5dXM4MHQwcF9JRmdQNWt5NWJTelJjLXN2bXdrZWNsWkI5azlnb25qd2IwMzQ0UDhBb1BxZVliaGNkS1Rpb3ZQN0dhQUdsVjRROGd5SWtsYTJzdW84eTZJd2hwZGJRN0ZZRDNMZFpWUHBjQldDT0tibmlnMTRuYTVjSXV2ZW5KOEpLMmUtZ014akNDT0hSbno3RUFnRDgxdXVXUTljdA?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.44847474747474747,0.44847474747474747,positive,1.0
2025-06-20,2025-06-20 07:00:00,"F&O Ban List: Biocon, Titagarh Rail among 7 stocks under trade ban on Friday - The Economic Times","<a href=""https://news.google.com/rss/articles/CBMi7wFBVV95cUxQR2RJbmpUVkl1bHhOMHd5SDNjY1BKR1hIX2dWUjduMEh1RkZwTFp4SU1OVmFSenYyU3BnTHUwN1FJTVdnUjdqcG9MeEtJYU5yQ3k1b210aGhNZVQ3TjRLN1hiaTBmM2NaeVdyZWhidjNCdkdVUDdFOTJNemNKZjJ0WDZiUkRFVlhLUl9tQkluLTBNVHR4VGdtbWtVMHhWSnFTT0pzVXJ4UC1HZExVOWYxLU82YmNKRGszZWRvX210NUtVS0FyekFRU1FtS3pIZ2czck8yZVN2Rll5N2NjRTlqNm51aGlFSUtfRHZHU0ZyWQ?oc=5"" target=""_blank"">F&amp;O Ban List: Biocon, Titagarh Rail among 7 stocks under trade ban on Friday</a>&nbsp;&nbsp;<font color=""#6f6f6f"">The Economic Times</font>",https://news.google.com/rss/articles/CBMi7wFBVV95cUxQR2RJbmpUVkl1bHhOMHd5SDNjY1BKR1hIX2dWUjduMEh1RkZwTFp4SU1OVmFSenYyU3BnTHUwN1FJTVdnUjdqcG9MeEtJYU5yQ3k1b210aGhNZVQ3TjRLN1hiaTBmM2NaeVdyZWhidjNCdkdVUDdFOTJNemNKZjJ0WDZiUkRFVlhLUl9tQkluLTBNVHR4VGdtbWtVMHhWSnFTT0pzVXJ4UC1HZExVOWYxLU82YmNKRGszZWRvX210NUtVS0FyekFRU1FtS3pIZ2czck8yZVN2Rll5N2NjRTlqNm51aGlFSUtfRHZHU0ZyWQ?oc=5,Google News - Market + Complete Company News,Biocon bonus shares,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.40188333333333337,-0.40188333333333337,negative,1.0
2025-06-21,2025-06-21 07:00:00,"Biocon raises Rs 4,500 crore via QIP - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon raises Rs 4,500 crore via QIP</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon dividend,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.0,0.0,neutral,1.0
2025-06-23,2025-06-23 07:00:00,No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal - CNBC TV18,"<a href=""https://news.google.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?oc=5"" target=""_blank"">No immediate plans for further stake sales or Biocon Biologics IPO: CEO Siddharth Mittal</a>&nbsp;&nbsp;<font color=""#6f6f6f"">CNBC TV18</font>",https://news.google.com/rss/articles/CBMisgFBVV95cUxQbUYxcjdzYzB3QWVyMHp4bTVvUEN1ei1mQzhzMHJyUXUwb1RDNlE4bXNEVTlSaDVqQV9zcWRzR1kyRUp4VlNLeEd3OS1JSXg4YWRkV2lRZmJPSm9fMXVING5SWWxQOGVMZkRsQ0k5ZWtjSmUwSmNtT2JSeDBDR0ozLThpOHZqdkdTQ3gxN1p2ZWNMYWVFdTcwSW1vOG5LSlpQNzNpb2pHYUE1d1Zqbm9LZDV30gG3AUFVX3lxTE9iVThYU1dveFFsU2Z2Wm1YclZhX3g5WnNlQ0o3SGpDaFNYUmNPRzV4Y2ZFVlZ3Y3dNZERJZjdhZHNwZFAtMkR6ZmFtdWdPZFA0a0dOMnlQZmJuRnlQYU9qRVZ1TVFWb1cyRlVBU2V5aGcyMVpRcWVQYjZqVG9LcldiLWtlVEdHWTdCOE5WZ0U4SU93RjNLa3B3NUI3UTFJRnU1TGJnRnlhZWg5bERtU3hhRGF2MnpENA?oc=5,Google News - Market + Complete Company News,Biocon promoter stake,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.148,-0.148,negative,1.0
2025-06-24,2025-06-24 04:41:44,National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved - BusinessToday Malaysia,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5"" target=""_blank"">National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.46085,-0.46085,negative,1.0
2025-06-24,2025-06-24 04:41:44,National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved - BusinessToday Malaysia,"<a href=""https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5"" target=""_blank"">National Cancer Malaysia Partners Biocon In Offering Affordable Cancer Care For The Underserved</a>&nbsp;&nbsp;<font color=""#6f6f6f"">BusinessToday Malaysia</font>",https://news.google.com/rss/articles/CBMi1wFBVV95cUxObllOQVNINDRHdkd6aWVtbGVJU24tZEwtcjN2NU9HUTM0S0UtdnVwcnBzVkVNRThQNHNQUDNwUm5hT01SbjR3THpyTnFuRUFNcTdUUXhxU0NNMTlOOVRZcTJmTkVheUZBbjNEdGRuOVNNZF9adGptR3h3ekZubjk2X3BDTkR2X3BUTjRQOUJiODFsdV8xTlJxQVNnZVBuN2Q0UkQ3c2J1WUg0Vlp1bXNrc29QdGVoUWhIYUEyTHprU0twRkRWTjVnRThCdTdBTnk4eUd6aC1lZw?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.46085,-0.46085,negative,1.0
2025-06-24,2025-06-24 06:35:18,Biocon Biologics partners Malaysia’s top cancer NGO for affordable cancer drugs - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxPSmNjSUpOR2xwcmZxN2ZwUTgyVEJUdHZBNjlxbFBMUjNFSFpmZzJscGRxMEJJVkNiSzc1SXpvNzRDZjB5Y0hOYlJnbjJseTFUNTUtZWNmcE9nbjlIQV8xVC16VDhSTjhpdUNFeWdWODFSZlJ1RW5pTzdteTc1aFNmYUlualJtX2JhWXlMMW1xLTh1WGdxaGNPdnJVSUJTZ0xlU0kzcVNZbEljTlNFRFZSc256NlR1eTItZG5rWDYzWE1Ob2V1ajY1RmRETVF0QXFMQU5sWg?oc=5"" target=""_blank"">Biocon Biologics partners Malaysia’s top cancer NGO for affordable cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPSmNjSUpOR2xwcmZxN2ZwUTgyVEJUdHZBNjlxbFBMUjNFSFpmZzJscGRxMEJJVkNiSzc1SXpvNzRDZjB5Y0hOYlJnbjJseTFUNTUtZWNmcE9nbjlIQV8xVC16VDhSTjhpdUNFeWdWODFSZlJ1RW5pTzdteTc1aFNmYUlualJtX2JhWXlMMW1xLTh1WGdxaGNPdnJVSUJTZ0xlU0kzcVNZbEljTlNFRFZSc256NlR1eTItZG5rWDYzWE1Ob2V1ajY1RmRETVF0QXFMQU5sWg?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.30918333333333337,-0.30918333333333337,negative,1.0
2025-06-24,2025-06-24 06:35:18,Biocon Biologics partners Malaysia’s top cancer NGO for affordable cancer drugs - financialexpress.com,"<a href=""https://news.google.com/rss/articles/CBMi1AFBVV95cUxPSmNjSUpOR2xwcmZxN2ZwUTgyVEJUdHZBNjlxbFBMUjNFSFpmZzJscGRxMEJJVkNiSzc1SXpvNzRDZjB5Y0hOYlJnbjJseTFUNTUtZWNmcE9nbjlIQV8xVC16VDhSTjhpdUNFeWdWODFSZlJ1RW5pTzdteTc1aFNmYUlualJtX2JhWXlMMW1xLTh1WGdxaGNPdnJVSUJTZ0xlU0kzcVNZbEljTlNFRFZSc256NlR1eTItZG5rWDYzWE1Ob2V1ajY1RmRETVF0QXFMQU5sWg?oc=5"" target=""_blank"">Biocon Biologics partners Malaysia’s top cancer NGO for affordable cancer drugs</a>&nbsp;&nbsp;<font color=""#6f6f6f"">financialexpress.com</font>",https://news.google.com/rss/articles/CBMi1AFBVV95cUxPSmNjSUpOR2xwcmZxN2ZwUTgyVEJUdHZBNjlxbFBMUjNFSFpmZzJscGRxMEJJVkNiSzc1SXpvNzRDZjB5Y0hOYlJnbjJseTFUNTUtZWNmcE9nbjlIQV8xVC16VDhSTjhpdUNFeWdWODFSZlJ1RW5pTzdteTc1aFNmYUlualJtX2JhWXlMMW1xLTh1WGdxaGNPdnJVSUJTZ0xlU0kzcVNZbEljTlNFRFZSc256NlR1eTItZG5rWDYzWE1Ob2V1ajY1RmRETVF0QXFMQU5sWg?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.30918333333333337,-0.30918333333333337,negative,1.0
2025-06-24,2025-06-24 15:01:23,"Biocon Biologics Collaborates With National Cancer Society Malaysia, Rolls Out Program To Expand Affordable Access to Biosimilars - TheCSRUniverse","<a href=""https://news.google.com/rss/articles/CBMi9wFBVV95cUxPRzNCY3J0aFpwS19abXNIb1c1NUtJTENEbVVfSDB4d3h5QlJ1bHYyYzhPMjNMS2dqbU5SSDhsc0Q1c0l4bTVsVHhRX3ZxN193VExNeVhubE1PY29odFVjOHZXSzlkWVdtbnJfbzJUZVktdG1uNWtySUlFMkFuVUU2OXh4R0dSX2NQZDFKeU1pWXJzejFWRFVoOG1EaDI0VVExcGNlOFdGMjlGQlpFYXBRVnhTWnlPZ0hTV2VlYTd4MnJJSUI2SklZRUFtZmg2aFY2dlpXMUFDT2hrMmtpcnpwYjNmYWF5ZkVvYU80eFZmZXBLXzZqNFdv?oc=5"" target=""_blank"">Biocon Biologics Collaborates With National Cancer Society Malaysia, Rolls Out Program To Expand Affordable Access to Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TheCSRUniverse</font>",https://news.google.com/rss/articles/CBMi9wFBVV95cUxPRzNCY3J0aFpwS19abXNIb1c1NUtJTENEbVVfSDB4d3h5QlJ1bHYyYzhPMjNMS2dqbU5SSDhsc0Q1c0l4bTVsVHhRX3ZxN193VExNeVhubE1PY29odFVjOHZXSzlkWVdtbnJfbzJUZVktdG1uNWtySUlFMkFuVUU2OXh4R0dSX2NQZDFKeU1pWXJzejFWRFVoOG1EaDI0VVExcGNlOFdGMjlGQlpFYXBRVnhTWnlPZ0hTV2VlYTd4MnJJSUI2SklZRUFtZmg2aFY2dlpXMUFDT2hrMmtpcnpwYjNmYWF5ZkVvYU80eFZmZXBLXzZqNFdv?oc=5,Google News - Market + Complete Company News,Biocon collaboration,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.36755,-0.36755,negative,1.0
2025-06-24,2025-06-24 15:16:45,"Biocon's ₹4,500 crore equity raise to reduce debt by FY26, says S&P - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's ₹4,500 crore equity raise to reduce debt by FY26, says S&amp;P</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2025-06-24,2025-06-24 15:16:45,"Biocon's ₹4,500 crore equity raise to reduce debt by FY26, says S&P - Business Standard","<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon's ₹4,500 crore equity raise to reduce debt by FY26, says S&amp;P</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Business Standard</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon rating upgrade,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,-0.3062,-0.3062,negative,1.0
2025-06-24,2025-06-24 19:07:39,Biocon shares in focus after launching QIP at floor price of Rs 340.20 - MSN,"<a href=""https://news.google.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?oc=5"" target=""_blank"">Biocon shares in focus after launching QIP at floor price of Rs 340.20</a>&nbsp;&nbsp;<font color=""#6f6f6f"">MSN</font>",https://news.google.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?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.26335,0.26335,positive,1.0
2025-06-25,2025-06-25 05:09:00,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5,Google News - Market + Complete Company News,Biocon quarterly results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49368333333333336,0.49368333333333336,positive,1.0
2025-06-25,2025-06-25 05:09:00,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5,Google News - Market + Complete Company News,Biocon revenue,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49368333333333336,0.49368333333333336,positive,1.0
2025-06-25,2025-06-25 05:09:00,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5,Google News - Market + Complete Company News,Biocon financial results,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49368333333333336,0.49368333333333336,positive,1.0
2025-06-25,2025-06-25 05:09:00,"Biocon Shares Gain Amid High Volume, Up by 0.47% - TradingView","<a href=""https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5"" target=""_blank"">Biocon Shares Gain Amid High Volume, Up by 0.47%</a>&nbsp;&nbsp;<font color=""#6f6f6f"">TradingView</font>",https://news.google.com/rss/articles/CBMirgFBVV95cUxNMUV4NjAwQWRUUmNka1VNVDh1ZXpMTTRzaklTZXZlVXhqRXRVYUQwelVlYWprSDZHbGFqRUhScmlNY0ZJeF9fdkdabnJFLWU1QkZtUUxvSU00UUw2RUtDdHVoWXlUWUhJck9LVHZpYkNidl9PWFpfNTlPc1RwdFZjQ0pHeVRiQ3F3MEE4ZWdJMlFuMzFveXVzWnRZX2xqVGZzN0swR29JcWJDQkFpb1E?oc=5,Google News - Market + Complete Company News,Biocon stock price,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.49368333333333336,0.49368333333333336,positive,1.0
2025-06-25,2025-06-25 07:10:15,Biocon Collaborates With NCSM To Expand Affordable Access To Biosimilars - Galen Centre,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQdy1tMFJENTFDVHhfbThFdWRZN1VXN1g2WUZyWkpmSU5ad3FCMnM0RjZwVkpxU09tOThYSEpTRnNWTWFPQ2hlQ1lrb0hCZE5YRG5oelhNQkxoaFB1SDZBZzBaZnRGcTc5bDVUX0psNXkzd1BPaUFrYkV2R1lNbmZUN0xDUUUzNjJwaVJzWmxIOEY0V1FpTmNmYndMd0EteVdETVY2TXhrXzZuVEZ0S25nWkVicFM?oc=5"" target=""_blank"">Biocon Collaborates With NCSM To Expand Affordable Access To Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQdy1tMFJENTFDVHhfbThFdWRZN1VXN1g2WUZyWkpmSU5ad3FCMnM0RjZwVkpxU09tOThYSEpTRnNWTWFPQ2hlQ1lrb0hCZE5YRG5oelhNQkxoaFB1SDZBZzBaZnRGcTc5bDVUX0psNXkzd1BPaUFrYkV2R1lNbmZUN0xDUUUzNjJwaVJzWmxIOEY0V1FpTmNmYndMd0EteVdETVY2TXhrXzZuVEZ0S25nWkVicFM?oc=5,Google News - Market + Complete Company News,Biocon partnership,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
2025-06-25,2025-06-25 07:10:15,Biocon Collaborates With NCSM To Expand Affordable Access To Biosimilars - Galen Centre,"<a href=""https://news.google.com/rss/articles/CBMitAFBVV95cUxQdy1tMFJENTFDVHhfbThFdWRZN1VXN1g2WUZyWkpmSU5ad3FCMnM0RjZwVkpxU09tOThYSEpTRnNWTWFPQ2hlQ1lrb0hCZE5YRG5oelhNQkxoaFB1SDZBZzBaZnRGcTc5bDVUX0psNXkzd1BPaUFrYkV2R1lNbmZUN0xDUUUzNjJwaVJzWmxIOEY0V1FpTmNmYndMd0EteVdETVY2TXhrXzZuVEZ0S25nWkVicFM?oc=5"" target=""_blank"">Biocon Collaborates With NCSM To Expand Affordable Access To Biosimilars</a>&nbsp;&nbsp;<font color=""#6f6f6f"">Galen Centre</font>",https://news.google.com/rss/articles/CBMitAFBVV95cUxQdy1tMFJENTFDVHhfbThFdWRZN1VXN1g2WUZyWkpmSU5ad3FCMnM0RjZwVkpxU09tOThYSEpTRnNWTWFPQ2hlQ1lrb0hCZE5YRG5oelhNQkxoaFB1SDZBZzBaZnRGcTc5bDVUX0psNXkzd1BPaUFrYkV2R1lNbmZUN0xDUUUzNjJwaVJzWmxIOEY0V1FpTmNmYndMd0EteVdETVY2TXhrXzZuVEZ0S25nWkVicFM?oc=5,Google News - Market + Complete Company News,Biocon expansion,Market + Complete Company News,2021-01-01_to_2025-06-26,Other,Other,Other,1,False,True,0.2787,0.2787,positive,1.0
